Clustering O 0 0.18405155837535858
of O 0 0.033733006566762924
missense O 1 0.8276121616363525
mutations O 1 0.6465530395507812
in O 0 0.019348450005054474
the O 0 0.02365720085799694
ataxia B-Disease 1 0.9999788999557495
- I-Disease 1 0.9964917302131653
telangiectasia I-Disease 1 0.9997238516807556
gene O 0 0.1652335673570633
in O 0 0.01477760262787342
a O 0 0.02040364034473896
sporadic B-Disease 0 0.3639870285987854
T I-Disease 1 0.997627317905426
- I-Disease 1 0.9593733549118042
cell I-Disease 1 0.9372796416282654
leukaemia I-Disease 1 0.9995558857917786
. O 0 0.04563102498650551

Ataxia B-Disease 1 0.9999730587005615
- I-Disease 1 0.99796462059021
telangiectasia I-Disease 1 0.9996970891952515
( O 0 0.046863995492458344
A B-Disease 0 0.034807220101356506
- I-Disease 1 0.7793335914611816
T I-Disease 1 0.9882992506027222
) O 0 0.014191378839313984
is O 0 0.008642931468784809
a O 0 0.01248148549348116
recessive B-Disease 1 0.9991311430931091
multi I-Disease 1 0.9807687401771545
- I-Disease 1 0.9952391386032104
system I-Disease 1 0.7923856377601624
disorder I-Disease 1 0.9999750852584839
caused O 0 0.42373257875442505
by O 0 0.013232605531811714
mutations O 0 0.1693027913570404
in O 0 0.009287631139159203
the O 0 0.012906991876661777
ATM O 0 0.06112538278102875
gene O 0 0.059182558208703995
at O 0 0.021976226940751076
11q22 O 0 0.3667331337928772
- O 0 0.30779027938842773
q23 O 0 0.2518436014652252
( O 0 0.021417228505015373
ref O 0 0.06061531975865364
. O 0 0.011320220306515694
3 O 0 0.01659364439547062
) O 0 0.017406808212399483
. O 0 0.020911958068609238

The O 0 0.03176387399435043
risk O 1 0.677390456199646
of O 0 0.0172163974493742
cancer B-Disease 1 0.9996882677078247
, O 0 0.014014717191457748
especially O 0 0.02448081597685814
lymphoid B-Disease 1 0.9782289862632751
neoplasias I-Disease 0 0.49641770124435425
, O 0 0.009570859372615814
is O 0 0.007545416243374348
substantially O 0 0.01742691546678543
elevated O 0 0.025660013779997826
in O 0 0.00787496380507946
A B-Disease 0 0.016312140971422195
- I-Disease 1 0.9874544143676758
T I-Disease 1 0.9998487234115601
patients O 1 0.9966347813606262
and O 0 0.006645499728620052
has O 0 0.006933764088898897
long O 0 0.00990874320268631
been O 0 0.007552152965217829
associated O 0 0.014393649064004421
with O 0 0.014100859872996807
chromosomal O 1 0.9950932264328003
instability O 1 0.9811920523643494
. O 0 0.03977075219154358

By O 0 0.04763626307249069
analysing O 0 0.20158496499061584
tumour B-Disease 1 0.9996515512466431
DNA O 0 0.07063190639019012
from O 0 0.018483515828847885
patients O 1 0.9974594712257385
with O 0 0.01708676852285862
sporadic B-Disease 1 0.7826077938079834
T I-Disease 1 0.9989656209945679
- I-Disease 1 0.9819911122322083
cell I-Disease 1 0.9852521419525146
prolymphocytic I-Disease 1 0.9992877840995789
leukaemia I-Disease 1 0.999992847442627
( O 1 0.56111741065979
T B-Disease 1 0.9989066123962402
- I-Disease 1 0.9270614981651306
PLL I-Disease 1 0.9961909055709839
) O 0 0.01592455431818962
, O 0 0.008544395677745342
a O 0 0.011706429533660412
rare O 0 0.03488912433385849
clonal B-Disease 1 0.784105658531189
malignancy I-Disease 1 0.992479681968689
with O 0 0.01208982802927494
similarities O 0 0.02357703261077404
to O 0 0.008457990363240242
a O 0 0.01333643775433302
mature B-Disease 0 0.3295098841190338
T I-Disease 1 0.9968697428703308
- I-Disease 1 0.9128449559211731
cell I-Disease 1 0.8478711247444153
leukaemia I-Disease 1 0.9997856020927429
seen O 0 0.01769544929265976
in O 0 0.0092055294662714
A B-Disease 0 0.016841500997543335
- I-Disease 1 0.5757754445075989
T I-Disease 1 0.971710205078125
, O 0 0.0070848530158400536
we O 0 0.004589866381138563
demonstrate O 0 0.00924607738852501
a O 0 0.006402316503226757
high O 0 0.009890579618513584
frequency O 0 0.017786404117941856
of O 0 0.008570173755288124
ATM O 0 0.06233740597963333
mutations O 0 0.4572369158267975
in O 0 0.01728993095457554
T B-Disease 1 0.9844455122947693
- I-Disease 1 0.7066102623939514
PLL I-Disease 1 0.9838038086891174
. O 0 0.042100414633750916

In O 0 0.02160549722611904
marked O 0 0.026384877040982246
contrast O 0 0.02073683589696884
to O 0 0.009072571061551571
the O 0 0.01176538411527872
ATM O 0 0.06914996355772018
mutation O 0 0.4548138976097107
pattern O 0 0.032653871923685074
in O 0 0.008708066307008266
A B-Disease 0 0.01619693636894226
- I-Disease 1 0.6175099015235901
T I-Disease 1 0.9726541638374329
, O 0 0.006890903692692518
the O 0 0.0053136167116463184
most O 0 0.006495773326605558
frequent O 0 0.020194265991449356
nucleotide O 0 0.03008120507001877
changes O 0 0.011530578136444092
in O 0 0.008076915517449379
this O 0 0.011055015958845615
leukaemia B-Disease 1 0.9991625547409058
were O 0 0.019671566784381866
missense O 1 0.8283348083496094
mutations O 1 0.7838048338890076
. O 0 0.04352413862943649

These O 0 0.0193644892424345
clustered O 0 0.031815364956855774
in O 0 0.007713415194302797
the O 0 0.006341816857457161
region O 0 0.010753863491117954
corresponding O 0 0.008902282454073429
to O 0 0.00510771619156003
the O 0 0.006077504716813564
kinase O 0 0.04432574659585953
domain O 0 0.012718857266008854
, O 0 0.004843140486627817
which O 0 0.004195543006062508
is O 0 0.00497833825647831
highly O 0 0.009493296965956688
conserved O 0 0.01493353396654129
in O 0 0.0072114369831979275
ATM O 0 0.04003668203949928
- O 0 0.0322716161608696
related O 0 0.018289238214492798
proteins O 0 0.01953643374145031
in O 0 0.008350146003067493
mouse O 0 0.04699566960334778
, O 0 0.012939093634486198
yeast O 0 0.06240449845790863
and O 0 0.016058506444096565
Drosophila O 0 0.07756412029266357
. O 0 0.033297061920166016

The O 0 0.032343197613954544
resulting O 0 0.05391530692577362
amino O 0 0.052063774317502975
- O 0 0.0920705646276474
acid O 0 0.06541285663843155
substitutions O 0 0.029461724683642387
are O 0 0.00769921625033021
predicted O 0 0.015317714773118496
to O 0 0.006908992305397987
interfere O 0 0.020565208047628403
with O 0 0.00990484282374382
ATP O 0 0.04100658372044563
binding O 0 0.026391802355647087
or O 0 0.01585269533097744
substrate O 0 0.04539037495851517
recognition O 0 0.03376379609107971
. O 0 0.026157742366194725

Two O 0 0.0225361455231905
of O 0 0.01677975431084633
seventeen O 0 0.04007755219936371
mutated O 1 0.8148618340492249
T B-Disease 1 0.992547333240509
- I-Disease 1 0.5966680645942688
PLL I-Disease 1 0.9724250435829163
samples O 0 0.024946052581071854
had O 0 0.00879450049251318
a O 0 0.008197305724024773
previously O 0 0.009418371133506298
reported O 0 0.01686316356062889
A B-Disease 0 0.02396586909890175
- I-Disease 1 0.6238941550254822
T I-Disease 1 0.9936519861221313
allele O 1 0.5230600237846375
. O 0 0.0419795997440815

In O 0 0.02684982307255268
contrast O 0 0.031223293393850327
, O 0 0.010834411717951298
no O 0 0.012888840399682522
mutations O 0 0.07264108955860138
were O 0 0.007440592627972364
detected O 0 0.022600263357162476
in O 0 0.006827096454799175
the O 0 0.009402787312865257
p53 O 0 0.22474299371242523
gene O 0 0.06261901557445526
, O 0 0.009021277539432049
suggesting O 0 0.015425103716552258
that O 0 0.006475029047578573
this O 0 0.009857341647148132
tumour B-Disease 1 0.9996545314788818
suppressor O 1 0.8067417740821838
is O 0 0.009432760067284107
not O 0 0.006857601460069418
frequently O 0 0.014992746524512768
altered O 0 0.019920555874705315
in O 0 0.009281719103455544
this O 0 0.012482814490795135
leukaemia B-Disease 1 0.9990981817245483
. O 0 0.030295800417661667

Occasional O 0 0.13410323858261108
missense O 1 0.6870285868644714
mutations O 0 0.261772483587265
in O 0 0.01836969517171383
ATM O 0 0.04380699247121811
were O 0 0.008318673819303513
also O 0 0.00690776202827692
found O 0 0.009705726988613605
in O 0 0.010226503014564514
tumour B-Disease 1 0.9994829893112183
DNA O 0 0.033295560628175735
from O 0 0.012280857190489769
patients O 1 0.9846007227897644
with O 0 0.011857070028781891
B B-Disease 0 0.48010337352752686
- I-Disease 1 0.6437282562255859
cell I-Disease 1 0.5792773365974426
non I-Disease 0 0.449856162071228
- I-Disease 1 0.9987175464630127
Hodgkins I-Disease 1 0.9999969005584717
lymphomas I-Disease 1 0.9999446868896484
( O 0 0.04397282376885414
B B-Disease 0 0.17400729656219482
- I-Disease 0 0.05139509588479996
NHL I-Disease 0 0.029727865010499954
) O 0 0.009876679629087448
and O 0 0.006391451228410006
a O 0 0.008893238380551338
B B-Disease 0 0.03427591174840927
- I-Disease 0 0.04117991775274277
NHL I-Disease 0 0.047579098492860794
cell O 0 0.0478082112967968
line O 0 0.028004178777337074
. O 0 0.023412147536873817

The O 0 0.01550438441336155
evidence O 0 0.0126620102673769
of O 0 0.005421782843768597
a O 0 0.0065120793879032135
significant O 0 0.008944917470216751
proportion O 0 0.012953169643878937
of O 0 0.0054953088983893394
loss O 0 0.02160850539803505
- O 0 0.022830704227089882
of O 0 0.007545587606728077
- O 0 0.03844776004552841
function O 0 0.018574880436062813
mutations O 0 0.0471346490085125
and O 0 0.004683604929596186
a O 0 0.005145582836121321
complete O 0 0.00666656531393528
absence O 0 0.008383037522435188
of O 0 0.0030784939881414175
the O 0 0.00379329826682806
normal O 0 0.010796650312840939
copy O 0 0.010257558897137642
of O 0 0.004778390750288963
ATM O 0 0.019711606204509735
in O 0 0.004380867816507816
the O 0 0.004601597785949707
majority O 0 0.011896119453012943
of O 0 0.009275775402784348
mutated O 1 0.9434819221496582
tumours B-Disease 1 0.9998610019683838
establishes O 1 0.5810253620147705
somatic O 1 0.8968105316162109
inactivation O 0 0.2596747875213623
of O 0 0.007722664624452591
this O 0 0.006353185977786779
gene O 0 0.0241900272667408
in O 0 0.005843868479132652
the O 0 0.007084087934345007
pathogenesis O 1 0.9744150042533875
of O 0 0.010494893416762352
sporadic B-Disease 0 0.34314432740211487
T I-Disease 1 0.9979952573776245
- I-Disease 1 0.8297668099403381
PLL I-Disease 1 0.9881696701049805
and O 0 0.011190122924745083
suggests O 0 0.021724296733736992
that O 0 0.008408722467720509
ATM O 0 0.03943566605448723
acts O 0 0.013496574945747852
as O 0 0.009361544623970985
a O 0 0.02152627892792225
tumour B-Disease 1 0.999452531337738
suppressor O 1 0.9636847972869873
. O 0 0.048223529011011124

As O 0 0.020333407446742058
constitutional O 0 0.01868152804672718
DNA O 0 0.02445678785443306
was O 0 0.006502095144242048
not O 0 0.004432957153767347
available O 0 0.005703264381736517
, O 0 0.005171834025532007
a O 0 0.008131997659802437
putative O 0 0.131000354886055
hereditary O 1 0.973021924495697
predisposition O 1 0.9950993657112122
to O 0 0.01912042312324047
T B-Disease 1 0.9952297210693359
- I-Disease 1 0.6791858673095703
PLL I-Disease 1 0.9902600646018982
will O 0 0.011909419670701027
require O 0 0.01601562462747097
further O 0 0.01061263307929039
investigation O 0 0.01655018888413906
. O 0 0.012128862552344799
. O 0 0.01838853769004345

Myotonic B-Disease 1 0.9999804496765137
dystrophy I-Disease 1 0.9999942779541016
protein O 0 0.45329412817955017
kinase O 0 0.4747779369354248
is O 0 0.011059626936912537
involved O 0 0.010225898586213589
in O 0 0.00566659402102232
the O 0 0.006108738016337156
modulation O 0 0.03274689242243767
of O 0 0.007278120145201683
the O 0 0.013582054525613785
Ca2 O 1 0.9814311265945435
+ O 1 0.6095114350318909
homeostasis O 1 0.9127761125564575
in O 0 0.025367842987179756
skeletal O 1 0.9975444674491882
muscle O 1 0.9988923668861389
cells O 1 0.8488901853561401
. O 0 0.03950303792953491

Myotonic B-Disease 1 0.9999945163726807
dystrophy I-Disease 1 0.9999994039535522
( O 1 0.9820599555969238
DM B-Disease 1 0.9999724626541138
) O 0 0.020512806251645088
, O 0 0.008003062568604946
the O 0 0.007455228827893734
most O 0 0.010757284238934517
prevalent O 1 0.9745213985443115
muscular B-Disease 1 0.9999818801879883
disorder I-Disease 1 0.9999754428863525
in O 0 0.010780385695397854
adults O 0 0.21210430562496185
, O 0 0.006717380601912737
is O 0 0.006009523291140795
caused O 0 0.01936020329594612
by O 0 0.007406098768115044
( O 0 0.0169475506991148
CTG O 1 0.6688560843467712
) O 0 0.017395799979567528
n O 0 0.026088856160640717
- O 0 0.033162184059619904
repeat O 0 0.03217056766152382
expansion O 0 0.017220910638570786
in O 0 0.008359351195394993
a O 0 0.01101125031709671
gene O 0 0.04331963509321213
encoding O 0 0.035209886729717255
a O 0 0.019985118880867958
protein O 0 0.06210090219974518
kinase O 1 0.900540828704834
( O 0 0.06829454004764557
DM B-Disease 1 0.9998674392700195
protein O 0 0.14518515765666962
kinase O 1 0.7689879536628723
; O 0 0.021391354501247406
DMPK O 0 0.20557597279548645
) O 0 0.010949626564979553
and O 0 0.006313090678304434
involves O 0 0.01729733869433403
changes O 0 0.014225280843675137
in O 0 0.008986991830170155
cytoarchitecture O 0 0.2001328319311142
and O 0 0.01619672402739525
ion O 0 0.12891070544719696
homeostasis O 1 0.7767183780670166
. O 0 0.02988109178841114

To O 0 0.018779711797833443
obtain O 0 0.022353192791342735
clues O 0 0.020555460825562477
to O 0 0.006914615165442228
the O 0 0.005979734938591719
normal O 0 0.015621114522218704
biological O 0 0.013611676171422005
role O 0 0.01159594114869833
of O 0 0.007695075124502182
DMPK O 0 0.10230842232704163
in O 0 0.009961151517927647
cellular O 0 0.03970951959490776
ion O 0 0.1278270184993744
homeostasis O 0 0.36144036054611206
, O 0 0.008419853635132313
we O 0 0.005670050624758005
have O 0 0.005784520413726568
compared O 0 0.010125439614057541
the O 0 0.008029874414205551
resting O 0 0.04947356879711151
[ O 0 0.04610804095864296
Ca2 O 1 0.9761161208152771
+ O 0 0.22075673937797546
] O 0 0.02705300785601139
i O 0 0.008580941706895828
, O 0 0.005057221278548241
the O 0 0.005249486304819584
amplitude O 0 0.022838609293103218
and O 0 0.006678265053778887
shape O 0 0.021008454263210297
of O 0 0.01126403920352459
depolarization O 1 0.9950220584869385
- O 1 0.986525297164917
induced O 1 0.9991208910942078
Ca2 O 1 0.9979854822158813
+ O 1 0.6571924090385437
transients O 0 0.4313696026802063
, O 0 0.006643389817327261
and O 0 0.0038352222181856632
the O 0 0.00421604048460722
content O 0 0.006532416213303804
of O 0 0.006308485753834248
ATP O 0 0.039733514189720154
- O 0 0.04130232334136963
driven O 0 0.034031786024570465
ion O 0 0.06042272225022316
pumps O 0 0.052922945469617844
in O 0 0.014112862758338451
cultured O 1 0.5670908093452454
skeletal O 1 0.9972770810127258
muscle O 1 0.9978455305099487
cells O 0 0.18251898884773254
of O 0 0.009937957860529423
wild O 0 0.025985252112150192
- O 0 0.046446867287158966
type O 0 0.029002105817198753
and O 0 0.01299781259149313
DMPK O 1 0.9636638164520264
[ O 0 0.1462813764810562
- O 1 0.8998320698738098
/ O 1 0.9869044423103333
- O 0 0.3843202292919159
] O 0 0.10126698017120361
knockout O 0 0.3035553991794586
mice O 0 0.458611398935318
. O 0 0.037395231425762177

In O 0 0.04595736414194107
vitro O 0 0.18246689438819885
- O 0 0.3214041292667389
differentiated O 1 0.6518715023994446
DMPK O 1 0.9927005767822266
[ O 0 0.4244500398635864
- O 1 0.9507696032524109
/ O 1 0.9920125603675842
- O 1 0.532377302646637
] O 0 0.06631500273942947
myotubes O 0 0.17441140115261078
exhibit O 0 0.026171568781137466
a O 0 0.012242335826158524
higher O 0 0.01984657347202301
resting O 0 0.05438580363988876
[ O 0 0.06536059826612473
Ca2 O 1 0.9730460047721863
+ O 0 0.30866971611976624
] O 0 0.03583433851599693
i O 0 0.010091729462146759
than O 0 0.0056309509091079235
do O 0 0.007245580665767193
wild O 0 0.014907876029610634
- O 0 0.03631337732076645
type O 0 0.024771232157945633
myotubes O 0 0.06381432712078094
because O 0 0.008770204149186611
of O 0 0.004931832198053598
an O 0 0.006252199411392212
altered O 0 0.016902096569538116
open O 0 0.01509113609790802
probability O 0 0.020322225987911224
of O 0 0.009583545848727226
voltage O 0 0.03964317589998245
- O 0 0.05730106681585312
dependent O 0 0.05250036343932152
l O 1 0.8919153213500977
- O 1 0.5793281197547913
type O 0 0.2480146586894989
Ca2 O 1 0.97728431224823
+ O 0 0.19170163571834564
and O 0 0.017337149009108543
Na O 1 0.5595611929893494
+ O 0 0.07787857204675674
channels O 0 0.04325494170188904
. O 0 0.027336662635207176

The O 0 0.03302871063351631
mutant O 0 0.09429778903722763
myotubes O 0 0.15591366589069366
exhibit O 0 0.04022550955414772
smaller O 0 0.01960695907473564
and O 0 0.012654298916459084
slower O 0 0.03691530227661133
Ca2 O 1 0.9460135698318481
+ O 0 0.10063806176185608
responses O 0 0.03295763209462166
upon O 0 0.012780767865478992
triggering O 0 0.038324590772390366
by O 0 0.012698102742433548
acetylcholine O 0 0.06693432480096817
or O 0 0.015983980149030685
high O 0 0.021290723234415054
external O 0 0.033987611532211304
K O 0 0.08689264953136444
+ O 0 0.08704911917448044
. O 0 0.02900056354701519

In O 0 0.016927793622016907
addition O 0 0.013656617142260075
, O 0 0.0069295624271035194
we O 0 0.0064301094971597195
observed O 0 0.011885215528309345
that O 0 0.005450600292533636
these O 0 0.00902433879673481
Ca2 O 1 0.9283956289291382
+ O 0 0.49560797214508057
transients O 1 0.7815203666687012
partially O 0 0.027914952486753464
result O 0 0.01430805679410696
from O 0 0.007626357953995466
an O 0 0.006486726459115744
influx O 0 0.025995468720793724
of O 0 0.011462305672466755
extracellular O 0 0.05566307529807091
Ca2 O 1 0.796390175819397
+ O 0 0.05116583779454231
through O 0 0.01442679949104786
the O 0 0.011655081994831562
l O 1 0.6454905271530151
- O 0 0.2957194447517395
type O 0 0.09790059924125671
Ca2 O 1 0.8978107571601868
+ O 0 0.09229929745197296
channel O 0 0.04849473387002945
. O 0 0.03302079439163208

Neither O 0 0.040308959782123566
the O 0 0.012577882036566734
content O 0 0.01570860482752323
nor O 0 0.01590593531727791
the O 0 0.007621105294674635
activity O 0 0.016842151060700417
of O 0 0.013042409904301167
Na O 1 0.9168211221694946
+ O 1 0.8379520177841187
/ O 1 0.9385830760002136
K O 0 0.2858341634273529
+ O 0 0.31210416555404663
ATPase O 1 0.8880230784416199
and O 0 0.026793885976076126
sarcoplasmic O 1 0.9966264963150024
reticulum O 1 0.9964314699172974
Ca2 O 1 0.9958876967430115
+ O 1 0.8987621068954468
- O 0 0.4801523983478546
ATPase O 1 0.850541889667511
are O 0 0.01609247550368309
affected O 0 0.03813501074910164
by O 0 0.017095323652029037
DMPK O 0 0.4856400191783905
absence O 0 0.045298729091882706
. O 0 0.028723182156682014

In O 0 0.018317796289920807
conclusion O 0 0.019182367250323296
, O 0 0.008352989330887794
our O 0 0.007583949249237776
data O 0 0.00783180445432663
suggest O 0 0.012021766975522041
that O 0 0.006368537899106741
DMPK O 0 0.036597803235054016
is O 0 0.006378872785717249
involved O 0 0.007873093709349632
in O 0 0.006068754475563765
modulating O 0 0.04054861143231392
the O 0 0.00726696290075779
initial O 0 0.014246759004890919
events O 0 0.01159537211060524
of O 0 0.00854580570012331
excitation O 0 0.19493256509304047
- O 1 0.5225962400436401
contraction O 1 0.5815051794052124
coupling O 0 0.08621000498533249
in O 0 0.019526615738868713
skeletal O 1 0.9916613101959229
muscle O 1 0.9909548163414001
. O 0 0.021220121532678604
. O 0 0.02672259882092476

Constitutional O 0 0.09798108041286469
RB1 O 1 0.9988260865211487
- O 1 0.9778559803962708
gene O 1 0.9266241788864136
mutations O 1 0.9811727404594421
in O 0 0.022532686591148376
patients O 1 0.9979935884475708
with O 0 0.02060610242187977
isolated O 0 0.2050590068101883
unilateral B-Disease 0 0.37939172983169556
retinoblastoma I-Disease 1 0.9973951578140259
. O 0 0.04063267260789871

In O 0 0.02789638563990593
most O 0 0.02042473666369915
patients O 1 0.9882537126541138
with O 0 0.016528654843568802
isolated O 0 0.3458574712276459
unilateral B-Disease 1 0.7774111032485962
retinoblastoma I-Disease 1 0.9997819066047668
, O 0 0.02298751473426819
tumor B-Disease 1 0.9968942403793335
development O 0 0.01581358164548874
is O 0 0.007755456026643515
initiated O 0 0.018774325028061867
by O 0 0.008814175613224506
somatic O 0 0.08300793915987015
inactivation O 0 0.05235769972205162
of O 0 0.006060453597456217
both O 0 0.008098061196506023
alleles O 0 0.05590156465768814
of O 0 0.009570792317390442
the O 0 0.017736656591296196
RB1 O 1 0.9948320388793945
gene O 0 0.19443245232105255
. O 0 0.038730986416339874

However O 0 0.019855745136737823
, O 0 0.008212508633732796
some O 0 0.00605378532782197
of O 0 0.005481041967868805
these O 0 0.008060123771429062
patients O 1 0.9875215888023376
can O 0 0.015776578336954117
transmit O 0 0.11594238877296448
retinoblastoma B-Disease 1 0.9986670017242432
predisposition O 1 0.9648184180259705
to O 0 0.011842669919133186
their O 0 0.012847288511693478
offspring O 0 0.05783361569046974
. O 0 0.027720065787434578

To O 0 0.01647656410932541
determine O 0 0.016025206074118614
the O 0 0.008610978722572327
frequency O 0 0.018039574846625328
and O 0 0.005583218298852444
nature O 0 0.011106380261480808
of O 0 0.007857665419578552
constitutional O 0 0.020346319302916527
RB1 O 1 0.9995288848876953
- O 1 0.9037202596664429
gene O 1 0.7860261797904968
mutations O 1 0.9363368153572083
in O 0 0.015112717635929585
patients O 1 0.9967832565307617
with O 0 0.01328827254474163
isolated O 0 0.09969504922628403
unilateral B-Disease 0 0.20975303649902344
retinoblastoma I-Disease 1 0.9961808919906616
, O 0 0.01078647468239069
we O 0 0.007167218718677759
analyzed O 0 0.017285378649830818
DNA O 0 0.021427441388368607
from O 0 0.01141079980880022
peripheral O 1 0.9646504521369934
blood O 1 0.7968406677246094
and O 0 0.011208741925656796
from O 0 0.01829414628446102
tumor B-Disease 1 0.9994922876358032
tissue O 1 0.9812033772468567
. O 0 0.0368686281144619

The O 0 0.02289718948304653
analysis O 0 0.0274492334574461
of O 0 0.013833926990628242
tumors B-Disease 1 0.9970079064369202
from O 0 0.01291293278336525
54 O 0 0.02348550222814083
( O 0 0.014220988377928734
71 O 0 0.01929125003516674
% O 0 0.010588406585156918
) O 0 0.007822192274034023
of O 0 0.005430552177131176
76 O 0 0.02517516538500786
informative O 0 0.029956091195344925
patients O 1 0.9838833212852478
showed O 0 0.01820208691060543
loss O 0 0.02510129101574421
of O 0 0.01103582326322794
constitutional O 0 0.027346830815076828
heterozygosity O 1 0.9881821274757385
( O 0 0.05890629068017006
LOH O 1 0.9946634769439697
) O 0 0.028780993074178696
at O 0 0.02385333552956581
intragenic O 0 0.21735170483589172
loci O 0 0.1495354175567627
. O 0 0.03423551470041275

Three O 0 0.02524324133992195
of O 0 0.016264988109469414
13 O 0 0.03279193490743637
uninformative O 1 0.9192943572998047
patients O 1 0.9904705286026001
had O 0 0.022287841886281967
constitutional O 0 0.027428725734353065
deletions O 0 0.0924055352807045
. O 0 0.03854888677597046

For O 0 0.026689432561397552
39 O 0 0.03638584911823273
randomly O 0 0.04358864948153496
selected O 0 0.02688320353627205
tumors B-Disease 1 0.9992865920066833
, O 0 0.017955055460333824
SSCP O 1 0.8655827045440674
, O 0 0.018111245706677437
hetero O 1 0.9951781034469604
- O 0 0.23762246966362
duplex O 0 0.33358052372932434
analysis O 0 0.01730700209736824
, O 0 0.007838466204702854
sequencing O 0 0.02043788507580757
, O 0 0.00552312983199954
and O 0 0.004720927216112614
Southern O 0 0.011682058684527874
blot O 0 0.03734755888581276
analysis O 0 0.012005110271275043
were O 0 0.005133890081197023
used O 0 0.006039745174348354
to O 0 0.007190205622464418
identify O 0 0.027579305693507195
mutations O 0 0.14346113801002502
. O 0 0.032665956765413284

Mutations O 0 0.3666520118713379
were O 0 0.016085749492049217
detected O 0 0.03231831267476082
in O 0 0.008116159588098526
21 O 0 0.011511880904436111
( O 0 0.012271679937839508
91 O 0 0.020965827628970146
% O 0 0.011377467773854733
) O 0 0.010020690970122814
of O 0 0.007796742953360081
23 O 0 0.02227678894996643
tumors B-Disease 1 0.9997979998588562
with O 0 0.023242324590682983
LOH O 1 0.9988560676574707
. O 0 0.038060519844293594

In O 0 0.01976441778242588
6 O 0 0.02305705100297928
( O 0 0.013998840004205704
38 O 0 0.016432570293545723
% O 0 0.010715996846556664
) O 0 0.008043346926569939
of O 0 0.006012497469782829
16 O 0 0.01499711349606514
tumors B-Disease 1 0.9997549653053284
without O 0 0.01714339666068554
LOH O 1 0.9974647760391235
, O 0 0.010112682357430458
one O 0 0.008140524849295616
mutation O 0 0.057665012776851654
was O 0 0.00658529344946146
detected O 0 0.017132891342043877
, O 0 0.004395196679979563
and O 0 0.0033808413427323103
in O 0 0.003873156849294901
9 O 0 0.007308971602469683
( O 0 0.0063360268250107765
56 O 0 0.008990389294922352
% O 0 0.007095732260495424
) O 0 0.005724647548049688
of O 0 0.0037148252595216036
the O 0 0.008309131488204002
tumors B-Disease 1 0.9998414516448975
without O 0 0.01637621968984604
LOH O 1 0.9984636306762695
, O 0 0.009703582152724266
both O 0 0.009480055421590805
mutations O 0 0.0713796317577362
were O 0 0.009941532276570797
found O 0 0.01730278693139553
. O 0 0.02229166589677334

Thus O 0 0.026078233495354652
, O 0 0.01026791799813509
a O 0 0.007425268646329641
total O 0 0.007106171455234289
of O 0 0.006113482639193535
45 O 0 0.014389825984835625
mutations O 0 0.054204728454351425
were O 0 0.005836453754454851
identified O 0 0.011846086010336876
in O 0 0.010259074158966541
tumors B-Disease 1 0.9990426898002625
of O 0 0.011197802610695362
36 O 0 0.03312006592750549
patients O 1 0.994408130645752
. O 0 0.029470333829522133

Thirty O 0 0.059404876083135605
- O 0 0.043446749448776245
nine O 0 0.01496350858360529
of O 0 0.007293416187167168
the O 0 0.009938211180269718
mutations O 0 0.14389416575431824
- O 0 0.026336614042520523
including O 0 0.009258841164410114
34 O 0 0.01562652550637722
small O 0 0.012125439941883087
mutations O 0 0.06776255369186401
, O 0 0.007360238581895828
2 O 0 0.008168401196599007
large O 0 0.008147481828927994
structural O 0 0.02149048075079918
alterations O 0 0.019752051681280136
, O 0 0.006879518274217844
and O 0 0.006287687458097935
hypermethylation O 1 0.8583922386169434
in O 0 0.009745819494128227
3 O 0 0.020280709490180016
tumors O 1 0.9999017715454102
- O 0 0.027527641505002975
were O 0 0.005196708720177412
not O 0 0.004823915660381317
detected O 0 0.016958268359303474
in O 0 0.005193348042666912
the O 0 0.006271788850426674
corresponding O 0 0.02171570621430874
peripheral O 1 0.8830170631408691
blood O 1 0.6253781318664551
DNA O 0 0.061830051243305206
. O 0 0.025444816797971725

In O 0 0.02118661068379879
6 O 0 0.019930532202124596
( O 0 0.013816515915095806
17 O 0 0.010485704988241196
% O 0 0.008028853684663773
) O 0 0.005564061459153891
of O 0 0.0034975423477590084
the O 0 0.005589527543634176
36 O 0 0.01445280946791172
patients O 1 0.9097626805305481
, O 0 0.006318662315607071
a O 0 0.006860778201371431
mutation O 0 0.23841463029384613
was O 0 0.006299912463873625
detected O 0 0.01717394031584263
in O 0 0.004281874746084213
constitutional O 0 0.006995942909270525
DNA O 0 0.01124444417655468
, O 0 0.003392772516235709
and O 0 0.002938555320724845
1 O 0 0.004629903007298708
of O 0 0.0032558306120336056
these O 0 0.004373959731310606
mutations O 0 0.02884451299905777
is O 0 0.004772819112986326
known O 0 0.005710221361368895
to O 0 0.0032616418320685625
be O 0 0.004106863867491484
associated O 0 0.010081478394567966
with O 0 0.009511033073067665
reduced O 0 0.035377420485019684
expressivity O 1 0.9347067475318909
. O 0 0.0363154374063015

The O 0 0.01622760109603405
presence O 0 0.020494069904088974
of O 0 0.007098706904798746
a O 0 0.009563923813402653
constitutional O 0 0.01460579875856638
mutation O 0 0.05198915675282478
was O 0 0.005924190394580364
not O 0 0.004417008720338345
associated O 0 0.0068369521759450436
with O 0 0.0038482665549963713
an O 0 0.005039689131081104
early O 0 0.009072883985936642
age O 0 0.013079560361802578
at O 0 0.013117318972945213
treatment O 1 0.7511984705924988
. O 0 0.024558186531066895

In O 0 0.030751202255487442
1 O 0 0.035509515553712845
patient O 1 0.7062849998474121
, O 0 0.017390143126249313
somatic O 1 0.6676527261734009
mosaicism O 1 0.9647368788719177
was O 0 0.011535161174833775
demonstrated O 0 0.01562459859997034
by O 0 0.006209569983184338
molecular O 0 0.016444019973278046
analysis O 0 0.010187361389398575
of O 0 0.004937666468322277
DNA O 0 0.018525267019867897
and O 0 0.007454492151737213
RNA O 0 0.035222142934799194
from O 0 0.013978615403175354
peripheral O 1 0.8317649364471436
blood O 1 0.6178203821182251
. O 0 0.029928211122751236

In O 0 0.027156468480825424
2 O 0 0.03101215325295925
patients O 1 0.9670417904853821
without O 0 0.01716957800090313
a O 0 0.01732685975730419
detectable O 0 0.14839573204517365
mutation O 1 0.6430339217185974
in O 0 0.01710086688399315
peripheral O 1 0.990056574344635
blood O 1 0.8989611864089966
, O 0 0.013517897576093674
mosaicism O 1 0.9867902398109436
was O 0 0.009172234684228897
suggested O 0 0.011213737539947033
because O 0 0.007191350217908621
1 O 0 0.00714047672227025
of O 0 0.005236317403614521
the O 0 0.00882395263761282
patients O 1 0.9994031190872192
showed O 1 0.5090035200119019
multifocal O 1 0.9999833106994629
tumors B-Disease 1 0.9998952150344849
and O 0 0.009160533547401428
the O 0 0.005599263124167919
other O 0 0.005249211564660072
later O 0 0.007845642045140266
developed O 0 0.021329406648874283
bilateral B-Disease 0 0.036364611238241196
retinoblastoma I-Disease 1 0.9947892427444458
. O 0 0.03614722564816475

In O 0 0.01689887046813965
conclusion O 0 0.018997440114617348
, O 0 0.007391971070319414
our O 0 0.008472672663629055
results O 0 0.010060714557766914
emphasize O 0 0.015629967674613
that O 0 0.004679556004703045
the O 0 0.005443486850708723
manifestation O 0 0.024472668766975403
and O 0 0.008020980283617973
transmissibility O 1 0.6917192935943604
of O 0 0.008041825145483017
retinoblastoma B-Disease 1 0.9560672640800476
depend O 0 0.011414852924644947
on O 0 0.003958079498261213
the O 0 0.003579147392883897
nature O 0 0.005964957643300295
of O 0 0.0032069250009953976
the O 0 0.0035331370308995247
first O 0 0.005170133430510759
mutation O 0 0.03221912682056427
, O 0 0.0037211854942142963
its O 0 0.003135531907901168
time O 0 0.003515892429277301
in O 0 0.0028099112678319216
development O 0 0.004603500012308359
, O 0 0.002637595636770129
and O 0 0.002154416171833873
the O 0 0.00248366454616189
number O 0 0.0029973469208925962
and O 0 0.0029512217734009027
types O 0 0.007479986175894737
of O 0 0.004991886205971241
cells O 0 0.01996319554746151
that O 0 0.00444587180390954
are O 0 0.00523397559300065
affected O 0 0.019060930237174034
. O 0 0.009204838424921036
. O 0 0.016307946294546127

Hereditary B-Disease 1 0.9988842606544495
deficiency I-Disease 1 0.9998713731765747
of I-Disease 0 0.013747621327638626
the I-Disease 0 0.008846523240208626
fifth I-Disease 0 0.016014495864510536
component I-Disease 0 0.016144994646310806
of I-Disease 0 0.006389065179973841
complement I-Disease 0 0.01911931298673153
in O 0 0.009618286043405533
man O 0 0.024544186890125275
. O 0 0.021542714908719063

I O 0 0.07289031893014908
. O 0 0.05514134466648102

Clinical O 1 0.8172962665557861
, O 0 0.02548256702721119
immunochemical O 0 0.09361930191516876
, O 0 0.012219960801303387
and O 0 0.010188635438680649
family O 0 0.019859399646520615
studies O 0 0.02692496031522751
. O 0 0.023063428699970245

The O 0 0.017104731872677803
first O 0 0.014179788529872894
recognized O 0 0.01936352252960205
human O 0 0.018851185217499733
kindred O 1 0.9599512815475464
with O 0 0.01784501038491726
hereditary B-Disease 1 0.9986748695373535
deficiency I-Disease 1 0.9999455213546753
of I-Disease 0 0.008677641861140728
the I-Disease 0 0.006913187447935343
fifth I-Disease 0 0.015061206184327602
component I-Disease 0 0.017188401892781258
of I-Disease 0 0.007320363540202379
complement I-Disease 0 0.025961805135011673
( O 0 0.01880233734846115
C5 O 0 0.36106589436531067
) O 0 0.01598072424530983
is O 0 0.010278381407260895
described O 0 0.021277904510498047
. O 0 0.020768074318766594

The O 0 0.027148040011525154
proband O 0 0.07577682286500931
, O 0 0.010974829085171223
a O 0 0.008372689597308636
20 O 0 0.010145570151507854
- O 0 0.025185011327266693
year O 0 0.01142260804772377
- O 0 0.03588682413101196
old O 0 0.018509630113840103
black O 0 0.04623221233487129
female O 0 0.22432339191436768
with O 0 0.4893992245197296
systemic B-Disease 1 0.9999998807907104
lupus I-Disease 1 1.0
erythematosus I-Disease 1 0.9999997615814209
since O 0 0.04307647794485092
age O 0 0.024330899119377136
11 O 0 0.01639491692185402
, O 0 0.01227239053696394
lacked O 0 0.14389434456825256
serum O 1 0.9983096122741699
hemolytic O 1 0.9999562501907349
complement O 0 0.05322845280170441
activity O 0 0.026154184713959694
, O 0 0.011305979453027248
even O 0 0.01516746636480093
during O 0 0.0206435676664114
remission O 1 0.9859156608581543
. O 0 0.029669800773262978

C5 O 1 0.6075325012207031
was O 0 0.028820225968956947
undetectable O 0 0.16940517723560333
in O 0 0.013048596680164337
her O 0 0.016507897526025772
serum O 0 0.12335872650146484
by O 0 0.011678526178002357
both O 0 0.013655884191393852
immunodiffusion O 0 0.42628446221351624
and O 0 0.027062101289629936
hemolytic O 1 0.9998868703842163
assays O 0 0.22984224557876587
. O 0 0.04737429693341255

Other O 0 0.02005578577518463
complement O 0 0.029335536062717438
components O 0 0.017705721780657768
were O 0 0.0071456232108175755
normal O 0 0.019242241978645325
during O 0 0.015024821273982525
remission O 1 0.9984188079833984
of O 0 0.012797999195754528
lupus O 1 0.9999957084655762
, O 0 0.013265258632600307
but O 0 0.010767050087451935
C1 O 1 0.9971784353256226
, O 0 0.014235795475542545
C4 O 1 0.6250995993614197
, O 0 0.012149780057370663
C2 O 1 0.9925644993782043
, O 0 0.010556863620877266
and O 0 0.01142873615026474
C3 O 1 0.9688228368759155
levels O 0 0.036085277795791626
fell O 0 0.03526553511619568
during O 0 0.033525604754686356
exacerbations O 1 0.9975429773330688
. O 0 0.04132303595542908

A O 0 0.029135137796401978
younger O 0 0.03573371842503548
half O 0 0.017522793263196945
- O 0 0.03464120626449585
sister O 0 0.0170728862285614
, O 0 0.0068384804762899876
who O 0 0.006771903019398451
had O 0 0.006213425658643246
no O 0 0.0075539518147706985
underlying O 0 0.4418821632862091
disease O 1 0.9998169541358948
, O 0 0.006112734787166119
was O 0 0.004297269508242607
also O 0 0.004884455353021622
found O 0 0.008055567741394043
to O 0 0.009322683326900005
lack O 0 0.025426965206861496
immunochemically O 1 0.5034886598587036
detectable O 0 0.3712233901023865
C5 O 1 0.8286881446838379
. O 0 0.04303234443068504

By O 0 0.06502266973257065
hemolytic O 1 0.9997718930244446
assay O 0 0.1029750406742096
, O 0 0.015735935419797897
she O 0 0.013982855714857578
exhibited O 0 0.021193858236074448
1 O 0 0.012263994663953781
- O 0 0.020086659118533134
2 O 0 0.009863421320915222
% O 0 0.008233247324824333
of O 0 0.004639478400349617
the O 0 0.008704173378646374
normal O 0 0.02528209239244461
serum O 1 0.6701499819755554
C5 O 1 0.570644199848175
level O 0 0.015337864868342876
and O 0 0.006824077572673559
normal O 0 0.015008042566478252
concentrations O 0 0.021869361400604248
of O 0 0.004805917385965586
other O 0 0.006109289359301329
complement O 0 0.022213539108633995
components O 0 0.024708379060029984
. O 0 0.021756263449788094

C5 O 0 0.3129902780056
levels O 0 0.027100810781121254
of O 0 0.00649922713637352
other O 0 0.00541669363155961
family O 0 0.008723367005586624
members O 0 0.005425118841230869
were O 0 0.003806399879977107
either O 0 0.006309797056019306
normal O 0 0.011850367300212383
or O 0 0.007085905876010656
approximately O 0 0.007832224480807781
half O 0 0.008581261150538921
- O 0 0.021090291440486908
normal O 0 0.01627650111913681
, O 0 0.007268549408763647
consistent O 0 0.016498161479830742
with O 0 0.011980983428657055
autosomal O 1 0.9990208148956299
codominant O 1 0.9288734793663025
inheritance O 0 0.05286729708313942
of O 0 0.011357301846146584
the O 0 0.013903195038437843
gene O 0 0.38885945081710815
determining O 0 0.1604238599538803
C5 B-Disease 1 0.9998635053634644
deficiency I-Disease 1 0.9999858140945435
. O 0 0.05509171634912491

Normal O 1 0.8276188373565674
hemolytic O 1 0.9998745918273926
titers O 1 0.9120627045631409
were O 0 0.01734740100800991
restored O 0 0.022429268807172775
to O 0 0.010046087205410004
both O 0 0.014727574773132801
homozygous O 1 0.5032373070716858
C5 B-Disease 1 0.9995813965797424
- I-Disease 1 0.9927571415901184
deficient I-Disease 1 0.9993507266044617
( O 0 0.04108051583170891
C5D B-Disease 1 0.9954872727394104
) O 0 0.017706627026200294
sera O 0 0.03950141742825508
by O 0 0.0073721869848668575
addition O 0 0.009929047897458076
of O 0 0.007906550541520119
highly O 0 0.021866409108042717
purified O 0 0.056207045912742615
human O 0 0.03557635098695755
C5 O 1 0.7259662747383118
. O 0 0.03203155845403671

In O 0 0.03148960694670677
specific O 0 0.03866489976644516
C5 O 1 0.9470506310462952
titrations O 1 0.9531079530715942
, O 0 0.009101346135139465
however O 0 0.005963250529021025
, O 0 0.003448390867561102
it O 0 0.002534148981794715
was O 0 0.0030224821530282497
noted O 0 0.005078678019344807
that O 0 0.0029243212193250656
when O 0 0.004230727441608906
limited O 0 0.0073937661945819855
amounts O 0 0.009812685661017895
of O 0 0.005526900291442871
C5 O 0 0.0586916022002697
were O 0 0.004593854770064354
assayed O 0 0.022868020460009575
in O 0 0.004797941539436579
the O 0 0.004928467329591513
presence O 0 0.010849262587726116
of O 0 0.006497827358543873
low O 0 0.021056227385997772
dilutions O 0 0.32473811507225037
of O 0 0.012108190916478634
either O 0 0.022145090624690056
C5D B-Disease 1 0.9943382143974304
serum O 1 0.8432655930519104
, O 0 0.012259738519787788
curving O 0 0.042009200900793076
rather O 0 0.013316825032234192
than O 0 0.011680155992507935
linear O 0 0.038204409182071686
dose O 1 0.9756863713264465
- O 0 0.051727842539548874
response O 0 0.017759310081601143
plots O 0 0.014811310917139053
were O 0 0.005520360078662634
consistently O 0 0.010645391419529915
obtained O 0 0.008524617180228233
, O 0 0.007091601379215717
suggesting O 0 0.019996153190732002
some O 0 0.012241960503160954
inhibitory O 0 0.1608736515045166
effect O 0 0.04244508966803551
. O 0 0.02679099328815937

Further O 0 0.028396708890795708
studies O 0 0.026006707921624184
suggested O 0 0.019143475219607353
that O 0 0.009946689009666443
low O 0 0.027555352076888084
dilutions O 1 0.7474362850189209
of O 0 0.016158580780029297
C5D B-Disease 1 0.994775652885437
serum O 1 0.6021841168403625
contain O 0 0.018757175654172897
a O 0 0.01176515780389309
factor O 0 0.022587958723306656
( O 0 0.010930207557976246
or O 0 0.008302622474730015
factors O 0 0.01531137153506279
) O 0 0.007918993011116982
interfering O 0 0.015461151488125324
at O 0 0.006222024094313383
some O 0 0.004348610527813435
step O 0 0.008385161869227886
in O 0 0.005196275655180216
the O 0 0.00894080102443695
hemolytic O 1 0.9999395608901978
assay O 0 0.05927959457039833
of O 0 0.009412117302417755
C5 O 0 0.3657127618789673
, O 0 0.006766308099031448
rather O 0 0.007784204091876745
than O 0 0.006732318550348282
a O 0 0.010987305082380772
true O 0 0.025975363329052925
C5 O 1 0.9639075398445129
inhibitor O 1 0.9586120843887329
or O 0 0.028378479182720184
inactivator O 0 0.23172110319137573
. O 0 0.03319172561168671

Of O 0 0.024375230073928833
clinical O 0 0.07619910687208176
interest O 0 0.013292135670781136
are O 0 0.005797230638563633
( O 0 0.007698276545852423
a O 0 0.0056580835953354836
) O 0 0.0062176198698580265
the O 0 0.005130714271217585
documentation O 0 0.014836185611784458
of O 0 0.013112271204590797
membranous O 1 0.9998007416725159
glomerulonephritis B-Disease 1 0.9999890327453613
, O 0 0.055492401123046875
vasculitis B-Disease 1 0.9999668598175049
, O 0 0.014683178626000881
and O 0 0.013729502446949482
arthritis B-Disease 1 0.9999973773956299
in O 0 0.008432180620729923
an O 0 0.006554560735821724
individual O 0 0.013802203349769115
lacking O 0 0.029712196439504623
C5 O 1 0.6720206141471863
( O 0 0.010561615228652954
and O 0 0.0047297403216362
its O 0 0.005681551992893219
biologic O 0 0.04766489937901497
functions O 0 0.008671257644891739
) O 0 0.006456208415329456
, O 0 0.004481643904000521
and O 0 0.0036847179289907217
( O 0 0.008373490534722805
b O 0 0.016848934814333916
) O 0 0.007146631367504597
a O 0 0.006680147722363472
remarkable O 0 0.015598773956298828
propensity O 1 0.5944880843162537
to O 0 0.013168355450034142
bacterial B-Disease 1 0.9999256134033203
infections I-Disease 1 0.9999632835388184
in O 0 0.009955054149031639
the O 0 0.00834486074745655
proband O 0 0.25007590651512146
, O 0 0.006271310616284609
even O 0 0.006632460746914148
during O 0 0.007863582111895084
periods O 0 0.016004273667931557
of O 0 0.006348256953060627
low O 0 0.024324452504515648
- O 0 0.16038070619106293
dose O 1 0.8280329704284668
or O 0 0.015307619236409664
alternate O 0 0.029378874227404594
- O 0 0.2510688602924347
day O 0 0.036167245358228683
corticosteroid O 1 0.9991940855979919
therapy O 1 0.9968259334564209
. O 0 0.0463559627532959

Other O 0 0.020988428965210915
observations O 0 0.02657036855816841
indicate O 0 0.01905563846230507
that O 0 0.006762829143553972
the O 0 0.007151945028454065
C5D B-Disease 0 0.21699769794940948
state O 0 0.007663165219128132
is O 0 0.005765424109995365
compatible O 0 0.0129512008279562
with O 0 0.0065980395302176476
normal O 0 0.019666841253638268
coagulation O 1 0.8433314561843872
function O 0 0.012662660330533981
and O 0 0.004563604015856981
the O 0 0.004371597431600094
capacity O 0 0.007662327494472265
to O 0 0.006863462273031473
mount O 0 0.027736863121390343
a O 0 0.021851593628525734
neutrophilic O 1 0.9993354678153992
leukocytosis O 1 0.9992755055427551
during O 0 0.17443756759166718
pyogenic B-Disease 1 0.9996367692947388
infection I-Disease 1 0.9996838569641113
. O 0 0.03281606361269951
. O 0 0.03404618799686432

Susceptibility O 1 0.9972871541976929
to O 0 0.059053730219602585
ankylosing B-Disease 1 0.9999773502349854
spondylitis I-Disease 1 0.9999803304672241
in O 0 0.024455631151795387
twins O 0 0.13275140523910522
: O 0 0.010427013970911503
the O 0 0.005564291495829821
role O 0 0.009877379052340984
of O 0 0.006997606251388788
genes O 0 0.03764686360955238
, O 0 0.010806310921907425
HLA O 1 0.9952749013900757
, O 0 0.007418151944875717
and O 0 0.004986072424799204
the O 0 0.007188980933278799
environment O 0 0.0218972135335207
. O 0 0.020054230466485023

OBJECTIVE O 0 0.03890649601817131
To O 0 0.010769066400825977
determine O 0 0.014070737175643444
the O 0 0.008080239407718182
relative O 0 0.017479337751865387
effects O 0 0.029268532991409302
of O 0 0.007607045583426952
genetic O 0 0.029028477147221565
and O 0 0.006731158588081598
environmental O 0 0.01682756468653679
factors O 0 0.020818404853343964
in O 0 0.012778554111719131
susceptibility O 1 0.9949628114700317
to O 0 0.027011530473828316
ankylosing B-Disease 1 0.9999908208847046
spondylitis I-Disease 1 0.9999908208847046
( O 0 0.03694135323166847
AS B-Disease 0 0.018786802887916565
) O 0 0.023914949968457222
. O 0 0.02130449004471302

METHODS O 0 0.04546113312244415
Twins O 0 0.0631469264626503
with O 0 0.010598612949252129
AS B-Disease 0 0.008006519638001919
were O 0 0.00437715882435441
identified O 0 0.0085214888677001
from O 0 0.004827375989407301
the O 0 0.005221760831773281
Royal O 0 0.01389354933053255
National O 0 0.015960058197379112
Hospital O 1 0.992124617099762
for O 0 0.024110808968544006
Rheumatic B-Disease 1 0.9999967813491821
Diseases I-Disease 1 0.9999344348907471
database O 0 0.05985382944345474
. O 0 0.03402482345700264

Clinical O 1 0.7662222981452942
and O 0 0.020525779575109482
radiographic O 1 0.662397027015686
examinations O 0 0.03159806877374649
were O 0 0.007210992276668549
performed O 0 0.011824587360024452
to O 0 0.006822849623858929
establish O 0 0.01823396421968937
diagnoses O 1 0.9963065385818481
, O 0 0.01046375185251236
and O 0 0.011869064532220364
disease O 1 0.9999401569366455
severity O 1 0.971138060092926
was O 0 0.007477667648345232
assessed O 0 0.015101793222129345
using O 0 0.006735470611602068
a O 0 0.007027041167020798
combination O 0 0.01982177048921585
of O 0 0.007119888439774513
validated O 0 0.02685638517141342
scoring O 0 0.020675718784332275
systems O 0 0.027810201048851013
. O 0 0.020845450460910797

HLA O 1 0.9919923543930054
typing O 0 0.1355137676000595
for O 0 0.03523220121860504
HLA O 1 0.9989878535270691
- O 1 0.7873550057411194
B27 O 1 0.7449029684066772
, O 0 0.024156074970960617
HLA O 1 0.9992308616638184
- O 0 0.41398847103118896
B60 O 0 0.3357004225254059
, O 0 0.013525249436497688
and O 0 0.01390750426799059
HLA O 1 0.9992326498031616
- O 0 0.3217303454875946
DR1 O 1 0.8068777918815613
was O 0 0.011399563401937485
performed O 0 0.014826808124780655
by O 0 0.009317281655967236
polymerase O 0 0.05286363512277603
chain O 0 0.028637928888201714
reaction O 0 0.02433539740741253
with O 0 0.00806567631661892
sequence O 0 0.019496768712997437
- O 0 0.023331861943006516
specific O 0 0.013630242086946964
primers O 0 0.036787811666727066
, O 0 0.006960798520594835
and O 0 0.007017887197434902
zygosity O 0 0.04445589333772659
was O 0 0.009685819037258625
assessed O 0 0.024448085576295853
using O 0 0.02229083515703678
microsatellite O 0 0.47894302010536194
markers O 0 0.08071461319923401
. O 0 0.038239482790231705

Genetic O 0 0.10350441932678223
and O 0 0.016112903133034706
environmental O 0 0.02352224662899971
variance O 0 0.02178812399506569
components O 0 0.011249259114265442
were O 0 0.004492008127272129
assessed O 0 0.012832771055400372
with O 0 0.00464533269405365
the O 0 0.005417423788458109
program O 0 0.011623332276940346
Mx O 0 0.15210002660751343
, O 0 0.004783328622579575
using O 0 0.004320284351706505
data O 0 0.004101652652025223
from O 0 0.0029545335564762354
this O 0 0.0023521059192717075
and O 0 0.002851927885785699
previous O 0 0.005828441120684147
studies O 0 0.007762453053146601
of O 0 0.005028230603784323
twins O 0 0.02989962138235569
with O 0 0.010227245278656483
AS B-Disease 0 0.014337231405079365
. O 0 0.020543405786156654

RESULTS O 0 0.04888708516955376
Six O 0 0.022428156808018684
of O 0 0.012728476896882057
8 O 0 0.02743726782500744
monozygotic O 1 0.9755567908287048
( O 0 0.04696889966726303
MZ O 1 0.9988594055175781
) O 0 0.025208409875631332
twin O 0 0.08681247383356094
pairs O 0 0.036391742527484894
were O 0 0.012125691398978233
disease O 1 0.9997408986091614
concordant O 0 0.31051701307296753
, O 0 0.009572876617312431
compared O 0 0.011361987330019474
with O 0 0.005675897933542728
4 O 0 0.008348716422915459
of O 0 0.005410126876085997
15 O 0 0.014619143679738045
B27 O 0 0.21137696504592896
- O 0 0.08675924688577652
positive O 0 0.039033014327287674
dizygotic O 1 0.9836620688438416
( O 0 0.026472527533769608
DZ O 1 0.9745545387268066
) O 0 0.018062660470604897
twin O 0 0.03831112012267113
pairs O 0 0.025510264560580254
( O 0 0.012922163121402264
27 O 0 0.01079992949962616
% O 0 0.008590340614318848
) O 0 0.005688727367669344
and O 0 0.003915692213922739
4 O 0 0.007619431708008051
of O 0 0.005482263397425413
32 O 0 0.015583682805299759
DZ O 1 0.9207640290260315
twin O 0 0.041646622121334076
pairs O 0 0.024058209732174873
overall O 0 0.014830290339887142
( O 0 0.011272512376308441
12 O 0 0.008322414942085743
. O 0 0.006193236913532019
5 O 0 0.010314596816897392
% O 0 0.013010792434215546
) O 0 0.015459959395229816
. O 0 0.014366972260177135

Nonsignificant O 0 0.4461185932159424
increases O 0 0.04952390864491463
in O 0 0.011675147339701653
similarity O 0 0.02114967443048954
with O 0 0.007996190339326859
regard O 0 0.013356486335396767
to O 0 0.007086781784892082
age O 0 0.019223827868700027
at O 0 0.018780533224344254
disease O 1 0.9999799728393555
onset O 1 0.9986714124679565
and O 0 0.005333826877176762
all O 0 0.003554165130481124
of O 0 0.004262638743966818
the O 0 0.0081953015178442
disease O 1 0.9999626874923706
severity O 1 0.9962294697761536
scores O 0 0.02189658023416996
assessed O 0 0.021496839821338654
were O 0 0.00641391146928072
noted O 0 0.012139933183789253
in O 0 0.015052232891321182
disease O 1 0.9998975992202759
- O 1 0.9463860392570496
concordant O 1 0.9828501343727112
MZ O 1 0.9994291663169861
twins O 1 0.6630040407180786
compared O 0 0.040309254080057144
with O 0 0.029872862622141838
concordant O 1 0.7886587977409363
DZ O 1 0.995046854019165
twins O 1 0.6248229742050171
. O 0 0.04764687269926071

HLA O 1 0.9990409016609192
- O 0 0.42428919672966003
B27 O 0 0.12637269496917725
and O 0 0.013419021852314472
B60 O 0 0.04901096597313881
were O 0 0.006534526590257883
associated O 0 0.008934947662055492
with O 0 0.005428531672805548
the O 0 0.00712432200089097
disease O 1 0.999516487121582
in O 0 0.007779535371810198
probands O 0 0.2541201710700989
, O 0 0.004815217573195696
and O 0 0.003656297456473112
the O 0 0.004883843474090099
rate O 0 0.012639698572456837
of O 0 0.00732162781059742
disease O 1 0.9997120499610901
concordance O 0 0.10402468591928482
was O 0 0.009543592110276222
significantly O 0 0.020415199920535088
increased O 0 0.017237136140465736
among O 0 0.015755001455545425
DZ O 1 0.9861215949058533
twin O 0 0.0434844046831131
pairs O 0 0.02146603912115097
in O 0 0.005655642598867416
which O 0 0.004696553107351065
the O 0 0.00620105117559433
co O 0 0.03140762448310852
- O 0 0.035249534994363785
twin O 0 0.0345303975045681
was O 0 0.008940658532083035
positive O 0 0.013538732193410397
for O 0 0.006417370866984129
both O 0 0.009090674109756947
B27 O 0 0.06300660967826843
and O 0 0.018793068826198578
DR1 O 1 0.9366942048072815
. O 0 0.029409930109977722

Additive O 0 0.492855429649353
genetic O 0 0.379047691822052
effects O 0 0.06612373143434525
were O 0 0.010373726487159729
estimated O 0 0.015162202529609203
to O 0 0.009234027937054634
contribute O 0 0.018867189064621925
97 O 0 0.021287087351083755
% O 0 0.010601002722978592
of O 0 0.006125320214778185
the O 0 0.007929312065243721
population O 0 0.018994644284248352
variance O 0 0.043731141835451126
. O 0 0.023073025047779083

CONCLUSION O 0 0.07415051758289337
Susceptibility O 1 0.5276457071304321
to O 0 0.011857149191200733
AS B-Disease 0 0.010073126293718815
is O 0 0.006503453478217125
largely O 0 0.010426649823784828
genetically O 0 0.01770993508398533
determined O 0 0.011069299653172493
, O 0 0.004305822774767876
and O 0 0.004383347928524017
the O 0 0.005424462724477053
environmental O 0 0.013405391946434975
trigger O 0 0.04791034013032913
for O 0 0.005996938329190016
the O 0 0.009306217543780804
disease O 1 0.999477207660675
is O 0 0.012796456925570965
probably O 0 0.02155274711549282
ubiquitous O 0 0.049234431236982346
. O 0 0.024603627622127533

HLA O 1 0.9987908005714417
- O 0 0.25188130140304565
B27 O 0 0.08948307484388351
accounts O 0 0.017671993002295494
for O 0 0.0061219544149935246
a O 0 0.006594574078917503
minority O 0 0.012560583651065826
of O 0 0.004666887689381838
the O 0 0.006785997189581394
overall O 0 0.024716472253203392
genetic O 0 0.19422774016857147
susceptibility O 1 0.8978675007820129
to O 0 0.012329839169979095
AS B-Disease 0 0.0174412839114666
. O 0 0.020556963980197906

Cell O 1 0.5295345783233643
cycle O 0 0.136736661195755
- O 0 0.08425173163414001
dependent O 0 0.0542440302670002
colocalization O 0 0.11747562885284424
of O 0 0.014568771235644817
BARD1 O 0 0.44567883014678955
and O 0 0.01622745580971241
BRCA1 O 1 0.9770382642745972
proteins O 0 0.03510546311736107
in O 0 0.012445502914488316
discrete O 0 0.036535125225782394
nuclear O 0 0.02931387722492218
domains O 0 0.04200325906276703
. O 0 0.02504078298807144

Germ O 1 0.9889922142028809
- O 0 0.11584918200969696
line O 0 0.03951917961239815
mutations O 0 0.08189481496810913
of O 0 0.012510507367551327
the O 0 0.018868274986743927
BRCA1 O 1 0.9981648325920105
gene O 1 0.8421258330345154
predispose O 1 0.9834358096122742
women O 0 0.02696293033659458
to O 0 0.012042484246194363
early O 0 0.050544142723083496
- O 1 0.9996292591094971
onset O 1 0.9999932050704956
breast B-Disease 1 0.9999980926513672
and I-Disease 1 0.9401381015777588
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999880790710449
by O 0 0.017325008288025856
compromising O 0 0.04202204942703247
the O 0 0.013654176145792007
genes O 0 0.060137033462524414
presumptive O 1 0.7529262900352478
function O 0 0.023965178057551384
as O 0 0.011043813079595566
a O 0 0.01934417150914669
tumor B-Disease 1 0.9992606043815613
suppressor O 1 0.9832397103309631
. O 0 0.03433362394571304

Although O 0 0.02763194963335991
the O 0 0.013174613937735558
biochemical O 0 0.04453118517994881
properties O 0 0.02488754689693451
of O 0 0.011898170225322247
BRCA1 O 1 0.9779202938079834
polypeptides O 0 0.046056173741817474
are O 0 0.00655518751591444
not O 0 0.005985581781715155
understood O 0 0.010910125449299812
, O 0 0.00468785222619772
their O 0 0.0047261775471270084
expression O 0 0.015318433754146099
pattern O 0 0.020567502826452255
and O 0 0.008492114022374153
subcellular O 0 0.03559499233961105
localization O 0 0.028965091332793236
suggest O 0 0.015051123686134815
a O 0 0.007275812793523073
role O 0 0.011199576780200005
in O 0 0.008617609739303589
cell O 0 0.0727124810218811
- O 0 0.15081247687339783
cycle O 0 0.0743529349565506
regulation O 0 0.04352101311087608
. O 0 0.027642028406262398

When O 0 0.04329269379377365
resting O 0 0.09069477021694183
cells O 0 0.12514810264110565
are O 0 0.0113028883934021
induced O 0 0.43887442350387573
to O 0 0.008427979424595833
proliferate O 0 0.02763504348695278
, O 0 0.0060503920540213585
the O 0 0.005515888333320618
steady O 0 0.015889620408415794
- O 0 0.018924351781606674
state O 0 0.0068391673266887665
levels O 0 0.014180448837578297
of O 0 0.007112631108611822
BRCA1 O 1 0.927557647228241
increase O 0 0.014469467103481293
in O 0 0.007193967700004578
late O 0 0.010967167094349861
G1 O 0 0.13485108315944672
and O 0 0.006574698723852634
reach O 0 0.011544136330485344
a O 0 0.008706139400601387
maximum O 0 0.015938833355903625
during O 0 0.01832662522792816
S O 0 0.061739061027765274
phase O 0 0.052877143025398254
. O 0 0.029670536518096924

Moreover O 0 0.05274936556816101
, O 0 0.015955721959471703
in O 0 0.013921288773417473
S O 0 0.11465173959732056
phase O 0 0.0760456845164299
cells O 0 0.10554219782352448
, O 0 0.015907300636172295
BRCA1 O 1 0.984662652015686
polypeptides O 0 0.07030761986970901
are O 0 0.014226885512471199
hyperphosphorylated O 0 0.06609376519918442
and O 0 0.012593152932822704
accumulate O 0 0.045545876026153564
into O 0 0.016787204891443253
discrete O 0 0.048601675778627396
subnuclear O 1 0.5746746063232422
foci O 1 0.7157362103462219
termed O 0 0.07965938746929169
" O 0 0.03440545126795769
BRCA1 O 1 0.9865626692771912
nuclear O 0 0.05887500196695328
dots O 0 0.11482828110456467
. O 0 0.04212246835231781

" O 0 0.059790488332509995
BRCA1 O 1 0.9939427971839905
associates O 0 0.267204225063324
in O 0 0.017889440059661865
vivo O 0 0.06260737031698227
with O 0 0.012009664438664913
a O 0 0.013519717380404472
structurally O 0 0.04576548933982849
related O 0 0.03345604985952377
protein O 0 0.0577366016805172
termed O 0 0.07809244096279144
BARD1 O 1 0.7560039758682251
. O 0 0.03686761483550072

Here O 0 0.018776804208755493
we O 0 0.00928656104952097
show O 0 0.009100138209760189
that O 0 0.0044551631435751915
the O 0 0.0055277966894209385
steady O 0 0.016363106667995453
- O 0 0.019148875027894974
state O 0 0.0077468701638281345
levels O 0 0.012791639193892479
of O 0 0.005989191122353077
BARD1 O 0 0.2228846698999405
, O 0 0.007125793490558863
unlike O 0 0.010014642961323261
those O 0 0.0054274736903607845
of O 0 0.006082362961024046
BRCA1 O 1 0.9859831929206848
, O 0 0.007908271625638008
remain O 0 0.010656291618943214
relatively O 0 0.015132732689380646
constant O 0 0.02246095985174179
during O 0 0.017340822145342827
cell O 0 0.19938306510448456
cycle O 0 0.22770005464553833
progression O 1 0.740105152130127
. O 0 0.03140062466263771

However O 0 0.03202522546052933
, O 0 0.020935293287038803
immunostaining O 0 0.07848481833934784
revealed O 0 0.027803611010313034
that O 0 0.0139433853328228
BARD1 O 0 0.18075108528137207
resides O 0 0.04089506343007088
within O 0 0.019834453240036964
BRCA1 O 1 0.9861342310905457
nuclear O 0 0.035799361765384674
dots O 0 0.04979531466960907
during O 0 0.014342083595693111
S O 0 0.03859886899590492
phase O 0 0.01725545898079872
of O 0 0.004534432664513588
the O 0 0.0057353675365448
cell O 0 0.02778710052371025
cycle O 0 0.0211652684956789
, O 0 0.004826161544770002
but O 0 0.0042425598949193954
not O 0 0.003577983006834984
during O 0 0.00875605084002018
the O 0 0.008568317629396915
G1 O 1 0.824984073638916
phase O 0 0.0613887794315815
. O 0 0.028442125767469406

Nevertheless O 0 0.05658724531531334
, O 0 0.022755449637770653
BARD1 O 0 0.12279299646615982
polypeptides O 0 0.04509955644607544
are O 0 0.006509790197014809
found O 0 0.007099132519215345
exclusively O 0 0.006817125715315342
in O 0 0.003883085446432233
the O 0 0.004504567943513393
nuclear O 0 0.010062451474368572
fractions O 0 0.013458920642733574
of O 0 0.005304643884301186
both O 0 0.007838613353669643
G1 O 1 0.8393275737762451
- O 0 0.046233247965574265
and O 0 0.011373991146683693
S O 0 0.4763147830963135
- O 0 0.4127936065196991
phase O 0 0.1033586859703064
cells O 0 0.13270756602287292
. O 0 0.030249906703829765

Therefore O 0 0.03606565296649933
, O 0 0.017504096031188965
progression O 0 0.08869186788797379
to O 0 0.010335646569728851
S O 0 0.03705389052629471
phase O 0 0.02308156155049801
is O 0 0.007340292911976576
accompanied O 0 0.010942821390926838
by O 0 0.005163472145795822
the O 0 0.005895831622183323
aggregation O 0 0.02464316040277481
of O 0 0.008924989029765129
nuclear O 0 0.025062045082449913
BARD1 O 0 0.11503173410892487
polypeptides O 0 0.06904273480176926
into O 0 0.029457641765475273
BRCA1 O 1 0.9838279485702515
nuclear O 0 0.06737310439348221
dots O 0 0.10794517397880554
. O 0 0.03833949565887451

This O 0 0.030796820297837257
cell O 0 0.07486265152692795
cycle O 0 0.06545352935791016
- O 0 0.05590490251779556
dependent O 0 0.03918231278657913
colocalization O 0 0.08135012537240982
of O 0 0.012497923336923122
BARD1 O 1 0.5764082670211792
and O 0 0.013590054586529732
BRCA1 O 1 0.9841710925102234
indicates O 0 0.023949645459651947
a O 0 0.008218461647629738
role O 0 0.01097661629319191
for O 0 0.009261942468583584
BARD1 O 1 0.5635916590690613
in O 0 0.018146393820643425
BRCA1 O 1 0.9997788071632385
- O 1 0.9956017732620239
mediated O 1 0.998953104019165
tumor B-Disease 1 0.9998138546943665
suppression O 1 0.7896980047225952
. O 0 0.038858190178871155

Ethnic O 0 0.0448593832552433
differences O 0 0.03477230668067932
in O 0 0.016296207904815674
the O 0 0.024806423112750053
HFE O 1 0.9453385472297668
codon O 0 0.1509404182434082
282 O 0 0.3208079934120178
( O 0 0.09301656484603882
Cys O 1 0.9988258481025696
/ O 1 0.9898536801338196
Tyr O 1 0.9830943942070007
) O 0 0.04699177294969559
polymorphism O 0 0.10724204033613205
. O 0 0.03627539426088333

Recent O 0 0.03460949286818504
studies O 0 0.023538904264569283
have O 0 0.010216805152595043
shown O 0 0.01623232290148735
that O 0 0.0124710937961936
hereditary B-Disease 1 0.9999358654022217
hemochromatosis I-Disease 1 0.9999996423721313
( O 1 0.7409563660621643
HH B-Disease 1 0.999889612197876
) O 0 0.010707401670515537
is O 0 0.00506479712203145
likely O 0 0.007924389094114304
to O 0 0.00415488425642252
be O 0 0.004347710404545069
caused O 0 0.015331887640058994
by O 0 0.006402823142707348
homozygosity O 0 0.034068454056978226
for O 0 0.00685023982077837
a O 0 0.010497522540390491
Cys282Tyr O 0 0.34297871589660645
mutation O 0 0.11807557195425034
in O 0 0.01126948930323124
the O 0 0.01418439019471407
HFE O 1 0.9633621573448181
gene O 0 0.07653464376926422
located O 0 0.03239984065294266
4 O 0 0.029286667704582214
. O 0 0.023871777579188347

5 O 0 0.07305959612131119
Mb O 0 0.35942697525024414
telomeric O 1 0.7518023252487183
to O 0 0.03183842822909355
HLA O 1 0.9943305253982544
- O 0 0.07173317670822144
A O 0 0.031952839344739914
. O 0 0.031092075631022453

Population O 0 0.03522519767284393
studies O 0 0.019870365038514137
of O 0 0.006632090546190739
this O 0 0.006032404024153948
polymorphism O 0 0.027248769998550415
are O 0 0.005239301361143589
facilitated O 0 0.014362096786499023
by O 0 0.004401280544698238
the O 0 0.004287471063435078
fact O 0 0.006739484611898661
that O 0 0.004769619088619947
the O 0 0.008677151054143906
Cys282Tyr O 1 0.6551350355148315
mutation O 1 0.5591233968734741
creates O 0 0.04210948199033737
a O 0 0.021930675953626633
Rsal O 0 0.2370305061340332
restriction O 0 0.04622456058859825
site O 0 0.030443018302321434
. O 0 0.027457280084490776

We O 0 0.01818842813372612
have O 0 0.01165041234344244
studied O 0 0.017733898013830185
the O 0 0.0129915252327919
codon O 0 0.07591225206851959
282 O 0 0.10673333704471588
( O 0 0.05741911381483078
Cys O 1 0.9987525939941406
/ O 1 0.9632128477096558
Tyr O 1 0.9192178845405579
) O 0 0.021902738139033318
polymorphism O 0 0.04038020968437195
in O 0 0.008958481252193451
different O 0 0.009216804057359695
ethnic O 0 0.018349401652812958
groups O 0 0.02186405658721924
. O 0 0.023993128910660744

In O 0 0.017264122143387794
agreement O 0 0.015145044773817062
with O 0 0.008450672030448914
previous O 0 0.010486769489943981
observations O 0 0.01711226813495159
the O 0 0.01019322406500578
Tyr O 1 0.6626649498939514
allele O 0 0.07199505716562271
appeared O 0 0.013478961773216724
to O 0 0.006317186634987593
be O 0 0.00532009219750762
rare O 0 0.013130930252373219
or O 0 0.008374219760298729
absent O 0 0.017699917778372765
in O 0 0.007029373198747635
Asiatic O 0 0.24923893809318542
( O 0 0.011432378552854061
Indian O 0 0.01039041206240654
, O 0 0.0073901936411857605
Chinese O 0 0.01085035689175129
) O 0 0.01786457747220993
populations O 0 0.043483760207891464
. O 0 0.024288054555654526

The O 0 0.030675780028104782
highest O 0 0.0430501364171505
allele O 0 0.09926754981279373
frequency O 0 0.03578738868236542
( O 0 0.014970066025853157
7 O 0 0.012203165329992771
. O 0 0.00618801498785615
5 O 0 0.008594834245741367
% O 0 0.009030412882566452
) O 0 0.007780573330819607
was O 0 0.0048169842921197414
found O 0 0.007294013164937496
in O 0 0.007828079164028168
Swedes O 0 0.03839931637048721
. O 0 0.0223669596016407

Saamis O 0 0.3520294427871704
( O 0 0.032155636698007584
2 O 0 0.01725265383720398
% O 0 0.015583625994622707
) O 0 0.010343818925321102
and O 0 0.006831022910773754
Mordvinians O 0 0.0408296138048172
( O 0 0.010991917923092842
1 O 0 0.008391889743506908
. O 0 0.005057192873209715
8 O 0 0.00751950079575181
% O 0 0.0075783454813063145
) O 0 0.005923169199377298
had O 0 0.005717535503208637
significantly O 0 0.014468642883002758
lower O 0 0.011954596266150475
frequencies O 0 0.01697894185781479
of O 0 0.00698342639952898
the O 0 0.012560583651065826
Tyr O 1 0.8955163359642029
allele O 0 0.42269018292427063
. O 0 0.04063700884580612

Comparisons O 0 0.06315909326076508
with O 0 0.020358750596642494
allele O 0 0.07681628316640854
frequencies O 0 0.03175894543528557
based O 0 0.013619822449982166
on O 0 0.009462968446314335
prevalence O 1 0.5889285802841187
estimates O 0 0.01946081966161728
of O 0 0.009284976869821548
HH B-Disease 1 0.9984956979751587
showed O 0 0.01697920262813568
some O 0 0.006410041358321905
disagreements O 0 0.01508126687258482
with O 0 0.00686850817874074
the O 0 0.007711692713201046
RFLP O 0 0.05903860181570053
data O 0 0.010524178855121136
, O 0 0.006574281491339207
particularly O 0 0.012734932824969292
in O 0 0.0103627759963274
Finns O 0 0.048055898398160934
. O 0 0.025786101818084717

The O 0 0.02546004019677639
newly O 0 0.03166602924466133
described O 0 0.03200382739305496
HFE O 1 0.8794745206832886
marker O 0 0.03666222468018532
provides O 0 0.014378090389072895
a O 0 0.006481805816292763
new O 0 0.005834318231791258
approach O 0 0.008989480324089527
to O 0 0.00410465756431222
the O 0 0.004528008867055178
screening O 0 0.017654549330472946
of O 0 0.005562631879001856
HH B-Disease 1 0.9930375218391418
as O 0 0.00496820081025362
well O 0 0.004225997719913721
as O 0 0.0036735909525305033
studies O 0 0.006865217350423336
of O 0 0.003427475690841675
the O 0 0.004946279339492321
relationship O 0 0.013808650895953178
between O 0 0.010316637344658375
the O 0 0.012907597236335278
HFE O 1 0.9961928129196167
Tyr O 1 0.9958561062812805
allele O 1 0.7486259937286377
and O 0 0.01687752828001976
different O 0 0.023545755073428154
disorders O 1 0.9998960494995117
including O 0 0.038613636046648026
cancer B-Disease 1 0.9998202919960022

Autosomal B-Disease 1 0.9993215799331665
dominant I-Disease 1 0.983903169631958
neurohypophyseal I-Disease 1 0.9993960857391357
diabetes I-Disease 1 0.9999920129776001
insipidus I-Disease 1 0.9997778534889221
associated O 0 0.04606024920940399
with O 0 0.020754164084792137
a O 0 0.026313353329896927
missense O 1 0.7509611248970032
mutation O 1 0.8823399543762207
encoding O 0 0.0812745988368988
Gly23 O 1 0.9708377718925476
- O 1 0.9087210893630981
- O 1 0.8617329001426697
> O 1 0.8539625406265259
Val O 1 0.8368735313415527
in O 0 0.026293553411960602
neurophysin O 1 0.6748872995376587
II O 0 0.07676931470632553
. O 0 0.03418842330574989

Autosomal B-Disease 1 0.9991632699966431
dominant I-Disease 1 0.9827526807785034
neurohypophyseal I-Disease 1 0.9995385408401489
diabetes I-Disease 1 0.9999953508377075
insipidus I-Disease 1 0.9999314546585083
( O 0 0.19969187676906586
ADNDI B-Disease 1 0.9807062149047852
) O 0 0.019510602578520775
is O 0 0.0117698535323143
an O 0 0.014479908160865307
inherited B-Disease 1 0.9999608993530273
disease I-Disease 1 0.9999985694885254
caused O 1 0.9574059247970581
by O 0 0.01382045354694128
progressive O 1 0.7481051683425903
degeneration O 1 0.9995238780975342
of O 0 0.010549763217568398
the O 0 0.013463865965604782
magnocellular O 1 0.993636965751648
neurons O 0 0.26276063919067383
of O 0 0.00727954413741827
the O 0 0.008832059800624847
hypothalamus O 0 0.14273163676261902
leading O 0 0.012962182983756065
to O 0 0.006550699006766081
decreased O 0 0.02030215971171856
ability O 0 0.011348220519721508
to O 0 0.0053559523075819016
produce O 0 0.01119785476475954
the O 0 0.011617591604590416
hormone O 1 0.8208431005477905
arginine O 0 0.3552583158016205
vasopressin O 1 0.968488335609436
( O 0 0.041238799691200256
AVP O 1 0.8497224450111389
) O 0 0.03383024036884308
. O 0 0.027038684114813805

Affected O 0 0.07000270485877991
individuals O 0 0.020485378801822662
are O 0 0.007921953685581684
not O 0 0.008560179732739925
symptomatic O 1 0.9841706156730652
at O 0 0.010809052735567093
birth O 0 0.0177068579941988
, O 0 0.006945745088160038
but O 0 0.007179899141192436
usually O 0 0.016756264492869377
develop O 1 0.7303375005722046
diabetes B-Disease 1 0.9999912977218628
insipidus I-Disease 1 0.9998456239700317
at O 0 0.02146822027862072
1 O 0 0.017735343426465988
- O 0 0.04256517440080643
6 O 0 0.02530709281563759
yr O 0 0.39403998851776123
of O 0 0.014712091535329819
age O 0 0.02891041338443756
. O 0 0.02444336749613285

The O 0 0.028757428750395775
genetic O 0 0.06938698887825012
locus O 0 0.06306155025959015
of O 0 0.009297112934291363
the O 0 0.010592329315841198
disease O 1 0.9989542961120605
is O 0 0.010236421599984169
the O 0 0.012204625643789768
AVP O 1 0.9953162670135498
- O 1 0.8305925130844116
neurophysin O 1 0.967613935470581
II O 0 0.32881584763526917
( O 0 0.027137521654367447
NPII O 1 0.7985439896583557
) O 0 0.018385393545031548
gene O 0 0.03802309185266495
, O 0 0.008060897700488567
and O 0 0.00865849107503891
mutations O 0 0.46931615471839905
that O 0 0.007284476421773434
cause O 0 0.10380126535892487
ADNDI B-Disease 0 0.43873101472854614
have O 0 0.005086673889309168
been O 0 0.004239422734826803
found O 0 0.0048958114348351955
in O 0 0.003594967070966959
both O 0 0.0033566420897841454
the O 0 0.004227337893098593
signal O 0 0.01470881700515747
peptide O 0 0.025591347366571426
of O 0 0.005608951207250357
the O 0 0.007670896593481302
prepro O 1 0.5912307500839233
- O 1 0.6659952402114868
AVP O 1 0.9935486912727356
- O 1 0.5592063665390015
NPII O 1 0.760509192943573
precursor O 0 0.04617748409509659
and O 0 0.011289766058325768
within O 0 0.016875771805644035
NPII O 0 0.1442289799451828
itself O 0 0.035273123532533646
. O 0 0.028373921290040016

An O 0 0.025912124663591385
affected O 0 0.041326288133859634
girl O 0 0.03806937113404274
who O 0 0.01162999588996172
presented O 0 0.00933537445962429
at O 0 0.006365008186548948
9 O 0 0.007535874377936125
months O 0 0.005900442134588957
of O 0 0.00334386364556849
age O 0 0.006920707877725363
and O 0 0.004175170324742794
her O 0 0.006976697128266096
similarly O 0 0.013863608241081238
affected O 0 0.018369160592556
younger O 0 0.013944821432232857
brother O 0 0.009406482800841331
and O 0 0.003620636183768511
father O 0 0.00549705047160387
were O 0 0.0025193565525114536
all O 0 0.002315864432603121
found O 0 0.0035967675503343344
to O 0 0.0030659169424325228
have O 0 0.00494538014754653
a O 0 0.008503656834363937
novel O 0 0.024340616539120674
missense O 1 0.7643123865127563
mutation O 1 0.908495306968689
( O 0 0.03260287269949913
G1758 O 1 0.8933470845222473
- O 1 0.8507106304168701
- O 1 0.7966529130935669
> O 1 0.9103242754936218
T O 1 0.6396340727806091
) O 0 0.017276519909501076
encoding O 0 0.028696056455373764
the O 0 0.010895001702010632
amino O 0 0.04144452512264252
acid O 0 0.15443755686283112
substitution O 0 0.06787077337503433
Gly23 O 1 0.9605224132537842
- O 1 0.8505949378013611
- O 1 0.8494968414306641
> O 1 0.8620113134384155
Val O 1 0.8319418430328369
within O 0 0.0326634906232357
NPII O 0 0.45245346426963806
. O 0 0.03828210011124611

The O 0 0.03177773952484131
mutation O 0 0.13089604675769806
was O 0 0.01636841893196106
confirmed O 0 0.025462564080953598
by O 0 0.015417180955410004
restriction O 0 0.050692569464445114
endonuclease O 0 0.244696244597435
analysis O 0 0.04559263586997986
. O 0 0.030397750437259674

A O 0 0.06917601823806763
T1 O 1 0.792415201663971
- O 0 0.07266177982091904
weighted O 0 0.04659280553460121
magnetic O 0 0.05080611631274223
resonance O 0 0.05187307670712471
imaging O 0 0.04334506392478943
of O 0 0.009564457461237907
the O 0 0.01127553079277277
fathers O 0 0.06009545922279358
pituitary O 1 0.9993224143981934
gland O 1 0.997832715511322
demonstrates O 0 0.06516803056001663
an O 0 0.022084008902311325
attenuated O 1 0.974060595035553
posterior O 1 0.9967899918556213
pituitary O 1 0.998988926410675
bright O 0 0.17781126499176025
spot O 0 0.05616879090666771
. O 0 0.036515723913908005

This O 0 0.02723347395658493
mutation O 0 0.20016613602638245
may O 0 0.014293914660811424
be O 0 0.005038795061409473
valuable O 0 0.008536797016859055
for O 0 0.004720288794487715
developing O 0 0.013391179032623768
models O 0 0.013466691598296165
of O 0 0.008804747834801674
dominantly B-Disease 1 0.8495374321937561
inherited I-Disease 1 0.9948195815086365
neurodegeneration I-Disease 1 0.9998528957366943
, O 0 0.009192954748868942
as O 0 0.00505156721919775
the O 0 0.005254253279417753
early O 0 0.008974828757345676
age O 0 0.012956353835761547
of O 0 0.008561152033507824
onset O 1 0.9995653033256531
of O 0 0.012289394624531269
symptoms O 1 0.9999593496322632
suggests O 0 0.024279439821839333
that O 0 0.006586245261132717
this O 0 0.006980552803725004
mutation O 0 0.40107598900794983
may O 0 0.011021162383258343
be O 0 0.0052284542471170425
particularly O 0 0.011701696552336216
deleterious O 0 0.10357171297073364
to O 0 0.010425965301692486
the O 0 0.015487302094697952
magnocellular O 1 0.9789902567863464
neuron O 1 0.8908580541610718
. O 0 0.02391805499792099
. O 0 0.02696818858385086

Frequent O 0 0.1530311554670334
inactivation O 1 0.6420388221740723
of O 0 0.03424551337957382
PTEN O 1 0.9994144439697266
/ O 1 0.9963861703872681
MMAC1 O 1 0.9782462120056152
in O 0 0.024807045236229897
primary O 1 0.7313936948776245
prostate B-Disease 1 0.9999979734420776
cancer I-Disease 1 0.9999842643737793
. O 0 0.05387824773788452

Sporadic B-Disease 1 0.9975641965866089
prostate I-Disease 1 0.9999947547912598
carcinoma I-Disease 1 0.9999810457229614
is O 0 0.013991015963256359
the O 0 0.00836949236690998
most O 0 0.008622254244983196
common O 0 0.016553014516830444
male B-Disease 0 0.11338524520397186
cancer I-Disease 1 0.9993769526481628
in O 0 0.004926661029458046
the O 0 0.0039056632667779922
Western O 0 0.0061464435420930386
world O 0 0.0056344070471823215
, O 0 0.0036612204276025295
yet O 0 0.003774711862206459
many O 0 0.002798967296257615
of O 0 0.0024394660722464323
the O 0 0.0037021206226199865
major O 0 0.007823288440704346
genetic O 0 0.02010270580649376
events O 0 0.00843681488186121
involved O 0 0.007181211840361357
in O 0 0.004504706710577011
the O 0 0.006149613298475742
progression O 0 0.06729432195425034
of O 0 0.006108559668064117
this O 0 0.007026771083474159
often O 0 0.01775948330760002
fatal O 1 0.9997609257698059
cancer B-Disease 1 0.9998168349266052
remain O 0 0.014827029779553413
to O 0 0.007293298840522766
be O 0 0.008809852413833141
elucidated O 0 0.05354815348982811
. O 0 0.023180624470114708

Numerous O 0 0.05915573239326477
cytogenetic O 1 0.5730283856391907
and O 0 0.02061905339360237
allelotype O 0 0.1144544929265976
studies O 0 0.02174619399011135
have O 0 0.009490893222391605
reported O 0 0.016180533915758133
frequent O 0 0.026239126920700073
loss O 0 0.024365825578570366
of O 0 0.010849482379853725
heterozygosity O 1 0.6786639094352722
on O 0 0.017794936895370483
chromosomal O 1 0.8580977916717529
arm O 1 0.6928585767745972
10q O 1 0.8899051547050476
in O 0 0.032772984355688095
sporadic B-Disease 1 0.9936670660972595
prostate I-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999880790710449
. O 0 0.05541723594069481

Deletion O 0 0.23304110765457153
mapping O 0 0.06526245921850204
studies O 0 0.030974088236689568
have O 0 0.013245992362499237
unambiguously O 0 0.036075737327337265
identified O 0 0.014025310985744
a O 0 0.008384556509554386
region O 0 0.015204411931335926
of O 0 0.007534433156251907
chromosome O 0 0.06559877097606659
10q23 O 0 0.03819252923130989
to O 0 0.005662248935550451
be O 0 0.0033585536293685436
the O 0 0.005533228162676096
minimal O 0 0.015748295933008194
area O 0 0.011025257408618927
of O 0 0.007049031089991331
loss O 0 0.0318325012922287
. O 0 0.02270454540848732

A O 0 0.05741889029741287
new O 0 0.053191736340522766
tumor B-Disease 1 0.999022364616394
suppressor O 1 0.99403977394104
gene O 1 0.6781411170959473
, O 0 0.027082793414592743
PTEN O 1 0.9992493987083435
/ O 1 0.9859464764595032
MMAC1 O 1 0.6394999027252197
, O 0 0.009998545050621033
was O 0 0.007127209100872278
isolated O 0 0.018689576536417007
recently O 0 0.010384461842477322
at O 0 0.006025705952197313
this O 0 0.0036959946155548096
region O 0 0.009937703609466553
of O 0 0.006331063341349363
chromosome O 0 0.0966358333826065
10q23 O 0 0.04084273427724838
and O 0 0.005624448414891958
found O 0 0.005575741641223431
to O 0 0.0038903835229575634
be O 0 0.004156000912189484
inactivated O 0 0.02424653246998787
by O 0 0.009593350812792778
mutation O 0 0.30692699551582336
in O 0 0.011508029885590076
three O 0 0.02166363224387169
prostate B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999936819076538
cell O 1 0.8785685896873474
lines O 0 0.046148139983415604
. O 0 0.03342949599027634

We O 0 0.0412796214222908
screened O 0 0.10904780775308609
80 O 0 0.18305060267448425
prostate B-Disease 1 0.9999750852584839
tumors I-Disease 1 0.9998440742492676
by O 0 0.019885577261447906
microsatellite O 0 0.4618449807167053
analysis O 0 0.019536133855581284
and O 0 0.008083607070147991
found O 0 0.01243129838258028
chromosome O 0 0.07569155097007751
10q23 O 0 0.04587397351861
to O 0 0.006570009980350733
be O 0 0.004786048550158739
deleted O 0 0.0153783168643713
in O 0 0.006934532430022955
23 O 0 0.016809649765491486
cases O 0 0.025102246552705765
. O 0 0.020743276923894882

We O 0 0.019484389573335648
then O 0 0.012909859418869019
proceeded O 0 0.017888186499476433
with O 0 0.008159921504557133
sequence O 0 0.014486182481050491
analysis O 0 0.009990180842578411
of O 0 0.005022241268306971
the O 0 0.00904971081763506
entire O 0 0.028118474408984184
PTEN O 1 0.9981738328933716
/ O 1 0.9627960324287415
MMAC1 O 1 0.7708292007446289
coding O 0 0.05614142864942551
region O 0 0.02270633727312088
and O 0 0.00869095977395773
tested O 0 0.022231340408325195
for O 0 0.007776252925395966
homozygous O 0 0.05723830685019493
deletion O 0 0.06776252388954163
with O 0 0.009017722681164742
new O 0 0.011210945434868336
intragenic O 0 0.06366574019193649
markers O 0 0.02518918551504612
in O 0 0.006263467483222485
these O 0 0.005801316350698471
23 O 0 0.010236643254756927
cases O 0 0.011556650511920452
with O 0 0.008174383081495762
10q23 O 0 0.2169809341430664
loss O 0 0.03663187846541405
of O 0 0.01477857492864132
heterozygosity O 1 0.9278111457824707
. O 0 0.041918955743312836

The O 0 0.018378404900431633
identification O 0 0.016448885202407837
of O 0 0.0057367682456970215
the O 0 0.006753134075552225
second O 0 0.01230577565729618
mutational O 0 0.2151261419057846
event O 0 0.01850745640695095
in O 0 0.006869061850011349
10 O 0 0.00920618511736393
( O 0 0.01152830757200718
43 O 0 0.018076397478580475
% O 0 0.016606518998742104
) O 0 0.028630422428250313
tumors B-Disease 1 0.9998772144317627
establishes O 1 0.9541547298431396
PTEN O 1 0.9997633099555969
/ O 1 0.9619226455688477
MMAC1 O 0 0.18454240262508392
as O 0 0.007572193630039692
a O 0 0.008340880274772644
main O 0 0.011179179884493351
inactivation O 0 0.05108015984296799
target O 0 0.01686701737344265
of O 0 0.00968894362449646
10q O 0 0.45148852467536926
loss O 0 0.2810002267360687
in O 0 0.019047042354941368
sporadic B-Disease 1 0.9954505562782288
prostate I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999897480010986
. O 0 0.024033034220337868
. O 0 0.027099130675196648

Risk O 1 0.9365467429161072
reversals O 0 0.20114436745643616
in O 0 0.02604260854423046
predictive O 0 0.09781941771507263
testing O 0 0.06414622068405151
for O 0 0.029219478368759155
Huntington B-Disease 1 0.9998774528503418
disease I-Disease 1 0.999954342842102
. O 0 0.05139051750302315

The O 0 0.024164317175745964
first O 0 0.021421702578663826
predictive O 0 0.07589039951562881
testing O 0 0.04617979750037193
for O 0 0.022263312712311745
Huntington B-Disease 1 0.9999269247055054
disease I-Disease 1 0.9999653100967407
( O 0 0.022385763004422188
HD B-Disease 0 0.04471123218536377
) O 0 0.009422936476767063
was O 0 0.004793244414031506
based O 0 0.006218126974999905
on O 0 0.004425307735800743
analysis O 0 0.01012884359806776
of O 0 0.007261986378580332
linked O 0 0.03135181590914726
polymorphic O 0 0.41994309425354004
DNA O 0 0.03301865607500076
markers O 0 0.026693085208535194
to O 0 0.007018485572189093
estimate O 0 0.01282555516809225
the O 0 0.005676360335201025
likelihood O 0 0.019118167459964752
of O 0 0.006528462283313274
inheriting O 0 0.04431765526533127
the O 0 0.013081823475658894
mutation O 0 0.11127109825611115
for O 0 0.015137176029384136
HD B-Disease 0 0.08544959872961044
. O 0 0.030548179522156715

Limits O 0 0.04022107645869255
to O 0 0.012124942615628242
accuracy O 0 0.01718062162399292
included O 0 0.011199449189007282
recombination O 0 0.03985390439629555
between O 0 0.008677220903337002
the O 0 0.007040254771709442
DNA O 0 0.020177239552140236
markers O 0 0.023220723494887352
and O 0 0.006148471496999264
the O 0 0.00752373319119215
mutation O 0 0.22859035432338715
, O 0 0.008381436578929424
pedigree O 0 0.03040826879441738
structure O 0 0.011266423389315605
, O 0 0.0053579979576170444
and O 0 0.004730696324259043
whether O 0 0.0073131597600877285
DNA O 0 0.01581055484712124
samples O 0 0.012418344616889954
were O 0 0.003892237087711692
available O 0 0.006129908375442028
from O 0 0.0063100578263401985
family O 0 0.012568557634949684
members O 0 0.01149721909314394
. O 0 0.017894376069307327

With O 0 0.022323118522763252
direct O 0 0.02611454576253891
tests O 0 0.01910114660859108
for O 0 0.008140680380165577
the O 0 0.00907081738114357
HD B-Disease 0 0.04968997836112976
mutation O 0 0.07364645600318909
, O 0 0.006656007841229439
we O 0 0.004397064447402954
have O 0 0.003939848858863115
assessed O 0 0.01037671696394682
the O 0 0.0038471973966807127
accuracy O 0 0.007976961322128773
of O 0 0.003930055536329746
results O 0 0.00786945503205061
obtained O 0 0.0061409203335642815
by O 0 0.005620989948511124
linkage O 0 0.02915460243821144
approaches O 0 0.017916755750775337
when O 0 0.006329971365630627
requested O 0 0.0072544654831290245
to O 0 0.004599287174642086
do O 0 0.004567483440041542
so O 0 0.003780274884775281
by O 0 0.003836011281237006
the O 0 0.005582278128713369
test O 0 0.016225852072238922
individuals O 0 0.018925080075860023
. O 0 0.022377321496605873

For O 0 0.015484350733458996
six O 0 0.01129261963069439
such O 0 0.006725947838276625
individuals O 0 0.009398963302373886
, O 0 0.004905256908386946
there O 0 0.004679774399846792
was O 0 0.004525601863861084
significant O 0 0.010152268223464489
disparity O 0 0.028955301269888878
between O 0 0.010005003772675991
the O 0 0.008305302821099758
tests O 0 0.025734908878803253
. O 0 0.02015848644077778

Three O 0 0.02043945901095867
went O 0 0.017087135463953018
from O 0 0.008726576343178749
a O 0 0.009485543705523014
decreased O 0 0.03012239560484886
risk O 0 0.05444435402750969
to O 0 0.005122295580804348
an O 0 0.005313744768500328
increased O 0 0.01128434482961893
risk O 0 0.03886645659804344
, O 0 0.004059766884893179
while O 0 0.0035084180999547243
in O 0 0.002884672023355961
another O 0 0.004660933278501034
three O 0 0.004441823344677687
the O 0 0.006302169058471918
risk O 0 0.03960196301341057
was O 0 0.011459609493613243
decreased O 0 0.04139342159032822
. O 0 0.02363819256424904

Knowledge O 0 0.025126907974481583
of O 0 0.008321858942508698
the O 0 0.0073610153049230576
potential O 0 0.012989764101803303
reasons O 0 0.008228584192693233
for O 0 0.004075855016708374
these O 0 0.003734211903065443
changes O 0 0.006316441111266613
in O 0 0.003693424863740802
results O 0 0.006972155999392271
and O 0 0.003793734824284911
impact O 0 0.009557638317346573
of O 0 0.00364872463978827
these O 0 0.005297455936670303
risk O 0 0.2960802912712097
reversals O 0 0.05452077463269234
on O 0 0.004986550193279982
both O 0 0.005764265079051256
patients O 1 0.9050658345222473
and O 0 0.004779398441314697
the O 0 0.005731294862926006
counseling O 0 0.0662306398153305
team O 0 0.007821164093911648
can O 0 0.004755791276693344
assist O 0 0.008176441304385662
in O 0 0.00325421872548759
the O 0 0.003197635756805539
development O 0 0.006101488135755062
of O 0 0.003837190568447113
strategies O 0 0.014888770878314972
for O 0 0.003968579228967428
the O 0 0.005209246650338173
prevention O 1 0.6985365748405457
and O 0 0.0041011618450284
, O 0 0.004046997055411339
where O 0 0.004121830221265554
necessary O 0 0.0051582795567810535
, O 0 0.004220138303935528
management O 0 0.00791869405657053
of O 0 0.00375781930051744
a O 0 0.006485543213784695
risk O 0 0.15683923661708832
reversal O 0 0.03354773670434952
in O 0 0.007181300316005945
any O 0 0.00843864120543003
predictive O 0 0.041453707963228226
testing O 0 0.026253778487443924
program O 0 0.021297506988048553
. O 0 0.012532503344118595
. O 0 0.01814330741763115

A O 0 0.042790487408638
novel O 0 0.052925676107406616
common O 0 0.0465971902012825
missense O 1 0.6574393510818481
mutation O 1 0.6142005324363708
G301C O 0 0.08371735364198685
in O 0 0.014349945820868015
the O 0 0.014563665725290775
N O 0 0.04500512033700943
- O 0 0.22287504374980927
acetylgalactosamine O 1 0.8557069301605225
- O 1 0.7499834895133972
6 O 0 0.056377850472927094
- O 1 0.9741038084030151
sulfate O 1 0.9991371035575867
sulfatase O 1 0.9988048076629639
gene O 0 0.35493725538253784
in O 0 0.032892629504203796
mucopolysaccharidosis B-Disease 1 0.9599512815475464
IVA I-Disease 1 0.9921268224716187
. O 0 0.05021987855434418

Mucopolysaccharidosis B-Disease 1 0.9918883442878723
IVA I-Disease 1 0.9984979629516602
( O 0 0.07257284224033356
MPS B-Disease 1 0.676348865032196
IVA I-Disease 1 0.9988653659820557
) O 0 0.02304755337536335
is O 0 0.012695478275418282
an O 0 0.01524600014090538
autosomal B-Disease 1 0.9999344348907471
recessive I-Disease 1 0.999987006187439
lysosomal I-Disease 1 0.9999758005142212
storage I-Disease 1 0.9928346872329712
disorder I-Disease 1 0.9999839067459106
caused O 1 0.5564123392105103
by O 0 0.014641485176980495
a O 0 0.017272084951400757
genetic B-Disease 1 0.82318115234375
defect I-Disease 1 0.9927991628646851
in O 0 0.017558662220835686
N O 0 0.07595159858465195
- O 0 0.4947562515735626
acetylgalactosamine O 1 0.9635350108146667
- O 1 0.7937340140342712
6 O 0 0.0536612831056118
- O 1 0.9777787327766418
sulfate O 1 0.9994122982025146
sulfatase O 1 0.9993197917938232
( O 0 0.04971254616975784
GALNS O 1 0.6745998859405518
) O 0 0.03322663530707359
. O 0 0.02975456416606903

In O 0 0.018944861367344856
previous O 0 0.014727402478456497
studies O 0 0.014250364154577255
, O 0 0.005034861620515585
we O 0 0.0038663081359118223
have O 0 0.003814829047769308
found O 0 0.00492876535281539
two O 0 0.0046524349600076675
common O 0 0.012604030780494213
mutations O 0 0.257724791765213
in O 0 0.007205737289041281
Caucasians O 0 0.24336829781532288
and O 0 0.007584659848362207
Japanese O 0 0.011801197193562984
, O 0 0.008556995540857315
respectively O 0 0.016287466511130333
. O 0 0.01794436387717724

To O 0 0.029763907194137573
characterize O 0 0.06514101475477219
the O 0 0.01934145949780941
mutational O 0 0.3383842408657074
spectrum O 0 0.031964197754859924
in O 0 0.007905339822173119
various O 0 0.006567750591784716
ethnic O 0 0.011361313052475452
groups O 0 0.012878772802650928
, O 0 0.008288940414786339
mutations O 0 0.05772446468472481
in O 0 0.007899649441242218
the O 0 0.009398408234119415
GALNS O 1 0.5157097578048706
gene O 0 0.051642462611198425
in O 0 0.01159337256103754
Colombian O 0 0.058882392942905426
MPS B-Disease 1 0.9461145997047424
IVA I-Disease 1 0.9999451637268066
patients O 1 0.9984149932861328
were O 0 0.008369777351617813
investigated O 0 0.015374910086393356
, O 0 0.005446892697364092
and O 0 0.005887456238269806
genetic O 0 0.02401229366660118
backgrounds O 0 0.017780307680368423
were O 0 0.00552799878641963
extensively O 0 0.010865947231650352
analyzed O 0 0.013112918473780155
to O 0 0.005508850794285536
identify O 0 0.01316563505679369
racial O 0 0.016601266339421272
origin O 0 0.011045563966035843
, O 0 0.005755284335464239
based O 0 0.007300081662833691
on O 0 0.007217837031930685
mitochondrial O 0 0.044891636818647385
DNA O 0 0.03731606900691986
( O 0 0.02418285235762596
mtDNA O 0 0.0681874006986618
) O 0 0.02370629459619522
lineages O 0 0.06985654681921005
. O 0 0.027357837185263634

Three O 0 0.039745625108480453
novel O 0 0.0550663024187088
missense O 1 0.6970846652984619
mutations O 0 0.3998335599899292
never O 0 0.017889391630887985
identified O 0 0.012358988635241985
previously O 0 0.007880542427301407
in O 0 0.004422198981046677
other O 0 0.00478443643078208
populations O 0 0.014864270575344563
and O 0 0.004558522719889879
found O 0 0.005401527974754572
in O 0 0.004045609850436449
16 O 0 0.0064564780332148075
out O 0 0.00518546300008893
of O 0 0.005627150647342205
19 O 0 0.014425340108573437
Colombian O 0 0.03097355365753174
MPS B-Disease 0 0.16867747902870178
IVA I-Disease 1 0.9974634647369385
unrelated O 0 0.06715098023414612
alleles O 0 0.20699720084667206
account O 0 0.025445759296417236
for O 0 0.01704050973057747
84 O 0 0.04716536030173302
. O 0 0.031000057235360146

2 O 0 0.028466103598475456
% O 0 0.016773264855146408
of O 0 0.006517826113849878
the O 0 0.008902674540877342
alleles O 0 0.05051150545477867
in O 0 0.010135490447282791
this O 0 0.009131303988397121
study O 0 0.020804716274142265
. O 0 0.01952824369072914

The O 0 0.03866599127650261
G301C O 0 0.11943957954645157
and O 0 0.025319529697299004
S162F O 0 0.1809542030096054
mutations O 0 0.10974282771348953
account O 0 0.024474069476127625
for O 0 0.01374230720102787
68 O 0 0.044448938220739365
. O 0 0.026177287101745605

4 O 0 0.03881509229540825
% O 0 0.023650063201785088
and O 0 0.011269929818809032
10 O 0 0.019073503091931343
. O 0 0.021156292408704758

5 O 0 0.029554517939686775
% O 0 0.01766330935060978
of O 0 0.009437751024961472
mutations O 0 0.06301625072956085
, O 0 0.006516869179904461
respectively O 0 0.007166464813053608
, O 0 0.004800292197614908
whereas O 0 0.008394497446715832
the O 0 0.004356797784566879
remaining O 0 0.009116278029978275
F69V O 0 0.040309105068445206
is O 0 0.006555076222866774
limited O 0 0.00862080417573452
to O 0 0.00574516411870718
a O 0 0.009596300311386585
single O 0 0.019744087010622025
allele O 0 0.09549335390329361
. O 0 0.031378671526908875

The O 0 0.034070130437612534
skewed O 0 0.09160870313644409
prevalence O 1 0.726908266544342
of O 0 0.014598057605326176
G301C O 0 0.06273458898067474
in O 0 0.011021405458450317
only O 0 0.009754925966262817
Colombian O 0 0.03741701319813728
patients O 1 0.9904657602310181
and O 0 0.011899863369762897
haplotype O 1 0.8095943927764893
analysis O 0 0.017819955945014954
by O 0 0.009371021762490273
restriction O 0 0.02389107458293438
fragment O 0 0.03698927164077759
length O 0 0.020280538126826286
polymorphisms O 0 0.06073710694909096
in O 0 0.010958160273730755
the O 0 0.012020527385175228
GALNS O 1 0.6504672765731812
gene O 0 0.062174320220947266
suggest O 0 0.022652361541986465
that O 0 0.009044205769896507
G301C O 0 0.045386698096990585
originated O 0 0.020198272541165352
from O 0 0.008882489055395126
a O 0 0.01010008342564106
common O 0 0.02210654318332672
ancestor O 0 0.04973578825592995
. O 0 0.03348312899470329

Investigation O 0 0.031508561223745346
of O 0 0.009700235910713673
the O 0 0.009061616845428944
genetic O 0 0.03396233543753624
background O 0 0.014725597575306892
by O 0 0.005548969842493534
means O 0 0.009131213650107384
of O 0 0.006481390446424484
mtDNA O 0 0.04172052443027496
lineages O 0 0.033357102423906326
indicate O 0 0.013437215238809586
that O 0 0.004619520157575607
all O 0 0.003750941948965192
our O 0 0.007161127403378487
patients O 1 0.7844005227088928
are O 0 0.005275839939713478
probably O 0 0.010233156383037567
of O 0 0.005763994064182043
native O 0 0.01500768307596445
American O 0 0.026542533189058304
descent O 0 0.08647474646568298

Low O 0 0.0954456478357315
frequency O 0 0.06701702624559402
of O 0 0.024022342637181282
BRCA1 O 1 0.9975638389587402
germline O 1 0.9956812858581543
mutations O 1 0.9523553848266602
in O 0 0.02075892686843872
45 O 0 0.05113773047924042
German O 1 0.9814119935035706
breast B-Disease 1 0.9999992847442627
/ I-Disease 1 0.9999940395355225
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999967813491821
families O 0 0.13638831675052643
. O 0 0.03407749533653259

In O 0 0.01651845872402191
this O 0 0.008702905848622322
study O 0 0.01450244802981615
we O 0 0.009696327149868011
investigated O 0 0.02656926028430462
45 O 0 0.038224756717681885
German O 1 0.970406174659729
breast B-Disease 1 0.9999994039535522
/ I-Disease 1 0.9999978542327881
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999974966049194
families O 0 0.0664006695151329
for O 0 0.017179276794195175
germline O 1 0.9948796033859253
mutations O 1 0.6655502915382385
in O 0 0.01325396541506052
the O 0 0.018846338614821434
BRCA1 O 1 0.9965196847915649
gene O 0 0.4250158965587616
. O 0 0.03962383791804314

We O 0 0.022778697311878204
identified O 0 0.02855951339006424
four O 0 0.019043345004320145
germline O 1 0.98946613073349
mutations O 1 0.8874713182449341
in O 0 0.0144455311819911
three O 0 0.017680270597338676
breast B-Disease 1 0.9999936819076538
cancer I-Disease 1 0.9999847412109375
families O 0 0.02276134118437767
and O 0 0.00732256006449461
in O 0 0.008963028900325298
one O 0 0.08837063610553741
breast B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999874830245972
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999969005584717
family O 0 0.024016249924898148
. O 0 0.006672125309705734
among O 0 0.006094736512750387
these O 0 0.004029464442282915
were O 0 0.004641006700694561
one O 0 0.008738867938518524
frameshift O 1 0.8783659934997559
mutation O 0 0.33399781584739685
, O 0 0.010064784437417984
one O 0 0.010998026467859745
nonsense O 0 0.030021721497178078
mutation O 0 0.06641359627246857
, O 0 0.007214380428195
one O 0 0.006694538053125143
novel O 0 0.0162665918469429
splice O 0 0.0640740841627121
site O 0 0.020598184317350388
mutation O 0 0.08799709379673004
, O 0 0.00958616379648447
and O 0 0.008091161958873272
one O 0 0.014381706714630127
missense O 0 0.46703171730041504
mutation O 1 0.7777953147888184
. O 0 0.03689802810549736

The O 0 0.04341037943959236
missense O 1 0.6060456037521362
mutation O 0 0.15071320533752441
was O 0 0.013748383149504662
also O 0 0.008223410695791245
found O 0 0.009485390968620777
in O 0 0.008993546478450298
2 O 0 0.018513549119234085
. O 0 0.020137637853622437

8 O 0 0.02720622718334198
% O 0 0.012034192681312561
of O 0 0.004583221860229969
the O 0 0.0040937443263828754
general O 0 0.00697332201525569
population O 0 0.008594606071710587
, O 0 0.005005802493542433
suggesting O 0 0.010232334956526756
that O 0 0.0037901103496551514
it O 0 0.004433138761669397
is O 0 0.006548161152750254
not O 0 0.008707522414624691
disease O 1 0.9993401169776917
associated O 0 0.028015118092298508
. O 0 0.024184102192521095

The O 0 0.024054771289229393
average O 0 0.029772665351629257
age O 0 0.025065073743462563
of O 0 0.015229872427880764
disease O 1 0.9999843835830688
onset O 1 0.9997313618659973
in O 0 0.011456051841378212
those O 0 0.010995795950293541
families O 0 0.0322282612323761
harbouring O 1 0.9938429594039917
causative O 1 0.9907982349395752
mutations O 1 0.7639104127883911
was O 0 0.015310163609683514
between O 0 0.01732771284878254
32 O 0 0.02975582517683506
. O 0 0.024562647566199303

3 O 0 0.04020509123802185
and O 0 0.018000595271587372
37 O 0 0.03895513340830803
. O 0 0.027212092652916908

4 O 0 0.02894522435963154
years O 0 0.014204980805516243
, O 0 0.00836307555437088
whereas O 0 0.013463955372571945
the O 0 0.0077437227591872215
family O 0 0.015999069437384605
harbouring O 0 0.39092135429382324
the O 0 0.014168555848300457
missense O 1 0.7129780054092407
mutation O 0 0.2684314250946045
had O 0 0.009203585796058178
an O 0 0.00597799476236105
average O 0 0.01112756785005331
age O 0 0.0117725171148777
of O 0 0.008413932286202908
onset O 1 0.9361886382102966
of O 0 0.011735322885215282
51 O 0 0.03638385236263275
. O 0 0.025137219578027725

2 O 0 0.050556909292936325
years O 0 0.03447622433304787
. O 0 0.03203802555799484

These O 0 0.0226295106112957
findings O 0 0.029375748708844185
show O 0 0.018558427691459656
that O 0 0.010222719050943851
BRCA1 O 1 0.8992128968238831
is O 0 0.009739529341459274
implicated O 0 0.027926286682486534
in O 0 0.0064956690184772015
a O 0 0.007055428344756365
small O 0 0.009559860453009605
fraction O 0 0.023889847099781036
of O 0 0.023989969864487648
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999980926513672
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999980926513672
families O 0 0.07406355440616608
suggesting O 0 0.024488400667905807
the O 0 0.008680932223796844
involvement O 0 0.019545909017324448
of O 0 0.009100831113755703
another O 0 0.01734917424619198
susceptibility O 1 0.9726300239562988
gene O 0 0.2904178202152252
( O 0 0.03787428140640259
s O 0 0.07702431827783585
) O 0 0.045234378427267075

Paternal O 1 0.918151319026947
transmission O 1 0.96670001745224
of O 0 0.11883333325386047
congenital B-Disease 1 0.9999983310699463
myotonic I-Disease 1 0.9999971389770508
dystrophy I-Disease 1 0.999997615814209
. O 0 0.0982421338558197

We O 0 0.02132251299917698
report O 0 0.016029974445700645
a O 0 0.013386612758040428
rare O 0 0.022300321608781815
case O 0 0.018306562677025795
of O 0 0.016827361658215523
paternally O 1 0.9972625970840454
transmitted O 1 0.9996517896652222
congenital B-Disease 1 0.9999997615814209
myotonic I-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9961994290351868
DM B-Disease 1 0.9999831914901733
) O 0 0.04653247073292732
. O 0 0.03552345559000969

The O 0 0.023549538105726242
proband O 0 0.06485682725906372
is O 0 0.009433187544345856
a O 0 0.008622645400464535
23 O 0 0.01203001569956541
year O 0 0.009353035129606724
old O 0 0.01258082501590252
, O 0 0.012219788506627083
mentally B-Disease 1 0.9981020092964172
retarded I-Disease 1 0.9990575909614563
male O 1 0.7167832851409912
who O 1 0.6292845606803894
suffers O 1 0.9999781847000122
severe O 1 0.9999370574951172
muscular B-Disease 1 0.9999415874481201
weakness I-Disease 1 0.9976701140403748
. O 0 0.04028074070811272

He O 0 0.02209319733083248
presented O 0 0.02278010919690132
with O 0 0.017980197444558144
respiratory O 1 0.9999151229858398
and O 0 0.01282440684735775
feeding O 0 0.04642867669463158
difficulties O 0 0.05412571132183075
at O 0 0.0236537866294384
birth O 0 0.046662647277116776
. O 0 0.027695124968886375

His O 0 0.04035230726003647
two O 0 0.03677018731832504
sibs O 1 0.9968851208686829
suffer O 1 0.9958635568618774
from O 0 0.04417230933904648
childhood O 1 0.9974989295005798
onset O 1 0.9999175071716309
DM B-Disease 1 0.9999275207519531
. O 0 0.05812269076704979

Their O 0 0.020084252581000328
late O 0 0.020819006487727165
father O 0 0.015179392881691456
had O 0 0.009038305841386318
the O 0 0.007126325741410255
adult O 0 0.020036796107888222
type O 0 0.022738663479685783
of O 0 0.011360670439898968
DM B-Disease 1 0.9999581575393677
, O 0 0.011096611618995667
with O 0 0.01308296900242567
onset O 1 0.9827032089233398
around O 0 0.016466638073325157
30 O 0 0.01676509529352188
years O 0 0.01745782047510147
. O 0 0.020026182755827904

Only O 0 0.015113824978470802
six O 0 0.01252773217856884
other O 0 0.00787839014083147
cases O 0 0.01622391678392887
of O 0 0.012089935131371021
paternal O 0 0.20104876160621643
transmission O 1 0.7883355021476746
of O 0 0.02604076638817787
congenital B-Disease 1 0.9999986886978149
DM I-Disease 1 0.9999908208847046
have O 0 0.015087203122675419
been O 0 0.00982687622308731
reported O 0 0.01866280287504196
recently O 0 0.023049479350447655
. O 0 0.022786090150475502

We O 0 0.021115096285939217
review O 0 0.01822984591126442
the O 0 0.009989021345973015
sex O 0 0.022850967943668365
related O 0 0.020993338897824287
effects O 0 0.05058946833014488
on O 0 0.011461679823696613
transmission O 0 0.2522793412208557
of O 0 0.0222444087266922
congenital B-Disease 1 0.9999961853027344
DM I-Disease 1 0.9999840259552002
. O 0 0.04949779063463211

Decreased O 0 0.4171704053878784
fertility O 0 0.4550722539424896
of O 0 0.017167750746011734
males O 0 0.04195815697312355
with O 0 0.020084086805582047
adult O 0 0.4714924693107605
onset O 1 0.9999359846115112
DM B-Disease 1 0.9999808073043823
and O 0 0.015529443509876728
contraction O 0 0.05603254958987236
of O 0 0.007041385862976313
the O 0 0.007954447530210018
repeat O 0 0.029978377744555473
upon O 0 0.010241609998047352
male O 0 0.022174082696437836
transmission O 0 0.030834775418043137
contribute O 0 0.01788996160030365
to O 0 0.006021892186254263
the O 0 0.005979893263429403
almost O 0 0.009002785198390484
absent O 0 0.025511719286441803
occurrence O 0 0.03504824638366699
of O 0 0.010727892629802227
paternal O 0 0.23575709760189056
transmission O 1 0.6482908129692078
of O 0 0.02942933887243271
congenital B-Disease 1 0.9999949932098389
DM I-Disease 1 0.9999873638153076
. O 0 0.05108916014432907

Also O 0 0.018068866804242134
the O 0 0.009872711263597012
fathers O 0 0.019879454746842384
of O 0 0.006214804016053677
the O 0 0.007497711572796106
reported O 0 0.020048024132847786
congenitally O 1 0.9361056089401245
affected O 0 0.047826167196035385
children O 0 0.01637803204357624
showed O 0 0.011375637724995613
, O 0 0.004955452401190996
on O 0 0.004272796213626862
average O 0 0.010645472444593906
, O 0 0.009216152131557465
shorter O 0 0.02988341636955738
CTG O 1 0.6671319007873535
repeat O 0 0.041863396763801575
lengths O 0 0.032264143228530884
and O 0 0.009735661558806896
hence O 0 0.02268141508102417
less O 0 0.020788030698895454
severe O 1 0.9998056292533875
clinical O 1 0.9997319579124451
symptoms O 1 0.9999616146087646
than O 0 0.00861953105777502
the O 0 0.007555027026683092
mothers O 0 0.061927881091833115
of O 0 0.007589183282107115
children O 0 0.025223923847079277
with O 0 0.027072103694081306
congenital B-Disease 1 0.9999964237213135
DM I-Disease 1 0.9999796152114868
. O 0 0.05674952268600464

We O 0 0.03234263136982918
conclude O 0 0.04464658722281456
that O 0 0.014945778995752335
paternal O 0 0.1660032570362091
transmission O 1 0.6827717423439026
of O 0 0.02740694396197796
congenital B-Disease 1 0.9999978542327881
DM I-Disease 1 0.9999878406524658
is O 0 0.01664128713309765
rare O 0 0.026432132348418236
and O 0 0.010373109951615334
preferentially O 0 0.17366372048854828
occurs O 0 0.032208673655986786
with O 0 0.012765484862029552
onset O 1 0.9974907636642456
of O 0 0.014126046560704708
DM B-Disease 1 0.9998584985733032
past O 0 0.018013468012213707
30 O 0 0.011268102563917637
years O 0 0.0066282968036830425
in O 0 0.004949773196130991
the O 0 0.0049963113851845264
father O 0 0.01230086199939251
. O 0 0.011862479150295258
. O 0 0.01990174874663353

The O 0 0.06295567005872726
RB1 O 1 0.9940924048423767
gene O 0 0.3215823471546173
mutation O 0 0.33052095770835876
in O 0 0.013058106414973736
a O 0 0.014917648397386074
child O 0 0.0335918664932251
with O 0 0.028355039656162262
ectopic B-Disease 1 0.9996157884597778
intracranial I-Disease 1 0.9996522665023804
retinoblastoma I-Disease 1 0.9990246295928955
. O 0 0.06292805075645447

The O 0 0.0593402273952961
RB1 O 1 0.9953755140304565
gene O 1 0.5197334289550781
mutation O 1 0.5152500867843628
was O 0 0.012368164956569672
investigated O 0 0.01978578045964241
in O 0 0.007924389094114304
a O 0 0.009916212409734726
child O 0 0.026371000334620476
with O 0 0.019407356157898903
ectopic B-Disease 1 0.9995720982551575
intracranial I-Disease 1 0.9995431900024414
retinoblastoma I-Disease 1 0.9959039092063904
using O 0 0.018184080719947815
DNA O 0 0.023995714262127876
obtained O 0 0.008917341008782387
from O 0 0.006266632117331028
both O 0 0.006170836742967367
the O 0 0.008551993407309055
pineal B-Disease 1 0.9963839054107666
and I-Disease 0 0.017425404861569405
retinal I-Disease 1 0.9998980760574341
tumours I-Disease 1 0.9995450377464294
of O 0 0.01279781199991703
the O 0 0.01646958850324154
patient O 1 0.7863335609436035
. O 0 0.028882283717393875

A O 0 0.04903186485171318
nonsense O 0 0.08316624909639359
mutation O 0 0.11559192091226578
in O 0 0.019949181005358696
exon O 0 0.06927167624235153
17 O 0 0.0272024217993021
( O 0 0.020811883732676506
codon O 0 0.0602896623313427
556 O 0 0.051083214581012726
) O 0 0.012844821438193321
of O 0 0.006565921939909458
the O 0 0.01087101735174656
RB1 O 1 0.9947226047515869
gene O 0 0.034018851816654205
was O 0 0.0059094661846756935
found O 0 0.005194703117012978
to O 0 0.0035937358625233173
be O 0 0.003478045342490077
present O 0 0.00660707475617528
homozygously O 0 0.02569771558046341
in O 0 0.005274869967252016
both O 0 0.0061109913513064384
the O 0 0.007973105646669865
retinal B-Disease 1 0.9937600493431091
and I-Disease 0 0.013081160373985767
the I-Disease 0 0.019049333408474922
pineal I-Disease 1 0.9990891218185425
tumours I-Disease 1 0.9995473027229309
. O 0 0.043919920921325684

The O 0 0.020398441702127457
same O 0 0.02002865821123123
mutation O 0 0.0679018422961235
was O 0 0.009868796914815903
present O 0 0.010760308243334293
heterozygously O 0 0.03408646211028099
in O 0 0.0054828934371471405
the O 0 0.004088389687240124
DNA O 0 0.012990509159862995
from O 0 0.004585506860166788
the O 0 0.004524385556578636
constitutional O 0 0.008076907135546207
cells O 0 0.017327385023236275
of O 0 0.004036746919155121
the O 0 0.005977778695523739
patient O 0 0.260151207447052
, O 0 0.005807876121252775
proving O 0 0.011915841139853
it O 0 0.0038362955674529076
to O 0 0.0040664649568498135
be O 0 0.004341806750744581
of O 0 0.00763049116358161
germline O 0 0.4115421175956726
origin O 0 0.030703077092766762
. O 0 0.025869732722640038

The O 0 0.02577563188970089
initial O 0 0.03868898004293442
mutation O 0 0.07594455778598785
was O 0 0.010132036171853542
shown O 0 0.010673174634575844
to O 0 0.005945300683379173
have O 0 0.005785375367850065
occurred O 0 0.013076727278530598
in O 0 0.0070898523554205894
the O 0 0.011708282865583897
paternally O 0 0.1078425869345665
derived O 0 0.060070428997278214
RB1 O 1 0.9921506643295288
allele O 0 0.44542115926742554
. O 0 0.047730475664138794

The O 0 0.02309098280966282
mutation O 0 0.06778379529714584
is O 0 0.007568493951112032
in O 0 0.004379687365144491
an O 0 0.003799986094236374
area O 0 0.005796071607619524
of O 0 0.003547273576259613
the O 0 0.005194846075028181
gene O 0 0.022351816296577454
that O 0 0.006204646080732346
encodes O 0 0.02251030132174492
the O 0 0.007667434401810169
protein O 0 0.02233721688389778
- O 0 0.024464944377541542
binding O 0 0.01826193928718567
region O 0 0.012860670685768127
known O 0 0.007994613610208035
as O 0 0.004105397965759039
the O 0 0.004666680004447699
pocket O 0 0.021680207923054695
region O 0 0.010131780058145523
and O 0 0.004095728043466806
has O 0 0.004034640267491341
been O 0 0.003919340670108795
detected O 0 0.01301676407456398
in O 0 0.004062592517584562
other O 0 0.004339978564530611
cases O 0 0.013011956587433815
of O 0 0.008834794163703918
retinoblastoma B-Disease 1 0.9943786263465881
. O 0 0.017252394929528236
. O 0 0.02365368790924549

Low O 0 0.058228377252817154
levels O 0 0.03767677769064903
of O 0 0.011586500331759453
beta O 0 0.03795275092124939
hexosaminidase O 0 0.06453907489776611
A O 0 0.011433480307459831
in O 0 0.008846953511238098
healthy O 0 0.05958321690559387
individuals O 0 0.014695919118821621
with O 0 0.01091492734849453
apparent O 1 0.7038543820381165
deficiency O 1 0.9999457597732544
of O 0 0.011372195556759834
this O 0 0.011895803734660149
enzyme O 0 0.061176847666502
. O 0 0.030750639736652374

Appreciable O 0 0.1649162322282791
beta O 0 0.07776544243097305
hexosaminidase O 0 0.09311117976903915
A O 0 0.02119630202651024
( O 0 0.017155269160866737
hex O 0 0.02969144843518734
A O 0 0.011736279353499413
) O 0 0.008861164562404156
activity O 0 0.010844958946108818
has O 0 0.005750485695898533
been O 0 0.00704614445567131
detected O 0 0.02704186737537384
in O 0 0.010266437195241451
cultured O 1 0.9673410058021545
skin O 1 0.9999773502349854
fibroblasts O 1 0.999775230884552
and O 0 0.2670935392379761
melanoma B-Disease 1 0.9999988079071045
tissue O 1 0.9964162111282349
from O 0 0.013806630857288837
healthy O 0 0.30262598395347595
individuals O 0 0.011710583232343197
previously O 0 0.009124085307121277
reported O 0 0.010764974169433117
as O 0 0.00666611734777689
having O 0 0.013370499014854431
deficiency B-Disease 1 0.9998117089271545
of I-Disease 0 0.00827758852392435
hex I-Disease 0 0.02725922502577305
A I-Disease 0 0.010202364064753056
activity O 0 0.015768123790621758
indistinguishable O 0 0.023855185136198997
from O 0 0.008179410360753536
that O 0 0.0057324632070958614
of O 0 0.009242269210517406
patients O 1 0.9996054768562317
with O 0 0.2875019311904907
Tay B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999103546142578
Sachs I-Disease 1 0.9999855756759644
disease I-Disease 1 0.9999936819076538
( O 0 0.27224668860435486
TSD B-Disease 1 0.9989331364631653
) O 0 0.03170667216181755
. O 0 0.026469117030501366

Identification O 0 0.05298811197280884
and O 0 0.01891733892261982
quantitation O 0 0.07823516428470612
of O 0 0.01171946618705988
hex O 0 0.03131524845957756
A O 0 0.010928500443696976
, O 0 0.008085216395556927
amounting O 0 0.024673303589224815
to O 0 0.01085574273020029
3 O 0 0.018815061077475548
. O 0 0.02137136459350586

5 O 0 0.05462581664323807
% O 0 0.042546484619379044
- O 0 0.067788265645504
6 O 0 0.04105886444449425
. O 0 0.029353845864534378

9 O 0 0.03156161308288574
% O 0 0.015888694673776627
of O 0 0.006833934225142002
total O 0 0.011393674649298191
beta O 0 0.02760334685444832
hexosaminidase O 0 0.06626497209072113
activity O 0 0.012894724495708942
, O 0 0.004827425815165043
has O 0 0.004386052023619413
been O 0 0.004286782816052437
obtained O 0 0.007855873554944992
by O 0 0.00897238589823246
cellulose O 0 0.23163369297981262
acetate O 1 0.9168558120727539
gel O 1 0.9797664880752563
electrophoresis O 1 0.735817015171051
, O 0 0.023033464327454567
DEAE O 1 0.9502537250518799
- O 1 0.5129424929618835
cellulose O 0 0.3794209063053131
ion O 0 0.23019257187843323
- O 0 0.06366005539894104
exchange O 0 0.026952434331178665
chromatography O 0 0.2620064616203308
, O 0 0.019287385046482086
radial O 1 0.7807217240333557
immunodiffusion O 0 0.4161050319671631
, O 0 0.013957619667053223
and O 0 0.015546435490250587
radioimmunoassay O 0 0.13143588602542877
. O 0 0.032173555344343185

Previous O 0 0.030328387394547462
family O 0 0.0230711679905653
studies O 0 0.016363942995667458
suggested O 0 0.010697990655899048
that O 0 0.004166725091636181
these O 0 0.003859423566609621
individuals O 0 0.006990337278693914
may O 0 0.0067178960889577866
be O 0 0.0040983231738209724
compound O 0 0.016230478882789612
heterozygotes O 0 0.14247331023216248
for O 0 0.004474370274692774
the O 0 0.006081644911319017
common O 0 0.01852409727871418
mutant O 0 0.30662593245506287
TSD B-Disease 1 0.998542070388794
gene O 0 0.06272627413272858
and O 0 0.009169921278953552
a O 0 0.0109030120074749
rare O 0 0.025095924735069275
( O 0 0.022256147116422653
allelic O 1 0.5930041074752808
) O 0 0.0261283777654171
mutant O 0 0.09117595851421356
gene O 0 0.09975604712963104
. O 0 0.03311893343925476

Thus O 0 0.02820904366672039
, O 0 0.01342441514134407
the O 0 0.012181112542748451
postulated O 0 0.0457196868956089
rate O 0 0.025505423545837402
mutant O 0 0.042416125535964966
gene O 0 0.038603611290454865
appears O 0 0.011530225165188313
to O 0 0.004502539057284594
code O 0 0.005421983078122139
for O 0 0.002886503702029586
the O 0 0.003882023273035884
expression O 0 0.010800613090395927
of O 0 0.0048861196264624596
low O 0 0.014968913048505783
amounts O 0 0.012607027776539326
of O 0 0.008086265996098518
hex O 0 0.04111923649907112
A O 0 0.01885802485048771
. O 0 0.023810934275388718

Heterozygotes O 1 0.5537315011024475
for O 0 0.016909284517169
the O 0 0.014158209785819054
rare O 0 0.029863370582461357
mutant O 0 0.043834250420331955
may O 0 0.015976661816239357
be O 0 0.0072958641685545444
indistinguishable O 0 0.026187945157289505
from O 0 0.010084010660648346
heterozygotes O 0 0.1520863175392151
for O 0 0.01040724478662014
the O 0 0.011839562095701694
common O 0 0.03012109361588955
TSD B-Disease 1 0.9944049119949341
mutant O 0 0.11746715009212494
. O 0 0.039609767496585846

However O 0 0.02084065042436123
, O 0 0.013617836870253086
direct O 0 0.019131403416395187
visualization O 0 0.03588629513978958
and O 0 0.009191888384521008
quantitation O 0 0.056675951927900314
of O 0 0.00786714255809784
hex O 0 0.022231722250580788
A O 0 0.007225419860333204
by O 0 0.004692352842539549
the O 0 0.0047057741321623325
methods O 0 0.010489397682249546
described O 0 0.012131410650908947
may O 0 0.012414193712174892
prevent O 0 0.021373653784394264
false O 0 0.02446844056248665
- O 1 0.6155599355697632
positive O 0 0.14546900987625122
prenatal O 1 0.9994555115699768
diagnosis O 1 0.9995965361595154
of O 0 0.015289588831365108
TSD B-Disease 1 0.9984462857246399
in O 0 0.012908121570944786
fetuses O 0 0.4123896360397339
having O 0 0.012593324296176434
the O 0 0.0069814883172512054
incomplete O 0 0.01749037206172943
hex B-Disease 0 0.03290095925331116
A I-Disease 0 0.013327373191714287
deficiency I-Disease 1 0.9997666478157043
of O 0 0.006250552833080292
the O 0 0.005885252263396978
type O 0 0.013747647404670715
described O 0 0.009509549476206303
in O 0 0.00493059866130352
the O 0 0.005709146149456501
four O 0 0.011094603687524796
healthy O 0 0.05349000543355942
individuals O 0 0.03949306160211563

The O 0 0.07792934775352478
tumor B-Disease 1 0.9990911483764648
suppressor O 1 0.9933753609657288
gene O 1 0.912916898727417
Smad4 O 1 0.9871757626533508
/ O 1 0.8974789381027222
Dpc4 O 0 0.10496009141206741
is O 0 0.009874241426587105
required O 0 0.010084758512675762
for O 0 0.0069213444367051125
gastrulation O 0 0.137956440448761
and O 0 0.006339948624372482
later O 0 0.006487506907433271
for O 0 0.005857502575963736
anterior O 0 0.33099493384361267
development O 0 0.010704043321311474
of O 0 0.006425365339964628
the O 0 0.011809286661446095
mouse O 0 0.0898141860961914
embryo O 0 0.12381036579608917
. O 0 0.03871138393878937

Mutations O 0 0.2877843677997589
in O 0 0.027595439925789833
the O 0 0.029919670894742012
SMAD4 O 1 0.9935961961746216
/ O 1 0.9983419179916382
DPC4 O 1 0.9980999827384949
tumor B-Disease 1 0.9997045397758484
suppressor O 1 0.9884817600250244
gene O 0 0.0670313611626625
, O 0 0.010364173911511898
a O 0 0.01040381658822298
key O 0 0.016238344833254814
signal O 0 0.02542220801115036
transducer O 0 0.04725227504968643
in O 0 0.007459908723831177
most O 0 0.008120083250105381
TGFbeta O 1 0.6101694703102112
- O 0 0.07883967459201813
related O 0 0.017398538067936897
pathways O 0 0.03370633348822594
, O 0 0.005233181640505791
are O 0 0.0034341569989919662
involved O 0 0.0061729722656309605
in O 0 0.004533133469521999
50 O 0 0.008635371923446655
% O 0 0.011590782552957535
of O 0 0.011618051677942276
pancreatic B-Disease 1 0.9998435974121094
cancers I-Disease 1 0.9998847246170044
. O 0 0.03676392510533333

Homozygous O 1 0.6116219162940979
Smad4 O 1 0.9417950510978699
mutant O 1 0.6736798286437988
mice O 1 0.9827736616134644
die O 0 0.40208926796913147
before O 0 0.021358588710427284
day O 0 0.020598066970705986
7 O 0 0.026533223688602448
. O 0 0.023468442261219025

5 O 0 0.04792136698961258
of O 0 0.023733200505375862
embryogenesis O 0 0.16927652060985565
. O 0 0.039969153702259064

Mutant O 0 0.11287001520395279
embryos O 0 0.05635268613696098
have O 0 0.013539985753595829
reduced O 0 0.018080689013004303
size O 0 0.012854564934968948
, O 0 0.008403397165238857
fail O 0 0.02388768270611763
to O 0 0.008701005019247532
gastrulate O 0 0.07381844520568848
or O 0 0.010635809041559696
express O 0 0.019362570717930794
a O 0 0.009829039685428143
mesodermal O 1 0.8950862884521484
marker O 0 0.031142981722950935
, O 0 0.008314975537359715
and O 0 0.008816499263048172
show O 0 0.02196492999792099
abnormal O 1 0.9020012617111206
visceral O 1 0.8700671792030334
endoderm O 1 0.9095260500907898
development O 0 0.041832227259874344
. O 0 0.03296952322125435

Growth B-Disease 1 0.8683140873908997
retardation I-Disease 1 0.9981598258018494
of O 0 0.016412943601608276
the O 0 0.01998630166053772
Smad4 O 1 0.9660009145736694
- O 1 0.6751339435577393
deficient O 1 0.9454911351203918
embryos O 0 0.0396387092769146
results O 0 0.01883787475526333
from O 0 0.009922102093696594
reduced O 0 0.019782595336437225
cell O 0 0.07621018588542938
proliferation O 0 0.04400873929262161
rather O 0 0.012157222256064415
than O 0 0.010377300903201103
increased O 0 0.02478756569325924
apoptosis O 0 0.12714466452598572
. O 0 0.02934410236775875

Aggregation O 0 0.10621602088212967
of O 0 0.028259839862585068
mutant O 0 0.10930265486240387
Smad4 O 1 0.9335950016975403
ES O 1 0.9081722497940063
cells O 0 0.08507827669382095
with O 0 0.01797518879175186
wild O 0 0.041524551808834076
- O 0 0.1903189867734909
type O 0 0.08579922467470169
tetraploid O 1 0.8395771384239197
morulae O 1 0.8675363659858704
rescues O 1 0.5635904669761658
the O 0 0.03883729875087738
gastrulation B-Disease 1 0.9893102645874023
defect I-Disease 1 0.9717478156089783
. O 0 0.057642679661512375

These O 0 0.018141377717256546
results O 0 0.01904994621872902
indicate O 0 0.015637343749403954
that O 0 0.0060578519478440285
Smad4 O 0 0.036025382578372955
is O 0 0.005754271522164345
initially O 0 0.007458193227648735
required O 0 0.005818634759634733
for O 0 0.003427665214985609
the O 0 0.004207481164485216
differentiation O 0 0.017262892797589302
of O 0 0.00508116977289319
the O 0 0.006451298948377371
visceral O 0 0.4604645073413849
endoderm O 1 0.777326762676239
and O 0 0.006345881149172783
that O 0 0.005257147829979658
the O 0 0.007958424277603626
gastrulation B-Disease 1 0.9909349083900452
defect I-Disease 1 0.8025945425033569
in O 0 0.008378325961530209
the O 0 0.008747815154492855
epiblast O 1 0.8590599894523621
is O 0 0.009924898855388165
secondary O 0 0.01619521901011467
and O 0 0.008296948857605457
non O 0 0.020147982984781265
- O 0 0.051068004220724106
cell O 0 0.04930312559008598
autonomous O 0 0.03366684541106224
. O 0 0.02544938400387764

Rescued O 0 0.2651379108428955
embryos O 0 0.23306716978549957
show O 0 0.043257229030132294
severe O 1 0.998228132724762
anterior O 1 0.9969087243080139
truncations O 1 0.605867862701416
, O 0 0.013850499875843525
indicating O 0 0.019180893898010254
a O 0 0.006927994079887867
second O 0 0.007804715074598789
important O 0 0.007161540910601616
role O 0 0.011165694333612919
for O 0 0.008528687991201878
Smad4 O 0 0.2432783991098404
in O 0 0.015585336834192276
anterior O 1 0.9906167387962341
patterning O 1 0.9864438772201538
during O 0 0.04173637181520462
embryogenesis O 1 0.666839599609375
. O 0 0.04249493405222893

Prevalence O 1 0.9597383141517639
of O 0 0.03610247001051903
p16 O 1 0.9418417811393738
and O 0 0.03188800439238548
CDK4 O 1 0.9864552021026611
germline O 1 0.9951125979423523
mutations O 1 0.9355364441871643
in O 0 0.023877587169408798
48 O 0 0.20519472658634186
melanoma B-Disease 1 0.9999939203262329
- O 1 0.9728411436080933
prone O 1 0.9185850024223328
families O 0 0.02758244425058365
in O 0 0.013816652819514275
France O 0 0.03396175056695938
. O 0 0.025425434112548828

The O 0 0.04929652810096741
French O 0 0.23127558827400208
Familial B-Disease 1 0.9998601675033569
Melanoma I-Disease 1 0.999987006187439
Study O 0 0.07325660437345505
Group O 0 0.04602864757180214
. O 0 0.03436199575662613

Germline O 1 0.9730908870697021
mutations O 0 0.3855251967906952
in O 0 0.01787475310266018
the O 0 0.016491089016199112
p16 O 1 0.6546804904937744
and O 0 0.015068847686052322
CDK4 O 1 0.6887965798377991
genes O 0 0.029817752540111542
have O 0 0.006667531561106443
been O 0 0.005248415283858776
reported O 0 0.007961354218423367
in O 0 0.004695055074989796
a O 0 0.006378297694027424
subset O 0 0.02112066186964512
of O 0 0.008232468739151955
melanoma B-Disease 1 0.9999812841415405
pedigrees O 0 0.3591788411140442
, O 0 0.0067583234049379826
but O 0 0.005512022878974676
their O 0 0.00586702860891819
prevalence O 0 0.4469420313835144
is O 0 0.005857613869011402
not O 0 0.005113671533763409
well O 0 0.007859650999307632
known O 0 0.017892686650156975
. O 0 0.0170082226395607

We O 0 0.023075414821505547
searched O 0 0.028717435896396637
for O 0 0.011467542499303818
such O 0 0.015915509313344955
germline O 1 0.9059397578239441
mutations O 0 0.32610946893692017
in O 0 0.0142699358984828
48 O 0 0.028039412572979927
French O 0 0.35633739829063416
melanoma B-Disease 1 0.9999970197677612
- O 1 0.8941219449043274
prone O 1 0.6417131423950195
families O 0 0.0130069050937891
selected O 0 0.007423030212521553
according O 0 0.004602514673024416
to O 0 0.0032928495202213526
two O 0 0.00315117253921926
major O 0 0.005928213242441416
criteria O 0 0.008604355156421661
families O 0 0.007424538489431143
with O 0 0.00490171555429697
at O 0 0.005307885818183422
least O 0 0.0054655433632433414
three O 0 0.004785825964063406
affected O 0 0.014766207896173
members O 0 0.008078948594629765
( O 0 0.011138666421175003
n O 0 0.018669869750738144
= O 0 0.026296019554138184
20 O 0 0.00810827873647213
) O 0 0.006573354359716177
or O 0 0.004533599596470594
families O 0 0.006014128215610981
with O 0 0.0036311582662165165
two O 0 0.0036217335145920515
affected O 0 0.010662234388291836
members O 0 0.005158568266779184
, O 0 0.0033057827968150377
one O 0 0.0024091119412332773
of O 0 0.002297823317348957
them O 0 0.003620460396632552
affected O 0 0.009503255598247051
before O 0 0.003915936220437288
the O 0 0.0035214268136769533
age O 0 0.007377165369689465
of O 0 0.004720017313957214
50 O 0 0.009998361580073833
( O 0 0.011805864982306957
n O 0 0.020186105743050575
= O 0 0.029693305492401123
28 O 0 0.008692528121173382
) O 0 0.005522823892533779
, O 0 0.0038884696550667286
and O 0 0.0040587130934000015
one O 0 0.0051564862951636314
additional O 0 0.010893306694924831
minor O 0 0.028778700157999992
criterion O 0 0.044085368514060974
. O 0 0.024535665288567543

Sixteen O 0 0.07486122101545334
different O 0 0.040492944419384
p16 O 1 0.9860425591468811
germline O 1 0.990723192691803
mutations O 0 0.30031225085258484
were O 0 0.007987670600414276
found O 0 0.0073686083778738976
in O 0 0.00496528809890151
21 O 0 0.008832164108753204
families O 0 0.008913522586226463
, O 0 0.005235957447439432
while O 0 0.0069963340647518635
one O 0 0.01088922843337059
germline O 1 0.9731146097183228
mutation O 1 0.7326627969741821
, O 0 0.012649819254875183
Arg24His O 0 0.10533081740140915
, O 0 0.009233619086444378
was O 0 0.007906071841716766
detected O 0 0.02533581294119358
in O 0 0.00837008561939001
the O 0 0.011611624620854855
CDK4 O 1 0.5008373260498047
gene O 0 0.0937078446149826
. O 0 0.03229006752371788

The O 0 0.029499920085072517
frequency O 0 0.05370568856596947
of O 0 0.01907380111515522
p16 O 1 0.9306243658065796
gene O 0 0.14779289066791534
mutation O 0 0.09123489260673523
in O 0 0.008263396099209785
our O 0 0.008524050936102867
sample O 0 0.014576542191207409
( O 0 0.010065188631415367
44 O 0 0.009859660640358925
% O 0 0.00736888637766242
) O 0 0.005393192637711763
is O 0 0.0035406334791332483
among O 0 0.004705443512648344
the O 0 0.004333933349698782
highest O 0 0.010477269068360329
rates O 0 0.013908544555306435
yet O 0 0.008081072941422462
reported O 0 0.010299498215317726
and O 0 0.005246338900178671
the O 0 0.008066660724580288
CDK4 O 1 0.63310706615448
mutation O 0 0.14045879244804382
is O 0 0.0059245615266263485
the O 0 0.005710827652364969
second O 0 0.013234349898993969
mutation O 0 0.15856096148490906
detected O 0 0.030325036495923996
in O 0 0.007978327572345734
this O 0 0.009061641059815884
gene O 0 0.0457548126578331
worldwide O 0 0.03233949840068817
. O 0 0.022895049303770065

In O 0 0.019993886351585388
summary O 0 0.025815695524215698
, O 0 0.007705447729676962
our O 0 0.008264618925750256
results O 0 0.011843747459352016
show O 0 0.010769356973469257
frequent O 0 0.019734367728233337
involvement O 0 0.019853491336107254
of O 0 0.006214695051312447
the O 0 0.011055589653551579
p16 O 1 0.9644069075584412
gene O 0 0.4047289788722992
in O 0 0.017093487083911896
familial B-Disease 1 0.9999269247055054
melanoma I-Disease 1 0.9999916553497314
and O 0 0.00911200512200594
confirm O 0 0.011186624877154827
the O 0 0.004713740665465593
role O 0 0.0076483129523694515
of O 0 0.004629159811884165
the O 0 0.007779703475534916
CDK4 O 1 0.6502732038497925
gene O 0 0.048470981419086456
as O 0 0.009411683306097984
a O 0 0.017689894884824753
melanoma B-Disease 1 0.9999940395355225
- O 1 0.9736754298210144
predisposing O 1 0.9848056435585022
gene O 0 0.17906376719474792
. O 0 0.02003251016139984
. O 0 0.027273206040263176

Progression O 1 0.7282466292381287
of O 0 0.0368502102792263
somatic O 1 0.6433588862419128
CTG O 1 0.9309688210487366
repeat O 0 0.07374844700098038
length O 0 0.03156403452157974
heterogeneity O 0 0.0520605742931366
in O 0 0.011656245216727257
the O 0 0.012022610753774643
blood O 1 0.940241277217865
cells O 1 0.9645774364471436
of O 0 0.04092821851372719
myotonic B-Disease 1 0.9999980926513672
dystrophy I-Disease 1 0.9999997615814209
patients O 1 0.9999059438705444
. O 0 0.051175326108932495

The O 0 0.026169991120696068
genetic O 0 0.055742695927619934
basis O 0 0.020466240122914314
of O 0 0.023319287225604057
myotonic B-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999997615814209
( O 1 0.9371984004974365
DM B-Disease 1 0.9999836683273315
) O 0 0.012075421400368214
is O 0 0.004747709259390831
the O 0 0.0043754600919783115
expansion O 0 0.009611466899514198
of O 0 0.004300372209399939
an O 0 0.007479834370315075
unstable O 0 0.29782772064208984
CTG O 1 0.7896182537078857
repeat O 0 0.028116706758737564
in O 0 0.006507860496640205
the O 0 0.007178682368248701
34 O 0 0.019607694819569588
UTR O 0 0.06620272248983383
of O 0 0.010480077937245369
the O 0 0.01778378151357174
DM B-Disease 1 0.9998124241828918
protein O 0 0.09600980579853058
kinase O 0 0.42179200053215027
gene O 0 0.06567662954330444
on O 0 0.01686178147792816
chromosome O 0 0.10455363243818283
19 O 0 0.031381238251924515
. O 0 0.0262043047696352

One O 0 0.01216762512922287
of O 0 0.0066779362969100475
the O 0 0.005639591719955206
principal O 0 0.01116217765957117
features O 0 0.00943351723253727
of O 0 0.006075932644307613
the O 0 0.01136756595224142
DM B-Disease 1 0.9999557733535767
mutation O 1 0.6451640129089355
is O 0 0.0084530059248209
an O 0 0.006221369374543428
extraordinarily O 0 0.017599787563085556
high O 0 0.00857490673661232
level O 0 0.009900596924126148
of O 0 0.007117647211998701
somatic O 1 0.7081472277641296
mosaicism O 1 0.9893219470977783
, O 0 0.007153082638978958
due O 0 0.007537510711699724
to O 0 0.004447197541594505
an O 0 0.004548412747681141
extremely O 0 0.010695290751755238
high O 0 0.008609244599938393
degree O 0 0.009524418972432613
of O 0 0.006470183841884136
somatic O 0 0.10263288766145706
instability O 0 0.040303051471710205
both O 0 0.006561531685292721
within O 0 0.005903156008571386
and O 0 0.004827952943742275
between O 0 0.009005415253341198
different O 0 0.012528244405984879
tissues O 0 0.08137046545743942
. O 0 0.026449302211403847

This O 0 0.026163171976804733
instability O 0 0.0549420528113842
appears O 0 0.017356200143694878
to O 0 0.006071993615478277
be O 0 0.004818449728190899
biased O 0 0.016575150191783905
towards O 0 0.008341464214026928
further O 0 0.006764696445316076
expansion O 0 0.009571162983775139
and O 0 0.004017939791083336
continuous O 0 0.008225526660680771
throughout O 0 0.004215179942548275
the O 0 0.00261473236605525
life O 0 0.0039036942180246115
of O 0 0.0024668455589562654
an O 0 0.0028946492820978165
individual O 0 0.00492502935230732
, O 0 0.002932296134531498
features O 0 0.004254076164215803
that O 0 0.002077970188111067
could O 0 0.002933235839009285
be O 0 0.0021645163651555777
associated O 0 0.0045279525220394135
with O 0 0.0032221993897110224
the O 0 0.0039032285567373037
progressive O 0 0.01709703728556633
nature O 0 0.011312314309179783
of O 0 0.006876547355204821
the O 0 0.012149316258728504
disease O 1 0.9994879961013794
. O 0 0.03263809531927109

Although O 0 0.034765589982271194
increasing O 0 0.03359128534793854
measured O 0 0.03634219244122505
allele O 0 0.07489393651485443
size O 0 0.023399634286761284
between O 0 0.0179924126714468
patients O 1 0.9902076125144958
clearly O 0 0.01951892487704754
correlates O 0 0.03363138437271118
with O 0 0.00838471855968237
an O 0 0.007318276911973953
increased O 0 0.01602412387728691
severity O 1 0.9758833050727844
of O 0 0.0074452427215874195
symptoms O 1 0.9996011853218079
and O 0 0.0052357935346663
an O 0 0.0042450022883713245
earlier O 0 0.007828985340893269
age O 0 0.009442179463803768
of O 0 0.006287899799644947
onset O 1 0.9893969297409058
, O 0 0.005888921674340963
this O 0 0.004468647297471762
correlation O 0 0.014259343035519123
is O 0 0.004348000977188349
not O 0 0.003980214707553387
precise O 0 0.012263874523341656
and O 0 0.006308634299784899
measured O 0 0.01457228884100914
allele O 0 0.035423628985881805
length O 0 0.01187985111027956
cannot O 0 0.006527627818286419
be O 0 0.002686859341338277
used O 0 0.0031124684028327465
as O 0 0.002947585890069604
an O 0 0.0042534880340099335
accurate O 0 0.011982660740613937
predictor O 0 0.040537670254707336
of O 0 0.006298885215073824
age O 0 0.01723216287791729
of O 0 0.01282891072332859
onset O 1 0.9962254762649536
. O 0 0.030548395588994026

In O 0 0.016790613532066345
order O 0 0.01012568362057209
to O 0 0.008213134482502937
further O 0 0.011209908872842789
characterize O 0 0.03160007297992706
the O 0 0.011364162899553776
dynamics O 0 0.04400208964943886
of O 0 0.021618256345391273
DM B-Disease 1 0.9999743700027466
CTG O 1 0.9981339573860168
repeat O 1 0.7865161299705505
somatic O 1 0.886708676815033
instability O 0 0.20023466646671295
, O 0 0.008676202967762947
we O 0 0.005399405024945736
have O 0 0.0051677534356713295
studied O 0 0.009207316674292088
repeat O 0 0.02036830596625805
length O 0 0.012137218378484249
changes O 0 0.009624838829040527
over O 0 0.007573512848466635
time O 0 0.010029608383774757
in O 0 0.01403422188013792
111 O 1 0.9928389191627502
myotonic B-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.9999181032180786
with O 0 0.019556446000933647
varying O 0 0.04474562779068947
clinical O 1 0.9869844913482666
severity O 1 0.9819056987762451
and O 0 0.015725865960121155
CTG O 1 0.7730304598808289
repeat O 0 0.04014085978269577
size O 0 0.0142854368314147
over O 0 0.00722750648856163
time O 0 0.006912382785230875
intervals O 0 0.014848344959318638
of O 0 0.005811902694404125
1 O 0 0.012136703357100487
- O 0 0.028252629563212395
7 O 0 0.0188898965716362
years O 0 0.015379725955426693
. O 0 0.018824303522706032

We O 0 0.017243601381778717
have O 0 0.009176119230687618
found O 0 0.007881827652454376
a O 0 0.0067375595681369305
direct O 0 0.012398198246955872
progression O 0 0.030550973489880562
of O 0 0.004909219685941935
the O 0 0.005252115894109011
size O 0 0.010582933202385902
heterogeneity O 0 0.03072146326303482
over O 0 0.006983456201851368
time O 0 0.006400578189641237
related O 0 0.009545702487230301
to O 0 0.006358480080962181
initial O 0 0.021110020577907562
CTG O 1 0.7219030261039734
repeat O 0 0.030354967340826988
size O 0 0.011845164000988007
and O 0 0.005219873506575823
the O 0 0.004765709396451712
time O 0 0.00612249318510294
interval O 0 0.01731300540268421
and O 0 0.006313323974609375
always O 0 0.01110835000872612
biased O 0 0.020571384578943253
towards O 0 0.013063381426036358
further O 0 0.015510848723351955
expansion O 0 0.030281340703368187
. O 0 0.02290024235844612

Attempts O 0 0.04366746172308922
to O 0 0.015624026767909527
mathematically O 0 0.02785920724272728
model O 0 0.015277009457349777
the O 0 0.007907180115580559
dynamics O 0 0.023450259119272232
have O 0 0.007569628767669201
proved O 0 0.011415578424930573
only O 0 0.005196230951696634
partially O 0 0.014378787018358707
successful O 0 0.010506050661206245
suggesting O 0 0.011768755502998829
that O 0 0.004621498286724091
individual O 0 0.009468426927924156
specific O 0 0.010678312741219997
genetic O 0 0.034432828426361084
and O 0 0.007271900773048401
/ O 1 0.6715729236602783
or O 0 0.007389577571302652
environmental O 0 0.012138523161411285
factors O 0 0.011808061972260475
also O 0 0.005419191438704729
play O 0 0.005661561619490385
a O 0 0.005237636622041464
role O 0 0.010290234349668026
in O 0 0.01104749646037817
somatic O 1 0.5361325740814209
mosaicism O 1 0.9848006963729858
. O 0 0.02207360602915287
. O 0 0.02818029373884201

Aspartylglucosaminuria B-Disease 1 0.7989085912704468
among O 0 0.04742294177412987
Palestinian O 0 0.06372147798538208
Arabs O 0 0.07697281241416931
. O 0 0.04249095544219017

Aspartylglucosaminuria B-Disease 1 0.9976462721824646
( O 0 0.21057429909706116
AGU B-Disease 1 0.9992865920066833
) O 0 0.02078712359070778
is O 0 0.009767566807568073
a O 0 0.01271874364465475
rare O 0 0.29118555784225464
disorder B-Disease 1 0.9998039603233337
of I-Disease 0 0.013934019953012466
glycoprotein I-Disease 1 0.9945830702781677
metabolism I-Disease 1 0.9465456008911133
caused O 0 0.10825363546609879
by O 0 0.009382031857967377
the O 0 0.011943956837058067
deficiency B-Disease 1 0.9998490810394287
of I-Disease 0 0.010392329655587673
the I-Disease 0 0.014600240625441074
lysosomal I-Disease 1 0.9915498495101929
enzyme I-Disease 0 0.4503754675388336
aspartylglucosaminidase I-Disease 1 0.9319487810134888
( O 0 0.03325647860765457
AGA O 0 0.20226366817951202
) O 0 0.024590831249952316
. O 0 0.02611871249973774

AGU B-Disease 1 0.9979158043861389
is O 0 0.03030424937605858
inherited O 0 0.4459787607192993
as O 0 0.01302414946258068
an O 0 0.015889381989836693
autosomal O 1 0.9998569488525391
recessive O 1 0.999854564666748
trait O 1 0.9759966135025024
and O 0 0.011641422286629677
occurs O 0 0.020825371146202087
with O 0 0.007242466788738966
a O 0 0.007571720983833075
high O 0 0.010117356665432453
frequency O 0 0.013354004360735416
in O 0 0.004679601173847914
Finland O 0 0.011624684557318687
because O 0 0.00590787036344409
of O 0 0.004230298101902008
a O 0 0.008494097739458084
founder O 0 0.026344148442149162
effect O 0 0.030811648815870285
. O 0 0.022825544700026512

While O 0 0.021929029375314713
very O 0 0.016761166974902153
few O 0 0.015950633212924004
patients O 1 0.9884499311447144
with O 0 0.012760893441736698
AGU B-Disease 1 0.9993435740470886
have O 0 0.008108831010758877
been O 0 0.006311206147074699
reported O 0 0.009619930759072304
from O 0 0.00625511584803462
non O 0 0.013728109188377857
- O 0 0.025497471913695335
Finnish O 0 0.018081998452544212
origin O 0 0.011984704993665218
, O 0 0.008071919903159142
we O 0 0.009066404774785042
diagnosed O 1 0.999923586845398
the O 0 0.01310641784220934
disorder O 1 0.9998674392700195
in O 0 0.01027662493288517
8 O 0 0.01813947968184948
patients O 1 0.9841322898864746
originating O 0 0.01968412473797798
from O 0 0.007624319288879633
3 O 0 0.010666168294847012
unrelated O 0 0.018443623557686806
families O 0 0.010259442031383514
, O 0 0.004828878678381443
all O 0 0.003504295600578189
Palestinian O 0 0.009495592676103115
Arabs O 0 0.011494601145386696
from O 0 0.005004240199923515
the O 0 0.005722715053707361
region O 0 0.014394068159162998
of O 0 0.00887819193303585
Jerusalem O 0 0.026561293751001358
. O 0 0.020707426592707634

The O 0 0.04067414626479149
clinical O 1 0.9870718121528625
diagnosis O 1 0.9991084933280945
of O 0 0.019866395741701126
AGU B-Disease 1 0.9994747042655945
is O 0 0.012038037180900574
often O 0 0.009585358202457428
difficult O 0 0.007870251312851906
, O 0 0.003600421128794551
in O 0 0.00350128673017025
particular O 0 0.005093174055218697
early O 0 0.004888772964477539
in O 0 0.002871103584766388
the O 0 0.003394609782844782
course O 0 0.0074821277521550655
of O 0 0.0037887063808739185
the O 0 0.0055007063783705235
disease O 1 0.9987454414367676
, O 0 0.00419463450089097
and O 0 0.0029647592455148697
most O 0 0.002994401613250375
of O 0 0.003145816270262003
the O 0 0.00535906245931983
patients O 1 0.9962294697761536
are O 0 0.00620500510558486
diagnosed O 1 0.9995444416999817
after O 0 0.008077817037701607
the O 0 0.005061402916908264
age O 0 0.008977020159363747
of O 0 0.005374961532652378
5 O 0 0.014260903932154179
years O 0 0.01339673064649105
. O 0 0.019661352038383484

However O 0 0.022671835497021675
, O 0 0.011283167637884617
since O 0 0.013077035546302795
these O 0 0.010435409843921661
patients O 1 0.9809815883636475
excrete O 0 0.48716092109680176
early O 0 0.014923176728188992
large O 0 0.010651013813912868
amounts O 0 0.013861757703125477
of O 0 0.007318111602216959
aspartylglucosamine O 0 0.05116526037454605
in O 0 0.00949320662766695
urine O 0 0.03726620972156525
, O 0 0.011921963654458523
biochemical O 0 0.045563679188489914
screening O 0 0.03650180250406265
is O 0 0.008520998060703278
easy O 0 0.013219748623669147
by O 0 0.009726068936288357
urine O 0 0.049112189561128616
chromatography O 0 0.15264756977558136
. O 0 0.017405249178409576
. O 0 0.0227444376796484

Detection O 0 0.10822489112615585
of O 0 0.022550921887159348
heterozygous O 0 0.08430472761392593
carriers O 0 0.052744291722774506
of O 0 0.012894190847873688
the O 0 0.01973763108253479
ataxia B-Disease 1 0.9999731779098511
- I-Disease 1 0.9969145059585571
telangiectasia I-Disease 1 0.999679684638977
( O 0 0.04709194228053093
ATM O 0 0.11041022092103958
) O 0 0.024249963462352753
gene O 0 0.056039195507764816
by O 0 0.019424140453338623
G2 O 1 0.9943338632583618
phase O 0 0.17090372741222382
chromosomal O 1 0.8978237509727478
radiosensitivity O 1 0.6446844339370728
of O 0 0.020699720829725266
peripheral O 1 0.9922022819519043
blood O 1 0.981825590133667
lymphocytes O 1 0.9905311465263367
. O 0 0.05066578462719917

In O 0 0.059409018605947495
ataxia B-Disease 1 0.9999628067016602
- I-Disease 1 0.9982946515083313
telangiectasia I-Disease 1 0.9997792840003967
( O 0 0.07749643176794052
A B-Disease 0 0.06891777366399765
- I-Disease 1 0.9880605936050415
T I-Disease 1 0.9995504021644592
) O 0 0.03225485235452652
patients O 1 0.9963499307632446
, O 0 0.008183310739696026
mutations O 0 0.04530289024114609
in O 0 0.005048167426139116
a O 0 0.006254777777940035
single O 0 0.0102698290720582
gene O 0 0.02728809416294098
, O 0 0.007855952717363834
ATM O 0 0.030069738626480103
, O 0 0.007371437735855579
result O 0 0.010492788627743721
in O 0 0.008062395267188549
an O 0 0.017352508381009102
autosomal B-Disease 1 0.9999960660934448
recessive I-Disease 1 0.9999979734420776
syndrome I-Disease 1 0.9999997615814209
that O 0 0.015761598944664
embraces O 0 0.030609630048274994
a O 0 0.009394166059792042
variety O 0 0.009246321395039558
of O 0 0.006350784096866846
clinical O 0 0.08378421515226364
features O 0 0.01123788207769394
and O 0 0.008210986852645874
manifests O 0 0.056056831032037735
extreme O 0 0.03403547778725624
radiosensitivity O 0 0.11542579531669617
and O 0 0.007013229187577963
a O 0 0.009147178381681442
strong O 0 0.014327126555144787
pre O 0 0.040229760110378265
- O 0 0.14813382923603058
disposition O 0 0.07667484879493713
to O 0 0.02084677666425705
malignancy B-Disease 1 0.9968430995941162
. O 0 0.03749420493841171

Heterozygotes O 0 0.38112422823905945
for O 0 0.019468458369374275
the O 0 0.01605304330587387
ATM O 0 0.0583014152944088
gene O 0 0.04297955334186554
have O 0 0.009493009187281132
no O 0 0.009579213336110115
clinical O 0 0.04935450106859207
expression O 0 0.01701551117002964
of O 0 0.007100159302353859
A B-Disease 0 0.0153233977034688
- I-Disease 1 0.8356336951255798
T I-Disease 1 0.9986421465873718
but O 0 0.008656853809952736
may O 0 0.012139596045017242
be O 0 0.007457014173269272
cancer B-Disease 1 0.9997169375419617
prone O 0 0.3159911632537842
with O 0 0.006574045401066542
a O 0 0.008425915613770485
moderate O 0 0.019282249733805656
increase O 0 0.013023915700614452
in O 0 0.007555649150162935
in O 0 0.011107971891760826
vitro O 0 0.09776993840932846
radiosensitivity O 1 0.6007856726646423
. O 0 0.027809202671051025

We O 0 0.02191069722175598
performed O 0 0.020511802285909653
a O 0 0.013785663060843945
blind O 0 0.04429396614432335
chromosomal O 0 0.18066400289535522
analysis O 0 0.020561031997203827
on O 0 0.012264878489077091
G2 O 1 0.9952735304832458
- O 0 0.34958991408348083
phase O 0 0.10441742092370987
lymphocytes O 1 0.826646089553833
from O 0 0.0160035602748394
7 O 0 0.017310701310634613
unrelated O 0 0.035520218312740326
A B-Disease 0 0.03227967396378517
- I-Disease 1 0.9928750991821289
T I-Disease 1 0.9998360872268677
patients O 1 0.9985217452049255
, O 0 0.010954352095723152
13 O 0 0.01524421852082014
obligate O 0 0.1318042278289795
A B-Disease 0 0.03426726907491684
- I-Disease 1 0.9773331880569458
T I-Disease 1 0.9993244409561157
heterozygotes O 1 0.9929373860359192
( O 0 0.017844075337052345
parents O 0 0.014033700339496136
of O 0 0.005959424655884504
the O 0 0.0069097355008125305
patients O 1 0.9655104875564575
) O 0 0.008503925055265427
, O 0 0.004635478835552931
and O 0 0.004638573154807091
14 O 0 0.008151736110448837
normal O 0 0.013740465976297855
controls O 0 0.014113062061369419
following O 0 0.010568085126578808
X O 0 0.035447798669338226
- O 0 0.037712931632995605
irradiation O 0 0.03888338431715965
with O 0 0.010493634268641472
1 O 0 0.015018188394606113
Gy O 0 0.0727577954530716
in O 0 0.00718334736302495
order O 0 0.006502892356365919
to O 0 0.005290675908327103
evaluate O 0 0.019280584529042244
this O 0 0.0069038220681250095
cytogenetic O 0 0.05786038190126419
method O 0 0.011543928645551205
as O 0 0.004207197111099958
a O 0 0.006562203634530306
tool O 0 0.01410583220422268
for O 0 0.007368315011262894
detection O 0 0.03042355179786682
of O 0 0.011932240799069405
ATM O 0 0.07149001955986023
carriers O 0 0.0761018618941307
. O 0 0.03170385956764221

Both O 0 0.03182079270482063
A B-Disease 0 0.042315006256103516
- I-Disease 1 0.9187167882919312
T I-Disease 1 0.9982988238334656
homozygotes O 1 0.9923382997512817
and O 0 0.01868850365281105
heterozygotes O 1 0.9338217973709106
showed O 0 0.025102678686380386
significantly O 0 0.024668382480740547
increased O 0 0.017762193456292152
levels O 0 0.021871773526072502
of O 0 0.014001110568642616
radiation O 1 0.9987795948982239
- O 1 0.9902955293655396
induced O 1 0.9990907907485962
chromatid O 1 0.9964392781257629
damage O 0 0.16897261142730713
relative O 0 0.01821090094745159
to O 0 0.005721255671232939
that O 0 0.005812481511384249
of O 0 0.0071879057213664055
normal O 0 0.023119984194636345
controls O 0 0.03495079278945923
. O 0 0.024163713678717613

These O 0 0.02150563895702362
results O 0 0.01963040605187416
show O 0 0.013027594424784184
that O 0 0.006331245880573988
the O 0 0.010499073192477226
G2 O 1 0.995475709438324
- O 0 0.336708664894104
phase O 0 0.11589539796113968
chromosomal O 1 0.9136523604393005
radiosensitivity O 0 0.4899526536464691
assay O 0 0.03718290105462074
can O 0 0.00769449258223176
be O 0 0.0032453108578920364
used O 0 0.003646357450634241
for O 0 0.0030653192661702633
the O 0 0.0051076775416731834
detection O 0 0.02047259919345379
of O 0 0.006511548534035683
A B-Disease 0 0.021092450246214867
- I-Disease 1 0.7239919304847717
T I-Disease 1 0.9963325262069702
heterozygotes O 1 0.9722657799720764
. O 0 0.03961637243628502

In O 0 0.023245174437761307
combination O 0 0.04280954971909523
with O 0 0.014658577740192413
molecular O 0 0.030006663873791695
genetic O 0 0.03529473766684532
analyses O 0 0.017848912626504898
, O 0 0.005238059442490339
this O 0 0.003624040400609374
test O 0 0.007552171591669321
may O 0 0.004774284549057484
be O 0 0.002056724624708295
of O 0 0.0025629568845033646
value O 0 0.00474779075011611
in O 0 0.003969491925090551
studies O 0 0.008543184027075768
of O 0 0.005929439328610897
familial B-Disease 1 0.9962052702903748
and I-Disease 0 0.009935423731803894
sporadic I-Disease 0 0.40656229853630066
cancers I-Disease 1 0.9992572665214539
aimed O 0 0.019045187160372734
at O 0 0.007706935983151197
determination O 0 0.010870168916881084
of O 0 0.004057612735778093
the O 0 0.00603514676913619
potential O 0 0.016510574147105217
involvement O 0 0.022707652300596237
of O 0 0.00869738683104515
ATM O 1 0.5798888802528381
mutations O 1 0.9591794013977051
in O 0 0.015040121972560883
tumor B-Disease 1 0.9997779726982117
risk O 1 0.8328150510787964
or O 0 0.012378315441310406
development O 0 0.016014525666832924
. O 0 0.011967298574745655
. O 0 0.019874822348356247

Ataxia B-Disease 1 0.9999750852584839
- I-Disease 1 0.9971181154251099
telangiectasia I-Disease 1 0.9992825388908386
: O 0 0.02826295979321003
identification O 0 0.020784292370080948
and O 0 0.010330823250114918
detection O 0 0.029878292232751846
of O 0 0.00887790322303772
founder O 0 0.025984201580286026
- O 0 0.1961047351360321
effect O 0 0.027775852009654045
mutations O 0 0.08666351437568665
in O 0 0.008983488194644451
the O 0 0.010847941972315311
ATM O 0 0.05062820389866829
gene O 0 0.043074317276477814
in O 0 0.010564505122601986
ethnic O 0 0.023630155250430107
populations O 0 0.0525527186691761
. O 0 0.02975231409072876

To O 0 0.016747741028666496
facilitate O 0 0.021393688395619392
the O 0 0.010326515883207321
evaluation O 0 0.02802152931690216
of O 0 0.01145455613732338
ATM O 0 0.09582529962062836
heterozygotes O 1 0.8732649683952332
for O 0 0.011845656670629978
susceptibility O 1 0.9393450617790222
to O 0 0.007656025234609842
other O 0 0.006551376078277826
diseases O 1 0.9996216297149658
, O 0 0.005784160923212767
such O 0 0.0058027468621730804
as O 0 0.008825495839118958
breast B-Disease 1 0.999994158744812
cancer I-Disease 1 0.9999607801437378
, O 0 0.006176834460347891
we O 0 0.003632534993812442
have O 0 0.003245839849114418
attempted O 0 0.006579478736966848
to O 0 0.00387519015930593
define O 0 0.008862839080393314
the O 0 0.0038386546075344086
most O 0 0.005021755117923021
common O 0 0.010274695232510567
mutations O 0 0.0365825779736042
and O 0 0.004622235894203186
their O 0 0.005478006787598133
frequencies O 0 0.02100842446088791
in O 0 0.012294629588723183
ataxia B-Disease 1 0.9999868869781494
- I-Disease 1 0.9973658919334412
telangiectasia I-Disease 1 0.9999009370803833
( O 0 0.03568045422434807
A B-Disease 0 0.028170032426714897
- I-Disease 1 0.9278018474578857
T I-Disease 1 0.9978476762771606
) O 0 0.024694863706827164
homozygotes O 1 0.6678651571273804
from O 0 0.01199560146778822
10 O 0 0.012986158020794392
ethnic O 0 0.01911085471510887
populations O 0 0.048800453543663025
. O 0 0.030004695057868958

Both O 0 0.030031802132725716
genomic O 0 0.10809586942195892
mutations O 0 0.18710339069366455
and O 0 0.01107904501259327
their O 0 0.010054019279778004
effects O 0 0.03313177451491356
on O 0 0.010390941984951496
cDNA O 0 0.055802762508392334
were O 0 0.012155531905591488
characterized O 0 0.052584875375032425
. O 0 0.026046492159366608

Protein O 0 0.10892143845558167
- O 0 0.08600534498691559
truncation O 0 0.08082207292318344
testing O 0 0.03131593391299248
of O 0 0.008412690833210945
the O 0 0.008524108678102493
entire O 0 0.024519268423318863
ATM O 0 0.06583163887262344
cDNA O 0 0.08434709906578064
detected O 0 0.05921350046992302
92 O 0 0.03968081623315811
( O 0 0.021532509475946426
66 O 0 0.031287144869565964
% O 0 0.02110203728079796
) O 0 0.018037917092442513
truncating O 0 0.16005052626132965
mutations O 0 0.11500992625951767
in O 0 0.01625611074268818
140 O 0 0.04580320790410042
mutant O 0 0.08787421882152557
alleles O 0 0.322818398475647
screened O 0 0.09090881049633026
. O 0 0.04584234580397606

The O 0 0.03273691236972809
haplotyping O 0 0.21136030554771423
of O 0 0.01631944812834263
patients O 1 0.9877192974090576
with O 0 0.011568580754101276
identical O 0 0.023948052898049355
mutations O 0 0.48651933670043945
indicates O 0 0.015776000916957855
that O 0 0.004339888226240873
almost O 0 0.004561479669064283
all O 0 0.0025884087663143873
of O 0 0.002898257691413164
these O 0 0.0034388930071145296
represent O 0 0.005263317842036486
common O 0 0.008674160577356815
ancestry O 0 0.015357580967247486
and O 0 0.005339714232832193
that O 0 0.005223906133323908
very O 0 0.007478029001504183
few O 0 0.010432349517941475
spontaneously O 0 0.05651305988430977
recurring O 0 0.3415231704711914
ATM O 1 0.5844950675964355
mutations O 1 0.7230690121650696
exist O 0 0.033345144242048264
. O 0 0.026876885443925858

Assays O 0 0.11504621803760529
requiring O 0 0.05057688057422638
minimal O 0 0.04196080565452576
amounts O 0 0.022074107080698013
of O 0 0.009088982827961445
genomic O 0 0.04225524887442589
DNA O 0 0.021661464124917984
were O 0 0.005191741976886988
designed O 0 0.00958551187068224
to O 0 0.005166312213987112
allow O 0 0.009612411260604858
rapid O 0 0.0231415294110775
screening O 0 0.023726852610707283
for O 0 0.007691824808716774
common O 0 0.018322095274925232
ethnic O 0 0.028634918853640556
mutations O 0 0.4655162990093231
. O 0 0.03500761836767197

These O 0 0.04089983180165291
rapid O 0 0.08040700852870941
assays O 0 0.08457481116056442
detected O 0 0.0854768455028534
mutations O 0 0.10847841948270798
in O 0 0.011748341843485832
76 O 0 0.024853568524122238
% O 0 0.012516810558736324
of O 0 0.007628242485225201
Costa O 0 0.027087153866887093
Rican O 0 0.03044532611966133
patients O 1 0.9641096591949463
( O 0 0.01285362709313631
3 O 0 0.009827674366533756
) O 0 0.006753134075552225
, O 0 0.003695364110171795
50 O 0 0.006125790998339653
% O 0 0.006474231369793415
of O 0 0.004423913080245256
Norwegian O 0 0.015042833052575588
patients O 1 0.9686550498008728
( O 0 0.009467307478189468
1 O 0 0.0066824862733483315
) O 0 0.005495390389114618
, O 0 0.0039756386540830135
25 O 0 0.005512216128408909
% O 0 0.0067120445892214775
of O 0 0.005396985448896885
Polish O 0 0.019853215664625168
patients O 1 0.9902055859565735
( O 0 0.01024648267775774
4 O 0 0.007857576943933964
) O 0 0.005328673403710127
, O 0 0.003332032123580575
and O 0 0.00332742091268301
14 O 0 0.006099082063883543
% O 0 0.006956685800105333
of O 0 0.005019273143261671
Italian O 0 0.02269420586526394
patients O 1 0.9910927414894104
( O 0 0.009792947210371494
1 O 0 0.0067217531614005566
) O 0 0.0044422876089811325
, O 0 0.0026359553448855877
as O 0 0.002286431146785617
well O 0 0.0030800665263086557
as O 0 0.0031731349881738424
in O 0 0.005074487067759037
patients O 1 0.9014280438423157
of O 0 0.00759486760944128
Amish O 0 0.139953151345253
/ O 1 0.5866543054580688
Mennonite O 0 0.051067329943180084
and O 0 0.011244275607168674
Irish O 0 0.022319607436656952
English O 0 0.01787986047565937
backgrounds O 0 0.04239076003432274
. O 0 0.029607299715280533

Additional O 0 0.045560322701931
mutations O 0 0.10674591362476349
were O 0 0.011804801411926746
observed O 0 0.016092775389552116
in O 0 0.005667588673532009
Japanese O 0 0.011187400668859482
, O 0 0.007223811931908131
Utah O 0 0.016278842464089394
Mormon O 0 0.01962488889694214
, O 0 0.006234017666429281
and O 0 0.006203869823366404
African O 0 0.020655106753110886
American O 0 0.024954289197921753
patients O 1 0.9922371506690979
. O 0 0.0321735180914402

These O 0 0.029351703822612762
assays O 0 0.05252711847424507
should O 0 0.014202429912984371
facilitate O 0 0.018983621150255203
screening O 0 0.02742750570178032
for O 0 0.00782631617039442
A B-Disease 0 0.01728649064898491
- I-Disease 1 0.7813658714294434
T I-Disease 1 0.9980847835540771
heterozygotes O 1 0.7524244785308838
in O 0 0.009887848980724812
the O 0 0.00882724765688181
populations O 0 0.03079582005739212
studied O 0 0.017034359276294708
. O 0 0.012818933464586735
. O 0 0.0206386037170887

The O 0 0.056822508573532104
von B-Disease 1 0.990494966506958
Hippel I-Disease 1 0.9993577599525452
- I-Disease 1 0.9981877207756042
Lindau I-Disease 1 0.999783456325531
tumor I-Disease 1 0.9997822642326355
suppressor O 1 0.986156702041626
gene O 0 0.07087723165750504
is O 0 0.011526617221534252
required O 0 0.011962423101067543
for O 0 0.009921845048666
cell O 0 0.041588760912418365
cycle O 0 0.049896299839019775
exit O 0 0.04145755618810654
upon O 0 0.01980426535010338
serum O 1 0.7917340397834778
withdrawal O 0 0.0656038150191307
. O 0 0.031671419739723206

The O 0 0.03500928357243538
inactivation O 0 0.09552322328090668
of O 0 0.01571183279156685
the O 0 0.021675921976566315
von B-Disease 1 0.9423573613166809
Hippel I-Disease 1 0.9989643096923828
- I-Disease 1 0.9937279224395752
Lindau I-Disease 1 0.9994465708732605
( I-Disease 0 0.44511234760284424
VHL I-Disease 1 0.9995008707046509
) I-Disease 0 0.3640561103820801
tumor I-Disease 1 0.9997768998146057
suppressor O 1 0.9975376129150391
gene O 1 0.9564980864524841
predisposes O 1 0.9974164962768555
affected O 0 0.06127604842185974
individuals O 0 0.015250584110617638
to O 0 0.008453677408397198
the O 0 0.01101015880703926
human O 1 0.7642716765403748
VHL B-Disease 1 0.999997615814209
cancer I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999990463256836
and O 0 0.011414442211389542
is O 0 0.009548552334308624
associated O 0 0.015830183401703835
with O 0 0.0163545124232769
sporadic B-Disease 1 0.9857139587402344
renal I-Disease 1 0.9999988079071045
cell I-Disease 1 0.9993583559989929
carcinomas I-Disease 1 0.9999715089797974
( O 0 0.32161733508110046
RCC B-Disease 1 0.9993199110031128
) O 0 0.023757899180054665
and O 0 0.01606767065823078
brain B-Disease 1 0.9450769424438477
hemangioblastomas I-Disease 1 0.6217391490936279
. O 0 0.03257047012448311

VHL O 1 0.9975616931915283
- O 1 0.8261501789093018
negative O 0 0.11838873475790024
786 O 1 0.9830580353736877
- O 1 0.8844158053398132
0 O 0 0.0859701931476593
RCC B-Disease 1 0.9955530762672424
cells O 0 0.08857154101133347
are O 0 0.012007725425064564
tumorigenic O 0 0.06202578544616699
in O 0 0.009835882112383842
nude O 0 0.0402226448059082
mice O 0 0.10053016245365143
which O 0 0.008043302223086357
is O 0 0.007001779042184353
suppressed O 0 0.018528513610363007
by O 0 0.007011052221059799
the O 0 0.008287787437438965
reintroduction O 0 0.053748585283756256
of O 0 0.017896130681037903
VHL B-Disease 1 0.9938629865646362
. O 0 0.04077954962849617

Remarkably O 0 0.06616634875535965
, O 0 0.016355019062757492
this O 0 0.010106269270181656
occurs O 0 0.023379605263471603
without O 0 0.010060437954962254
affecting O 0 0.019327271729707718
the O 0 0.0065545449033379555
growth O 0 0.013154148124158382
rate O 0 0.013085925951600075
and O 0 0.006133744493126869
cell O 0 0.029706958681344986
cycle O 0 0.026174316182732582
profile O 0 0.01658443547785282
of O 0 0.005069540347903967
these O 0 0.006073922850191593
cells O 0 0.0265364870429039
in O 0 0.0077990381978452206
culture O 0 0.02026171237230301
. O 0 0.016818178817629814

The O 0 0.042465560138225555
786 O 1 0.785393476486206
- O 0 0.17243507504463196
0 O 0 0.04001820459961891
cell O 0 0.03416670113801956
line O 0 0.0139853460714221
, O 0 0.006391747388988733
like O 0 0.009145560674369335
many O 0 0.008675223216414452
cancer B-Disease 1 0.9998635053634644
cells O 0 0.4783917963504791
, O 0 0.007664474193006754
fails O 0 0.02198696881532669
to O 0 0.0065706330351531506
exit O 0 0.020086631178855896
the O 0 0.0084084989503026
cell O 0 0.03347323089838028
cycle O 0 0.04194312170147896
upon O 0 0.01902005635201931
serum O 0 0.48674896359443665
withdrawal O 0 0.07548190653324127
. O 0 0.0343991257250309

Here O 0 0.018423350527882576
, O 0 0.008976571261882782
it O 0 0.005263457540422678
is O 0 0.004964303225278854
shown O 0 0.00759649183601141
that O 0 0.004899483174085617
reintroduction O 0 0.02656356804072857
of O 0 0.004907598719000816
the O 0 0.007293968461453915
wild O 0 0.02803313173353672
- O 0 0.30069753527641296
type O 0 0.18481826782226562
VHL B-Disease 1 0.997521698474884
gene O 0 0.1119881123304367
restores O 0 0.04907090216875076
the O 0 0.01032570656388998
ability O 0 0.021446045488119125
of O 0 0.013855671510100365
VHL O 1 0.9996554851531982
- O 1 0.9940342307090759
negative O 1 0.9232722520828247
RCC B-Disease 1 0.9999594688415527
cancer I-Disease 1 0.9999569654464722
cells O 0 0.3623845875263214
to O 0 0.010642322711646557
exit O 0 0.02704223245382309
the O 0 0.010780060663819313
cell O 0 0.03607933968305588
cycle O 0 0.041478611528873444
and O 0 0.015111063607037067
enter O 0 0.04283282905817032
G0 O 1 0.9989326596260071
/ O 1 0.9704915881156921
quiescence O 1 0.7901849150657654
in O 0 0.024425337091088295
low O 0 0.06005539372563362
serum O 1 0.6148446202278137
. O 0 0.038126975297927856

Both O 0 0.05064494535326958
VHL O 1 0.9974873065948486
- O 1 0.5737661719322205
positive O 0 0.04725700244307518
and O 0 0.02162449061870575
VHL O 1 0.9992052912712097
- O 1 0.8409010171890259
negative O 0 0.11466759443283081
RCC B-Disease 1 0.9965194463729858
cells O 0 0.29166379570961
exit O 0 0.03843196481466293
the O 0 0.01195463165640831
cell O 0 0.0435994528234005
cycle O 0 0.037367258220911026
by O 0 0.014703931286931038
contact O 0 0.04275563359260559
inhibition O 0 0.21670973300933838
. O 0 0.030553698539733887

The O 0 0.0505051389336586
cyclin O 1 0.9848244786262512
- O 1 0.7183050513267517
dependent O 0 0.1841799020767212
kinase O 1 0.9882547855377197
inhibitor O 1 0.9945532083511353
, O 0 0.018907206133008003
p27 O 1 0.9690662622451782
, O 0 0.014866030775010586
accumulates O 0 0.04961055889725685
upon O 0 0.015820715576410294
serum O 1 0.6006748676300049
withdrawal O 0 0.02377709373831749
, O 0 0.004765207413583994
only O 0 0.003034193767234683
in O 0 0.0028445960488170385
the O 0 0.0035108996089547873
presence O 0 0.00907075684517622
of O 0 0.005745823495090008
VHL B-Disease 1 0.9655000567436218
, O 0 0.006019797176122665
as O 0 0.0038460097275674343
a O 0 0.005007076542824507
result O 0 0.006161167751997709
of O 0 0.0039320532232522964
the O 0 0.005138640757650137
stabilization O 0 0.029696598649024963
of O 0 0.00690214429050684
the O 0 0.010117758065462112
protein O 0 0.04285351559519768
. O 0 0.02440616674721241

We O 0 0.021177906543016434
propose O 0 0.031057020649313927
that O 0 0.007415330037474632
the O 0 0.00650728028267622
loss O 0 0.01772278919816017
of O 0 0.007046971935778856
wild O 0 0.024750495329499245
- O 0 0.30376917123794556
type O 0 0.1979091763496399
VHL B-Disease 1 0.9971166849136353
gene O 0 0.0594199076294899
results O 0 0.01461785938590765
in O 0 0.0059714531525969505
a O 0 0.007908638566732407
specific O 0 0.012024367228150368
cellular O 0 0.040979351848363876
defect O 1 0.9357531666755676
in O 0 0.012682282365858555
serum O 1 0.9341914057731628
- O 0 0.10548484325408936
dependent O 0 0.03189779818058014
growth O 0 0.020273717120289803
control O 0 0.016974980011582375
, O 0 0.008350844494998455
which O 0 0.009840848855674267
may O 0 0.020410144701600075
initiate O 0 0.16304539144039154
tumor B-Disease 1 0.9985144734382629
formation O 0 0.0728730782866478
. O 0 0.032601479440927505

This O 0 0.015061900019645691
is O 0 0.010022327303886414
corrected O 0 0.028545327484607697
by O 0 0.007929579354822636
the O 0 0.00718565983697772
reintroduction O 0 0.04205380752682686
of O 0 0.01030010636895895
wild O 0 0.029570942744612694
- O 0 0.4879200756549835
type O 0 0.31862571835517883
VHL B-Disease 1 0.9988812804222107
, O 0 0.021043315529823303
implicating O 1 0.6897358894348145
VHL B-Disease 1 0.994564414024353
as O 0 0.0089390454813838
the O 0 0.008981217630207539
first O 0 0.014851588755846024
tumor B-Disease 1 0.9953923225402832
suppressor O 1 0.720391035079956
involved O 0 0.012770519591867924
in O 0 0.0049621039070189
the O 0 0.005528430920094252
regulation O 0 0.014556795358657837
of O 0 0.00705366488546133
cell O 0 0.032731931656599045
cycle O 0 0.026620518416166306
exit O 0 0.018435461446642876
, O 0 0.004720620345324278
which O 0 0.003372729988768697
is O 0 0.003823226550593972
consistent O 0 0.007159120868891478
with O 0 0.004999498371034861
its O 0 0.006434193812310696
gatekeeper O 0 0.1725817769765854
function O 0 0.012499082833528519
in O 0 0.006487802602350712
the O 0 0.00949231069535017
kidney O 1 0.9989194869995117
. O 0 0.014514905400574207
. O 0 0.01926583983004093

Piebaldism B-Disease 1 0.9936471581459045
with O 0 0.046140942722558975
deafness B-Disease 1 0.9998692274093628
: O 0 0.026613879948854446
molecular O 0 0.028245268389582634
evidence O 0 0.012715756893157959
for O 0 0.007902029901742935
an O 0 0.010218512266874313
expanded O 0 0.0321933813393116
syndrome O 1 0.9999783039093018
. O 0 0.03321575000882149

In O 0 0.023678632453083992
a O 0 0.017196811735630035
South O 0 0.02093805931508541
African O 0 0.025861384347081184
girl O 0 0.03379325196146965
of O 0 0.01126142032444477
Xhosa O 1 0.864497721195221
stock O 0 0.07176965475082397
with O 0 0.0189028549939394
severe O 1 0.9989047050476074
piebaldism B-Disease 1 0.9957928657531738
and O 0 0.029655108228325844
profound O 1 0.9967992305755615
congenital O 1 0.9999996423721313
sensorineural B-Disease 1 0.9999949932098389
deafness I-Disease 1 0.9999891519546509
we O 0 0.014158588834106922
identified O 0 0.015868637710809708
a O 0 0.010644563473761082
novel O 0 0.01980714313685894
missense O 0 0.13882474601268768
substitution O 0 0.031054146587848663
at O 0 0.009824426844716072
a O 0 0.008592472411692142
highly O 0 0.012958938255906105
conserved O 0 0.020303545519709587
residue O 0 0.0267634354531765
in O 0 0.007110977545380592
the O 0 0.008302591741085052
intracellular O 0 0.055966343730688095
kinase O 0 0.0664578378200531
domain O 0 0.016350341960787773
of O 0 0.006170044653117657
the O 0 0.009877398610115051
KIT O 0 0.37017229199409485
proto O 1 0.9233803749084473
- O 1 0.6162474155426025
oncogene O 1 0.9696012735366821
, O 0 0.027900146320462227
R796G O 0 0.11947281658649445
. O 0 0.03669176995754242

Though O 0 0.05367119982838631
auditory B-Disease 1 0.9300950169563293
anomalies I-Disease 0 0.15218891203403473
have O 0 0.009681137278676033
been O 0 0.00852287095040083
observed O 0 0.015012702904641628
in O 0 0.007322018966078758
mice O 0 0.07403077930212021
with O 0 0.010487591847777367
dominant O 0 0.034574978053569794
white O 0 0.06506635993719101
spotting O 1 0.9107174873352051
( O 0 0.028338000178337097
W O 1 0.8925663232803345
) O 0 0.010610228404402733
due O 0 0.010450908914208412
to O 0 0.008997214958071709
KIT O 1 0.8853883147239685
mutations O 1 0.9766142964363098
, O 0 0.01571621373295784
deafness B-Disease 1 0.9997010231018066
is O 0 0.009336848743259907
not O 0 0.006257605738937855
typical O 0 0.014924594201147556
in O 0 0.008970283903181553
human O 0 0.024181082844734192
piebaldism B-Disease 0 0.33213454484939575
. O 0 0.03108968958258629

Thus O 0 0.03195243701338768
, O 0 0.01478386577218771
the O 0 0.01090260036289692
occurrence O 0 0.0564783550798893
of O 0 0.01660035364329815
sensorineural B-Disease 1 0.9999336004257202
deafness I-Disease 1 0.9999624490737915
in O 0 0.014462266117334366
this O 0 0.011755761690437794
patient O 0 0.4269704520702362
extends O 0 0.029444435611367226
considerably O 0 0.019042061641812325
the O 0 0.008200415410101414
phenotypic O 0 0.03721529617905617
range O 0 0.015526007860898972
of O 0 0.007726843003183603
piebaldism B-Disease 0 0.05595899745821953
due O 0 0.011934618465602398
to O 0 0.00899091549217701
KIT O 1 0.5307378172874451
gene O 0 0.2623199224472046
mutation O 1 0.5231433510780334
in O 0 0.010840587317943573
humans O 0 0.02262406423687935
and O 0 0.009784762747585773
tightens O 1 0.6295865774154663
the O 0 0.009633589535951614
clinical O 0 0.14035531878471375
similarity O 0 0.020524628460407257
between O 0 0.009008998982608318
piebaldism B-Disease 0 0.036851830780506134
and O 0 0.004555763676762581
the O 0 0.004094094503670931
various O 0 0.0055715651251375675
forms O 0 0.01676708459854126
of O 0 0.019027570262551308
Waardenburg B-Disease 1 0.9999812841415405
syndrome I-Disease 1 0.9999970197677612
. O 0 0.026851912960410118
. O 0 0.030877981334924698

Cycloheximide O 0 0.21086753904819489
facilitates O 0 0.06941365450620651
the O 0 0.014835460111498833
identification O 0 0.021482184529304504
of O 0 0.011356600560247898
aberrant O 0 0.06708799302577972
transcripts O 0 0.025597911328077316
resulting O 0 0.020234838128089905
from O 0 0.008967545814812183
a O 0 0.009812147356569767
novel O 0 0.02377230115234852
splice O 0 0.10329435020685196
- O 0 0.06732002645730972
site O 0 0.02431836910545826
mutation O 0 0.10920685529708862
in O 0 0.012049516662955284
COL17A1 O 0 0.2446718066930771
in O 0 0.009063885547220707
a O 0 0.013589837588369846
patient O 1 0.9163007736206055
with O 0 0.02702227421104908
generalized O 1 0.9961315393447876
atrophic B-Disease 1 0.9999508857727051
benign I-Disease 1 0.999799907207489
epidermolysis I-Disease 1 0.9999516010284424
bullosa I-Disease 1 0.9997077584266663
. O 0 0.08594389259815216

Patients O 1 0.9990037083625793
with O 0 0.0571327731013298
generalized O 1 0.9974236488342285
atrophic B-Disease 1 0.999958872795105
benign I-Disease 1 0.9999212026596069
epidermolysis I-Disease 1 0.9999642372131348
bullosa I-Disease 1 0.999789297580719
often O 0 0.05039266124367714
show O 0 0.02982964739203453
decreased O 0 0.04679621383547783
expression O 0 0.02969766966998577
of O 0 0.012608797289431095
type O 0 0.22352859377861023
XVII O 1 0.9978737831115723
collagen O 1 0.9839175939559937
, O 0 0.01605861261487007
a O 0 0.019949479028582573
transmembrane O 0 0.09139980375766754
hemidesmosomal O 0 0.10417450964450836
protein O 0 0.045966967940330505
encoded O 0 0.02841760590672493
by O 0 0.016531355679035187
COL17A1 O 0 0.14151960611343384
. O 0 0.03321196883916855

This O 0 0.01600896567106247
report O 0 0.01324634812772274
documents O 0 0.011550188064575195
a O 0 0.01077817939221859
novel O 0 0.02226659655570984
splice O 0 0.11122234910726547
- O 0 0.055366724729537964
site O 0 0.0217963345348835
mutation O 0 0.09652554243803024
in O 0 0.01074700802564621
COL17A1 O 0 0.2211810201406479
in O 0 0.008022179827094078
a O 0 0.011199764907360077
patient O 1 0.9660928249359131
with O 0 0.021475480869412422
generalized O 1 0.9985675811767578
atrophic B-Disease 1 0.9999758005142212
benign I-Disease 1 0.9999340772628784
epidermolysis I-Disease 1 0.9999698400497437
bullosa I-Disease 1 0.9997681975364685
, O 0 0.01814633049070835
and O 0 0.008659730665385723
applies O 0 0.013222272507846355
a O 0 0.006830091588199139
new O 0 0.006805520039051771
methodology O 0 0.015089301392436028
to O 0 0.005482614506036043
define O 0 0.014457211829721928
and O 0 0.007671767845749855
characterize O 0 0.03320034593343735
the O 0 0.012695545330643654
resulting O 0 0.03897516056895256
mRNA O 0 0.0665334090590477
splice O 0 0.13441678881645203
variants O 0 0.08146730065345764
. O 0 0.042682286351919174

Mutational O 1 0.701087474822998
analysis O 0 0.04523991793394089
of O 0 0.015344795770943165
COL17A1 O 0 0.12889359891414642
identified O 0 0.026571767404675484
a O 0 0.017164196819067
maternally O 0 0.4001150131225586
inherited O 1 0.8314830660820007
G O 1 0.6146751046180725
- O 0 0.0505119226872921
to O 0 0.012952171266078949
- O 0 0.2584395408630371
T O 1 0.8846279382705688
transversion O 0 0.06882822513580322
at O 0 0.008938292972743511
the O 0 0.006450244225561619
- O 0 0.018447505310177803
1 O 0 0.009366595186293125
position O 0 0.0077310968190431595
of O 0 0.007948621176183224
exon O 0 0.0561843067407608
32 O 0 0.03749891370534897
. O 0 0.025992605835199356

This O 0 0.0334574431180954
acceptor O 0 0.11199579387903214
splice O 0 0.20541776716709137
- O 0 0.060222264379262924
site O 0 0.021974509581923485
mutation O 0 0.05865897238254547
led O 0 0.012539622373878956
to O 0 0.00569321122020483
the O 0 0.006343380082398653
formation O 0 0.016454704105854034
of O 0 0.0073298742063343525
aberrant O 0 0.058677710592746735
transcripts O 0 0.023386847227811813
present O 0 0.010999026708304882
at O 0 0.011343319900333881
extremely O 0 0.01973634399473667
low O 0 0.024615628644824028
levels O 0 0.033256880939006805
. O 0 0.02320157177746296

Based O 0 0.026342343538999557
on O 0 0.010514450259506702
our O 0 0.012863505631685257
recent O 0 0.01633780635893345
finding O 0 0.020065750926733017
that O 0 0.012891181744635105
cycloheximide O 0 0.22130125761032104
stabilized O 0 0.4787195324897766
mutant O 0 0.08594389259815216
COL17A1 O 1 0.5580397248268127
transcripts O 0 0.03686162084341049
in O 0 0.013751501217484474
keratinocytes O 1 0.7384077310562134
homozygous O 0 0.06554988771677017
for O 0 0.012378757819533348
a O 0 0.01690269075334072
frameshift O 1 0.9719783663749695
mutation O 1 0.5287012457847595
, O 0 0.009401197545230389
the O 0 0.006892280653119087
effects O 0 0.022965556010603905
of O 0 0.0066077630035579205
the O 0 0.009291463531553745
splice O 0 0.07449815422296524
- O 0 0.04565228521823883
site O 0 0.020227473229169846
mutation O 0 0.062161751091480255
on O 0 0.01007622666656971
splicing O 0 0.042162902653217316
of O 0 0.010887841694056988
COL17A1 O 0 0.06556009501218796
transcripts O 0 0.020642556250095367
were O 0 0.006938467267900705
determined O 0 0.014390199445188046
using O 0 0.01497562974691391
reverse O 0 0.04563425853848457
transcriptase O 1 0.8498489856719971
polymerase O 0 0.1976841539144516
chain O 0 0.04495926573872566
reaction O 0 0.027735896408557892
of O 0 0.007522173225879669
total O 0 0.014157682657241821
RNA O 0 0.038773003965616226
from O 0 0.012807654216885567
keratinocytes O 0 0.36488011479377747
incubated O 0 0.047709088772535324
for O 0 0.012797841802239418
2 O 0 0.023665841668844223
. O 0 0.020201394334435463

5 O 0 0.03638361766934395
h O 0 0.04177903011441231
in O 0 0.009712629951536655
the O 0 0.006981793325394392
presence O 0 0.01319736149162054
or O 0 0.00893483031541109
absence O 0 0.013903875835239887
of O 0 0.00652400404214859
10 O 0 0.013044433668255806
microg O 0 0.18181335926055908
cycloheximide O 0 0.25995898246765137
per O 0 0.03317926824092865
ml O 0 0.38222622871398926
. O 0 0.03796078637242317

Using O 0 0.023446407169103622
this O 0 0.012387845665216446
approach O 0 0.017659148201346397
, O 0 0.008688648231327534
an O 0 0.009226318448781967
abnormally O 0 0.07132413238286972
spliced O 0 0.06390411406755447
transcript O 0 0.029076125472784042
was O 0 0.007138424552977085
identified O 0 0.009188596159219742
that O 0 0.004194733686745167
contains O 0 0.006151741370558739
an O 0 0.004965698346495628
extra O 0 0.014267997816205025
264 O 0 0.028695914894342422
bases O 0 0.017779290676116943
upstream O 0 0.025676002725958824
from O 0 0.011726432479918003
exon O 0 0.04519190266728401
32 O 0 0.016817810013890266
, O 0 0.00802308227866888
resulting O 0 0.015507753007113934
in O 0 0.00861639529466629
a O 0 0.013792106881737709
premature O 1 0.7580294013023376
termination O 0 0.44685304164886475
codon O 0 0.07864468544721603
27 O 0 0.02668670564889908
bp O 0 0.04864443093538284
downstream O 0 0.0375562384724617
from O 0 0.013257397338747978
the O 0 0.013181162066757679
cryptic O 0 0.06761826574802399
splice O 0 0.1165120005607605
site O 0 0.03680529445409775
. O 0 0.03000986948609352

Three O 0 0.02328871376812458
other O 0 0.013401289470493793
splice O 0 0.05974094197154045
variants O 0 0.023639056831598282
, O 0 0.005671432241797447
including O 0 0.0050682201981544495
one O 0 0.004494857974350452
derived O 0 0.008087271824479103
from O 0 0.005061849020421505
the O 0 0.005974083207547665
skipping O 0 0.02274150401353836
of O 0 0.007157648913562298
exon O 0 0.04391299560666084
32 O 0 0.016467249020934105
, O 0 0.006873562000691891
were O 0 0.005623138975352049
also O 0 0.007338729687035084
identified O 0 0.020050490275025368
. O 0 0.019457265734672546

These O 0 0.019468240439891815
results O 0 0.02182050421833992
indicate O 0 0.020749608054757118
the O 0 0.009558135643601418
usefulness O 0 0.03471905738115311
of O 0 0.010410682298243046
cycloheximide O 1 0.7512026429176331
treatment O 1 0.5579750537872314
in O 0 0.008429493755102158
evaluating O 0 0.019939318299293518
the O 0 0.00820043496787548
abnormal O 0 0.06096537783741951
processing O 0 0.011146745644509792
of O 0 0.005444503389298916
mRNA O 0 0.01933491975069046
due O 0 0.009103592485189438
to O 0 0.00793559942394495
splice O 0 0.1914030909538269
- O 0 0.10371873527765274
site O 0 0.016478097066283226
mutations O 0 0.3100123703479767
, O 0 0.008118167519569397
because O 0 0.0077068558894097805
( O 0 0.010540328919887543
i O 0 0.010644403286278248
) O 0 0.013671011663973331
aberrant O 0 0.059662312269210815
splicing O 0 0.06904633343219757
often O 0 0.02091488055884838
generates O 0 0.035777777433395386
a O 0 0.01892920956015587
premature O 1 0.8631742000579834
termination O 1 0.6714500188827515
codon O 0 0.060254521667957306
, O 0 0.013571701012551785
( O 0 0.015710599720478058
ii O 0 0.020169509574770927
) O 0 0.011965753510594368
transcripts O 0 0.01780320517718792
with O 0 0.011910238303244114
premature O 1 0.8140988945960999
termination O 1 0.7745444774627686
codons O 0 0.06005209684371948
can O 0 0.014422954991459846
occur O 0 0.019371381029486656
at O 0 0.009749592281877995
low O 0 0.015117757022380829
or O 0 0.011340068653225899
undetectable O 1 0.5604339838027954
levels O 0 0.01866217702627182
due O 0 0.011086391285061836
to O 0 0.009774935431778431
nonsense O 0 0.03270592913031578
- O 0 0.05088503658771515
mediated O 0 0.19927191734313965
mRNA O 0 0.03824806213378906
decay O 0 0.024857476353645325
, O 0 0.0067862868309021
and O 0 0.004819144960492849
( O 0 0.008332128636538982
iii O 0 0.015479133464396
) O 0 0.005820566788315773
the O 0 0.003938604611903429
levels O 0 0.008855078369379044
of O 0 0.0036770713049918413
these O 0 0.004240167327225208
transcripts O 0 0.01070436742156744
can O 0 0.006210765335708857
be O 0 0.0041172802448272705
increased O 0 0.012359349988400936
by O 0 0.010399850085377693
cycloheximide O 0 0.09084373712539673
. O 0 0.02566341869533062

A O 0 0.05929309502243996
deletion O 1 0.5308047533035278
mutation O 0 0.39414405822753906
in O 0 0.01405769120901823
COL17A1 O 0 0.12631289660930634
in O 0 0.010238721035420895
five O 0 0.012524445541203022
Austrian O 0 0.03390201926231384
families O 0 0.023594843223690987
with O 0 0.023196788504719734
generalized O 1 0.9967886209487915
atrophic B-Disease 1 0.9999308586120605
benign I-Disease 1 0.9999018907546997
epidermolysis I-Disease 1 0.9999096393585205
bullosa I-Disease 1 0.9995961785316467
represents O 0 0.05721930414438248
propagation O 0 0.05226724222302437
of O 0 0.012056663632392883
an O 0 0.014224772341549397
ancestral O 0 0.05855441093444824
allele O 0 0.21319513022899628
. O 0 0.03743276745080948

Patients O 1 0.9985764026641846
with O 0 0.07118674367666245
generalized O 1 0.9970425963401794
atrophic B-Disease 1 0.9999480247497559
benign I-Disease 1 0.9998413324356079
epidermolysis I-Disease 1 0.999931812286377
bullosa I-Disease 1 0.9995226860046387
, O 0 0.02932601049542427
a O 0 0.020596249029040337
usually O 0 0.0252087265253067
nonlethal O 0 0.07836833596229553
form O 0 0.029093895107507706
of O 0 0.028549717739224434
junctional B-Disease 1 0.9993401169776917
epidermolysis I-Disease 1 0.9999159574508667
bullosa I-Disease 1 0.9997425675392151
, O 0 0.028994642198085785
have O 0 0.019573599100112915
generalized O 1 0.9269629716873169
blistering B-Disease 1 0.9789398312568665
, O 0 0.04876270517706871
nail B-Disease 1 0.9998475313186646
dystrophy I-Disease 1 0.999997615814209
, O 0 0.32459181547164917
patchy B-Disease 1 0.9997547268867493
alopecia I-Disease 1 0.9999943971633911
, O 0 0.02565929666161537
and O 0 0.021660080179572105
dental B-Disease 1 0.999194324016571
abnormalities I-Disease 1 0.9979154467582703
. O 0 0.04037157818675041

Skin B-Disease 1 0.9996225833892822
fragility I-Disease 1 0.913152813911438
in O 0 0.013215313665568829
most O 0 0.008577266708016396
cases O 0 0.011885871179401875
is O 0 0.005518765654414892
due O 0 0.008316179737448692
to O 0 0.007235194556415081
mutations O 0 0.03901335224509239
in O 0 0.007681029848754406
the O 0 0.008801809512078762
gene O 0 0.060285795480012894
encoding O 0 0.05128731578588486
type O 1 0.5893396139144897
XVII O 1 0.9989461302757263
collagen O 1 0.9980375170707703
( O 0 0.043426450341939926
COL17A1 O 1 0.7402234077453613
) O 0 0.03490966558456421
. O 0 0.02940918318927288

Recently O 0 0.04443449154496193
, O 0 0.014094616286456585
we O 0 0.009345549158751965
reported O 0 0.014380097389221191
five O 0 0.010846856981515884
Austrian O 0 0.03022909350693226
families O 0 0.023728523403406143
with O 0 0.022819386795163155
generalized O 1 0.9973202347755432
atrophic B-Disease 1 0.9999662637710571
benign I-Disease 1 0.9999260902404785
epidermolysis I-Disease 1 0.9999746084213257
bullosa I-Disease 1 0.9997155070304871
who O 0 0.030091367661952972
share O 0 0.026388341560959816
the O 0 0.015052396804094315
same O 0 0.025963913649320602
COL17A1 O 1 0.8185288906097412
mutation O 1 0.7021018266677856
. O 0 0.04244732856750488

Affected O 0 0.056280702352523804
individuals O 0 0.019253630191087723
in O 0 0.007539123762398958
three O 0 0.006142646074295044
families O 0 0.011715225875377655
are O 0 0.005788322072476149
homozygous O 0 0.029608549550175667
for O 0 0.006957767065614462
4003delTC O 0 0.03320792689919472
, O 0 0.006197693757712841
whereas O 0 0.009118059650063515
those O 0 0.0037938610184937716
in O 0 0.0039525264874100685
two O 0 0.0040731304325163364
others O 0 0.007881846278905869
are O 0 0.007585316430777311
compound O 0 0.03643405809998512
heterozygotes O 1 0.8984790444374084
. O 0 0.030592167750000954

To O 0 0.01609865017235279
determine O 0 0.01581381820142269
if O 0 0.00795454066246748
the O 0 0.006238858215510845
occurrence O 0 0.023543497547507286
of O 0 0.006645080167800188
4003delTC O 0 0.03239211067557335
in O 0 0.006406871136277914
these O 0 0.005780559033155441
unrelated O 0 0.022768596187233925
families O 0 0.018900521099567413
signifies O 0 0.035435304045677185
propagation O 0 0.026331981644034386
of O 0 0.006103459745645523
an O 0 0.008291130885481834
ancestral O 0 0.03137597441673279
allele O 0 0.07423947751522064
or O 0 0.016433292999863625
a O 0 0.015891261398792267
mutational O 1 0.9396185278892517
hot O 0 0.033513277769088745
spot O 0 0.02255241386592388
, O 0 0.010338100604712963
haplotypes O 0 0.09400463104248047
were O 0 0.0071027944795787334
determined O 0 0.011460663750767708
for O 0 0.006805007345974445
polymorphisms O 0 0.039810869842767715
both O 0 0.007209838833659887
within O 0 0.009800720028579235
and O 0 0.010501674376428127
flanking O 0 0.07679779082536697
COL17A1 O 1 0.6686925292015076
. O 0 0.03732803836464882

Five O 0 0.04462340474128723
intragenic O 0 0.12907056510448456
polymorphisms O 0 0.08467502892017365
were O 0 0.009531035088002682
chosen O 0 0.011306650005280972
based O 0 0.007785787805914879
on O 0 0.006516202352941036
their O 0 0.010672399774193764
informativeness O 0 0.09072931855916977
. O 0 0.027492519468069077

One O 0 0.014132888056337833
of O 0 0.006678328383713961
these O 0 0.0056046973913908005
, O 0 0.00422521959990263
not O 0 0.0035772263072431087
previously O 0 0.005648482590913773
reported O 0 0.008310156874358654
, O 0 0.00424477644264698
was O 0 0.005462514236569405
2988 O 0 0.029885996133089066
A O 0 0.007787102833390236
or O 0 0.007850676774978638
C O 0 0.01770901493728161
that O 0 0.004602204542607069
introduces O 0 0.013780814595520496
a O 0 0.006651722360402346
new O 0 0.006840553134679794
restriction O 0 0.014460078440606594
site O 0 0.010244892910122871
for O 0 0.008915637619793415
Eco0109 O 0 0.06029774621129036
I O 0 0.022221971303224564
. O 0 0.02267918735742569

All O 0 0.018910136073827744
the O 0 0.01590040698647499
4003delTC O 0 0.08724804222583771
alleles O 0 0.09568512439727783
showed O 0 0.016297997906804085
the O 0 0.0070276097394526005
same O 0 0.009194284677505493
haplotype O 0 0.2638351321220398
for O 0 0.006097226869314909
these O 0 0.007640304043889046
five O 0 0.01381708774715662
polymorphic O 0 0.24544498324394226
markers O 0 0.06908762454986572
. O 0 0.03405018523335457

Fourteen O 0 0.0883045643568039
microsatellite O 0 0.33147409558296204
polymorphisms O 0 0.0952577292919159
were O 0 0.00983925350010395
selected O 0 0.009474296122789383
based O 0 0.007055224850773811
on O 0 0.004221096634864807
their O 0 0.005834971088916063
high O 0 0.010592863894999027
heterozygosity O 0 0.06474960595369339
and O 0 0.006408072542399168
their O 0 0.00699008209630847
location O 0 0.014254395850002766
within O 0 0.012949427589774132
10q23 O 0 0.11442886292934418
- O 0 0.08819932490587234
q25 O 0 0.1673392504453659
near O 0 0.048104092478752136
COL17A1 O 1 0.526645302772522
. O 0 0.03542189672589302

Three O 0 0.02659969963133335
families O 0 0.03425835445523262
shared O 0 0.040047530084848404
microsatellite O 1 0.5259097218513489
polymorphisms O 0 0.11722777783870697
covering O 0 0.028399070724844933
at O 0 0.012337355874478817
most O 0 0.006785894278436899
19 O 0 0.010962285101413727
cM O 0 0.017834600061178207
, O 0 0.0052954102866351604
whereas O 0 0.009332134388387203
the O 0 0.004585247952491045
others O 0 0.0065352641977369785
shared O 0 0.00965453777462244
smaller O 0 0.00929789524525404
regions O 0 0.012875341810286045
consistent O 0 0.011966035701334476
with O 0 0.005838640499860048
cross O 0 0.01168801635503769
- O 0 0.016448354348540306
over O 0 0.00615871325135231
events O 0 0.008405376225709915
during O 0 0.0075593264773488045
passage O 0 0.010180137120187283
of O 0 0.005270432680845261
this O 0 0.006735137198120356
mutation O 0 0.042573556303977966
through O 0 0.010949058458209038
several O 0 0.010967228561639786
generations O 0 0.03539016470313072
. O 0 0.02684340812265873

These O 0 0.02060738392174244
results O 0 0.02422657608985901
indicate O 0 0.02255813591182232
that O 0 0.009550102986395359
4003delTC O 0 0.04850973188877106
occurs O 0 0.018650131300091743
on O 0 0.005340063478797674
a O 0 0.006581093184649944
single O 0 0.011764086782932281
ancestral O 0 0.03592521697282791
allele O 0 0.10415875911712646
. O 0 0.015565618872642517
. O 0 0.02126428484916687

The O 0 0.05087868496775627
haptoglobin O 1 0.9462070465087891
- O 0 0.4444792568683624
gene O 0 0.1455916464328766
deletion O 0 0.13372625410556793
responsible O 0 0.03767360746860504
for O 0 0.02023155428469181
anhaptoglobinemia B-Disease 0 0.21079663932323456
. O 0 0.03464820608496666

We O 0 0.01923234388232231
have O 0 0.00991781335324049
found O 0 0.010644652880728245
an O 0 0.009142519906163216
allelic O 0 0.11605318635702133
deletion O 0 0.05706267058849335
of O 0 0.010598532855510712
the O 0 0.013074488379061222
haptoglobin O 1 0.5032345056533813
( O 0 0.021560881286859512
Hp O 0 0.04137728735804558
) O 0 0.014532574452459812
gene O 0 0.024748779833316803
from O 0 0.007328347768634558
an O 0 0.005869042593985796
individual O 0 0.01094958558678627
with O 0 0.012140569277107716
anhaptoglobinemia B-Disease 0 0.16619873046875
. O 0 0.025237977504730225

The O 0 0.03845364600419998
Hp O 0 0.09733220934867859
gene O 0 0.0811765193939209
cluster O 0 0.041510481387376785
consists O 0 0.01328093372285366
of O 0 0.007288704626262188
coding O 0 0.03150905668735504
regions O 0 0.016301406547427177
of O 0 0.005928528029471636
the O 0 0.006907272152602673
alpha O 0 0.0217788964509964
chain O 0 0.022049451246857643
and O 0 0.006940681487321854
beta O 0 0.022937212139368057
chain O 0 0.02043435163795948
of O 0 0.0070373727940022945
the O 0 0.009856021031737328
haptoglobin O 1 0.7224634289741516
gene O 0 0.0668591558933258
( O 0 0.0174563005566597
Hp O 0 0.027222581207752228
) O 0 0.006953985430300236
and O 0 0.0034482001792639494
of O 0 0.0036325142718851566
the O 0 0.0055937268771231174
alpha O 0 0.017051998525857925
chain O 0 0.019549889490008354
and O 0 0.007654076907783747
beta O 0 0.022787287831306458
chain O 0 0.019544867798686028
of O 0 0.00674983998760581
the O 0 0.01101958192884922
haptoglobin O 1 0.9543046355247498
- O 0 0.3431246280670166
related O 0 0.03485821187496185
gene O 0 0.23319999873638153
( O 0 0.022629601880908012
Hpr O 1 0.7718093991279602
) O 0 0.012199223041534424
, O 0 0.005668142344802618
in O 0 0.0056307693012058735
tandem O 0 0.018196171149611473
from O 0 0.006115348543971777
the O 0 0.006514618638902903
5 O 0 0.014109227806329727
side O 0 0.020666198804974556
. O 0 0.01960390992462635

Southern O 0 0.06574136018753052
blot O 0 0.12298592925071716
and O 0 0.020147059112787247
PCR O 0 0.06271056830883026
analyses O 0 0.0230207908898592
have O 0 0.006839251145720482
indicated O 0 0.010198828764259815
that O 0 0.0034228407312184572
the O 0 0.0037627031560987234
individual O 0 0.007234568241983652
with O 0 0.006768792401999235
anhaptoglobinemia B-Disease 0 0.03806528449058533
was O 0 0.00619110930711031
homozygous O 0 0.0281089898198843
for O 0 0.0056971898302435875
the O 0 0.006713296752423048
gene O 0 0.03714418411254883
deletion O 0 0.040487855672836304
and O 0 0.00518815265968442
that O 0 0.004327982198446989
the O 0 0.0054999287240207195
gene O 0 0.030389849096536636
deletion O 0 0.03394177556037903
was O 0 0.005754620768129826
included O 0 0.005390477366745472
at O 0 0.004729080479592085
least O 0 0.0055494061671197414
from O 0 0.00418119365349412
the O 0 0.005079444032162428
promoter O 0 0.026607079431414604
region O 0 0.012992740608751774
of O 0 0.006131558679044247
Hp O 0 0.02829817868769169
to O 0 0.009612814523279667
Hpr O 0 0.258606493473053
alpha O 0 0.023339951410889626
but O 0 0.007357706781476736
not O 0 0.005760055035352707
to O 0 0.009472925215959549
Hpr O 1 0.5299116969108582
beta O 0 0.051965925842523575
( O 0 0.027512479573488235
Hpdel O 0 0.29444122314453125
) O 0 0.026188895106315613
. O 0 0.02191072888672352

In O 0 0.016004474833607674
addition O 0 0.012042001821100712
, O 0 0.00557502219453454
we O 0 0.004036250524222851
found O 0 0.0046980599872767925
seven O 0 0.005191130563616753
individuals O 0 0.006920688319951296
with O 0 0.004958837293088436
hypohaptoglobinemia B-Disease 0 0.025517107918858528
in O 0 0.0036322143860161304
three O 0 0.0034527978859841824
families O 0 0.005961508955806494
, O 0 0.0032915943302214146
and O 0 0.003114712191745639
the O 0 0.004113153088837862
genotypes O 0 0.02877226658165455
of O 0 0.0033022984862327576
six O 0 0.003975497093051672
of O 0 0.002720987657085061
the O 0 0.0031200305093079805
seven O 0 0.005436433479189873
individuals O 0 0.006637354381382465
were O 0 0.0038405656814575195
found O 0 0.00588042801246047
to O 0 0.005637753289192915
be O 0 0.008155577816069126
Hp2 O 1 0.7305202484130859
/ O 1 0.8590942025184631
Hpdel O 0 0.46291959285736084
. O 0 0.02635808289051056

The O 0 0.032614320516586304
phenotypes O 0 0.17197348177433014
and O 0 0.013309158384799957
genotypes O 0 0.0738215520977974
in O 0 0.006693034432828426
one O 0 0.0042536817491054535
of O 0 0.0031861932948231697
these O 0 0.0030213817954063416
three O 0 0.0035394581500440836
families O 0 0.0069089168682694435
showed O 0 0.007741634733974934
the O 0 0.0036259193439036608
father O 0 0.007464987691491842
to O 0 0.004954947158694267
be O 0 0.006519641727209091
hypohaptoglobinemic B-Disease 0 0.05625428631901741
( O 0 0.014983841218054295
Hp2 O 0 0.14524856209754944
) O 0 0.011239833198487759
and O 0 0.0077460529282689095
Hp2 O 1 0.8937640190124512
/ O 1 0.8050902485847473
Hpdel O 0 0.06007450819015503
, O 0 0.00617204187437892
the O 0 0.004536622669547796
mother O 0 0.010276266373693943
to O 0 0.004854578524827957
be O 0 0.005084280390292406
Hp2 O 0 0.07059456408023834
- O 0 0.025888774544000626
1 O 0 0.011981830932199955
and O 0 0.009550255723297596
Hp1 O 1 0.9360621571540833
/ O 1 0.774761974811554
Hp2 O 0 0.05275993421673775
, O 0 0.005271967966109514
one O 0 0.0031155445612967014
of O 0 0.0026088280137628317
the O 0 0.0029946090653538704
two O 0 0.003336253808811307
children O 0 0.00722649646922946
to O 0 0.0050566671416163445
be O 0 0.005622616037726402
hypohaptoglobinemic B-Disease 0 0.10000325739383698
( O 0 0.01615121215581894
Hp2 O 0 0.14831605553627014
) O 0 0.012932884506881237
and O 0 0.008154208771884441
Hp2 O 1 0.930493175983429
/ O 1 0.8469881415367126
Hpdel O 0 0.2005792111158371
, O 0 0.005120167043060064
and O 0 0.0032457474153488874
the O 0 0.0033164075575768948
other O 0 0.0036180373281240463
child O 0 0.010134360752999783
to O 0 0.0045231059193611145
be O 0 0.005500596947968006
Hp1 O 0 0.11678078770637512
and O 0 0.010442829690873623
Hp1 O 1 0.9366925358772278
/ O 1 0.8261591792106628
Hpdel O 0 0.15780100226402283
, O 0 0.007778672967106104
showing O 0 0.011840835213661194
an O 0 0.008230787701904774
anomalous O 0 0.049978818744421005
inheritance O 0 0.0361381396651268
of O 0 0.01100665982812643
Hp O 0 0.09709847718477249
phenotypes O 0 0.1480490267276764
in O 0 0.008901345543563366
the O 0 0.008703300729393959
child O 0 0.023279739543795586
with O 0 0.01712915115058422
Hp1 O 0 0.31891706585884094
. O 0 0.03183215856552124

The O 0 0.04878576844930649
Hp2 O 1 0.9707728028297424
/ O 1 0.9587977528572083
Hpdel O 0 0.32402923703193665
individuals O 0 0.01786447875201702
had O 0 0.008211890235543251
an O 0 0.005869238171726465
extremely O 0 0.012046092189848423
low O 0 0.012771976180374622
level O 0 0.009542401880025864
of O 0 0.0058494010008871555
Hp O 0 0.04433310404419899
( O 0 0.016003387048840523
mean O 0 0.022609559819102287
+ O 1 0.5254740715026855
/ O 1 0.809579074382782
- O 0 0.09360899776220322
SD O 0 0.23266106843948364
= O 0 0.07240007817745209
0 O 0 0.03613539785146713
. O 0 0.019589656963944435
049 O 1 0.9926108717918396
+ O 1 0.8301319479942322
/ O 1 0.8643302917480469
- O 0 0.06606784462928772
0 O 0 0.035612720996141434
. O 0 0.018651818856596947
043 O 1 0.9730275869369507
mg O 1 0.992624044418335
/ O 1 0.9861564636230469
ml O 1 0.8748053908348083
; O 0 0.02133580483496189
n O 0 0.03276366367936134
= O 0 0.03782699629664421
6 O 0 0.012667889706790447
) O 0 0.00686990050598979
, O 0 0.0040617999620735645
compared O 0 0.0064409272745251656
with O 0 0.003942218143492937
the O 0 0.0041803778149187565
level O 0 0.008572692982852459
( O 0 0.008275178261101246
1 O 0 0.0074850223027169704
. O 0 0.006865737959742546
64 O 0 0.01864214800298214
+ O 0 0.24214217066764832
/ O 0 0.46846380829811096
- O 0 0.03126920014619827
1 O 0 0.01226293295621872
. O 0 0.011979144997894764
07 O 0 0.23521825671195984
mg O 1 0.9633315205574036
/ O 1 0.8629764914512634
ml O 0 0.3156772255897522
) O 0 0.01237612497061491
obtained O 0 0.008794392459094524
from O 0 0.007756005972623825
52 O 0 0.018319910392165184
healthy O 0 0.029613535851240158
volunteers O 0 0.026742182672023773
having O 0 0.016248654574155807
phenotype O 1 0.9797709584236145
Hp2 O 0 0.3321736752986908
, O 0 0.008626583963632584
whereas O 0 0.0127944927662611
the O 0 0.008301187306642532
serum O 0 0.18515628576278687
Hp O 0 0.026230866089463234
level O 0 0.009789865463972092
of O 0 0.004002028610557318
an O 0 0.004704697988927364
individual O 0 0.00949875172227621
with O 0 0.011638307012617588
Hp1 O 1 0.9065719246864319
/ O 1 0.8346700072288513
Hpdel O 0 0.3114459216594696
was O 0 0.016142750158905983
0 O 0 0.0354478694498539
. O 0 0.02273928001523018

50 O 0 0.07233347743749619
mg O 1 0.967947781085968
/ O 1 0.9371961951255798
ml O 0 0.2156600058078766
, O 0 0.008735126815736294
which O 0 0.004703691229224205
was O 0 0.0038302247412502766
approximately O 0 0.005163697525858879
half O 0 0.004985755309462547
the O 0 0.003471547970548272
level O 0 0.006443988531827927
of O 0 0.004617871716618538
Hp O 0 0.019733402878046036
in O 0 0.006666369736194611
control O 0 0.014697755686938763
sera O 0 0.04022695869207382
from O 0 0.009310315363109112
the O 0 0.009679500013589859
Hp1 O 1 0.5682753324508667
phenotype O 1 0.9287962317466736
( O 0 0.013863036409020424
1 O 0 0.01013959664851427
. O 0 0.006501980125904083
26 O 0 0.014785517938435078
+ O 0 0.09004153311252594
/ O 0 0.3734130561351776
- O 0 0.0315818153321743
0 O 0 0.022870777174830437
. O 0 0.011284594424068928
33 O 0 0.02422979287803173
mg O 1 0.929838240146637
/ O 1 0.9554283022880554
ml O 1 0.7771098017692566
; O 0 0.021060023456811905
n O 0 0.03050919622182846
= O 0 0.035160090774297714
9 O 0 0.012195753864943981
) O 0 0.008097004145383835
, O 0 0.005152513273060322
showing O 0 0.01313256286084652
a O 0 0.011959745548665524
gene O 0 0.11337435990571976
- O 1 0.5080232620239258
dosage O 1 0.9799235463142395
effect O 0 0.04939592257142067
. O 0 0.026939041912555695

The O 0 0.026353273540735245
other O 0 0.01871967315673828
allele O 0 0.10906170308589935
( O 0 0.025783509016036987
Hp2 O 0 0.06695655733346939
) O 0 0.010812378488481045
of O 0 0.0057760197669267654
individuals O 0 0.010377789847552776
with O 0 0.010899752378463745
Hp2 O 1 0.9327576160430908
/ O 1 0.8674405217170715
Hpdel O 0 0.12364006042480469
was O 0 0.006096472032368183
found O 0 0.005113074090331793
to O 0 0.00316844810731709
have O 0 0.0032881891820579767
, O 0 0.002743467688560486
in O 0 0.0032612308859825134
all O 0 0.004038217477500439
exons O 0 0.02739405445754528
, O 0 0.006427067331969738
no O 0 0.008435131050646305
mutation O 0 0.05403362959623337
, O 0 0.008001208305358887
by O 0 0.008565968833863735
DNA O 0 0.035828690975904465
sequencing O 0 0.05282887443900108
. O 0 0.024433501064777374

On O 0 0.010945893824100494
the O 0 0.006567732896655798
basis O 0 0.005955019500106573
of O 0 0.003606016281992197
the O 0 0.004103934392333031
present O 0 0.006090711336582899
study O 0 0.006670055910944939
, O 0 0.004075255244970322
the O 0 0.0038460225332528353
mechanism O 0 0.012027409859001637
of O 0 0.004566844552755356
anhaptoglobinemia B-Disease 0 0.028687957674264908
and O 0 0.005081565119326115
the O 0 0.005243430845439434
mechanism O 0 0.019282935187220573
of O 0 0.007952230982482433
anomalous O 0 0.053834158927202225
inheritance O 0 0.04135897755622864
of O 0 0.011916897259652615
Hp O 0 0.10576743632555008
phenotypes O 0 0.20864611864089966
were O 0 0.009277334436774254
well O 0 0.013152341358363628
explained O 0 0.025741640478372574
. O 0 0.021324805915355682

However O 0 0.02153674326837063
, O 0 0.011306620202958584
the O 0 0.009906786493957043
mechanism O 0 0.028948133811354637
of O 0 0.014665419235825539
hypohaptoglobinemia B-Disease 0 0.1262151002883911
remains O 0 0.03882736340165138
unknown O 0 0.05857902392745018

ATM O 1 0.5462814569473267
mutations O 1 0.8251755833625793
and O 0 0.025924215093255043
phenotypes O 1 0.9442747235298157
in O 0 0.03225189447402954
ataxia B-Disease 1 0.999990701675415
- I-Disease 1 0.9972710013389587
telangiectasia I-Disease 1 0.9996329545974731
families O 0 0.024908805266022682
in O 0 0.00895883608609438
the O 0 0.008684027940034866
British O 0 0.01666894741356373
Isles O 0 0.03665017709136009
: O 0 0.013436672277748585
expression O 0 0.015474657528102398
of O 0 0.006643673405051231
mutant O 0 0.0341164655983448
ATM O 0 0.03552013635635376
and O 0 0.006194504909217358
the O 0 0.007773188408464193
risk O 1 0.9049561619758606
of O 0 0.018810942769050598
leukemia B-Disease 1 0.9999996423721313
, O 1 0.8610039949417114
lymphoma B-Disease 1 0.9999998807907104
, O 0 0.0325123630464077
and O 0 0.053972892463207245
breast B-Disease 1 0.9999921321868896
cancer I-Disease 1 0.9999641180038452
. O 0 0.04002600908279419

We O 0 0.01700328104197979
report O 0 0.012875668704509735
the O 0 0.008481328375637531
spectrum O 0 0.02258133701980114
of O 0 0.008171589113771915
59 O 0 0.03018164448440075
ATM O 0 0.2075677067041397
mutations O 1 0.7379181981086731
observed O 0 0.0337056890130043
in O 0 0.021394629031419754
ataxia B-Disease 1 0.9999899864196777
- I-Disease 1 0.9984816908836365
telangiectasia I-Disease 1 0.9999104738235474
( O 0 0.046938277781009674
A B-Disease 0 0.03377007693052292
- I-Disease 1 0.9850941896438599
T I-Disease 1 0.9994901418685913
) O 0 0.020132897421717644
patients O 1 0.9106059074401855
in O 0 0.00790434330701828
the O 0 0.009637192822992802
British O 0 0.023418908938765526
Isles O 0 0.07416854053735733
. O 0 0.03392289578914642

Of O 0 0.03383674472570419
51 O 0 0.056412022560834885
ATM O 0 0.1253920942544937
mutations O 0 0.2413673847913742
identified O 0 0.016461804509162903
in O 0 0.006481860298663378
families O 0 0.009467482566833496
native O 0 0.007484281435608864
to O 0 0.004037625156342983
the O 0 0.00488280039280653
British O 0 0.01037650741636753
Isles O 0 0.02330086939036846
, O 0 0.006130727473646402
11 O 0 0.0072016180492937565
were O 0 0.00457626162096858
founder O 0 0.014767109416425228
mutations O 0 0.03782186657190323
, O 0 0.004970087204128504
and O 0 0.0037822003941982985
2 O 0 0.0045785256661474705
of O 0 0.003023953875526786
these O 0 0.0036068179178982973
11 O 0 0.0074208141304552555
conferred O 0 0.016749218106269836
a O 0 0.011616726405918598
milder O 1 0.9804681539535522
clinical O 1 0.9835784435272217
phenotype O 1 0.9633386135101318
with O 0 0.00892276968806982
respect O 0 0.010130018927156925
to O 0 0.006486855447292328
both O 0 0.010843598283827305
cerebellar B-Disease 1 0.9997624754905701
degeneration I-Disease 1 0.9998273253440857
and O 0 0.015301280654966831
cellular O 0 0.047822173684835434
features O 0 0.029432425275444984
. O 0 0.024483641609549522

We O 0 0.016637884080410004
report O 0 0.011478153057396412
, O 0 0.005387170240283012
in O 0 0.00395226152613759
two O 0 0.004852666519582272
A B-Disease 0 0.010790489614009857
- I-Disease 0 0.41791975498199463
T I-Disease 1 0.9893432855606079
families O 0 0.01689521037042141
, O 0 0.008207845501601696
an O 0 0.009916811250150204
ATM O 0 0.08389878273010254
mutation O 1 0.645086944103241
( O 0 0.028312336653470993
7271T O 1 0.7838273644447327
- O 1 0.8796080350875854
- O 1 0.8113182783126831
> O 1 0.7229536175727844
G O 0 0.0932990312576294
) O 0 0.009149891324341297
that O 0 0.004234300460666418
may O 0 0.005935912486165762
be O 0 0.0025917580351233482
associated O 0 0.0055623892694711685
with O 0 0.003928585443645716
an O 0 0.004559248220175505
increased O 0 0.013627653010189533
risk O 1 0.9039726853370667
of O 0 0.011702150106430054
breast B-Disease 1 0.9999910593032837
cancer I-Disease 1 0.9999459981918335
in O 0 0.010306699201464653
both O 0 0.01088530570268631
homozygotes O 1 0.9901413321495056
and O 0 0.012837603688240051
heterozygotes O 1 0.9725348353385925
( O 0 0.01874079927802086
relative O 0 0.019856519997119904
risk O 0 0.03413819149136543
12 O 0 0.009752870537340641
. O 0 0.0064205750823020935
7 O 0 0.01194323506206274
; O 0 0.013478359207510948
P O 0 0.2277469038963318
= O 0 0.05051031336188316
. O 0 0.011324938386678696
0025 O 1 0.9657710194587708
) O 0 0.010063744150102139
, O 0 0.004991225432604551
although O 0 0.004581269342452288
there O 0 0.0032789381220936775
is O 0 0.0036032418720424175
a O 0 0.0053584398701786995
less O 0 0.008421200327575207
severe O 1 0.9723504185676575
A B-Disease 0 0.01971900835633278
- I-Disease 1 0.9504968523979187
T I-Disease 1 0.9984859824180603
phenotype O 1 0.8005826473236084
in O 0 0.0060252039693295956
terms O 0 0.005634866189211607
of O 0 0.003607328748330474
the O 0 0.004767579957842827
degree O 0 0.013503458350896835
of O 0 0.010532529093325138
cerebellar B-Disease 1 0.9998334646224976
degeneration I-Disease 1 0.9998575448989868
. O 0 0.04300840198993683

This O 0 0.04511589556932449
mutation O 1 0.6524356007575989
( O 0 0.04189380630850792
7271T O 1 0.7965613007545471
- O 1 0.8129075169563293
- O 1 0.7246890664100647
> O 1 0.5459666848182678
G O 0 0.04998858645558357
) O 0 0.009512403979897499
also O 0 0.004651991650462151
allows O 0 0.008281723596155643
expression O 0 0.010108095593750477
of O 0 0.004121387843042612
full O 0 0.008518451824784279
- O 0 0.021419333294034004
length O 0 0.019923387095332146
ATM O 0 0.04056456312537193
protein O 0 0.020389582961797714
at O 0 0.006967525463551283
a O 0 0.005688916426151991
level O 0 0.008881322108209133
comparable O 0 0.010810326784849167
with O 0 0.005158727522939444
that O 0 0.005380174610763788
in O 0 0.007460813038051128
unaffected O 0 0.05487189069390297
individuals O 0 0.023729383945465088
. O 0 0.023216664791107178

In O 0 0.0171876922249794
addition O 0 0.01246438268572092
, O 0 0.00590991135686636
we O 0 0.004335805773735046
have O 0 0.004188556224107742
studied O 0 0.007921773940324783
18 O 0 0.00821414403617382
A B-Disease 0 0.013138681650161743
- I-Disease 1 0.9500665664672852
T I-Disease 1 0.9996844530105591
patients O 1 0.9935516119003296
, O 0 0.006619454827159643
in O 0 0.005073264241218567
15 O 0 0.008093021810054779
families O 0 0.01064277719706297
, O 0 0.007330671884119511
who O 0 0.013785486109554768
developed O 1 0.9205901622772217
leukemia B-Disease 1 0.9999994039535522
, O 1 0.6456766724586487
lymphoma B-Disease 1 0.9999997615814209
, O 0 0.04721662402153015
preleukemic O 1 0.9983392953872681
T O 1 0.9996366500854492
- O 1 0.9840173125267029
cell O 1 0.9442697167396545
proliferation O 1 0.9222661256790161
, O 0 0.01552177406847477
or O 1 0.5455718636512756
Hodgkin B-Disease 1 0.9999991655349731
lymphoma I-Disease 1 0.9999992847442627
, O 0 0.01775554195046425
mostly O 0 0.01697448641061783
in O 0 0.013378679752349854
childhood O 0 0.17537733912467957
. O 0 0.028938818722963333

A O 0 0.02706124819815159
wide O 0 0.026866551488637924
variety O 0 0.01731216348707676
of O 0 0.011800963431596756
ATM O 0 0.10249408334493637
mutation O 1 0.5447512865066528
types O 0 0.021099096164107323
, O 0 0.0080995699390769
including O 0 0.010082469321787357
missense O 0 0.4443579912185669
mutations O 0 0.14225688576698303
and O 0 0.006315190810710192
in O 0 0.006377077661454678
- O 0 0.03246230632066727
frame O 0 0.0190974622964859
deletions O 0 0.03483472764492035
, O 0 0.006228661630302668
were O 0 0.00472594890743494
seen O 0 0.008683601394295692
in O 0 0.005956492852419615
these O 0 0.010192791000008583
patients O 1 0.9824946522712708
. O 0 0.02174324542284012

We O 0 0.015000791288912296
also O 0 0.007112957537174225
show O 0 0.00898338295519352
that O 0 0.004196685738861561
25 O 0 0.005764229688793421
% O 0 0.006121031939983368
of O 0 0.003984523471444845
all O 0 0.0052262479439377785
A B-Disease 0 0.014093981124460697
- I-Disease 1 0.9368636608123779
T I-Disease 1 0.9997701048851013
patients O 1 0.9942955374717712
carried O 0 0.013123556040227413
in O 0 0.008440045639872551
- O 0 0.043451882898807526
frame O 0 0.03271692618727684
deletions O 0 0.09591084718704224
or O 0 0.021927623078227043
missense O 1 0.9186908006668091
mutations O 0 0.3622417747974396
, O 0 0.007598904427140951
many O 0 0.0038646042812615633
of O 0 0.0028830512892454863
which O 0 0.003010702319443226
were O 0 0.0027999230660498142
also O 0 0.003378882072865963
associated O 0 0.006687052082270384
with O 0 0.005560012999922037
expression O 0 0.014280443079769611
of O 0 0.0077389320358633995
mutant O 0 0.059636566787958145
ATM O 0 0.07925048470497131
protein O 0 0.057284172624349594
. O 0 0.024382231757044792

The O 0 0.04229526221752167
DMPK O 1 0.8627502918243408
gene O 0 0.21585945785045624
of O 0 0.02640346996486187
severely O 1 0.9973502159118652
affected O 1 0.9995939135551453
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.9999411106109619
is O 0 0.023183859884738922
hypermethylated O 1 0.8786708116531372
proximal O 1 0.9124997854232788
to O 0 0.010441705584526062
the O 0 0.010240188799798489
largely O 0 0.020855054259300232
expanded O 0 0.029191654175519943
CTG O 1 0.8022719621658325
repeat O 0 0.09054113179445267
. O 0 0.03265649825334549

Using O 0 0.0405324324965477
methylation O 0 0.08144088834524155
- O 0 0.05823921412229538
sensitive O 0 0.028639614582061768
restriction O 0 0.03087605908513069
enzymes O 0 0.028179503977298737
, O 0 0.007742821704596281
we O 0 0.006496247835457325
characterized O 0 0.02108142524957657
the O 0 0.0074479421600699425
methylation O 0 0.0275693628937006
pattern O 0 0.01753503829240799
on O 0 0.004792148247361183
the O 0 0.004871893674135208
5 O 0 0.007164225913584232
side O 0 0.007453881204128265
of O 0 0.004421934485435486
the O 0 0.007459153886884451
CTG O 0 0.3921177387237549
repeat O 0 0.0246177576482296
in O 0 0.006523089483380318
the O 0 0.006920262239873409
DMPK O 0 0.1887201964855194
gene O 0 0.027098512277007103
of O 0 0.005237696226686239
normal O 0 0.012173564173281193
individuals O 0 0.008119799196720123
and O 0 0.004659782629460096
of O 0 0.00678899884223938
patients O 1 0.9998072981834412
affected O 1 0.7822349667549133
with O 0 0.08936810493469238
myotonic B-Disease 1 0.9999980926513672
dystrophy I-Disease 1 0.9999991655349731
, O 0 0.020391877740621567
showing O 0 0.02283155359327793
expansions O 0 0.03074965998530388
of O 0 0.009567555971443653
the O 0 0.012702024541795254
repetitive O 0 0.09568804502487183
sequence O 0 0.044969573616981506
. O 0 0.028775814920663834

The O 0 0.031842704862356186
gene O 0 0.07756837457418442
segment O 0 0.04593861475586891
analyzed O 0 0.032390207052230835
corresponds O 0 0.024073153734207153
to O 0 0.00847652181982994
the O 0 0.01120662409812212
genomic O 0 0.07859716564416885
SacI O 1 0.7527211308479309
- O 0 0.07779283821582794
HindIII O 0 0.11322592198848724
fragment O 0 0.047854598611593246
carrying O 0 0.02398112416267395
exons O 0 0.06033036485314369
11 O 0 0.02273871749639511
- O 0 0.03771230950951576
15 O 0 0.022354809567332268
. O 0 0.02510019950568676

There O 0 0.027560943737626076
is O 0 0.016234666109085083
constitutive O 0 0.06441875547170639
methylation O 0 0.05759969726204872
in O 0 0.015152310021221638
intron O 0 0.28736114501953125
12 O 0 0.016168223693966866
at O 0 0.009562036022543907
restriction O 0 0.018841126933693886
sites O 0 0.010365534573793411
of O 0 0.0068172551691532135
SacII O 0 0.05620710179209709
and O 0 0.009945269674062729
HhaI O 0 0.08484193682670593
, O 0 0.01045494806021452
localized O 0 0.038986947387456894
1 O 0 0.010999469086527824
, O 0 0.0070304181426763535
159 O 0 0.026320645585656166
- O 0 0.027739575132727623
1 O 0 0.011056444607675076
, O 0 0.007377856411039829
232 O 0 0.026594318449497223
bp O 0 0.02775055728852749
upstream O 0 0.017104554921388626
of O 0 0.005316924303770065
the O 0 0.007776171434670687
CTG O 1 0.8086712956428528
repeat O 0 0.03325089439749718
, O 0 0.00677398731932044
whereas O 0 0.008471670560538769
most O 0 0.0032509162556380033
, O 0 0.0030692298896610737
if O 0 0.0031111384741961956
not O 0 0.002012130804359913
all O 0 0.0018217500764876604
, O 0 0.0019846276845782995
of O 0 0.0016805175691843033
the O 0 0.0023364669177681208
other O 0 0.0025467686355113983
sites O 0 0.005056256428360939
of O 0 0.004395801108330488
SacII O 0 0.08761147409677505
, O 0 0.007277417927980423
HhaI O 0 0.04981596767902374
, O 0 0.005574625451117754
and O 0 0.004975523333996534
HpaII O 0 0.03171205148100853
in O 0 0.004782422445714474
this O 0 0.003951204940676689
region O 0 0.009028219617903233
are O 0 0.004899357911199331
unmethylated O 0 0.11880995333194733
, O 0 0.005678740330040455
in O 0 0.004864318761974573
normal O 0 0.009830969385802746
individuals O 0 0.006577415391802788
and O 0 0.003908243495970964
most O 0 0.004354521166533232
of O 0 0.004600542597472668
the O 0 0.009561385959386826
patients O 1 0.9869458079338074
. O 0 0.02510949969291687

In O 0 0.0133952172473073
a O 0 0.009890533052384853
number O 0 0.006061137188225985
of O 0 0.0051937466487288475
young O 0 0.011197169311344624
and O 0 0.007362116128206253
severely O 1 0.8683768510818481
affected O 1 0.6348772048950195
patients O 1 0.9979531764984131
, O 0 0.0055221812799572945
however O 0 0.005640731658786535
, O 0 0.004634401295334101
complete O 0 0.0063597578555345535
methylation O 0 0.01759929582476616
of O 0 0.0033108454663306475
these O 0 0.003590772859752178
restriction O 0 0.010526556521654129
sites O 0 0.0061771743930876255
was O 0 0.003926347009837627
found O 0 0.0053126332350075245
in O 0 0.0053173331543803215
the O 0 0.008754693903028965
mutated O 0 0.0878092423081398
allele O 0 0.19562427699565887
. O 0 0.032787125557661057

In O 0 0.015251019969582558
most O 0 0.008550934493541718
of O 0 0.005385012365877628
these O 0 0.007090785540640354
patients O 1 0.9709648489952087
, O 0 0.006949291564524174
the O 0 0.008011281490325928
onset O 1 0.9961662292480469
of O 0 0.008212613873183727
the O 0 0.014404833316802979
disease O 1 0.9999266862869263
was O 0 0.02638990432024002
congenital O 1 0.999955415725708
. O 0 0.04030193015933037

Preliminary O 0 0.051069341599941254
in O 0 0.02558920718729496
vivo O 0 0.22225195169448853
footprinting O 1 0.8745354413986206
data O 0 0.016158731654286385
gave O 0 0.013138861395418644
evidence O 0 0.009593917988240719
for O 0 0.007587822619825602
protein O 0 0.026536043733358383
- O 0 0.031071655452251434
DNA O 0 0.025488143786787987
contact O 0 0.016292676329612732
in O 0 0.006918689701706171
normal O 0 0.018599271774291992
genes O 0 0.03026277758181095
at O 0 0.010451012291014194
an O 0 0.009912279434502125
Sp1 O 0 0.46283993124961853
consensus O 0 0.02052169479429722
binding O 0 0.0197824127972126
site O 0 0.010973147116601467
upstream O 0 0.018118828535079956
of O 0 0.004970591515302658
the O 0 0.006825913675129414
CTG O 0 0.3968958258628845
repeat O 0 0.020544840022921562
and O 0 0.004546577576547861
for O 0 0.003362052608281374
a O 0 0.004343297332525253
significant O 0 0.006997328717261553
reduction O 0 0.011006254702806473
of O 0 0.0033196972217410803
this O 0 0.004017167259007692
interaction O 0 0.010723273269832134
in O 0 0.0061060115694999695
cells O 0 0.025761323049664497
with O 0 0.00897243618965149
a O 0 0.015321382321417332
hypermethylated O 1 0.6497780084609985
DMPK O 1 0.8650875091552734
gene O 0 0.07541142404079437
. O 0 0.018167365342378616
. O 0 0.024800477549433708

The O 0 0.05905826389789581
hemochromatosis B-Disease 1 0.9998339414596558
gene O 0 0.3086708188056946
product O 0 0.03039615787565708
complexes O 0 0.0405890978872776
with O 0 0.01207540463656187
the O 0 0.013240578584372997
transferrin O 0 0.46868985891342163
receptor O 0 0.12212764471769333
and O 0 0.01211358793079853
lowers O 0 0.08881187438964844
its O 0 0.012056943029165268
affinity O 0 0.039029818028211594
for O 0 0.013381605967879295
ligand O 0 0.0706295296549797
binding O 0 0.048060864210128784
. O 0 0.028425458818674088

We O 0 0.020177219063043594
recently O 0 0.018966156989336014
reported O 0 0.015380281955003738
the O 0 0.008437659591436386
positional O 0 0.034131575375795364
cloning O 0 0.027093658223748207
of O 0 0.006188342813402414
a O 0 0.008161719888448715
candidate O 0 0.016303792595863342
gene O 0 0.09202754497528076
for O 0 0.0161902979016304
hereditary B-Disease 1 0.9992521405220032
hemochromatosis I-Disease 1 0.9999877214431763
called O 0 0.07637940347194672
HFE O 1 0.9923185110092163
. O 0 0.056264959275722504

The O 0 0.025689346715807915
gene O 0 0.05521092191338539
product O 0 0.0158602986484766
, O 0 0.006615097634494305
a O 0 0.005136832594871521
member O 0 0.004749669693410397
of O 0 0.0035241851583123207
the O 0 0.0057234750129282475
major O 0 0.013662026263773441
histocompatibility O 1 0.9822048544883728
complex O 0 0.018934642896056175
class O 0 0.01851290836930275
I O 0 0.011433785781264305
- O 0 0.019287211820483208
like O 0 0.007582434918731451
family O 0 0.007831264287233353
, O 0 0.004074156284332275
was O 0 0.003106244606897235
found O 0 0.004028649535030127
to O 0 0.003388681448996067
have O 0 0.004557320382446051
a O 0 0.008552081882953644
mutation O 0 0.12890610098838806
, O 0 0.013637693598866463
Cys O 1 0.9968953132629395
- O 1 0.6523812413215637
282 O 1 0.6489152908325195
- O 1 0.9513947367668152
- O 1 0.947047770023346
> O 1 0.943466067314148
Tyr O 1 0.9901803731918335
( O 0 0.02572190761566162
C282Y O 0 0.0525628924369812
) O 0 0.010649164207279682
, O 0 0.005306380335241556
in O 0 0.004677921999245882
85 O 0 0.015026303008198738
% O 0 0.010861222632229328
of O 0 0.0090571204200387
patient O 0 0.41478702425956726
chromosomes O 0 0.0844583660364151
. O 0 0.03206270560622215

This O 0 0.03595435246825218
mutation O 0 0.18252533674240112
eliminates O 0 0.05550171807408333
the O 0 0.010619433596730232
ability O 0 0.016995154321193695
of O 0 0.009088930673897266
HFE O 1 0.586225688457489
to O 0 0.01054990105330944
associate O 0 0.02085907571017742
with O 0 0.012018815614283085
beta2 O 1 0.5322251915931702
- O 0 0.41910505294799805
microglobulin O 1 0.8588181138038635
( O 0 0.02118762955069542
beta2m O 0 0.2657983899116516
) O 0 0.01278997678309679
and O 0 0.008924512192606926
prevents O 0 0.06828303635120392
cell O 0 0.11977177113294601
- O 0 0.09519065171480179
surface O 0 0.03784649074077606
expression O 0 0.03856732323765755
. O 0 0.0253202635794878

A O 0 0.028208347037434578
second O 0 0.019235584884881973
mutation O 0 0.05145517736673355
that O 0 0.007026843726634979
has O 0 0.005892274901270866
no O 0 0.006679961923509836
effect O 0 0.011816873215138912
on O 0 0.0051830182783305645
beta2m O 0 0.1217970997095108
association O 0 0.01437755674123764
, O 0 0.007953494787216187
H63D O 0 0.060020800679922104
, O 0 0.004687376320362091
was O 0 0.0038563543930649757
found O 0 0.00437506940215826
in O 0 0.003404053393751383
eight O 0 0.004448387771844864
out O 0 0.004361611790955067
of O 0 0.004103129263967276
nine O 0 0.01093612052500248
patients O 1 0.9148088693618774
heterozygous O 0 0.043350666761398315
for O 0 0.00888915080577135
the O 0 0.011817969381809235
C282Y O 0 0.07433317601680756
mutant O 0 0.07767835259437561
. O 0 0.03051110729575157

In O 0 0.01623818464577198
this O 0 0.008879458531737328
report O 0 0.00974944606423378
, O 0 0.0064390054903924465
we O 0 0.005678368732333183
demonstrate O 0 0.01404064241796732
in O 0 0.009483679197728634
cultured O 0 0.05288612097501755
293 O 0 0.4282705783843994
cells O 1 0.6435351371765137
overexpressing O 1 0.9860348701477051
wild O 0 0.04934161901473999
- O 0 0.19705675542354584
type O 0 0.03991313278675079
or O 0 0.017925696447491646
mutant O 0 0.06590056419372559
HFE O 1 0.9616493582725525
proteins O 0 0.019856194034218788
that O 0 0.004970133770257235
both O 0 0.005255564581602812
the O 0 0.0055561731569468975
wild O 0 0.019783949479460716
- O 0 0.03523790463805199
type O 0 0.028803091496229172
and O 0 0.013103863224387169
H63D O 1 0.8998607397079468
HFE O 1 0.9847866892814636
proteins O 0 0.03392989560961723
form O 0 0.02029353193938732
stable O 0 0.03292526304721832
complexes O 0 0.038761984556913376
with O 0 0.011715037748217583
the O 0 0.01504284143447876
transferrin O 1 0.9149314761161804
receptor O 1 0.6746970415115356
( O 0 0.03308219835162163
TfR O 1 0.9146206378936768
) O 0 0.02942611090838909
. O 0 0.024751154705882072

The O 0 0.04297386854887009
C282Y O 0 0.20903944969177246
mutation O 0 0.33513128757476807
nearly O 0 0.028942473232746124
completely O 0 0.02322733774781227
prevents O 0 0.029788419604301453
the O 0 0.007978825829923153
association O 0 0.01234481856226921
of O 0 0.005874019581824541
the O 0 0.009054665453732014
mutant O 0 0.056763164699077606
HFE O 1 0.9585820436477661
protein O 0 0.04027639329433441
with O 0 0.015505117364227772
the O 0 0.018746821209788322
TfR O 1 0.9395148754119873
. O 0 0.036689627915620804

Studies O 0 0.04749274253845215
on O 0 0.01639263518154621
cell O 0 0.05417971685528755
- O 0 0.048782069236040115
associated O 0 0.025487640872597694
transferrin O 0 0.12377806007862091
at O 0 0.015743868425488472
37 O 0 0.018786897882819176
degrees O 0 0.018125904724001884
C O 0 0.02465534210205078
suggest O 0 0.013687764294445515
that O 0 0.005418138112872839
the O 0 0.008007837459445
overexpressed O 0 0.3249191343784332
wild O 0 0.03579096123576164
- O 0 0.18341593444347382
type O 0 0.08115975558757782
HFE O 1 0.9874711632728577
protein O 0 0.043167594820261
decreases O 0 0.03390205278992653
the O 0 0.008797884918749332
affinity O 0 0.031018052250146866
of O 0 0.008362292312085629
the O 0 0.01192572619765997
TfR O 1 0.8303248286247253
for O 0 0.019761240109801292
transferrin O 0 0.4147760570049286
. O 0 0.03512166813015938

The O 0 0.04295700043439865
overexpressed O 1 0.644891619682312
H63D O 1 0.570995032787323
protein O 0 0.036684997379779816
does O 0 0.01082206703722477
not O 0 0.0047415257431566715
have O 0 0.004058739636093378
this O 0 0.0036721026990562677
effect O 0 0.00791262835264206
, O 0 0.0030106680933386087
providing O 0 0.005286090541630983
the O 0 0.002874149475246668
first O 0 0.0032281868625432253
direct O 0 0.005752986762672663
evidence O 0 0.005348613485693932
for O 0 0.0038122585974633694
a O 0 0.005501196254044771
functional O 0 0.016347043216228485
consequence O 0 0.018699489533901215
of O 0 0.006189979147166014
the O 0 0.012071531265974045
H63D O 1 0.8235496878623962
mutation O 1 0.7340558171272278
. O 0 0.03252096101641655

Addition O 0 0.032844480127096176
of O 0 0.019632598385214806
soluble O 0 0.1002190113067627
wild O 0 0.053502246737480164
- O 1 0.6471006274223328
type O 1 0.6658510565757751
HFE O 1 0.9990414977073669
/ O 1 0.9916607737541199
beta2m O 1 0.8549035787582397
heterodimers O 1 0.8992024064064026
to O 0 0.017168032005429268
cultured O 0 0.06790958344936371
cells O 0 0.05658125504851341
also O 0 0.009361200034618378
decreased O 0 0.01998654194176197
the O 0 0.007454057224094868
apparent O 0 0.02043541520833969
affinity O 0 0.0227709598839283
of O 0 0.005915578920394182
the O 0 0.006872607860714197
TfR O 0 0.4059939980506897
for O 0 0.0064082457683980465
its O 0 0.006974857300519943
ligand O 0 0.028695950284600258
under O 0 0.008064882829785347
steady O 0 0.017879828810691833
- O 0 0.020197968930006027
state O 0 0.006985288113355637
conditions O 0 0.011173384264111519
, O 0 0.0047650448977947235
both O 0 0.004696894437074661
in O 0 0.006373096257448196
293 O 0 0.04055221751332283
cells O 0 0.0394647940993309
and O 0 0.010235965251922607
in O 0 0.015513119287788868
HeLa O 1 0.9424363374710083
cells O 0 0.24924521148204803
. O 0 0.03505386412143707

Furthermore O 0 0.04148710519075394
, O 0 0.012289290316402912
at O 0 0.010418347083032131
4 O 0 0.011377097107470036
degrees O 0 0.01392942201346159
C O 0 0.01940675638616085
, O 0 0.005374161526560783
the O 0 0.006203064229339361
added O 0 0.009470993652939796
soluble O 0 0.03114638477563858
complex O 0 0.01939350552856922
of O 0 0.013264091685414314
HFE O 1 0.9985394477844238
/ O 1 0.9704683423042297
beta2m O 1 0.6613876223564148
inhibited O 0 0.11134215444326401
binding O 0 0.03182360157370567
of O 0 0.01346040889620781
transferrin O 0 0.12109250575304031
to O 0 0.01642005704343319
HeLa O 1 0.9580954909324646
cell O 0 0.16145244240760803
TfR O 1 0.891184389591217
in O 0 0.011450176127254963
a O 0 0.014305595308542252
concentration O 0 0.04241124540567398
- O 0 0.04391675069928169
dependent O 0 0.042065106332302094
manner O 0 0.034835491329431534
. O 0 0.02866615541279316

Scatchard O 0 0.130332350730896
plots O 0 0.035001158714294434
of O 0 0.008793984539806843
these O 0 0.006547246128320694
data O 0 0.006418160628527403
indicate O 0 0.008328615687787533
that O 0 0.003989763092249632
the O 0 0.0052629937417805195
added O 0 0.01026825699955225
heterodimer O 0 0.1656518131494522
substantially O 0 0.022615399211645126
reduced O 0 0.015171370469033718
the O 0 0.009133953601121902
affinity O 0 0.031847033649683
of O 0 0.010853192768990993
TfR O 1 0.918694019317627
for O 0 0.017448728904128075
transferrin O 1 0.5015312433242798
. O 0 0.03315751627087593

These O 0 0.015795022249221802
results O 0 0.018395770341157913
establish O 0 0.018846984952688217
a O 0 0.01188623532652855
molecular O 0 0.029937833547592163
link O 0 0.025334415957331657
between O 0 0.01288541778922081
HFE O 1 0.6747628450393677
and O 0 0.005941297393292189
a O 0 0.006620677653700113
key O 0 0.008646924048662186
protein O 0 0.014401206746697426
involved O 0 0.007407191209495068
in O 0 0.0048177847638726234
iron O 0 0.012531222775578499
transport O 0 0.009978782385587692
, O 0 0.005229630507528782
the O 0 0.005368968937546015
TfR O 1 0.7480653524398804
, O 0 0.004509145859628916
and O 0 0.0035809455439448357
raise O 0 0.008278442546725273
the O 0 0.004052865784615278
possibility O 0 0.01014919113367796
that O 0 0.004856011364609003
alterations O 0 0.014313599094748497
in O 0 0.004690020345151424
this O 0 0.004630192648619413
regulatory O 0 0.01769801788032055
mechanism O 0 0.01900402083992958
may O 0 0.007128843571990728
play O 0 0.004305495880544186
a O 0 0.004496951587498188
role O 0 0.007185258436948061
in O 0 0.005248823203146458
the O 0 0.008789114654064178
pathogenesis O 1 0.9960718154907227
of O 0 0.01697908528149128
hereditary B-Disease 1 0.9997150301933289
hemochromatosis I-Disease 1 0.999994158744812
. O 0 0.027020223438739777
. O 0 0.02877139113843441

Genomic O 0 0.11823410540819168
organization O 0 0.03651268035173416
of O 0 0.01529536210000515
the O 0 0.019864743575453758
UBE3A O 1 0.9979865550994873
/ O 1 0.9943404197692871
E6 O 1 0.9914668798446655
- O 1 0.6204257011413574
AP O 0 0.0599362887442112
gene O 0 0.049713704735040665
and O 0 0.013288735412061214
related O 0 0.030909080058336258
pseudogenes O 0 0.15085351467132568
. O 0 0.034837156534194946

The O 0 0.0482214130461216
UBE3A O 1 0.7272544503211975
gene O 0 0.10907270759344101
encodes O 0 0.061776917427778244
the O 0 0.023577691987156868
E6 O 1 0.8920643925666809
- O 0 0.3280177116394043
AP O 0 0.06846947968006134
ubiquitin O 0 0.1776687055826187
- O 0 0.061647310853004456
protein O 0 0.034772057086229324
ligase O 0 0.033519670367240906
and O 0 0.006267208140343428
has O 0 0.006450657267123461
recently O 0 0.008506547659635544
been O 0 0.005233593285083771
shown O 0 0.008157668635249138
to O 0 0.005877206102013588
be O 0 0.008086073212325573
mutated O 1 0.953177273273468
in O 0 0.42687341570854187
Angelman B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
patients O 1 0.9999127388000488
who O 0 0.029645651578903198
lack O 0 0.048766426742076874
15q11 O 1 0.8472941517829895
- O 1 0.5933278799057007
q13 O 1 0.6151754260063171
deletions O 0 0.11221998184919357
or O 0 0.029971424490213394
chromosome O 1 0.7272052764892578
15 O 0 0.03328636288642883
paternal O 0 0.44665709137916565
uniparental B-Disease 1 0.9984248876571655
disomy I-Disease 1 0.9034637212753296
. O 0 0.04941534250974655

Previous O 0 0.07483936101198196
UBE3A O 1 0.7213972806930542
cDNA O 0 0.10011052340269089
analysis O 0 0.025995884090662003
has O 0 0.010568244382739067
shown O 0 0.013280384242534637
a O 0 0.009543826803565025
coding O 0 0.0350821428000927
region O 0 0.017106762155890465
of O 0 0.008485025726258755
approximately O 0 0.01738107204437256
2 O 0 0.022133301943540573
. O 0 0.021378951147198677

6 O 0 0.04874091222882271
kb O 0 0.06338080763816833
and O 0 0.0108867222443223
a O 0 0.012959707528352737
3 O 0 0.01930212788283825
- O 0 0.04201429709792137
untranslated O 0 0.16216693818569183
region O 0 0.03185528889298439
( O 0 0.02304949052631855
UTR O 0 0.19553926587104797
) O 0 0.014656850136816502
of O 0 0.00884691160172224
< O 0 0.06109372153878212
50 O 0 0.013964615762233734
bp O 0 0.025194760411977768
, O 0 0.006672684568911791
whereas O 0 0.011898797936737537
Northern O 0 0.010152018629014492
analysis O 0 0.010884176008403301
has O 0 0.006982096936553717
indicated O 0 0.014539445750415325
mRNA O 0 0.022592749446630478
sizes O 0 0.01640072464942932
of O 0 0.007481215056031942
5 O 0 0.016583066433668137
- O 0 0.03444575145840645
8 O 0 0.024742398411035538
kb O 0 0.07980786263942719
. O 0 0.031186627224087715

We O 0 0.019891981035470963
have O 0 0.013231372460722923
analyzed O 0 0.02418654039502144
additional O 0 0.01517390739172697
cDNA O 0 0.04824058338999748
clones O 0 0.0335819348692894
and O 0 0.005936145782470703
provide O 0 0.00868892204016447
evidence O 0 0.0068628257140517235
for O 0 0.00416308781132102
an O 0 0.004633309785276651
additional O 0 0.011392579413950443
0 O 0 0.0270988792181015
. O 0 0.01995217427611351

5 O 0 0.04500286281108856
kb O 0 0.06608997285366058
of O 0 0.01495426893234253
5 O 0 0.023068787530064583
- O 0 0.04824639484286308
UTR O 0 0.12723404169082642
and O 0 0.01467228215187788
> O 0 0.05546970292925835
2 O 0 0.018344318494200706
kb O 0 0.03671727329492569
of O 0 0.010373461060225964
3 O 0 0.025539876893162727
- O 0 0.0650549903512001
UTR O 0 0.4804372787475586
. O 0 0.04059532284736633

We O 0 0.016124973073601723
have O 0 0.009656152687966824
established O 0 0.009496328420937061
the O 0 0.007142927963286638
genomic O 0 0.03383033350110054
organization O 0 0.013538661412894726
of O 0 0.007495759520679712
UBE3A O 0 0.3812083899974823
and O 0 0.008552582934498787
the O 0 0.00832411926239729
sequence O 0 0.019442634657025337
of O 0 0.012267651036381721
intron O 1 0.7912667989730835
- O 0 0.10995285212993622
exon O 0 0.12185763567686081
borders O 0 0.06764966249465942
. O 0 0.04327613487839699

We O 0 0.018745535984635353
have O 0 0.008967015892267227
also O 0 0.007428815588355064
mapped O 0 0.018668243661522865
two O 0 0.007566283922642469
highly O 0 0.016695987433195114
homologous O 0 0.0567304790019989
processed O 0 0.02599206194281578
pseudogenes O 0 0.08141153305768967
, O 0 0.013196870684623718
UBE3AP1 O 0 0.12400680035352707
and O 0 0.009186686016619205
UBE3AP2 O 0 0.06078283116221428
, O 0 0.0064524388872087
to O 0 0.004775997716933489
chromosomes O 0 0.01852424629032612
2 O 0 0.0070070428773760796
and O 0 0.0038343898486346006
21 O 0 0.007658406160771847
, O 0 0.004454049281775951
respectively O 0 0.006120924372226
, O 0 0.0039045342709869146
and O 0 0.004171454813331366
determined O 0 0.009486636146903038
their O 0 0.0075668711215257645
genomic O 0 0.04782736301422119
organization O 0 0.02718448080122471
. O 0 0.02235102280974388

These O 0 0.016223734244704247
results O 0 0.015706069767475128
will O 0 0.0059684147126972675
form O 0 0.00676551042124629
the O 0 0.003903656732290983
basis O 0 0.005738007370382547
for O 0 0.004391786642372608
studies O 0 0.010034124366939068
of O 0 0.007103514391928911
mutation O 0 0.11714475601911545
and O 0 0.012281781993806362
imprinting O 0 0.30347195267677307
of O 0 0.019489379599690437
UBE3A O 1 0.9594936370849609
. O 0 0.03893231600522995

Mutation O 1 0.8936002254486084
spectrum O 0 0.09700097143650055
and O 0 0.02568812482059002
genotype O 1 0.9877864122390747
- O 1 0.9120199680328369
phenotype O 1 0.9951556921005249
analyses O 0 0.0842006728053093
in O 0 0.03200653940439224
Cowden B-Disease 1 0.9999837875366211
disease I-Disease 1 0.9999884366989136
and O 0 0.06704569607973099
Bannayan B-Disease 1 0.9997871518135071
- I-Disease 1 0.999724805355072
Zonana I-Disease 1 0.9999749660491943
syndrome I-Disease 1 0.9999985694885254
, O 0 0.02464168705046177
two O 0 0.02738095261156559
hamartoma B-Disease 1 0.9999442100524902
syndromes I-Disease 1 0.9999833106994629
with O 0 0.06972425431013107
germline O 1 0.9980149269104004
PTEN O 1 0.9982481002807617
mutation O 1 0.9737662672996521
. O 0 0.058402229100465775

The O 0 0.07286718487739563
tumour B-Disease 1 0.9995527863502502
suppressor O 1 0.991295576095581
gene O 1 0.7022031545639038
PTEN O 1 0.9748086929321289
, O 0 0.015832887962460518
which O 0 0.009155341424047947
maps O 0 0.01713753305375576
to O 0 0.013326614163815975
10q23 O 0 0.07765098661184311
. O 0 0.02741413563489914

3 O 0 0.029459938406944275
and O 0 0.01425485871732235
encodes O 0 0.043053802102804184
a O 0 0.019474022090435028
403 O 0 0.06255888193845749
amino O 0 0.051155515015125275
acid O 0 0.06752751767635345
dual O 0 0.04664335772395134
specificity O 0 0.07504482567310333
phosphatase O 1 0.9433931112289429
( O 0 0.03304259106516838
protein O 0 0.056011416018009186
tyrosine O 0 0.17557568848133087
phosphatase O 1 0.9295080900192261
; O 0 0.020353535190224648
PTPase O 0 0.10053069144487381
) O 0 0.01053957361727953
, O 0 0.004876105114817619
was O 0 0.004363660700619221
shown O 0 0.006741291377693415
recently O 0 0.006821182556450367
to O 0 0.003414594102650881
play O 0 0.004396590404212475
a O 0 0.005647073499858379
broad O 0 0.014188897795975208
role O 0 0.012586322613060474
in O 0 0.009577615186572075
human O 0 0.027472175657749176
malignancy B-Disease 1 0.997385561466217
. O 0 0.03375080227851868

Somatic O 1 0.9620965123176575
PTEN O 1 0.994856595993042
deletions O 0 0.263304740190506
and O 0 0.02481989935040474
mutations O 0 0.24926520884037018
were O 0 0.011370527558028698
observed O 0 0.021952800452709198
in O 0 0.010966494679450989
sporadic B-Disease 1 0.889263927936554
breast I-Disease 1 0.9999867677688599
, I-Disease 0 0.05976125970482826
brain I-Disease 1 0.9998437166213989
, I-Disease 0 0.1616138368844986
prostate I-Disease 1 0.9999974966049194
and I-Disease 0 0.38965776562690735
kidney I-Disease 1 0.999997615814209
cancer I-Disease 1 0.9999905824661255
cell O 0 0.43888336420059204
lines O 0 0.01371248159557581
and O 0 0.0050607360899448395
in O 0 0.004741566255688667
several O 0 0.006830641068518162
primary O 0 0.024595772847533226
tumours B-Disease 1 0.9998781681060791
such O 0 0.013516416773200035
as O 0 0.026686793193221092
endometrial B-Disease 1 0.9999972581863403
carcinomas I-Disease 1 0.999998927116394
, O 1 0.9961344003677368
malignant B-Disease 1 0.9999998807907104
melanoma I-Disease 1 0.9999998807907104
and O 1 0.9064304828643799
thyroid B-Disease 1 0.9999970197677612
tumours I-Disease 1 0.9999575614929199
. O 0 0.06085195764899254

In O 0 0.02332017570734024
addition O 0 0.02152825891971588
, O 0 0.01561606302857399
PTEN O 1 0.7497370839118958
was O 0 0.009697874076664448
identified O 0 0.011266604997217655
as O 0 0.005286662373691797
the O 0 0.007940344512462616
susceptibility O 1 0.9554021954536438
gene O 0 0.059525106102228165
for O 0 0.010558960027992725
two O 0 0.02627178654074669
hamartoma B-Disease 1 0.9999934434890747
syndromes I-Disease 1 0.9999995231628418
Cowden B-Disease 1 0.9999953508377075
disease I-Disease 1 0.999990701675415
( O 0 0.0433652438223362
CD B-Disease 0 0.039168581366539
; O 0 0.022234881296753883
MIM O 1 0.9860365986824036
158350 O 0 0.18123942613601685
) O 0 0.018258152529597282
and O 0 0.012199257500469685
Bannayan B-Disease 1 0.7983154058456421
- I-Disease 1 0.7592954635620117
Zonana I-Disease 1 0.991312563419342
( I-Disease 0 0.04006845876574516
BZS I-Disease 1 0.9440467953681946
) I-Disease 0 0.02620258927345276
or I-Disease 0 0.026102416217327118
Ruvalcaba I-Disease 1 0.9993701577186584
- I-Disease 1 0.9893246293067932
Riley I-Disease 1 0.9893961548805237
- I-Disease 1 0.9976629018783569
Smith I-Disease 1 0.9914723038673401
syndrome I-Disease 1 0.9999967813491821
( O 0 0.08873134106397629
MIM O 1 0.9954739212989807
153480 O 1 0.6678232550621033
) O 0 0.03482833504676819
. O 0 0.027492405846714973

Constitutive O 0 0.13368608057498932
DNA O 0 0.05937499925494194
from O 0 0.01908191852271557
37 O 0 0.022663401439785957
CD B-Disease 0 0.02042541466653347
families O 0 0.01530652865767479
and O 0 0.007577431388199329
seven O 0 0.015587231144309044
BZS B-Disease 1 0.6667600870132446
families O 0 0.0227105263620615
was O 0 0.01304016262292862
screened O 0 0.04541076719760895
for O 0 0.023526113480329514
germline O 1 0.9863442182540894
PTEN O 1 0.9966409206390381
mutations O 1 0.936981201171875
. O 0 0.05197637155652046

PTEN O 1 0.9931668639183044
mutations O 0 0.24362631142139435
were O 0 0.010976248420774937
identified O 0 0.012159500271081924
in O 0 0.00536528043448925
30 O 0 0.006440634373575449
of O 0 0.004284642171114683
37 O 0 0.01285440195351839
( O 0 0.008989973925054073
81 O 0 0.014041481539607048
% O 0 0.009572934359312057
) O 0 0.0069459886290133
CD B-Disease 0 0.010666520334780216
families O 0 0.008674976415932178
, O 0 0.004716790746897459
including O 0 0.0064049893990159035
missense O 0 0.053234655410051346
and O 0 0.007569578010588884
nonsense O 0 0.026525650173425674
point O 0 0.014039578847587109
mutations O 0 0.17150428891181946
, O 0 0.010220793075859547
deletions O 0 0.04277568310499191
, O 0 0.010386510752141476
insertions O 0 0.05200882628560066
, O 0 0.010319500230252743
a O 0 0.013594030402600765
deletion O 1 0.5614745020866394
/ O 1 0.8450713157653809
insertion O 0 0.08094428479671478
and O 0 0.017647406086325645
splice O 0 0.13508212566375732
site O 0 0.04175170138478279
mutations O 0 0.29860445857048035
. O 0 0.035416144877672195

These O 0 0.026587536558508873
mutations O 0 0.0638132095336914
were O 0 0.008953876793384552
scattered O 0 0.013639207929372787
over O 0 0.0057488479651510715
the O 0 0.004835411440581083
entire O 0 0.00971794780343771
length O 0 0.012126348912715912
of O 0 0.006651060190051794
PTEN O 1 0.7227262258529663
, O 0 0.005077675450593233
with O 0 0.0037139139603823423
the O 0 0.0036286714021116495
exception O 0 0.006782950833439827
of O 0 0.0027076490223407745
the O 0 0.00286399619653821
first O 0 0.00392146548256278
, O 0 0.00443373154848814
fourth O 0 0.007748714182525873
and O 0 0.006377143319696188
last O 0 0.014697162434458733
exons O 0 0.06554876267910004
. O 0 0.026847831904888153

A O 0 0.034945882856845856
hot O 0 0.04777340963482857
spot O 0 0.03317679464817047
for O 0 0.015453326515853405
PTEN O 1 0.9825164079666138
mutation O 0 0.11434399336576462
in O 0 0.00892388354986906
CD B-Disease 0 0.016070518642663956
was O 0 0.0059117586351931095
identified O 0 0.008429154753684998
in O 0 0.004967324435710907
exon O 0 0.028370041400194168
5 O 0 0.008210222236812115
that O 0 0.004461127333343029
contains O 0 0.006402504630386829
the O 0 0.005091786850243807
PTPase O 0 0.03518768027424812
core O 0 0.012740484438836575
motif O 0 0.01911497674882412
, O 0 0.00458716182038188
with O 0 0.0042901854030787945
13 O 0 0.006705066654831171
of O 0 0.0039888364262878895
30 O 0 0.007433440536260605
( O 0 0.00696930754929781
43 O 0 0.011932156048715115
% O 0 0.009915406815707684
) O 0 0.01007804460823536
CD B-Disease 0 0.02011743001639843
mutations O 0 0.04624437913298607
identified O 0 0.013572302646934986
in O 0 0.007118566893041134
this O 0 0.008486727252602577
exon O 0 0.06470965594053268
. O 0 0.027920696884393692

Seven O 0 0.024443218484520912
of O 0 0.009965620003640652
30 O 0 0.01409628614783287
( O 0 0.011940962634980679
23 O 0 0.009439103305339813
% O 0 0.007269071880728006
) O 0 0.005386654287576675
were O 0 0.0024818279780447483
within O 0 0.003754216944798827
the O 0 0.0032004578970372677
core O 0 0.008330908603966236
motif O 0 0.015401121228933334
, O 0 0.0037541366182267666
the O 0 0.003523092018440366
majority O 0 0.007003705017268658
( O 0 0.005869860760867596
five O 0 0.0036742642987519503
of O 0 0.002807163167744875
seven O 0 0.004684907384216785
) O 0 0.004934788215905428
of O 0 0.00313000101596117
which O 0 0.005006833933293819
were O 0 0.005995775107294321
missense O 1 0.5918564200401306
mutations O 0 0.29955604672431946
, O 0 0.007293608970940113
possibly O 0 0.010894560255110264
pointing O 0 0.011024978011846542
to O 0 0.004025294911116362
the O 0 0.004501280840486288
functional O 0 0.012146917171776295
significance O 0 0.009778236038982868
of O 0 0.0059968214482069016
this O 0 0.007999935187399387
region O 0 0.024908287450671196
. O 0 0.02188136614859104

Germline O 1 0.9956650137901306
PTEN O 1 0.9965015649795532
mutations O 0 0.2904506325721741
were O 0 0.009620468132197857
identified O 0 0.01038041990250349
in O 0 0.0047662933357059956
four O 0 0.004467642400413752
of O 0 0.003823078004643321
seven O 0 0.007741294335573912
( O 0 0.010268083773553371
57 O 0 0.020491894334554672
% O 0 0.017028560861945152
) O 0 0.02030380442738533
BZS B-Disease 1 0.7023172974586487
families O 0 0.0315970778465271
studied O 0 0.02728414349257946
. O 0 0.0257819052785635

Interestingly O 0 0.06755898147821426
, O 0 0.012297217734158039
none O 0 0.012952780351042747
of O 0 0.005187055096030235
these O 0 0.007596258539706469
mutations O 0 0.041421741247177124
was O 0 0.006951767019927502
observed O 0 0.01282600685954094
in O 0 0.00562119809910655
the O 0 0.008839957416057587
PTPase O 0 0.0675579234957695
core O 0 0.032248321920633316
motif O 0 0.06788677722215652
. O 0 0.031915221363306046

It O 0 0.014528820291161537
is O 0 0.009366516023874283
also O 0 0.006428714841604233
worthy O 0 0.014702646061778069
of O 0 0.0049149394035339355
note O 0 0.010706174187362194
that O 0 0.004701666999608278
a O 0 0.007046124432235956
single O 0 0.011810654774308205
nonsense O 0 0.02646394446492195
point O 0 0.01233617588877678
mutation O 0 0.12321808189153671
, O 0 0.008870743215084076
R233X O 0 0.036833617836236954
, O 0 0.0068183597177267075
was O 0 0.0059331441298127174
observed O 0 0.009866141714155674
in O 0 0.005069353152066469
the O 0 0.006985165644437075
germline O 0 0.42226091027259827
DNA O 0 0.021252466365695
from O 0 0.006326292175799608
two O 0 0.005049942526966333
unrelated O 0 0.018107136711478233
CD B-Disease 0 0.016110923141241074
families O 0 0.012461764737963676
and O 0 0.0070707653649151325
one O 0 0.010273492895066738
BZS B-Disease 1 0.5891535878181458
family O 0 0.03371363878250122
. O 0 0.028615513816475868

Genotype O 1 0.991424560546875
- O 1 0.8484599590301514
phenotype O 1 0.9361140727996826
studies O 0 0.02173934131860733
were O 0 0.006102485116571188
not O 0 0.004268768709152937
performed O 0 0.00650347163900733
on O 0 0.0037677432410418987
this O 0 0.003921909257769585
small O 0 0.007426825352013111
group O 0 0.010471387766301632
of O 0 0.010381707921624184
BZS B-Disease 1 0.7866190671920776
families O 0 0.03727736696600914
. O 0 0.030708102509379387

However O 0 0.037260837852954865
, O 0 0.027306005358695984
genotype O 1 0.9314238429069519
- O 0 0.4457958936691284
phenotype O 1 0.9295128583908081
analysis O 0 0.03189224377274513
inthe O 0 0.07554379850625992
group O 0 0.014793772250413895
of O 0 0.00676221726462245
CD B-Disease 0 0.015719696879386902
families O 0 0.010116148740053177
revealed O 0 0.011241709813475609
two O 0 0.005058728624135256
possible O 0 0.009365043602883816
associations O 0 0.012585127726197243
worthy O 0 0.015140565112233162
of O 0 0.00516723096370697
follow O 0 0.009882047772407532
- O 0 0.016060059890151024
up O 0 0.007351029198616743
in O 0 0.006158432923257351
independent O 0 0.012897803448140621
analyses O 0 0.02957160584628582
. O 0 0.02538173831999302

The O 0 0.01429363340139389
first O 0 0.008925966918468475
was O 0 0.005931810941547155
an O 0 0.004718044772744179
association O 0 0.008837103843688965
noted O 0 0.006158491130918264
in O 0 0.0035315523855388165
the O 0 0.0034208367578685284
group O 0 0.007893686182796955
of O 0 0.005292803980410099
CD B-Disease 0 0.018967997282743454
families O 0 0.020844947546720505
with O 0 0.02604265697300434
breast B-Disease 1 0.999983549118042
disease I-Disease 1 0.9999665021896362
. O 0 0.04222898557782173

A O 0 0.03576640412211418
correlation O 0 0.040321338921785355
was O 0 0.009991603903472424
observed O 0 0.013339618220925331
between O 0 0.006671970710158348
the O 0 0.0059015327133238316
presence O 0 0.015910647809505463
/ O 0 0.22830525040626526
absence O 0 0.013834659941494465
of O 0 0.006255933083593845
a O 0 0.011755038052797318
PTEN O 1 0.9947007894515991
mutation O 0 0.4348566234111786
and O 0 0.007163924630731344
the O 0 0.006077136378735304
type O 0 0.022901440039277077
of O 0 0.011415648274123669
breast O 1 0.9998537302017212
involvement O 1 0.5292649865150452
( O 0 0.0361759252846241
unaffected O 1 0.9395536184310913
versus O 1 0.8910436034202576
benign O 1 0.9994275569915771
versus O 1 0.9808158278465271
malignant O 1 0.9999005794525146
) O 0 0.03901011869311333
. O 0 0.031334616243839264

Specifically O 0 0.025051139295101166
and O 0 0.008240406401455402
more O 0 0.005157748237252235
directly O 0 0.006503354758024216
, O 0 0.0036148587241768837
an O 0 0.0036931775975972414
association O 0 0.0064672608859837055
was O 0 0.0034472516272217035
also O 0 0.003298005321994424
observed O 0 0.007465860806405544
between O 0 0.004819090012460947
the O 0 0.0040372759103775024
presence O 0 0.010663336142897606
of O 0 0.006531425751745701
a O 0 0.015086409635841846
PTEN O 1 0.9998161196708679
mutation O 1 0.9995656609535217
and O 1 0.6534701585769653
malignant B-Disease 1 0.9999990463256836
breast I-Disease 1 0.9999985694885254
disease I-Disease 1 0.9999871253967285
. O 0 0.05623999238014221

Secondly O 0 0.05050298944115639
, O 0 0.010128885507583618
there O 0 0.006443479098379612
appeared O 0 0.007667775731533766
to O 0 0.004489876329898834
be O 0 0.0035109457094222307
an O 0 0.005248201545327902
interdependent O 0 0.034165214747190475
association O 0 0.014107092283666134
between O 0 0.010294376872479916
mutations O 0 0.0680081769824028
upstream O 0 0.018599646165966988
and O 0 0.0053706299513578415
within O 0 0.007268954534083605
the O 0 0.006404540501534939
PTPase O 0 0.04599211737513542
core O 0 0.01693606562912464
motif O 0 0.0268072709441185
, O 0 0.007129116449505091
the O 0 0.004543313290923834
core O 0 0.012509194202721119
motif O 0 0.022276882082223892
containing O 0 0.008373633027076721
the O 0 0.0050555807538330555
majority O 0 0.011098516173660755
of O 0 0.008702017366886139
missense O 1 0.533310055732727
mutations O 0 0.20793834328651428
, O 0 0.005835170391947031
and O 0 0.003837571246549487
the O 0 0.003669993719086051
involvement O 0 0.011387007310986519
of O 0 0.003186667338013649
all O 0 0.0035801695194095373
major O 0 0.008602879010140896
organ O 0 0.053047437220811844
systems O 0 0.017904646694660187
( O 0 0.011572386138141155
central O 0 0.011502237990498543
nervous O 1 0.9716939926147461
system O 0 0.021689020097255707
, O 0 0.019706226885318756
thyroid O 1 0.9999967813491821
, O 0 0.20754794776439667
breast O 1 0.9999942779541016
, O 0 0.13834746181964874
skin O 1 0.9999866485595703
and O 0 0.13582363724708557
gastrointestinal O 1 0.9999889135360718
tract O 1 0.9996640682220459
) O 0 0.03526528179645538
. O 0 0.02764113061130047

However O 0 0.02016371861100197
, O 0 0.007612837012857199
these O 0 0.005313931033015251
observations O 0 0.008544734679162502
would O 0 0.004226069897413254
need O 0 0.0058833882212638855
to O 0 0.0030226116068661213
be O 0 0.003015811089426279
confirmed O 0 0.00548472348600626
by O 0 0.0031098639592528343
studying O 0 0.005435082130134106
a O 0 0.005025618709623814
larger O 0 0.007752264384180307
number O 0 0.0054683201014995575
of O 0 0.0059941615909338
CD B-Disease 0 0.023724131286144257
families O 0 0.02879953384399414
. O 0 0.02551187016069889

Molecular O 0 0.1542564481496811
defects O 1 0.8973128199577332
leading O 0 0.029163260012865067
to O 0 0.01325851958245039
human O 0 0.023724764585494995
complement B-Disease 0 0.04473259299993515
component I-Disease 1 0.6868537068367004
C6 I-Disease 1 0.9999510049819946
deficiency I-Disease 1 0.9999853372573853
in O 0 0.013350587338209152
an O 0 0.010010035708546638
African O 0 0.02418343909084797
- O 0 0.03838827833533287
American O 0 0.02176186442375183
family O 0 0.02806912735104561
. O 0 0.028175832703709602

Complement B-Disease 1 0.634143054485321
component I-Disease 1 0.9808696508407593
C6 I-Disease 1 0.9999790191650391
deficiency I-Disease 1 0.9999983310699463
( O 0 0.09705599397420883
C6D B-Disease 1 0.9449698328971863
) O 0 0.013552646152675152
was O 0 0.008546852506697178
diagnosed O 1 0.9906303286552429
in O 0 0.006221861112862825
a O 0 0.006301047280430794
16 O 0 0.008836623281240463
- O 0 0.0193888321518898
year O 0 0.008870629593729973
- O 0 0.02577351965010166
old O 0 0.015928126871585846
African O 0 0.02495228499174118
- O 0 0.08051896840333939
American O 0 0.025286981835961342
male O 0 0.2261020988225937
with O 0 0.06477280706167221
meningococcal B-Disease 1 0.999995231628418
meningitis I-Disease 1 0.9999914169311523
. O 0 0.05456600710749626

The O 0 0.028587380424141884
patients O 1 0.9366057515144348
father O 0 0.015327217988669872
and O 0 0.006036834791302681
two O 0 0.006049267947673798
brothers O 0 0.013841187581419945
also O 0 0.005592751782387495
had O 0 0.007465171627700329
C6D B-Disease 0 0.09812413156032562
, O 0 0.005012229550629854
but O 0 0.004713038448244333
gave O 0 0.006897187791764736
no O 0 0.005671066697686911
history O 0 0.007512777578085661
of O 0 0.008191550150513649
meningitis B-Disease 1 0.9999500513076782
or O 0 0.01767854019999504
other O 0 0.013327975757420063
neisserial B-Disease 1 0.995465099811554
infection I-Disease 1 0.999763548374176
. O 0 0.03427965193986893

By O 0 0.0277780182659626
using O 0 0.029352134093642235
exon O 0 0.08956808596849442
- O 0 0.07059280574321747
specific O 0 0.03610732778906822
polymerase O 0 0.29003116488456726
chain O 0 0.06660923361778259
reaction O 0 0.06295547634363174
( O 0 0.026200084015727043
PCR O 0 0.09828878939151764
) O 0 0.01844945177435875
/ O 0 0.05675489082932472
single O 0 0.017874453216791153
- O 0 0.03860636055469513
strand O 0 0.05606427416205406
conformation O 0 0.05813363939523697
polymorphism O 0 0.055646996945142746
as O 0 0.010655385442078114
a O 0 0.010627527721226215
screening O 0 0.027870429679751396
step O 0 0.014408620074391365
and O 0 0.007668624632060528
nucleotide O 0 0.02907862327992916
sequencing O 0 0.02500513754785061
of O 0 0.007046098355203867
target O 0 0.012885812669992447
exons O 0 0.02857491746544838
, O 0 0.005809236783534288
we O 0 0.0039593433029949665
determined O 0 0.00632295710965991
that O 0 0.003907374572008848
the O 0 0.005036256741732359
proband O 0 0.0309305302798748
was O 0 0.006802336312830448
a O 0 0.00888905767351389
compound O 0 0.02773008495569229
heterozygote O 0 0.3235611617565155
for O 0 0.0125489616766572
two O 0 0.01751174032688141
C6 O 1 0.987851083278656
gene O 1 0.6009340882301331
mutations O 1 0.8887591361999512
. O 0 0.038673341274261475

The O 0 0.017398327589035034
first O 0 0.012912599369883537
, O 0 0.011784286238253117
1195delC O 0 0.05021059513092041
located O 0 0.015997808426618576
in O 0 0.00760459853336215
exon O 0 0.037467941641807556
7 O 0 0.012043993920087814
, O 0 0.005405500065535307
is O 0 0.004834637511521578
a O 0 0.006408913992345333
novel O 0 0.011525498703122139
mutation O 0 0.03958500549197197
, O 0 0.0046737720258533955
while O 0 0.0039144293405115604
the O 0 0.0037794597446918488
second O 0 0.006230228580534458
, O 0 0.006239531561732292
1936delG O 0 0.03129813075065613
in O 0 0.006860401481389999
exon O 0 0.030452512204647064
12 O 0 0.009002436883747578
, O 0 0.004367699846625328
has O 0 0.004345665220171213
been O 0 0.004513488616794348
described O 0 0.00661736074835062
before O 0 0.005176838953047991
to O 0 0.005162411835044622
cause O 0 0.02490869164466858
C6D B-Disease 0 0.07328231632709503
in O 0 0.006405838765203953
an O 0 0.006367645226418972
unrelated O 0 0.024034451693296432
African O 0 0.02924799732863903
- O 0 0.043178971856832504
American O 0 0.022161126136779785
individual O 0 0.0274548027664423
. O 0 0.026538604870438576

Both O 0 0.04293369501829147
mutations O 1 0.5818224549293518
result O 0 0.03291039168834686
in O 0 0.02004719339311123
premature O 1 0.9346965551376343
termination O 1 0.8035045266151428
codons O 0 0.092525415122509
and O 0 0.026848409324884415
C6 O 1 0.9614719152450562
null O 0 0.10727270692586899
alleles O 0 0.4207651615142822
. O 0 0.04577234759926796

Allele O 1 0.6169498562812805
- O 0 0.10253283381462097
specific O 0 0.0350884310901165
PCR O 0 0.07748261094093323
indicated O 0 0.020747484639286995
that O 0 0.006100418046116829
the O 0 0.006980980280786753
probands O 0 0.033552419394254684
two O 0 0.007719395216554403
brothers O 0 0.016585858538746834
also O 0 0.007486945949494839
inherited O 0 0.04338691011071205
the O 0 0.0108441561460495
1195delC O 0 0.21691468358039856
mutation O 0 0.11172061413526535
from O 0 0.007878740318119526
their O 0 0.007431291043758392
heterozygous O 0 0.04026535525918007
mother O 0 0.016439538449048996
and O 0 0.007003480102866888
the O 0 0.008484160527586937
1936delG O 0 0.1710672527551651
mutation O 0 0.10578736662864685
from O 0 0.009432636201381683
their O 0 0.009591820649802685
homozygous O 0 0.05479725822806358
father O 0 0.02487255074083805
. O 0 0.016091929748654366
. O 0 0.023434612900018692

PAX6 O 1 0.9899252653121948
mutations O 1 0.8900133371353149
reviewed O 0 0.08619629591703415
. O 0 0.04814516007900238

Mutations O 1 0.7492519617080688
in O 0 0.023706043139100075
PAX6 O 1 0.8846562504768372
are O 0 0.008150596171617508
responsible O 0 0.010731267742812634
for O 0 0.005307510960847139
human O 0 0.011438136920332909
aniridia B-Disease 1 0.5521398186683655
and O 0 0.004866237286478281
have O 0 0.004176161251962185
also O 0 0.003558114171028137
been O 0 0.00377731304615736
found O 0 0.005840796511620283
in O 0 0.006332864053547382
patients O 1 0.9969447255134583
with O 0 0.012200596742331982
Peters B-Disease 1 0.9981783628463745
anomaly I-Disease 1 0.9992413520812988
, O 0 0.013396869413554668
with O 0 0.039584528654813766
congenital B-Disease 1 0.9999994039535522
cataracts I-Disease 1 0.9999966621398926
, O 0 0.017847800627350807
with O 0 0.02068527601659298
autosomal B-Disease 1 0.9999058246612549
dominant I-Disease 1 0.9868749976158142
keratitis I-Disease 1 0.9999760389328003
, O 0 0.01551588624715805
and O 0 0.009407788515090942
with O 0 0.014989487826824188
isolated B-Disease 0 0.43603193759918213
foveal I-Disease 1 0.9983620047569275
hypoplasia I-Disease 1 0.9997400641441345
. O 0 0.048907794058322906

No O 0 0.04302205517888069
locus O 0 0.07853689789772034
other O 0 0.014761671423912048
than O 0 0.01492959912866354
chromosome O 0 0.11381470412015915
11p13 O 0 0.07269740849733353
has O 0 0.010607067495584488
been O 0 0.008851022459566593
implicated O 0 0.035511523485183716
in O 0 0.01014507282525301
aniridia B-Disease 1 0.8924742341041565
, O 0 0.009050438180565834
and O 0 0.007751897443085909
PAX6 O 1 0.9473034739494324
is O 0 0.00551389018073678
clearly O 0 0.006652156822383404
the O 0 0.0035356462467461824
major O 0 0.005794884171336889
, O 0 0.0036057885736227036
if O 0 0.0038074804469943047
not O 0 0.003138371044769883
only O 0 0.0037961609195917845
, O 0 0.006664785090833902
gene O 0 0.03316376730799675
responsible O 0 0.022572750225663185
. O 0 0.02031187154352665

Twenty O 0 0.053154535591602325
- O 0 0.04783395305275917
eight O 0 0.01759958267211914
percent O 0 0.017749885097146034
of O 0 0.010066899470984936
identified O 0 0.027420416474342346
PAX6 O 1 0.9975409507751465
mutations O 1 0.8307451009750366
are O 0 0.01236258540302515
C O 0 0.2462230920791626
- O 0 0.46241170167922974
T O 1 0.8795629143714905
changes O 0 0.021104298532009125
at O 0 0.016753727570176125
CpG O 0 0.36142295598983765
dinucleotides O 0 0.07651319354772568
, O 0 0.00940650887787342
20 O 0 0.00890805758535862
% O 0 0.0085359001532197
are O 0 0.005664397031068802
splicing O 0 0.028176968917250633
errors O 0 0.01367907039821148
, O 0 0.003957771230489016
and O 0 0.002809640020132065
more O 0 0.002644445514306426
than O 0 0.0032121101394295692
30 O 0 0.005043674260377884
% O 0 0.006707719061523676
are O 0 0.0053676883690059185
deletion O 0 0.05631241574883461
or O 0 0.015615534968674183
insertion O 0 0.07205308973789215
events O 0 0.029219530522823334
. O 0 0.02531142346560955

There O 0 0.01899378001689911
is O 0 0.01073390617966652
a O 0 0.011308186687529087
noticeably O 0 0.030413076281547546
elevated O 0 0.02997487597167492
level O 0 0.012644246220588684
of O 0 0.005863958969712257
mutation O 0 0.04103392735123634
in O 0 0.005714091472327709
the O 0 0.005639319773763418
paired O 0 0.02018432505428791
domain O 0 0.012409798800945282
compared O 0 0.008407414890825748
with O 0 0.004404321312904358
the O 0 0.003998657688498497
rest O 0 0.008013221435248852
of O 0 0.00515782181173563
the O 0 0.009059774689376354
gene O 0 0.05697952210903168
. O 0 0.024463893845677376

Increased O 0 0.054225120693445206
mutation O 0 0.08626452088356018
in O 0 0.011080986820161343
the O 0 0.008847187273204327
homeodomain O 0 0.06270300596952438
is O 0 0.008554695174098015
accounted O 0 0.015335696749389172
for O 0 0.005842638202011585
by O 0 0.007129699923098087
the O 0 0.011434793472290039
hypermutable O 0 0.3302933871746063
CpG O 1 0.84396892786026
dinucleotide O 0 0.19139541685581207
in O 0 0.021029574796557426
codon O 0 0.08559752255678177
240 O 0 0.05238683894276619
. O 0 0.03143710643053055

Very O 0 0.026840263977646828
nearly O 0 0.021425209939479828
all O 0 0.010556802153587341
mutations O 0 0.14167778193950653
appear O 0 0.012794180773198605
to O 0 0.006266008131206036
cause O 0 0.02549493871629238
loss O 0 0.014404406771063805
of O 0 0.005238775163888931
function O 0 0.008177793584764004
of O 0 0.004767727572470903
the O 0 0.005941386800259352
mutant O 0 0.03386717662215233
allele O 0 0.045858342200517654
, O 0 0.005642287898808718
and O 0 0.004064096603542566
more O 0 0.0037961110938340425
than O 0 0.004710198845714331
80 O 0 0.010382241569459438
% O 0 0.009847084991633892
of O 0 0.007402320392429829
exonic O 0 0.079283207654953
substitutions O 0 0.03747791051864624
result O 0 0.018215278163552284
in O 0 0.012675085105001926
nonsense O 0 0.04791310057044029
codons O 0 0.07877688854932785
. O 0 0.029412725940346718

In O 0 0.021398702636361122
a O 0 0.015554084442555904
gene O 0 0.032052792608737946
with O 0 0.008859556168317795
such O 0 0.008321097120642662
extraordinarily O 0 0.028684956952929497
high O 0 0.014504315331578255
sequence O 0 0.017904723063111305
conservation O 0 0.016443902626633644
throughout O 0 0.009420711547136307
evolution O 0 0.011722935363650322
, O 0 0.006525450386106968
there O 0 0.006059844512492418
are O 0 0.006430472247302532
presumed O 0 0.03097657673060894
undiscovered O 1 0.5283278822898865
missense O 1 0.896489679813385
mutations O 0 0.40298542380332947
, O 0 0.007332736626267433
these O 0 0.004749838728457689
are O 0 0.004268766846507788
hypothesized O 0 0.02041512355208397
to O 0 0.004603791516274214
exist O 0 0.0063905250281095505
in O 0 0.004685099236667156
as O 0 0.00554830115288496
- O 0 0.022146137431263924
yet O 0 0.014100554399192333
unidentified O 0 0.037466421723365784
phenotypes O 0 0.47350794076919556
. O 0 0.02203303389251232
. O 0 0.026068251579999924

Genetic O 0 0.35321399569511414
heterogeneity O 0 0.11360020935535431
and O 0 0.020896559581160545
penetrance O 0 0.16712701320648193
analysis O 0 0.016797123476862907
of O 0 0.00715351989492774
the O 0 0.012004205957055092
BRCA1 O 1 0.9963896870613098
and O 0 0.024361077696084976
BRCA2 O 1 0.9997474551200867
genes O 1 0.9811305999755859
in O 0 0.0754537582397461
breast B-Disease 1 0.9999934434890747
cancer I-Disease 1 0.9999678134918213
families O 0 0.08886884897947311
. O 0 0.040983881801366806

The O 0 0.1771891713142395
Breast B-Disease 1 0.9999920129776001
Cancer I-Disease 1 0.9999860525131226
Linkage O 1 0.983970582485199
Consortium O 0 0.2935262620449066
. O 0 0.04978971928358078

The O 0 0.023376982659101486
contribution O 0 0.03006608784198761
of O 0 0.016629287973046303
BRCA1 O 1 0.997129499912262
and O 0 0.021819863468408585
BRCA2 O 1 0.999829888343811
to O 0 0.0414833202958107
inherited B-Disease 1 0.9999641180038452
breast I-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999921321868896
was O 0 0.015308230184018612
assessed O 0 0.029013091698288918
by O 0 0.01110687106847763
linkage O 0 0.0612558089196682
and O 0 0.009099364280700684
mutation O 0 0.15456810593605042
analysis O 0 0.012392045930027962
in O 0 0.006083337590098381
237 O 0 0.019979819655418396
families O 0 0.009948443621397018
, O 0 0.004371457267552614
each O 0 0.003204449312761426
with O 0 0.0033612234983593225
at O 0 0.004146389663219452
least O 0 0.004758685361593962
four O 0 0.005656575784087181
cases O 0 0.014188350178301334
of O 0 0.009694164618849754
breast B-Disease 1 0.9999946355819702
cancer I-Disease 1 0.999954104423523
, O 0 0.007569557521492243
collected O 0 0.00754957739263773
by O 0 0.008560107089579105
the O 0 0.016623349860310555
Breast B-Disease 1 0.9999969005584717
Cancer I-Disease 1 0.9999905824661255
Linkage O 1 0.9874123334884644
Consortium O 0 0.3065541684627533
. O 0 0.04172136262059212

Families O 0 0.02896270900964737
were O 0 0.00817010086029768
included O 0 0.008054970763623714
without O 0 0.006669799331575632
regard O 0 0.008424983359873295
to O 0 0.00433872826397419
the O 0 0.006177104078233242
occurrence O 0 0.031135227531194687
of O 0 0.009721201844513416
ovarian B-Disease 1 0.9999496936798096
or I-Disease 0 0.018823331221938133
other I-Disease 0 0.01647658832371235
cancers I-Disease 1 0.9995667338371277
. O 0 0.03111768327653408

Overall O 0 0.07871033251285553
, O 0 0.02419034205377102
disease O 1 0.9991262555122375
was O 0 0.011204752139747143
linked O 0 0.0226852148771286
to O 0 0.007784450892359018
BRCA1 O 1 0.7638452649116516
in O 0 0.006241626106202602
an O 0 0.004417944233864546
estimated O 0 0.008627892471849918
52 O 0 0.011033392511308193
% O 0 0.006537481211125851
of O 0 0.0036562143359333277
families O 0 0.008405305445194244
, O 0 0.004849458113312721
to O 0 0.005215133540332317
BRCA2 O 1 0.8775153756141663
in O 0 0.006804002448916435
32 O 0 0.009112728759646416
% O 0 0.006187521852552891
of O 0 0.0033340693917125463
families O 0 0.006760856602340937
, O 0 0.00384929939173162
and O 0 0.0031881353352218866
to O 0 0.003940657712519169
neither O 0 0.008832015097141266
gene O 0 0.01964942365884781
in O 0 0.005384587682783604
16 O 0 0.00897134281694889
% O 0 0.010706724599003792
( O 0 0.009746940806508064
95 O 0 0.015419810079038143
% O 0 0.011351557448506355
confidence O 0 0.020203080028295517
interval O 0 0.04383242502808571
[ O 0 0.0382687970995903
CI O 1 0.9067263603210449
] O 0 0.03485112264752388
6 O 0 0.01491420716047287
% O 0 0.012706534005701542
- O 0 0.0214513149112463
28 O 0 0.011544984765350819
% O 0 0.010649365372955799
) O 0 0.008658172562718391
, O 0 0.0065636769868433475
suggesting O 0 0.01691461354494095
other O 0 0.01006839144974947
predisposition O 1 0.9538095593452454
genes O 0 0.08013048768043518
. O 0 0.031016157940030098

The O 0 0.024060329422354698
majority O 0 0.02795380912721157
( O 0 0.0188056118786335
81 O 0 0.023173974826931953
% O 0 0.010311398655176163
) O 0 0.008160978555679321
of O 0 0.00617551151663065
the O 0 0.018185431137681007
breast B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999878406524658
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999997615814209
families O 0 0.0224886704236269
were O 0 0.005952606908977032
due O 0 0.007913893088698387
to O 0 0.005768800154328346
BRCA1 O 1 0.971342921257019
, O 0 0.005811539012938738
with O 0 0.004363830201327801
most O 0 0.004554141778498888
others O 0 0.006057783495634794
( O 0 0.008242846466600895
14 O 0 0.006982031278312206
% O 0 0.00894684623926878
) O 0 0.008306766860187054
due O 0 0.011291714385151863
to O 0 0.012447255663573742
BRCA2 O 1 0.9906811118125916
. O 0 0.031304873526096344

Conversely O 0 0.07056194543838501
, O 0 0.012065038084983826
the O 0 0.007541446480900049
majority O 0 0.010463288053870201
of O 0 0.005316601600497961
families O 0 0.01152339018881321
with O 0 0.008623280562460423
male B-Disease 0 0.02735498920083046
and I-Disease 0 0.010369057767093182
female I-Disease 1 0.6698428392410278
breast I-Disease 1 0.9999942779541016
cancer I-Disease 1 0.999962568283081
were O 0 0.008609559386968613
due O 0 0.012687640264630318
to O 0 0.011273319832980633
BRCA2 O 1 0.9951175451278687
( O 0 0.024030571803450584
76 O 0 0.03639303147792816
% O 0 0.02362615056335926
) O 0 0.023460494354367256
. O 0 0.02165425568819046

The O 0 0.02179582603275776
largest O 0 0.027916718274354935
proportion O 0 0.027448853477835655
( O 0 0.014888602308928967
67 O 0 0.019173553213477135
% O 0 0.008882967755198479
) O 0 0.005330230575054884
of O 0 0.003230062313377857
families O 0 0.0068406048230826855
due O 0 0.005307465326040983
to O 0 0.003313441062346101
other O 0 0.0034315225202590227
genes O 0 0.012591124512255192
was O 0 0.003146243980154395
found O 0 0.00349739589728415
in O 0 0.0026000558864325285
families O 0 0.005436082370579243
with O 0 0.003449349431321025
four O 0 0.003964724950492382
or O 0 0.005238630808889866
five O 0 0.0056230854243040085
cases O 0 0.010949946008622646
of O 0 0.007583324331790209
female O 1 0.5018945932388306
breast B-Disease 1 0.9999909400939941
cancer I-Disease 1 0.9999319314956665
only O 0 0.018917212262749672
. O 0 0.02386436238884926

These O 0 0.01660781353712082
estimates O 0 0.02042160928249359
were O 0 0.006103315390646458
not O 0 0.005758730694651604
substantially O 0 0.016090013086795807
affected O 0 0.01611563190817833
either O 0 0.007212085649371147
by O 0 0.0050138914957642555
changing O 0 0.011735050939023495
the O 0 0.006591409910470247
assumed O 0 0.020737893879413605
penetrance O 0 0.31516003608703613
model O 0 0.016238780692219734
for O 0 0.008348077535629272
BRCA1 O 1 0.9372553825378418
or O 0 0.009403958916664124
by O 0 0.006365376524627209
including O 0 0.00761069729924202
or O 0 0.012426582165062428
excluding O 0 0.028833260759711266
BRCA1 O 1 0.9970719814300537
mutation O 1 0.8622680306434631
data O 0 0.025955144315958023
. O 0 0.02765755169093609

Among O 0 0.03068719059228897
those O 0 0.015045158565044403
families O 0 0.019258439540863037
with O 0 0.014443127438426018
disease O 1 0.9998051524162292
due O 0 0.013265409506857395
to O 0 0.007920626550912857
BRCA1 O 1 0.9299921989440918
that O 0 0.005309772212058306
were O 0 0.003935166168957949
tested O 0 0.010687382891774178
by O 0 0.0033218390308320522
one O 0 0.0031197902280837297
of O 0 0.00276501988992095
the O 0 0.0045572142116725445
standard O 0 0.011477774009108543
screening O 0 0.021422795951366425
methods O 0 0.012646764516830444
, O 0 0.008245260454714298
mutations O 0 0.04315370321273804
were O 0 0.005756954196840525
detected O 0 0.018062226474285126
in O 0 0.005527471657842398
the O 0 0.005772444419562817
coding O 0 0.031005656346678734
sequence O 0 0.01597459241747856
or O 0 0.009846160188317299
splice O 0 0.03945942223072052
sites O 0 0.010323098860681057
in O 0 0.005322694778442383
an O 0 0.005233072675764561
estimated O 0 0.011744224466383457
63 O 0 0.018194133415818214
% O 0 0.010470370762050152
( O 0 0.010066214948892593
95 O 0 0.015717763453722
% O 0 0.015787657350301743
CI O 1 0.8233311176300049
51 O 0 0.025435013696551323
% O 0 0.018083317205309868
- O 0 0.036186497658491135
77 O 0 0.031387705355882645
% O 0 0.02035232074558735
) O 0 0.02094585821032524
. O 0 0.021696675568819046

The O 0 0.01836596243083477
estimated O 0 0.023195507004857063
sensitivity O 0 0.029453784227371216
was O 0 0.007681327871978283
identical O 0 0.010250677354633808
for O 0 0.005359204951673746
direct O 0 0.010284747928380966
sequencing O 0 0.02000831812620163
and O 0 0.005650599021464586
other O 0 0.007485007867217064
techniques O 0 0.023328810930252075
. O 0 0.020928381010890007

The O 0 0.029406482353806496
penetrance O 0 0.24057883024215698
of O 0 0.01691310666501522
BRCA2 O 1 0.9629455804824829
was O 0 0.013094007037580013
estimated O 0 0.015073122456669807
by O 0 0.008864079602062702
maximizing O 0 0.03505061939358711
the O 0 0.012493463233113289
LOD O 0 0.4532617926597595
score O 0 0.016299068927764893
in O 0 0.01309507992118597
BRCA2 O 1 0.9995743632316589
- O 1 0.8998095989227295
mutation O 1 0.8815068602561951
families O 0 0.01699449121952057
, O 0 0.006677316036075354
over O 0 0.006096920929849148
all O 0 0.005827292334288359
possible O 0 0.013605441898107529
penetrance O 0 0.24483951926231384
functions O 0 0.022031011059880257
. O 0 0.02339000254869461

The O 0 0.029413927346467972
estimated O 0 0.03869660198688507
cumulative O 0 0.28775468468666077
risk O 1 0.8973102569580078
of O 0 0.022371353581547737
breast B-Disease 1 0.999976634979248
cancer I-Disease 1 0.9999260902404785
reached O 0 0.018355395644903183
28 O 0 0.012878300622105598
% O 0 0.010567675344645977
( O 0 0.010922492481768131
95 O 0 0.016004212200641632
% O 0 0.015704570338129997
CI O 1 0.7820084095001221
9 O 0 0.014842166565358639
% O 0 0.011670151725411415
- O 0 0.018907196819782257
44 O 0 0.012193477712571621
% O 0 0.009110274724662304
) O 0 0.007283324375748634
by O 0 0.0037082440685480833
age O 0 0.007246986497193575
50 O 0 0.006827817298471928
years O 0 0.005328324623405933
and O 0 0.00462520495057106
84 O 0 0.014876367524266243
% O 0 0.009338890202343464
( O 0 0.010046988725662231
95 O 0 0.014168876223266125
% O 0 0.012982991524040699
CI O 1 0.7648316621780396
43 O 0 0.0162793155759573
% O 0 0.011530421674251556
- O 0 0.01923564448952675
95 O 0 0.013306752778589725
% O 0 0.010770799592137337
) O 0 0.007891379296779633
by O 0 0.005708364304155111
age O 0 0.013297177851200104
70 O 0 0.015026683919131756
years O 0 0.015152174048125744
. O 0 0.01912059262394905

The O 0 0.054195307195186615
corresponding O 1 0.84884113073349
ovarian B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999943971633911
risks O 1 0.9278507828712463
were O 0 0.020660968497395515
0 O 0 0.04179690405726433
. O 0 0.021420657634735107

4 O 0 0.04209557920694351
% O 0 0.02580748125910759
( O 0 0.019009970128536224
95 O 0 0.02362820878624916
% O 0 0.02082902193069458
CI O 1 0.8097464442253113
0 O 0 0.022474709898233414
% O 0 0.012473320588469505
- O 0 0.019830996170639992
1 O 0 0.008063883520662785
% O 0 0.008548527956008911
) O 0 0.005721451248973608
by O 0 0.004120644647628069
age O 0 0.006934910546988249
50 O 0 0.006055200006812811
years O 0 0.004350508097559214
and O 0 0.004068062175065279
27 O 0 0.008502430282533169
% O 0 0.008993224240839481
( O 0 0.010041546076536179
95 O 0 0.015167023055255413
% O 0 0.0141560398042202
CI O 1 0.8290840983390808
0 O 0 0.02120203711092472
% O 0 0.012207086198031902
- O 0 0.021163592115044594
47 O 0 0.01648137718439102
% O 0 0.010428067296743393
) O 0 0.00886528566479683
by O 0 0.006144830025732517
age O 0 0.01339051779359579
70 O 0 0.018281932920217514
years O 0 0.014710701070725918
. O 0 0.016933707520365715

The O 0 0.033104341477155685
lifetime O 0 0.39911505579948425
risk O 1 0.9679948091506958
of O 0 0.026661192998290062
breast B-Disease 1 0.9999942779541016
cancer I-Disease 1 0.9999663829803467
appears O 0 0.02403702586889267
similar O 0 0.010820386931300163
to O 0 0.0050698332488536835
the O 0 0.006977869663387537
risk O 0 0.14602607488632202
in O 0 0.008585610426962376
BRCA1 O 1 0.9988216757774353
carriers O 0 0.0782916322350502
, O 0 0.004942005034536123
but O 0 0.0035862645599991083
there O 0 0.003098508110269904
was O 0 0.003159493673592806
some O 0 0.0034171068109571934
suggestion O 0 0.009194258600473404
of O 0 0.004296549130231142
a O 0 0.006748373154550791
lower O 0 0.015726013109087944
risk O 0 0.3783566355705261
in O 0 0.014428934082388878
BRCA2 O 1 0.9989811778068542
carriers O 1 0.7581968903541565
< O 0 0.34701764583587646
50 O 0 0.016992541030049324
years O 0 0.009957353584468365
of O 0 0.008595052175223827
age O 0 0.02441675029695034
. O 0 0.021805619820952415

Eye B-Disease 1 0.9754301905632019
movement I-Disease 0 0.0702301636338234
abnormalities I-Disease 1 0.9860517978668213
correlate O 0 0.08539574593305588
with O 0 0.028949487954378128
genotype O 1 0.9561169743537903
in O 0 0.0342642143368721
autosomal O 1 0.9995231628417969
dominant O 1 0.9878101348876953
cerebellar B-Disease 1 0.9999409914016724
ataxia I-Disease 1 0.9999537467956543
type I-Disease 1 0.8119603991508484
I I-Disease 0 0.04954037442803383
. O 0 0.0328604057431221

We O 0 0.033923499286174774
compared O 0 0.037477582693099976
horizontal O 0 0.07355700433254242
eye O 1 0.5234437584877014
movements O 0 0.035058099776506424
( O 0 0.02227044478058815
visually O 0 0.0406852550804615
guided O 0 0.04092787206172943
saccades O 1 0.989875853061676
, O 0 0.013756928034126759
antisaccades O 0 0.051092907786369324
, O 0 0.007717182394117117
and O 0 0.005546357482671738
smooth O 0 0.016574250534176826
pursuit O 0 0.020829830318689346
) O 0 0.008512050844728947
in O 0 0.005441233515739441
control O 0 0.011998535133898258
subjects O 0 0.012531105428934097
( O 0 0.01333966851234436
n O 0 0.022384637966752052
= O 0 0.02732584811747074
14 O 0 0.008935467340052128
) O 0 0.006810872349888086
and O 0 0.004562865477055311
patients O 0 0.3823803663253784
with O 0 0.00474554905667901
three O 0 0.00508016487583518
forms O 0 0.010853796266019344
of O 0 0.010706194676458836
autosomal O 1 0.9994562268257141
dominant O 1 0.9132622480392456
cerebellar B-Disease 1 0.9999164342880249
ataxias I-Disease 1 0.9969077706336975
type I-Disease 1 0.6991538405418396
I I-Disease 0 0.0523974634706974
spinocerebellar B-Disease 1 0.9988399147987366
ataxias I-Disease 0 0.2479163408279419
1 I-Disease 0 0.01217399537563324
and I-Disease 0 0.00813104398548603
2 I-Disease 0 0.01237020269036293
( O 0 0.013960382901132107
SCA1 B-Disease 0 0.09780142456293106
, O 0 0.010809989646077156
n O 0 0.028976893052458763
= O 0 0.03779449686408043
11 O 0 0.013719835318624973
; O 0 0.01379141304641962
SCA2 B-Disease 0 0.0636138841509819
, O 0 0.009498687461018562
n O 0 0.022103261202573776
= O 0 0.030903002247214317
10 O 0 0.010252340696752071
) O 0 0.011681200936436653
and O 0 0.010715456679463387
SCA3 B-Disease 1 0.9986492991447449
/ O 1 0.9946849346160889
Machado B-Disease 1 0.9542653560638428
- I-Disease 1 0.9846134185791016
Joseph I-Disease 1 0.636756956577301
disease I-Disease 1 0.9999446868896484
( O 0 0.03793745115399361
MJD B-Disease 1 0.9925655126571655
) O 0 0.019022462889552116
( O 0 0.017599424347281456
n O 0 0.03110131248831749
= O 0 0.041617169976234436
16 O 0 0.015704549849033356
) O 0 0.018832460045814514
. O 0 0.01846425235271454

In O 0 0.041799865663051605
SCA1 B-Disease 0 0.1820715218782425
, O 0 0.027215057983994484
saccade O 0 0.20753945410251617
amplitude O 0 0.05804406479001045
was O 0 0.012440938502550125
significantly O 0 0.024222660809755325
increased O 0 0.018014905974268913
, O 0 0.009332853369414806
resulting O 0 0.022674301639199257
in O 0 0.013910036534070969
hypermetria B-Disease 0 0.2038496881723404
. O 0 0.028535226359963417

The O 0 0.029728522524237633
smooth O 0 0.05082527548074722
pursuit O 0 0.05226217955350876
gain O 0 0.03471894562244415
was O 0 0.018669063225388527
decreased O 0 0.04966115579009056
. O 0 0.02901436947286129

In O 0 0.04599127545952797
SCA2 B-Disease 0 0.260415643453598
, O 0 0.034220147877931595
saccade O 0 0.3346518278121948
velocity O 0 0.07309781759977341
was O 0 0.02394874393939972
markedly O 0 0.07271889597177505
decreased O 0 0.07807773351669312
. O 0 0.036838896572589874

The O 0 0.01726854033768177
percentage O 0 0.02138737216591835
of O 0 0.009550861082971096
errors O 0 0.021296313032507896
in O 0 0.009697571396827698
antisaccades O 0 0.0882471576333046
was O 0 0.0074534788727760315
greatly O 0 0.01324594859033823
increased O 0 0.011129096150398254
and O 0 0.004634765908122063
was O 0 0.006385906133800745
significantly O 0 0.01738281175494194
correlated O 0 0.0327913872897625
with O 0 0.011336413212120533
age O 0 0.027256960049271584
at O 0 0.032692763954401016
disease O 1 0.9999779462814331
onset O 1 0.9996035695075989
. O 0 0.03850165009498596

In O 0 0.017153307795524597
addition O 0 0.014556330628693104
, O 0 0.007467559538781643
a O 0 0.00838035810738802
correlation O 0 0.0224998090416193
between O 0 0.009827136062085629
smooth O 0 0.01955205202102661
pursuit O 0 0.021033840253949165
gain O 0 0.012977865524590015
and O 0 0.004911067895591259
the O 0 0.004966041538864374
number O 0 0.006237853318452835
of O 0 0.007219156250357628
trinucleotide O 1 0.9373775124549866
repeats O 0 0.03661428391933441
was O 0 0.01114849653095007
found O 0 0.014370894990861416
. O 0 0.018207401037216187

In O 0 0.03782796859741211
SCA3 B-Disease 1 0.9907581806182861
, O 0 0.02766360715031624
gaze B-Disease 1 0.6204442381858826
- I-Disease 1 0.6950547695159912
evoked I-Disease 1 0.6464112401008606
nystagmus I-Disease 1 0.9907746911048889
was O 0 0.010794277302920818
often O 0 0.010118607431650162
present O 0 0.008063188754022121
as O 0 0.005855460185557604
was O 0 0.008922248147428036
saccade O 0 0.29588583111763
hypometria O 0 0.08826081454753876
and O 0 0.01051107794046402
smooth O 0 0.03016282245516777
pursuit O 0 0.039469532668590546
gain O 0 0.027396734803915024
was O 0 0.014403256587684155
markedly O 0 0.05533751845359802
decreased O 0 0.06469811499118805
. O 0 0.03126346319913864

Three O 0 0.02679566852748394
major O 0 0.02745119296014309
criteria O 0 0.029165854677557945
, O 0 0.018404463306069374
saccade O 0 0.27248919010162354
amplitude O 0 0.06263330578804016
, O 0 0.01596798375248909
saccade O 0 0.23552322387695312
velocity O 0 0.03255201503634453
, O 0 0.007846497930586338
and O 0 0.006479690317064524
presence O 0 0.012893213890492916
of O 0 0.00839944090694189
gaze B-Disease 1 0.5094107389450073
- I-Disease 1 0.6438645720481873
evoked I-Disease 1 0.6308256387710571
nystagmus I-Disease 1 0.9959139227867126
, O 0 0.009663788601756096
permitted O 0 0.01091129332780838
the O 0 0.006678486242890358
correct O 0 0.017358355224132538
assignment O 0 0.01571531593799591
of O 0 0.005513304378837347
90 O 0 0.009493974037468433
% O 0 0.0068351193331182
of O 0 0.003666707081720233
the O 0 0.0048819067887961864
SCA1 B-Disease 0 0.052849359810352325
, O 0 0.006353318691253662
90 O 0 0.009862033650279045
% O 0 0.007997053675353527
of O 0 0.0038136227522045374
the O 0 0.005431376397609711
SCA2 B-Disease 0 0.06075209006667137
, O 0 0.005596773233264685
and O 0 0.0043510738760232925
93 O 0 0.012947672046720982
% O 0 0.00678721209987998
of O 0 0.00378805142827332
the O 0 0.005963142961263657
patients O 1 0.9368837475776672
with O 0 0.00860041007399559
SCA3 B-Disease 1 0.9096888303756714
to O 0 0.006244744174182415
their O 0 0.006412641145288944
genetically O 0 0.024482524022459984
confirmed O 0 0.01592988893389702
patient O 1 0.6299006938934326
group O 0 0.009781048633158207
and O 0 0.004447916988283396
, O 0 0.004106002394109964
therefore O 0 0.005305315833538771
, O 0 0.0042862133122980595
may O 0 0.008298634551465511
help O 0 0.011971673928201199
orient O 0 0.03549319878220558
diagnoses O 1 0.9706041812896729
of O 0 0.00968306977301836
SCA1 B-Disease 1 0.7748479843139648
, O 0 0.00921486597508192
SCA2 B-Disease 0 0.34872686862945557
, O 0 0.007683352567255497
and O 0 0.00721764238551259
SCA3 B-Disease 1 0.8956151008605957
at O 0 0.00960709247738123
early O 0 0.011987794190645218
clinical O 0 0.16574421525001526
stages O 0 0.019997045397758484
of O 0 0.007064600940793753
the O 0 0.010673406533896923
diseases O 1 0.9985175728797913
. O 0 0.01682489737868309
. O 0 0.02070675790309906

Genetic O 0 0.09245819598436356
basis O 0 0.023006025701761246
and O 0 0.015423929318785667
molecular O 0 0.049768831580877304
mechanism O 0 0.1184026226401329
for O 0 0.03811345621943474
idiopathic B-Disease 1 0.9999949932098389
ventricular I-Disease 1 0.999969482421875
fibrillation I-Disease 1 0.9999794960021973
. O 0 0.062086764723062515

Ventricular B-Disease 1 0.999921441078186
fibrillation I-Disease 1 0.9999619722366333
causes O 1 0.8164312839508057
more O 0 0.010676831938326359
than O 0 0.009718869812786579
300 O 0 0.014796885661780834
, O 0 0.00951316673308611
000 O 0 0.027693796902894974
sudden O 0 0.23235353827476501
deaths O 0 0.024946656078100204
each O 0 0.005765561014413834
year O 0 0.006008167285472155
in O 0 0.0053724683821201324
the O 0 0.007045884616672993
USA O 0 0.028888104483485222
alone O 0 0.024248119443655014
. O 0 0.02047095261514187

In O 0 0.016924558207392693
approximately O 0 0.018178068101406097
5 O 0 0.013441817834973335
- O 0 0.020668528974056244
12 O 0 0.009186740964651108
% O 0 0.006273022852838039
of O 0 0.003443952649831772
these O 0 0.003983283415436745
cases O 0 0.008271136321127415
, O 0 0.003820764599367976
there O 0 0.003645668039098382
are O 0 0.0034544849768280983
no O 0 0.007743412163108587
demonstrable O 1 0.9877477884292603
cardiac O 1 0.9998669624328613
or O 0 0.01602146215736866
non O 0 0.33566203713417053
- O 1 0.9919840693473816
cardiac O 1 0.9999502897262573
causes O 1 0.5373886823654175
to O 0 0.004750309512019157
account O 0 0.005327667109668255
for O 0 0.003030700609087944
the O 0 0.004349750000983477
episode O 0 0.008911577984690666
, O 0 0.00407872861251235
which O 0 0.004472051281481981
is O 0 0.005649569910019636
therefore O 0 0.00901742372661829
classified O 0 0.02167903631925583
as O 0 0.02047552354633808
idiopathic B-Disease 1 0.999995231628418
ventricular I-Disease 1 0.9999898672103882
fibrillation I-Disease 1 0.999997615814209
( O 1 0.633806049823761
IVF B-Disease 1 0.999151349067688
) O 0 0.04451329633593559
. O 0 0.034458789974451065

A O 0 0.030655445531010628
distinct O 0 0.03248091787099838
group O 0 0.0241885706782341
of O 0 0.015562600456178188
IVF B-Disease 1 0.9998435974121094
patients O 1 0.9969329833984375
has O 0 0.00686181103810668
been O 0 0.004682615865021944
found O 0 0.0040474142879247665
to O 0 0.0030183768831193447
present O 0 0.0051544178277254105
with O 0 0.005906402133405209
a O 0 0.010283785872161388
characteristic O 0 0.03887127339839935
electrocardiographic O 1 0.6220932602882385
pattern O 0 0.07418223470449448
. O 0 0.033128079026937485

Because O 0 0.01657884381711483
of O 0 0.006476095877587795
the O 0 0.00515843415632844
small O 0 0.006933534052222967
size O 0 0.00707637844607234
of O 0 0.003923539537936449
most O 0 0.005043312907218933
pedigrees O 0 0.022113783285021782
and O 0 0.004591779783368111
the O 0 0.005899210926145315
high O 0 0.012983798049390316
incidence O 1 0.9708040356636047
of O 0 0.008141850121319294
sudden B-Disease 1 0.5901634693145752
death I-Disease 0 0.015170051716268063
, O 0 0.005851519759744406
however O 0 0.00728161446750164
, O 0 0.007216894067823887
molecular O 0 0.02098723128437996
genetic O 0 0.031725626438856125
studies O 0 0.014239207841455936
of O 0 0.006788684520870447
IVF B-Disease 1 0.992787778377533
have O 0 0.006033528130501509
not O 0 0.004674096591770649
yet O 0 0.006566551048308611
been O 0 0.006873480975627899
done O 0 0.012195482850074768
. O 0 0.01506687980145216

Because O 1 0.5565846562385559
IVF B-Disease 1 0.9999068975448608
causes O 1 0.9995070695877075
cardiac O 1 0.9999167919158936
rhythm O 1 0.7821063995361328
disturbance O 1 0.6999754309654236
, O 0 0.01217648945748806
we O 0 0.008453665301203728
investigated O 0 0.021071618422865868
whether O 0 0.013468085788190365
malfunction O 0 0.14100182056427002
of O 0 0.009813588112592697
ion O 0 0.04286327585577965
channels O 0 0.021671723574399948
could O 0 0.011821344494819641
cause O 0 0.0727408155798912
the O 0 0.010840101167559624
disorder O 1 0.998957633972168
by O 0 0.01078842394053936
studying O 0 0.02068614587187767
mutations O 0 0.13098908960819244
in O 0 0.012250213883817196
the O 0 0.016110001131892204
cardiac O 1 0.9989380240440369
sodium O 0 0.26901179552078247
channel O 0 0.049988530576229095
gene O 0 0.15467321872711182
SCN5A O 1 0.6743305325508118
. O 0 0.03684219717979431

We O 0 0.016130873933434486
have O 0 0.009403390809893608
now O 0 0.010427397675812244
identified O 0 0.014176164753735065
a O 0 0.012262891046702862
missense O 0 0.3213673233985901
mutation O 0 0.3099574148654938
, O 0 0.011157647706568241
a O 0 0.013713822700083256
splice O 0 0.47548091411590576
- O 1 0.7029617428779602
donor O 1 0.7192251682281494
mutation O 1 0.6880346536636353
, O 0 0.010561914183199406
and O 0 0.008096359670162201
a O 0 0.013836685568094254
frameshift O 1 0.88276207447052
mutation O 0 0.13945595920085907
in O 0 0.008535726927220821
the O 0 0.009178373962640762
coding O 0 0.03971080109477043
region O 0 0.019167281687259674
of O 0 0.008298996835947037
SCN5A O 0 0.13664470613002777
in O 0 0.009114404208958149
three O 0 0.014333472587168217
IVF B-Disease 1 0.997596800327301
families O 0 0.03186190128326416
. O 0 0.024974552914500237

We O 0 0.01990719512104988
show O 0 0.01738506183028221
that O 0 0.0091813700273633
sodium O 0 0.030500318855047226
channels O 0 0.017257459461688995
with O 0 0.00801779329776764
the O 0 0.012690065428614616
missense O 1 0.8758177757263184
mutation O 1 0.9328065514564514
recover O 0 0.24517963826656342
from O 0 0.014673972502350807
inactivation O 0 0.06770706176757812
more O 0 0.008267124183475971
rapidly O 0 0.014729713089764118
than O 0 0.0056726206094026566
normal O 0 0.010585110634565353
and O 0 0.004187929444015026
that O 0 0.005008691921830177
the O 0 0.009503910318017006
frameshift O 1 0.9826734066009521
mutation O 1 0.9157888889312744
causes O 0 0.1618044376373291
the O 0 0.01064328197389841
sodium O 0 0.034691523760557175
channel O 0 0.01648562401533127
to O 0 0.006071208510547876
be O 0 0.005554724484682083
non O 0 0.01754220388829708
- O 0 0.041070789098739624
functional O 0 0.0408727191388607
. O 0 0.028089120984077454

Our O 0 0.03061678819358349
results O 0 0.02643454447388649
indicate O 0 0.0232757106423378
that O 0 0.011725190095603466
mutations O 0 0.380449116230011
in O 0 0.01639443449676037
cardiac O 1 0.9994163513183594
ion O 0 0.17196466028690338
- O 0 0.0433807373046875
channel O 0 0.026381375268101692
genes O 0 0.03206022083759308
contribute O 0 0.018123939633369446
to O 0 0.005200003273785114
the O 0 0.006250711623579264
risk O 0 0.040724463760852814
of O 0 0.008883252739906311
developing O 0 0.039205413311719894
IVF B-Disease 1 0.9974058270454407
. O 0 0.019535034894943237
. O 0 0.025589967146515846

Molecular O 0 0.11086967587471008
heterogeneity O 0 0.11249403655529022
in O 0 0.024303695186972618
mucopolysaccharidosis B-Disease 1 0.5154385566711426
IVA I-Disease 1 0.8624321222305298
in O 0 0.009024099446833134
Australia O 0 0.00927258562296629
and O 0 0.005119360983371735
Northern O 0 0.011416138149797916
Ireland O 0 0.01252096239477396
: O 0 0.009199211373925209
nine O 0 0.010729219764471054
novel O 0 0.018208535388112068
mutations O 0 0.06583923101425171
including O 0 0.01113506406545639
T312S O 0 0.04857432842254639
, O 0 0.008330396376550198
a O 0 0.009239534847438335
common O 0 0.017535662278532982
allele O 0 0.07765431702136993
that O 0 0.01133780274540186
confers O 0 0.14996293187141418
a O 0 0.022643910720944405
mild O 1 0.9847967624664307
phenotype O 1 0.9879232048988342
. O 0 0.04141155257821083

Mucopolysaccharidosis B-Disease 1 0.9859787821769714
IVA I-Disease 1 0.996623158454895
( O 0 0.06839606910943985
MPS B-Disease 1 0.5514497756958008
IVA I-Disease 1 0.9982478618621826
) O 0 0.022763855755329132
is O 0 0.012159248813986778
an O 0 0.01710490882396698
autosomal B-Disease 1 0.9999219179153442
recessive I-Disease 1 0.999984622001648
lysosomal I-Disease 1 0.9999494552612305
storage I-Disease 1 0.987987220287323
disorder I-Disease 1 0.9999784231185913
caused O 1 0.5132413506507874
by O 0 0.012395302765071392
a O 0 0.016377680003643036
genetic B-Disease 1 0.7431610822677612
defect I-Disease 1 0.9927661418914795
in O 0 0.01614270731806755
N O 0 0.08283913135528564
- O 1 0.6186447143554688
acetylgalactosamine O 1 0.9468910098075867
- O 1 0.7974070310592651
6 O 0 0.06037849932909012
- O 1 0.9863227605819702
sulfate O 1 0.9995906949043274
sulfatase O 1 0.9993945360183716
( O 0 0.04973168671131134
GALNS O 1 0.7856614589691162
) O 0 0.03121570684015751
. O 0 0.02737589366734028

Previous O 0 0.029410135000944138
studies O 0 0.023834483698010445
of O 0 0.009883774444460869
patients O 1 0.7750840783119202
from O 0 0.00806916318833828
a O 0 0.008510498329997063
British O 0 0.012762797996401787
- O 0 0.02521562948822975
Irish O 0 0.015400447882711887
population O 0 0.01100845541805029
showed O 0 0.010536312125623226
that O 0 0.0053155370987951756
the O 0 0.00759606808423996
I113F O 0 0.11431430280208588
mutation O 0 0.0706101730465889
is O 0 0.006279103923588991
the O 0 0.004525105468928814
most O 0 0.005908206570893526
common O 0 0.012593460269272327
single O 0 0.01706426404416561
mutation O 1 0.8464546203613281
among O 0 0.023113476112484932
MPS B-Disease 1 0.949417233467102
IVA I-Disease 1 0.999956488609314
patients O 1 0.9994102716445923
and O 0 0.014206689782440662
produces O 0 0.047294605523347855
a O 0 0.02411852777004242
severe O 1 0.9989438652992249
clinical O 1 0.994838535785675
phenotype O 1 0.9955558180809021
. O 0 0.04696926102042198

We O 0 0.027827389538288116
studied O 0 0.02875998243689537
mutations O 0 0.06366131454706192
in O 0 0.010057942010462284
the O 0 0.011622247286140919
GALNS O 0 0.24162663519382477
gene O 0 0.04415079951286316
from O 0 0.01138436608016491
23 O 0 0.016452118754386902
additional O 0 0.01911204494535923
MPS B-Disease 1 0.5372634530067444
IVA I-Disease 1 0.9998082518577576
patients O 1 0.9979416728019714
( O 0 0.012829557992517948
15 O 0 0.008479380048811436
from O 0 0.004857583902776241
Australia O 0 0.0054160719737410545
, O 0 0.0038563706912100315
8 O 0 0.006055006757378578
from O 0 0.0044174096547067165
Northern O 0 0.007271074689924717
Ireland O 0 0.00855568889528513
) O 0 0.006149893160909414
, O 0 0.0034937516320496798
with O 0 0.004097545053809881
various O 0 0.006311357952654362
clinical O 1 0.9727137088775635
phenotypes O 1 0.9961225390434265
( O 0 0.03130015358328819
severe O 1 0.9850106835365295
, O 0 0.006782314274460077
16 O 0 0.0089521249756217
cases O 0 0.01002390868961811
; O 0 0.007590901106595993
intermediate O 0 0.011151500046253204
, O 0 0.005292809102684259
4 O 0 0.008403928950428963
cases O 0 0.012925447896122932
; O 0 0.010551147162914276
mild O 1 0.7805435657501221
, O 0 0.007526140194386244
3 O 0 0.011061713099479675
cases O 0 0.017173826694488525
) O 0 0.014896144159138203
. O 0 0.017923975363373756

We O 0 0.016065843403339386
found O 0 0.01176114846020937
two O 0 0.007704172749072313
common O 0 0.015273185446858406
mutations O 0 0.05763305723667145
that O 0 0.0051552727818489075
together O 0 0.00609564920887351
accounted O 0 0.010657134465873241
for O 0 0.003842819482088089
32 O 0 0.0074384878389537334
% O 0 0.00570513354614377
of O 0 0.0032844480592757463
the O 0 0.005269313231110573
44 O 0 0.013252856209874153
unrelated O 0 0.027802517637610435
alleles O 0 0.39269697666168213
in O 0 0.011797650717198849
these O 0 0.013718441128730774
patients O 1 0.9882408380508423
. O 0 0.028044791892170906

One O 0 0.022308481857180595
is O 0 0.014504043385386467
the O 0 0.013790512457489967
T312S O 0 0.11589052528142929
mutation O 0 0.1465165764093399
, O 0 0.009237811900675297
a O 0 0.009966561570763588
novel O 0 0.021806569769978523
mutation O 0 0.07406172156333923
found O 0 0.01318857166916132
exclusively O 0 0.014893372543156147
in O 0 0.014486182481050491
milder O 1 0.9801729321479797
patients O 1 0.996830403804779
. O 0 0.03307140991091728

The O 0 0.015440600924193859
other O 0 0.007077799178659916
is O 0 0.005677114240825176
the O 0 0.005787933245301247
previously O 0 0.010538866743445396
described O 0 0.015589389950037003
I113F O 0 0.048238880932331085
that O 0 0.01070757769048214
produces O 0 0.029209457337856293
a O 0 0.022697588428854942
severe O 1 0.9852643013000488
phenotype O 1 0.9869197607040405
. O 0 0.043913185596466064

The O 0 0.03621140867471695
I113F O 0 0.09993958473205566
and O 0 0.019853578880429268
T312S O 0 0.14937828481197357
mutations O 0 0.20278926193714142
accounted O 0 0.02275148779153824
for O 0 0.007345085497945547
8 O 0 0.010310621000826359
( O 0 0.008770613931119442
18 O 0 0.007679300382733345
% O 0 0.0073071732185781
) O 0 0.005929483100771904
and O 0 0.00403837114572525
6 O 0 0.006889089476317167
( O 0 0.0066524650901556015
14 O 0 0.006418644916266203
% O 0 0.006510660517960787
) O 0 0.005600951611995697
of O 0 0.003942596726119518
44 O 0 0.013130647130310535
unrelated O 0 0.02583981119096279
alleles O 0 0.1980326622724533
, O 0 0.011914942413568497
respectively O 0 0.02227257378399372
. O 0 0.021431634202599525

The O 0 0.029065364971756935
relatively O 0 0.036451321095228195
high O 0 0.02718731015920639
residual O 0 0.10695425420999527
GALNS O 1 0.505157470703125
activity O 0 0.02970920316874981
seen O 0 0.01630789414048195
when O 0 0.00995924137532711
the O 0 0.01100839301943779
T312S O 0 0.0664505735039711
mutant O 0 0.06057485193014145
cDNA O 0 0.06056060642004013
is O 0 0.01253935880959034
overexpressed O 0 0.067393958568573
in O 0 0.01122506707906723
mutant O 0 0.04418563470244408
cells O 0 0.03672120347619057
provides O 0 0.013760686852037907
an O 0 0.0058993687853217125
explanation O 0 0.010462467558681965
for O 0 0.005305939819663763
the O 0 0.009079119190573692
mild O 1 0.994256317615509
phenotype O 1 0.9967749714851379
in O 0 0.01270416472107172
patients O 1 0.9899048209190369
with O 0 0.01181660033762455
this O 0 0.012992392294108868
mutation O 0 0.25459739565849304
. O 0 0.03304772451519966

The O 0 0.017626678571105003
distribution O 0 0.01715334877371788
and O 0 0.007452300749719143
relative O 0 0.01497301273047924
frequencies O 0 0.013991943560540676
of O 0 0.004962350707501173
the O 0 0.0073079755529761314
I113F O 0 0.04679786413908005
and O 0 0.009981515817344189
T312S O 0 0.07931704819202423
mutations O 0 0.05866266041994095
in O 0 0.006430396344512701
Australia O 0 0.00784994475543499
corresponded O 0 0.01422132272273302
to O 0 0.00463572982698679
those O 0 0.004565868992358446
observed O 0 0.009303241968154907
in O 0 0.00383504549972713
Northern O 0 0.006590567994862795
Ireland O 0 0.006231182254850864
and O 0 0.002711215056478977
are O 0 0.0025020656175911427
unique O 0 0.0038621965795755386
to O 0 0.002436857670545578
these O 0 0.0028742316644638777
two O 0 0.0038027665577828884
populations O 0 0.013837582431733608
, O 0 0.004937172867357731
suggesting O 0 0.009624742902815342
that O 0 0.003974150866270065
both O 0 0.005994883365929127
mutations O 0 0.033855605870485306
were O 0 0.004168607294559479
probably O 0 0.007518745958805084
introduced O 0 0.006487476639449596
to O 0 0.003746401285752654
Australia O 0 0.005183999892324209
by O 0 0.004269778728485107
Irish O 0 0.010048857890069485
migrants O 0 0.013761192560195923
during O 0 0.008582008071243763
the O 0 0.006703126709908247
19th O 0 0.01880999282002449
century O 0 0.020800793543457985
. O 0 0.0204937607049942

Haplotype O 1 0.6934217214584351
analysis O 0 0.03926556184887886
using O 0 0.021087409928441048
6 O 0 0.02110723964869976
RFLPs O 0 0.05027713626623154
provides O 0 0.015700340270996094
additional O 0 0.00865592248737812
data O 0 0.006848459132015705
that O 0 0.004378576297312975
the O 0 0.007007559761404991
I113F O 0 0.08530144393444061
mutation O 0 0.2189953774213791
originated O 0 0.02117687463760376
from O 0 0.009378151036798954
a O 0 0.010255452245473862
common O 0 0.023338066413998604
ancestor O 0 0.05286280810832977
. O 0 0.030201490968465805

The O 0 0.01722283847630024
other O 0 0.013004413805902004
9 O 0 0.018522441387176514
novel O 0 0.022602755576372147
mutations O 0 0.05321992188692093
identified O 0 0.013227052055299282
in O 0 0.0052430653013288975
these O 0 0.004974451847374439
23 O 0 0.009260574355721474
patients O 0 0.301434189081192
were O 0 0.00332548632286489
each O 0 0.0036126612685620785
limited O 0 0.006340408232063055
to O 0 0.0035961917601525784
a O 0 0.0056430804543197155
single O 0 0.011413661763072014
family O 0 0.016488198190927505
. O 0 0.017713012173771858

These O 0 0.014578817412257195
data O 0 0.011585037223994732
provide O 0 0.010189217515289783
further O 0 0.008631463162600994
evidence O 0 0.008834798820316792
for O 0 0.007361983880400658
extensive O 0 0.022476373240351677
allelic O 1 0.513349175453186
heterogeneity O 0 0.08849937468767166
in O 0 0.017521817237138748
MPS B-Disease 0 0.11434181779623032
IVA I-Disease 1 0.9958980679512024
in O 0 0.013411548919975758
British O 0 0.01933470368385315
- O 0 0.16227661073207855
Irish O 0 0.028849128633737564
patients O 1 0.9686141014099121
and O 0 0.005971928592771292
provide O 0 0.006504494231194258
evidence O 0 0.005295199807733297
for O 0 0.002808389952406287
their O 0 0.003601417411118746
transmission O 0 0.01498125959187746
to O 0 0.004450379870831966
Australia O 0 0.005444168113172054
by O 0 0.00528902979567647
British O 0 0.012097877450287342
- O 0 0.027734892442822456
Irish O 0 0.022162068635225296
migrants O 0 0.02492302656173706
. O 0 0.014127600006759167
. O 0 0.021318020299077034

Identification O 0 0.05547461286187172
of O 0 0.021922655403614044
constitutional O 0 0.034468211233615875
WT1 O 1 0.9978471994400024
mutations O 1 0.9414804577827454
, O 0 0.013764298520982265
in O 0 0.011089863255620003
patients O 1 0.998664379119873
with O 0 0.019343845546245575
isolated O 1 0.9901418089866638
diffuse B-Disease 1 0.9999194145202637
mesangial I-Disease 1 0.9999978542327881
sclerosis I-Disease 1 0.9999988079071045
, O 0 0.013771187514066696
and O 0 0.008124593645334244
analysis O 0 0.012657742016017437
of O 0 0.009499176405370235
genotype O 1 0.9954802989959717
/ O 1 0.9842139482498169
phenotype O 1 0.9516119956970215
correlations O 0 0.03623811900615692
by O 0 0.007666629273444414
use O 0 0.007965045981109142
of O 0 0.0063413879834115505
a O 0 0.012423345819115639
computerized O 0 0.05687672644853592
mutation O 0 0.21299341320991516
database O 0 0.04006575047969818
. O 0 0.03047332912683487

Constitutional O 0 0.05798414349555969
mutations O 0 0.11443684995174408
of O 0 0.01582409255206585
the O 0 0.01611647941172123
WT1 O 1 0.9754801988601685
gene O 0 0.06264706701040268
, O 0 0.0128360316157341
encoding O 0 0.028892353177070618
a O 0 0.01584991253912449
zinc O 1 0.8473826050758362
- O 0 0.2054852545261383
finger O 0 0.24617233872413635
transcription O 0 0.07260176539421082
factor O 0 0.03816425800323486
involved O 0 0.018736254423856735
in O 0 0.014949704520404339
renal O 1 0.9999799728393555
and O 0 0.01340478751808405
gonadal O 1 0.9991893172264099
development O 0 0.01228500995784998
, O 0 0.004940256010740995
are O 0 0.0033161479514092207
found O 0 0.004595318343490362
in O 0 0.004082922823727131
most O 0 0.006701529026031494
patients O 1 0.9945117235183716
with O 0 0.016538845375180244
Denys B-Disease 1 0.9998390674591064
- I-Disease 1 0.9998100399971008
Drash I-Disease 1 0.9999562501907349
syndrome I-Disease 1 0.9999997615814209
( O 1 0.67266446352005
DDS B-Disease 1 0.9998990297317505
) O 0 0.02359519526362419
, O 0 0.013003538362681866
or O 0 0.04810315743088722
diffuse B-Disease 1 0.9998687505722046
mesangial I-Disease 1 0.9999977350234985
sclerosis I-Disease 1 0.9999998807907104
( O 1 0.8200166821479797
DMS B-Disease 1 0.9997074007987976
) O 0 0.020101869478821754
associated O 0 0.016811244189739227
with O 0 0.011468262411653996
pseudohermaphroditism B-Disease 1 0.9912080764770508
and O 0 0.017675533890724182
/ O 1 0.9927805066108704
or O 0 0.06937281787395477
Wilms B-Disease 1 0.9999502897262573
tumor I-Disease 1 0.9998986721038818
( O 0 0.11954860389232635
WT B-Disease 1 0.9972820281982422
) O 0 0.029628761112689972
. O 0 0.025329869240522385

Most O 0 0.0512470006942749
mutations O 1 0.8044766783714294
in O 0 0.03552611917257309
DDS B-Disease 1 0.9997468590736389
patients O 1 0.9981383085250854
lie O 0 0.040105585008859634
in O 0 0.015727709978818893
exon O 0 0.06822716444730759
8 O 0 0.021753933280706406
or O 0 0.015201485715806484
exon O 0 0.050992462784051895
9 O 0 0.017863156273961067
, O 0 0.011501001194119453
encoding O 0 0.032501254230737686
zinc O 0 0.4747852385044098
finger O 0 0.06268984824419022
2 O 0 0.017245685681700706
or O 0 0.014535510912537575
zinc O 1 0.5796756744384766
finger O 0 0.03746107593178749
3 O 0 0.009990490972995758
, O 0 0.004877044353634119
respectively O 0 0.006421403028070927
, O 0 0.0036520406138151884
with O 0 0.004208336118608713
a O 0 0.006521421018987894
hot O 0 0.016989529132843018
spot O 0 0.017104042693972588
( O 0 0.014217392541468143
R394W O 0 0.04347808659076691
) O 0 0.012090379372239113
in O 0 0.010553386993706226
exon O 0 0.05928603559732437
9 O 0 0.030856559053063393
. O 0 0.028622055426239967

We O 0 0.022056052461266518
analyzed O 0 0.028317749500274658
a O 0 0.01181920524686575
series O 0 0.013689838349819183
of O 0 0.0070799775421619415
24 O 0 0.01411423645913601
patients O 1 0.8144367337226868
, O 0 0.007255059666931629
10 O 0 0.008692885749042034
with O 0 0.00956722628325224
isolated B-Disease 0 0.1635456085205078
DMS I-Disease 1 0.9994838237762451
( O 0 0.02938351407647133
IDMS B-Disease 1 0.995644211769104
) O 0 0.011701530776917934
, O 0 0.006517832167446613
10 O 0 0.007886114530265331
with O 0 0.008239011280238628
DDS B-Disease 1 0.9973700046539307
, O 0 0.006848783232271671
and O 0 0.005656248889863491
4 O 0 0.012060413137078285
with O 0 0.012534776702523232
urogenital B-Disease 1 0.9989619255065918
abnormalities I-Disease 1 0.9989991784095764
and O 0 0.017096828669309616
/ O 1 0.9724352955818176
or O 0 0.02844819612801075
WT B-Disease 1 0.9965288043022156
. O 0 0.034333448857069016

We O 0 0.034577976912260056
report O 0 0.04036669060587883
WT1 O 1 0.9798181056976318
heterozygous O 0 0.330234557390213
mutations O 0 0.4259539246559143
in O 0 0.013186442665755749
16 O 0 0.016032645478844643
patients O 1 0.9438058733940125
, O 0 0.006850537844002247
4 O 0 0.0076775564812123775
of O 0 0.004509544465690851
whom O 0 0.011893988586962223
presented O 0 0.014051703736186028
with O 0 0.017740046605467796
IDMS B-Disease 1 0.9890493154525757
. O 0 0.03780962899327278

One O 0 0.022728603333234787
male O 0 0.032114993780851364
and O 0 0.01057580579072237
two O 0 0.013390895910561085
female O 0 0.06405137479305267
IDMS B-Disease 1 0.9998329877853394
patients O 1 0.9995669722557068
with O 0 0.037711020559072495
WT1 O 1 0.9996261596679688
mutations O 1 0.9968550205230713
underwent O 1 0.985566258430481
normal O 0 0.11525071412324905
puberty O 1 0.9775386452674866
. O 0 0.043372564017772675

Two O 0 0.03656119480729103
mutations O 1 0.5265035033226013
associated O 0 0.026806052774190903
with O 0 0.014303215779364109
IDMS B-Disease 1 0.9820497632026672
are O 0 0.007032016292214394
different O 0 0.006939229555428028
from O 0 0.006856718100607395
those O 0 0.00849179271608591
described O 0 0.018197307363152504
in O 0 0.016925152391195297
DDS B-Disease 1 0.999875545501709
patients O 1 0.9987712502479553
. O 0 0.0348503515124321

No O 0 0.06330787390470505
WT1 O 1 0.9915698766708374
mutations O 0 0.39535537362098694
were O 0 0.014233173802495003
detected O 0 0.02959090657532215
in O 0 0.006670545320957899
the O 0 0.0063586910255253315
six O 0 0.009685572236776352
other O 0 0.011275362223386765
IDMS B-Disease 1 0.9998868703842163
patients O 1 0.9993298053741455
, O 0 0.012998510152101517
suggesting O 0 0.02743394300341606
genetic O 0 0.19090136885643005
heterogeneity O 0 0.17478047311306
of O 0 0.012327244505286217
this O 0 0.016700146719813347
disease O 1 0.9994531273841858
. O 0 0.029408670961856842

We O 0 0.04122410714626312
analyzed O 0 0.07691528648138046
genotype O 1 0.989816427230835
/ O 1 0.9864180088043213
phenotype O 1 0.9287606477737427
correlations O 0 0.03918559104204178
, O 0 0.005842729937285185
on O 0 0.003508227411657572
the O 0 0.0028441387694329023
basis O 0 0.003910577856004238
of O 0 0.003035049419850111
the O 0 0.003621055744588375
constitution O 0 0.005998777691274881
of O 0 0.005522226449102163
a O 0 0.012882707640528679
WT1 O 1 0.9875081181526184
mutation O 0 0.22316239774227142
database O 0 0.018735941499471664
of O 0 0.007375233806669712
84 O 0 0.03162498027086258
germ O 1 0.9944888353347778
- O 0 0.13424821197986603
line O 0 0.020166659727692604
mutations O 0 0.10424376279115677
, O 0 0.007174881175160408
to O 0 0.00497544277459383
compare O 0 0.013989333063364029
the O 0 0.004508426878601313
distribution O 0 0.008203022181987762
and O 0 0.004776827525347471
type O 0 0.01346690021455288
of O 0 0.005595245398581028
mutations O 0 0.04544549435377121
, O 0 0.004777602385729551
according O 0 0.004908950068056583
to O 0 0.004237104207277298
the O 0 0.006357049103826284
different O 0 0.0110398568212986
symptoms O 1 0.9987267851829529
. O 0 0.02842891216278076

This O 0 0.020102476701140404
demonstrated O 0 0.025642134249210358
( O 0 0.012563427910208702
1 O 0 0.009273855946958065
) O 0 0.006818021181970835
the O 0 0.004778395406901836
association O 0 0.013673531822860241
between O 0 0.01071429904550314
mutations O 0 0.04768022894859314
in O 0 0.008021227084100246
exons O 0 0.03303651511669159
8 O 0 0.011923771351575851
and O 0 0.004990554414689541
9 O 0 0.0096596609801054
and O 0 0.007497888058423996
DMS B-Disease 1 0.9961917400360107
; O 0 0.011468066833913326
( O 0 0.009458360262215137
2 O 0 0.008843650110065937
) O 0 0.00892592966556549
among O 0 0.00921295490115881
patients O 1 0.9720160365104675
with O 0 0.009249292314052582
DMS B-Disease 1 0.992548942565918
, O 0 0.005874386988580227
a O 0 0.006563875824213028
higher O 0 0.010035925544798374
frequency O 0 0.018447643145918846
of O 0 0.006703224964439869
exon O 0 0.048423200845718384
8 O 0 0.023889217525720596
mutations O 0 0.14572899043560028
among O 0 0.015419360250234604
46 O 0 0.027860043570399284
, O 0 0.01621783711016178
XY O 1 0.9989199638366699
patients O 1 0.9931055903434753
with O 0 0.01251139584928751
female O 0 0.027017826214432716
phenotype O 1 0.7507206201553345
than O 0 0.009894288145005703
among O 0 0.01106149423867464
46 O 0 0.019184552133083344
, O 0 0.013081775978207588
XY O 1 0.9996398687362671
patients O 1 0.9975311160087585
with O 0 0.009806057438254356
sexual O 0 0.025231696665287018
ambiguity O 0 0.030165867879986763
or O 0 0.015250089578330517
male O 0 0.05785229429602623
phenotype O 1 0.9886437654495239
; O 0 0.0114615922793746
and O 0 0.0060538738034665585
( O 0 0.008604729548096657
3 O 0 0.008757516741752625
) O 0 0.007761586923152208
statistically O 0 0.01400025561451912
significant O 0 0.008430722169578075
evidence O 0 0.006776002701371908
that O 0 0.005502232816070318
mutations O 0 0.03595984727144241
in O 0 0.007592460140585899
exons O 0 0.03428126871585846
8 O 0 0.01180900726467371
and O 0 0.006240363232791424
9 O 0 0.013104911893606186
preferentially O 0 0.03459969535470009
affect O 0 0.022644538432359695
amino O 0 0.022570373490452766
acids O 0 0.018932148814201355
with O 0 0.006456765811890364
different O 0 0.006853160448372364
functions O 0 0.010501014068722725
. O 0 0.010499073192477226
. O 0 0.01734003983438015

The O 0 0.058754000812768936
185delAG O 1 0.7285226583480835
BRCA1 O 1 0.9957584738731384
mutation O 1 0.7170342803001404
originated O 0 0.03540332615375519
before O 0 0.009770211763679981
the O 0 0.006478520575910807
dispersion O 0 0.02386951632797718
of O 0 0.00461511081084609
Jews O 0 0.007800971623510122
in O 0 0.004533387254923582
the O 0 0.004775544162839651
diaspora O 0 0.016331790015101433
and O 0 0.0046579171903431416
is O 0 0.004250173456966877
not O 0 0.004551868420094252
limited O 0 0.008847136981785297
to O 0 0.009873643517494202
Ashkenazim O 0 0.22705107927322388
. O 0 0.030106719583272934

The O 0 0.039937809109687805
185delAG O 0 0.33162325620651245
mutation O 0 0.46703988313674927
in O 0 0.017679674550890923
BRCA1 O 1 0.991540253162384
is O 0 0.013540535233914852
detected O 0 0.030625376850366592
in O 0 0.008007053285837173
Ashkenazi O 0 0.04870719462633133
Jews O 0 0.012014605104923248
both O 0 0.00844542682170868
in O 0 0.013583306223154068
familial B-Disease 1 0.9999873638153076
breast I-Disease 1 0.9999991655349731
and I-Disease 1 0.9476898908615112
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999842643737793
and O 0 0.008505051024258137
in O 0 0.005935529712587595
the O 0 0.005972488783299923
general O 0 0.012240721844136715
population O 0 0.022626809775829315
. O 0 0.022339824587106705

All O 0 0.03437118977308273
tested O 0 0.07308309525251389
Ashkenazi O 0 0.48082324862480164
mutation O 1 0.7190637588500977
carriers O 0 0.05256945267319679
share O 0 0.019805097952485085
the O 0 0.008769727312028408
same O 0 0.012562647461891174
allelic O 0 0.2702633738517761
pattern O 0 0.04361816123127937
at O 0 0.017744101583957672
the O 0 0.01821669563651085
BRCA1 O 1 0.9824328422546387
locus O 0 0.20456285774707794
. O 0 0.041266150772571564

Our O 0 0.023160692304372787
previous O 0 0.020795656368136406
study O 0 0.016312697902321815
showed O 0 0.015268410556018353
that O 0 0.0060548726469278336
this O 0 0.007337881717830896
Ashkenazi O 0 0.12398573011159897
mutation O 0 0.4231496751308441
also O 0 0.008596910163760185
occurs O 0 0.017232131212949753
in O 0 0.005384746473282576
Iraqi O 0 0.010616118088364601
Jews O 0 0.009606984443962574
with O 0 0.006088304333388805
a O 0 0.009598386473953724
similar O 0 0.017073748633265495
allelic O 1 0.7069175839424133
pattern O 0 0.0771215632557869
. O 0 0.035985153168439865

We O 0 0.017680883407592773
extended O 0 0.019634118303656578
our O 0 0.008468590676784515
analysis O 0 0.010421918705105782
to O 0 0.005584441125392914
other O 0 0.0057852002792060375
non O 0 0.019316358491778374
- O 0 0.03941088169813156
Ashkenazi O 0 0.0696379691362381
subsets O 0 0.04607535898685455
354 O 0 0.04375877231359482
of O 0 0.009711125865578651
Moroccan O 0 0.027341023087501526
origin O 0 0.014283006079494953
, O 0 0.008564130403101444
200 O 0 0.014447079040110111
Yemenites O 0 0.0648672878742218
and O 0 0.00888197310268879
150 O 0 0.01803290657699108
Iranian O 0 0.01850380375981331
Jews O 0 0.025678245350718498
. O 0 0.024954766035079956

Heteroduplex O 0 0.20060597360134125
analysis O 0 0.04451459273695946
complemented O 0 0.03990471735596657
by O 0 0.014073045924305916
direct O 0 0.02097015455365181
DNA O 0 0.03164155036211014
sequencing O 0 0.03930848836898804
of O 0 0.01092582382261753
abnormally O 0 0.09742709994316101
migrating O 0 0.048877570778131485
bands O 0 0.0291257556527853
were O 0 0.011396104469895363
employed O 0 0.026409342885017395
. O 0 0.023427261039614677

Four O 0 0.019610382616519928
of O 0 0.011297604069113731
Moroccan O 0 0.026989920064806938
origin O 0 0.013194269500672817
( O 0 0.009472175501286983
1 O 0 0.006778005510568619
. O 0 0.00396013492718339
1 O 0 0.00547316949814558
% O 0 0.005555164534598589
) O 0 0.004788418300449848
and O 0 0.0027698257472366095
none O 0 0.005489922594279051
of O 0 0.0030032719951123
the O 0 0.004298004321753979
Yemenites O 0 0.08340856432914734
or O 0 0.009185617789626122
Iranians O 0 0.012090361677110195
was O 0 0.005270992871373892
a O 0 0.0067724441178143024
carrier O 0 0.022846590727567673
of O 0 0.00848462525755167
the O 0 0.013579051941633224
185delAG O 0 0.40159961581230164
mutation O 1 0.6467354893684387
. O 0 0.03231735900044441

BRCA1 O 1 0.9969969987869263
allelic O 1 0.8767090439796448
patterns O 0 0.04325847700238228
were O 0 0.008470756933093071
determined O 0 0.010973743163049221
for O 0 0.0033066533505916595
four O 0 0.003376999171450734
of O 0 0.0029123080894351006
these O 0 0.0031315546948462725
individuals O 0 0.005947323981672525
and O 0 0.003276810050010681
for O 0 0.003772919764742255
12 O 0 0.007303237449377775
additional O 0 0.009193598292768002
non O 0 0.020235631614923477
- O 0 0.20943979918956757
Ashkenazi O 1 0.8755477666854858
185delAG O 1 0.9800364375114441
mutation O 1 0.9944087862968445
carriers O 1 0.9144836664199829
who O 0 0.07897990942001343
had O 1 0.7500689625740051
breast B-Disease 1 0.9999992847442627
/ I-Disease 1 0.9999940395355225
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999929666519165
. O 0 0.056494127959012985

Six O 0 0.04199305921792984
non O 0 0.04215369001030922
- O 0 0.0686533972620964
Ashkenazi O 0 0.09979354590177536
individuals O 0 0.01762077398598194
shared O 0 0.015618989244103432
the O 0 0.008281370624899864
common O 0 0.019531771540641785
Ashkenazi O 0 0.48299288749694824
haplotype O 1 0.8665509223937988
, O 0 0.007115177344530821
four O 0 0.0050713540986180305
had O 0 0.0050618587993085384
a O 0 0.005198952741920948
closely O 0 0.00814921222627163
related O 0 0.011332465335726738
pattern O 0 0.017297152429819107
, O 0 0.0049931081011891365
and O 0 0.0036450272891670465
the O 0 0.0039033677894622087
rest O 0 0.010020786896348
( O 0 0.012366719543933868
n O 0 0.021577991545200348
= O 0 0.03205869346857071
6 O 0 0.012768164277076721
) O 0 0.008462662808597088
displayed O 0 0.011900383979082108
a O 0 0.01226923055946827
distinct O 0 0.03524891287088394
BRCA1 O 1 0.9953083395957947
allelic O 1 0.9744375944137573
pattern O 0 0.14030683040618896
. O 0 0.038225218653678894

We O 0 0.021153511479496956
conclude O 0 0.032536882907152176
that O 0 0.010833082720637321
the O 0 0.014402078464627266
185delAG O 1 0.7919725179672241
BRCA1 O 1 0.9990100860595703
mutation O 1 0.9814090728759766
occurs O 0 0.03324341028928757
in O 0 0.007185823284089565
some O 0 0.007334277965128422
non O 0 0.018279748037457466
- O 0 0.10841634124517441
Ashkenazi O 0 0.35870805382728577
populations O 0 0.04014759510755539
at O 0 0.012312221340835094
rates O 0 0.018063539639115334
comparable O 0 0.018096234649419785
with O 0 0.0065750852227211
that O 0 0.006907990667968988
of O 0 0.011903210543096066
Ashkenazim O 0 0.4027242660522461
. O 0 0.03048965334892273

The O 0 0.020920997485518456
majority O 0 0.025202201679348946
of O 0 0.012505154125392437
Jewish O 0 0.03357197344303131
185delAG O 1 0.779363214969635
mutation O 1 0.8445267081260681
carriers O 0 0.05572960525751114
have O 0 0.009636832401156425
a O 0 0.010698813013732433
common O 0 0.01951930671930313
allelic O 1 0.6760941743850708
pattern O 0 0.03657384216785431
, O 0 0.008201955817639828
supporting O 0 0.011277839541435242
the O 0 0.00643598847091198
founder O 0 0.0185202918946743
effect O 0 0.016173945739865303
notion O 0 0.011886011809110641
, O 0 0.0049840305000543594
but O 0 0.004564919043332338
dating O 0 0.009084474295377731
the O 0 0.0053509860299527645
mutations O 0 0.03173278272151947
origin O 0 0.009220924228429794
to O 0 0.004819707944989204
an O 0 0.004436586517840624
earlier O 0 0.0074355024844408035
date O 0 0.008496459573507309
than O 0 0.006555777974426746
currently O 0 0.01002824492752552
estimated O 0 0.020520128309726715
. O 0 0.01860484853386879

However O 0 0.0197390578687191
, O 0 0.010632578283548355
the O 0 0.007698036264628172
different O 0 0.010409798473119736
allelic O 0 0.10377469658851624
pattern O 0 0.03531233221292496
at O 0 0.012012387625873089
the O 0 0.01054345816373825
BRCA1 O 1 0.9752124547958374
locus O 0 0.06531158834695816
even O 0 0.010784480720758438
in O 0 0.006089169532060623
some O 0 0.006261402741074562
Jewish O 0 0.01689586043357849
mutation O 1 0.8822333216667175
carriers O 0 0.11805832386016846
, O 0 0.007532275747507811
might O 0 0.01073658186942339
suggest O 0 0.012878195382654667
that O 0 0.0057915388606488705
the O 0 0.00759748462587595
mutation O 0 0.12532317638397217
arose O 0 0.028143687173724174
independently O 0 0.01739910989999771
. O 0 0.0132910730317235
. O 0 0.020447978749871254

Crystal O 0 0.06848671287298203
structure O 0 0.02483864314854145
of O 0 0.011926636099815369
the O 0 0.018023408949375153
hemochromatosis B-Disease 1 0.9998729228973389
protein O 0 0.0787949189543724
HFE O 1 0.9189742207527161
and O 0 0.012020867317914963
characterization O 0 0.024652594700455666
of O 0 0.006685240659862757
its O 0 0.00928163155913353
interaction O 0 0.024262581020593643
with O 0 0.01883033663034439
transferrin O 1 0.7863515615463257
receptor O 0 0.32346904277801514
. O 0 0.037242915481328964

HFE O 1 0.9114893674850464
is O 0 0.028100626543164253
an O 0 0.01992846094071865
MHC O 1 0.9833626747131348
- O 0 0.09713370352983475
related O 0 0.022648576647043228
protein O 0 0.02357083559036255
that O 0 0.005815976765006781
is O 0 0.00601839879527688
mutated O 0 0.03572181984782219
in O 0 0.008737883530557156
the O 0 0.011275818571448326
iron B-Disease 1 0.9822725057601929
- I-Disease 1 0.9996009469032288
overload I-Disease 1 0.9999517202377319
disease I-Disease 1 0.9999972581863403
hereditary B-Disease 1 0.9999680519104004
hemochromatosis I-Disease 1 0.9999945163726807
. O 0 0.07081020623445511

HFE O 1 0.9560316801071167
binds O 0 0.13790741562843323
to O 0 0.03869613632559776
transferrin O 1 0.8495070934295654
receptor O 1 0.6553851366043091
( O 0 0.03722139447927475
TfR O 1 0.9058050513267517
) O 0 0.016039950773119926
and O 0 0.007687701378017664
reduces O 0 0.02965070679783821
its O 0 0.008116251789033413
affinity O 0 0.02456735633313656
for O 0 0.007480195723474026
iron O 0 0.027790237218141556
- O 0 0.04185700789093971
loaded O 0 0.03113657794892788
transferrin O 0 0.3938245475292206
, O 0 0.01863935962319374
implicating O 0 0.1301501840353012
HFE O 1 0.9632644653320312
in O 0 0.02333117090165615
iron O 0 0.06248817965388298
metabolism O 0 0.18998019397258759
. O 0 0.04046083986759186

The O 0 0.03261078894138336
2 O 0 0.042148757725954056
. O 0 0.033627551048994064

6 O 0 0.033317286521196365
A O 0 0.021564781665802002
crystal O 0 0.03246499225497246
structure O 0 0.018044330179691315
of O 0 0.01087524276226759
HFE O 1 0.91805499792099
reveals O 0 0.03605151176452637
the O 0 0.01145430188626051
locations O 0 0.01888270676136017
of O 0 0.012948288582265377
hemochromatosis B-Disease 1 0.9999511241912842
mutations O 1 0.8241820335388184
and O 0 0.009302350692451
a O 0 0.009497278369963169
patch O 0 0.35790717601776123
of O 0 0.008216695860028267
histidines O 0 0.07127560675144196
that O 0 0.004416700452566147
could O 0 0.00485058082267642
be O 0 0.003852437948808074
involved O 0 0.008099689148366451
in O 0 0.008277385495603085
pH O 0 0.4957967698574066
- O 0 0.057986967265605927
dependent O 0 0.04431450366973877
interactions O 0 0.0487472303211689
. O 0 0.029276229441165924

We O 0 0.02020910196006298
also O 0 0.01227650698274374
demonstrate O 0 0.022870266810059547
that O 0 0.012244757264852524
soluble O 0 0.09689205884933472
TfR O 1 0.9551350474357605
and O 0 0.015309803187847137
HFE O 1 0.9718706011772156
bind O 0 0.043494220823049545
tightly O 0 0.021794799715280533
at O 0 0.007162076886743307
the O 0 0.004853039979934692
basic O 0 0.009718627668917179
pH O 0 0.03428144007921219
of O 0 0.0053097158670425415
the O 0 0.005419026594609022
cell O 0 0.019527846947312355
surface O 0 0.010395307093858719
, O 0 0.004601619206368923
but O 0 0.004101648926734924
not O 0 0.0036633743438869715
at O 0 0.005835114978253841
the O 0 0.007200401276350021
acidic O 0 0.062696672976017
pH O 0 0.11488360911607742
of O 0 0.0147478636354208
intracellular O 0 0.12440240383148193
vesicles O 0 0.20370639860630035
. O 0 0.03736109659075737

TfR O 1 0.9938353300094604
HFE O 1 0.991748571395874
stoichiometry O 0 0.42854881286621094
( O 0 0.033473871648311615
2 O 0 0.020730895921587944
1 O 0 0.016587451100349426
) O 0 0.013994285836815834
differs O 0 0.024126632139086723
from O 0 0.013300644233822823
TfR O 1 0.9879859089851379
transferrin O 1 0.9281786680221558
stoichiometry O 0 0.17901024222373962
( O 0 0.016117176041007042
2 O 0 0.011373274028301239
2 O 0 0.010490902699530125
) O 0 0.007197794038802385
, O 0 0.004632219672203064
implying O 0 0.012629544362425804
a O 0 0.005178199615329504
different O 0 0.005010631866753101
mode O 0 0.01343262754380703
of O 0 0.004903046414256096
binding O 0 0.015568752773106098
for O 0 0.008314312435686588
HFE O 1 0.8911749124526978
and O 0 0.009833356365561485
transferrin O 0 0.1409182995557785
to O 0 0.010341262444853783
TfR O 0 0.4446049928665161
, O 0 0.007431555073708296
consistent O 0 0.01211430225521326
with O 0 0.006060671992599964
our O 0 0.008351476863026619
demonstration O 0 0.016357459127902985
that O 0 0.00856755580753088
HFE O 1 0.948384702205658
, O 0 0.011179476045072079
transferrin O 0 0.18086610734462738
, O 0 0.007568611763417721
and O 0 0.008571899496018887
TfR O 1 0.7873712778091431
form O 0 0.016895601525902748
a O 0 0.013063319027423859
ternary O 0 0.047989215701818466
complex O 0 0.03250629082322121
. O 0 0.02608625590801239

Identification O 0 0.033082980662584305
of O 0 0.010751266963779926
three O 0 0.009531065821647644
novel O 0 0.01972159929573536
mutations O 0 0.04602740705013275
and O 0 0.007454205770045519
a O 0 0.0073377881199121475
high O 0 0.010038845241069794
frequency O 0 0.014746205881237984
of O 0 0.005329307168722153
the O 0 0.008839630521833897
Arg778Leu O 1 0.5501705408096313
mutation O 1 0.7448436617851257
in O 0 0.014019752852618694
Korean O 0 0.06950238347053528
patients O 1 0.9992341995239258
with O 0 0.020632466301321983
Wilson B-Disease 1 0.9684150815010071
disease I-Disease 1 0.9998936653137207
. O 0 0.031318292021751404

Four O 0 0.04876207560300827
mutations O 1 0.9150347709655762
- O 1 0.6052027940750122
- O 0 0.2676692306995392
R778L O 0 0.2271011620759964
, O 0 0.015063400380313396
A874V O 0 0.06406441330909729
, O 0 0.011864379048347473
L1083F O 0 0.042949870228767395
, O 0 0.0076883090659976006
and O 0 0.007091970648616552
2304delC O 0 0.1250709593296051
- O 0 0.040773045271635056
- O 0 0.020264919847249985
in O 0 0.005628062877804041
the O 0 0.0067920926958322525
copper O 0 0.022142108529806137
- O 0 0.0345754399895668
transporting O 0 0.03013177402317524
enzyme O 0 0.05287076532840729
, O 0 0.016444595530629158
P O 1 0.6462539434432983
- O 0 0.2614297866821289
type O 0 0.09600922465324402
ATPase O 1 0.9801315665245056
( O 0 0.025519371032714844
ATP7B O 0 0.32033073902130127
) O 0 0.009730580262839794
, O 0 0.004827774129807949
were O 0 0.0037025040946900845
identified O 0 0.00811363011598587
in O 0 0.006575148086994886
Korean O 0 0.02782830409705639
Patients O 1 0.9981179237365723
with O 0 0.01876366138458252
Wilson B-Disease 1 0.9267299175262451
disease I-Disease 1 0.9998723268508911
. O 0 0.03789278119802475

Arg778Leu O 0 0.16469980776309967
, O 0 0.015255567617714405
the O 0 0.009008742868900299
most O 0 0.007501472253352404
frequently O 0 0.012861773371696472
reported O 0 0.01468952652066946
mutation O 0 0.050573576241731644
of O 0 0.00552879786118865
this O 0 0.004267490468919277
enzyme O 0 0.016439206898212433
, O 0 0.0042229690589010715
was O 0 0.0036777646746486425
found O 0 0.0042659807950258255
in O 0 0.0030398517847061157
six O 0 0.004270024131983519
of O 0 0.0037011781241744757
eight O 0 0.00811072625219822
unrelated O 0 0.038310110569000244
patients O 1 0.971503496170044
studied O 0 0.013174392282962799
, O 0 0.0076286750845611095
an O 0 0.008442376740276814
allele O 0 0.05812002718448639
frequency O 0 0.027296407148241997
of O 0 0.00991652999073267
37 O 0 0.0284798052161932
. O 0 0.023607365787029266

5 O 0 0.030110133811831474
% O 0 0.015518379397690296
, O 0 0.006723613012582064
which O 0 0.004836221691220999
is O 0 0.004725235514342785
considerably O 0 0.010776563547551632
higher O 0 0.007068007253110409
than O 0 0.004413357935845852
those O 0 0.004201176110655069
in O 0 0.0043816836550831795
other O 0 0.005549712106585503
Asian O 0 0.025122148916125298
populations O 0 0.0434713140130043
. O 0 0.02611958235502243

The O 0 0.028710108250379562
novel O 0 0.038082610815763474
single O 0 0.032353054732084274
nucleotide O 0 0.06957097351551056
deletion O 0 0.08705508708953857
, O 0 0.013301821425557137
2304delC O 0 0.04275574907660484
, O 0 0.006477998569607735
was O 0 0.005345623474568129
found O 0 0.005890543106943369
in O 0 0.005958102643489838
one O 0 0.010055433958768845
patient O 0 0.4699406623840332
. O 0 0.029010869562625885

Since O 0 0.045609455555677414
a O 0 0.03380082547664642
mutation O 0 0.1272139549255371
at O 0 0.030112896114587784
cDNA O 0 0.09907115250825882
nucleotide O 0 0.11631220579147339
2302 O 1 0.9900882840156555
( O 0 0.02829248644411564
2302insC O 0 0.059531185775995255
) O 0 0.010604994371533394
had O 0 0.005813522730022669
been O 0 0.004315023776143789
previously O 0 0.005170992109924555
described O 0 0.006672827061265707
, O 0 0.0032817882020026445
this O 0 0.003180192783474922
region O 0 0.008014745078980923
of O 0 0.0044668614864349365
the O 0 0.006474157329648733
ATP7B O 1 0.8894827961921692
gene O 0 0.16046424210071564
may O 0 0.013988937251269817
be O 0 0.007539687212556601
susceptible O 0 0.3716515600681305
to O 0 0.01441456563770771
gene O 1 0.6074534058570862
rearrangements O 1 0.9488866925239563
causing O 1 0.9495059847831726
Wilson B-Disease 1 0.9057371020317078
disease I-Disease 1 0.9997542500495911
. O 0 0.046268220990896225

Disruption O 0 0.11050491780042648
of O 0 0.02417660877108574
splicing O 0 0.08496758341789246
regulated O 0 0.04052088037133217
by O 0 0.014561268500983715
a O 0 0.01898275502026081
CUG O 1 0.716902494430542
- O 0 0.12107086926698685
binding O 0 0.046478696167469025
protein O 0 0.07408005744218826
in O 0 0.030708756297826767
myotonic B-Disease 1 0.9999765157699585
dystrophy I-Disease 1 0.9999949932098389
. O 0 0.06445572525262833

Myotonic B-Disease 1 0.9999953508377075
dystrophy I-Disease 1 0.9999994039535522
( O 1 0.983702540397644
DM B-Disease 1 0.9999616146087646
) O 0 0.027109937742352486
is O 0 0.010370426811277866
caused O 0 0.023177925497293472
by O 0 0.007895666174590588
a O 0 0.010599474422633648
CTG O 0 0.09171192348003387
expansion O 0 0.01586705818772316
in O 0 0.005699429661035538
the O 0 0.005947323981672525
3 O 0 0.014418644830584526
untranslated O 0 0.049226064234972
region O 0 0.019128508865833282
of O 0 0.009721633046865463
the O 0 0.018954357132315636
DM B-Disease 1 0.9998375177383423
gene O 0 0.25528809428215027
. O 0 0.03365200385451317

One O 0 0.029237929731607437
model O 0 0.037480615079402924
of O 0 0.0235985666513443
DM B-Disease 1 0.999964714050293
pathogenesis O 1 0.9981999397277832
suggests O 0 0.03265311196446419
that O 0 0.00900170486420393
RNAs O 0 0.035360146313905716
from O 0 0.006447962485253811
the O 0 0.0052752201445400715
expanded O 0 0.011484971269965172
allele O 0 0.037712983787059784
create O 0 0.013493120670318604
a O 0 0.008368494920432568
gain O 0 0.015516659244894981
- O 0 0.020652584731578827
of O 0 0.006608971860259771
- O 0 0.033653900027275085
function O 0 0.016614994034171104
mutation O 0 0.059539277106523514
by O 0 0.0064981067553162575
the O 0 0.006105438806116581
inappropriate O 0 0.020090671256184578
binding O 0 0.01473222579807043
of O 0 0.005179669242352247
proteins O 0 0.01686307042837143
to O 0 0.007235640659928322
the O 0 0.010884078219532967
CUG O 0 0.26112139225006104
repeats O 0 0.07323791086673737
. O 0 0.02795066125690937

Data O 0 0.020033633336424828
presented O 0 0.01317162811756134
here O 0 0.008120371960103512
indicate O 0 0.010992871597409248
that O 0 0.004752743057906628
the O 0 0.0066558001562952995
conserved O 0 0.02497226558625698
heterogeneous O 0 0.05057089403271675
nuclear O 0 0.03363553807139397
ribonucleoprotein O 1 0.794950008392334
, O 0 0.01811584271490574
CUG O 0 0.48351696133613586
- O 0 0.059021566063165665
binding O 0 0.03391015902161598
protein O 0 0.039307914674282074
( O 0 0.02137478068470955
CUG O 1 0.8461318016052246
- O 0 0.07851901650428772
BP O 0 0.04537990316748619
) O 0 0.011731513775885105
, O 0 0.006881302688270807
may O 0 0.010978324338793755
mediate O 0 0.030451864004135132
the O 0 0.008583862334489822
trans O 0 0.25405097007751465
- O 0 0.04929076135158539
dominant O 0 0.02895120531320572
effect O 0 0.017439331859350204
of O 0 0.0077217998914420605
the O 0 0.010539861395955086
RNA O 0 0.05441054329276085
. O 0 0.028361637145280838

CUG O 1 0.8478268980979919
- O 0 0.08884540945291519
BP O 0 0.053473882377147675
was O 0 0.010760719887912273
found O 0 0.008868588134646416
to O 0 0.006299118511378765
bind O 0 0.020722946152091026
to O 0 0.007037569303065538
the O 0 0.009894018061459064
human O 0 0.04456187039613724
cardiac O 1 0.999948263168335
troponin O 1 0.9997509121894836
T O 1 0.9933217167854309
( O 0 0.02832973003387451
cTNT O 0 0.23326288163661957
) O 0 0.01809583604335785
pre O 0 0.03548412024974823
- O 0 0.04614482447504997
messenger O 0 0.0506303496658802
RNA O 0 0.043083228170871735
and O 0 0.009979273192584515
regulate O 0 0.026365071535110474
its O 0 0.012234463356435299
alternative O 0 0.032912999391555786
splicing O 0 0.09042223542928696
. O 0 0.032455701380968094

Splicing O 0 0.1374487429857254
of O 0 0.025940410792827606
cTNT O 0 0.11547284573316574
was O 0 0.02040957473218441
disrupted O 0 0.07309121638536453
in O 0 0.027718765661120415
DM B-Disease 1 0.9999895095825195
striated O 1 0.9993153810501099
muscle O 1 0.9944159984588623
and O 0 0.01117501687258482
in O 0 0.009616134688258171
normal O 0 0.021679623052477837
cells O 0 0.08126313239336014
expressing O 0 0.025402553379535675
transcripts O 0 0.02379496395587921
that O 0 0.009600072167813778
contain O 0 0.02488972619175911
CUG O 0 0.22076407074928284
repeats O 0 0.08147020637989044
. O 0 0.03464606776833534

Altered O 0 0.07316771149635315
expression O 0 0.04265434667468071
of O 0 0.013434972614049911
genes O 0 0.053119104355573654
regulated O 0 0.046366430819034576
posttranscriptionally O 0 0.12688902020454407
by O 0 0.016810234636068344
CUG O 1 0.7697960138320923
- O 0 0.08628429472446442
BP O 0 0.06263597309589386
therefore O 0 0.01778991147875786
may O 0 0.016936082392930984
contribute O 0 0.025359516963362694
to O 0 0.019521187990903854
DM B-Disease 1 0.9999518394470215
pathogenesis O 1 0.9973582625389099
. O 0 0.027286268770694733
. O 0 0.026588905602693558

Identification O 0 0.03390191122889519
of O 0 0.011393256485462189
a O 0 0.014947786927223206
novel O 0 0.026565516367554665
nonsense O 0 0.046255555003881454
mutation O 0 0.07829053699970245
and O 0 0.010170551016926765
a O 0 0.012174131348729134
missense O 0 0.08721783012151718
substitution O 0 0.028621800243854523
in O 0 0.008574509993195534
the O 0 0.011248867027461529
vasopressin O 1 0.9483818411827087
- O 0 0.3450172543525696
neurophysin O 1 0.7089377045631409
II O 0 0.04585713520646095
gene O 0 0.0390138179063797
in O 0 0.008967800065875053
two O 0 0.008826042525470257
Spanish O 0 0.027424434199929237
kindreds O 1 0.8247504830360413
with O 0 0.029800688847899437
familial B-Disease 1 0.9997408986091614
neurohypophyseal I-Disease 1 0.999767005443573
diabetes I-Disease 1 0.9999967813491821
insipidus I-Disease 1 0.9998358488082886
. O 0 0.07154785096645355

Familial B-Disease 1 0.9997459053993225
neurohypophyseal I-Disease 1 0.9994891881942749
diabetes I-Disease 1 0.9999970197677612
insipidus I-Disease 1 0.9999383687973022
( O 0 0.40908581018447876
FNDI B-Disease 1 0.996340274810791
) O 0 0.019738640636205673
is O 0 0.010234512388706207
an O 0 0.013641979545354843
autosomal B-Disease 1 0.9999206066131592
dominant I-Disease 1 0.9989126920700073
disease I-Disease 1 0.9999982118606567
caused O 1 0.9935421943664551
by O 0 0.019154146313667297
deficiency O 1 0.999974250793457
in O 0 0.01593216322362423
the O 0 0.01852411963045597
antidiuretic O 1 0.9984220266342163
hormone O 1 0.9979615211486816
arginine O 1 0.8899462223052979
vasopressin O 1 0.9776484370231628
( O 0 0.03669893741607666
AVP O 1 0.5330259203910828
) O 0 0.01659400574862957
encoded O 0 0.016105933114886284
by O 0 0.008952158503234386
the O 0 0.010590524412691593
AVP O 1 0.9094012379646301
- O 0 0.3694920241832733
neurophysin O 1 0.8051058650016785
II O 0 0.29162681102752686
( O 0 0.033955030143260956
AVP O 1 0.9722211360931396
- O 0 0.39506059885025024
NPII O 1 0.8185494542121887
) O 0 0.03028716705739498
gene O 0 0.05797769874334335
on O 0 0.021411122754216194
chromosome O 0 0.33906474709510803
20p13 O 0 0.27588605880737305
. O 0 0.0351996049284935

In O 0 0.016325589269399643
this O 0 0.009299598634243011
study O 0 0.010845921002328396
, O 0 0.0060228933580219746
we O 0 0.005176612641662359
analyzed O 0 0.011041704565286636
two O 0 0.004579651169478893
families O 0 0.010018733330070972
with O 0 0.009337633848190308
FNDI B-Disease 0 0.30666202306747437
using O 0 0.01241300068795681
direct O 0 0.01648811437189579
automated O 0 0.02687506005167961
fluorescent O 0 0.03299989923834801
, O 0 0.007845470681786537
solid O 0 0.014073152095079422
phase O 0 0.01950635388493538
, O 0 0.0071009984239935875
single O 0 0.011183327995240688
- O 0 0.026212645694613457
stranded O 0 0.04133116826415062
DNA O 0 0.03294476494193077
sequencing O 0 0.03880007937550545
of O 0 0.012774886563420296
PCR O 0 0.11353398859500885
- O 0 0.09930332005023956
amplified O 0 0.10276482254266739
AVP O 1 0.9822576642036438
- O 1 0.5274237990379333
NPII O 1 0.8801171779632568
DNA O 0 0.0793408676981926
. O 0 0.03368540480732918

In O 0 0.013866973109543324
one O 0 0.0066709681414067745
of O 0 0.004675678443163633
the O 0 0.004854679573327303
families O 0 0.010984383523464203
, O 0 0.006967261433601379
affected O 0 0.016586488112807274
individuals O 0 0.01165265403687954
presented O 0 0.00946101825684309
a O 0 0.009720614179968834
novel O 0 0.01692354306578636
nonsense O 0 0.038618505001068115
mutation O 0 0.05551935359835625
in O 0 0.009134161286056042
exon O 0 0.037815168499946594
3 O 0 0.00957767479121685
of O 0 0.0042671989649534225
the O 0 0.004754452500492334
gene O 0 0.021801907569169998
, O 0 0.005337900947779417
consisting O 0 0.007200254593044519
in O 0 0.004920067731291056
a O 0 0.00774929067119956
G O 0 0.028081899508833885
to O 0 0.008893134072422981
T O 0 0.14042764902114868
transition O 0 0.0218963585793972
at O 0 0.014064460061490536
nucleotide O 0 0.04814673587679863
2101 O 0 0.1592915654182434
, O 0 0.00890311598777771
which O 0 0.006647658068686724
produces O 0 0.01705140620470047
a O 0 0.00843888521194458
stop O 0 0.01580810546875
signal O 0 0.02005283161997795
in O 0 0.010852747596800327
codon O 0 0.054151374846696854
82 O 0 0.03437286242842674
( O 0 0.02506827749311924
Glu O 1 0.865501344203949
) O 0 0.018377387896180153
of O 0 0.013987972401082516
NPII O 0 0.2032075822353363
. O 0 0.03314421325922012

The O 0 0.043387070298194885
premature O 1 0.8732112050056458
termination O 0 0.3399699330329895
eliminates O 0 0.058881767094135284
part O 0 0.013738573528826237
of O 0 0.0064777289517223835
the O 0 0.007903559133410454
C O 0 0.03177113085985184
- O 0 0.027965687215328217
terminal O 0 0.02473035268485546
domain O 0 0.014430446550250053
of O 0 0.006469117011874914
NPII O 0 0.07067126780748367
, O 0 0.006044791080057621
including O 0 0.005348415579646826
a O 0 0.0063820346258580685
cysteine O 0 0.024696845561265945
residue O 0 0.021073630079627037
in O 0 0.005370351951569319
position O 0 0.006164480000734329
85 O 0 0.009767545387148857
, O 0 0.0031711221672594547
which O 0 0.002882750006392598
could O 0 0.00311517552472651
be O 0 0.0024202377535402775
involved O 0 0.004798597190529108
in O 0 0.0029219975695014
the O 0 0.004127287305891514
correct O 0 0.01442804653197527
folding O 0 0.023628834635019302
of O 0 0.0071047889068722725
the O 0 0.013836555182933807
prohormone O 1 0.8931980729103088
. O 0 0.032852448523044586

In O 0 0.017195893451571465
the O 0 0.008330742828547955
second O 0 0.010630711913108826
family O 0 0.011169585399329662
, O 0 0.006379338447004557
a O 0 0.008167396299540997
G279A O 0 0.040487438440322876
substitution O 0 0.022713053971529007
at O 0 0.007863117381930351
position O 0 0.007288401946425438
- O 0 0.016068965196609497
1 O 0 0.007105222903192043
of O 0 0.004082199186086655
the O 0 0.005888471379876137
signal O 0 0.019662901759147644
peptide O 0 0.03473116457462311
was O 0 0.006474108435213566
observed O 0 0.011328836902976036
in O 0 0.00526531133800745
all O 0 0.0071086883544921875
affected O 0 0.0265747532248497
individuals O 0 0.023274661973118782
. O 0 0.02301444672048092

This O 0 0.040892861783504486
missense O 0 0.45062878727912903
mutation O 0 0.42761194705963135
, O 0 0.016001801937818527
which O 0 0.011226052418351173
replaces O 0 0.06391708552837372
Ala O 1 0.8537593483924866
with O 0 0.014573987573385239
Thr O 1 0.9961652755737305
, O 0 0.010187307372689247
is O 0 0.00874100811779499
frequent O 0 0.02397691085934639
among O 0 0.016991743817925453
FNDI B-Disease 1 0.9995982050895691
patients O 1 0.9945007562637329
and O 0 0.006011947523802519
is O 0 0.0042625172063708305
thought O 0 0.006414500996470451
to O 0 0.0036388642620295286
reduce O 0 0.012644752860069275
the O 0 0.005071426276117563
efficiency O 0 0.01544444914907217
of O 0 0.0075911870226264
cleavage O 0 0.0945264995098114
by O 0 0.012755734845995903
signal O 0 0.03445889428257942
peptidases O 0 0.10007064044475555
. O 0 0.017763519659638405
. O 0 0.023967768996953964

Genetic O 0 0.26417484879493713
heterogeneity O 0 0.2520267367362976
of O 0 0.03417275846004486
Saethre B-Disease 1 0.998354434967041
- I-Disease 1 0.9989462494850159
Chotzen I-Disease 1 0.9997798800468445
syndrome I-Disease 1 0.9999972581863403
, O 0 0.013558091595768929
due O 0 0.01327342540025711
to O 0 0.009820809587836266
TWIST O 0 0.057603657245635986
and O 0 0.015920832753181458
FGFR O 1 0.9266161918640137
mutations O 1 0.677081823348999
. O 0 0.03387272730469704

Thirty O 0 0.057426463812589645
- O 0 0.05514643341302872
two O 0 0.013484301045536995
unrelated O 0 0.047367703169584274
patients O 1 0.9773609638214111
with O 0 0.009741498157382011
features O 0 0.013754386454820633
of O 0 0.010212255641818047
Saethre B-Disease 1 0.998256504535675
- I-Disease 1 0.9987862706184387
Chotzen I-Disease 1 0.9998351335525513
syndrome I-Disease 1 0.9999978542327881
, O 0 0.013306884095072746
a O 0 0.01248535979539156
common O 0 0.02980203367769718
autosomal B-Disease 1 0.99965500831604
dominant I-Disease 1 0.7620670795440674
condition I-Disease 1 0.949190080165863
of O 0 0.015308409929275513
craniosynostosis B-Disease 1 0.999826967716217
and O 0 0.020975444465875626
limb B-Disease 1 0.9994885921478271
anomalies I-Disease 1 0.7165989875793457
, O 0 0.00826189573854208
were O 0 0.00623386912047863
screened O 0 0.019820302724838257
for O 0 0.007520180195569992
mutations O 0 0.08249342441558838
in O 0 0.008782602846622467
TWIST O 0 0.04143816977739334
, O 0 0.01045186072587967
FGFR2 O 0 0.20112955570220947
, O 0 0.01143207773566246
and O 0 0.012519746087491512
FGFR3 O 0 0.3974839150905609
. O 0 0.0298125259578228

Nine O 0 0.02966141514480114
novel O 0 0.023785332217812538
and O 0 0.011916412971913815
three O 0 0.014000406488776207
recurrent O 1 0.9457505941390991
TWIST O 0 0.41134750843048096
mutations O 0 0.1598404049873352
were O 0 0.008713286370038986
found O 0 0.00948586966842413
in O 0 0.007668558973819017
12 O 0 0.013498237356543541
families O 0 0.021397674456238747
. O 0 0.0201786570250988

Seven O 0 0.02419239655137062
families O 0 0.017375437542796135
were O 0 0.006164821796119213
found O 0 0.006038337480276823
to O 0 0.004183892626315355
have O 0 0.004919564351439476
the O 0 0.006602066103368998
FGFR3 O 1 0.8749809861183167
P250R O 1 0.527315080165863
mutation O 0 0.2630910575389862
, O 0 0.004865260794758797
and O 0 0.003607548074796796
one O 0 0.0036003391724079847
individual O 0 0.005172270350158215
was O 0 0.003695232328027487
found O 0 0.00439454335719347
to O 0 0.003590463660657406
have O 0 0.004396911710500717
an O 0 0.008300951682031155
FGFR2 O 0 0.28882819414138794
VV269 O 0 0.2064724713563919
- O 0 0.0740206316113472
270 O 0 0.0706397220492363
deletion O 0 0.2325519472360611
. O 0 0.042279038578271866

To O 0 0.020236076787114143
date O 0 0.017005814239382744
, O 0 0.008423620834946632
our O 0 0.009880658239126205
detection O 0 0.03089604154229164
rate O 0 0.017793402075767517
for O 0 0.007520162500441074
TWIST O 0 0.05237571895122528
or O 0 0.01694577746093273
FGFR O 1 0.9073044061660767
mutations O 0 0.16632382571697235
is O 0 0.00892607681453228
68 O 0 0.01769496686756611
% O 0 0.0101000452414155
in O 0 0.006948712281882763
our O 0 0.01353093795478344
Saethre B-Disease 1 0.9993239641189575
- I-Disease 1 0.9995582699775696
Chotzen I-Disease 1 0.9999655485153198
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.9997791647911072
, O 0 0.008385907858610153
including O 0 0.006281448528170586
our O 0 0.006228708196431398
five O 0 0.008743412792682648
patients O 1 0.9937076568603516
elsewhere O 0 0.017124462872743607
reported O 0 0.019308321177959442
with O 0 0.013745177537202835
TWIST O 0 0.40491005778312683
mutations O 1 0.8527182340621948
. O 0 0.03279467299580574

More O 0 0.019820433109998703
than O 0 0.013367248699069023
35 O 0 0.017548663541674614
different O 0 0.0113445445895195
TWIST O 0 0.07021863758563995
mutations O 0 0.07312729209661484
are O 0 0.005681266542524099
now O 0 0.006246942561119795
known O 0 0.006028825882822275
in O 0 0.004092858172953129
the O 0 0.0059848325327038765
literature O 0 0.014278464019298553
. O 0 0.016740204766392708

The O 0 0.01920418255031109
most O 0 0.012146866880357265
common O 0 0.015872331336140633
phenotypic O 0 0.03432072326540947
features O 0 0.011233306489884853
, O 0 0.005039507057517767
present O 0 0.004666812252253294
in O 0 0.0030719449277967215
more O 0 0.002499643713235855
than O 0 0.0030675875023007393
a O 0 0.00346633093431592
third O 0 0.005110333673655987
of O 0 0.004375198390334845
our O 0 0.008159840479493141
patients O 1 0.9717288613319397
with O 0 0.011433026753365993
TWIST O 1 0.6680727005004883
mutations O 1 0.8097467422485352
, O 0 0.010962575674057007
are O 0 0.010397234000265598
coronal B-Disease 0 0.35776486992836
synostosis I-Disease 0 0.37938565015792847
, O 0 0.013827149756252766
brachycephaly B-Disease 0 0.35457366704940796
, O 0 0.015982436016201973
low B-Disease 0 0.06863712519407272
frontal I-Disease 1 0.9985476136207581
hairline I-Disease 1 0.999922513961792
, O 0 0.0350944809615612
facial B-Disease 1 0.9994834661483765
asymmetry I-Disease 1 0.9914599657058716
, O 0 0.027117770165205002
ptosis B-Disease 1 0.9998887777328491
, O 0 0.021358761936426163
hypertelorism B-Disease 1 0.9946610331535339
, O 0 0.01403291616588831
broad B-Disease 0 0.024404974654316902
great I-Disease 0 0.017657874152064323
toes I-Disease 0 0.08526434004306793
, O 0 0.010401494801044464
and O 0 0.010920188389718533
clinodactyly B-Disease 0 0.2160789519548416
. O 0 0.02806812711060047

Significant O 0 0.049215782433748245
intra O 0 0.07725010067224503
- O 0 0.07063964009284973
and O 0 0.017766954377293587
interfamilial O 0 0.3441290855407715
phenotypic O 0 0.06491390615701675
variability O 0 0.05031093209981918
is O 0 0.007965155877172947
present O 0 0.007142261136323214
for O 0 0.0061428905464708805
either O 0 0.0143002113327384
TWIST O 0 0.19467273354530334
mutations O 1 0.8625401258468628
or O 0 0.03431691601872444
FGFR O 1 0.9694815874099731
mutations O 1 0.8944271802902222
. O 0 0.04065914452075958

The O 0 0.02080954611301422
overlap O 0 0.034360792487859726
in O 0 0.010067963972687721
clinical O 0 0.03854919597506523
features O 0 0.010002091526985168
and O 0 0.004656683187931776
the O 0 0.004405766725540161
presence O 0 0.008139108307659626
, O 0 0.003342759096994996
in O 0 0.0028237805236130953
the O 0 0.0031684390269219875
same O 0 0.0048696119338274
genes O 0 0.016787197440862656
, O 0 0.005116177722811699
of O 0 0.004498811438679695
mutations O 0 0.027792738750576973
for O 0 0.004185247700661421
more O 0 0.0037831347435712814
than O 0 0.00521069997921586
one O 0 0.006448227446526289
craniosynostotic B-Disease 1 0.6212863326072693
condition I-Disease 0 0.3004860281944275
- O 0 0.023613538593053818
such O 0 0.007481126580387354
as O 0 0.008073516190052032
Saethre B-Disease 1 0.8190804123878479
- I-Disease 0 0.34428563714027405
Chotzen I-Disease 1 0.774121105670929
, I-Disease 0 0.012823713012039661
Crouzon I-Disease 1 0.5489595532417297
, I-Disease 0 0.009636305272579193
and I-Disease 0 0.011308416724205017
Pfeiffer I-Disease 1 0.999734103679657
syndromes I-Disease 1 0.9999788999557495
- O 0 0.06882012635469437
support O 0 0.011638175696134567
the O 0 0.007131374906748533
hypothesis O 0 0.01930827833712101
that O 0 0.006141406483948231
TWIST O 0 0.026232756674289703
and O 0 0.005845929495990276
FGFRs O 0 0.031771328300237656
are O 0 0.0038754644338041544
components O 0 0.006322843488305807
of O 0 0.0032379385083913803
the O 0 0.004126724787056446
same O 0 0.006711261812597513
molecular O 0 0.019096756353974342
pathway O 0 0.028368858620524406
involved O 0 0.009585665538907051
in O 0 0.004868377931416035
the O 0 0.005967961624264717
modulation O 0 0.04997079074382782
of O 0 0.009598512202501297
craniofacial O 1 0.9997666478157043
and O 0 0.012490891851484776
limb O 1 0.9941752552986145
development O 0 0.015866387635469437
in O 0 0.008956457488238811
humans O 0 0.023542236536741257
. O 0 0.013117024675011635
. O 0 0.018625760450959206

Mutation O 1 0.6891903281211853
analysis O 0 0.062104787677526474
of O 0 0.02945566736161709
UBE3A O 1 0.9994221925735474
in O 1 0.8505594730377197
Angelman B-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.9998615980148315
. O 0 0.05148369446396828

Angelman B-Disease 1 0.9999980926513672
syndrome I-Disease 1 0.9999995231628418
( O 0 0.047407396137714386
AS B-Disease 0 0.017299463972449303
) O 0 0.01468350924551487
is O 0 0.00981444027274847
caused O 0 0.029397161677479744
by O 0 0.012968102470040321
chromosome O 1 0.6985796689987183
15q11 O 1 0.8264797925949097
- O 0 0.15362560749053955
q13 O 0 0.15035967528820038
deletions O 0 0.049417078495025635
of O 0 0.009831271134316921
maternal O 0 0.05302349105477333
origin O 0 0.01800192892551422
, O 0 0.010128552094101906
by O 0 0.013859280385077
paternal O 0 0.4248034656047821
uniparental B-Disease 1 0.9992480874061584
disomy I-Disease 1 0.9901859760284424
( O 0 0.044004108756780624
UPD B-Disease 1 0.9980949759483337
) O 0 0.015236188657581806
15 O 0 0.010592364706099033
, O 0 0.0069279116578400135
by O 0 0.008579817600548267
imprinting O 1 0.9650930166244507
defects O 1 0.9555352926254272
, O 0 0.007588264066725969
and O 0 0.005871082656085491
by O 0 0.007863184437155724
mutations O 0 0.06129315122961998
in O 0 0.00906120054423809
the O 0 0.013583241030573845
UBE3A O 1 0.9753736257553101
gene O 0 0.11431287229061127
. O 0 0.03374404460191727

UBE3A O 1 0.7941931486129761
encodes O 0 0.10800787061452866
a O 0 0.03580275550484657
ubiquitin O 0 0.12078168243169785
- O 0 0.09016896784305573
protein O 0 0.05588666722178459
ligase O 0 0.06018485873937607
and O 0 0.013811948709189892
shows O 0 0.02424527332186699
brain O 1 0.9348364472389221
- O 0 0.07047440111637115
specific O 0 0.030422091484069824
imprinting O 1 0.6169615387916565
. O 0 0.035868290811777115

Here O 0 0.037004709243774414
we O 0 0.021311046555638313
describe O 0 0.048990942537784576
UBE3A O 1 0.9834822416305542
coding O 0 0.288422167301178
- O 0 0.35312163829803467
region O 0 0.05060451477766037
mutations O 1 0.9056710600852966
detected O 0 0.04962335526943207
by O 0 0.01164916716516018
SSCP O 0 0.10181911289691925
analysis O 0 0.013530321419239044
in O 0 0.00588061660528183
13 O 0 0.00915321335196495
AS B-Disease 0 0.008447712287306786
individuals O 0 0.013314506970345974
or O 0 0.013204573653638363
families O 0 0.020205959677696228
. O 0 0.022451484575867653

Two O 0 0.034543946385383606
identical O 0 0.04921366646885872
de O 0 0.06555335223674774
novo O 0 0.08812277019023895
5 O 0 0.030906103551387787
- O 0 0.05006583780050278
bp O 0 0.04974398761987686
duplications O 0 0.054772429168224335
in O 0 0.012363389134407043
exon O 0 0.04972214251756668
16 O 0 0.017238803207874298
were O 0 0.008792966604232788
found O 0 0.01433220598846674
. O 0 0.018740998581051826

Among O 0 0.02261757291853428
the O 0 0.009262261912226677
other O 0 0.007008634973317385
11 O 0 0.011448764242231846
unique O 0 0.012502179481089115
mutations O 0 0.049011629074811935
, O 0 0.006911164615303278
8 O 0 0.008026042953133583
were O 0 0.004523977637290955
small O 0 0.008233383297920227
deletions O 0 0.030047442764043808
or O 0 0.01172985415905714
insertions O 0 0.08346191793680191
predicted O 0 0.020032182335853577
to O 0 0.008913717232644558
cause O 0 0.03192976862192154
frameshifts O 0 0.0559079609811306
, O 0 0.007328260689973831
1 O 0 0.007647708058357239
was O 0 0.005357527639716864
a O 0 0.00669732503592968
mutation O 0 0.030664650723338127
to O 0 0.0061345999129116535
a O 0 0.007800026331096888
stop O 0 0.015714386478066444
codon O 0 0.03131907433271408
, O 0 0.005998356267809868
1 O 0 0.008600296452641487
was O 0 0.006277000997215509
a O 0 0.009677141904830933
missense O 0 0.2742120027542114
mutation O 0 0.1484827697277069
, O 0 0.006513985805213451
and O 0 0.004379495978355408
1 O 0 0.006231158971786499
was O 0 0.004615768790245056
predicted O 0 0.011501750908792019
to O 0 0.005673740524798632
cause O 0 0.020879821851849556
insertion O 0 0.027606042101979256
of O 0 0.005545444320887327
an O 0 0.005832620430737734
isoleucine O 0 0.031860753893852234
in O 0 0.00555861322209239
the O 0 0.006023718975484371
hect O 0 0.03460121154785156
domain O 0 0.016327325254678726
of O 0 0.005822175182402134
the O 0 0.009312348440289497
UBE3A O 0 0.4971170127391815
protein O 0 0.02512131631374359
, O 0 0.005922231357544661
which O 0 0.005649677012115717
functions O 0 0.008310001343488693
in O 0 0.008304971270263195
E2 O 0 0.09121358394622803
binding O 0 0.022858252748847008
and O 0 0.01294833142310381
ubiquitin O 0 0.06204431876540184
transfer O 0 0.02934902533888817
. O 0 0.025122571736574173

Eight O 0 0.024504419416189194
of O 0 0.00924130342900753
the O 0 0.007789973169565201
cases O 0 0.015618733130395412
were O 0 0.007848096080124378
familial O 1 0.9267851114273071
, O 0 0.007856379263103008
and O 0 0.006001148838549852
five O 0 0.00876727793365717
were O 0 0.008536518551409245
sporadic O 0 0.04333297163248062
. O 0 0.02583662047982216

In O 0 0.02020665630698204
two O 0 0.017481409013271332
familial O 1 0.990342378616333
cases O 0 0.02352863736450672
and O 0 0.007695792708545923
one O 0 0.007734224665910006
sporadic O 0 0.028407497331500053
case O 0 0.014636768028140068
, O 0 0.01184442825615406
mosaicism O 1 0.9721492528915405
for O 0 0.014208019711077213
UBE3A O 1 0.992715060710907
mutations O 0 0.475452721118927
was O 0 0.009054211899638176
detected O 0 0.018345830962061882
in O 0 0.004190768115222454
the O 0 0.003688570810481906
mother O 0 0.00813798513263464
of O 0 0.003110127290710807
three O 0 0.0042470223270356655
AS B-Disease 0 0.005112564656883478
sons O 0 0.01154164969921112
, O 0 0.003863345133140683
in O 0 0.003547745058313012
the O 0 0.0037571750581264496
maternal O 0 0.02397388033568859
grandfather O 0 0.011487110517919064
of O 0 0.0035732975229620934
two O 0 0.0033874160144478083
AS B-Disease 0 0.0038819052278995514
first O 0 0.003864438971504569
cousins O 0 0.011418730951845646
, O 0 0.003246503649279475
and O 0 0.0026778406463563442
in O 0 0.002811457496136427
the O 0 0.003194462275132537
mother O 0 0.008138308301568031
of O 0 0.004301511216908693
an O 0 0.006505976896733046
AS B-Disease 0 0.011673837900161743
daughter O 0 0.03162770718336105
. O 0 0.024059727787971497

The O 0 0.01838330179452896
frequencies O 0 0.02801021933555603
with O 0 0.00875370018184185
which O 0 0.006634748540818691
we O 0 0.007389137055724859
detected O 0 0.023679815232753754
mutations O 0 0.03628431260585785
were O 0 0.005120162386447191
5 O 0 0.008451961912214756
( O 0 0.007162143941968679
14 O 0 0.006870727054774761
% O 0 0.0066140517592430115
) O 0 0.0047218590043485165
of O 0 0.003212238661944866
35 O 0 0.007436369080096483
in O 0 0.005023365840315819
sporadic O 0 0.018936321139335632
cases O 0 0.008814262226223946
and O 0 0.004610403440892696
8 O 0 0.007762114517390728
( O 0 0.006888548377901316
80 O 0 0.008481825701892376
% O 0 0.006999448407441378
) O 0 0.005268553271889687
of O 0 0.0032047717832028866
10 O 0 0.005879195407032967
in O 0 0.007039311807602644
familial O 1 0.9831520318984985
cases O 0 0.024754511192440987
. O 0 0.014778518117964268
. O 0 0.019533399492502213

The O 0 0.06945858150720596
hemochromatosis B-Disease 1 0.9997950196266174
845 O 1 0.9920927882194519
G O 1 0.9552732706069946
- O 1 0.6394460797309875
- O 0 0.3019794225692749
> O 0 0.0816161036491394
A O 0 0.01568962261080742
and O 0 0.010282334871590137
187 O 0 0.04427819326519966
C O 0 0.26081928610801697
- O 1 0.8840674757957458
- O 1 0.9413939714431763
> O 1 0.9711399674415588
G O 1 0.9145447015762329
mutations O 1 0.8546813130378723
: O 0 0.024166060611605644
prevalence O 1 0.7742630839347839
in O 0 0.013927575200796127
non O 0 0.03335794433951378
- O 0 0.3596239686012268
Caucasian O 1 0.9438932538032532
populations O 0 0.11987778544425964
. O 0 0.04378267377614975

Hemochromatosis B-Disease 1 0.9997556805610657
, O 0 0.02801729552447796
the O 0 0.020586321130394936
inherited B-Disease 1 0.9997441172599792
disorder I-Disease 1 0.9999865293502808
of I-Disease 0 0.015508358366787434
iron I-Disease 1 0.5510887503623962
metabolism I-Disease 1 0.753963053226471
, O 0 0.010444095358252525
leads O 0 0.022596562281250954
, O 0 0.007706739008426666
if O 0 0.008564016781747341
untreated O 1 0.940363347530365
, O 0 0.006898544263094664
to O 0 0.008444943465292454
progressive O 0 0.1252974420785904
iron B-Disease 1 0.6410084366798401
overload I-Disease 1 0.990900993347168
and O 0 0.019357575103640556
premature B-Disease 1 0.9077653884887695
death I-Disease 0 0.04020758718252182
. O 0 0.02881232649087906

The O 0 0.06056839972734451
hemochromatosis B-Disease 1 0.9998195767402649
gene O 1 0.5265290141105652
, O 0 0.023310255259275436
HFE O 1 0.949506402015686
, O 0 0.011019052937626839
recently O 0 0.01244824007153511
has O 0 0.005445998627692461
been O 0 0.0046411496587097645
identified O 0 0.007790592964738607
, O 0 0.00419720821082592
and O 0 0.003944698255509138
characterization O 0 0.013151047751307487
of O 0 0.003740930464118719
this O 0 0.004553650971502066
gene O 0 0.019935207441449165
has O 0 0.0049264878034591675
shown O 0 0.006069030147045851
that O 0 0.0030394401401281357
it O 0 0.0032267177011817694
contains O 0 0.004789867904037237
two O 0 0.004764596465975046
mutations O 0 0.03524991124868393
that O 0 0.0061508659273386
result O 0 0.01001117005944252
in O 0 0.007834436371922493
amino O 0 0.02758832462131977
acid O 0 0.05261872708797455
substitutions O 0 0.04182817414402962
- O 0 0.06681615114212036
cDNA O 0 0.10127589106559753
nucleotides O 0 0.09274566173553467
845 O 1 0.9595017433166504
G O 1 0.857650637626648
- O 1 0.5567827224731445
- O 0 0.24796944856643677
> O 0 0.10274209827184677
A O 0 0.014448625035583973
( O 0 0.01886514201760292
C282Y O 0 0.043720416724681854
) O 0 0.011755198240280151
and O 0 0.008015003055334091
187 O 0 0.031988952308893204
C O 0 0.20217829942703247
- O 1 0.5626623630523682
- O 1 0.682766854763031
> O 1 0.8643651008605957
G O 0 0.488107293844223
( O 0 0.030563438311219215
H63D O 0 0.3227893114089966
) O 0 0.025695065036416054
. O 0 0.02136625535786152

Although O 0 0.05372538045048714
hemochromatosis B-Disease 1 0.9995375871658325
is O 0 0.01654626987874508
common O 0 0.016357503831386566
in O 0 0.010447871871292591
Caucasians O 1 0.6222039461135864
, O 0 0.01531781442463398
affecting O 0 0.10951031744480133
> O 1 0.7357845902442932
= O 0 0.0675884261727333
1 O 0 0.01462873537093401
/ O 0 0.04202613607048988
300 O 0 0.010104341432452202
individuals O 0 0.006591720040887594
of O 0 0.003318779170513153
northern O 0 0.006336639169603586
European O 0 0.005915878806263208
origin O 0 0.005801431369036436
, O 0 0.003098849905654788
it O 0 0.0022580286022275686
has O 0 0.0030341476667672396
not O 0 0.00212086015380919
been O 0 0.0026712038088589907
recognized O 0 0.006627583876252174
in O 0 0.004604896996170282
other O 0 0.0066035836935043335
populations O 0 0.028687885031104088
. O 0 0.017164671793580055

The O 0 0.019958065822720528
present O 0 0.018114985898137093
study O 0 0.017880506813526154
used O 0 0.012720360420644283
PCR O 0 0.054790616035461426
and O 0 0.009933754801750183
restriction O 0 0.027016790583729744
- O 0 0.065826915204525
enzyme O 0 0.049080513417720795
digestion O 0 0.05638078600168228
to O 0 0.00917468499392271
analyze O 0 0.018032319843769073
the O 0 0.0072357021272182465
frequency O 0 0.016552655026316643
of O 0 0.005774141754955053
the O 0 0.009691949933767319
845 O 1 0.7642679214477539
G O 1 0.6433632969856262
- O 0 0.21034160256385803
- O 0 0.07933006435632706
> O 0 0.059054870158433914
A O 0 0.013362878933548927
and O 0 0.009595299139618874
187 O 0 0.04471854493021965
C O 0 0.1543917953968048
- O 1 0.7437845468521118
- O 1 0.8586729764938354
> O 1 0.9512715339660645
G O 1 0.6834543943405151
mutations O 1 0.7216036915779114
in O 0 0.020015928894281387
HLA O 1 0.9978723526000977
- O 0 0.054284416139125824
typed O 0 0.03319075331091881
samples O 0 0.02329733595252037
from O 0 0.01235391478985548
non O 0 0.022933416068553925
- O 0 0.08605046570301056
Caucasian O 1 0.6612969040870667
populations O 0 0.03488100692629814
, O 0 0.008579119108617306
comprising O 0 0.011608036234974861
Australian O 0 0.01077223289757967
Aboriginal O 0 0.01956595666706562
, O 0 0.007370833307504654
Chinese O 0 0.007807455491274595
, O 0 0.006651898380368948
and O 0 0.007531616371124983
Pacific O 0 0.02860616147518158
Islanders O 0 0.06039174646139145
. O 0 0.029332736507058144

Results O 0 0.03604435548186302
showed O 0 0.022218143567442894
that O 0 0.008036420680582523
the O 0 0.010778291150927544
845 O 1 0.9216881990432739
G O 1 0.8785630464553833
- O 1 0.6277234554290771
- O 0 0.4646967649459839
> O 0 0.27484768629074097
A O 0 0.014623342081904411
mutation O 0 0.05485277995467186
was O 0 0.006367688067257404
present O 0 0.006905035115778446
in O 0 0.004765135236084461
these O 0 0.005563478916883469
populations O 0 0.022749250754714012
( O 0 0.01393407303839922
allele O 0 0.047026585787534714
frequency O 0 0.020118407905101776
0 O 0 0.0152474045753479
. O 0 0.004722336772829294
32 O 0 0.009128190577030182
% O 0 0.006660165265202522
) O 0 0.005276706535369158
, O 0 0.002889420138671994
and O 0 0.002847486175596714
, O 0 0.003098767250776291
furthermore O 0 0.006300580687820911
, O 0 0.003014609683305025
it O 0 0.0023725302889943123
was O 0 0.0033851549960672855
always O 0 0.005717023275792599
seen O 0 0.005838485434651375
in O 0 0.0047332365065813065
conjunction O 0 0.016150305047631264
with O 0 0.010894066654145718
HLA O 1 0.9994283318519592
haplotypes O 1 0.8653768301010132
common O 0 0.01647006720304489
in O 0 0.009432394988834858
Caucasians O 1 0.559016764163971
, O 0 0.01142815500497818
suggesting O 0 0.020106546580791473
that O 0 0.010666687041521072
845 O 1 0.9564884901046753
G O 1 0.9234881401062012
- O 1 0.6849547028541565
- O 0 0.34395939111709595
> O 0 0.10366641730070114
A O 0 0.009041676297783852
may O 0 0.006314163561910391
have O 0 0.0035854193847626448
been O 0 0.0036618744488805532
introduced O 0 0.0060653844848275185
into O 0 0.005937437992542982
these O 0 0.006972647737711668
populations O 0 0.027736589312553406
by O 0 0.013724797405302525
Caucasian O 1 0.6533249020576477
admixture O 1 0.9468802213668823
. O 0 0.04239291697740555

187 O 0 0.1409568041563034
C O 0 0.2513948082923889
- O 1 0.6657976508140564
- O 0 0.48277315497398376
> O 0 0.33436357975006104
G O 0 0.042887624353170395
was O 0 0.007407990749925375
present O 0 0.006601337343454361
at O 0 0.006285811308771372
an O 0 0.006644199136644602
allele O 0 0.04445285722613335
frequency O 0 0.022693516686558723
of O 0 0.009381924755871296
2 O 0 0.021339688450098038
. O 0 0.020590920001268387

68 O 0 0.05432846024632454
% O 0 0.017238108441233635
in O 0 0.006692020688205957
the O 0 0.005500752944499254
two O 0 0.007051247637718916
populations O 0 0.023046640679240227
analyzed O 0 0.019273504614830017
( O 0 0.010895134881138802
Australian O 0 0.0107776103541255
Aboriginal O 0 0.018726620823144913
and O 0 0.007445010356605053
Chinese O 0 0.011962090618908405
) O 0 0.015826260671019554
. O 0 0.019402911886572838

In O 0 0.015384831465780735
the O 0 0.01066733617335558
Australian O 0 0.016253912821412086
Aboriginal O 0 0.03012772463262081
samples O 0 0.029050346463918686
, O 0 0.01380564458668232
187 O 0 0.03921215981245041
C O 0 0.10428229719400406
- O 0 0.42981237173080444
- O 0 0.4967011511325836
> O 0 0.4100281000137329
G O 0 0.03389565274119377
was O 0 0.005823414772748947
found O 0 0.005051505286246538
to O 0 0.003216381883248687
be O 0 0.004005508031696081
associated O 0 0.009939298033714294
with O 0 0.00952793750911951
HLA O 1 0.999358594417572
haplotypes O 1 0.9443459510803223
common O 0 0.017678547650575638
in O 0 0.008187414146959782
Caucasians O 0 0.3467375338077545
, O 0 0.007482234854251146
suggesting O 0 0.012192548252642155
that O 0 0.003865000559017062
it O 0 0.00349552184343338
was O 0 0.004754220601171255
introduced O 0 0.008647201582789421
by O 0 0.007137906737625599
recent O 0 0.02130056917667389
admixture O 0 0.32069674134254456
. O 0 0.032028473913669586

In O 0 0.016347479075193405
the O 0 0.009826124645769596
Chinese O 0 0.012068847194314003
samples O 0 0.022002087906003
analyzed O 0 0.024091634899377823
, O 0 0.009937148541212082
187 O 0 0.033666111528873444
C O 0 0.08443485200405121
- O 0 0.41265615820884705
- O 0 0.37238261103630066
> O 0 0.4254739284515381
G O 0 0.03812567517161369
was O 0 0.00565792853012681
present O 0 0.005980066489428282
in O 0 0.004128196742385626
association O 0 0.008768724277615547
with O 0 0.005002662073820829
a O 0 0.005654187873005867
wide O 0 0.009551353752613068
variety O 0 0.009627548046410084
of O 0 0.009478037245571613
HLA O 1 0.9995585083961487
haplotypes O 1 0.9504942893981934
, O 0 0.009958015754818916
showing O 0 0.012132644653320312
this O 0 0.00588685879483819
mutation O 0 0.03320804983377457
to O 0 0.003837771713733673
be O 0 0.00362055329605937
widespread O 0 0.009610133245587349
and O 0 0.004714876879006624
likely O 0 0.00959076453000307
to O 0 0.00516355549916625
predate O 0 0.02304452657699585
the O 0 0.00534848915413022
more O 0 0.007055535446852446
genetically O 0 0.02724805474281311
restricted O 0 0.02989059127867222
845 O 1 0.968231201171875
G O 1 0.9218544363975525
- O 1 0.684299886226654
- O 0 0.41333678364753723
> O 0 0.3475835621356964
A O 0 0.03219976648688316
mutation O 0 0.43196341395378113
. O 0 0.03561987727880478

Genotype O 1 0.9893529415130615
- O 1 0.9715622067451477
phenotype O 1 0.9892760515213013
correlations O 1 0.5773031711578369
in O 0 0.06406808644533157
attenuated B-Disease 1 0.9991592168807983
adenomatous I-Disease 1 0.9999960660934448
polyposis I-Disease 1 0.9999942779541016
coli I-Disease 1 0.999847412109375
. O 0 0.08736047893762589

Germ O 1 0.9934815168380737
- O 0 0.3344191014766693
line O 0 0.03571256622672081
mutations O 0 0.17629297077655792
of O 0 0.012041757814586163
the O 0 0.017119791358709335
tumor B-Disease 1 0.9994257688522339
suppressor O 1 0.9957857728004456
APC O 1 0.9309948682785034
are O 0 0.016991853713989258
implicated O 1 0.7899508476257324
in O 0 0.03567177429795265
attenuated B-Disease 1 0.9997872710227966
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9999992847442627
coli I-Disease 1 0.9999871253967285
( O 1 0.8181825280189514
AAPC B-Disease 1 0.9996596574783325
) O 0 0.022038348019123077
, O 0 0.010502065531909466
a O 0 0.012295456603169441
variant O 0 0.2618662118911743
of O 0 0.023227812722325325
familial B-Disease 1 0.9999890327453613
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9999991655349731
( O 1 0.9561744928359985
FAP B-Disease 1 0.9995855689048767
) O 0 0.049718111753463745
. O 0 0.03609517961740494

AAPC B-Disease 1 0.9936542510986328
is O 0 0.020178841426968575
recognized O 0 0.01936744526028633
by O 0 0.00884804967790842
the O 0 0.009350194595754147
occurrence O 0 0.04051140695810318
of O 0 0.014431498013436794
< O 0 0.413068026304245
100 O 0 0.025774961337447166
colonic B-Disease 1 0.995934247970581
adenomas I-Disease 1 0.9987022876739502
and O 0 0.010485725477337837
a O 0 0.011793915182352066
later O 0 0.014596824534237385
onset O 1 0.9998257756233215
of O 0 0.07507819682359695
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999978542327881
( O 0 0.07981471717357635
age O 0 0.028922749683260918
> O 0 0.17240279912948608
40 O 0 0.01753922738134861
years O 0 0.01270050648599863
) O 0 0.018278736621141434
. O 0 0.020976003259420395

The O 0 0.016864700242877007
aim O 0 0.020644323900341988
of O 0 0.006203493103384972
this O 0 0.005674146115779877
study O 0 0.008814382366836071
was O 0 0.005736204795539379
to O 0 0.008577939122915268
assess O 0 0.041166555136442184
genotype O 1 0.985559344291687
- O 1 0.7277035713195801
phenotype O 1 0.9820879101753235
correlations O 0 0.14156584441661835
in O 0 0.029920555651187897
AAPC B-Disease 1 0.9988080263137817
families O 0 0.05151830613613129
. O 0 0.03561493381857872

By O 0 0.035567961633205414
protein O 0 0.06426508724689484
- O 0 0.06665344536304474
truncation O 0 0.0865635797381401
test O 0 0.030270148068666458
( O 0 0.02008853666484356
PTT O 0 0.03340887650847435
) O 0 0.01169845461845398
assay O 0 0.023341646417975426
, O 0 0.0055907657369971275
the O 0 0.0051204487681388855
entire O 0 0.010933484882116318
coding O 0 0.029288141056895256
region O 0 0.014074660837650299
of O 0 0.006401051767170429
the O 0 0.008354355581104755
APC B-Disease 0 0.21948540210723877
gene O 0 0.04288669303059578
was O 0 0.009340186603367329
screened O 0 0.021232808008790016
in O 0 0.008024567738175392
affected O 0 0.018176667392253876
individuals O 0 0.011305462568998337
from O 0 0.009130558930337429
11 O 0 0.016892509534955025
AAPC B-Disease 1 0.9997289776802063
kindreds O 1 0.868324875831604
, O 0 0.00994968879967928
and O 0 0.006837479304522276
their O 0 0.007321537937968969
phenotypic O 0 0.0386410728096962
differences O 0 0.021554764360189438
were O 0 0.011967642232775688
examined O 0 0.04374302178621292
. O 0 0.026460932567715645

Five O 0 0.038262419402599335
novel O 0 0.04645707830786705
germ O 1 0.9872003793716431
- O 0 0.17946651577949524
line O 0 0.03261785954236984
APC B-Disease 1 0.8077752590179443
mutations O 0 0.16413389146327972
were O 0 0.009516856633126736
identified O 0 0.01594053953886032
in O 0 0.00946736242622137
seven O 0 0.01891462132334709
kindreds O 0 0.3473719358444214
. O 0 0.03341387212276459

Mutations O 0 0.13379667699337006
were O 0 0.011769331991672516
located O 0 0.009640496224164963
in O 0 0.004612071439623833
three O 0 0.004196519497781992
different O 0 0.004235436674207449
regions O 0 0.008846117183566093
of O 0 0.004743529018014669
the O 0 0.007068274542689323
APC B-Disease 0 0.44015106558799744
gene O 0 0.04435095563530922
( O 0 0.010899421758949757
1 O 0 0.007225313689559698
) O 0 0.00600419333204627
at O 0 0.003968914970755577
the O 0 0.0033086955081671476
5 O 0 0.007355860434472561
end O 0 0.008071121759712696
spanning O 0 0.01772104576230049
exons O 0 0.03145585209131241
4 O 0 0.010199032723903656
and O 0 0.0044061350636184216
5 O 0 0.006579780951142311
, O 0 0.004209287464618683
( O 0 0.006165180820971727
2 O 0 0.006065045483410358
) O 0 0.0058161974884569645
within O 0 0.00617856765165925
exon O 0 0.024243991822004318
9 O 0 0.00890002865344286
, O 0 0.004311579745262861
and O 0 0.0038952003233134747
( O 0 0.0068338243290781975
3 O 0 0.0071571143344044685
) O 0 0.004517411347478628
at O 0 0.0037891690153628588
the O 0 0.004085046239197254
3 O 0 0.01045737974345684
distal O 0 0.30696752667427063
end O 0 0.009998229332268238
of O 0 0.006195960566401482
the O 0 0.009706322103738785
gene O 0 0.055906038731336594
. O 0 0.02603002078831196

Variability O 0 0.09396510571241379
in O 0 0.01246738899499178
the O 0 0.008364911191165447
number O 0 0.01050370093435049
of O 0 0.013427799567580223
colorectal B-Disease 1 0.9999982118606567
adenomas I-Disease 1 0.9999233484268188
was O 0 0.010129588656127453
most O 0 0.007195136044174433
apparent O 0 0.017196157947182655
in O 0 0.005284683778882027
individuals O 0 0.009092452935874462
with O 0 0.006359708495438099
mutations O 0 0.07863817363977432
in O 0 0.005873836111277342
region O 0 0.011225078254938126
1 O 0 0.007445461582392454
, O 0 0.004793603904545307
and O 0 0.006051521748304367
upper O 1 0.7054022550582886
- O 1 0.9945780038833618
gastrointestinal O 1 0.99997878074646
manifestations O 1 0.861557126045227
were O 0 0.0070046670734882355
more O 0 0.00757620157673955
severe O 1 0.7266102433204651
in O 0 0.009526138193905354
them O 0 0.010894447565078735
. O 0 0.020122958347201347

In O 0 0.01863846741616726
individuals O 0 0.017379166558384895
with O 0 0.010582813993096352
mutations O 0 0.0779624655842781
in O 0 0.00671420618891716
either O 0 0.00749255670234561
region O 0 0.010998379439115524
2 O 0 0.006969393230974674
or O 0 0.006011112127453089
region O 0 0.010580716654658318
3 O 0 0.00631435913965106
, O 0 0.0035831190180033445
the O 0 0.0034899022430181503
average O 0 0.007618581410497427
number O 0 0.005348436068743467
of O 0 0.006120521109551191
adenomas B-Disease 1 0.993655800819397
tended O 0 0.017923252657055855
to O 0 0.0049703409895300865
be O 0 0.003302409779280424
lower O 0 0.007438691332936287
than O 0 0.0036858106032013893
those O 0 0.003750306088477373
in O 0 0.0036012993659824133
individuals O 0 0.00782062392681837
with O 0 0.00680239824578166
mutations O 0 0.04686430096626282
in O 0 0.0065773786045610905
region O 0 0.012859122827649117
1 O 0 0.008820934221148491
, O 0 0.005833720788359642
although O 0 0.00838222075253725
age O 0 0.012559211812913418
at O 0 0.0114070363342762
diagnosis O 1 0.980205237865448
was O 0 0.010167660191655159
similar O 0 0.019142944365739822
. O 0 0.0183203537017107

In O 0 0.0287873987108469
all O 0 0.02228735387325287
AAPC B-Disease 1 0.998313307762146
kindreds O 1 0.8058254718780518
, O 0 0.013962562195956707
a O 0 0.013141032308340073
predominance O 0 0.051687803119421005
of O 0 0.01206360012292862
right O 0 0.0648420974612236
- O 1 0.9972965121269226
sided O 1 0.9997624754905701
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999959468841553
and O 0 0.3812117874622345
rectal B-Disease 1 0.9999830722808838
polyp I-Disease 1 0.9999350309371948
sparing O 1 0.8912325501441956
was O 0 0.025644363835453987
observed O 0 0.04562602937221527
. O 0 0.031181838363409042

No O 0 0.052270252257585526
desmoid B-Disease 1 0.9802553653717041
tumors I-Disease 1 0.9993372559547424
were O 0 0.010021641850471497
found O 0 0.010174853727221489
in O 0 0.007903926074504852
these O 0 0.012047499418258667
kindreds O 0 0.3861768841743469
. O 0 0.03271882236003876

Our O 0 0.021887708455324173
data O 0 0.013554394245147705
suggest O 0 0.014932671561837196
that O 0 0.0056974031031131744
, O 0 0.006491073407232761
in O 0 0.007700586691498756
AAPC B-Disease 1 0.9987401366233826
families O 0 0.01358944084495306
, O 0 0.005252439994364977
the O 0 0.0043094465509057045
location O 0 0.006883708760142326
of O 0 0.0051951021887362
the O 0 0.00963011384010315
APC B-Disease 1 0.8504241704940796
mutation O 1 0.9112598299980164
may O 0 0.02483116090297699
partially O 0 0.03986082971096039
predict O 0 0.04076049104332924
specific O 0 0.02448469214141369
phenotypic O 0 0.06998735666275024
expression O 0 0.05091622471809387
. O 0 0.02965758740901947

This O 0 0.016370713710784912
should O 0 0.00983570609241724
help O 0 0.010697728954255581
in O 0 0.00484464131295681
the O 0 0.004642008803784847
design O 0 0.008611341007053852
of O 0 0.005724810063838959
tailored O 0 0.03933024778962135
clinical O 1 0.8882311582565308
- O 0 0.1742337942123413
management O 0 0.022491950541734695
protocols O 0 0.019299233332276344
in O 0 0.0064389873296022415
this O 0 0.00691288011148572
subset O 0 0.028566710650920868
of O 0 0.013138397596776485
FAP B-Disease 1 0.9999305009841919
patients O 1 0.999126136302948
. O 0 0.018239013850688934
. O 0 0.022052112966775894

Wilms B-Disease 1 0.9987006187438965
' I-Disease 1 0.5526514649391174
tumor I-Disease 1 0.9918531775474548
1 O 0 0.0263980720192194
and O 0 0.014370612800121307
Dax O 0 0.2163490355014801
- O 0 0.04964858293533325
1 O 0 0.019881784915924072
modulate O 0 0.09943826496601105
the O 0 0.014368019066751003
orphan O 1 0.8688635230064392
nuclear O 0 0.04718851298093796
receptor O 1 0.7940618395805359
SF O 1 0.9754595756530762
- O 0 0.04199676588177681
1 O 0 0.015094391070306301
in O 0 0.009480481967329979
sex O 0 0.025850070640444756
- O 0 0.03996926546096802
specific O 0 0.022600220516324043
gene O 0 0.07282278686761856
expression O 0 0.04657739773392677
. O 0 0.025624914094805717

Products O 0 0.04767794534564018
of O 0 0.024077659472823143
steroidogenic O 1 0.984889566898346
factor O 0 0.05656156688928604
1 O 0 0.0232764333486557
( O 0 0.026717757806181908
SF O 1 0.9805701375007629
- O 0 0.049392085522413254
1 O 0 0.01581374555826187
) O 0 0.013822832144796848
and O 0 0.014139067381620407
Wilms B-Disease 1 0.9998390674591064
tumor I-Disease 1 0.9992212057113647
1 O 0 0.02180812880396843
( O 0 0.023810287937521935
WT1 O 1 0.9857448935508728
) O 0 0.014340493828058243
genes O 0 0.024575652554631233
are O 0 0.005314195994287729
essential O 0 0.009018604643642902
for O 0 0.006136658135801554
mammalian O 0 0.045499760657548904
gonadogenesis O 0 0.108835369348526
prior O 0 0.014283370226621628
to O 0 0.008865831419825554
sexual O 0 0.0290211271494627
differentiation O 0 0.0654781237244606
. O 0 0.026590408757328987

In O 0 0.02795323170721531
males O 0 0.050392135977745056
, O 0 0.018039293587207794
SF O 1 0.9791722893714905
- O 0 0.040209535509347916
1 O 0 0.012891885824501514
participates O 0 0.02040006034076214
in O 0 0.006370928604155779
sexual O 0 0.015497077256441116
development O 0 0.009711310267448425
by O 0 0.006912591867148876
regulating O 0 0.024898909032344818
expression O 0 0.01901661418378353
of O 0 0.008035913109779358
the O 0 0.012846296653151512
polypeptide O 1 0.5656424164772034
hormone O 1 0.9979493021965027
Mullerian O 1 0.9989388585090637
inhibiting O 1 0.9892278909683228
substance O 1 0.9165391325950623
( O 0 0.06059075891971588
MIS O 1 0.9823102355003357
) O 0 0.034214287996292114
. O 0 0.025729462504386902

Here O 0 0.021874219179153442
, O 0 0.011739675886929035
we O 0 0.009451357647776604
show O 0 0.016071302816271782
that O 0 0.013766124844551086
WT1 O 1 0.9882118105888367
- O 0 0.49886396527290344
KTS O 1 0.9822346568107605
isoforms O 0 0.07468122988939285
associate O 0 0.03378555178642273
and O 0 0.014860465191304684
synergize O 1 0.625722348690033
with O 0 0.020578691735863686
SF O 1 0.9172329306602478
- O 0 0.04249740391969681
1 O 0 0.01688634604215622
to O 0 0.010817652568221092
promote O 0 0.029002834111452103
MIS O 1 0.8641074895858765
expression O 0 0.057417452335357666
. O 0 0.034103699028491974

In O 0 0.031999554485082626
contrast O 0 0.053005363792181015
, O 0 0.030279239639639854
WT1 O 1 0.9969989061355591
missense O 1 0.9744579792022705
mutations O 1 0.7337920665740967
, O 0 0.014334510080516338
associated O 0 0.017380256205797195
with O 0 0.01276606135070324
male B-Disease 0 0.036713968962430954
pseudohermaphroditism I-Disease 1 0.9895853400230408
in O 0 0.017729662358760834
Denys B-Disease 1 0.9995520710945129
- I-Disease 1 0.9992456436157227
Drash I-Disease 1 0.9997708201408386
syndrome I-Disease 1 0.9999980926513672
, O 0 0.01838669739663601
fail O 0 0.04576251283288002
to O 0 0.013576273806393147
synergize O 1 0.774782121181488
with O 0 0.019459541887044907
SF O 1 0.986221432685852
- O 0 0.06957152485847473
1 O 0 0.03087538480758667
. O 0 0.02985641360282898

Additionally O 0 0.03960026800632477
, O 0 0.01548396609723568
the O 0 0.011534128338098526
X O 0 0.03662519156932831
- O 0 0.03967708349227905
linked O 0 0.026679083704948425
, O 0 0.009747341275215149
candidate O 0 0.01731613650918007
dosage O 1 0.9660350680351257
- O 0 0.2411332130432129
sensitive O 0 0.02746131643652916
sex O 0 0.04321729391813278
- O 1 0.5830087661743164
reversal O 0 0.4186089336872101
gene O 0 0.08826139569282532
, O 0 0.014157183468341827
Dax O 0 0.3887603282928467
- O 0 0.046722427010536194
1 O 0 0.01873193122446537
, O 0 0.012690344825387001
antagonizes O 1 0.7393038272857666
synergy O 0 0.23958654701709747
between O 0 0.02171209827065468
SF O 1 0.9841673970222473
- O 0 0.04559847339987755
1 O 0 0.015897512435913086
and O 0 0.009974765591323376
WT1 O 1 0.8569727540016174
, O 0 0.006938247010111809
most O 0 0.00535391503944993
likely O 0 0.008532979525625706
through O 0 0.0062962002120912075
a O 0 0.005972460377961397
direct O 0 0.01132868230342865
interaction O 0 0.01828058622777462
with O 0 0.013419149443507195
SF O 1 0.9699320793151855
- O 0 0.0561441071331501
1 O 0 0.024001281708478928
. O 0 0.021379418671131134

We O 0 0.030486490577459335
propose O 0 0.04888765513896942
that O 0 0.0173443965613842
WT1 O 1 0.8458076119422913
and O 0 0.015040679834783077
Dax O 0 0.338886022567749
- O 0 0.040494486689567566
1 O 0 0.016254067420959473
functionally O 0 0.033191900700330734
oppose O 0 0.017095467075705528
each O 0 0.005170123651623726
other O 0 0.0053221918642520905
in O 0 0.007550374139100313
testis O 0 0.4829047620296478
development O 0 0.0198021549731493
by O 0 0.015509828925132751
modulating O 1 0.8215641379356384
SF O 1 0.9943059086799622
- O 0 0.15777336061000824
1 O 0 0.030025141313672066
- O 0 0.10377317667007446
mediated O 1 0.5125356912612915
transactivation O 1 0.8700220584869385
. O 0 0.025257224217057228
. O 0 0.02826225385069847

A O 0 0.04593786969780922
mouse O 0 0.09867572784423828
model O 0 0.043790869414806366
for O 0 0.03588475286960602
Prader B-Disease 1 0.999993085861206
- I-Disease 1 0.9999123811721802
Willi I-Disease 1 0.9999974966049194
syndrome I-Disease 1 0.9999992847442627
imprinting O 1 0.9983896017074585
- O 1 0.9378270506858826
centre O 0 0.07298168540000916
mutations O 1 0.8146984577178955
. O 0 0.038527701050043106

Imprinting O 0 0.20141726732254028
in O 0 0.01984088309109211
the O 0 0.01733371987938881
15q11 O 0 0.21583035588264465
- O 0 0.08731590956449509
q13 O 0 0.12544624507427216
region O 0 0.028313182294368744
involves O 0 0.02559162862598896
an O 0 0.011312431655824184
imprinting O 0 0.46166741847991943
centre O 0 0.022421270608901978
( O 0 0.01522160042077303
IC O 0 0.2942523658275604
) O 0 0.009211424738168716
, O 0 0.004679288249462843
mapping O 0 0.010547571815550327
in O 0 0.003900120733305812
part O 0 0.004995245020836592
to O 0 0.004062497988343239
the O 0 0.005020997021347284
promoter O 0 0.025680022314190865
and O 0 0.00736306793987751
first O 0 0.009766687639057636
exon O 0 0.05660690367221832
of O 0 0.017512839287519455
SNRPN O 0 0.33316341042518616
. O 0 0.030131908133625984

Deletion O 0 0.12999506294727325
of O 0 0.0197298564016819
this O 0 0.019875314086675644
IC O 1 0.6161952018737793
abolishes O 0 0.2932232916355133
local O 0 0.020028401166200638
paternally O 0 0.09083057940006256
derived O 0 0.02988944947719574
gene O 0 0.05105091631412506
expression O 0 0.02265065722167492
and O 0 0.008292767219245434
results O 0 0.019363462924957275
in O 0 0.021260904148221016
Prader B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999597072601318
Willi I-Disease 1 0.9999986886978149
syndrome I-Disease 1 0.9999996423721313
( O 1 0.9115548133850098
PWS B-Disease 1 0.9998970031738281
) O 0 0.042121775448322296
. O 0 0.034374479204416275

We O 0 0.01990661956369877
have O 0 0.011413796804845333
created O 0 0.01534934900701046
two O 0 0.01068117842078209
deletion O 0 0.325510710477829
mutations O 0 0.4190826416015625
in O 0 0.011857186444103718
mice O 0 0.19512182474136353
to O 0 0.01097932830452919
understand O 0 0.023067642003297806
PWS B-Disease 1 0.9993593096733093
and O 0 0.007144811563193798
the O 0 0.005756812170147896
mechanism O 0 0.018244588747620583
of O 0 0.007236517034471035
this O 0 0.011011986993253231
IC O 0 0.2677193582057953
. O 0 0.026722637936472893

Mice O 1 0.9058735370635986
harbouring O 1 0.5995290279388428
an O 0 0.028102755546569824
intragenic O 0 0.4287523031234741
deletion O 0 0.18698742985725403
in O 0 0.01664550043642521
Snrpn O 0 0.16883529722690582
are O 0 0.012886229902505875
phenotypically O 0 0.10412579774856567
normal O 0 0.02228715270757675
, O 0 0.008906777948141098
suggesting O 0 0.017686564475297928
that O 0 0.007115833926945925
mutations O 0 0.05367644503712654
of O 0 0.006779668852686882
SNRPN O 0 0.10102447122335434
are O 0 0.005723734851926565
not O 0 0.006444846745580435
sufficient O 0 0.01586138643324375
to O 0 0.013580648228526115
induce O 1 0.5785692930221558
PWS B-Disease 1 0.9992493987083435
. O 0 0.04666030779480934

Mice O 0 0.21675275266170502
with O 0 0.018888939172029495
a O 0 0.017213011160492897
larger O 0 0.023575853556394577
deletion O 0 0.06165632978081703
involving O 0 0.02465401403605938
both O 0 0.014392539858818054
Snrpn O 0 0.07320072501897812
and O 0 0.010594477877020836
the O 0 0.013493526726961136
putative O 1 0.8721787333488464
PWS O 1 0.9999624490737915
- O 1 0.8920320868492126
IC O 1 0.8893133401870728
lack O 0 0.024609120562672615
expression O 0 0.018275730311870575
of O 0 0.00657225726172328
the O 0 0.01042657159268856
imprinted O 0 0.07846341282129288
genes O 0 0.07800158858299255
Zfp127 O 1 0.6461164355278015
( O 0 0.027989352121949196
mouse O 0 0.07264714688062668
homologue O 0 0.08215447515249252
of O 0 0.016223758459091187
ZNF127 O 1 0.6451238989830017
) O 0 0.018942544236779213
, O 0 0.012764559127390385
Ndn O 1 0.79060959815979
and O 0 0.010569452308118343
Ipw O 0 0.04685930535197258
, O 0 0.008070476353168488
and O 0 0.007514758501201868
manifest O 0 0.022131238132715225
several O 0 0.010741190053522587
phenotypes O 1 0.5964599847793579
common O 0 0.029722070321440697
to O 0 0.023875495418906212
PWS B-Disease 1 0.9999511241912842
infants O 1 0.9958451390266418
. O 0 0.03685440868139267

These O 0 0.014289011247456074
data O 0 0.0099055590108037
demonstrate O 0 0.01053374819457531
that O 0 0.003177451901137829
both O 0 0.002633020980283618
the O 0 0.002294665202498436
position O 0 0.003783878870308399
of O 0 0.002664231462404132
the O 0 0.003511402988806367
IC O 0 0.026610320433974266
and O 0 0.003313259920105338
its O 0 0.003128275740891695
role O 0 0.005308165214955807
in O 0 0.0034802870359271765
the O 0 0.0040177106857299805
coordinate O 0 0.01726493053138256
expression O 0 0.014191605150699615
of O 0 0.006000426597893238
genes O 0 0.021149493753910065
is O 0 0.007280945777893066
conserved O 0 0.014786964282393456
between O 0 0.00885326974093914
mouse O 0 0.025485176593065262
and O 0 0.004765128251165152
human O 0 0.006531951949000359
, O 0 0.003300498705357313
and O 0 0.003180130384862423
indicate O 0 0.006684360094368458
that O 0 0.0027633982244879007
the O 0 0.0036111099179834127
mouse O 0 0.01873474195599556
is O 0 0.0037990764249116182
a O 0 0.004166857805103064
suitable O 0 0.008160986937582493
model O 0 0.007439128123223782
system O 0 0.005684025585651398
in O 0 0.002958088181912899
which O 0 0.0029404519591480494
to O 0 0.003586342791095376
investigate O 0 0.009736066684126854
the O 0 0.005042554344981909
molecular O 0 0.01697240211069584
mechanisms O 0 0.017222192138433456
of O 0 0.005660828668624163
imprinting O 0 0.0410340391099453
in O 0 0.005173176527023315
this O 0 0.0038830451667308807
region O 0 0.008434955962002277
of O 0 0.004224624950438738
the O 0 0.006711097434163094
genome O 0 0.03684254363179207
. O 0 0.015189534053206444
. O 0 0.02151487208902836

Mutations O 0 0.2027686983346939
of O 0 0.020793305709958076
the O 0 0.019120335578918457
ATM O 0 0.09395257383584976
gene O 0 0.14766660332679749
detected O 0 0.08233898878097534
in O 0 0.015963247045874596
Japanese O 0 0.24334365129470825
ataxia B-Disease 1 0.9999971389770508
- I-Disease 1 0.9998314380645752
telangiectasia I-Disease 1 0.9999915361404419
patients O 1 0.9997566342353821
: O 0 0.016227837651968002
possible O 0 0.01266517024487257
preponderance O 0 0.03130383417010307
of O 0 0.005045550409704447
the O 0 0.0060287718661129475
two O 0 0.008532592095434666
founder O 0 0.033615872263908386
mutations O 1 0.5912983417510986
4612del165 O 0 0.18430516123771667
and O 0 0.019015971571207047
7883del5 O 0 0.12218873202800751
. O 0 0.031192423775792122

The O 0 0.030627842992544174
ATM O 0 0.07320650666952133
( O 0 0.027141695842146873
A O 0 0.02457675151526928
- O 1 0.7070903182029724
T O 1 0.9922493696212769
, O 0 0.01564614661037922
mutated O 0 0.09616047143936157
) O 0 0.017171204090118408
gene O 0 0.03785543143749237
on O 0 0.01058605033904314
human O 0 0.026382947340607643
chromosome O 1 0.6324267387390137
11q22 O 0 0.29333794116973877
. O 0 0.03106984682381153

3 O 0 0.03258129954338074
has O 0 0.013555898331105709
recently O 0 0.014608241617679596
been O 0 0.006747807841747999
identified O 0 0.008218628354370594
as O 0 0.004349609836935997
the O 0 0.004406027961522341
gene O 0 0.02110316976904869
responsible O 0 0.011185728013515472
for O 0 0.0056357295252382755
the O 0 0.008301076479256153
human O 0 0.4988328516483307
recessive B-Disease 1 0.9999964237213135
disease I-Disease 1 0.9999997615814209
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9997450709342957
telangiectasia I-Disease 1 0.9999604225158691
( O 0 0.07335241883993149
A B-Disease 0 0.04641783982515335
- I-Disease 1 0.9394615292549133
T I-Disease 1 0.9958317875862122
) O 0 0.02871393784880638
. O 0 0.025585029274225235

In O 0 0.015200122259557247
order O 0 0.011499066837131977
to O 0 0.006338104605674744
define O 0 0.013933653011918068
the O 0 0.006662354338914156
types O 0 0.016126424074172974
of O 0 0.010399728082120419
disease O 1 0.9999798536300659
- O 1 0.980626106262207
causing O 1 0.884535551071167
ATM O 1 0.6437170505523682
mutations O 1 0.5466213226318359
in O 0 0.009256829507648945
Japanese O 0 0.014899028465151787
A B-Disease 0 0.02323690429329872
- I-Disease 1 0.9906061291694641
T I-Disease 1 0.9997937083244324
patients O 1 0.9914406538009644
as O 0 0.004078314173966646
well O 0 0.003654696512967348
as O 0 0.003189866431057453
to O 0 0.0036791940219700336
look O 0 0.008197564631700516
for O 0 0.005780317354947329
possible O 0 0.016289621591567993
mutational O 1 0.860684335231781
hotspots O 0 0.11817319691181183
, O 0 0.012068449519574642
reverse O 0 0.03347523882985115
- O 0 0.03887304663658142
transcribed O 0 0.03934464603662491
RNA O 0 0.040278445929288864
derived O 0 0.01865242049098015
from O 0 0.008723350241780281
ten O 0 0.011055965907871723
patients O 0 0.4748811721801758
belonging O 0 0.013829738833010197
to O 0 0.0056698378175497055
eight O 0 0.008955704048275948
unrelated O 0 0.01889188215136528
Japanese O 0 0.016293976455926895
A B-Disease 0 0.019429488107562065
- I-Disease 1 0.5774793028831482
T I-Disease 1 0.9911314845085144
families O 0 0.01656506583094597
was O 0 0.007201229687780142
analyzed O 0 0.014356651343405247
for O 0 0.007438539527356625
mutations O 0 0.04738806560635567
by O 0 0.00861771497875452
the O 0 0.010666721500456333
restriction O 0 0.04429538920521736
endonuclease O 0 0.44651487469673157
fingerprinting O 0 0.08461569249629974
method O 0 0.04578414559364319
. O 0 0.02964373677968979

As O 0 0.01499826181679964
has O 0 0.00872973632067442
been O 0 0.005891906563192606
reported O 0 0.008344130590558052
by O 0 0.004856855142861605
others O 0 0.007466326933354139
, O 0 0.006954933982342482
mutations O 0 0.0470496267080307
that O 0 0.0058106305077672005
lead O 0 0.012184309773147106
to O 0 0.007136555854231119
exon O 0 0.04941277578473091
skipping O 0 0.04854610189795494
or O 0 0.019794616848230362
premature O 1 0.69086754322052
protein O 0 0.0342167466878891
truncation O 0 0.037871815264225006
were O 0 0.0064410679042339325
also O 0 0.006828279700130224
predominant O 0 0.017199020832777023
in O 0 0.007646673824638128
our O 0 0.01318457443267107
mutants O 0 0.05918761342763901
. O 0 0.027369167655706406

Six O 0 0.02936476841568947
different O 0 0.017478076741099358
mutations O 0 0.05315861105918884
were O 0 0.007033814676105976
identified O 0 0.009549828246235847
on O 0 0.004058363847434521
12 O 0 0.006595999002456665
of O 0 0.0039487360045313835
the O 0 0.006319866515696049
16 O 0 0.016809256747364998
alleles O 0 0.13649259507656097
examined O 0 0.049974843859672546
. O 0 0.026058942079544067

Four O 0 0.022117482498288155
were O 0 0.012460497207939625
deletions O 0 0.04683201014995575
involving O 0 0.022030508145689964
a O 0 0.009374518878757954
loss O 0 0.016316616907715797
of O 0 0.0054269591346383095
a O 0 0.008013373240828514
single O 0 0.01549405138939619
exon O 0 0.0530996210873127
exon O 0 0.06193076819181442
7 O 0 0.017463622614741325
, O 0 0.010335827246308327
exon O 0 0.04215705394744873
16 O 0 0.016222182661294937
, O 0 0.010886112228035927
exon O 0 0.054443951696157455
33 O 0 0.024842271581292152
or O 0 0.01741081476211548
exon O 0 0.07147099822759628
35 O 0 0.03524089977145195
. O 0 0.025901377201080322

The O 0 0.020564135164022446
others O 0 0.016822556033730507
were O 0 0.009207473136484623
minute O 0 0.022061031311750412
deletions O 0 0.0403091199696064
, O 0 0.01032017171382904
4649delA O 0 0.04029383882880211
in O 0 0.010419286787509918
exon O 0 0.0544162318110466
33 O 0 0.023332953453063965
and O 0 0.011530138552188873
7883del5 O 0 0.05377069115638733
in O 0 0.015037160366773605
exon O 0 0.07539646327495575
55 O 0 0.0424656867980957
. O 0 0.030855512246489525

The O 0 0.03308331221342087
mutations O 1 0.6498833298683167
4612del165 O 0 0.08504553139209747
and O 0 0.010385235771536827
7883del5 O 0 0.03738971799612045
were O 0 0.004667423665523529
found O 0 0.004969139117747545
in O 0 0.0037820565048605204
more O 0 0.0029936383944004774
than O 0 0.003606334561482072
two O 0 0.004094230011105537
unrelated O 0 0.012781322002410889
families O 0 0.01039324700832367
; O 0 0.007913054898381233
44 O 0 0.009292284026741982
% O 0 0.008376732468605042
( O 0 0.006731763947755098
7 O 0 0.005848712753504515
of O 0 0.0030695712193846703
16 O 0 0.0056744772009551525
) O 0 0.004506454337388277
of O 0 0.00290147983469069
the O 0 0.004588677082210779
mutant O 0 0.029173551127314568
alleles O 0 0.053120121359825134
had O 0 0.006781832780689001
one O 0 0.004794511944055557
of O 0 0.004495993256568909
the O 0 0.007146455813199282
two O 0 0.01146855391561985
mutations O 0 0.1341882348060608
. O 0 0.025182504206895828

The O 0 0.03084125556051731
4612del165 O 0 0.14264005422592163
mutations O 0 0.07146193087100983
in O 0 0.008328087627887726
three O 0 0.005067107267677784
different O 0 0.005023332312703133
families O 0 0.007012405898422003
were O 0 0.0028465779032558203
all O 0 0.00303923012688756
ascribed O 0 0.013836665078997612
to O 0 0.004066722001880407
the O 0 0.005196418147534132
same O 0 0.010678760707378387
T O 1 0.9644895195960999
- O 0 0.4531526267528534
- O 0 0.24632170796394348
> O 0 0.08229482918977737
A O 0 0.01360377762466669
substitution O 0 0.028492186218500137
at O 0 0.011021027341485023
the O 0 0.009157516062259674
splice O 0 0.058416955173015594
donor O 0 0.0499429777264595
site O 0 0.016280867159366608
in O 0 0.013639259152114391
intron O 0 0.4726271629333496
33 O 0 0.04731189087033272
. O 0 0.03442712873220444

Microsatellite O 1 0.6052164435386658
genotyping O 0 0.16008873283863068
around O 0 0.025991208851337433
the O 0 0.014562488533556461
ATM O 0 0.05508996918797493
locus O 0 0.04884558916091919
also O 0 0.009237183257937431
indicated O 0 0.014833732508122921
that O 0 0.006178892217576504
a O 0 0.00776415690779686
common O 0 0.01582159847021103
haplotype O 0 0.4704110324382782
was O 0 0.006995168048888445
shared O 0 0.008537378162145615
by O 0 0.005658022128045559
the O 0 0.007374665234237909
mutant O 0 0.04118836298584938
alleles O 0 0.07711827009916306
in O 0 0.011749904602766037
both O 0 0.016402648761868477
mutations O 0 0.42069733142852783
. O 0 0.02973981201648712

This O 0 0.01730031706392765
suggests O 0 0.022212814539670944
that O 0 0.006666281726211309
these O 0 0.005445722956210375
two O 0 0.006773250177502632
founder O 0 0.020413612946867943
mutations O 0 0.18765699863433838
may O 0 0.012707814574241638
be O 0 0.005909612402319908
predominant O 0 0.02090008743107319
among O 0 0.011522076092660427
Japanese O 0 0.025097044184803963
ATM O 0 0.0785469114780426
mutant O 0 0.10305805504322052
alleles O 0 0.3871499300003052
. O 0 0.043571267277002335

W474C O 0 0.29563361406326294
amino O 0 0.11756861954927444
acid O 0 0.18736279010772705
substitution O 0 0.068404920399189
affects O 0 0.08727774769067764
early O 0 0.014822949655354023
processing O 0 0.011400289833545685
of O 0 0.005900852847844362
the O 0 0.008427521213889122
alpha O 0 0.024826137349009514
- O 0 0.028641648590564728
subunit O 0 0.039372269064188004
of O 0 0.009994865395128727
beta O 0 0.028178654611110687
- O 0 0.03555962070822716
hexosaminidase O 0 0.049204420298337936
A O 0 0.00940773542970419
and O 0 0.005456621292978525
is O 0 0.0065942127257585526
associated O 0 0.013249526731669903
with O 0 0.013833822682499886
subacute O 1 0.99980229139328
G B-Disease 1 0.9141635894775391
( I-Disease 0 0.03228641673922539
M2 I-Disease 0 0.2686663866043091
) I-Disease 0 0.029933711513876915
gangliosidosis I-Disease 0 0.24183820188045502
. O 0 0.03269929438829422

Mutations O 0 0.3232007324695587
in O 0 0.019172020256519318
the O 0 0.018174748867750168
HEXA O 1 0.9909231066703796
gene O 0 0.05820314213633537
, O 0 0.012152515351772308
encoding O 0 0.022453954443335533
the O 0 0.0086051719263196
alpha O 0 0.02865937165915966
- O 0 0.030337000265717506
subunit O 0 0.039239928126335144
of O 0 0.009757505729794502
beta O 0 0.03406601399183273
- O 0 0.043521542102098465
hexosaminidase O 0 0.07956316322088242
A O 0 0.0158054418861866
( O 0 0.013341056182980537
Hex O 0 0.023710034787654877
A O 0 0.008003485389053822
) O 0 0.006674849893897772
, O 0 0.005129113327711821
that O 0 0.005060634110122919
abolish O 0 0.024823714047670364
Hex O 0 0.03445230424404144
A O 0 0.017368078231811523
enzyme O 0 0.34101709723472595
activity O 1 0.5080579519271851
cause O 1 0.9996515512466431
Tay B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999219179153442
Sachs I-Disease 1 0.9999861717224121
disease I-Disease 1 0.9999939203262329
( O 0 0.3066389858722687
TSD B-Disease 1 0.9992409944534302
) O 0 0.01807183027267456
, O 0 0.00868433527648449
the O 0 0.011091349646449089
fatal O 1 0.9955722093582153
infantile B-Disease 1 0.9988732933998108
form I-Disease 0 0.020493675023317337
of I-Disease 0 0.01115525234490633
G I-Disease 0 0.34169963002204895
( I-Disease 0 0.020190060138702393
M2 I-Disease 0 0.16288290917873383
) I-Disease 0 0.01766638644039631
gangliosidosis I-Disease 0 0.06969102472066879
, I-Disease 0 0.012563351541757584
Type I-Disease 0 0.028812231495976448
1 I-Disease 0 0.021053120493888855
. O 0 0.019788185134530067

Less O 0 0.07481022924184799
severe O 1 0.9985727071762085
, O 0 0.052254509180784225
subacute O 1 0.9999598264694214
( O 1 0.6920782923698425
juvenile O 1 0.9991227984428406
- O 1 0.9983969330787659
onset O 1 0.999890923500061
) O 0 0.021473079919815063
and O 0 0.013519830070436
chronic O 1 0.9999831914901733
( O 0 0.03727254271507263
adult O 0 0.2293318659067154
- O 1 0.9845259189605713
onset O 1 0.9993306398391724
) O 0 0.015797166153788567
variants O 0 0.01863943412899971
are O 0 0.0054366709664464
characterized O 0 0.019116222858428955
by O 0 0.0053031425923109055
a O 0 0.007813507691025734
broad O 0 0.019910816103219986
spectrum O 0 0.024345247074961662
of O 0 0.007249738555401564
clinical O 1 0.7835981845855713
manifestations O 0 0.1441648304462433
and O 0 0.004994818940758705
are O 0 0.004313614685088396
associated O 0 0.00846985261887312
with O 0 0.006473795510828495
residual O 0 0.03373432904481888
levels O 0 0.0186415184289217
of O 0 0.00848436914384365
Hex O 0 0.037285804748535156
A O 0 0.018615327775478363
enzyme O 0 0.0545588843524456
activity O 0 0.038858089596033096
. O 0 0.02735826000571251

We O 0 0.028266530483961105
identified O 0 0.033617787063121796
a O 0 0.026675555855035782
1422 O 1 0.9779261946678162
G O 1 0.8444043397903442
- O 1 0.7670249342918396
- O 1 0.7164188027381897
> O 1 0.7038971185684204
C O 0 0.06751923263072968
( O 0 0.02398631162941456
amino O 0 0.039676323533058167
acid O 0 0.06670577824115753
W474C O 0 0.05641444772481918
) O 0 0.010478870943188667
substitution O 0 0.015433882363140583
in O 0 0.004017672501504421
the O 0 0.0038043351378291845
first O 0 0.004058660939335823
position O 0 0.00613380828872323
of O 0 0.005337375216186047
exon O 0 0.032453350722789764
13 O 0 0.011149122379720211
of O 0 0.00698726624250412
HEXA O 1 0.8026633262634277
of O 0 0.007550145033746958
a O 0 0.010336607694625854
non O 0 0.02019866183400154
- O 0 0.046427641063928604
Jewish O 0 0.027024367824196815
proband O 0 0.40920165181159973
who O 0 0.02070852927863598
manifested O 0 0.09219080954790115
a O 0 0.02546539716422558
subacute O 1 0.999312162399292
variant O 0 0.17273859679698944
of O 0 0.016754435375332832
G B-Disease 0 0.4404201805591583
( I-Disease 0 0.028321344405412674
M2 I-Disease 0 0.1979425698518753
) I-Disease 0 0.02646249532699585
gangliosidosis I-Disease 0 0.1415930837392807
. O 0 0.033942513167858124

On O 0 0.018819067627191544
the O 0 0.014685110189020634
second O 0 0.020415613427758217
maternally O 0 0.21736003458499908
inherited O 1 0.5892773270606995
allele O 0 0.15588220953941345
, O 0 0.011789926327764988
we O 0 0.008275291882455349
identified O 0 0.011553873308002949
the O 0 0.008656051941215992
common O 0 0.31183871626853943
infantile O 1 0.9999948740005493
disease O 1 0.9999970197677612
- O 1 0.9907530546188354
causing O 1 0.6753116846084595
4 O 0 0.023230263963341713
- O 0 0.09100687503814697
bp O 0 0.06469614803791046
insertion O 0 0.16879808902740479
, O 0 0.01942582242190838
+ O 0 0.22480855882167816
TATC O 1 0.8541079759597778
1278 O 1 0.5622899532318115
, O 0 0.01487508974969387
in O 0 0.013604208827018738
exon O 0 0.06826287508010864
11 O 0 0.033783022314310074
. O 0 0.027633480727672577

Pulse O 1 0.5180602669715881
- O 0 0.10055828839540482
chase O 0 0.07096496969461441
analysis O 0 0.03089301288127899
using O 0 0.020489685237407684
proband O 0 0.29174095392227173
fibroblasts O 0 0.3535059690475464
revealed O 0 0.02184126526117325
that O 0 0.006995863746851683
the O 0 0.008489713072776794
W474C O 0 0.051440030336380005
- O 0 0.03320641815662384
containing O 0 0.01910463534295559
alpha O 0 0.034051988273859024
- O 0 0.03925224393606186
subunit O 0 0.04971640184521675
precursor O 0 0.03418862819671631
was O 0 0.009344561025500298
normally O 0 0.013784372247755527
synthesized O 0 0.021564127877354622
, O 0 0.005618866533041
but O 0 0.004454728215932846
not O 0 0.00483768992125988
phosphorylated O 0 0.025906413793563843
or O 0 0.009368092752993107
secreted O 0 0.023936070501804352
, O 0 0.0048979115672409534
and O 0 0.004705948289483786
the O 0 0.007323343772441149
mature O 0 0.0387566015124321
lysosomal O 1 0.898982048034668
alpha O 0 0.0398128442466259
- O 0 0.04020121321082115
subunit O 0 0.04346920922398567
was O 0 0.011601723730564117
not O 0 0.009906544350087643
detected O 0 0.04825732484459877
. O 0 0.023276519030332565

When O 0 0.03153696283698082
the O 0 0.020029304549098015
W474C O 0 0.07631717622280121
- O 0 0.042739059776067734
containing O 0 0.024401264265179634
alpha O 0 0.04147261008620262
- O 0 0.045209284871816635
subunit O 0 0.049458470195531845
was O 0 0.01233662199229002
transiently O 0 0.14683368802070618
co O 0 0.03624675050377846
- O 0 0.025194700807332993
expressed O 0 0.010550339706242085
with O 0 0.006054659839719534
the O 0 0.0067757233045995235
beta O 0 0.02506590075790882
- O 0 0.025049034506082535
subunit O 0 0.02743406966328621
to O 0 0.0073378621600568295
produce O 0 0.011917917989194393
Hex O 0 0.028959235176444054
A O 0 0.010453300550580025
( O 0 0.013124358840286732
alphabeta O 0 0.04539208114147186
) O 0 0.009888638742268085
in O 0 0.008008393459022045
COS O 1 0.9613932371139526
- O 0 0.039504025131464005
7 O 0 0.015484053641557693
cells O 0 0.024698220193386078
, O 0 0.005351457744836807
the O 0 0.005364942364394665
mature O 0 0.022100141271948814
alpha O 0 0.021432800218462944
- O 0 0.024467768147587776
subunit O 0 0.024014964699745178
was O 0 0.004081829451024532
present O 0 0.00440179044380784
, O 0 0.003015346359461546
but O 0 0.002771568950265646
its O 0 0.0029631725046783686
level O 0 0.005163452588021755
was O 0 0.003271808149293065
much O 0 0.0038003071676939726
lower O 0 0.007268338464200497
than O 0 0.003982061520218849
that O 0 0.003469147253781557
from O 0 0.005583371501415968
normal O 0 0.014310317113995552
alpha O 0 0.021222781389951706
- O 0 0.03148910403251648
subunit O 0 0.04230055212974548
transfections O 0 0.04899759218096733
, O 0 0.006236747372895479
although O 0 0.005764406640082598
higher O 0 0.0067811394110322
than O 0 0.004481010138988495
in O 0 0.004416074138134718
those O 0 0.005716185085475445
cells O 0 0.0325392447412014
transfected O 0 0.2240784466266632
with O 0 0.008972113952040672
an O 0 0.00887278001755476
alpha O 0 0.0330033078789711
- O 0 0.04700712859630585
subunit O 0 0.06259651482105255
associated O 0 0.03156236186623573
with O 0 0.02728615701198578
infantile O 1 0.9992486834526062
TSD B-Disease 1 0.9978000521659851
. O 0 0.052155278623104095

Furthermore O 0 0.0387922003865242
, O 0 0.011531268246471882
the O 0 0.007943782955408096
precursor O 0 0.0229649655520916
level O 0 0.010160618461668491
of O 0 0.005124295596033335
the O 0 0.006955071818083525
W474C O 0 0.045400556176900864
alpha O 0 0.027114467695355415
- O 0 0.025962231680750847
subunit O 0 0.027793504297733307
was O 0 0.0065286168828606606
found O 0 0.006383825093507767
to O 0 0.005714402999728918
accumulate O 0 0.02279455028474331
in O 0 0.005024796351790428
comparison O 0 0.01053884718567133
to O 0 0.00452027702704072
the O 0 0.006486084777861834
normal O 0 0.01825070194900036
alpha O 0 0.02917044423520565
- O 0 0.05223923921585083
subunit O 0 0.0683668926358223
precursor O 0 0.05839114263653755
levels O 0 0.044391922652721405
. O 0 0.031055688858032227

We O 0 0.0254253800958395
conclude O 0 0.040025290101766586
that O 0 0.011983444914221764
the O 0 0.015136043541133404
1422 O 1 0.981165885925293
G O 1 0.851275622844696
- O 1 0.8550567626953125
- O 1 0.7916129231452942
> O 1 0.8498313426971436
C O 0 0.09993396699428558
mutation O 0 0.14481304585933685
is O 0 0.007951674051582813
the O 0 0.006506022997200489
cause O 0 0.01880669593811035
of O 0 0.007067517843097448
Hex B-Disease 0 0.0424736924469471
A I-Disease 0 0.02031598426401615
enzyme I-Disease 1 0.9956079125404358
deficiency I-Disease 1 0.9999856948852539
in O 0 0.014359558932483196
the O 0 0.017134850844740868
proband O 0 0.2682986557483673
. O 0 0.033817801624536514

The O 0 0.03462601080536842
resulting O 0 0.0588267520070076
W474C O 0 0.12158559262752533
substitution O 0 0.051295794546604156
clearly O 0 0.02533610910177231
interferes O 0 0.05387813597917557
with O 0 0.011845052242279053
alpha O 0 0.03109857626259327
- O 0 0.03410705178976059
subunit O 0 0.038266927003860474
processing O 0 0.011966035701334476
, O 0 0.005514371208846569
but O 0 0.004036447964608669
because O 0 0.004791733808815479
the O 0 0.004529659636318684
base O 0 0.010392650030553341
substitution O 0 0.01804056204855442
falls O 0 0.014435344375669956
at O 0 0.005668340716511011
the O 0 0.003555768635123968
first O 0 0.004124039318412542
position O 0 0.005883170757442713
of O 0 0.005098889581859112
exon O 0 0.0386178158223629
13 O 0 0.014873226173222065
, O 0 0.009926281869411469
aberrant O 0 0.06714458018541336
splicing O 0 0.05037238076329231
may O 0 0.01201661303639412
also O 0 0.006463012658059597
contribute O 0 0.014422141015529633
to O 0 0.007336173672229052
Hex B-Disease 0 0.03206125646829605
A I-Disease 0 0.01503575686365366
deficiency I-Disease 1 0.9997988343238831
in O 0 0.009681299328804016
this O 0 0.009532330557703972
proband O 0 0.09059323370456696
. O 0 0.01766822300851345
. O 0 0.023197205737233162

Two O 0 0.0601886622607708
frequent O 0 0.1485893279314041
missense O 1 0.9693862199783325
mutations O 1 0.9885613322257996
in O 0 0.06318263709545135
Pendred B-Disease 1 0.9996556043624878
syndrome I-Disease 1 0.9999974966049194
. O 0 0.06559308618307114

Pendred B-Disease 1 0.9999359846115112
syndrome I-Disease 1 0.9999994039535522
is O 0 0.09919807314872742
an O 0 0.19535279273986816
autosomal B-Disease 1 0.999998927116394
recessive I-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999998807907104
characterized O 1 0.9964039325714111
by O 0 0.027849720790982246
early O 0 0.0639561265707016
childhood O 1 0.9989245533943176
deafness B-Disease 1 0.999982476234436
and O 0 0.05111445486545563
goiter B-Disease 1 0.9999375343322754
. O 0 0.0511881448328495

A O 0 0.023476066067814827
century O 0 0.013973950408399105
after O 0 0.008517380803823471
its O 0 0.006306109484285116
recognition O 0 0.011634599417448044
as O 0 0.006857341155409813
a O 0 0.013420283794403076
syndrome O 1 0.9999885559082031
by O 0 0.013912889175117016
Vaughan O 0 0.07745961844921112
Pendred O 1 0.7512898445129395
, O 0 0.01063748449087143
the O 0 0.01337180845439434
disease O 1 0.999853253364563
gene O 1 0.6206903457641602
( O 0 0.02586556412279606
PDS O 1 0.8977973461151123
) O 0 0.012241020798683167
was O 0 0.008167884312570095
mapped O 0 0.022162415087223053
to O 0 0.01390584371984005
chromosome O 0 0.33604297041893005
7q22 O 0 0.4545695185661316
- O 0 0.18371614813804626
q31 O 0 0.2250482738018036
. O 0 0.04210924729704857

1 O 0 0.025873305276036263
and O 0 0.009029046632349491
, O 0 0.0073089092038571835
recently O 0 0.010309740900993347
, O 0 0.0054027726873755455
found O 0 0.006974912714213133
to O 0 0.005785781424492598
encode O 0 0.02148086205124855
a O 0 0.017657775431871414
putative O 0 0.16148479282855988
sulfate O 1 0.9917404651641846
transporter O 1 0.7895074486732483
. O 0 0.03976687416434288

We O 0 0.028492946177721024
performed O 0 0.027208834886550903
mutation O 0 0.06484223902225494
analysis O 0 0.0143562201410532
of O 0 0.0068702553398907185
the O 0 0.010011443868279457
PDS B-Disease 1 0.9838406443595886
gene O 0 0.1929447203874588
in O 0 0.011374451220035553
patients O 1 0.9675161838531494
from O 0 0.009759919717907906
14 O 0 0.013127744197845459
Pendred B-Disease 0 0.12440706044435501
families O 0 0.013888741843402386
originating O 0 0.01503051072359085
from O 0 0.005950081627815962
seven O 0 0.006669319700449705
countries O 0 0.006876879371702671
and O 0 0.00607203459367156
identified O 0 0.011833098717033863
all O 0 0.009878670796751976
mutations O 0 0.2201990932226181
. O 0 0.023006998002529144

The O 0 0.030321694910526276
mutations O 0 0.08790942281484604
include O 0 0.01531918067485094
three O 0 0.008739115670323372
single O 0 0.013133341446518898
base O 0 0.01659334823489189
deletions O 0 0.03412070870399475
, O 0 0.009736076928675175
one O 0 0.010615797713398933
splice O 0 0.07264482975006104
site O 0 0.024078847840428352
mutation O 0 0.09249609708786011
and O 0 0.01574811153113842
10 O 0 0.02830592729151249
missense O 1 0.5060223340988159
mutations O 1 0.728458046913147
. O 0 0.04654901102185249

One O 0 0.058034442365169525
missense O 1 0.8468641042709351
mutation O 1 0.8909580707550049
( O 0 0.03096724860370159
L236P O 0 0.0637589767575264
) O 0 0.010868057608604431
was O 0 0.005143708549439907
found O 0 0.005634185392409563
in O 0 0.004241263028234243
a O 0 0.00671572657302022
homozygous O 0 0.025220666080713272
state O 0 0.006055681966245174
in O 0 0.004585106857120991
two O 0 0.006208787672221661
consanguineous O 0 0.18998771905899048
families O 0 0.011339117772877216
and O 0 0.00496493699029088
in O 0 0.004849154036492109
a O 0 0.0064730169251561165
heterozygous O 0 0.02534221112728119
state O 0 0.005565186496824026
in O 0 0.004498700611293316
five O 0 0.006105407141149044
additional O 0 0.011313625611364841
non O 0 0.02282167412340641
- O 0 0.12850835919380188
consanguineous O 1 0.9164638519287109
families O 0 0.042388953268527985
. O 0 0.03181836009025574

Another O 0 0.0743703842163086
missense O 1 0.7955976128578186
mutation O 1 0.8355613350868225
( O 0 0.0354941189289093
T416P O 0 0.06019137427210808
) O 0 0.012006168253719807
was O 0 0.005131544545292854
found O 0 0.005324095021933317
in O 0 0.003953810315579176
a O 0 0.0054609808139503
homozygous O 0 0.021486209705471992
state O 0 0.0048576476983726025
in O 0 0.002885454101487994
one O 0 0.0033517612610012293
family O 0 0.005445720162242651
and O 0 0.003432626836001873
in O 0 0.0033986743073910475
a O 0 0.00513717345893383
heterozygous O 0 0.022575171664357185
state O 0 0.005348955746740103
in O 0 0.0048616742715239525
four O 0 0.007732328958809376
families O 0 0.019510919228196144
. O 0 0.01992231048643589

Pendred B-Disease 1 0.9683931469917297
patients O 1 0.9625700116157532
in O 0 0.012683821842074394
three O 0 0.010904574766755104
non O 0 0.022061873227357864
- O 0 0.08356696367263794
consanguineous O 1 0.7696436643600464
families O 0 0.016412921249866486
were O 0 0.005684909876435995
shown O 0 0.008538867346942425
to O 0 0.005541328340768814
be O 0 0.006229289807379246
compound O 0 0.025335155427455902
heterozygotes O 0 0.23742803931236267
for O 0 0.011535064317286015
L236P O 0 0.06437169760465622
and O 0 0.01707758568227291
T416P O 0 0.10976941138505936
. O 0 0.03281575068831444

In O 0 0.014436917379498482
total O 0 0.009255875833332539
, O 0 0.005378646310418844
one O 0 0.004276167135685682
or O 0 0.004653537180274725
both O 0 0.0031290638726204634
of O 0 0.002928846050053835
these O 0 0.004136473871767521
mutations O 0 0.02653021179139614
were O 0 0.0035939645022153854
found O 0 0.0037700708489865065
in O 0 0.002522811060771346
nine O 0 0.0036070682108402252
of O 0 0.0028828843496739864
the O 0 0.004952647723257542
14 O 0 0.011855784803628922
families O 0 0.01685956120491028
analyzed O 0 0.03402707353234291
. O 0 0.022188613191246986

The O 0 0.01937352493405342
identification O 0 0.02089431881904602
of O 0 0.007829363457858562
two O 0 0.010030990466475487
frequent O 0 0.041971590369939804
PDS B-Disease 1 0.9939078092575073
mutations O 0 0.47786271572113037
will O 0 0.010448625311255455
facilitate O 0 0.020355936139822006
the O 0 0.01381456758826971
molecular O 0 0.0826387107372284
diagnosis O 1 0.9994701743125916
of O 0 0.030816176906228065
Pendred B-Disease 1 0.9998102784156799
syndrome I-Disease 1 0.9999985694885254
. O 0 0.05598055198788643

Insertional O 1 0.8633131980895996
mutation O 1 0.6156086921691895
by O 0 0.027664683759212494
transposable O 0 0.3847584128379822
element O 0 0.034327421337366104
, O 0 0.014176630415022373
L1 O 0 0.3919798731803894
, O 0 0.009140066802501678
in O 0 0.008407283574342728
the O 0 0.013858942314982414
DMD B-Disease 1 0.9999308586120605
gene O 0 0.14791245758533478
results O 0 0.024007711559534073
in O 0 0.012357683852314949
X B-Disease 1 0.5620068907737732
- I-Disease 1 0.922864556312561
linked I-Disease 1 0.9464443325996399
dilated I-Disease 1 0.99974125623703
cardiomyopathy I-Disease 1 0.9999886751174927
. O 0 0.053202878683805466

X B-Disease 1 0.9170154333114624
- I-Disease 1 0.9900790452957153
linked I-Disease 1 0.9920797944068909
dilated I-Disease 1 0.9999057054519653
cardiomyopathy I-Disease 1 0.9999974966049194
( O 0 0.10173410922288895
XLDCM B-Disease 1 0.9015792608261108
) O 0 0.014031187631189823
is O 0 0.007734633516520262
a O 0 0.010344238951802254
clinical O 1 0.6061870455741882
phenotype O 1 0.7828158140182495
of O 0 0.008754421025514603
dystrophinopathy B-Disease 0 0.2202925831079483
which O 0 0.007457657251507044
is O 0 0.00755712715908885
characterized O 0 0.04978920519351959
by O 0 0.010822460055351257
preferential O 1 0.9822027683258057
myocardial B-Disease 1 0.9999374151229858
involvement I-Disease 0 0.05161712318658829
without O 0 0.014433898031711578
any O 0 0.01259431429207325
overt O 0 0.11611241102218628
clinical O 1 0.9808469414710999
signs O 0 0.04607278108596802
of O 0 0.02061053179204464
skeletal B-Disease 1 0.9996567964553833
myopathy I-Disease 1 0.9999632835388184
. O 0 0.04687156528234482

To O 0 0.015883322805166245
date O 0 0.013978603295981884
, O 0 0.00779961422085762
several O 0 0.008264892734587193
mutations O 0 0.16791392862796783
in O 0 0.011633162386715412
the O 0 0.020762434229254723
Duchenne B-Disease 1 0.999991774559021
muscular I-Disease 1 0.9999940395355225
dystrophy I-Disease 1 0.9999995231628418
gene O 1 0.9979337453842163
, O 0 0.046018555760383606
DMD O 1 0.9999821186065674
, O 0 0.009359992109239101
have O 0 0.005213004071265459
been O 0 0.004772163461893797
identified O 0 0.009286516346037388
in O 0 0.006402986589819193
patients O 1 0.9850682616233826
with O 0 0.007878689095377922
XLDCM B-Disease 1 0.6162416934967041
, O 0 0.005946636665612459
but O 0 0.006116197910159826
a O 0 0.008133282884955406
pathogenic O 0 0.044581592082977295
correlation O 0 0.025141503661870956
of O 0 0.006611162796616554
these O 0 0.009283016435801983
cardiospecific O 1 0.7387809753417969
mutations O 1 0.7446773648262024
in O 0 0.013364927843213081
DMD O 1 0.999916672706604
with O 0 0.010904569178819656
the O 0 0.01051149982959032
XLDCM B-Disease 1 0.8765057325363159
phenotype O 1 0.8103098273277283
has O 0 0.008615978993475437
remained O 0 0.008251247927546501
to O 0 0.005342964548617601
be O 0 0.007604556158185005
elucidated O 0 0.05051830783486366
. O 0 0.026241334155201912

We O 0 0.017076311632990837
report O 0 0.011309360153973103
here O 0 0.006655699107795954
the O 0 0.0048380205407738686
identification O 0 0.010404733940958977
of O 0 0.004978842567652464
a O 0 0.00856719259172678
unique O 0 0.014533297158777714
de O 0 0.032980773597955704
novo O 0 0.08002033084630966
L1 O 1 0.6634155511856079
insertion O 0 0.06387240439653397
in O 0 0.011407573707401752
the O 0 0.012650278396904469
muscle O 1 0.8859009146690369
exon O 0 0.06938596814870834
1 O 0 0.020968731492757797
in O 0 0.01454785093665123
DMD O 1 0.9997135996818542
in O 0 0.013907629065215588
three O 0 0.0134069062769413
XLDCM B-Disease 1 0.9736551642417908
patients O 1 0.9720891118049622
from O 0 0.009951181709766388
two O 0 0.008968714624643326
unrelated O 0 0.027398880571126938
Japanese O 0 0.02415047213435173
families O 0 0.02942170575261116
. O 0 0.028456326574087143

The O 0 0.023775942623615265
insertion O 0 0.05979764461517334
was O 0 0.012944460846483707
a O 0 0.010425528511404991
5 O 0 0.013573254458606243
- O 0 0.027022473514080048
truncated O 0 0.028456194326281548
form O 0 0.012105237692594528
of O 0 0.007336298935115337
human O 0 0.01661895215511322
L1 O 0 0.21526384353637695
inversely O 0 0.04266749322414398
integrated O 0 0.01969330944120884
in O 0 0.008018122985959053
the O 0 0.0066331117413938046
5 O 0 0.014325229451060295
- O 0 0.03070216253399849
untranslated O 0 0.06319105625152588
region O 0 0.018964504823088646
in O 0 0.0074378252029418945
the O 0 0.008843488059937954
muscle O 1 0.8484141230583191
exon O 0 0.049651794135570526
1 O 0 0.011420712806284428
, O 0 0.005446926690638065
which O 0 0.00402568094432354
affected O 0 0.01083974726498127
the O 0 0.005107156466692686
transcription O 0 0.021107321605086327
or O 0 0.005945379380136728
the O 0 0.004314175806939602
stability O 0 0.010498058050870895
of O 0 0.004233793821185827
the O 0 0.006464218255132437
muscle O 1 0.6480575203895569
form O 0 0.011112048290669918
of O 0 0.006892195902764797
dystrophin O 1 0.8190000653266907
transcripts O 0 0.019223513081669807
but O 0 0.004878752399235964
not O 0 0.0028881635516881943
that O 0 0.002714786445721984
of O 0 0.0033830406609922647
the O 0 0.006373709067702293
brain O 1 0.9454209804534912
or O 0 0.014454950578510761
Purkinje O 1 0.9973015785217285
cell O 0 0.08785906434059143
form O 0 0.011245791800320148
, O 0 0.005764917936176062
probably O 0 0.006757312919944525
due O 0 0.004884710535407066
to O 0 0.002976577263325453
its O 0 0.00391377555206418
unique O 0 0.007510556373745203
site O 0 0.008638989180326462
of O 0 0.006986098363995552
integration O 0 0.023947183042764664
. O 0 0.019602280110120773

We O 0 0.024950874969363213
speculate O 0 0.03321300446987152
that O 0 0.00835555698722601
this O 0 0.006480890791863203
insertion O 0 0.025368675589561462
of O 0 0.006427119020372629
an O 0 0.008515753783285618
L1 O 0 0.4412723481655121
sequence O 0 0.021647600457072258
in O 0 0.010450084693729877
DMD O 1 0.9998243451118469
is O 0 0.0064580258913338184
responsible O 0 0.006312498357146978
for O 0 0.002621338702738285
some O 0 0.0025394256226718426
of O 0 0.002270190976560116
the O 0 0.003093155799433589
population O 0 0.007130119018256664
of O 0 0.005339127033948898
Japanese O 0 0.015377494506537914
patients O 1 0.9514161944389343
with O 0 0.013532109558582306
XLDCM B-Disease 1 0.5752909183502197
. O 0 0.015265945345163345
. O 0 0.020207123830914497

Severe O 1 0.9996601343154907
early O 1 0.7428133487701416
- O 1 0.9997408986091614
onset O 1 0.9999885559082031
obesity B-Disease 1 0.9999964237213135
, O 1 0.7745057344436646
adrenal B-Disease 1 0.9999852180480957
insufficiency I-Disease 1 0.9999741315841675
and O 0 0.0279217716306448
red O 1 0.9453599452972412
hair O 1 0.998862624168396
pigmentation O 1 0.9999232292175293
caused O 1 0.9143665432929993
by O 0 0.02582194283604622
POMC O 1 0.998128354549408
mutations O 1 0.7620111107826233
in O 0 0.023315301164984703
humans O 0 0.054883092641830444
. O 0 0.03367302566766739

Sequential O 0 0.09105759114027023
cleavage O 0 0.10809283703565598
of O 0 0.013162827119231224
the O 0 0.01308806799352169
precursor O 0 0.04973973333835602
protein O 0 0.039853285998106
pre O 0 0.04570292681455612
- O 0 0.0691668838262558
pro O 0 0.0384223535656929
- O 0 0.3390929698944092
opiomelanocortin O 1 0.7982097864151001
( O 0 0.03671298921108246
POMC O 1 0.9899096488952637
) O 0 0.027274811640381813
generates O 0 0.042729414999485016
the O 0 0.02211838774383068
melanocortin O 1 0.9797918200492859
peptides O 0 0.33199799060821533
adrenocorticotrophin O 1 0.8782796859741211
( O 0 0.046311717480421066
ACTH O 1 0.9901305437088013
) O 0 0.028043311089277267
, O 0 0.018271904438734055
melanocyte O 1 0.9985494017601013
- O 1 0.9097643494606018
stimulating O 1 0.9772896766662598
hormones O 1 0.9870386123657227
( O 0 0.052886150777339935
MSH O 1 0.9983505010604858
) O 0 0.019392022863030434
alpha O 0 0.022528115659952164
, O 0 0.00745883584022522
beta O 0 0.018330035731196404
and O 0 0.005958746653050184
gamma O 0 0.022509761154651642
as O 0 0.004449557978659868
well O 0 0.00478651886805892
as O 0 0.004702822305262089
the O 0 0.009110437706112862
opioid O 1 0.9899360537528992
- O 1 0.7138429284095764
receptor O 1 0.7902753353118896
ligand O 0 0.4726153314113617
beta O 0 0.1526726484298706
- O 1 0.5824893712997437
endorphin O 1 0.9710546731948853
. O 0 0.0540560744702816

While O 0 0.02157413773238659
a O 0 0.014385735616087914
few O 0 0.012990583665668964
cases O 0 0.01874951645731926
of O 0 0.011976898647844791
isolated O 1 0.9556860327720642
ACTH B-Disease 1 0.999966025352478
deficiency I-Disease 1 0.9999911785125732
have O 0 0.014998197555541992
been O 0 0.010669590905308723
reported O 0 0.020446553826332092
( O 0 0.02542501501739025
OMIM O 1 0.9986891150474548
201400 O 1 0.6230559349060059
) O 0 0.014985467307269573
, O 0 0.00811345037072897
an O 0 0.009313052520155907
inherited O 1 0.9641437530517578
POMC O 1 0.9995656609535217
defect O 1 0.9814629554748535
has O 0 0.009450094774365425
not O 0 0.0052938335575163364
been O 0 0.005952025298029184
described O 0 0.01084963046014309
so O 0 0.0088516715914011
far O 0 0.01545023638755083
. O 0 0.0188148096203804

Recent O 0 0.04121244326233864
studies O 0 0.02570251189172268
in O 0 0.010875774547457695
animal O 0 0.022890500724315643
models O 0 0.019052833318710327
elucidated O 0 0.035434745252132416
a O 0 0.008840391412377357
central O 0 0.008671295829117298
role O 0 0.00931589026004076
of O 0 0.006459574680775404
alpha O 0 0.028724288567900658
- O 0 0.10426123440265656
MSH O 1 0.9886921644210815
in O 0 0.008206157945096493
the O 0 0.005963058210909367
regulation O 0 0.0149075323715806
of O 0 0.0058278837241232395
food O 0 0.013795384205877781
intake O 0 0.03541860356926918
by O 0 0.009044740349054337
activation O 0 0.03617120906710625
of O 0 0.007741223555058241
the O 0 0.011204224079847336
brain O 1 0.978004515171051
melanocortin O 1 0.9953081011772156
- O 0 0.4618939459323883
4 O 0 0.03604630380868912
- O 1 0.7197644710540771
receptor O 1 0.9001944661140442
( O 0 0.03894428908824921
MC4 O 1 0.999305009841919
- O 1 0.5500255227088928
R O 0 0.15659861266613007
; O 0 0.01624619960784912
refs O 0 0.052850913256406784
3 O 0 0.015827523544430733
- O 0 0.024005133658647537
5 O 0 0.010367236100137234
) O 0 0.007100935094058514
and O 0 0.003769551869481802
the O 0 0.005226473789662123
linkage O 0 0.030142297968268394
of O 0 0.00585835799574852
human O 0 0.015312306582927704
obesity B-Disease 1 0.9991635084152222
to O 0 0.010350766591727734
chromosome O 0 0.05417850613594055
2 O 0 0.00869037676602602
in O 0 0.005334405694156885
close O 0 0.008987687528133392
proximity O 0 0.01382647268474102
to O 0 0.005532563664019108
the O 0 0.0070693958550691605
POMC O 1 0.9612756967544556
locus O 0 0.04113846644759178
, O 0 0.0063121686689555645
led O 0 0.007232907693833113
to O 0 0.00315477536059916
the O 0 0.003162447363138199
proposal O 0 0.007067183498293161
of O 0 0.0036044062580913305
an O 0 0.004398335702717304
association O 0 0.013887227512896061
of O 0 0.010002856142818928
POMC O 1 0.9963610768318176
with O 0 0.016335884109139442
human O 0 0.038414109498262405
obesity B-Disease 1 0.9996358156204224
. O 0 0.03743725270032883

The O 0 0.024150220677256584
dual O 0 0.03532187640666962
role O 0 0.02181924693286419
of O 0 0.011577199213206768
alpha O 0 0.041298769414424896
- O 0 0.21148590743541718
MSH O 1 0.9945690631866455
in O 0 0.01423580851405859
regulating O 0 0.03989632427692413
food O 0 0.02518629841506481
intake O 0 0.08404980599880219
and O 0 0.013614616356790066
influencing O 0 0.0677032470703125
hair O 1 0.9812870621681213
pigmentation O 1 0.9993115663528442
predicts O 0 0.0847310721874237
that O 0 0.0073593477718532085
the O 0 0.008754702284932137
phenotype O 1 0.8315074443817139
associated O 0 0.01363609079271555
with O 0 0.008578993380069733
a O 0 0.01154919620603323
defect O 1 0.8230510354042053
in O 0 0.014029154554009438
POMC O 1 0.9935715198516846
function O 0 0.021758195012807846
would O 0 0.010322685353457928
include O 0 0.016428939998149872
obesity B-Disease 1 0.9997872710227966
, O 0 0.01564297452569008
alteration O 0 0.09897099435329437
in O 0 0.017015255987644196
pigmentation O 1 0.9997453093528748
and O 0 0.08043700456619263
ACTH B-Disease 1 0.9998971223831177
deficiency I-Disease 1 0.9999805688858032
. O 0 0.0470975860953331

The O 0 0.02227114886045456
observation O 0 0.031891848891973495
of O 0 0.009857150726020336
these O 0 0.010267884470522404
symptoms O 1 0.9952622652053833
in O 0 0.0071169594302773476
two O 0 0.007680724374949932
probands O 0 0.18163710832595825
prompted O 0 0.021216807886958122
us O 0 0.010760790668427944
to O 0 0.00613950053229928
search O 0 0.01287616603076458
for O 0 0.007781316991895437
mutations O 0 0.05465288832783699
within O 0 0.013858512043952942
their O 0 0.015049758367240429
POMC O 1 0.9880207180976868
genes O 0 0.09868697077035904
. O 0 0.03756750375032425

Patient O 1 0.7287126779556274
1 O 0 0.017568569630384445
was O 0 0.006401215214282274
found O 0 0.006411128677427769
to O 0 0.0038247520569711924
be O 0 0.003948079887777567
a O 0 0.006633011158555746
compound O 0 0.020043184980750084
heterozygote O 0 0.10686760395765305
for O 0 0.007781846448779106
two O 0 0.008369001559913158
mutations O 0 0.05099357292056084
in O 0 0.010652951896190643
exon O 0 0.052884265780448914
3 O 0 0.017548153176903725
( O 0 0.0166811291128397
G7013T O 0 0.04640837386250496
, O 0 0.008861152455210686
C7133delta O 0 0.05855405330657959
) O 0 0.008514675311744213
which O 0 0.005105749238282442
interfere O 0 0.013673635199666023
with O 0 0.006270718760788441
appropriate O 0 0.01320646796375513
synthesis O 0 0.022993652150034904
of O 0 0.009553405456244946
ACTH O 1 0.8450821042060852
and O 0 0.016008703038096428
alpha O 0 0.05516689270734787
- O 1 0.6068134307861328
MSH O 1 0.9961829781532288
. O 0 0.0449858196079731

Patient O 1 0.6471256017684937
2 O 0 0.024966919794678688
was O 0 0.012872274965047836
homozygous O 0 0.04320536553859711
for O 0 0.010097327642142773
a O 0 0.012911669909954071
mutation O 0 0.05796780064702034
in O 0 0.012199211865663528
exon O 0 0.0633237361907959
2 O 0 0.021658292040228844
( O 0 0.021956689655780792
C3804A O 0 0.061386819928884506
) O 0 0.01813097484409809
which O 0 0.01685313507914543
abolishes O 0 0.4748378396034241
POMC O 1 0.9797278046607971
translation O 0 0.04190097749233246
. O 0 0.03244641795754433

These O 0 0.016154350712895393
findings O 0 0.018428931012749672
represent O 0 0.007883737795054913
the O 0 0.0045834374614059925
first O 0 0.005278471391648054
examples O 0 0.008077633567154408
of O 0 0.005444059614092112
a O 0 0.010832787491381168
genetic B-Disease 1 0.5127144455909729
defect I-Disease 1 0.9750728011131287
within O 0 0.014429747126996517
the O 0 0.011840934865176678
POMC O 1 0.9948318004608154
gene O 0 0.04359903559088707
and O 0 0.008625829592347145
define O 0 0.01890082284808159
a O 0 0.01221134141087532
new O 0 0.02157818339765072
monogenic B-Disease 1 0.9998261332511902
endocrine I-Disease 1 0.9999847412109375
disorder I-Disease 1 0.9999756813049316
resulting O 0 0.1294117271900177
in O 0 0.013457116670906544
early O 0 0.09189365059137344
- O 1 0.9996449947357178
onset O 1 0.9999934434890747
obesity B-Disease 1 0.9999966621398926
, O 1 0.6862073540687561
adrenal B-Disease 1 0.9999877214431763
insufficiency I-Disease 1 0.9999756813049316
and O 0 0.02255263552069664
red O 1 0.8806304931640625
hair O 1 0.9940398931503296
pigmentation O 1 0.9994640946388245
. O 0 0.023376164957880974
. O 0 0.027202706784009933

A O 0 0.046891070902347565
European O 0 0.040915511548519135
multicenter O 1 0.9702327251434326
study O 0 0.04138719663023949
of O 0 0.025276558473706245
phenylalanine B-Disease 1 0.9956778883934021
hydroxylase I-Disease 1 0.9996187686920166
deficiency I-Disease 1 0.9999943971633911
: O 0 0.026974674314260483
classification O 0 0.03167475387454033
of O 0 0.008411359041929245
105 O 0 0.02499016374349594
mutations O 0 0.049594685435295105
and O 0 0.005615944508463144
a O 0 0.005508542526513338
general O 0 0.007269395049661398
system O 0 0.010256750509142876
for O 0 0.006730048917233944
genotype O 0 0.45802706480026245
- O 0 0.03442521393299103
based O 0 0.015241469256579876
prediction O 0 0.035958223044872284
of O 0 0.01624109596014023
metabolic O 1 0.9883971810340881
phenotype O 1 0.9927880167961121
. O 0 0.03884299471974373

Phenylketonuria B-Disease 1 0.9996634721755981
( O 1 0.587496817111969
PKU B-Disease 1 0.9998164772987366
) O 0 0.03421597182750702
and O 0 0.017232809215784073
mild B-Disease 1 0.9991389513015747
hyperphenylalaninemia I-Disease 1 0.9995800852775574
( O 1 0.5154756307601929
MHP B-Disease 1 0.9999171495437622
) O 0 0.0219807717949152
are O 0 0.012991572730243206
allelic B-Disease 1 0.9990463852882385
disorders I-Disease 1 0.9999785423278809
caused O 1 0.5037426948547363
by O 0 0.012373874895274639
mutations O 0 0.06431055068969727
in O 0 0.008863459341228008
the O 0 0.010803806595504284
gene O 0 0.060851387679576874
encoding O 0 0.05594242736697197
phenylalanine O 1 0.5783124566078186
hydroxylase O 1 0.9818582534790039
( O 0 0.06948217004537582
PAH O 1 0.9994240999221802
) O 0 0.040210600942373276
. O 0 0.032776203006505966

Previous O 0 0.029008513316512108
studies O 0 0.023623401299118996
have O 0 0.008542150259017944
suggested O 0 0.012376507744193077
that O 0 0.00556774390861392
the O 0 0.008353826589882374
highly O 0 0.02275256998836994
variable O 0 0.1836150884628296
metabolic O 1 0.9983115196228027
phenotypes O 1 0.9984742999076843
of O 0 0.12319844216108322
PAH B-Disease 1 0.9999972581863403
deficiency I-Disease 1 0.9999964237213135
correlate O 1 0.9232733845710754
with O 0 0.0580376498401165
PAH O 1 0.9998817443847656
genotypes O 1 0.98698490858078
. O 0 0.054332438856363297

We O 0 0.026202574372291565
identified O 0 0.030253740027546883
both O 0 0.02045833319425583
causative O 1 0.9466081857681274
mutations O 1 0.9461909532546997
in O 0 0.016403310000896454
686 O 1 0.9855659604072571
patients O 1 0.9901202917098999
from O 0 0.010436060838401318
seven O 0 0.013454546220600605
European O 0 0.019846221432089806
centers O 0 0.03192722797393799
. O 0 0.02059859037399292

On O 0 0.011964435689151287
the O 0 0.007981151342391968
basis O 0 0.008612534031271935
of O 0 0.0050719743594527245
the O 0 0.006436320953071117
phenotypic O 0 0.03582494705915451
characteristics O 0 0.019983531907200813
of O 0 0.010816887021064758
297 O 0 0.14466404914855957
functionally O 0 0.4856615364551544
hemizygous O 1 0.9838842749595642
patients O 1 0.986930251121521
, O 0 0.00840831734240055
105 O 0 0.01464088261127472
of O 0 0.0049570775590837
the O 0 0.005400805734097958
mutations O 0 0.029328379780054092
were O 0 0.004333995748311281
assigned O 0 0.0072310385294258595
to O 0 0.003093009814620018
one O 0 0.003210763679817319
of O 0 0.0032246201299130917
four O 0 0.007749609649181366
arbitrary O 0 0.02227085456252098
phenotype O 1 0.7062428593635559
categories O 0 0.033517368137836456
. O 0 0.02709801308810711

We O 0 0.01753416657447815
proposed O 0 0.017336968332529068
and O 0 0.008215815760195255
tested O 0 0.020946893841028214
a O 0 0.007754112593829632
simple O 0 0.011024799197912216
model O 0 0.011170633137226105
for O 0 0.006340194959193468
correlation O 0 0.02628081478178501
between O 0 0.012763655744493008
genotype O 0 0.31619060039520264
and O 0 0.013706897385418415
phenotypic O 0 0.06685733050107956
outcome O 0 0.039891935884952545
. O 0 0.029473615810275078

The O 0 0.032506853342056274
observed O 0 0.05307624861598015
phenotype O 1 0.7421723008155823
matched O 0 0.04239186644554138
the O 0 0.014070472680032253
predicted O 0 0.027854954823851585
phenotype O 0 0.32708775997161865
in O 0 0.008932980708777905
79 O 0 0.016281019896268845
% O 0 0.007007088512182236
of O 0 0.003101325361058116
the O 0 0.0032343026250600815
cases O 0 0.006610587239265442
, O 0 0.002895183628425002
and O 0 0.002416316419839859
in O 0 0.00240968051366508
only O 0 0.0030387998558580875
5 O 0 0.0059080603532493114
of O 0 0.004322253633290529
184 O 0 0.025372443720698357
patients O 1 0.867669939994812
was O 0 0.0064538512378931046
the O 0 0.006533938925713301
observed O 0 0.015334567055106163
phenotype O 0 0.09618734568357468
more O 0 0.004883412271738052
than O 0 0.004305358976125717
one O 0 0.003860179102048278
category O 0 0.009384523145854473
away O 0 0.006241815164685249
from O 0 0.005476048216223717
that O 0 0.005877500865608454
expected O 0 0.013777134008705616
. O 0 0.01774168387055397

Among O 0 0.020945129916071892
the O 0 0.008714530616998672
seven O 0 0.011349406093358994
contributing O 0 0.018922045826911926
centers O 0 0.014279892668128014
, O 0 0.004872538615018129
the O 0 0.0051618702709674835
proportion O 0 0.013418554328382015
of O 0 0.006248805206269026
patients O 1 0.9092811942100525
for O 0 0.005817253142595291
whom O 0 0.011206215247511864
the O 0 0.0058741760440170765
observed O 0 0.0166630856692791
phenotype O 1 0.5987200736999512
did O 0 0.007958229631185532
not O 0 0.004599942360073328
match O 0 0.008227269165217876
the O 0 0.006481502205133438
predicted O 0 0.021045468747615814
phenotype O 0 0.1681753247976303
was O 0 0.008854272775352001
4 O 0 0.011117802932858467
% O 0 0.011681697331368923
- O 0 0.023993438109755516
23 O 0 0.015509828925132751
% O 0 0.015060427598655224
( O 0 0.01905493251979351
P O 1 0.6902254223823547
< O 1 0.686441957950592
. O 0 0.010867751203477383
0001 O 0 0.4217855930328369
) O 0 0.00983546394854784
, O 0 0.005089638289064169
suggesting O 0 0.00879158265888691
that O 0 0.003386199241504073
differences O 0 0.007119996007531881
in O 0 0.004049558192491531
methods O 0 0.007736490573734045
used O 0 0.006530389189720154
for O 0 0.007465553004294634
mutation O 1 0.7453414797782898
detection O 0 0.30933257937431335
or O 0 0.017681114375591278
phenotype O 1 0.9872275590896606
classification O 0 0.039307016879320145
may O 0 0.009639604948461056
account O 0 0.008225482888519764
for O 0 0.004416222218424082
a O 0 0.00628019031137228
considerable O 0 0.013622423633933067
proportion O 0 0.018451187759637833
of O 0 0.011438945308327675
genotype O 1 0.9888851642608643
- O 1 0.8300521969795227
phenotype O 1 0.9895002245903015
inconsistencies O 0 0.08707593381404877
. O 0 0.03923451900482178

Our O 0 0.025441834703087807
data O 0 0.01891995221376419
indicate O 0 0.019079146906733513
that O 0 0.007768500596284866
the O 0 0.011625643819570541
PAH O 1 0.9999122619628906
- O 1 0.6638240814208984
mutation O 1 0.8590238690376282
genotype O 0 0.484998494386673
is O 0 0.009606276638805866
the O 0 0.0064643011428415775
main O 0 0.011097009293735027
determinant O 0 0.0347309336066246
of O 0 0.011668733321130276
metabolic O 1 0.9875934720039368
phenotype O 1 0.9900908470153809
in O 0 0.013685370795428753
most O 0 0.014379422180354595
patients O 1 0.9998078942298889
with O 0 0.34588003158569336
PAH B-Disease 1 0.9999959468841553
deficiency I-Disease 1 0.9999926090240479
. O 0 0.04799545183777809

In O 0 0.016170600429177284
the O 0 0.008588230237364769
present O 0 0.009347575716674328
study O 0 0.010339201427996159
, O 0 0.005839542951434851
the O 0 0.005857713520526886
classification O 0 0.02268173173069954
of O 0 0.009871043264865875
105 O 0 0.14177174866199493
PAH O 1 0.9999278783798218
mutations O 1 0.8729689121246338
may O 0 0.01428761426359415
allow O 0 0.009218519553542137
the O 0 0.00612223893404007
prediction O 0 0.018147481605410576
of O 0 0.0061658937484025955
the O 0 0.007398243062198162
biochemical O 0 0.047093380242586136
phenotype O 1 0.8003730177879333
in O 0 0.011792948469519615
> O 0 0.04925709217786789
10 O 0 0.00857388973236084
, O 0 0.005822912789881229
000 O 0 0.019475722685456276
genotypes O 0 0.2725973427295685
, O 0 0.005065900273621082
which O 0 0.00375408330000937
may O 0 0.005067323334515095
be O 0 0.0025215260684490204
useful O 0 0.004398623947054148
for O 0 0.0025916644372045994
the O 0 0.003687584772706032
management O 0 0.011112687177956104
of O 0 0.007169269025325775
hyperphenylalaninemia B-Disease 1 0.8490298986434937
in O 0 0.01613973081111908
newborns O 1 0.9595956802368164
. O 0 0.03312942758202553

Somatic O 1 0.7352041006088257
instability O 0 0.09855865687131882
of O 0 0.01297712791711092
the O 0 0.014505434781312943
CTG O 1 0.8056298494338989
repeat O 0 0.05180540680885315
in O 0 0.012782501056790352
mice O 0 0.2176009714603424
transgenic O 0 0.04653378203511238
for O 0 0.010788454674184322
the O 0 0.017314733937382698
myotonic B-Disease 1 0.9999938011169434
dystrophy I-Disease 1 0.999997615814209
region O 0 0.04367632046341896
is O 0 0.011174437589943409
age O 0 0.01368918176740408
dependent O 0 0.016213633120059967
but O 0 0.006251515354961157
not O 0 0.005379495210945606
correlated O 0 0.020968766883015633
to O 0 0.0057676080614328384
the O 0 0.0067714788019657135
relative O 0 0.02225293405354023
intertissue O 0 0.3115770220756531
transcription O 0 0.05619136244058609
levels O 0 0.03045983612537384
and O 0 0.016665758565068245
proliferative O 1 0.9982640147209167
capacities O 0 0.06697477400302887
. O 0 0.03709109500050545

A O 0 0.045625004917383194
( O 0 0.0417981781065464
CTG O 1 0.5245415568351746
) O 0 0.020198509097099304
nexpansion O 0 0.041360870003700256
in O 0 0.006980007980018854
the O 0 0.006513193249702454
3 O 0 0.013712616637349129
- O 0 0.03173845633864403
untranslated O 0 0.12616941332817078
region O 0 0.028256550431251526
( O 0 0.022033462300896645
UTR O 0 0.08273079246282578
) O 0 0.012570830062031746
of O 0 0.007980591617524624
the O 0 0.014518458396196365
DM O 1 0.9998928308486938
protein O 0 0.12053738534450531
kinase O 1 0.8596397638320923
gene O 0 0.09366495907306671
( O 0 0.023884715512394905
DMPK O 0 0.4577510952949524
) O 0 0.013249384239315987
is O 0 0.00695182615891099
responsible O 0 0.013662444427609444
for O 0 0.013235782273113728
causing O 1 0.9977403879165649
myotonic B-Disease 1 0.9999985694885254
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9832495450973511
DM B-Disease 1 0.9999814033508301
) O 0 0.03815198317170143
. O 0 0.026607753708958626

Major O 0 0.03912420570850372
instability O 0 0.06608540564775467
, O 0 0.008975910022854805
with O 0 0.005999397486448288
very O 0 0.006784775760024786
large O 0 0.009152356535196304
expansions O 0 0.019932225346565247
between O 0 0.007580834906548262
generations O 0 0.014226590283215046
and O 0 0.006443753372877836
high O 0 0.011275548487901688
levels O 0 0.016397956758737564
of O 0 0.008482620120048523
somatic O 1 0.5717271566390991
mosaicism O 1 0.9864553213119507
, O 0 0.010572030209004879
is O 0 0.00937214121222496
observed O 0 0.019894056022167206
in O 0 0.012899520806968212
patients O 1 0.9838061332702637
. O 0 0.0268073920160532

There O 0 0.016813432797789574
is O 0 0.00905067753046751
a O 0 0.008650391362607479
good O 0 0.01070315483957529
correlation O 0 0.024264482781291008
between O 0 0.010035933926701546
repeat O 0 0.02359958365559578
size O 0 0.012516475282609463
( O 0 0.008553532883524895
at O 0 0.005167083814740181
least O 0 0.005873963236808777
in O 0 0.005817426834255457
leucocytes O 0 0.31742313504219055
) O 0 0.011077748611569405
, O 0 0.008222671225667
clinical O 1 0.7975593209266663
severity O 1 0.9383079409599304
and O 0 0.008338620886206627
age O 0 0.01504385843873024
of O 0 0.012633980251848698
onset O 1 0.9956724643707275
. O 0 0.03568703681230545

The O 0 0.055642034858465195
trinucleotide O 1 0.992289125919342
repeat O 1 0.5519554018974304
instability O 1 0.5534548759460449
mechanisms O 0 0.05317372828722
involved O 0 0.02271617390215397
in O 0 0.014088481664657593
DM B-Disease 1 0.9999316930770874
and O 0 0.010279031470417976
other O 0 0.007909480482339859
human O 0 0.028770431876182556
genetic B-Disease 1 0.998263418674469
diseases I-Disease 1 0.999945878982544
are O 0 0.017545701935887337
unknown O 0 0.032462216913700104
. O 0 0.025182876735925674

We O 0 0.03275887668132782
studied O 0 0.03997046500444412
somatic O 0 0.2145729511976242
instability O 0 0.07737858593463898
by O 0 0.014598764479160309
measuring O 0 0.029424481093883514
the O 0 0.012925801798701286
CTG O 0 0.4807632565498352
repeat O 0 0.03665228560566902
length O 0 0.017235586419701576
at O 0 0.007487378548830748
several O 0 0.0056503573432564735
ages O 0 0.014140596613287926
in O 0 0.0055435835383832455
various O 0 0.006725429091602564
tissues O 0 0.028109582141041756
of O 0 0.008626820519566536
transgenic O 0 0.04763708636164665
mice O 0 0.1056423932313919
carrying O 0 0.016747301444411278
a O 0 0.014907986856997013
( O 0 0.019623856991529465
CTG O 1 0.7069937586784363
) O 0 0.016226444393396378
55expansion O 0 0.05587807297706604
surrounded O 0 0.01653735712170601
by O 0 0.00658146757632494
45 O 0 0.012026938609778881
kb O 0 0.02727397531270981
of O 0 0.006547187454998493
the O 0 0.007595183327794075
human O 0 0.022813839837908745
DM B-Disease 1 0.9998613595962524
region O 0 0.023238947615027428
, O 0 0.009144646115601063
using O 0 0.010309876874089241
small O 0 0.015134762972593307
- O 0 0.05369007959961891
pool O 0 0.07056970149278641
PCR O 0 0.13690748810768127
. O 0 0.041844435036182404

These O 0 0.020415842533111572
mice O 0 0.06107509881258011
have O 0 0.008277004584670067
been O 0 0.0057951780036091805
shown O 0 0.007592883426696062
to O 0 0.004392776172608137
reproduce O 0 0.015934711322188377
the O 0 0.0064475275576114655
intergenerational O 0 0.1980905532836914
and O 0 0.009585089981555939
somatic O 0 0.2626950740814209
instability O 0 0.04188281297683716
of O 0 0.006767811719328165
the O 0 0.007637686561793089
55 O 0 0.022673524916172028
CTG O 1 0.9270326495170593
repeat O 0 0.04157025367021561
suggesting O 0 0.019200574606657028
that O 0 0.007005105260759592
surrounding O 0 0.012852678075432777
sequences O 0 0.013132537715137005
and O 0 0.005793917458504438
the O 0 0.006059236824512482
chromatin O 0 0.030848534777760506
environment O 0 0.012714912183582783
are O 0 0.005898825358599424
involved O 0 0.01189014408737421
in O 0 0.009774770587682724
instability O 0 0.07230770587921143
mechanisms O 0 0.04693014919757843
. O 0 0.025477882474660873

As O 0 0.01746533252298832
observed O 0 0.01567555032670498
in O 0 0.00501081719994545
some O 0 0.003524136496707797
of O 0 0.0037105826195329428
the O 0 0.005447101779282093
tissues O 0 0.3664639890193939
of O 0 0.012130907736718655
DM B-Disease 1 0.9999980926513672
patients O 1 0.9993811845779419
, O 0 0.006447760388255119
there O 0 0.004914002027362585
is O 0 0.004585102200508118
a O 0 0.005723236594349146
tendency O 0 0.016618920490145683
for O 0 0.005535188131034374
repeat O 0 0.022410476580262184
length O 0 0.014244095422327518
and O 0 0.008379685692489147
somatic O 0 0.2478308528661728
mosaicism O 1 0.8101622462272644
to O 0 0.0070365662686526775
increase O 0 0.008900444954633713
with O 0 0.004987957887351513
the O 0 0.005102400202304125
age O 0 0.009585113264620304
of O 0 0.006261017173528671
the O 0 0.010871539823710918
mouse O 0 0.06783629953861237
. O 0 0.030025387182831764

Furthermore O 0 0.0416363850235939
, O 0 0.011737611144781113
we O 0 0.007457804400473833
observed O 0 0.0129728764295578
no O 0 0.007596016861498356
correlation O 0 0.01986728236079216
between O 0 0.008480694144964218
the O 0 0.008960834704339504
somatic O 1 0.7354838848114014
mutation O 1 0.9245699048042297
rate O 0 0.024890126660466194
and O 0 0.01246394868940115
tissue O 1 0.9454125761985779
proliferation O 0 0.21423177421092987
capacity O 0 0.027386074885725975
. O 0 0.02512599341571331

The O 0 0.04638296365737915
somatic O 1 0.8412522077560425
mutation O 1 0.7083569169044495
rates O 0 0.029716484248638153
in O 0 0.007550048641860485
different O 0 0.006494487170130014
tissues O 0 0.01915520615875721
were O 0 0.004314519930630922
also O 0 0.004013475496321917
not O 0 0.004032064229249954
correlated O 0 0.015104798600077629
to O 0 0.0040992069989442825
the O 0 0.005201365333050489
relative O 0 0.013238683342933655
inter O 0 0.027506334707140923
- O 0 0.15181338787078857
tissue O 1 0.5842810869216919
difference O 0 0.01689988560974598
in O 0 0.007637897040694952
transcriptional O 0 0.033573079854249954
levels O 0 0.011563085950911045
of O 0 0.004062321037054062
the O 0 0.00479492312297225
three O 0 0.006524733267724514
genes O 0 0.030072661116719246
( O 0 0.01585346832871437
DMAHP O 1 0.6356204152107239
, O 0 0.00855065044015646
DMPK O 0 0.09471694380044937
and O 0 0.006498556584119797
59 O 0 0.016602611169219017
) O 0 0.008457175455987453
surrounding O 0 0.012917383573949337
the O 0 0.008526760153472424
repeat O 0 0.03280843421816826
. O 0 0.012082003988325596
. O 0 0.019179359078407288

A O 0 0.050892021507024765
novel O 0 0.06273818761110306
missense O 1 0.8631271123886108
mutation O 1 0.9361407160758972
in O 0 0.020985322073101997
patients O 1 0.991356372833252
from O 0 0.016145849600434303
a O 0 0.015337317250669003
retinoblastoma B-Disease 1 0.9957292675971985
pedigree O 0 0.24102802574634552
showing O 0 0.023256901651620865
only O 0 0.010704638436436653
mild O 1 0.614646315574646
expression O 0 0.023980576545000076
of O 0 0.009476461447775364
the O 0 0.01798785664141178
tumor B-Disease 1 0.9986263513565063
phenotype O 1 0.9936540126800537
. O 0 0.04495597630739212

We O 0 0.017768235877156258
have O 0 0.009498167783021927
used O 0 0.010248243808746338
single O 0 0.01668928936123848
strand O 0 0.045573893934488297
conformation O 0 0.04927467182278633
polymorphism O 0 0.04584385082125664
analysis O 0 0.013519768603146076
to O 0 0.005675903055816889
study O 0 0.008350872434675694
the O 0 0.005129515193402767
27 O 0 0.010459774173796177
exons O 0 0.02611849457025528
of O 0 0.006065188907086849
the O 0 0.008937904611229897
RB1 O 1 0.9865308403968811
gene O 0 0.039827924221754074
in O 0 0.007708876393735409
individuals O 0 0.010141520760953426
from O 0 0.006719680968672037
a O 0 0.0073365624994039536
family O 0 0.014701485633850098
showing O 0 0.018898000940680504
mild O 1 0.7163512706756592
expression O 0 0.022875744849443436
of O 0 0.009321608580648899
the O 0 0.017137981951236725
retinoblastoma B-Disease 1 0.9978340268135071
phenotype O 1 0.9936835765838623
. O 0 0.04442519694566727

In O 0 0.019379815086722374
this O 0 0.0106117008253932
family O 0 0.019047236070036888
affected O 0 0.0314522385597229
individuals O 0 0.01849454827606678
developed O 0 0.03240488842129707
unilateral B-Disease 1 0.617148220539093
tumors I-Disease 1 0.999815046787262
and O 0 0.006036070641130209
, O 0 0.004602218046784401
as O 0 0.003325256984680891
a O 0 0.004585069138556719
result O 0 0.006939193699508905
of O 0 0.004902833607047796
linkage O 0 0.05999905243515968
analysis O 0 0.015924807637929916
, O 0 0.011556624434888363
unaffected O 0 0.40491917729377747
mutation O 1 0.7348625659942627
carriers O 0 0.03548732027411461
were O 0 0.006468500941991806
also O 0 0.006237633526325226
identified O 0 0.010754960589110851
within O 0 0.009392602369189262
the O 0 0.0108852693811059
pedigree O 0 0.06324368715286255
. O 0 0.030636589974164963

A O 0 0.03705649822950363
single O 0 0.02724592573940754
band O 0 0.031134234741330147
shift O 0 0.03251466155052185
using O 0 0.017595749348402023
SSCP O 0 0.05960795655846596
was O 0 0.008129097521305084
identified O 0 0.01040422823280096
in O 0 0.00597563199698925
exon O 0 0.032185718417167664
21 O 0 0.01071613933891058
which O 0 0.005809325259178877
resulted O 0 0.011740272864699364
in O 0 0.006584572605788708
a O 0 0.011955182068049908
missense O 0 0.13046684861183167
mutation O 0 0.1540275514125824
converting O 0 0.03135628625750542
a O 0 0.024100711569190025
cys O 1 0.9979909658432007
- O 1 0.9459884166717529
- O 1 0.8568787574768066
> O 1 0.8561332821846008
arg O 1 0.7453556656837463
at O 0 0.019510962069034576
nucleotide O 0 0.04254920408129692
position O 0 0.012927211821079254
28 O 0 0.013177912682294846
in O 0 0.007207293063402176
the O 0 0.010491466149687767
exon O 0 0.07490045577287674
. O 0 0.02962489053606987

The O 0 0.03624190017580986
mutation O 0 0.17126362025737762
destroyed O 0 0.0375603586435318
an O 0 0.020275520160794258
NdeI O 0 0.1285713165998459
restriction O 0 0.054198652505874634
enzyme O 0 0.07143747806549072
site O 0 0.03610154241323471
. O 0 0.02705712802708149

Analysis O 0 0.02583964914083481
of O 0 0.0080207334831357
all O 0 0.005759792402386665
family O 0 0.009263452142477036
members O 0 0.007079488132148981
demonstrated O 0 0.01195709127932787
that O 0 0.006150717847049236
the O 0 0.009745552204549313
missense O 1 0.8031999468803406
mutation O 1 0.9790759086608887
co O 1 0.6900559663772583
- O 0 0.36651527881622314
segregated O 0 0.12341821938753128
with O 0 0.016664912924170494
patients O 1 0.9995452761650085
with O 0 0.017220281064510345
tumors B-Disease 1 0.9999284744262695
or O 0 0.007881328463554382
who O 0 0.005457387305796146
, O 0 0.0035329891834408045
as O 0 0.0032134405337274075
a O 0 0.004026820417493582
result O 0 0.006315016653388739
of O 0 0.004300555679947138
linkage O 0 0.030285295099020004
analysis O 0 0.008707606233656406
had O 0 0.004638212267309427
been O 0 0.004523585084825754
predicted O 0 0.008853060193359852
to O 0 0.004865897819399834
carry O 0 0.009821365587413311
the O 0 0.010701539926230907
predisposing O 1 0.6816304922103882
mutation O 1 0.7092169523239136
. O 0 0.03646091744303703

These O 0 0.016573719680309296
observations O 0 0.02011105790734291
point O 0 0.009542785584926605
to O 0 0.005043888930231333
another O 0 0.006775601301342249
region O 0 0.012023811228573322
of O 0 0.006265913136303425
the O 0 0.01141420565545559
RB1 O 1 0.9976561069488525
gene O 0 0.07213087379932404
where O 0 0.011728804558515549
mutations O 0 0.04517468065023422
only O 0 0.0055707041174173355
modify O 0 0.015392852015793324
the O 0 0.004529298283159733
function O 0 0.007220912724733353
of O 0 0.0033426813315600157
the O 0 0.004027559421956539
gene O 0 0.01781143620610237
and O 0 0.004584357608109713
raise O 0 0.010825155302882195
important O 0 0.005533075891435146
questions O 0 0.008145127445459366
for O 0 0.0054642194882035255
genetic O 0 0.03103095293045044
counseling O 0 0.14008720219135284
in O 0 0.005729865748435259
families O 0 0.009746274910867214
with O 0 0.00669254083186388
these O 0 0.007212819065898657
distinctive O 0 0.033712077885866165
phenotypes O 1 0.597158670425415
. O 0 0.016080129891633987
. O 0 0.023770952597260475

Maternal B-Disease 1 0.9860565662384033
disomy I-Disease 1 0.9937018156051636
and O 0 0.4827350378036499
Prader B-Disease 1 0.9999958276748657
- I-Disease 1 0.9999188184738159
Willi I-Disease 1 0.9999966621398926
syndrome I-Disease 1 0.9999978542327881
consistent O 0 0.05178138241171837
with O 0 0.022858835756778717
gamete O 1 0.9320120215415955
complementation O 1 0.9775405526161194
in O 0 0.010792749933898449
a O 0 0.008757309056818485
case O 0 0.011373396962881088
of O 0 0.009310685098171234
familial O 1 0.9950990080833435
translocation O 1 0.8123747706413269
( O 0 0.018298519775271416
3 O 0 0.01121089793741703
; O 0 0.008241748437285423
15 O 0 0.009328334592282772
) O 0 0.01073096040636301
( O 0 0.015189762227237225
p25 O 1 0.7450335025787354
; O 0 0.014355221763253212
q11 O 0 0.043270405381917953
. O 0 0.008356252685189247
2 O 0 0.01322950515896082
) O 0 0.014438118785619736
. O 0 0.017664095386862755

Maternal B-Disease 1 0.9812502264976501
uniparental I-Disease 1 0.9976136684417725
disomy I-Disease 1 0.9817511439323425
( I-Disease 0 0.05473994091153145
UPD I-Disease 1 0.99562007188797
) I-Disease 0 0.017271695658564568
for I-Disease 0 0.008295885287225246
chromosome I-Disease 0 0.04284954443573952
15 I-Disease 0 0.008792205713689327
is O 0 0.005077732726931572
responsible O 0 0.007297656964510679
for O 0 0.0033038100227713585
an O 0 0.0039117904379963875
estimated O 0 0.008402378298342228
30 O 0 0.0074876402504742146
% O 0 0.008013668470084667
of O 0 0.0054723829962313175
cases O 0 0.020423928275704384
of O 0 0.024941030889749527
Prader B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999791383743286
Willi I-Disease 1 0.9999991655349731
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9439855813980103
PWS B-Disease 1 0.9999315738677979
) O 0 0.04246453940868378
. O 0 0.030371293425559998

We O 0 0.01599632203578949
report O 0 0.011237787082791328
on O 0 0.0061036222614347935
an O 0 0.005816718563437462
unusual O 0 0.013792549259960651
case O 0 0.010773838497698307
of O 0 0.00859918538480997
maternal B-Disease 0 0.15097975730895996
disomy I-Disease 0 0.28837305307388306
15 I-Disease 0 0.016193024814128876
in O 0 0.010899371467530727
PWS B-Disease 1 0.9987488985061646
that O 0 0.005663339048624039
is O 0 0.004598480183631182
most O 0 0.003958671819418669
consistent O 0 0.008470765314996243
with O 0 0.004961562342941761
adjacent O 0 0.011907916516065598
- O 0 0.019260386005043983
1 O 0 0.010002478025853634
segregation O 0 0.019969603046774864
of O 0 0.00563560938462615
a O 0 0.00897705927491188
paternal O 0 0.09679629653692245
t O 1 0.5653994679450989
( O 0 0.013630704022943974
3 O 0 0.011867147870361805
; O 0 0.009303668513894081
15 O 0 0.00928077194839716
) O 0 0.010710477828979492
( O 0 0.01331591047346592
p25 O 1 0.6899253129959106
; O 0 0.012192456051707268
q11 O 0 0.03761928528547287
. O 0 0.006928528659045696
2 O 0 0.00895786378532648
) O 0 0.008032673969864845
with O 0 0.00742559926584363
simultaneous O 0 0.026600664481520653
maternal O 0 0.4040071368217468
meiotic O 1 0.9748615026473999
nondisjunction O 0 0.3578903377056122
for O 0 0.01782493107020855
chromosome O 0 0.17194108664989471
15 O 0 0.02624291181564331
. O 0 0.023143436759710312

The O 0 0.03405313566327095
patient O 1 0.9534679055213928
( O 0 0.023490849882364273
J O 0 0.4438146650791168
. O 0 0.00793741550296545
B O 0 0.02150769531726837
. O 0 0.005325755104422569
) O 0 0.005813644267618656
, O 0 0.0037788923364132643
a O 0 0.004642947111278772
17 O 0 0.010080727748572826
- O 0 0.019559547305107117
year O 0 0.008430617861449718
- O 0 0.02614838071167469
old O 0 0.012197833508253098
white O 0 0.02158409170806408
male O 0 0.024774035438895226
with O 0 0.010952053591609001
PWS B-Disease 1 0.9998341798782349
, O 0 0.006458411458879709
was O 0 0.004030145704746246
found O 0 0.0043673161417245865
to O 0 0.003640309674665332
have O 0 0.004321192856878042
47 O 0 0.011468379758298397
chromosomes O 0 0.02189655974507332
with O 0 0.007269306108355522
a O 0 0.009287380613386631
supernumerary O 0 0.05015594884753227
, O 0 0.011266072280704975
paternal O 0 0.06849677860736847
der O 0 0.07955291122198105
( O 0 0.011439473368227482
15 O 0 0.007953159511089325
) O 0 0.0049337344244122505
consisting O 0 0.005426052492111921
of O 0 0.0035675836261361837
the O 0 0.004236541222780943
short O 0 0.010103917680680752
arm O 0 0.019402647390961647
and O 0 0.0056081959046423435
the O 0 0.007217023521661758
proximal O 1 0.8776434063911438
long O 0 0.01710670255124569
arm O 0 0.03296405076980591
of O 0 0.008720332756638527
chromosome O 0 0.11195430904626846
15 O 0 0.011208218522369862
, O 0 0.00820938777178526
and O 0 0.010507628321647644
distal O 1 0.9936554431915283
chromosome O 1 0.9786307215690613
arm O 1 0.891721785068512
3p O 1 0.9672057032585144
. O 0 0.041645150631666183

The O 0 0.031457509845495224
t O 0 0.19202208518981934
( O 0 0.02105763927102089
3 O 0 0.013270153664052486
; O 0 0.008316329680383205
15 O 0 0.006461454089730978
) O 0 0.005045758094638586
was O 0 0.003156482707709074
present O 0 0.003831869689747691
in O 0 0.00261126970872283
the O 0 0.0031211969908326864
balanced O 0 0.009112400934100151
state O 0 0.004939529579132795
in O 0 0.004256368614733219
the O 0 0.005975416861474514
patients O 1 0.8691408038139343
father O 0 0.011791253462433815
and O 0 0.006383002270013094
a O 0 0.010857963934540749
sister O 0 0.028840459883213043
. O 0 0.02190670371055603

Fluorescent O 0 0.12142819166183472
in O 0 0.03079489804804325
situ O 0 0.09583979845046997
hybridization O 0 0.06536411494016647
analysis O 0 0.020256616175174713
demonstrated O 0 0.018375921994447708
that O 0 0.00765179842710495
the O 0 0.01059064082801342
PWS B-Disease 1 0.9992665648460388
critical O 0 0.023308319970965385
region O 0 0.01723819598555565
resided O 0 0.019917968660593033
on O 0 0.0056739444844424725
the O 0 0.0059636859223246574
derivative O 0 0.028084561228752136
chromosome O 0 0.049534283578395844
3 O 0 0.0071774800308048725
and O 0 0.0033150934614241123
that O 0 0.0026490679010748863
there O 0 0.003344101831316948
was O 0 0.003490111092105508
no O 0 0.004584483802318573
deletion O 0 0.024450667202472687
of O 0 0.004777960479259491
the O 0 0.007502743974328041
PWS B-Disease 1 0.9987548589706421
region O 0 0.013290160335600376
on O 0 0.004658259451389313
the O 0 0.0048743970692157745
normal O 0 0.012433512136340141
pair O 0 0.014214599505066872
of O 0 0.00815691240131855
15s O 0 0.05252262204885483
present O 0 0.0152474045753479
in O 0 0.015325600281357765
J O 1 0.5920275449752808
. O 0 0.025695547461509705

B O 0 0.17515169084072113
. O 0 0.06649553030729294

Methylation O 0 0.11286308616399765
analysis O 0 0.03684486076235771
at O 0 0.019162140786647797
exon O 0 0.04752986505627632
alpha O 0 0.02319202944636345
of O 0 0.006503009703010321
the O 0 0.00723812123760581
small O 0 0.013291167095303535
nuclear O 0 0.02438618242740631
ribonucleoprotein O 1 0.9604700207710266
- O 0 0.13532043993473053
associated O 0 0.025088155642151833
polypeptide O 0 0.09817176312208176
N O 0 0.05192991718649864
( O 0 0.022596610710024834
SNRPN O 1 0.5323725938796997
) O 0 0.015497295185923576
gene O 0 0.034136250615119934
showed O 0 0.011448374949395657
a O 0 0.007990481331944466
pattern O 0 0.01925775408744812
characteristic O 0 0.013574153184890747
of O 0 0.004222332965582609
only O 0 0.004710376728326082
the O 0 0.00778059521690011
maternal O 0 0.05989817529916763
chromosome O 0 0.13456089794635773
15 O 0 0.017395101487636566
in O 0 0.016058264300227165
J O 1 0.62159663438797
. O 0 0.031002700328826904

B O 0 0.1641450673341751
. O 0 0.061049945652484894

Maternal B-Disease 1 0.6514108180999756
disomy I-Disease 0 0.20963536202907562
was O 0 0.021913252770900726
confirmed O 0 0.02517629973590374
by O 0 0.012536972761154175
polymerase O 0 0.06892015784978867
chain O 0 0.04128365218639374
reaction O 0 0.03147866949439049
analysis O 0 0.019276181235909462
of O 0 0.01039155013859272
microsatellite O 0 0.10729028284549713
repeats O 0 0.046279165893793106
at O 0 0.014331585727632046
the O 0 0.012829895131289959
gamma O 0 0.09841331839561462
- O 0 0.3077731430530548
aminobutyric O 1 0.8741099834442139
acid O 1 0.678209662437439
receptor O 1 0.6186294555664062
beta3 O 1 0.5178914666175842
subunit O 0 0.10562590509653091
( O 0 0.03775571659207344
GABRB3 O 0 0.3494984805583954
) O 0 0.036807432770729065
locus O 0 0.09870244562625885
. O 0 0.03609113395214081

A O 0 0.04453010857105255
niece O 0 0.08768933266401291
( O 0 0.027466824278235435
B O 0 0.03282419592142105
. O 0 0.008260766044259071
B O 0 0.020772971212863922
. O 0 0.006183234043419361
) O 0 0.005605058278888464
with O 0 0.0042105186730623245
45 O 0 0.008845138363540173
chromosomes O 0 0.01766495779156685
and O 0 0.004643683787435293
the O 0 0.004633239936083555
derivative O 0 0.01911805383861065
3 O 0 0.007692020386457443
but O 0 0.0040299491956830025
without O 0 0.005895370617508888
the O 0 0.006264773663133383
der O 0 0.035603538155555725
( O 0 0.011162915267050266
15 O 0 0.00888204388320446
) O 0 0.008900667540729046
demonstrated O 0 0.013037965632975101
a O 0 0.0075471410527825356
phenotype O 0 0.3532310128211975
consistent O 0 0.011994121596217155
with O 0 0.005285047460347414
that O 0 0.0049844118766486645
reported O 0 0.010092249140143394
for O 0 0.006253915373235941
haploinsufficiency O 0 0.05378532409667969
of O 0 0.009634862653911114
distal O 1 0.9396945238113403
3 O 0 0.03160044923424721
p O 0 0.0782061442732811
. O 0 0.027153380215168

Uniparental B-Disease 1 0.998691737651825
disomy I-Disease 1 0.97703617811203
associated O 0 0.042941056191921234
with O 0 0.019311580806970596
unbalanced O 0 0.07793231308460236
segregation O 0 0.04580266773700714
of O 0 0.01254607830196619
non O 0 0.029375290498137474
- O 0 0.2766987383365631
Robertsonian O 1 0.8083028793334961
translocations O 0 0.46548154950141907
has O 0 0.010448536835610867
been O 0 0.006204857956618071
reported O 0 0.008424115367233753
previously O 0 0.005003879312425852
but O 0 0.002991783432662487
has O 0 0.0028530561830848455
not O 0 0.002011673292145133
, O 0 0.0021423129364848137
to O 0 0.0022851196117699146
our O 0 0.0029019778594374657
knowledge O 0 0.005302332807332277
, O 0 0.0033285855315625668
been O 0 0.0036714852321892977
observed O 0 0.008651535958051682
in O 0 0.004213334526866674
a O 0 0.0059826914221048355
case O 0 0.012003441341221333
of O 0 0.012304302304983139
PWS B-Disease 1 0.9995050430297852
. O 0 0.033406876027584076

Furthermore O 0 0.04099684953689575
, O 0 0.014335290528833866
our O 0 0.010508816689252853
findings O 0 0.014871644787490368
are O 0 0.005337280686944723
best O 0 0.008569217287003994
interpreted O 0 0.012529383413493633
as O 0 0.008420249447226524
true O 0 0.021424012258648872
gamete O 1 0.7032912969589233
complementation O 1 0.9952099919319153
resulting O 0 0.05663933977484703
in O 0 0.02327028103172779
maternal B-Disease 1 0.8796414136886597
UPD I-Disease 1 0.9987786412239075
15 I-Disease 0 0.05013151094317436
and O 0 0.04109107330441475
PWS B-Disease 1 0.9987301230430603

Schwartz B-Disease 1 0.9940582513809204
- I-Disease 1 0.9975852966308594
Jampel I-Disease 1 0.9994454979896545
syndrome I-Disease 1 0.9999957084655762
type I-Disease 0 0.19971062242984772
2 I-Disease 0 0.02280813828110695
and O 0 0.016130540519952774
Stuve B-Disease 1 0.9985131621360779
- I-Disease 1 0.9993540644645691
Wiedemann I-Disease 1 0.9999309778213501
syndrome I-Disease 1 0.9999964237213135
: O 0 0.019262658432126045
a O 0 0.01035566721111536
case O 0 0.011567098088562489
for O 0 0.007050192914903164
" O 0 0.01258354913443327
lumping O 0 0.058095771819353104
" O 0 0.02056681178510189
. O 0 0.024789132177829742

Recent O 0 0.03904382511973381
studies O 0 0.0259062759578228
demonstrated O 0 0.018742430955171585
the O 0 0.006227970588952303
existence O 0 0.009368534199893475
of O 0 0.005367772653698921
a O 0 0.006885814946144819
genetically O 0 0.019768571481108665
distinct O 0 0.016524672508239746
, O 0 0.006996817886829376
usually O 0 0.009258560836315155
lethal O 0 0.02569909580051899
form O 0 0.007457204628735781
of O 0 0.0058256350457668304
the O 0 0.009536176919937134
Schwartz B-Disease 1 0.9963058233261108
- I-Disease 1 0.9982531666755676
Jampel I-Disease 1 0.9999220371246338
syndrome I-Disease 1 0.9999995231628418
( O 1 0.6885472536087036
SJS B-Disease 1 0.9999034404754639
) O 0 0.022136447951197624
of O 0 0.014280490577220917
myotonia B-Disease 1 0.9998608827590942
and O 0 0.023985497653484344
skeletal B-Disease 1 0.999235987663269
dysplasia I-Disease 1 0.9999701976776123
, O 0 0.013775825500488281
which O 0 0.009803510271012783
we O 0 0.010504485107958317
called O 0 0.02125072479248047
SJS B-Disease 1 0.9995442032814026
type I-Disease 0 0.04473833739757538
2 I-Disease 0 0.024764448404312134
. O 0 0.02477443963289261

This O 0 0.03802817314863205
disorder O 1 0.9991965889930725
is O 0 0.01283869706094265
reminiscent O 0 0.024516254663467407
of O 0 0.007699918933212757
another O 0 0.00999644584953785
rare O 0 0.02166423574090004
condition O 0 0.09500189125537872
, O 0 0.007440952584147453
the O 0 0.011319025419652462
Stuve B-Disease 1 0.9991894364356995
- I-Disease 1 0.9996272325515747
Wiedemann I-Disease 1 0.9999607801437378
syndrome I-Disease 1 0.9999983310699463
( O 0 0.0694354921579361
SWS B-Disease 1 0.9942591190338135
) O 0 0.01424404140561819
, O 0 0.006280068773776293
which O 0 0.005352282430976629
comprises O 0 0.014786727726459503
campomelia B-Disease 0 0.08992773294448853
at O 0 0.012076337821781635
birth O 0 0.024441342800855637
with O 0 0.017637712880969048
skeletal B-Disease 1 0.9997106194496155
dysplasia I-Disease 1 0.9999915361404419
, O 0 0.028746124356985092
contractures B-Disease 1 0.9987418055534363
, O 0 0.013056263327598572
and O 0 0.008432124741375446
early B-Disease 0 0.017783913761377335
death I-Disease 0 0.028293680399656296
. O 0 0.02343558892607689

To O 0 0.019780032336711884
test O 0 0.023001128807663918
for O 0 0.011593012139201164
possible O 0 0.015034089796245098
nosologic O 0 0.051788490265607834
identity O 0 0.014946664683520794
between O 0 0.009354691952466965
these O 0 0.007939931936562061
disorders O 1 0.9995936751365662
, O 0 0.00568396644666791
we O 0 0.0037190646398812532
reviewed O 0 0.00555748026818037
the O 0 0.0030638377647846937
literature O 0 0.004322227090597153
and O 0 0.003170160809531808
obtained O 0 0.00425755325704813
a O 0 0.004556355997920036
follow O 0 0.007224516477435827
- O 0 0.011125228367745876
up O 0 0.003996432758867741
of O 0 0.0025607196148484945
the O 0 0.0030985611956566572
only O 0 0.0029163211584091187
two O 0 0.003947884775698185
surviving O 0 0.01568257063627243
patients O 1 0.9535263776779175
, O 0 0.005641006864607334
one O 0 0.005523305386304855
with O 0 0.01012398675084114
SJS B-Disease 1 0.9997348189353943
type I-Disease 0 0.023469217121601105
2 I-Disease 0 0.009777836501598358
at O 0 0.005821353290230036
age O 0 0.0069458563812077045
10 O 0 0.005294155329465866
years O 0 0.00481942854821682
and O 0 0.004157812800258398
another O 0 0.007089993450790644
with O 0 0.00827429722994566
SWS B-Disease 1 0.9334732890129089
at O 0 0.01093528512865305
age O 0 0.013970941305160522
7 O 0 0.016070125624537468
years O 0 0.014441756531596184
. O 0 0.019875571131706238

Patients O 1 0.9967910647392273
reported O 0 0.03408031165599823
as O 0 0.01221787091344595
having O 0 0.01950007490813732
either O 0 0.034503672271966934
neonatal O 1 0.9999735355377197
SJS B-Disease 1 0.9999428987503052
or O 0 0.03046983666718006
SWS B-Disease 1 0.9852871894836426
presented O 0 0.017008205875754356
a O 0 0.010634975507855415
combination O 0 0.02225624956190586
of O 0 0.006926879286766052
a O 0 0.013808423653244972
severe O 1 0.9992225170135498
, O 0 0.0654929131269455
prenatal O 1 0.9999799728393555
- O 1 0.999963641166687
onset O 1 0.9999988079071045
neuromuscular B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999988079071045
( O 1 0.8694822192192078
with O 0 0.2009878009557724
congenital B-Disease 1 0.9999992847442627
joint I-Disease 1 0.9989796280860901
contractures I-Disease 1 0.9999947547912598
, O 0 0.20719848573207855
respiratory O 1 0.9999929666519165
and O 0 0.01353761088103056
feeding O 0 0.08037598431110382
difficulties O 0 0.08073990792036057
, O 0 0.00989475566893816
tendency O 0 0.04553261399269104
to O 0 0.009938712231814861
hyperthermia B-Disease 1 0.9991650581359863
, O 0 0.008401752449572086
and O 0 0.006846373900771141
frequent O 0 0.02182161435484886
death O 0 0.015428724698722363
in O 0 0.00820204894989729
infancy O 0 0.04456751048564911
) O 0 0.009542853571474552
with O 0 0.007036855444312096
a O 0 0.010900727473199368
distinct O 0 0.030039163306355476
campomelic B-Disease 1 0.9792305827140808
- I-Disease 1 0.969745934009552
metaphyseal I-Disease 1 0.9935564398765564
skeletal I-Disease 1 0.9988791346549988
dysplasia I-Disease 1 0.9999176263809204
. O 0 0.06001107394695282

The O 0 0.016079556196928024
similarity O 0 0.024915188550949097
of O 0 0.006986965890973806
the O 0 0.008422856219112873
clinical O 0 0.17536291480064392
and O 0 0.008593874052166939
radiographic O 1 0.8951048851013184
findings O 0 0.017033927142620087
is O 0 0.0057369740679860115
so O 0 0.005210522096604109
extensive O 0 0.009274916723370552
that O 0 0.005140040069818497
these O 0 0.006364013999700546
disorders O 1 0.9992449283599854
appear O 0 0.00982553232461214
to O 0 0.004400770645588636
be O 0 0.0039565302431583405
a O 0 0.007180762942880392
single O 0 0.013714867644011974
entity O 0 0.030767491087317467
. O 0 0.02051946148276329

The O 0 0.019550766795873642
follow O 0 0.0227202121168375
- O 0 0.024929184466600418
up O 0 0.008028318174183369
observation O 0 0.013690236955881119
of O 0 0.004331502132117748
an O 0 0.004282543435692787
identical O 0 0.00903721246868372
and O 0 0.005406135693192482
unique O 0 0.009450867772102356
pattern O 0 0.02428734302520752
of O 0 0.008557518012821674
progressive O 1 0.9549002647399902
bone B-Disease 1 0.9998990297317505
dysplasia I-Disease 1 0.9999644756317139
in O 0 0.009071203880012035
the O 0 0.00685199536383152
two O 0 0.007305609527975321
patients O 1 0.9899672269821167
( O 0 0.009937187656760216
one O 0 0.006043428089469671
with O 0 0.009387652389705181
SJS B-Disease 1 0.9997467398643494
type I-Disease 0 0.022556817159056664
2 I-Disease 0 0.00980919599533081
, O 0 0.0052749696187675
one O 0 0.0048485491424798965
with O 0 0.008132985793054104
SWS B-Disease 1 0.9839856028556824
) O 0 0.013158977963030338
surviving O 0 0.019999567419290543
beyond O 0 0.018721330910921097
infancy O 0 0.06956061720848083
adds O 0 0.01596948131918907
to O 0 0.004373490810394287
the O 0 0.004118058364838362
evidence O 0 0.007553644012659788
in O 0 0.005509681534022093
favor O 0 0.01309949904680252
of O 0 0.008279631845653057
identity O 0 0.026576103642582893
. O 0 0.022219780832529068

The O 0 0.030827974900603294
hypothesis O 0 0.058257222175598145
that O 0 0.019665252417325974
SWS B-Disease 1 0.9942136406898499
and O 0 0.02171682007610798
SJS B-Disease 1 0.9996191263198853
type I-Disease 0 0.028271231800317764
2 I-Disease 0 0.009344344027340412
are O 0 0.0042860317043960094
the O 0 0.004500321578234434
same O 0 0.009353535249829292
disorder O 1 0.9982523322105408
should O 0 0.007618451490998268
be O 0 0.0052608768455684185
testable O 0 0.024530842900276184
by O 0 0.009099811315536499
molecular O 0 0.027837570756673813
methods O 0 0.01943689025938511
. O 0 0.014284731820225716
. O 0 0.021119168028235435

A O 0 0.05426282808184624
mouse O 0 0.10413946211338043
model O 0 0.0423227921128273
of O 0 0.02623768523335457
severe O 1 0.999911904335022
von B-Disease 1 0.9999808073043823
Willebrand I-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999995231628418
: O 1 0.8288410902023315
defects O 1 0.9993391633033752
in O 0 0.029559554532170296
hemostasis O 1 0.9995006322860718
and O 0 0.038020212203264236
thrombosis B-Disease 1 0.9999657869338989
. O 0 0.043195128440856934

von B-Disease 1 0.9954718351364136
Willebrand I-Disease 1 0.9998188614845276
factor I-Disease 1 0.9710242748260498
( I-Disease 1 0.8678947687149048
vWf I-Disease 1 0.9998770952224731
) I-Disease 1 0.9974954128265381
deficiency I-Disease 1 0.9999997615814209
causes O 1 0.9999794960021973
severe O 1 0.9999943971633911
von B-Disease 1 0.9999853372573853
Willebrand I-Disease 1 0.9999982118606567
disease I-Disease 1 0.9999958276748657
in O 0 0.028706680983304977
humans O 0 0.09918835014104843
. O 0 0.035293176770210266

We O 0 0.027916891500353813
generated O 0 0.029985198751091957
a O 0 0.015275984071195126
mouse O 0 0.04231800138950348
model O 0 0.015715552493929863
for O 0 0.006464515347033739
this O 0 0.008430120535194874
disease O 1 0.9911696910858154
by O 0 0.011073795147240162
using O 0 0.016864098608493805
gene O 0 0.06328641623258591
targeting O 0 0.05523388832807541
. O 0 0.0300485510379076

vWf B-Disease 1 0.9942307472229004
- I-Disease 1 0.9749533534049988
deficient I-Disease 1 0.9894744157791138
mice O 1 0.7823691368103027
appeared O 0 0.02252151630818844
normal O 0 0.021788565441966057
at O 0 0.009483939036726952
birth O 0 0.017430255189538002
; O 0 0.0072789923287928104
they O 0 0.004318137187510729
were O 0 0.004547998309135437
viable O 0 0.017957890406250954
and O 0 0.009747051633894444
fertile O 0 0.049161601811647415
. O 0 0.02521578222513199

Neither O 0 0.1321435272693634
vWf O 1 0.9622687697410583
nor O 0 0.13677053153514862
vWf O 1 0.9898866415023804
propolypeptide O 1 0.9875812530517578
( O 0 0.2224569469690323
von B-Disease 1 0.9957998394966125
Willebrand I-Disease 1 0.9998526573181152
antigen O 1 0.9979425072669983
II O 0 0.0756865069270134
) O 0 0.016763737425208092
were O 0 0.008177971467375755
detectable O 0 0.04161302372813225
in O 0 0.010120919905602932
plasma O 0 0.0390758290886879
, O 0 0.011684218421578407
platelets O 1 0.6487816572189331
, O 0 0.010974538512527943
or O 0 0.01564614661037922
endothelial O 1 0.961769700050354
cells O 0 0.04387381672859192
of O 0 0.008649736642837524
the O 0 0.012962659820914268
homozygous O 0 0.09608419984579086
mutant O 0 0.16892555356025696
mice O 1 0.7415916919708252
. O 0 0.04485037177801132

The O 0 0.037915587425231934
mutant O 0 0.18204176425933838
mice O 1 0.9319178462028503
exhibited O 0 0.2009563148021698
defects O 1 0.989732563495636
in O 0 0.015962867066264153
hemostasis O 1 0.9945085644721985
with O 0 0.01200620923191309
a O 0 0.012623618356883526
highly O 0 0.027336712926626205
prolonged O 1 0.9959943294525146
bleeding O 1 0.9994485974311829
time O 0 0.01359507255256176
and O 0 0.010383614338934422
spontaneous O 0 0.07862019538879395
bleeding O 1 0.9915391802787781
events O 0 0.01161698903888464
in O 0 0.005789685994386673
approximately O 0 0.009609933011233807
10 O 0 0.007799603044986725
% O 0 0.011344731785356998
of O 0 0.011111995205283165
neonates O 1 0.9226151704788208
. O 0 0.03148966282606125

As O 0 0.015287213958799839
in O 0 0.009094026871025562
the O 0 0.008660717867314816
human O 0 0.018179599195718765
disease O 1 0.9994890689849854
, O 0 0.008197057992219925
the O 0 0.00705020921304822
factor O 0 0.022479254752397537
VIII O 0 0.08025770634412766
level O 0 0.009984489530324936
in O 0 0.004938442260026932
these O 0 0.005495423451066017
mice O 0 0.031018713489174843
was O 0 0.005355345085263252
reduced O 0 0.009793054312467575
strongly O 0 0.007546751759946346
as O 0 0.0031310133635997772
a O 0 0.003666954580694437
result O 0 0.0050740898586809635
of O 0 0.0023959979880601168
the O 0 0.003294417867437005
lack O 0 0.008217990398406982
of O 0 0.004301364999264479
protection O 0 0.013483704999089241
provided O 0 0.013357083313167095
by O 0 0.013437620364129543
vWf O 1 0.7487298250198364
. O 0 0.03108096681535244

Defective O 1 0.9968949556350708
thrombosis B-Disease 1 0.9999018907546997
in O 0 0.03024503029882908
mutant O 0 0.09241671860218048
mice O 0 0.1353941261768341
was O 0 0.008914770558476448
also O 0 0.005380516406148672
evident O 0 0.011089727282524109
in O 0 0.004484293516725302
an O 0 0.004595632199198008
in O 0 0.0066407788544893265
vivo O 0 0.046783994883298874
model O 0 0.01630569063127041
of O 0 0.012752269394695759
vascular B-Disease 1 0.9999289512634277
injury I-Disease 1 0.9917391538619995
. O 0 0.03549947217106819

In O 0 0.01796838641166687
this O 0 0.00900814775377512
model O 0 0.016791028901934624
, O 0 0.007800528779625893
the O 0 0.00988007988780737
exteriorized O 0 0.15501537919044495
mesentery O 1 0.735174298286438
was O 0 0.015124063938856125
superfused O 0 0.32094869017601013
with O 0 0.015822622925043106
ferric O 1 0.9926486611366272
chloride O 0 0.3521204888820648
and O 0 0.009463713504374027
the O 0 0.009106668643653393
accumulation O 0 0.045462656766176224
of O 0 0.013116331771016121
fluorescently O 1 0.7046239972114563
labeled O 0 0.05369578301906586
platelets O 1 0.6538947820663452
was O 0 0.01765473373234272
observed O 0 0.028680644929409027
by O 0 0.016278591006994247
intravital O 0 0.11535043269395828
microscopy O 0 0.09367311745882034
. O 0 0.033365022391080856

We O 0 0.023819593712687492
conclude O 0 0.03410187363624573
that O 0 0.008960539475083351
these O 0 0.009428136982023716
mice O 0 0.10350744426250458
very O 0 0.013897006399929523
closely O 0 0.025541717186570168
mimic O 1 0.9982039928436279
severe O 1 0.9999023675918579
human O 1 0.9725604057312012
von B-Disease 1 0.9999806880950928
Willebrand I-Disease 1 0.9999983310699463
disease I-Disease 1 0.9999943971633911
and O 0 0.007237099576741457
will O 0 0.004214347340166569
be O 0 0.0026483701076358557
very O 0 0.003744899295270443
useful O 0 0.004641431383788586
for O 0 0.0027602852787822485
investigating O 0 0.008055191487073898
the O 0 0.003729782998561859
role O 0 0.007754277903586626
of O 0 0.006143088918179274
vWf O 1 0.5297154188156128
in O 0 0.008899607695639133
normal O 0 0.02059721201658249
physiology O 0 0.04883793741464615
and O 0 0.008157633244991302
in O 0 0.009259173646569252
disease O 1 0.9991559982299805
models O 0 0.022069154307246208
. O 0 0.011672352440655231
. O 0 0.022757485508918762

Oral O 0 0.2541688084602356
contraceptives O 0 0.49545037746429443
and O 0 0.014877808280289173
the O 0 0.012331523001194
risk O 1 0.9663596749305725
of O 0 0.0240543931722641
hereditary B-Disease 1 0.9999481439590454
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999940395355225
. O 0 0.06340913474559784

Hereditary B-Disease 1 0.9999213218688965
Ovarian I-Disease 1 0.9999986886978149
Cancer I-Disease 1 0.9999865293502808
Clinical O 1 0.9948700666427612
Study O 0 0.05451943352818489
Group O 0 0.03968818858265877
. O 0 0.03193504735827446

BACKGROUND O 0 0.059539396315813065
Women O 0 0.029086392372846603
with O 0 0.015319577418267727
mutations O 0 0.07965446263551712
in O 0 0.009639094583690166
either O 0 0.011057999916374683
the O 0 0.008726509287953377
BRCA1 O 1 0.9835436344146729
or O 0 0.014883888885378838
the O 0 0.01074542198330164
BRCA2 O 1 0.9980796575546265
gene O 0 0.05958959087729454
have O 0 0.007387941237539053
a O 0 0.007991448976099491
high O 0 0.014848623424768448
lifetime O 0 0.3086627721786499
risk O 1 0.9876086711883545
of O 0 0.029276758432388306
ovarian B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999938011169434
. O 0 0.043044738471508026

Oral O 1 0.9420497417449951
contraceptives O 1 0.9964009523391724
protect O 1 0.7510105967521667
against O 1 0.8936956524848938
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999878406524658
in O 0 0.00796527974307537
general O 0 0.006263945251703262
, O 0 0.0038956019561737776
but O 0 0.0030419162940233946
it O 0 0.0022015550639480352
is O 0 0.0024948117788881063
not O 0 0.0023540547117590904
known O 0 0.0035763783380389214
whether O 0 0.0038722555618733168
they O 0 0.0027976527344435453
also O 0 0.0034025264903903008
protect O 0 0.011755058541893959
against O 0 0.01074964553117752
hereditary B-Disease 1 0.8563010692596436
forms I-Disease 0 0.03992334008216858
of I-Disease 0 0.03512923792004585
ovarian I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999938011169434
. O 0 0.0488467738032341

METHODS O 0 0.04670261591672897
We O 0 0.01983826234936714
enrolled O 0 0.04116630554199219
207 O 0 0.35462018847465515
women O 0 0.0718652606010437
with O 0 0.040943682193756104
hereditary B-Disease 1 0.9999591112136841
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999903440475464
and O 0 0.01013265922665596
161 O 0 0.022327618673443794
of O 0 0.005177476909011602
their O 0 0.005049056373536587
sisters O 0 0.013929028064012527
as O 0 0.005360811948776245
controls O 0 0.01266913115978241
in O 0 0.005133305210620165
a O 0 0.007198076695203781
case O 0 0.0106118218973279
- O 0 0.030860351398587227
control O 0 0.02432606741786003
study O 0 0.02296185865998268
. O 0 0.021917903795838356

All O 0 0.015843568369746208
the O 0 0.014121782965958118
patients O 1 0.9247147440910339
carried O 0 0.015134870074689388
a O 0 0.013752756640315056
pathogenic O 0 0.278730183839798
mutation O 0 0.3709944188594818
in O 0 0.012739423662424088
either O 0 0.01766597479581833
BRCA1 O 1 0.9945664405822754
( O 0 0.023063600063323975
179 O 0 0.036209836602211
women O 0 0.02059333398938179
) O 0 0.01523568108677864
or O 0 0.017091277986764908
BRCA2 O 1 0.9968215227127075
( O 0 0.023419281467795372
28 O 0 0.018789881840348244
women O 0 0.019512305036187172
) O 0 0.01932383142411709
. O 0 0.01664537563920021

The O 0 0.02118293195962906
control O 0 0.02337358519434929
women O 0 0.015318447723984718
were O 0 0.00672987662255764
enrolled O 0 0.013922455720603466
regardless O 0 0.010140667669475079
of O 0 0.003509287955239415
whether O 0 0.0053937435150146484
or O 0 0.0051430207677185535
not O 0 0.003354666056111455
they O 0 0.004040587227791548
had O 0 0.007440909743309021
either O 0 0.01426918525248766
mutation O 0 0.25949859619140625
. O 0 0.02579398639500141

Lifetime O 0 0.09097898006439209
histories O 0 0.05000121518969536
of O 0 0.012218566611409187
oral O 0 0.1166330948472023
- O 0 0.35964637994766235
contraceptive O 1 0.8605578541755676
use O 0 0.009684263728559017
were O 0 0.004397587385028601
obtained O 0 0.00501616857945919
by O 0 0.003682696493342519
interview O 0 0.008243478834629059
or O 0 0.005089574959129095
by O 0 0.0035871134605258703
written O 0 0.004623087123036385
questionnaire O 0 0.014691183343529701
and O 0 0.004110298119485378
were O 0 0.003567021107301116
compared O 0 0.008081508800387383
between O 0 0.007843566127121449
patients O 1 0.9886720180511475
and O 0 0.005300275050103664
control O 0 0.010481808334589005
women O 0 0.009118573740124702
, O 0 0.004298722371459007
after O 0 0.0055295848287642
adjustment O 0 0.012542298063635826
for O 0 0.004047865979373455
year O 0 0.005364407319575548
of O 0 0.005011263769119978
birth O 0 0.016322746872901917
and O 0 0.00990082137286663
parity O 0 0.04088088497519493
. O 0 0.02338271774351597

RESULTS O 0 0.04199495166540146
The O 0 0.02060132846236229
adjusted O 0 0.04184381663799286
odds O 0 0.08297285437583923
ratio O 0 0.1699368953704834
for O 0 0.039442285895347595
ovarian B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999849796295166
associated O 0 0.019556988030672073
with O 0 0.00769289443269372
any O 0 0.005976617801934481
past O 0 0.007426850963383913
use O 0 0.006383940111845732
of O 0 0.005861146841198206
oral O 0 0.0342988483607769
contraceptives O 0 0.40570032596588135
was O 0 0.01594468206167221
0 O 0 0.03417881205677986
. O 0 0.019833700731396675

5 O 0 0.040729962289333344
( O 0 0.020200202241539955
95 O 0 0.019569262862205505
percent O 0 0.016230052337050438
confidence O 0 0.017707521095871925
interval O 0 0.021944968029856682
, O 0 0.006971033290028572
0 O 0 0.011317466385662556
. O 0 0.0046114232391119
3 O 0 0.006882046349346638
to O 0 0.0051778703927993774
0 O 0 0.01372634805738926
. O 0 0.005784701090306044
8 O 0 0.011966871097683907
) O 0 0.014145302586257458
. O 0 0.018272794783115387

The O 0 0.027862053364515305
risk O 0 0.4472859501838684
decreased O 0 0.031062357127666473
with O 0 0.00998289231210947
increasing O 0 0.015789035707712173
duration O 0 0.022948693484067917
of O 0 0.006472998298704624
use O 0 0.009006326086819172
( O 0 0.013096054084599018
P O 0 0.032698292285203934
for O 0 0.007802784442901611
trend O 0 0.02279147505760193
, O 0 0.010873646475374699
< O 0 0.0956549271941185
0 O 0 0.018885331228375435
. O 0 0.007335138972848654
001 O 0 0.04344780743122101
) O 0 0.007928630337119102
; O 0 0.0056694019585847855
use O 0 0.003779750782996416
for O 0 0.0026048074942082167
six O 0 0.00394310662522912
or O 0 0.003986851312220097
more O 0 0.0029715325217694044
years O 0 0.003711446886882186
was O 0 0.0031714614015072584
associated O 0 0.005990474484860897
with O 0 0.004056564066559076
a O 0 0.005191924516111612
60 O 0 0.0103077981621027
percent O 0 0.013563744723796844
reduction O 0 0.030682295560836792
in O 0 0.01206712331622839
risk O 0 0.26978805661201477
. O 0 0.027689052745699883

Oral O 1 0.8141716718673706
- O 1 0.9188576340675354
contraceptive O 1 0.9945276379585266
use O 0 0.024405185133218765
protected O 0 0.08506844192743301
against O 0 0.3242529630661011
ovarian B-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999716281890869
both O 0 0.010716992430388927
for O 0 0.006665542256087065
carriers O 0 0.026222070679068565
of O 0 0.007497001904994249
the O 0 0.012620581313967705
BRCA1 O 1 0.9983671307563782
mutation O 1 0.962399959564209
( O 0 0.0206710584461689
odds O 0 0.03190956264734268
ratio O 0 0.021856756880879402
, O 0 0.0071092406287789345
0 O 0 0.011524302884936333
. O 0 0.004717153497040272
5 O 0 0.007604602258652449
; O 0 0.006606489885598421
95 O 0 0.011031967587769032
percent O 0 0.009191618300974369
confidence O 0 0.013526101596653461
interval O 0 0.017756596207618713
, O 0 0.005776488222181797
0 O 0 0.0100755225867033
. O 0 0.004051250405609608
3 O 0 0.0056959898211061954
to O 0 0.004275992512702942
0 O 0 0.010353313758969307
. O 0 0.003730334574356675
9 O 0 0.006918556056916714
) O 0 0.0048013124614953995
and O 0 0.00294354441575706
for O 0 0.003420980181545019
carriers O 0 0.015156899578869343
of O 0 0.006117412820458412
the O 0 0.01110615860670805
BRCA2 O 1 0.9991724491119385
mutation O 1 0.984519362449646
( O 0 0.02156822383403778
odds O 0 0.032552462071180344
ratio O 0 0.02552538365125656
, O 0 0.00826126616448164
0 O 0 0.013888441026210785
. O 0 0.0056638335809111595
4 O 0 0.00873270258307457
; O 0 0.007025899365544319
95 O 0 0.009911143220961094
percent O 0 0.008935919031500816
confidence O 0 0.013369536958634853
interval O 0 0.01906231790781021
, O 0 0.006899948697537184
0 O 0 0.010805116966366768
. O 0 0.003340994706377387
2 O 0 0.004863012582063675
to O 0 0.003680143505334854
1 O 0 0.006870691664516926
. O 0 0.0048481374979019165
1 O 0 0.010967280715703964
) O 0 0.013265240006148815
. O 0 0.015404454432427883

CONCLUSIONS O 0 0.07952073216438293
Oral O 0 0.4307279884815216
- O 1 0.7375664114952087
contraceptive O 1 0.9821734428405762
use O 0 0.016106130555272102
may O 0 0.01432078517973423
reduce O 0 0.023127270862460136
the O 0 0.009400872513651848
risk O 1 0.9770524501800537
of O 0 0.02689938060939312
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999995231628418
in O 0 0.010596662759780884
women O 0 0.019919846206903458
with O 0 0.014041507616639137
pathogenic O 1 0.8884120583534241
mutations O 1 0.6368516087532043
in O 0 0.013581370003521442
the O 0 0.016418427228927612
BRCA1 O 1 0.9975415468215942
or O 0 0.06072253733873367
BRCA2 O 1 0.9983002543449402
gene O 1 0.9214484691619873

A O 0 0.03223666548728943
Japanese O 0 0.03161286190152168
family O 0 0.026721667498350143
with O 0 0.019296884536743164
adrenoleukodystrophy B-Disease 1 0.9997113347053528
with O 0 0.017279338091611862
a O 0 0.01892012730240822
codon O 0 0.07595651596784592
291 O 0 0.1579255610704422
deletion O 0 0.4086264371871948
: O 0 0.015072246082127094
a O 0 0.010391246527433395
clinical O 0 0.3497661054134369
, O 0 0.008796404115855694
biochemical O 0 0.042937956750392914
, O 0 0.00958616379648447
pathological O 0 0.1668626368045807
, O 0 0.006613578647375107
and O 0 0.006901065818965435
genetic O 0 0.040928591042757034
report O 0 0.017185840755701065
. O 0 0.021826032549142838

We O 0 0.01674950122833252
report O 0 0.012306204065680504
a O 0 0.009210296906530857
Japanese O 0 0.015030666254460812
family O 0 0.019350333139300346
with O 0 0.017222506925463676
adrenoleukodystrophy B-Disease 1 0.999983549118042
( O 0 0.26622703671455383
ALD B-Disease 1 0.999910831451416
) O 0 0.013190915808081627
with O 0 0.005914600566029549
a O 0 0.006725361570715904
three O 0 0.006982315331697464
base O 0 0.015336785465478897
pair O 0 0.02242174558341503
deletion O 0 0.19683992862701416
( O 0 0.02324007637798786
delGAG O 0 0.3880610466003418
291 O 0 0.056051868945360184
) O 0 0.014040583744645119
in O 0 0.010702397674322128
the O 0 0.02045217528939247
ALD B-Disease 1 0.9998570680618286
gene O 0 0.39495930075645447
. O 0 0.041618842631578445

A O 0 0.025922836735844612
variety O 0 0.01942560076713562
of O 0 0.010298230685293674
phenotypes O 0 0.05336788669228554
were O 0 0.008109861984848976
observed O 0 0.014726387336850166
within O 0 0.007562313694506884
this O 0 0.006671562325209379
family O 0 0.01700180023908615
. O 0 0.01638995110988617

While O 0 0.023964617401361465
the O 0 0.017306063324213028
proband O 0 0.2748682498931885
( O 0 0.020946519449353218
patient O 0 0.375628799200058
1 O 0 0.009618518874049187
) O 0 0.006837735418230295
was O 0 0.0038835799787193537
classified O 0 0.006967208813875914
as O 0 0.0036826252471655607
having O 0 0.006379283033311367
a O 0 0.006162181030958891
rare O 0 0.014018275775015354
intermediate O 0 0.016650887206196785
type O 0 0.01690348982810974
of O 0 0.007982577197253704
adult O 0 0.03053892031311989
cerebral O 1 0.9991876482963562
and O 0 0.01606430672109127
cerebello O 1 0.9964663982391357
- O 1 0.9867126941680908
brain O 1 0.9975526928901672
stem O 0 0.14869259297847748
forms O 0 0.012833410874009132
, O 0 0.006107224151492119
his O 0 0.007246815599501133
younger O 0 0.01855773851275444
brother O 0 0.01669812574982643
( O 0 0.012719664722681046
patient O 0 0.24902470409870148
2 O 0 0.01101258397102356
) O 0 0.0083139818161726
and O 0 0.005589056294411421
nephew O 0 0.026315370574593544
( O 0 0.014311136677861214
patient O 0 0.4317921996116638
3 O 0 0.011004967615008354
) O 0 0.009279078803956509
had O 0 0.008579318411648273
a O 0 0.015269111841917038
childhood O 1 0.9732614755630493
ALD B-Disease 1 0.99994957447052
type O 0 0.24569807946681976
. O 0 0.03529239445924759

Another O 0 0.04846254736185074
nephew O 0 0.08573244512081146
( O 0 0.03523842990398407
patient O 0 0.3123985826969147
4 O 0 0.018492260947823524
) O 0 0.011602315120398998
of O 0 0.00645755510777235
patient O 0 0.06255857646465302
1 O 0 0.008927341550588608
was O 0 0.005557317286729813
classified O 0 0.010440396144986153
as O 0 0.004562487360090017
having O 0 0.007753724232316017
an O 0 0.00845861155539751
adolescent O 0 0.3984828591346741
form O 0 0.027253204956650734
. O 0 0.024442944675683975

The O 0 0.02607962116599083
tau O 0 0.06220025196671486
level O 0 0.019377075135707855
in O 0 0.00959139782935381
the O 0 0.012387294322252274
cerebrospinal O 1 0.9954293966293335
fluid O 1 0.7701929807662964
( O 0 0.02889479324221611
CSF O 1 0.9866956472396851
) O 0 0.012168782763183117
in O 0 0.006556361448019743
patient O 0 0.0965380072593689
1 O 0 0.00579537870362401
was O 0 0.003453667741268873
as O 0 0.0026809214614331722
high O 0 0.004881459288299084
as O 0 0.0028941980563104153
that O 0 0.0038062476087361574
of O 0 0.006484729237854481
patients O 1 0.9998587369918823
with O 0 0.17985351383686066
Alzheimers B-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999926090240479
( O 0 0.04473802447319031
AD B-Disease 0 0.15567274391651154
) O 0 0.025879379361867905
. O 0 0.02314400114119053

His O 0 0.04957880079746246
brain O 1 0.807207465171814
magnetic O 0 0.05995703488588333
resonance O 0 0.058892346918582916
image O 0 0.032493773847818375
( O 0 0.02023962140083313
MRI O 1 0.8891995549201965
) O 0 0.014236398041248322
showed O 0 0.01429832261055708
abnormalities B-Disease 1 0.8052846789360046
in I-Disease 0 0.005457377526909113
the I-Disease 0 0.006765285972505808
bilateral I-Disease 0 0.025388626381754875
cerebellar I-Disease 1 0.9997437596321106
hemispheres I-Disease 1 0.8614779710769653
and O 0 0.012041978538036346
brain O 1 0.9974209070205688
stem O 0 0.1920916736125946
, O 0 0.005856433883309364
but O 0 0.004575425758957863
not O 0 0.0036618392914533615
in O 0 0.004081456921994686
the O 0 0.006500441115349531
cerebral O 1 0.9958898425102234
white O 0 0.02148098684847355
matter O 0 0.00866687297821045
, O 0 0.005495455116033554
where O 0 0.006003066897392273
marked O 0 0.010526234284043312
reductions O 0 0.01880287565290928
of O 0 0.005954488646239042
the O 0 0.009266612119972706
cerebral O 1 0.9990938901901245
blood O 1 0.6866791248321533
flow O 0 0.03321940079331398
and O 0 0.012288706377148628
oxygen O 0 0.05666687712073326
metabolism O 0 0.05305503308773041
were O 0 0.008879275061190128
clearly O 0 0.017435720190405846
demonstrated O 0 0.020896360278129578
by O 0 0.014113287441432476
positron O 0 0.4410930573940277
emission O 0 0.09243682771921158
tomography O 0 0.3709629774093628
( O 0 0.03307988867163658
PET O 0 0.07418528199195862
) O 0 0.024550888687372208
. O 0 0.02441251091659069

In O 0 0.029275093227624893
patients O 1 0.9554663896560669
2 O 0 0.01326989009976387
and O 0 0.006264417432248592
3 O 0 0.007931980304419994
, O 0 0.004384587984532118
the O 0 0.005501201376318932
autopsy O 0 0.031851306557655334
findings O 0 0.019731227308511734
showed O 0 0.01776077225804329
massive O 0 0.03794819861650467
demyelination B-Disease 1 0.9987253546714783
of I-Disease 0 0.008370409719645977
the I-Disease 0 0.01046883873641491
cerebral I-Disease 1 0.9979164004325867
white I-Disease 0 0.01891169138252735
matter I-Disease 0 0.008662822656333447
with O 0 0.006532945670187473
sparing O 0 0.025492094457149506
of O 0 0.00570314796641469
the O 0 0.007887541316449642
U O 0 0.07922154664993286
- O 0 0.07884381711483002
fibers O 0 0.09484855830669403
, O 0 0.006258273031562567
compatible O 0 0.0112697072327137
with O 0 0.005873523652553558
the O 0 0.006486056838184595
findings O 0 0.018305663019418716
of O 0 0.012549255974590778
childhood O 1 0.9747163653373718
ALD B-Disease 1 0.9999277591705322
. O 0 0.045954205095767975

Oleic O 1 0.5779392719268799
and O 0 0.039808452129364014
erucic O 1 0.9598283767700195
acids O 0 0.06829383224248886
( O 0 0.02756440080702305
Lorenzos O 0 0.07774512469768524
Oil O 0 0.01922648958861828
) O 0 0.010624917224049568
were O 0 0.004585019778460264
administered O 0 0.01594424806535244
to O 0 0.006751080974936485
patients O 1 0.6553199887275696
1 O 0 0.006749661639332771
and O 0 0.004115321673452854
4 O 0 0.0064107151702046394
, O 0 0.004036945756524801
but O 0 0.004489663522690535
sufficient O 0 0.01042530220001936
effectiveness O 0 0.02022448368370533
was O 0 0.005595700815320015
not O 0 0.0067659905180335045
obtained O 0 0.013830654323101044
. O 0 0.01777375489473343

The O 0 0.017538800835609436
findings O 0 0.020579753443598747
in O 0 0.006866371259093285
this O 0 0.005426269024610519
family O 0 0.00921684317290783
suggest O 0 0.01036453153938055
that O 0 0.004492669366300106
delGAG291 O 0 0.023780250921845436
is O 0 0.004196973517537117
part O 0 0.004785330966114998
of O 0 0.0032702721655368805
the O 0 0.005028984509408474
cause O 0 0.018698079511523247
of O 0 0.0068327379412949085
Japanese O 0 0.023598963394761086
ALD B-Disease 1 0.9998161196708679
with O 0 0.019969981163740158
phenotypic O 0 0.08152894675731659
variations O 0 0.05521534010767937
. O 0 0.032837774604558945

Moreover O 0 0.040294937789440155
, O 0 0.009962723590433598
although O 0 0.007120626047253609
the O 0 0.004429822787642479
scale O 0 0.010664941743016243
of O 0 0.003733348101377487
the O 0 0.00406058132648468
study O 0 0.006772781256586313
is O 0 0.0035817588213831186
limited O 0 0.0049662236124277115
, O 0 0.0026913376059383154
there O 0 0.0029972156044095755
is O 0 0.0026652123779058456
a O 0 0.003991453442722559
possibility O 0 0.008986353874206543
that O 0 0.005786974914371967
PET O 0 0.039801035076379776
can O 0 0.01079872902482748
detect O 0 0.03927234932780266
an O 0 0.01189512014389038
insidious B-Disease 1 0.9688142538070679
lesion I-Disease 1 0.9987038373947144
which O 0 0.012996540404856205
is O 0 0.011750014498829842
undetectable O 0 0.09404145926237106
by O 0 0.01192591805011034
computed O 0 0.03821737319231033
tomogram O 1 0.5792545080184937
( O 0 0.022457465529441833
CT O 1 0.9940885305404663
) O 0 0.01202338095754385
or O 0 0.008654898963868618
MRI O 0 0.09778372198343277
analysis O 0 0.008355683647096157
, O 0 0.00307771866209805
and O 0 0.0022882474586367607
that O 0 0.0021843372378498316
the O 0 0.0029007308185100555
higher O 0 0.006859303452074528
level O 0 0.007242016959935427
of O 0 0.004520388785749674
tau O 0 0.0212256982922554
reflects O 0 0.01300155557692051
the O 0 0.005768253467977047
process O 0 0.010216428898274899
of O 0 0.012290195561945438
neuronal B-Disease 1 0.9896457195281982
degeneration I-Disease 1 0.999883770942688
in O 0 0.03341333940625191
ALD B-Disease 1 0.9999459981918335
. O 0 0.047630153596401215

Lorenzos O 0 0.15767759084701538
Oil O 0 0.029853247106075287
should O 0 0.010951516218483448
be O 0 0.0048421272076666355
given O 0 0.00500190956518054
in O 0 0.0037542469799518585
the O 0 0.004621445666998625
early O 0 0.00993269495666027
stage O 0 0.01845180056989193
. O 0 0.010389589704573154
. O 0 0.016895560547709465

Nonsense O 0 0.11842086166143417
mutation O 0 0.16893990337848663
in O 0 0.01967175118625164
exon O 0 0.05739681422710419
4 O 0 0.01874353550374508
of O 0 0.008623631671071053
human O 0 0.01897330954670906
complement O 0 0.034579236060380936
C9 O 1 0.9899605512619019
gene O 0 0.05632726848125458
is O 0 0.009210196323692799
the O 0 0.006242454517632723
major O 0 0.011938178911805153
cause O 0 0.026009825989603996
of O 0 0.0085351737216115
Japanese O 0 0.027111314237117767
complement B-Disease 0 0.19827720522880554
C9 I-Disease 1 0.9997401833534241
deficiency I-Disease 1 0.999974250793457
. O 0 0.05055149272084236

Deficiency B-Disease 1 0.9995622038841248
of I-Disease 0 0.015422084368765354
the I-Disease 0 0.01040749903768301
ninth I-Disease 0 0.024877799674868584
component I-Disease 0 0.020031562075018883
of I-Disease 0 0.007989441975951195
human I-Disease 0 0.014743968844413757
complement I-Disease 0 0.02773205004632473
( O 0 0.017148267477750778
C9 O 1 0.9022191166877747
) O 0 0.008625361137092113
is O 0 0.004221110604703426
the O 0 0.004209495149552822
most O 0 0.005219719372689724
common O 0 0.01615055277943611
complement B-Disease 1 0.8880022168159485
deficiency I-Disease 1 0.9999926090240479
in O 0 0.007993048056960106
Japan O 0 0.009132064878940582
but O 0 0.004442177712917328
is O 0 0.004370120353996754
rare O 0 0.010152441449463367
in O 0 0.004963069222867489
other O 0 0.004823518916964531
countries O 0 0.012454080395400524
. O 0 0.01864778995513916

We O 0 0.01991155557334423
studied O 0 0.018800467252731323
the O 0 0.008808842860162258
molecular O 0 0.022374922409653664
basis O 0 0.011617569252848625
of O 0 0.01294173114001751
C9 B-Disease 1 0.9997289776802063
deficiency I-Disease 1 0.9999616146087646
in O 0 0.012716718949377537
four O 0 0.01200947817414999
Japanese O 0 0.031070133671164513
C9 B-Disease 1 0.9996691942214966
- I-Disease 1 0.9971684813499451
deficient I-Disease 1 0.9993656277656555
patients O 1 0.9997571110725403
who O 0 0.026178808882832527
had O 0 0.02364603616297245
suffered O 1 0.9990980625152588
from O 0 0.21303856372833252
meningococcal B-Disease 1 0.9999959468841553
meningitis I-Disease 1 0.999990701675415
. O 0 0.05859586223959923

Direct O 0 0.058294642716646194
sequencing O 0 0.0679619163274765
of O 0 0.02375956065952778
amplified O 0 0.08453837037086487
C9 O 1 0.7198141813278198
cDNA O 0 0.07948854565620422
and O 0 0.015054035000503063
DNA O 0 0.03295423090457916
revealed O 0 0.021225757896900177
a O 0 0.01502404548227787
nonsense O 0 0.041246239095926285
substitution O 0 0.04515592008829117
( O 0 0.024416601285338402
CGA O 0 0.3266143798828125
- O 1 0.8109756708145142
- O 1 0.7821236848831177
> O 1 0.841683566570282
TGA O 1 0.9716286063194275
) O 0 0.021319841966032982
at O 0 0.0145332096144557
codon O 0 0.038865454494953156
95 O 0 0.016599295660853386
in O 0 0.008216094225645065
exon O 0 0.0352523997426033
4 O 0 0.009736458770930767
in O 0 0.0053977095521986485
the O 0 0.006246520206332207
four O 0 0.012534965761005878
C9 B-Disease 1 0.9973976612091064
- I-Disease 1 0.7261763215065002
deficient I-Disease 1 0.9088088274002075
individuals O 0 0.03975488245487213
. O 0 0.03171778842806816

An O 0 0.045628391206264496
allele O 0 0.1737263798713684
- O 0 0.09420889616012573
specific O 0 0.044031113386154175
polymerase O 0 0.10253462940454483
chain O 0 0.04463275521993637
reaction O 0 0.029014328494668007
system O 0 0.013423486612737179
designed O 0 0.011234777979552746
to O 0 0.005286742467433214
detect O 0 0.02028672583401203
exclusively O 0 0.007442368194460869
only O 0 0.0036969883367419243
one O 0 0.003194917691871524
of O 0 0.0029636938124895096
the O 0 0.003958124667406082
normal O 0 0.012022769078612328
and O 0 0.006785382982343435
mutant O 0 0.03734666854143143
alleles O 0 0.1044655367732048
indicated O 0 0.012128793634474277
that O 0 0.0036776596680283546
all O 0 0.0029991171322762966
the O 0 0.003697729902341962
four O 0 0.00520125450566411
patients O 1 0.6212480664253235
were O 0 0.005226882174611092
homozygous O 0 0.02300943061709404
for O 0 0.004452059511095285
the O 0 0.005483150016516447
mutation O 0 0.04264872148633003
in O 0 0.0063291676342487335
exon O 0 0.032120559364557266
4 O 0 0.008466321043670177
and O 0 0.0036088270135223866
that O 0 0.003216212149709463
the O 0 0.003728057723492384
parents O 0 0.009444725699722767
of O 0 0.006006914656609297
patient O 0 0.24023723602294922
2 O 0 0.016374099999666214
were O 0 0.01015475019812584
heterozygous O 0 0.07006731629371643
. O 0 0.02803012914955616

The O 0 0.028973417356610298
common O 0 0.04151621833443642
mutation O 0 0.1097278967499733
at O 0 0.02018827572464943
codon O 0 0.0467078797519207
95 O 0 0.01643751934170723
in O 0 0.008039508014917374
exon O 0 0.035512425005435944
4 O 0 0.01070259977132082
might O 0 0.008580617606639862
be O 0 0.0036598569713532925
responsible O 0 0.008067301474511623
for O 0 0.004993302281945944
most O 0 0.007651017513126135
Japanese O 0 0.023483747616410255
C9 B-Disease 1 0.9997164607048035
deficiency I-Disease 1 0.9999700784683228
. O 0 0.02553832344710827
. O 0 0.02536364644765854

BRCA1 O 1 0.9562622904777527
required O 0 0.033863939344882965
for O 0 0.01931467093527317
transcription O 0 0.07240379601716995
- O 0 0.19534899294376373
coupled O 0 0.06069624423980713
repair O 0 0.17856112122535706
of O 0 0.020767731592059135
oxidative O 1 0.8621713519096375
DNA O 0 0.07829327136278152
damage O 0 0.19143031537532806
. O 0 0.03401178494095802

The O 0 0.0697212815284729
breast B-Disease 1 0.9999780654907227
and I-Disease 1 0.9532850384712219
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999983310699463
susceptibility O 1 0.9997912049293518
gene O 1 0.9799688458442688
BRCA1 O 1 0.9982299208641052
encodes O 0 0.0796448215842247
a O 0 0.02482793666422367
zinc O 1 0.5953182578086853
finger O 0 0.06663504242897034
protein O 0 0.034325215965509415
of O 0 0.009620379656553268
unknown O 0 0.02065235748887062
function O 0 0.025932321324944496
. O 0 0.020904913544654846

Association O 0 0.045345623046159744
of O 0 0.01443867664784193
the O 0 0.016435682773590088
BRCA1 O 1 0.9207907319068909
protein O 0 0.03324263170361519
with O 0 0.009513171389698982
the O 0 0.010170934721827507
DNA O 0 0.03146049380302429
repair O 0 0.21600958704948425
protein O 0 0.04335244745016098
Rad51 O 1 0.7999526858329773
and O 0 0.0078100780956447124
changes O 0 0.008970851078629494
in O 0 0.0042546759359538555
the O 0 0.005091831088066101
phosphorylation O 0 0.020642729476094246
and O 0 0.006487654987722635
cellular O 0 0.02342677302658558
localization O 0 0.02109125629067421
of O 0 0.005236359313130379
the O 0 0.005914438050240278
protein O 0 0.01784648187458515
after O 0 0.009735488332808018
exposure O 0 0.2850826680660248
to O 0 0.007543166168034077
DNA O 0 0.02614111267030239
- O 0 0.042663462460041046
damaging O 0 0.03233106806874275
agents O 0 0.013299956917762756
are O 0 0.004407161846756935
consistent O 0 0.0078373271971941
with O 0 0.0043173437006771564
a O 0 0.005084632430225611
role O 0 0.0085303895175457
for O 0 0.006964702159166336
BRCA1 O 1 0.9778257608413696
in O 0 0.013695472851395607
DNA O 0 0.04666725918650627
repair O 0 0.25335848331451416
. O 0 0.03351806476712227

Here O 0 0.017407745122909546
, O 0 0.008508277125656605
it O 0 0.005710242781788111
is O 0 0.005608988460153341
shown O 0 0.01016933098435402
that O 0 0.008103631436824799
mouse O 0 0.2558380365371704
embryonic O 1 0.8812853693962097
stem O 1 0.9514594674110413
cells O 1 0.90900057554245
deficient B-Disease 1 0.9290592670440674
in I-Disease 0 0.010375351645052433
BRCA1 I-Disease 1 0.9900156855583191
are O 0 0.0078095607459545135
defective O 0 0.050888773053884506
in O 0 0.004604879301041365
the O 0 0.004083535168319941
ability O 0 0.008023773320019245
to O 0 0.004060785751789808
carry O 0 0.008838520385324955
out O 0 0.008537797257304192
transcription O 0 0.03614121302962303
- O 0 0.10287347435951233
coupled O 0 0.06149682402610779
repair O 0 0.47779837250709534
of O 0 0.012558052316308022
oxidative O 1 0.9535725116729736
DNA O 0 0.04084862768650055
damage O 0 0.03943851590156555
, O 0 0.0064577748998999596
and O 0 0.005606377497315407
are O 0 0.007557596080005169
hypersensitive O 0 0.10491004586219788
to O 0 0.01601664535701275
ionizing O 1 0.9078406095504761
radiation O 1 0.762824296951294
and O 0 0.019357934594154358
hydrogen O 0 0.06528659909963608
peroxide O 0 0.4201611280441284
. O 0 0.039154697209596634

These O 0 0.02127331867814064
results O 0 0.022549519315361977
suggest O 0 0.020806044340133667
that O 0 0.008455555886030197
BRCA1 O 1 0.9371433258056641
participates O 0 0.029581420123577118
, O 0 0.006993107497692108
directly O 0 0.007551842834800482
or O 0 0.0072467876598238945
indirectly O 0 0.01567937433719635
, O 0 0.005821709055453539
in O 0 0.007221439853310585
transcription O 0 0.04318288713693619
- O 0 0.186853289604187
coupled O 0 0.06485915929079056
repair O 0 0.41465428471565247
of O 0 0.01415198016911745
oxidative O 1 0.9029018878936768
DNA O 0 0.06022176519036293
damage O 0 0.10641911625862122
. O 0 0.017618579789996147
. O 0 0.022655829787254333

Truncation O 0 0.2547464370727539
mutations O 0 0.15185701847076416
in O 0 0.01514221541583538
the O 0 0.01327939610928297
transactivation O 0 0.21221384406089783
region O 0 0.02862708270549774
of O 0 0.011951758526265621
PAX6 O 1 0.9867861866950989
result O 0 0.022408686578273773
in O 0 0.01212481688708067
dominant O 0 0.04138410463929176
- O 0 0.10593163967132568
negative O 0 0.05709274858236313
mutants O 0 0.09969887882471085
. O 0 0.03594920039176941

PAX6 O 1 0.876499593257904
is O 0 0.02035677246749401
a O 0 0.016968445852398872
transcription O 0 0.041646286845207214
factor O 0 0.0215894877910614
with O 0 0.00731115834787488
two O 0 0.007667601108551025
DNA O 0 0.02520863339304924
- O 0 0.03152116388082504
binding O 0 0.02728394977748394
domains O 0 0.0277852900326252
( O 0 0.015415444038808346
paired O 0 0.029768066480755806
box O 0 0.01950027234852314
and O 0 0.008319593966007233
homeobox O 1 0.8841091394424438
) O 0 0.010937260463833809
and O 0 0.006340693682432175
a O 0 0.011017804965376854
proline O 0 0.0844501331448555
- O 0 0.07671105116605759
serine O 0 0.13940675556659698
- O 0 0.20044317841529846
threonine O 0 0.30560073256492615
( O 0 0.033826421946287155
PST O 1 0.9117842316627502
) O 0 0.02361713908612728
- O 0 0.04456300660967827
rich O 0 0.04062590375542641
transactivation O 0 0.42149266600608826
domain O 0 0.05754416063427925
. O 0 0.03411634638905525

PAX6 O 1 0.9857818484306335
regulates O 0 0.3356529772281647
eye O 1 0.6522263288497925
development O 0 0.02260509692132473
in O 0 0.012007463723421097
animals O 0 0.02045082114636898
ranging O 0 0.020245473831892014
from O 0 0.011833650059998035
jellyfish O 0 0.041806288063526154
to O 0 0.011191974394023418
Drosophila O 0 0.04668733477592468
to O 0 0.013952075503766537
humans O 0 0.0405413880944252
. O 0 0.0278298519551754

Heterozygous O 0 0.24372798204421997
mutations O 0 0.17694883048534393
in O 0 0.01551325898617506
the O 0 0.015035983175039291
human O 0 0.028835561126470566
PAX6 O 1 0.9927899837493896
gene O 0 0.07476767152547836
result O 0 0.017692407593131065
in O 0 0.008052997291088104
various O 0 0.009092050604522228
phenotypes O 0 0.25250980257987976
, O 0 0.010653224773705006
including O 0 0.013120072893798351
aniridia B-Disease 1 0.9873480796813965
, O 0 0.02041773684322834
Peters B-Disease 1 0.9665858149528503
anomaly I-Disease 1 0.994971752166748
, O 0 0.02614545449614525
autosomal B-Disease 1 0.9994921684265137
dominant I-Disease 1 0.9675281047821045
keratitis I-Disease 1 0.9999752044677734
, O 0 0.02500562183558941
and O 0 0.02358139678835869
familial B-Disease 1 0.9997037053108215
foveal I-Disease 1 0.9985673427581787
dysplasia I-Disease 1 0.9999549388885498
. O 0 0.05230091139674187

It O 0 0.017144715413451195
is O 0 0.010454686358571053
believed O 0 0.01111555378884077
that O 0 0.0058451201766729355
the O 0 0.008336488157510757
mutated O 0 0.06995008885860443
allele O 0 0.08908694237470627
of O 0 0.016347166150808334
PAX6 O 1 0.9616678953170776
produces O 0 0.03979579731822014
an O 0 0.01413156557828188
inactive O 0 0.037535034120082855
protein O 0 0.030042050406336784
and O 0 0.009780717082321644
aniridia B-Disease 1 0.8920878171920776
is O 0 0.012455957941710949
caused O 0 0.028253816068172455
due O 0 0.014361321926116943
to O 0 0.014315523207187653
genetic O 0 0.07049406319856644
haploinsufficiency O 0 0.30147093534469604
. O 0 0.03875133767724037

However O 0 0.022460544481873512
, O 0 0.013491103425621986
several O 0 0.011066972278058529
truncation O 0 0.06413067877292633
mutations O 0 0.0811665877699852
have O 0 0.007879755459725857
been O 0 0.005108244717121124
found O 0 0.005818580277264118
to O 0 0.0038561178371310234
occur O 0 0.009762740693986416
in O 0 0.004101740196347237
the O 0 0.0054360623471438885
C O 0 0.029377007856965065
- O 0 0.02727704495191574
terminal O 0 0.024551071226596832
half O 0 0.0104293217882514
of O 0 0.007491896860301495
PAX6 O 1 0.9937332272529602
in O 0 0.010264003649353981
patients O 1 0.990180253982544
with O 0 0.012116869911551476
Aniridia B-Disease 1 0.9733766913414001
resulting O 0 0.02271413244307041
in O 0 0.00853422936052084
mutant O 0 0.031345780938863754
proteins O 0 0.01968095824122429
that O 0 0.006154986098408699
retain O 0 0.015406242571771145
the O 0 0.007776656653732061
DNA O 0 0.02116709016263485
- O 0 0.02381686121225357
binding O 0 0.016622820869088173
domains O 0 0.01641308329999447
but O 0 0.004867131356149912
have O 0 0.003736825892701745
lost O 0 0.0062438445165753365
most O 0 0.0038559860549867153
of O 0 0.004173982422798872
the O 0 0.00806382205337286
transactivation O 0 0.14234228432178497
domain O 0 0.03951633349061012
. O 0 0.027654973790049553

It O 0 0.01485294196754694
is O 0 0.009627166204154491
not O 0 0.006698714569211006
clear O 0 0.009111376479268074
whether O 0 0.008821876719594002
such O 0 0.007359350565820932
mutants O 0 0.03669706732034683
really O 0 0.016050279140472412
behave O 0 0.021612105891108513
as O 0 0.0068563735112547874
loss O 0 0.020149318501353264
- O 0 0.01970498450100422
of O 0 0.0077384780161082745
- O 0 0.02924499846994877
function O 0 0.020325541496276855
mutants O 0 0.036983538419008255
as O 0 0.009311881847679615
predicted O 0 0.022854097187519073
by O 0 0.013905627653002739
haploinsufficiency O 0 0.09253236651420593
. O 0 0.03356720879673958

Contrary O 0 0.03004852496087551
to O 0 0.009453857317566872
this O 0 0.005658148322254419
theory O 0 0.009012892842292786
, O 0 0.004260700196027756
our O 0 0.004855682607740164
data O 0 0.0052605075761675835
showed O 0 0.008164970204234123
that O 0 0.003913169261068106
these O 0 0.004318369086831808
mutants O 0 0.020906848832964897
are O 0 0.006072402931749821
dominant O 0 0.02383805625140667
- O 0 0.057080045342445374
negative O 0 0.028475536033511162
in O 0 0.011522369459271431
transient O 1 0.9496637582778931
transfection O 1 0.980923056602478
assays O 0 0.04374770075082779
when O 0 0.011213229969143867
they O 0 0.0062518795020878315
are O 0 0.007279402110725641
coexpressed O 0 0.044645681977272034
with O 0 0.012019134126603603
wild O 0 0.030726812779903412
- O 0 0.14144659042358398
type O 0 0.10888856649398804
PAX6 O 1 0.9901614189147949
. O 0 0.03822135180234909

We O 0 0.0169802475720644
found O 0 0.011966272257268429
that O 0 0.006881537847220898
the O 0 0.007890894077718258
dominant O 0 0.03185248002409935
- O 0 0.23137007653713226
negative O 0 0.03257471323013306
effects O 0 0.06322706490755081
result O 0 0.011532388627529144
from O 0 0.006413340102881193
the O 0 0.006284819915890694
enhanced O 0 0.023303305730223656
DNA O 0 0.02409326657652855
binding O 0 0.017848270013928413
ability O 0 0.013471988029778004
of O 0 0.007004268933087587
these O 0 0.010121484287083149
mutants O 0 0.054801035672426224
. O 0 0.026443300768733025

Kinetic O 0 0.08399852365255356
studies O 0 0.03517918661236763
of O 0 0.01258852332830429
binding O 0 0.02500920742750168
and O 0 0.012804760597646236
dissociation O 0 0.059572983533144
revealed O 0 0.018245667219161987
that O 0 0.00664234533905983
various O 0 0.008136490359902382
truncation O 0 0.0467650331556797
mutants O 0 0.033696409314870834
have O 0 0.008108378387987614
3 O 0 0.011745608411729336
- O 0 0.02466273307800293
5 O 0 0.012881743721663952
- O 0 0.022779304534196854
fold O 0 0.02275117114186287
higher O 0 0.011910442262887955
affinity O 0 0.019867731258273125
to O 0 0.0048953513614833355
various O 0 0.005872098729014397
DNA O 0 0.01988658495247364
- O 0 0.022438865154981613
binding O 0 0.01486422773450613
sites O 0 0.009021771140396595
when O 0 0.006108055356889963
compared O 0 0.007538338657468557
with O 0 0.005481140222400427
the O 0 0.007074696011841297
wild O 0 0.027577096596360207
- O 0 0.22673408687114716
type O 0 0.09901043772697449
PAX6 O 1 0.990321695804596
. O 0 0.044173385947942734

These O 0 0.0179714597761631
results O 0 0.016649998724460602
provide O 0 0.010596456937491894
a O 0 0.006954881828278303
new O 0 0.006670779082924128
insight O 0 0.01579337939620018
into O 0 0.005781159270554781
the O 0 0.005360033363103867
role O 0 0.010079708881676197
of O 0 0.007674876134842634
mutant O 0 0.0736444741487503
PAX6 O 1 0.9936409592628479
in O 0 0.01950867287814617
causing O 0 0.2774670422077179
aniridia B-Disease 1 0.9496449828147888
. O 0 0.022342730313539505
. O 0 0.02622622810304165

Reversal O 1 0.8940529227256775
of O 0 0.04920745640993118
severe O 1 0.9998754262924194
hypertrophic B-Disease 1 0.9999960660934448
cardiomyopathy I-Disease 1 0.9999942779541016
and O 0 0.020669642835855484
excellent O 0 0.029445936903357506
neuropsychologic O 0 0.2718518376350403
outcome O 0 0.01981978304684162
in O 0 0.007706819102168083
very B-Disease 0 0.00966267567127943
- I-Disease 0 0.07203756272792816
long I-Disease 0 0.024136967957019806
- I-Disease 1 0.8224499821662903
chain I-Disease 1 0.5400471091270447
acyl I-Disease 1 0.9981561303138733
- I-Disease 1 0.9782387018203735
coenzyme I-Disease 1 0.9829088449478149
A I-Disease 0 0.11186668276786804
dehydrogenase I-Disease 1 0.999473512172699
deficiency I-Disease 1 0.9999529123306274
. O 0 0.06502748280763626

Very B-Disease 0 0.043549537658691406
- I-Disease 0 0.11534307897090912
long I-Disease 0 0.04251791164278984
- I-Disease 1 0.5716617703437805
chain I-Disease 0 0.3723979890346527
acyl I-Disease 1 0.9949523210525513
- I-Disease 1 0.9285199046134949
coenzyme I-Disease 1 0.9039478302001953
A I-Disease 0 0.04602934420108795
dehydrogenase I-Disease 1 0.9980127811431885
( I-Disease 0 0.14901095628738403
VLCAD I-Disease 1 0.9985213875770569
) I-Disease 0 0.33031055331230164
deficiency I-Disease 1 0.9999802112579346
is O 0 0.012263180688023567
a O 0 0.013504227623343468
disorder O 1 0.9996761083602905
of O 0 0.01171783171594143
fatty O 1 0.9146803021430969
acid O 1 0.6897925734519958
beta O 0 0.06064332276582718
oxidation O 0 0.049836788326501846
that O 0 0.006851128302514553
reportedly O 0 0.014503974467515945
has O 0 0.0072251600213348866
high O 0 0.011208958923816681
rates O 0 0.019178127869963646
of O 0 0.008799872361123562
morbidity O 1 0.951848030090332
and O 0 0.014484671875834465
mortality O 1 0.7433238625526428
. O 0 0.02674071118235588

We O 0 0.01885148696601391
describe O 0 0.022184979170560837
the O 0 0.007599102333188057
outcome O 0 0.011985290795564651
of O 0 0.00472983717918396
a O 0 0.007418207824230194
5 O 0 0.010304744355380535
- O 0 0.023165762424468994
year O 0 0.010569571517407894
- O 0 0.03388144075870514
old O 0 0.017705000936985016
girl O 0 0.08624526113271713
with O 0 0.017911799252033234
VLCAD B-Disease 1 0.9998859167098999
deficiency I-Disease 1 0.9999957084655762
who O 0 0.010219987481832504
was O 0 0.005017925053834915
first O 0 0.004473662935197353
seen O 0 0.006460865959525108
at O 0 0.005114054307341576
5 O 0 0.0064968448132276535
months O 0 0.0061157769523561
of O 0 0.004624482709914446
age O 0 0.014780442230403423
with O 0 0.03309176117181778
severe O 1 0.9999805688858032
hypertrophic B-Disease 1 0.9999994039535522
cardiomyopathy I-Disease 1 0.9999998807907104
, O 1 0.9471365809440613
hepatomegaly B-Disease 1 0.9999920129776001
, O 0 0.343887060880661
encephalopathy B-Disease 1 0.9999737739562988
, O 0 0.022649571299552917
and O 0 0.02256128191947937
hypotonia B-Disease 1 0.9962471127510071
. O 0 0.03558535873889923

Biochemical O 1 0.8024872541427612
studies O 0 0.16273431479930878
indicated O 1 0.8834548592567444
VLCAD B-Disease 1 0.9999016523361206
deficiency I-Disease 1 0.9999969005584717
caused O 0 0.3999061584472656
by O 0 0.01399292517453432
a O 0 0.01685287430882454
stable O 0 0.0381191186606884
yet O 0 0.025246167555451393
inactive O 0 0.06551281362771988
enzyme O 0 0.08747735619544983
. O 0 0.03298687934875488

Molecular O 0 0.09887854009866714
genetic O 0 0.07016147673130035
analysis O 0 0.02383998967707157
of O 0 0.00957417394965887
her O 0 0.020482230931520462
VLCAD O 1 0.6570144295692444
gene O 0 0.059555064886808395
revealed O 0 0.02714375965297222
a O 0 0.016697047278285027
T1372C O 0 0.13499951362609863
( O 0 0.026400895789265633
F458L O 0 0.16484279930591583
) O 0 0.0254252627491951
missense O 0 0.42892077565193176
mutation O 0 0.15345700085163116
and O 0 0.013414237648248672
a O 0 0.021683722734451294
1668 O 1 0.7871600389480591
ACAG O 1 0.8953576683998108
1669 O 1 0.5828765034675598
splice O 0 0.22393377125263214
site O 0 0.06495510041713715
mutation O 0 0.38730669021606445
. O 0 0.04747658595442772

After O 0 0.042037494480609894
initial O 0 0.04562525078654289
treatment O 1 0.7669757008552551
with O 0 0.018420305103063583
intravenous O 1 0.980350911617279
glucose O 1 0.5901601314544678
and O 0 0.01575770601630211
carnitine O 1 0.990675151348114
, O 0 0.010464121587574482
the O 0 0.008123192004859447
patient O 0 0.17205382883548737
has O 0 0.008062679320573807
thrived O 0 0.023083871230483055
on O 0 0.005638699512928724
a O 0 0.007997740991413593
low O 0 0.020763972774147987
- O 0 0.053692396730184555
fat O 0 0.04241124540567398
diet O 0 0.048489734530448914
supplemented O 0 0.02705950103700161
with O 0 0.011464163661003113
medium O 0 0.027313722297549248
- O 0 0.07586543262004852
chain O 0 0.04869450256228447
triglyceride O 0 0.3401438593864441
oil O 0 0.024326477199792862
and O 0 0.013442778959870338
carnitine O 1 0.992439866065979
and O 0 0.017828552052378654
avoidance O 1 0.8330981731414795
of O 0 0.0176810584962368
fasting O 0 0.08067214488983154
. O 0 0.03167915716767311

Her O 0 0.12393644452095032
ventricular O 1 0.9996230602264404
hypertrophy O 1 0.9991971850395203
resolved O 0 0.04571027308702469
significantly O 0 0.025543972849845886
over O 0 0.008363612927496433
1 O 0 0.008108976297080517
year O 0 0.006323765963315964
, O 0 0.004415126051753759
and O 0 0.00479053845629096
cognitively O 0 0.05373799428343773
, O 0 0.004636750556528568
she O 0 0.004704229533672333
is O 0 0.002974370727315545
in O 0 0.0028246508445590734
the O 0 0.0036197034642100334
superior O 0 0.013140506111085415
range O 0 0.011727864854037762
for O 0 0.006372769828885794
age O 0 0.01908586360514164
. O 0 0.017084958031773567

Clinical O 1 0.8304232954978943
recognition O 0 0.0448310412466526
of O 0 0.019027801230549812
VLCAD B-Disease 1 0.9998557567596436
deficiency I-Disease 1 0.9999926090240479
is O 0 0.008487177081406116
important O 0 0.005741510074585676
because O 0 0.004886017646640539
it O 0 0.002531869802623987
is O 0 0.002557571977376938
one O 0 0.002518066205084324
of O 0 0.002635753247886896
the O 0 0.004627975635230541
few O 0 0.009082401171326637
directly O 0 0.018755856901407242
treatable O 1 0.9998958110809326
causes O 1 0.9924512505531311
of O 0 0.015576764941215515
cardiomyopathy B-Disease 1 0.9999889135360718
in O 0 0.014021215960383415
children O 0 0.023997291922569275
. O 0 0.014208397828042507
. O 0 0.021796775981783867

Cloning O 0 0.07125149667263031
of O 0 0.012440352700650692
a O 0 0.011277550831437111
novel O 0 0.013667154125869274
member O 0 0.008577680215239525
of O 0 0.005206361413002014
the O 0 0.007731334306299686
low O 0 0.028258133679628372
- O 0 0.1618531495332718
density O 0 0.06940609216690063
lipoprotein O 1 0.9910784363746643
receptor O 1 0.6899186372756958
family O 0 0.04515928030014038
. O 0 0.03397800028324127

A O 0 0.04868774488568306
gene O 0 0.07148854434490204
encoding O 0 0.040419723838567734
a O 0 0.016344988718628883
novel O 0 0.025745458900928497
transmembrane O 0 0.0647045150399208
protein O 0 0.028319893404841423
was O 0 0.009255858138203621
identified O 0 0.011722228489816189
by O 0 0.006530516315251589
DNA O 0 0.022311998531222343
sequence O 0 0.01653902418911457
analysis O 0 0.012297490611672401
within O 0 0.009063954465091228
the O 0 0.012136897072196007
insulin B-Disease 1 0.9989877343177795
- I-Disease 1 0.996990442276001
dependent I-Disease 1 0.9959424138069153
diabetes I-Disease 1 0.9999995231628418
mellitus I-Disease 1 0.9999858140945435
( O 0 0.09600905328989029
IDDM B-Disease 1 0.9581122398376465
) O 0 0.028491461649537086
locus O 0 0.08643987029790878
IDDM4 O 0 0.27385032176971436
on O 0 0.023201797157526016
chromosome O 0 0.23180687427520752
11q13 O 0 0.15488721430301666
. O 0 0.04369848221540451

Based O 0 0.023378480225801468
on O 0 0.009219765663146973
its O 0 0.009557755663990974
chromosomal O 0 0.047505974769592285
position O 0 0.008880171924829483
, O 0 0.00518697127699852
this O 0 0.004766487050801516
gene O 0 0.021788503974676132
is O 0 0.0060017830692231655
a O 0 0.00678648566827178
candidate O 0 0.011660102754831314
for O 0 0.008864041417837143
conferring O 0 0.06283250451087952
susceptibility O 1 0.9927470088005066
to O 0 0.02843458577990532
diabetes B-Disease 1 0.9998775720596313
. O 0 0.04283837974071503

The O 0 0.03364429250359535
gene O 0 0.07795609533786774
, O 0 0.018889278173446655
termed O 0 0.047059930860996246
low O 0 0.04597485437989235
- O 0 0.42991968989372253
density O 0 0.09970278292894363
lipoprotein O 1 0.9958884119987488
receptor O 1 0.6727973818778992
related O 0 0.031251925975084305
protein O 0 0.029384439811110497
5 O 0 0.01567651517689228
( O 0 0.013059385120868683
LRP5 O 0 0.07351581007242203
) O 0 0.01042415015399456
, O 0 0.006316902115941048
encodes O 0 0.01930856518447399
a O 0 0.00792160164564848
protein O 0 0.018213825300335884
of O 0 0.007421685382723808
1615 O 0 0.044452812522649765
amino O 0 0.024435129016637802
acids O 0 0.021652471274137497
that O 0 0.005456842016428709
contains O 0 0.007268487475812435
conserved O 0 0.012868301011621952
modules O 0 0.012536711990833282
which O 0 0.004370230250060558
are O 0 0.0033672237768769264
characteristic O 0 0.010092239826917648
of O 0 0.004867140203714371
the O 0 0.0069112470373511314
low O 0 0.028316348791122437
- O 0 0.3019687831401825
density O 0 0.13010995090007782
lipoprotein O 1 0.9979281425476074
( O 0 0.08723561465740204
LDL O 1 0.9980378746986389
) O 0 0.04140496626496315
receptor O 0 0.23610486090183258
family O 0 0.03497421368956566
. O 0 0.030392969027161598

These O 0 0.021172193810343742
modules O 0 0.03307677060365677
include O 0 0.01305576041340828
a O 0 0.014596783556044102
putative O 0 0.04798434302210808
signal O 0 0.02950398065149784
peptide O 0 0.039969414472579956
for O 0 0.00795613694936037
protein O 0 0.020897528156638145
export O 0 0.011532007716596127
, O 0 0.008280790410935879
four O 0 0.01136694848537445
epidermal O 1 0.9976784586906433
growth O 0 0.043963782489299774
factor O 0 0.0465724840760231
( O 0 0.0233574490994215
EGF O 1 0.9822694063186646
) O 0 0.017765656113624573
repeats O 0 0.03127271682024002
with O 0 0.00972357951104641
associated O 0 0.015444927848875523
spacer O 0 0.12202649563550949
domains O 0 0.032499246299266815
, O 0 0.012157633900642395
three O 0 0.0146353580057621
LDL O 1 0.9988312125205994
- O 1 0.8144218921661377
receptor O 1 0.7772911190986633
( O 0 0.02659010887145996
LDLR O 0 0.47319647669792175
) O 0 0.014097333885729313
repeats O 0 0.024709247052669525
, O 0 0.00650456827133894
a O 0 0.006955322809517384
single O 0 0.010773996822535992
transmembrane O 0 0.036831505596637726
spanning O 0 0.019156845286488533
domain O 0 0.013363470323383808
, O 0 0.004916730802506208
and O 0 0.005185258574783802
a O 0 0.01103002205491066
cytoplasmic O 0 0.054776713252067566
domain O 0 0.04099893569946289
. O 0 0.024443482980132103

The O 0 0.019716989248991013
encoded O 0 0.02575008198618889
protein O 0 0.02527003549039364
has O 0 0.007763209752738476
a O 0 0.007293202448636293
unique O 0 0.009674875065684319
organization O 0 0.011112921871244907
of O 0 0.008991082198917866
EGF O 1 0.9811962842941284
and O 0 0.012097933329641819
LDLR O 1 0.6416468024253845
repeats O 0 0.041085656732320786
; O 0 0.012636052444577217
therefore O 0 0.01015526708215475
, O 0 0.006887569557875395
LRP5 O 0 0.242744579911232
likely O 0 0.012512722052633762
represents O 0 0.010676669888198376
a O 0 0.0059641324914991856
new O 0 0.006127533968538046
category O 0 0.009375830180943012
of O 0 0.005213931668549776
the O 0 0.008997156284749508
LDLR O 0 0.36445799469947815
family O 0 0.026799559593200684
. O 0 0.024954093620181084

Both O 0 0.025096429511904716
human O 0 0.02528367005288601
and O 0 0.01573215425014496
mouse O 0 0.17397265136241913
LRP5 O 1 0.8439165353775024
cDNAs O 0 0.20564866065979004
have O 0 0.00930846855044365
been O 0 0.006679638288915157
isolated O 0 0.014020266011357307
and O 0 0.004610856529325247
the O 0 0.005234750919044018
encoded O 0 0.013334485702216625
mature O 0 0.020026132464408875
proteins O 0 0.013632039539515972
are O 0 0.0044292546808719635
95 O 0 0.009656512178480625
% O 0 0.00699162483215332
identical O 0 0.009137368761003017
, O 0 0.005574345588684082
indicating O 0 0.01201528962701559
a O 0 0.005071531515568495
high O 0 0.007827678695321083
degree O 0 0.009144165553152561
of O 0 0.00584137300029397
evolutionary O 0 0.022364558652043343
conservation O 0 0.022035984322428703
. O 0 0.014398600906133652
. O 0 0.021815743297338486

The O 0 0.03748010843992233
APC B-Disease 0 0.36599186062812805
variants O 0 0.07513757795095444
I1307K O 0 0.12500961124897003
and O 0 0.01612826995551586
E1317Q O 0 0.17345009744167328
are O 0 0.01144934631884098
associated O 0 0.022057922556996346
with O 0 0.06390409171581268
colorectal B-Disease 1 0.9999996423721313
tumors I-Disease 1 0.9999945163726807
, O 0 0.011014437302947044
but O 0 0.006562551949173212
not O 0 0.0045492821373045444
always O 0 0.006690708454698324
with O 0 0.0049082511104643345
a O 0 0.008278856985270977
family O 0 0.015262331813573837
history O 0 0.018011456355452538
. O 0 0.02036307193338871

Classical O 0 0.4087654948234558
familial B-Disease 1 0.9999661445617676
adenomatous I-Disease 1 0.999997615814209
polyposis I-Disease 1 0.9999983310699463
( O 1 0.8907344341278076
FAP B-Disease 1 0.9993403553962708
) O 0 0.021713964641094208
is O 0 0.008891426958143711
a O 0 0.00964741874486208
high O 0 0.01975926384329796
- O 1 0.9753972887992859
penetrance O 1 0.99968421459198
autosomal B-Disease 1 0.9999648332595825
dominant I-Disease 1 0.9971067309379578
disease I-Disease 1 0.9999778270721436
that O 0 0.015145515091717243
predisposes O 1 0.9866943359375
to O 0 0.009779192507266998
hundreds O 0 0.012871160171926022
or O 0 0.010896606370806694
thousands O 0 0.0151949692517519
of O 0 0.014629671350121498
colorectal B-Disease 1 0.9999997615814209
adenomas I-Disease 1 0.9999972581863403
and I-Disease 0 0.08636178821325302
carcinoma I-Disease 1 0.9999922513961792
and O 0 0.009512192569673061
that O 0 0.006958973128348589
results O 0 0.012293458916246891
from O 0 0.010803069919347763
truncating O 1 0.5194514393806458
mutations O 0 0.31728291511535645
in O 0 0.012191089801490307
the O 0 0.015502010472118855
APC B-Disease 1 0.565008819103241
gene O 0 0.13151270151138306
. O 0 0.03598686307668686

A O 0 0.044727765023708344
variant O 0 0.10335198044776917
of O 0 0.030580727383494377
FAP B-Disease 1 0.999727189540863
is O 0 0.1604730188846588
attenuated B-Disease 1 0.9997394680976868
adenomatous I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999983310699463
coli I-Disease 1 0.9998552799224854
, O 0 0.02099457196891308
which O 0 0.01048241276293993
results O 0 0.016644658520817757
from O 0 0.01194211095571518
germ O 1 0.9585054516792297
- O 0 0.05466371029615402
line O 0 0.02005743235349655
mutations O 0 0.045331958681344986
in O 0 0.005902758799493313
the O 0 0.005292023532092571
5 O 0 0.007905676029622555
and O 0 0.005046045873314142
3 O 0 0.009399833157658577
regions O 0 0.012904451228678226
of O 0 0.00638698972761631
the O 0 0.012095979414880276
APC B-Disease 0 0.4765796661376953
gene O 0 0.1172332838177681
. O 0 0.03023904748260975

Attenuated B-Disease 1 0.9998506307601929
adenomatous I-Disease 1 0.9999990463256836
polyposis I-Disease 1 0.9999995231628418
coli I-Disease 1 0.9999961853027344
patients O 1 0.9998751878738403
have O 0 0.020864320918917656
" O 0 0.016769003123044968
multiple O 0 0.04192531481385231
" O 0 0.09903228282928467
colorectal B-Disease 1 0.9999986886978149
adenomas I-Disease 1 0.9999626874923706
( O 0 0.022694382816553116
typically O 0 0.013727826066315174
fewer O 0 0.012522163800895214
than O 0 0.006355979945510626
100 O 0 0.007778372149914503
) O 0 0.007935091853141785
without O 0 0.007041606120765209
the O 0 0.008523020893335342
florid O 0 0.3400026857852936
phenotype O 1 0.6767709851264954
of O 0 0.018054233863949776
classical O 0 0.047859061509370804
FAP B-Disease 1 0.996100902557373
. O 0 0.03915058448910713

Another O 0 0.032306771725416183
group O 0 0.021257052198052406
of O 0 0.011391806416213512
patients O 1 0.9732257127761841
with O 0 0.01213163323700428
multiple O 0 0.030378568917512894
adenomas B-Disease 1 0.9989287257194519
has O 0 0.010373050346970558
no O 0 0.009729606099426746
mutations O 0 0.049264777451753616
in O 0 0.005974243860691786
the O 0 0.007411519531160593
APC B-Disease 1 0.5749269127845764
gene O 0 0.0363343171775341
, O 0 0.006918061058968306
and O 0 0.005880683194845915
their O 0 0.007388801779597998
phenotype O 1 0.6876022219657898
probably O 0 0.015621811151504517
results O 0 0.01136175636202097
from O 0 0.006534365471452475
variation O 0 0.017467640340328217
at O 0 0.007052209228277206
a O 0 0.007808685302734375
locus O 0 0.0355420857667923
, O 0 0.007885408587753773
or O 0 0.01081811636686325
loci O 0 0.04220247268676758
, O 0 0.006606749724596739
elsewhere O 0 0.009257861413061619
in O 0 0.005091366823762655
the O 0 0.007726619951426983
genome O 0 0.04704596847295761
. O 0 0.022318566218018532

Recently O 0 0.03753072768449783
, O 0 0.01301584579050541
however O 0 0.008511843159794807
, O 0 0.007756653241813183
a O 0 0.011982067488133907
missense O 0 0.10658672451972961
variant O 0 0.04761234298348427
of O 0 0.013089892454445362
APC B-Disease 1 0.7584295868873596
( O 0 0.018109820783138275
I1307K O 0 0.06340114772319794
) O 0 0.01121022179722786
was O 0 0.005459458101540804
described O 0 0.008828016929328442
that O 0 0.005521011538803577
confers O 0 0.029431859031319618
an O 0 0.0074150217697024345
increased O 0 0.026861384510993958
risk O 1 0.9941933751106262
of O 0 0.032359011471271515
colorectal B-Disease 1 0.9999998807907104
tumors I-Disease 1 0.9999970197677612
, O 0 0.0134118078276515
including O 0 0.01075645163655281
multiple O 0 0.031975917518138885
adenomas B-Disease 1 0.9990893602371216
, O 0 0.01540706679224968
in O 0 0.017344459891319275
Ashkenazim O 1 0.7910477519035339
. O 0 0.034237392246723175

We O 0 0.01711116172373295
have O 0 0.008194449357688427
studied O 0 0.010020682588219643
a O 0 0.006293539423495531
set O 0 0.006173156201839447
of O 0 0.006621737964451313
164 O 0 0.052937790751457214
patients O 1 0.9989880919456482
with O 0 0.015267564915120602
multiple O 1 0.9671576619148254
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999963045120239
and I-Disease 0 0.06287931650876999
/ I-Disease 1 0.9990215301513672
or I-Disease 0 0.03974208980798721
carcinoma I-Disease 1 0.9999850988388062
and O 0 0.01568613201379776
analyzed O 0 0.04529111832380295
codons O 0 0.10791485011577606
1263 O 1 0.9870243072509766
- O 0 0.4187361001968384
1377 O 1 0.8340380787849426
( O 0 0.03436721861362457
exon O 0 0.0759609118103981
15G O 0 0.10794255137443542
) O 0 0.011748917400836945
of O 0 0.006896492093801498
the O 0 0.00940729957073927
APC B-Disease 0 0.39210987091064453
gene O 0 0.062240395694971085
for O 0 0.014133485034108162
germ O 1 0.8927077651023865
- O 0 0.05821089446544647
line O 0 0.029404938220977783
variants O 0 0.0521736778318882
. O 0 0.03161381930112839

Three O 0 0.02625844068825245
patients O 1 0.8635600805282593
with O 0 0.012093637138605118
the O 0 0.012029647827148438
I1307K O 0 0.07504933327436447
allele O 0 0.062310781329870224
were O 0 0.009334337897598743
detected O 0 0.025490157306194305
, O 0 0.006337089464068413
each O 0 0.007459146436303854
of O 0 0.009171437472105026
Ashkenazi O 0 0.0725746750831604
descent O 0 0.05457109957933426
. O 0 0.02836420387029648

Four O 0 0.03799132630228996
patients O 1 0.9521845579147339
had O 0 0.015174789354205132
a O 0 0.01790732890367508
germ O 1 0.9599833488464355
- O 0 0.07447151839733124
line O 0 0.032937705516815186
E1317Q O 0 0.3141951858997345
missense O 1 0.543432354927063
variant O 0 0.05369366705417633
of O 0 0.009512114338576794
APC O 0 0.06489090621471405
that O 0 0.004764867946505547
was O 0 0.004059449303895235
not O 0 0.00316702201962471
present O 0 0.0046430290676653385
in O 0 0.003787401830777526
controls O 0 0.009282130748033524
; O 0 0.005052214488387108
one O 0 0.0026891129091382027
of O 0 0.0025402770843356848
these O 0 0.002716067712754011
individuals O 0 0.0057367789559066296
had O 0 0.004339261446148157
an O 0 0.0041039325296878815
unusually O 0 0.013533522374927998
large O 0 0.007009783759713173
number O 0 0.005618735682219267
of O 0 0.006856841966509819
metaplastic B-Disease 1 0.6335307359695435
polyps I-Disease 1 0.9881382584571838
of I-Disease 0 0.00940924696624279
the I-Disease 0 0.014057875610888004
colorectum I-Disease 0 0.2050195336341858
. O 0 0.025879494845867157

There O 0 0.017963239923119545
is O 0 0.009469366632401943
increasing O 0 0.013234722428023815
evidence O 0 0.007734832353889942
that O 0 0.004948546644300222
there O 0 0.006078536622226238
exist O 0 0.011642486788332462
germ O 1 0.8472249507904053
- O 0 0.025795333087444305
line O 0 0.012087874114513397
variants O 0 0.018960556015372276
of O 0 0.005537272430956364
the O 0 0.007174167316406965
APC B-Disease 0 0.46592333912849426
gene O 0 0.039753373712301254
that O 0 0.00832038838416338
predispose O 0 0.06721217185258865
to O 0 0.006367246620357037
the O 0 0.005366590805351734
development O 0 0.01027623750269413
of O 0 0.01047566719353199
multiple O 1 0.8383561372756958
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999957084655762
and I-Disease 0 0.3207322955131531
carcinoma I-Disease 1 0.9999966621398926
, O 0 0.010181001387536526
but O 0 0.006764959078282118
without O 0 0.00743796257302165
the O 0 0.008993418887257576
florid O 0 0.4119020700454712
phenotype O 1 0.8060898780822754
of O 0 0.012954950332641602
classical O 0 0.025704218074679375
FAP B-Disease 1 0.9979124665260315
, O 0 0.008943654596805573
and O 0 0.0060690538957715034
possibly O 0 0.01164277270436287
with O 0 0.006763178389519453
importance O 0 0.014109950512647629
for O 0 0.03729461133480072
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
risk O 1 0.9643126726150513
in O 0 0.007396372966468334
the O 0 0.005173460580408573
general O 0 0.008827758021652699
population O 0 0.012763994745910168
. O 0 0.010860585607588291
. O 0 0.017764657735824585

Genomic O 0 0.10939397662878036
structure O 0 0.02890249900519848
of O 0 0.011941874399781227
the O 0 0.016436191275715828
human O 1 0.8858115673065186
congenital B-Disease 1 0.9999996423721313
chloride I-Disease 1 0.9999945163726807
diarrhea I-Disease 1 0.9999997615814209
( O 1 0.9380304217338562
CLD B-Disease 1 0.999889612197876
) O 0 0.03888488933444023
gene O 0 0.10039988160133362
. O 0 0.02847498469054699

Congenital B-Disease 1 0.9999992847442627
chloride I-Disease 1 0.9999830722808838
diarrhea I-Disease 1 0.9999995231628418
( O 1 0.9554378986358643
CLD B-Disease 1 0.999902606010437
) O 0 0.027016909793019295
is O 0 0.011443820782005787
caused O 0 0.030681557953357697
by O 0 0.009040717966854572
mutations O 0 0.05681439861655235
in O 0 0.008815732784569263
a O 0 0.009860125370323658
gene O 0 0.032003335654735565
which O 0 0.009432688355445862
encodes O 0 0.03723558411002159
an O 0 0.018625186756253242
intestinal O 1 0.9995806813240051
anion O 1 0.9559386372566223
transporter O 1 0.8133515119552612
. O 0 0.039410244673490524

We O 0 0.014311406761407852
report O 0 0.010782232508063316
here O 0 0.006118175107985735
the O 0 0.005459727719426155
complete O 0 0.009845471940934658
genomic O 0 0.031072035431861877
organization O 0 0.010131745599210262
of O 0 0.004837993532419205
the O 0 0.007914750836789608
human O 0 0.02249947562813759
CLD B-Disease 1 0.9991381168365479
gene O 0 0.05895587429404259
which O 0 0.009816099889576435
spans O 0 0.02846766822040081
approximately O 0 0.014440629631280899
39kb O 0 0.04196564853191376
, O 0 0.008281323127448559
and O 0 0.007044753525406122
comprises O 0 0.016495343297719955
21 O 0 0.02178112044930458
exons O 0 0.07014524191617966
. O 0 0.02810782380402088

All O 0 0.04396675527095795
exon O 0 0.15664087235927582
/ O 0 0.35361769795417786
intron O 0 0.16011247038841248
boundaries O 0 0.02806789241731167
conform O 0 0.03029893897473812
to O 0 0.012880045920610428
the O 0 0.01863022893667221
GT O 1 0.8513383269309998
/ O 1 0.9660012722015381
AG O 1 0.9513692259788513
rule O 0 0.04581000655889511
. O 0 0.03404607996344566

An O 0 0.01897459290921688
analysis O 0 0.017890891060233116
of O 0 0.008838753215968609
the O 0 0.011354973539710045
putative O 0 0.059086378663778305
promoter O 0 0.06411049515008926
region O 0 0.026622872799634933
sequence O 0 0.022215716540813446
shows O 0 0.014668787829577923
a O 0 0.011987224221229553
putative O 0 0.047468800097703934
TATA O 0 0.06336427479982376
box O 0 0.028205910697579384
and O 0 0.011209903284907341
predicts O 0 0.046678051352500916
multiple O 0 0.03386104106903076
transcription O 0 0.06344258785247803
factor O 0 0.0433969646692276
binding O 0 0.03255876153707504
sites O 0 0.02710576355457306
. O 0 0.023766081780195236

The O 0 0.02666233293712139
genomic O 0 0.07123745232820511
structure O 0 0.020232120528817177
was O 0 0.008918559178709984
determined O 0 0.01466038916260004
using O 0 0.009113340638577938
DNA O 0 0.017263054847717285
from O 0 0.0047136335633695126
several O 0 0.004891650285571814
sources O 0 0.006961213890463114
including O 0 0.005405561067163944
multiple O 0 0.014150270260870457
large O 0 0.012143691070377827
- O 0 0.04586510732769966
insert O 0 0.06361916661262512
libaries O 0 0.11106736212968826
and O 0 0.012424358166754246
genomic O 0 0.06322374194860458
DNA O 0 0.036729712039232254
from O 0 0.01788795180618763
Finnish O 0 0.12189830094575882
CLD B-Disease 1 0.9998581409454346
patients O 1 0.9971457123756409
and O 0 0.01924888975918293
controls O 0 0.043919697403907776
. O 0 0.027232615277171135

Exon O 0 0.16798295080661774
- O 0 0.08394761383533478
specific O 0 0.03259572014212608
primers O 0 0.059006091207265854
developed O 0 0.017486603930592537
in O 0 0.006372136063873768
this O 0 0.006051025353372097
study O 0 0.009661456570029259
will O 0 0.007518579717725515
facilitate O 0 0.019177276641130447
mutation O 1 0.61481112241745
screening O 0 0.06396997720003128
studies O 0 0.016353294253349304
of O 0 0.007391271181404591
patients O 1 0.9953572154045105
with O 0 0.010182212106883526
the O 0 0.013914458453655243
disease O 1 0.9998700618743896
. O 0 0.0262130256742239

Genomic O 0 0.13098424673080444
sequencing O 0 0.07071734219789505
of O 0 0.01887924037873745
a O 0 0.024483298882842064
BAC O 1 0.9822202920913696
clone O 1 0.9069538116455078
H O 1 0.9656534194946289
_ O 0 0.022039424628019333
RG364P16 O 0 0.04678093269467354
revealed O 0 0.011898315511643887
the O 0 0.005004230886697769
presence O 0 0.009294197894632816
of O 0 0.004040628671646118
another O 0 0.005889013409614563
, O 0 0.006426425185054541
highly O 0 0.012405818328261375
homologous O 0 0.04709942266345024
gene O 0 0.03607461228966713
3 O 0 0.011985840275883675
of O 0 0.006504691671580076
the O 0 0.011210755445063114
CLD B-Disease 1 0.9986948370933533
gene O 0 0.04213687404990196
, O 0 0.007608314044773579
with O 0 0.00595802953466773
a O 0 0.00679638609290123
similar O 0 0.01074813399463892
genomic O 0 0.033016402274370193
structure O 0 0.011612370610237122
, O 0 0.005938974674791098
recently O 0 0.01022136677056551
identified O 0 0.011125711724162102
as O 0 0.00707198353484273
the O 0 0.014025712385773659
Pendred B-Disease 1 0.9998860359191895
syndrome I-Disease 1 0.9999995231628418
gene O 1 0.9722955226898193
( O 0 0.043557267636060715
PDS B-Disease 1 0.9880059361457825
) O 0 0.01644362509250641
. O 0 0.010885070078074932
. O 0 0.0173319261521101

The O 0 0.04285101592540741
APCI1307K O 1 0.9295791983604431
allele O 1 0.893975555896759
and O 0 0.026194533333182335
cancer B-Disease 1 0.9999278783798218
risk O 0 0.42051419615745544
in O 0 0.007422928232699633
a O 0 0.007704529445618391
community O 0 0.01115976832807064
- O 0 0.01954224333167076
based O 0 0.00891598779708147
study O 0 0.01225738413631916
of O 0 0.008499971590936184
Ashkenazi O 0 0.08912374824285507
Jews O 0 0.032380275428295135
. O 0 0.0240427628159523

Mutations O 1 0.6614039540290833
in O 0 0.026854274794459343
APC O 1 0.5747660994529724
are O 0 0.017770247533917427
classically O 1 0.8358160853385925
associated O 0 0.03547161445021629
with O 0 0.04293433949351311
familial B-Disease 1 0.999990701675415
adenomatous I-Disease 1 0.9999988079071045
polyposis I-Disease 1 0.9999992847442627
( O 1 0.9121150374412537
FAP B-Disease 1 0.99956876039505
) O 0 0.02556740678846836
, O 0 0.012775697745382786
a O 0 0.016030576080083847
highly O 0 0.05106692388653755
penetrant O 1 0.9998433589935303
autosomal B-Disease 1 0.9999918937683105
dominant I-Disease 1 0.9994161128997803
disorder I-Disease 1 0.9999988079071045
characterized O 1 0.9904504418373108
by O 0 0.019824612885713577
multiple O 1 0.7774993181228638
intestinal O 1 0.9999908208847046
polyps B-Disease 1 0.9997852444648743
and O 0 0.010350347496569157
, O 0 0.008893536403775215
without O 0 0.010453141294419765
surgical O 1 0.9894914627075195
intervention O 0 0.06191646680235863
, O 0 0.005957826040685177
the O 0 0.006116061471402645
development O 0 0.014889021404087543
of O 0 0.019289657473564148
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999977350234985
( O 0 0.17967036366462708
CRC B-Disease 1 0.9555001258850098
) O 0 0.030440442264080048
. O 0 0.026329711079597473

APC B-Disease 1 0.7044990062713623
is O 0 0.028431132435798645
a O 0 0.028426477685570717
tumour O 1 0.9998695850372314
- O 1 0.9762786626815796
suppressor O 1 0.9874492883682251
gene O 0 0.07880786806344986
, O 0 0.013060355558991432
and O 0 0.012472215108573437
somatic O 1 0.8213706016540527
loss O 0 0.3376408815383911
occurs O 0 0.0708216056227684
in O 0 0.02196558564901352
tumours B-Disease 1 0.9986633062362671
. O 0 0.03907417133450508

The O 0 0.041891079396009445
germline O 1 0.9912958145141602
T O 1 0.9620481729507446
- O 0 0.048255790024995804
to O 0 0.011620516888797283
- O 0 0.030001183971762657
A O 0 0.01473157573491335
transversion O 0 0.045620374381542206
responsible O 0 0.015433982945978642
for O 0 0.007745584473013878
the O 0 0.009514905512332916
APC O 0 0.15225058794021606
I1307K O 0 0.08034837245941162
allele O 0 0.07751037925481796
converts O 0 0.030116155743598938
the O 0 0.010616088286042213
wild O 0 0.025426587089896202
- O 0 0.03543493524193764
type O 0 0.028199050575494766
sequence O 0 0.017505932599306107
to O 0 0.008638936094939709
a O 0 0.0133068161085248
homopolymer O 1 0.8919451832771301
tract O 1 0.9937503933906555
( O 0 0.021844353526830673
A8 O 1 0.7320312261581421
) O 0 0.012204707600176334
that O 0 0.0059479414485394955
is O 0 0.006442416924983263
genetically O 0 0.025007979944348335
unstable O 0 0.14957058429718018
and O 0 0.011473235674202442
prone O 0 0.20893509685993195
to O 0 0.018335027620196342
somatic O 1 0.7615150213241577
mutation O 1 0.8332422375679016
. O 0 0.04041580483317375

The O 0 0.04033458232879639
I1307K O 0 0.11913853138685226
allele O 0 0.0902639850974083
was O 0 0.015104281716048717
found O 0 0.012419129721820354
in O 0 0.010370912030339241
6 O 0 0.022410450503230095
. O 0 0.019931530579924583

1 O 0 0.03417529538273811
% O 0 0.02442849986255169
of O 0 0.012685908004641533
unselected O 0 0.09644646942615509
Ashkenazi O 0 0.07420889288187027
Jews O 0 0.0148811349645257
and O 0 0.00769152631983161
higher O 0 0.01224335003644228
proportions O 0 0.02884822152554989
of O 0 0.006830453407019377
Ashkenazim O 0 0.28392887115478516
with O 0 0.007971962913870811
family O 0 0.011622591875493526
or O 0 0.007631758693605661
personal O 0 0.011120880022644997
histories O 0 0.025613687932491302
of O 0 0.01028453465551138
CRC B-Disease 1 0.8105402588844299
( O 0 0.02051030658185482
ref O 0 0.06550978124141693
. O 0 0.010211954824626446
2 O 0 0.014777365140616894
) O 0 0.01629064418375492
. O 0 0.017079897224903107

To O 0 0.022789955139160156
evaluate O 0 0.03382233902812004
the O 0 0.009609139524400234
role O 0 0.013291248120367527
of O 0 0.008367370814085007
I1307K O 0 0.20248878002166748
in O 0 0.011615714989602566
cancer B-Disease 1 0.9990634322166443
, O 0 0.009328925050795078
we O 0 0.009844839572906494
genotyped O 0 0.10482264310121536
5 O 0 0.016407618299126625
, O 0 0.010889053344726562
081 O 1 0.570604145526886
Ashkenazi O 0 0.057928286492824554
volunteers O 0 0.02631969563663006
in O 0 0.008601934649050236
a O 0 0.009741189889609814
community O 0 0.019478697329759598
survey O 0 0.02539725974202156
. O 0 0.022914009168744087

Risk O 1 0.9506375193595886
of O 0 0.023264233022928238
developing O 1 0.9548737406730652
colorectal B-Disease 1 0.999996542930603
, I-Disease 0 0.04606572911143303
breast I-Disease 1 0.9998674392700195
and I-Disease 0 0.009606842882931232
other I-Disease 0 0.009366790764033794
cancers I-Disease 1 0.9989307522773743
were O 0 0.00730969849973917
compared O 0 0.01471980195492506
between O 0 0.01335135381668806
genotyped O 1 0.5795887112617493
I1307K O 0 0.2684326171875
carriers O 0 0.038621943444013596
and O 0 0.007796809542924166
non O 0 0.016372811049222946
- O 0 0.03280752897262573
carriers O 0 0.023293867707252502
and O 0 0.005169251002371311
their O 0 0.006065356079488993
first O 0 0.009286868385970592
- O 0 0.028815876692533493
degree O 0 0.02353614941239357
relatives O 0 0.03375088796019554
. O 0 0.024952542036771774

Sperm O 0 0.13157039880752563
DNA O 0 0.06468337029218674
analysis O 0 0.027607161551713943
in O 0 0.014880072325468063
a O 0 0.024037137627601624
Friedreich B-Disease 1 0.999350368976593
ataxia I-Disease 1 0.999871015548706
premutation O 1 0.9763779640197754
carrier O 0 0.24745500087738037
suggests O 0 0.03535662963986397
both O 0 0.016224846243858337
meiotic O 1 0.5886780023574829
and O 0 0.014332368038594723
mitotic O 0 0.06810164451599121
expansion O 0 0.021433254703879356
in O 0 0.009202228859066963
the O 0 0.011527800932526588
FRDA B-Disease 1 0.5303484797477722
gene O 0 0.0895693227648735
. O 0 0.032445430755615234

Friedreich B-Disease 1 0.9991863369941711
ataxia I-Disease 1 0.999439537525177
is O 0 0.02271493524312973
usually O 0 0.020445508882403374
caused O 0 0.02220519445836544
by O 0 0.006091597490012646
an O 0 0.005300974473357201
expansion O 0 0.011672132648527622
of O 0 0.005671190097928047
a O 0 0.012835457921028137
GAA O 0 0.05059933662414551
trinucleotide O 1 0.9565781950950623
repeat O 0 0.04788889363408089
in O 0 0.012462697923183441
intron O 0 0.1916353553533554
1 O 0 0.012898245826363564
of O 0 0.007953081279993057
the O 0 0.012849695980548859
FRDA B-Disease 1 0.5101192593574524
gene O 0 0.09176836907863617
. O 0 0.03455526754260063

Occasionally O 0 0.04600951075553894
, O 0 0.012478313408792019
a O 0 0.010367657989263535
fully O 0 0.013011178001761436
expanded O 0 0.014770259149372578
allele O 0 0.041554175317287445
has O 0 0.007104496471583843
been O 0 0.004782107193022966
found O 0 0.004791038576513529
to O 0 0.004297379404306412
arise O 0 0.013493870384991169
from O 0 0.005388335324823856
a O 0 0.006041124928742647
premutation O 0 0.030278421938419342
of O 0 0.0061401319690048695
100 O 0 0.010654691606760025
or O 0 0.012358492240309715
less O 0 0.01658812165260315
triplet O 0 0.13859015703201294
repeats O 0 0.07892241328954697
. O 0 0.030804431065917015

We O 0 0.021529214456677437
have O 0 0.011001459322869778
examined O 0 0.022621387615799904
the O 0 0.010184798389673233
sperm O 0 0.0390445739030838
DNA O 0 0.025230778381228447
of O 0 0.008253328502178192
a O 0 0.0151438657194376
premutation O 0 0.20941489934921265
carrier O 0 0.06436113268136978
. O 0 0.02920537255704403

This O 0 0.032298099249601364
mans O 0 0.08115977793931961
leucocyte O 0 0.11747050285339355
DNA O 0 0.04590462148189545
showed O 0 0.023264512419700623
one O 0 0.010615897364914417
normal O 0 0.020403848960995674
allele O 0 0.042576584964990616
and O 0 0.0064888098277151585
one O 0 0.006138368975371122
allele O 0 0.0357452929019928
of O 0 0.008053500205278397
approximately O 0 0.015532560646533966
100 O 0 0.021137280389666557
repeats O 0 0.05533328652381897
. O 0 0.02838945761322975

His O 0 0.030779842287302017
sperm O 0 0.058863189071416855
showed O 0 0.018817570060491562
an O 0 0.009275056421756744
expanded O 0 0.015706347301602364
allele O 0 0.04336978495121002
in O 0 0.008525515906512737
a O 0 0.006850898265838623
tight O 0 0.015261759981513023
range O 0 0.011840332299470901
centering O 0 0.019631220027804375
on O 0 0.005350539460778236
a O 0 0.0060757738538086414
size O 0 0.011388595215976238
of O 0 0.006754896603524685
approximately O 0 0.019582532346248627
320 O 0 0.05594237521290779
trinucleotide O 1 0.9049286246299744
repeats O 0 0.095230333507061
. O 0 0.03849406912922859

His O 0 0.03092924878001213
affected O 0 0.04862799495458603
son O 0 0.0365799143910408
has O 0 0.014461037702858448
repeat O 0 0.036659542471170425
sizes O 0 0.02240472100675106
of O 0 0.01107607688754797
1040 O 0 0.09282712638378143
and O 0 0.015409475192427635
540 O 0 0.07244496047496796
. O 0 0.028621478006243706

These O 0 0.019625023007392883
data O 0 0.014569133520126343
suggest O 0 0.015140608884394169
that O 0 0.005912615451961756
expansion O 0 0.01155923306941986
occurs O 0 0.013213603757321835
in O 0 0.004048855975270271
two O 0 0.0038250084035098553
stages O 0 0.01205345056951046
, O 0 0.0038099016528576612
the O 0 0.003566112369298935
first O 0 0.004971412010490894
during O 0 0.00799076072871685
meiosis O 0 0.033414341509342194
followed O 0 0.009961104020476341
by O 0 0.005861230660229921
a O 0 0.009074521251022816
second O 0 0.015398402698338032
mitotic O 0 0.08850711584091187
expansion O 0 0.04296574741601944
. O 0 0.02755824103951454

We O 0 0.01692795380949974
also O 0 0.007387074641883373
show O 0 0.007791164331138134
that O 0 0.00413733022287488
in O 0 0.00343633652664721
all O 0 0.004164471756666899
informative O 0 0.0148078054189682
carrier O 0 0.020018352195620537
father O 0 0.009891299530863762
to O 0 0.006393146701157093
affected O 0 0.015713706612586975
child O 0 0.015238972380757332
transmissions O 0 0.02104552835226059
, O 0 0.004302585497498512
with O 0 0.004335686564445496
the O 0 0.004026209004223347
notable O 0 0.007919094525277615
exception O 0 0.010451539419591427
of O 0 0.004693507216870785
the O 0 0.006767067592591047
premutation O 0 0.052189432084560394
carrier O 0 0.02651796117424965
, O 0 0.006990744732320309
the O 0 0.007199341431260109
expansion O 0 0.018062029033899307
size O 0 0.01947242021560669
decreases O 0 0.03715568035840988
. O 0 0.016528338193893433
. O 0 0.024877775460481644

The O 0 0.04142243415117264
R496H O 0 0.2567319869995117
mutation O 0 0.29959630966186523
of O 0 0.014845429919660091
arylsulfatase O 0 0.17338301241397858
A O 0 0.016319332644343376
does O 0 0.016383565962314606
not O 0 0.011361751705408096
cause O 1 0.6185507774353027
metachromatic B-Disease 1 0.9973973035812378
leukodystrophy I-Disease 1 0.9998156428337097
. O 0 0.04786792770028114

Deficiency B-Disease 1 0.999826967716217
of I-Disease 0 0.03611045330762863
arylsulfatase I-Disease 0 0.4074196219444275
A I-Disease 0 0.038279980421066284
( O 0 0.04389467090368271
ARSA O 1 0.9898292422294617
) O 0 0.03839953616261482
enzyme O 0 0.23052693903446198
activity O 0 0.12279117852449417
causes O 1 0.9968030452728271
metachromatic B-Disease 1 0.9993929862976074
leukodystrophy I-Disease 1 0.999968409538269
( O 0 0.39934223890304565
MLD B-Disease 1 0.9991070628166199
) O 0 0.05103156343102455
. O 0 0.03801334276795387

A O 0 0.03042209893465042
number O 0 0.017589205875992775
of O 0 0.015620389021933079
ARSA O 1 0.9940670728683472
gene O 0 0.450175940990448
mutations O 1 0.718930184841156
responsible O 0 0.02653140015900135
for O 0 0.014886587858200073
MLD B-Disease 1 0.9979852437973022
have O 0 0.01291500125080347
been O 0 0.01246594451367855
identified O 0 0.02314484864473343
. O 0 0.021283641457557678

Recently O 0 0.04152073711156845
, O 0 0.016642706468701363
the O 0 0.013360514305531979
R496H O 0 0.09834221005439758
mutation O 0 0.13407905399799347
of O 0 0.013721279799938202
ARSA O 1 0.8708966374397278
was O 0 0.007960710674524307
proposed O 0 0.009749707765877247
to O 0 0.004897391423583031
be O 0 0.00490935705602169
a O 0 0.007155335508286953
cause O 0 0.029331542551517487
of O 0 0.012924876995384693
MLD B-Disease 1 0.9995121955871582
( O 0 0.030933333560824394
Draghia O 1 0.6678686738014221
et O 0 0.06587743759155273
al O 0 0.032809823751449585
. O 0 0.010087105445563793
, O 0 0.00963740237057209
1997 O 0 0.019524063915014267
) O 0 0.016932271420955658
. O 0 0.01920941099524498

We O 0 0.01849442347884178
have O 0 0.011620921082794666
investigated O 0 0.020567312836647034
the O 0 0.010319367982447147
R496H O 0 0.09148941934108734
mutation O 0 0.1443544626235962
and O 0 0.006456214934587479
found O 0 0.007983098737895489
this O 0 0.005811853799968958
mutation O 0 0.040380410850048065
at O 0 0.006620872300118208
a O 0 0.005829676520079374
relatively O 0 0.00835820846259594
high O 0 0.008553747087717056
frequency O 0 0.012079370208084583
in O 0 0.004070953465998173
an O 0 0.004466446116566658
African O 0 0.014159300364553928
American O 0 0.010997135192155838
population O 0 0.014349831268191338
( O 0 0.014362860471010208
f O 0 0.029849939048290253
= O 0 0.03715614229440689
0 O 0 0.017718836665153503
. O 0 0.007395376451313496
09 O 0 0.026764435693621635
, O 0 0.010683129541575909
n O 0 0.03469143807888031
= O 0 0.04577506333589554
61 O 0 0.02458343841135502
subjects O 0 0.019611572846770287
) O 0 0.020779184997081757
. O 0 0.022687135264277458

The O 0 0.048616524785757065
ARSA O 1 0.9729272723197937
enzyme O 0 0.07255841791629791
activity O 0 0.023510266095399857
in O 0 0.007408552337437868
subjects O 0 0.010717412456870079
with O 0 0.0053625563159585
and O 0 0.0051869903691112995
without O 0 0.007120019756257534
the O 0 0.008191190659999847
R496H O 0 0.07906496524810791
mutation O 0 0.0921262875199318
was O 0 0.006978305522352457
determined O 0 0.009364984929561615
and O 0 0.003958053421229124
found O 0 0.0055608018301427364
to O 0 0.0046226088888943195
be O 0 0.005750624928623438
normal O 0 0.020795466378331184
. O 0 0.01709371991455555

It O 0 0.01533535961061716
is O 0 0.010253817774355412
therefore O 0 0.009929154068231583
concluded O 0 0.014184603467583656
that O 0 0.005863308906555176
the O 0 0.008462347090244293
R496H O 0 0.18812178075313568
mutation O 0 0.44957438111305237
of O 0 0.012077696621418
ARSA O 1 0.990067720413208
does O 0 0.013508464209735394
not O 0 0.006537260953336954
negatively O 0 0.01685241051018238
influence O 0 0.009217444807291031
the O 0 0.005242224782705307
activity O 0 0.011602062731981277
of O 0 0.006680935155600309
ARSA O 1 0.911170482635498
and O 0 0.006489059422165155
is O 0 0.0057495455257594585
not O 0 0.005502370186150074
a O 0 0.010753645561635494
cause O 0 0.0430879071354866
of O 0 0.02524207904934883
MLD B-Disease 1 0.9979077577590942

Down O 0 0.04944070801138878
- O 0 0.06456804275512695
regulation O 0 0.039029739797115326
of O 0 0.02043008990585804
transmembrane O 1 0.9235196709632874
carbonic O 1 0.9969479441642761
anhydrases O 1 0.9945389628410339
in O 0 0.09901998937129974
renal B-Disease 1 0.9999983310699463
cell I-Disease 1 0.9992387294769287
carcinoma I-Disease 1 0.9999958276748657
cell O 1 0.5135322213172913
lines O 0 0.023563766852021217
by O 0 0.012971754185855389
wild O 0 0.034052442759275436
- O 1 0.5293413996696472
type O 0 0.3940221667289734
von B-Disease 1 0.9747675657272339
Hippel I-Disease 1 0.9980859756469727
- I-Disease 1 0.9729759097099304
Lindau I-Disease 1 0.9962655901908875
transgenes O 1 0.9065501689910889
. O 0 0.061239056289196014

To O 0 0.03354794904589653
discover O 0 0.06477886438369751
genes O 0 0.05959590896964073
involved O 0 0.029049502685666084
in O 0 0.020598506554961205
von B-Disease 1 0.9593642354011536
Hippel I-Disease 1 0.9989131689071655
- I-Disease 1 0.9828985929489136
Lindau I-Disease 1 0.9991005659103394
( O 0 0.15523938834667206
VHL B-Disease 1 0.9994878768920898
) O 0 0.030316343531012535
- O 1 0.5279507637023926
mediated O 1 0.9806463718414307
carcinogenesis O 1 0.9980840682983398
, O 0 0.013391046784818172
we O 0 0.010255016386508942
used O 0 0.020105605944991112
renal B-Disease 1 0.9999954700469971
cell I-Disease 1 0.9982126951217651
carcinoma I-Disease 1 0.999994158744812
cell O 1 0.7739213705062866
lines O 0 0.041901666671037674
stably O 0 0.23062680661678314
transfected O 1 0.9378076791763306
with O 0 0.024120448157191277
wild O 0 0.051213860511779785
- O 1 0.8759884238243103
type O 1 0.774195671081543
VHL O 1 0.9993525147438049
- O 1 0.7336796522140503
expressing O 0 0.08311827480792999
transgenes O 1 0.7780622839927673
. O 0 0.04777132719755173

Large O 0 0.04156837984919548
- O 0 0.06474283337593079
scale O 0 0.04291399195790291
RNA O 0 0.04885351285338402
differential O 0 0.03379448875784874
display O 0 0.012455920688807964
technology O 0 0.011362704448401928
applied O 0 0.008135444484651089
to O 0 0.004859135020524263
these O 0 0.0051720719784498215
cell O 0 0.018900636583566666
lines O 0 0.0132378488779068
identified O 0 0.010468523018062115
several O 0 0.0072352085262537
differentially O 0 0.03921918198466301
expressed O 0 0.016128497198224068
genes O 0 0.03120751492679119
, O 0 0.008363677188754082
including O 0 0.009166352450847626
an O 0 0.011117886751890182
alpha O 0 0.05063373222947121
carbonic O 1 0.9769167304039001
anhydrase O 1 0.9816115498542786
gene O 0 0.12199496477842331
, O 0 0.025793729349970818
termed O 0 0.07562626153230667
CA12 O 1 0.6942175030708313
. O 0 0.040831390768289566

The O 0 0.025854745879769325
deduced O 0 0.050041038542985916
protein O 0 0.03053686022758484
sequence O 0 0.018078019842505455
was O 0 0.006586182862520218
classified O 0 0.010611630976200104
as O 0 0.004129938315600157
a O 0 0.00486136507242918
one O 0 0.0057633607648313046
- O 0 0.02473560906946659
pass O 0 0.01969563215970993
transmembrane O 0 0.07466323673725128
CA O 0 0.029532475396990776
possessing O 0 0.019624000415205956
an O 0 0.008590186946094036
apparently O 0 0.02168845944106579
intact O 0 0.02909630723297596
catalytic O 0 0.04039044678211212
domain O 0 0.01830841414630413
in O 0 0.0077274576760828495
the O 0 0.009236359037458897
extracellular O 0 0.05136607959866524
CA O 0 0.04793797805905342
module O 0 0.05343375727534294
. O 0 0.02926573157310486

Reintroduced O 0 0.1530117243528366
wild O 0 0.0975353941321373
- O 1 0.7708327770233154
type O 0 0.30842384696006775
VHL B-Disease 1 0.9956966638565063
strongly O 0 0.037901509553194046
inhibited O 0 0.06499294191598892
the O 0 0.013035008683800697
overexpression O 0 0.05650678649544716
of O 0 0.00862802378833294
the O 0 0.00954169500619173
CA12 O 1 0.596359372138977
gene O 0 0.048014216125011444
in O 0 0.010950271040201187
the O 0 0.015629790723323822
parental O 1 0.9956923127174377
renal B-Disease 1 0.9999982118606567
cell I-Disease 1 0.999222993850708
carcinoma I-Disease 1 0.9999943971633911
cell O 1 0.75761878490448
lines O 0 0.050627585500478745
. O 0 0.035820066928863525

Similar O 0 0.034542445093393326
results O 0 0.01985308527946472
were O 0 0.0070696803741157055
obtained O 0 0.011241566389799118
with O 0 0.010744331404566765
CA9 O 1 0.9715458750724792
, O 0 0.011043616570532322
encoding O 0 0.028816035017371178
another O 0 0.016004091128706932
transmembrane O 0 0.048753973096609116
CA O 0 0.02306210994720459
with O 0 0.007671038154512644
an O 0 0.00896226242184639
intact O 0 0.028080511838197708
catalytic O 0 0.05613609403371811
domain O 0 0.03960563242435455
. O 0 0.02686218172311783

Although O 0 0.023888958618044853
both O 0 0.01140032708644867
domains O 0 0.02538706362247467
of O 0 0.007478616666048765
the O 0 0.012137218378484249
VHL B-Disease 1 0.9790367484092712
protein O 0 0.03684806078672409
contribute O 0 0.023137981072068214
to O 0 0.007222176995128393
regulation O 0 0.018873216584324837
of O 0 0.008892259560525417
CA12 O 0 0.19098377227783203
expression O 0 0.021109767258167267
, O 0 0.006833345629274845
the O 0 0.007562210317701101
elongin O 0 0.05274306610226631
binding O 0 0.026044471189379692
domain O 0 0.02194373495876789
alone O 0 0.01716039329767227
could O 0 0.012712415307760239
effectively O 0 0.028012624010443687
regulate O 0 0.0737905278801918
CA9 O 1 0.9945806860923767
expression O 0 0.06834908574819565
. O 0 0.036260657012462616

We O 0 0.03708915784955025
mapped O 0 0.06015879660844803
CA12 O 0 0.4377600848674774
and O 0 0.024480577558279037
CA9 O 1 0.989346444606781
loci O 0 0.12550370395183563
to O 0 0.0220186784863472
chromosome O 0 0.10838186740875244
bands O 0 0.04175705462694168
15q22 O 0 0.09024696052074432
and O 0 0.022261662408709526
17q21 O 0 0.09548219293355942
. O 0 0.031787071377038956

2 O 0 0.028704164549708366
respectively O 0 0.02205703966319561
, O 0 0.01078396663069725
regions O 0 0.02112600766122341
prone O 0 0.07601721584796906
to O 0 0.010609809309244156
amplification O 0 0.03819788619875908
in O 0 0.007365406956523657
some O 0 0.009282130748033524
human O 0 0.02873021923005581
cancers B-Disease 1 0.999387264251709
. O 0 0.030237160623073578

Additional O 0 0.031024226918816566
experiments O 0 0.028254743665456772
are O 0 0.007450769655406475
needed O 0 0.010021624155342579
to O 0 0.005603065714240074
define O 0 0.011176249012351036
the O 0 0.0050175730139017105
role O 0 0.00868909526616335
of O 0 0.006698394659906626
CA O 0 0.027990009635686874
IX O 0 0.1587972342967987
and O 0 0.009290202520787716
CA O 0 0.0321359857916832
XII O 0 0.10619212687015533
enzymes O 0 0.02142675593495369
in O 0 0.006053151097148657
the O 0 0.006046882830560207
regulation O 0 0.015108106657862663
of O 0 0.006975190714001656
pH O 0 0.0449201837182045
in O 0 0.006505751516669989
the O 0 0.007381189148873091
extracellular O 0 0.03919385001063347
microenvironment O 1 0.566883385181427
and O 0 0.006742945406585932
its O 0 0.006725441664457321
potential O 0 0.016558540984988213
impact O 0 0.02003023587167263
on O 0 0.011841570027172565
cancer B-Disease 1 0.9998552799224854
cell O 0 0.44907161593437195
growth O 0 0.03601901978254318
. O 0 0.023559831082820892

A O 0 0.04829065501689911
gene O 0 0.07077504694461823
encoding O 0 0.04525221884250641
a O 0 0.022035758942365646
transmembrane O 0 0.07855653762817383
protein O 0 0.03884110599756241
is O 0 0.013702437281608582
mutated O 1 0.7326790690422058
in O 0 0.016452541574835777
patients O 1 0.9999303817749023
with O 1 0.6556509733200073
diabetes B-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.999998927116394
and O 1 0.8840664625167847
optic B-Disease 1 0.9999961853027344
atrophy I-Disease 1 0.9999949932098389
( O 1 0.9964503049850464
Wolfram B-Disease 1 0.999976634979248
syndrome I-Disease 1 0.9999990463256836
) O 0 0.045532695949077606
. O 0 0.0328337624669075

Wolfram B-Disease 1 0.9999133348464966
syndrome I-Disease 1 0.9999988079071045
( O 1 0.7877843379974365
WFS B-Disease 1 0.999472439289093
; O 0 0.09099447727203369
OMIM O 1 0.9984028935432434
222300 O 1 0.6754516363143921
) O 0 0.022773664444684982
is O 0 0.011985852383077145
an O 0 0.017489373683929443
autosomal B-Disease 1 0.9999661445617676
recessive I-Disease 1 0.9999953508377075
neurodegenerative I-Disease 1 0.9999985694885254
disorder I-Disease 1 0.9999841451644897
defined O 0 0.033906009048223495
by O 0 0.015615938231348991
young O 0 0.26827648282051086
- O 1 0.9957225322723389
onset O 1 0.9999079704284668
non O 1 0.9581364393234253
- O 1 0.9995002746582031
immune O 1 0.9999794960021973
insulin B-Disease 1 0.9999552965164185
- I-Disease 1 0.999542236328125
dependent I-Disease 1 0.9985635876655579
diabetes I-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999940395355225
and O 0 0.07134038209915161
progressive O 1 0.9918169379234314
optic B-Disease 1 0.9999088048934937
atrophy I-Disease 1 0.9996899366378784
. O 0 0.051301222294569016

Linkage O 0 0.13649186491966248
to O 0 0.021197609603405
markers O 0 0.049536462873220444
on O 0 0.01673615537583828
chromosome O 1 0.531713604927063
4p O 1 0.8724850416183472
was O 0 0.009937328286468983
confirmed O 0 0.012224623002111912
in O 0 0.006689928937703371
five O 0 0.00965553242713213
families O 0 0.021488532423973083
. O 0 0.020191345363855362

On O 0 0.013817925937473774
the O 0 0.007862759754061699
basis O 0 0.010228804312646389
of O 0 0.00932212732732296
meiotic O 1 0.9934043288230896
recombinants O 1 0.9945840239524841
and O 0 0.02564939484000206
disease O 1 0.9999761581420898
- O 1 0.8311916589736938
associated O 0 0.03399837389588356
haplotypes O 1 0.9309309124946594
, O 0 0.01484498381614685
the O 0 0.014339255169034004
WFS B-Disease 1 0.994473397731781
gene O 0 0.057894352823495865
was O 0 0.013320058584213257
localized O 0 0.04298499971628189
to O 0 0.009056804701685905
a O 0 0.016166983172297478
BAC O 1 0.9855577349662781
/ O 1 0.9354979395866394
P1 O 1 0.5129323601722717
contig O 0 0.06114472821354866
of O 0 0.00853964127600193
less O 0 0.011499891057610512
than O 0 0.010112687014043331
250 O 0 0.027148770168423653
kb O 0 0.06404412537813187
. O 0 0.028493104502558708

Mutations O 0 0.22622285783290863
in O 0 0.018371492624282837
a O 0 0.015848321840167046
novel O 0 0.031135747209191322
gene O 0 0.05960302799940109
( O 0 0.02347968891263008
WFS1 O 0 0.14033401012420654
) O 0 0.014274679124355316
encoding O 0 0.023978112265467644
a O 0 0.011842552572488785
putative O 0 0.04931902885437012
transmembrane O 0 0.05353523790836334
protein O 0 0.019540254026651382
were O 0 0.004751475527882576
found O 0 0.004760573618113995
in O 0 0.003214544616639614
all O 0 0.0033374743070453405
affected O 0 0.01216871477663517
individuals O 0 0.008729059249162674
in O 0 0.0057366942055523396
six O 0 0.010209815576672554
WFS B-Disease 1 0.996417760848999
families O 0 0.013718634843826294
, O 0 0.005064261145889759
and O 0 0.004260497633367777
these O 0 0.005152412690222263
mutations O 0 0.04413926973938942
were O 0 0.004124734550714493
associated O 0 0.008890814147889614
with O 0 0.0066498261876404285
the O 0 0.012559967115521431
disease O 1 0.9999294281005859
phenotype O 1 0.9976288676261902
. O 0 0.034955188632011414

WFS1 O 0 0.3580779731273651
appears O 0 0.03485481068491936
to O 0 0.011500460095703602
function O 0 0.015956180170178413
in O 0 0.00904508214443922
survival O 0 0.03553647920489311
of O 0 0.012527531012892723
islet O 0 0.1809113323688507
beta O 0 0.06737751513719559
- O 0 0.20522208511829376
cells O 0 0.12207963317632675
and O 0 0.013174398802220821
neurons O 0 0.22769998013973236
. O 0 0.017919424921274185
. O 0 0.023442307487130165

Stable O 0 0.06356611102819443
interaction O 0 0.03497779741883278
between O 0 0.011685319244861603
the O 0 0.006350588984787464
products O 0 0.011175806634128094
of O 0 0.006692226510494947
the O 0 0.01185532659292221
BRCA1 O 1 0.9981741905212402
and O 0 0.030776789411902428
BRCA2 O 1 0.9999366998672485
tumor B-Disease 1 0.9998801946640015
suppressor O 1 0.9918913841247559
genes O 0 0.08191061019897461
in O 0 0.01825428567826748
mitotic O 0 0.28274601697921753
and O 0 0.027398208156228065
meiotic O 1 0.9856706261634827
cells O 1 0.5460640788078308
. O 0 0.04284657537937164

BRCA1 O 1 0.9928519129753113
and O 0 0.032076116651296616
BRCA2 O 1 0.9872859120368958
account O 0 0.015475703403353691
for O 0 0.00597081845626235
most O 0 0.005294085014611483
cases O 0 0.01164950244128704
of O 0 0.0062950062565505505
familial O 1 0.9994576573371887
, O 0 0.016339223831892014
early O 0 0.1302541196346283
onset O 1 0.9999899864196777
breast B-Disease 1 0.9999939203262329
and I-Disease 0 0.24140818417072296
/ I-Disease 1 0.9999488592147827
or I-Disease 1 0.9600568413734436
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999984622001648
and O 0 0.009057916700839996
encode O 0 0.018454303964972496
products O 0 0.010581585578620434
that O 0 0.004267677199095488
each O 0 0.006353089585900307
interact O 0 0.02096008136868477
with O 0 0.011136738583445549
hRAD51 O 0 0.07949318736791611
. O 0 0.024631135165691376

Results O 0 0.03695384040474892
presented O 0 0.01915324665606022
here O 0 0.011555730365216732
show O 0 0.014444947242736816
that O 0 0.010129651054739952
BRCA1 O 1 0.977024257183075
and O 0 0.014726828783750534
BRCA2 O 1 0.9978456497192383
coexist O 0 0.03951737657189369
in O 0 0.009791959077119827
a O 0 0.010689319111406803
biochemical O 0 0.036434106528759
complex O 0 0.017192116007208824
and O 0 0.009816735982894897
colocalize O 0 0.08704525232315063
in O 0 0.012877341359853745
subnuclear O 0 0.2221694141626358
foci O 0 0.3890864849090576
in O 0 0.012763645499944687
somatic O 0 0.1583213210105896
cells O 0 0.028939401730895042
and O 0 0.005532606039196253
on O 0 0.004282555542886257
the O 0 0.005890959408134222
axial O 0 0.04271029680967331
elements O 0 0.011366423219442368
of O 0 0.008464472368359566
developing O 0 0.034636240452528
synaptonemal O 1 0.6399274468421936
complexes O 0 0.14009983837604523
. O 0 0.03627528250217438

Like O 0 0.07423397898674011
BRCA1 O 1 0.9805132746696472
and O 0 0.03938085213303566
RAD51 O 1 0.9883253574371338
, O 0 0.033191703259944916
BRCA2 O 1 0.9941205382347107
relocates O 0 0.4204387664794922
to O 0 0.029636384919285774
PCNA O 1 0.9895703792572021
+ O 0 0.2512422502040863
replication O 0 0.10863423347473145
sites O 0 0.022515306249260902
following O 0 0.017810361459851265
exposure O 0 0.2957116961479187
of O 0 0.011832814663648605
S O 0 0.3435175120830536
phase O 0 0.08073613792657852
cells O 0 0.13810960948467255
to O 0 0.018404515460133553
hydroxyurea O 1 0.994979202747345
or O 0 0.0376923605799675
UV O 1 0.9957036375999451
irradiation O 0 0.38862860202789307
. O 0 0.039107780903577805

Thus O 0 0.04035622999072075
, O 0 0.019856857135891914
BRCA1 O 1 0.9836138486862183
and O 0 0.015376021154224873
BRCA2 O 1 0.9908837676048279
participate O 0 0.014990316703915596
, O 0 0.006830137223005295
together O 0 0.005605378188192844
, O 0 0.004714420530945063
in O 0 0.004892416298389435
a O 0 0.007742946967482567
pathway O 0 0.04608934000134468
( O 0 0.012217963114380836
s O 0 0.023584621027112007
) O 0 0.007483420893549919
associated O 0 0.005861574783921242
with O 0 0.0042353137396276
the O 0 0.004764723591506481
activation O 0 0.024683300405740738
of O 0 0.006906172726303339
double O 0 0.02551918849349022
- O 0 0.06349034607410431
strand O 0 0.0492728166282177
break O 0 0.030659159645438194
repair O 0 0.1622096449136734
and O 0 0.013843582943081856
/ O 0 0.4869816303253174
or O 0 0.022944077849388123
homologous O 0 0.12817512452602386
recombination O 0 0.3567711412906647
. O 0 0.03815126419067383

Dysfunction O 1 0.9979939460754395
of O 0 0.01464572548866272
this O 0 0.009530512616038322
pathway O 0 0.040965575724840164
may O 0 0.00870850682258606
be O 0 0.0031221387907862663
a O 0 0.0038719135336577892
general O 0 0.005451389122754335
phenomenon O 0 0.01346508227288723
in O 0 0.003541385754942894
the O 0 0.0034782274160534143
majority O 0 0.00668129650875926
of O 0 0.004478279501199722
cases O 0 0.01244716253131628
of O 0 0.008701968006789684
hereditary B-Disease 1 0.9996217489242554
breast I-Disease 1 0.9999940395355225
and I-Disease 0 0.2333427220582962
/ I-Disease 1 0.9999091625213623
or I-Disease 1 0.9589579105377197
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999945163726807
. O 0 0.02460183948278427
. O 0 0.027107009664177895

A O 0 0.048567160964012146
novel O 0 0.05033054202795029
Arg362Ser O 0 0.2755468189716339
mutation O 0 0.09143410623073578
in O 0 0.014489450491964817
the O 0 0.015411575324833393
sterol O 1 0.5130504965782166
27 O 0 0.03566545620560646
- O 0 0.40690547227859497
hydroxylase O 1 0.9054301977157593
gene O 0 0.22109518945217133
( O 0 0.023840216919779778
CYP27 O 0 0.14690230786800385
) O 0 0.011562181636691093
: O 0 0.007602216210216284
its O 0 0.0059480005875229836
effects O 0 0.021747315302491188
on O 0 0.006856101565063
pre O 0 0.028713546693325043
- O 0 0.035846274346113205
mRNA O 0 0.04603780433535576
splicing O 0 0.07103042304515839
and O 0 0.017198538407683372
enzyme O 0 0.06565860658884048
activity O 0 0.03886662423610687
. O 0 0.025982053950428963

A O 0 0.02813606709241867
novel O 0 0.028977608308196068
C O 0 0.03352569416165352
to O 0 0.009424302726984024
A O 0 0.012701760977506638
mutation O 0 0.04777307063341141
in O 0 0.009975015185773373
the O 0 0.010726050473749638
sterol O 0 0.3952024579048157
27 O 0 0.03509105369448662
- O 0 0.3770216703414917
hydroxylase O 1 0.943039059638977
gene O 0 0.1670440435409546
( O 0 0.023899028077721596
CYP27 O 0 0.23648467659950256
) O 0 0.011150583624839783
was O 0 0.006810668855905533
identified O 0 0.011827792041003704
by O 0 0.008594517596065998
sequencing O 0 0.039763208478689194
amplified O 0 0.05179809406399727
CYP27 O 0 0.4261167645454407
gene O 0 0.046394363045692444
products O 0 0.013984802179038525
from O 0 0.009430978447198868
a O 0 0.011959925293922424
patient O 1 0.6298969388008118
with O 0 0.018266983330249786
cerebrotendinous B-Disease 1 0.992720901966095
xanthomatosis I-Disease 1 0.9952907562255859
( O 0 0.04959941655397415
CTX B-Disease 1 0.9966901540756226
) O 0 0.03874824568629265
. O 0 0.027143992483615875

The O 0 0.03660702705383301
mutation O 0 0.12064587324857712
changed O 0 0.026531288400292397
the O 0 0.016307832673192024
adrenodoxin O 0 0.21974222362041473
cofactor O 0 0.13582105934619904
binding O 0 0.04409382492303848
residue O 0 0.06714966148138046
362Arg O 0 0.08382575213909149
to O 0 0.01801256462931633
362Ser O 0 0.12924325466156006
( O 0 0.033518314361572266
CGT O 1 0.7355610728263855
362Arg O 0 0.312000036239624
to O 0 0.02054893970489502
AGT O 1 0.9984637498855591
362Ser O 0 0.11952408403158188
) O 0 0.01406419463455677
, O 0 0.005386858247220516
and O 0 0.004367660265415907
was O 0 0.0053169140592217445
responsible O 0 0.010866858996450901
for O 0 0.007629483938217163
deficiency O 1 0.9997938275337219
in O 0 0.00893162190914154
the O 0 0.010467509739100933
sterol O 1 0.7326048612594604
27 O 0 0.022392665967345238
- O 0 0.22753280401229858
hydroxylase O 1 0.6158698201179504
activity O 0 0.017446309328079224
, O 0 0.00548553979024291
as O 0 0.004155257251113653
confirmed O 0 0.008732971735298634
by O 0 0.00541546568274498
expression O 0 0.014081820845603943
of O 0 0.007363524753600359
mutant O 0 0.04774424061179161
cDNA O 0 0.06048406660556793
into O 0 0.020600121468305588
COS O 1 0.9313352108001709
- O 0 0.11665456742048264
1 O 0 0.03418399766087532
cells O 0 0.09082590788602829
. O 0 0.03253263607621193

Quantitative O 0 0.06492006778717041
analysis O 0 0.026052994653582573
showed O 0 0.01568187028169632
that O 0 0.0050291698426008224
the O 0 0.00543161341920495
expression O 0 0.014253712259232998
of O 0 0.0076051633805036545
CYP27 O 0 0.22269971668720245
gene O 0 0.04158494994044304
mRNA O 0 0.027750276029109955
in O 0 0.00818560179322958
the O 0 0.009412403218448162
patient O 0 0.0808391198515892
represented O 0 0.02082109823822975
52 O 0 0.03275314345955849
. O 0 0.022841274738311768

5 O 0 0.030438244342803955
% O 0 0.015034520998597145
of O 0 0.00663509126752615
the O 0 0.008159593679010868
normal O 0 0.02408660762012005
level O 0 0.02382797747850418
. O 0 0.023904118686914444

As O 0 0.022028975188732147
the O 0 0.01946236938238144
mutation O 0 0.12977080047130585
occurred O 0 0.022108929231762886
at O 0 0.008913540281355381
the O 0 0.006972958333790302
penultimate O 0 0.042093150317668915
nucleotide O 0 0.038237959146499634
of O 0 0.008638527244329453
exon O 0 0.048513803631067276
6 O 0 0.017990119755268097
( O 0 0.0132506238296628
- O 0 0.021833648905158043
2 O 0 0.00992563460022211
position O 0 0.006974523887038231
of O 0 0.007090399973094463
exon O 0 0.048996858298778534
6 O 0 0.02350747212767601
- O 0 0.05582323670387268
intron O 1 0.6882201433181763
6 O 0 0.02547690086066723
splice O 0 0.061589132994413376
site O 0 0.013278034515678883
) O 0 0.007830915972590446
of O 0 0.0041191852651536465
the O 0 0.005875222850590944
gene O 0 0.025246145203709602
, O 0 0.005708001554012299
we O 0 0.004759457893669605
hypothesized O 0 0.020122138783335686
that O 0 0.004933638498187065
the O 0 0.007051287218928337
mutation O 0 0.24867264926433563
may O 0 0.015340573154389858
partially O 0 0.025359125807881355
affect O 0 0.02104119583964348
the O 0 0.008803215809166431
normal O 0 0.02112317457795143
splicing O 0 0.044354017823934555
efficiency O 0 0.02108575589954853
in O 0 0.009653918445110321
exon O 0 0.04730968549847603
6 O 0 0.017624126747250557
and O 0 0.008749084547162056
cause O 0 0.030602773651480675
alternative O 0 0.020614322274923325
splicing O 0 0.045347344130277634
elsewhere O 0 0.014079119078814983
, O 0 0.005512927658855915
which O 0 0.004493168089538813
resulted O 0 0.011541122570633888
in O 0 0.005535183474421501
decreased O 0 0.020802132785320282
transcript O 0 0.020287929102778435
in O 0 0.00791854690760374
the O 0 0.011727488599717617
patient O 1 0.5984181761741638
. O 0 0.02698924019932747

Transfection O 1 0.5642004013061523
of O 0 0.019090617075562477
constructed O 0 0.02249288372695446
minigenes O 0 0.05600447952747345
, O 0 0.0067442553117871284
with O 0 0.00508921779692173
or O 0 0.006341222207993269
without O 0 0.005584382917732
the O 0 0.006013705860823393
mutation O 0 0.05333004891872406
, O 0 0.006797525100409985
into O 0 0.010189342312514782
COS O 1 0.9860171675682068
- O 0 0.08704142272472382
1 O 0 0.015601960942149162
cells O 0 0.032551415264606476
confirmed O 0 0.010157261975109577
that O 0 0.004109911620616913
the O 0 0.005708499811589718
mutant O 0 0.03336476534605026
minigene O 0 0.04066579416394234
was O 0 0.006134343333542347
responsible O 0 0.00913232285529375
for O 0 0.005383880343288183
a O 0 0.007292790804058313
mRNA O 0 0.02346317283809185
species O 0 0.016295811161398888
alternatively O 0 0.02966582030057907
spliced O 0 0.04578256979584694
at O 0 0.012051381170749664
an O 0 0.010339583270251751
activated O 0 0.041901472955942154
cryptic O 0 0.0512329638004303
5 O 0 0.019880065694451332
splice O 0 0.06202864274382591
site O 0 0.018606549128890038
88 O 0 0.02594872936606407
bp O 0 0.029138511046767235
upstream O 0 0.02165563404560089
from O 0 0.006321042776107788
the O 0 0.005830691196024418
3 O 0 0.009477195329964161
end O 0 0.009127233177423477
of O 0 0.007993611507117748
exon O 0 0.05511905252933502
6 O 0 0.02970142848789692
. O 0 0.024604618549346924

Our O 0 0.021568305790424347
data O 0 0.013329011388123035
suggest O 0 0.013253075070679188
that O 0 0.004381396342068911
the O 0 0.005143211223185062
C O 0 0.017457837238907814
to O 0 0.00445989053696394
A O 0 0.007469398435205221
mutation O 0 0.03691745549440384
at O 0 0.007953012362122536
the O 0 0.006439256016165018
penultimate O 0 0.035925790667533875
nucleotide O 0 0.035143572837114334
of O 0 0.007656220346689224
exon O 0 0.03428550064563751
6 O 0 0.010758786462247372
of O 0 0.004826858174055815
the O 0 0.007690292317420244
CYP27 O 0 0.3954586386680603
gene O 0 0.034388963133096695
not O 0 0.0062829917296767235
only O 0 0.005912379827350378
causes O 0 0.44276392459869385
the O 0 0.009183058515191078
deficiency B-Disease 1 0.9998809099197388
in I-Disease 0 0.00987965427339077
the I-Disease 0 0.009826942346990108
sterol I-Disease 1 0.7598375678062439
27 I-Disease 0 0.024597443640232086
- I-Disease 0 0.1326160877943039
hydroxylase I-Disease 1 0.6415500044822693
activity I-Disease 0 0.016928335651755333
, O 0 0.006138342432677746
but O 0 0.005096630658954382
also O 0 0.005054688546806574
partially O 0 0.01619579643011093
leads O 0 0.014604260213673115
to O 0 0.006063045002520084
alternative O 0 0.014603621326386929
pre O 0 0.027638733386993408
- O 0 0.03373157978057861
mRNA O 0 0.038265857845544815
splicing O 0 0.04664452373981476
of O 0 0.00986501481384039
the O 0 0.014026055112481117
gene O 0 0.06628157198429108
. O 0 0.02506607212126255

To O 0 0.015986895188689232
our O 0 0.01108590979129076
knowledge O 0 0.009898349642753601
, O 0 0.00460497522726655
this O 0 0.0032231661025434732
is O 0 0.002937383484095335
the O 0 0.0028598622884601355
first O 0 0.004075903911143541
report O 0 0.006759181618690491
regarding O 0 0.008355390280485153
effects O 0 0.01916513592004776
on O 0 0.005776660051196814
pre O 0 0.02482374757528305
- O 0 0.0288974829018116
mRNA O 0 0.029590051621198654
splicing O 0 0.034582458436489105
of O 0 0.007279715966433287
a O 0 0.008971097879111767
mutation O 0 0.03884246572852135
at O 0 0.0073156654834747314
the O 0 0.005060159135609865
- O 0 0.01535207312554121
2 O 0 0.007691824808716774
position O 0 0.006555796600878239
of O 0 0.0044896421022713184
a O 0 0.007951026782393456
5 O 0 0.01565396972000599
splice O 0 0.07110583037137985
site O 0 0.02396395243704319
. O 0 0.021833814680576324

ATM O 1 0.8061339259147644
germline O 1 0.9736748337745667
mutations O 1 0.7294588685035706
in O 0 0.03204725310206413
classical O 0 0.07372810691595078
ataxia B-Disease 1 0.9999922513961792
- I-Disease 1 0.9994720816612244
telangiectasia I-Disease 1 0.9999654293060303
patients O 1 0.9987351298332214
in O 0 0.013327637687325478
the O 0 0.01217630598694086
Dutch O 0 0.027968617156147957
population O 0 0.026336759328842163
. O 0 0.022567566484212875

Germline O 1 0.9882009029388428
mutations O 0 0.3829369843006134
in O 0 0.013642942532896996
the O 0 0.01180378906428814
ATM O 0 0.04583442211151123
gene O 0 0.031622592359781265
are O 0 0.0059604523703455925
responsible O 0 0.011267001740634441
for O 0 0.007518393453210592
the O 0 0.02100071683526039
autosomal B-Disease 1 0.9999984502792358
recessive I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999901294708252
telangiectasia I-Disease 1 0.99997878074646
( O 0 0.16133667528629303
A B-Disease 0 0.052579816430807114
- I-Disease 1 0.9524759650230408
T I-Disease 1 0.9961463212966919
) O 0 0.031045380979776382
. O 0 0.025634098798036575

In O 0 0.014796913601458073
our O 0 0.011438880115747452
study O 0 0.011401810683310032
, O 0 0.004932709503918886
we O 0 0.004488795530050993
have O 0 0.004414815921336412
determined O 0 0.009269803762435913
the O 0 0.00654129683971405
ATM O 0 0.03920675441622734
mutation O 0 0.06574093550443649
spectrum O 0 0.022993270307779312
in O 0 0.006726368330419064
19 O 0 0.010744402185082436
classical O 0 0.014774116687476635
A B-Disease 0 0.019330685958266258
- I-Disease 1 0.9907960891723633
T I-Disease 1 0.9998311996459961
patients O 1 0.9939919114112854
, O 0 0.006140062119811773
including O 0 0.0049001295119524
some O 0 0.004666626453399658
immigrant O 0 0.0148382056504488
populations O 0 0.017017384991049767
, O 0 0.004081930033862591
as O 0 0.0029912369791418314
well O 0 0.0034469261299818754
as O 0 0.002632567659020424
12 O 0 0.004802880343049765
of O 0 0.004282258450984955
Dutch O 0 0.014700712636113167
ethnic O 0 0.016698088496923447
origin O 0 0.026253199204802513
. O 0 0.026568474248051643

Both O 0 0.02597518265247345
the O 0 0.016834191977977753
protein O 0 0.04411998391151428
truncation O 0 0.06239381805062294
test O 0 0.02559063956141472
( O 0 0.01647116430103779
PTT O 0 0.032389406114816666
) O 0 0.008129720576107502
and O 0 0.005646556615829468
the O 0 0.00765136769041419
restriction O 0 0.028617413714528084
endonuclease O 1 0.5163923501968384
fingerprinting O 0 0.06028757616877556
( O 0 0.01961318589746952
REF O 0 0.06860403716564178
) O 0 0.010213883593678474
method O 0 0.008655041456222534
were O 0 0.0031162730883806944
used O 0 0.003970208577811718
and O 0 0.003335825400426984
compared O 0 0.005980584304779768
for O 0 0.0031110530253499746
their O 0 0.0044398014433681965
detection O 0 0.02391989901661873
efficiency O 0 0.014459324069321156
, O 0 0.005736454855650663
identifying O 0 0.01573258265852928
76 O 0 0.01835618168115616
% O 0 0.00800378993153572
and O 0 0.003993378486484289
60 O 0 0.008206012658774853
% O 0 0.006413483060896397
of O 0 0.004255639389157295
the O 0 0.0070122405886650085
mutations O 0 0.12399555742740631
, O 0 0.009978896006941795
respectively O 0 0.01788610778748989
. O 0 0.019672753289341927

Most O 0 0.029762478545308113
patients O 1 0.8383095264434814
were O 0 0.009250311180949211
found O 0 0.01060444489121437
to O 0 0.007634380832314491
be O 0 0.009499209001660347
compound O 0 0.04145614430308342
heterozygote O 1 0.8628108501434326
. O 0 0.03591509535908699

Seventeen O 0 0.06199754402041435
mutations O 0 0.08585964888334274
were O 0 0.009587774984538555
distinct O 0 0.014394623227417469
, O 0 0.00495914276689291
of O 0 0.0036959017161279917
which O 0 0.004072206560522318
10 O 0 0.0050263176672160625
were O 0 0.0036788966972380877
not O 0 0.004824620671570301
reported O 0 0.01406321581453085
previously O 0 0.014777595177292824
. O 0 0.019264834001660347

Mutations O 0 0.46588417887687683
are O 0 0.018304338678717613
small O 0 0.01868528686463833
deletions O 0 0.058711957186460495
or O 0 0.019645901396870613
point O 0 0.021871427074074745
mutations O 0 0.2570873498916626
frequently O 0 0.0372876301407814
affecting O 0 0.055338356643915176
splice O 0 0.11131362617015839
sites O 0 0.03656959533691406
. O 0 0.03139036148786545

Moreover O 0 0.05655202642083168
, O 0 0.018572742119431496
a O 0 0.017778873443603516
16 O 0 0.024142177775502205
. O 0 0.023108037188649178

7 O 0 0.06517573446035385
- O 0 0.09511067718267441
kb O 0 0.09988589584827423
genomic O 0 0.08516813069581985
deletion O 0 0.050971224904060364
of O 0 0.006499313283711672
the O 0 0.004768772982060909
3 O 0 0.006832517217844725
end O 0 0.00535944290459156
of O 0 0.003273248439654708
the O 0 0.004502900410443544
gene O 0 0.017867641523480415
, O 0 0.004128243774175644
most O 0 0.003623988013714552
likely O 0 0.00672641908749938
a O 0 0.004021672066301107
result O 0 0.006191103253513575
of O 0 0.003655495122075081
recombination O 0 0.027941446751356125
between O 0 0.00647209957242012
two O 0 0.00434478186070919
LINE O 0 0.008350805379450321
elements O 0 0.007368695456534624
, O 0 0.005812299903482199
was O 0 0.006918617989867926
identified O 0 0.016329847276210785
. O 0 0.018015960231423378

The O 0 0.01894341967999935
most O 0 0.011248113587498665
frequently O 0 0.017795728519558907
found O 0 0.012704560533165932
mutation O 0 0.058528974652290344
, O 0 0.005851808004081249
identified O 0 0.007513763383030891
in O 0 0.0036701823119074106
three O 0 0.004395133350044489
unrelated O 0 0.01588667556643486
Turkish O 0 0.015188313089311123
A B-Disease 0 0.014780649915337563
- I-Disease 1 0.6539040207862854
T I-Disease 1 0.9930874705314636
individuals O 0 0.010373412631452084
, O 0 0.004702356178313494
was O 0 0.0036461602430790663
previously O 0 0.004019518382847309
described O 0 0.004653899930417538
to O 0 0.0031607525888830423
be O 0 0.0030270880088210106
a O 0 0.0052025276236236095
Turkish O 0 0.012649301439523697
A B-Disease 0 0.016420351341366768
- I-Disease 1 0.6566595435142517
T I-Disease 1 0.997678816318512
founder O 0 0.06333759427070618
mutation O 1 0.5360310077667236
. O 0 0.03490746021270752

The O 0 0.017665669322013855
presence O 0 0.02191462554037571
of O 0 0.007927088998258114
a O 0 0.011552181094884872
founder O 0 0.027041567489504814
mutation O 0 0.08544590324163437
among O 0 0.010578769259154797
relatively O 0 0.010920559987425804
small O 0 0.007288160268217325
ethnic O 0 0.0107069481164217
population O 0 0.010650133714079857
groups O 0 0.0075872852467000484
in O 0 0.00479618925601244
Western O 0 0.010461630299687386
Europe O 0 0.009142468683421612
could O 0 0.006629791110754013
indicate O 0 0.010985180735588074
a O 0 0.006514380685985088
high O 0 0.011438756249845028
carrier O 0 0.025581996887922287
frequency O 0 0.021712692454457283
in O 0 0.007105955854058266
such O 0 0.008386177942156792
communities O 0 0.022470444440841675
. O 0 0.022617893293499947

In O 0 0.02881651557981968
patients O 1 0.8894638419151306
of O 0 0.008396399207413197
Dutch O 0 0.016142848879098892
ethnic O 0 0.01047886535525322
origin O 0 0.010527396574616432
, O 0 0.004683804698288441
however O 0 0.004046951420605183
, O 0 0.0036962353624403477
no O 0 0.004516974091529846
significant O 0 0.007448073010891676
founder O 0 0.01340564526617527
effect O 0 0.012771976180374622
could O 0 0.007357072550803423
be O 0 0.006108245812356472
identified O 0 0.01668214611709118
. O 0 0.019542019814252853

The O 0 0.023250311613082886
observed O 0 0.036430809646844864
genetic O 0 0.04801177605986595
heterogeneity O 0 0.0407935231924057
including O 0 0.007509948220103979
the O 0 0.005455403123050928
relative O 0 0.01218130812048912
high O 0 0.009666125290095806
percentage O 0 0.012456760741770267
of O 0 0.008188110776245594
splice O 0 0.1736029088497162
- O 0 0.08249767869710922
site O 0 0.01776413433253765
mutations O 0 0.0721093937754631
had O 0 0.010302925482392311
no O 0 0.0089988699182868
reflection O 0 0.020885717123746872
on O 0 0.008348800241947174
the O 0 0.013914181850850582
phenotype O 1 0.8020216226577759
. O 0 0.032136622816324234

All O 0 0.04204756021499634
patients O 1 0.9843185544013977
manifested O 0 0.10595126450061798
classical O 0 0.0310512762516737
A B-Disease 0 0.02678419090807438
- I-Disease 0 0.4724487364292145
T I-Disease 1 0.9761942625045776
and O 0 0.011901079677045345
increased O 0 0.02278110943734646
cellular O 0 0.05527448281645775
radioresistant O 0 0.3380691409111023
DNA O 0 0.06251770257949829
synthesis O 0 0.06342557817697525
. O 0 0.032890282571315765

Determination O 0 0.0383434072136879
of O 0 0.009851423092186451
the O 0 0.00920362863689661
genomic O 0 0.03291775658726692
structure O 0 0.011636771261692047
of O 0 0.005391888320446014
the O 0 0.007802522275596857
COL4A4 O 0 0.43988415598869324
gene O 0 0.0366445891559124
and O 0 0.007523024454712868
of O 0 0.009679659269750118
novel O 0 0.036552511155605316
mutations O 1 0.9977477192878723
causing O 1 0.9988065958023071
autosomal B-Disease 1 0.9999892711639404
recessive I-Disease 1 0.9999959468841553
Alport I-Disease 1 0.999997615814209
syndrome I-Disease 1 0.9999985694885254
. O 0 0.09212171286344528

Autosomal B-Disease 1 0.9999690055847168
recessive I-Disease 1 0.9999938011169434
Alport I-Disease 1 0.9999963045120239
syndrome I-Disease 1 0.9999980926513672
is O 0 0.03476211801171303
a O 0 0.028141971677541733
progressive O 1 0.6962612867355347
hematuric B-Disease 1 0.9975646734237671
glomerulonephritis I-Disease 1 0.9999470710754395
characterized O 1 0.8901407122612
by O 0 0.02579321712255478
glomerular B-Disease 1 0.9990123510360718
basement I-Disease 1 0.6984756588935852
membrane I-Disease 1 0.5482113361358643
abnormalities I-Disease 1 0.9946616291999817
and O 0 0.009947242215275764
associated O 0 0.014606799930334091
with O 0 0.008337217383086681
mutations O 0 0.049906402826309204
in O 0 0.0069421748630702496
either O 0 0.007973844185471535
the O 0 0.0072999922558665276
COL4A3 O 0 0.12197417765855789
or O 0 0.01003202237188816
the O 0 0.009346953593194485
COL4A4 O 0 0.22045888006687164
gene O 0 0.029844745993614197
, O 0 0.005798148922622204
which O 0 0.005085713695734739
encode O 0 0.015248564071953297
the O 0 0.007604681421071291
alpha3 O 0 0.06332036107778549
and O 0 0.01287133153527975
alpha4 O 1 0.7790066003799438
type O 0 0.29516515135765076
IV O 1 0.9907426238059998
collagen O 1 0.9946001768112183
chains O 0 0.05253659933805466
, O 0 0.01599898748099804
respectively O 0 0.0264422707259655
. O 0 0.023985542356967926

To O 0 0.021179640665650368
date O 0 0.020181994885206223
, O 0 0.014004824683070183
mutation O 0 0.07311290502548218
screening O 0 0.024323083460330963
in O 0 0.0048587871715426445
the O 0 0.004118707962334156
two O 0 0.004440838471055031
genes O 0 0.017909642308950424
has O 0 0.005752779543399811
been O 0 0.004857837222516537
hampered O 0 0.02446817234158516
by O 0 0.005826394073665142
the O 0 0.005628847982734442
lack O 0 0.013377535156905651
of O 0 0.007373470813035965
genomic O 0 0.047106560319662094
structure O 0 0.01921132206916809
information O 0 0.01706446334719658
. O 0 0.022309906780719757

We O 0 0.017557229846715927
report O 0 0.012445767410099506
here O 0 0.007615207694470882
the O 0 0.00532580865547061
complete O 0 0.009758786298334599
characterization O 0 0.016941465437412262
of O 0 0.004629204049706459
the O 0 0.0052154650911688805
48 O 0 0.01238175481557846
exons O 0 0.026098906993865967
of O 0 0.006313012447208166
the O 0 0.007323537487536669
COL4A4 O 0 0.34696656465530396
gene O 0 0.03300878405570984
, O 0 0.00628388486802578
a O 0 0.00747185992076993
comprehensive O 0 0.015886206179857254
gene O 0 0.028064213693141937
screen O 0 0.01184413768351078
, O 0 0.004644137341529131
and O 0 0.003491341834887862
the O 0 0.004165229387581348
subsequent O 0 0.012056674808263779
detection O 0 0.02173580415546894
of O 0 0.005751098971813917
10 O 0 0.009983711875975132
novel O 0 0.015284579247236252
mutations O 0 0.3327634036540985
in O 0 0.011495663784444332
eight O 0 0.03032873198390007
patients O 1 0.9999761581420898
diagnosed O 1 0.9999971389770508
with O 1 0.7902629375457764
autosomal B-Disease 1 0.9999971389770508
recessive I-Disease 1 0.9999980926513672
Alport I-Disease 1 0.9999983310699463
syndrome I-Disease 1 0.9999992847442627
. O 0 0.08697883039712906

Furthermore O 0 0.039406586438417435
, O 0 0.011846828274428844
we O 0 0.00856371782720089
identified O 0 0.012847649864852428
a O 0 0.009300514124333858
glycine O 0 0.03712569549679756
to O 0 0.009127621538937092
alanine O 0 0.04536985978484154
substitution O 0 0.02470218762755394
in O 0 0.006785431411117315
the O 0 0.008118470199406147
collagenous O 1 0.5966792702674866
domain O 0 0.01993645168840885
that O 0 0.005992832127958536
is O 0 0.0071756793186068535
apparently O 0 0.01419154554605484
silent O 0 0.01743326708674431
in O 0 0.005657722242176533
the O 0 0.006611695513129234
heterozygous O 0 0.042594607919454575
carriers O 0 0.03261391818523407
, O 0 0.009001348167657852
in O 0 0.008819679729640484
11 O 0 0.01960153691470623
. O 0 0.01884479448199272

5 O 0 0.025534488260746002
% O 0 0.011867622844874859
of O 0 0.005041707772761583
all O 0 0.004691582638770342
control O 0 0.009861261583864689
individuals O 0 0.007846425287425518
, O 0 0.0035353016573935747
and O 0 0.0035630231723189354
in O 0 0.0034981006756424904
one O 0 0.004195204004645348
control O 0 0.010470419190824032
individual O 0 0.009185140952467918
homozygous O 0 0.032828204333782196
for O 0 0.006457561161369085
this O 0 0.009881814941763878
glycine O 0 0.06644421815872192
substitution O 0 0.050783492624759674
. O 0 0.02718442678451538

There O 0 0.017139799892902374
has O 0 0.009280307218432426
been O 0 0.0055888197384774685
no O 0 0.005261990241706371
previous O 0 0.0062673925422132015
finding O 0 0.008021398447453976
of O 0 0.0040716263465583324
a O 0 0.006257019005715847
glycine O 0 0.027546947821974754
substitution O 0 0.016944928094744682
that O 0 0.003454127348959446
is O 0 0.004147491883486509
not O 0 0.0033067113254219294
associated O 0 0.0062570516020059586
with O 0 0.0048863235861063
any O 0 0.007015607785433531
obvious O 0 0.022457826882600784
phenotype O 1 0.7498307228088379
in O 0 0.013205748051404953
homozygous O 0 0.08903525769710541
individuals O 0 0.03237798810005188
. O 0 0.02932783029973507

Founder O 0 0.22456657886505127
BRCA1 O 1 0.9930747747421265
and O 0 0.04469472914934158
BRCA2 O 1 0.9987491369247437
mutations O 1 0.9458860158920288
in O 0 0.021662313491106033
French O 0 0.04733653366565704
Canadian O 0 0.47943010926246643
breast B-Disease 1 0.9999874830245972
and I-Disease 1 0.8435038924217224
ovarian I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999951124191284
families O 0 0.13805915415287018
. O 0 0.04462571442127228

We O 0 0.016897208988666534
have O 0 0.009575972333550453
identified O 0 0.013623871840536594
four O 0 0.008127284236252308
mutations O 0 0.03228103742003441
in O 0 0.0048770904541015625
each O 0 0.005165971349924803
of O 0 0.006048837676644325
the O 0 0.01459744106978178
breast B-Disease 1 0.9999964237213135
cancer I-Disease 1 0.9999977350234985
- O 1 0.997534990310669
susceptibility O 1 0.9992011189460754
genes O 0 0.24309708178043365
, O 0 0.018079904839396477
BRCA1 O 1 0.9967790246009827
and O 0 0.014103644527494907
BRCA2 O 1 0.9962926506996155
, O 0 0.012266010046005249
in O 0 0.009137148037552834
French O 0 0.04102940112352371
Canadian O 1 0.8804213404655457
breast B-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999994039535522
and O 1 0.9917404651641846
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.999998927116394
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999967813491821
families O 0 0.06014638394117355
from O 0 0.021560344845056534
Quebec O 0 0.06090513616800308
. O 0 0.03163953498005867

To O 0 0.02246549353003502
identify O 0 0.035314563661813736
founder O 0 0.034056391566991806
effects O 0 0.047055166214704514
, O 0 0.009973056614398956
we O 0 0.008073699660599232
examined O 0 0.0205822866410017
independently O 0 0.018515072762966156
ascertained O 0 0.03597971796989441
French O 0 0.023278769105672836
Canadian O 0 0.023986391723155975
cancer B-Disease 1 0.9987103939056396
families O 0 0.01081980112940073
for O 0 0.004324064124375582
the O 0 0.003958545625209808
distribution O 0 0.007857427932322025
of O 0 0.004511111881583929
these O 0 0.007320750970393419
eight O 0 0.015367360785603523
mutations O 0 0.16706357896327972
. O 0 0.02590683475136757

Mutations O 0 0.14182493090629578
were O 0 0.012589856050908566
found O 0 0.013212118297815323
in O 0 0.007871952839195728
41 O 0 0.017407452687621117
of O 0 0.008546997793018818
97 O 0 0.03560435399413109
families O 0 0.02849682606756687
. O 0 0.026430781930685043

Six O 0 0.02340563014149666
of O 0 0.011312046088278294
eight O 0 0.017429379746317863
mutations O 0 0.05513016879558563
were O 0 0.008384115993976593
observed O 0 0.017207970842719078
at O 0 0.009168951772153378
least O 0 0.01311641838401556
twice O 0 0.019478851929306984
. O 0 0.021931227296590805

The O 0 0.046537674963474274
BRCA1 O 1 0.9964993000030518
C4446T O 1 0.8084360957145691
mutation O 0 0.24060840904712677
was O 0 0.008641350083053112
the O 0 0.005602009128779173
most O 0 0.0066485716961324215
common O 0 0.013566411100327969
mutation O 1 0.5059128403663635
found O 0 0.009842813946306705
, O 0 0.006156716495752335
followed O 0 0.009458160027861595
by O 0 0.009087543934583664
the O 0 0.015220020897686481
BRCA2 O 1 0.9974066615104675
8765delAG O 1 0.9414961338043213
mutation O 1 0.8875073194503784
. O 0 0.04186311736702919

Together O 0 0.020496569573879242
, O 0 0.009377836249768734
these O 0 0.008575279265642166
mutations O 0 0.036064598709344864
were O 0 0.005121225956827402
found O 0 0.005426295101642609
in O 0 0.0039611635729670525
28 O 0 0.006565244402736425
of O 0 0.003803211497142911
41 O 0 0.010614406317472458
families O 0 0.009703526273369789
identified O 0 0.009593953378498554
to O 0 0.006260986905544996
have O 0 0.00738239660859108
a O 0 0.013338395394384861
mutation O 0 0.21945595741271973
. O 0 0.02424652688205242

The O 0 0.021437229588627815
odds O 0 0.03374900668859482
of O 0 0.008986193686723709
detection O 0 0.024892648681998253
of O 0 0.004979519173502922
any O 0 0.004085897468030453
of O 0 0.0036339331418275833
the O 0 0.005601143464446068
four O 0 0.011403100565075874
BRCA1 O 1 0.9939039349555969
mutations O 1 0.5052623748779297
was O 0 0.01348106749355793
18 O 0 0.017840715125203133
. O 0 0.019721755757927895

7x O 1 0.8535351157188416
greater O 0 0.030372541397809982
if O 0 0.011351087130606174
one O 0 0.006165914237499237
or O 0 0.006747960578650236
more O 0 0.004970347974449396
cases O 0 0.025398220866918564
of O 0 0.012702497653663158
ovarian B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999791383743286
were O 0 0.006713620852679014
also O 0 0.005059434566646814
present O 0 0.005622283089905977
in O 0 0.003994239028543234
the O 0 0.006440714001655579
family O 0 0.018804999068379402
. O 0 0.018701976165175438

The O 0 0.019502349197864532
odds O 0 0.034296803176403046
of O 0 0.007856344804167747
detection O 0 0.0230312068015337
of O 0 0.004094433039426804
any O 0 0.004083399660885334
of O 0 0.0037597010377794504
the O 0 0.005239490419626236
four O 0 0.011418592184782028
BRCA2 O 1 0.9977039694786072
mutations O 1 0.6405594944953918
was O 0 0.013906609266996384
5 O 0 0.022175095975399017
. O 0 0.01892145350575447

3x O 0 0.15686644613742828
greater O 0 0.027757475152611732
if O 0 0.009531763382256031
there O 0 0.0048044896684587
were O 0 0.0033667900133877993
at O 0 0.004482495132833719
least O 0 0.005836299154907465
five O 0 0.0056413309648633
cases O 0 0.012935612350702286
of O 0 0.009713685140013695
breast B-Disease 1 0.9999861717224121
cancer I-Disease 1 0.999922513961792
in O 0 0.010447096079587936
the O 0 0.008648894727230072
family O 0 0.01932327076792717
. O 0 0.02075342647731304

Interestingly O 0 0.06219884753227234
, O 0 0.011488539166748524
the O 0 0.008521796204149723
presence O 0 0.015543780289590359
of O 0 0.00792936235666275
a O 0 0.021471278741955757
breast B-Disease 1 0.9999908208847046
cancer I-Disease 1 0.9999831914901733
case O 0 0.037959691137075424
< O 0 0.47352129220962524
36 O 0 0.014357177540659904
years O 0 0.00716759916394949
of O 0 0.004100624471902847
age O 0 0.0077781667932868
was O 0 0.004439388867467642
strongly O 0 0.007915847934782505
predictive O 0 0.01962091401219368
of O 0 0.0037382340524345636
the O 0 0.0033159221056848764
presence O 0 0.006680619437247515
of O 0 0.002950770314782858
any O 0 0.003643472446128726
of O 0 0.0035770616959780455
the O 0 0.006398977246135473
eight O 0 0.015231574885547161
mutations O 0 0.2490694671869278
screened O 0 0.05494506284594536
. O 0 0.028625182807445526

Carriers O 0 0.06643515080213547
of O 0 0.011614559218287468
the O 0 0.00913845095783472
same O 0 0.011660026386380196
mutation O 0 0.051448848098516464
, O 0 0.006253370083868504
from O 0 0.0049529909156262875
different O 0 0.004928881768137217
families O 0 0.008459053933620453
, O 0 0.00536492932587862
shared O 0 0.010075237601995468
similar O 0 0.012513687834143639
haplotypes O 1 0.7722399830818176
, O 0 0.006869393400847912
indicating O 0 0.011974122375249863
that O 0 0.004051695112138987
the O 0 0.004970294423401356
mutant O 0 0.0318954698741436
alleles O 0 0.0551479272544384
were O 0 0.00557849183678627
likely O 0 0.008259945549070835
to O 0 0.003378544934093952
be O 0 0.0028416700661182404
identical O 0 0.0074074226431548595
by O 0 0.004161641467362642
descent O 0 0.012412825599312782
for O 0 0.005082879215478897
a O 0 0.007741209119558334
mutation O 0 0.0395793542265892
in O 0 0.006611203774809837
the O 0 0.00770978070795536
founder O 0 0.02479010447859764
population O 0 0.023232348263263702
. O 0 0.02111215703189373

The O 0 0.023655042052268982
identification O 0 0.02581712231040001
of O 0 0.011973383836448193
common O 0 0.03172864392399788
BRCA1 O 1 0.9975425004959106
and O 0 0.02165859565138817
BRCA2 O 1 0.9992832541465759
mutations O 1 0.8860891461372375
will O 0 0.012582861818373203
facilitate O 0 0.022881831973791122
carrier O 0 0.05239051580429077
detection O 0 0.05075804144144058
in O 0 0.011659801006317139
French O 0 0.039540864527225494
Canadian O 1 0.8776483535766602
breast B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999994039535522
and O 1 0.98834627866745
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999983310699463
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999973773956299
families O 0 0.27439093589782715
. O 0 0.034474823623895645

Are O 0 0.034586962312459946
Dp71 O 0 0.1934899389743805
and O 0 0.03115001693367958
Dp140 O 1 0.8509764075279236
brain O 1 0.992952287197113
dystrophin O 1 0.9897650480270386
isoforms O 0 0.10340457409620285
related O 0 0.037977155297994614
to O 0 0.020622625946998596
cognitive B-Disease 1 0.9132046103477478
impairment I-Disease 1 0.9992007613182068
in O 0 0.062375254929065704
Duchenne B-Disease 1 0.9999703168869019
muscular I-Disease 1 0.9999768733978271
dystrophy I-Disease 1 0.9999961853027344
? O 1 0.8939472436904907

Molecular O 0 0.08224545419216156
study O 0 0.03252671658992767
and O 0 0.012600245885550976
neuropsychological O 0 0.1092439740896225
analysis O 0 0.015466420911252499
were O 0 0.0060150655917823315
performed O 0 0.00950181856751442
concurrently O 0 0.010044988244771957
on O 0 0.007294171489775181
49 O 0 0.03241487592458725
patients O 1 0.9994743466377258
with O 0 0.16258761286735535
Duchenne B-Disease 1 0.9999979734420776
muscular I-Disease 1 0.9999979734420776
dystrophy I-Disease 1 0.9999996423721313
( O 1 0.9398679137229919
DMD B-Disease 1 0.9999865293502808
) O 0 0.012444226071238518
in O 0 0.004996857140213251
order O 0 0.004699301905930042
to O 0 0.0036742123775184155
find O 0 0.006704494822770357
a O 0 0.005555254407227039
molecular O 0 0.013561422936618328
explanation O 0 0.010735644027590752
for O 0 0.004721733741462231
the O 0 0.006651104427874088
cognitive B-Disease 0 0.36917561292648315
impairment I-Disease 1 0.9933860898017883
observed O 0 0.026902373880147934
in O 0 0.012192444875836372
most O 0 0.022255361080169678
DMD B-Disease 1 0.999985933303833
patients O 1 0.9992830157279968
. O 0 0.04289289191365242

Complete O 0 0.03137635439634323
analysis O 0 0.022839607670903206
of O 0 0.009273444302380085
the O 0 0.011321747675538063
dystrophin O 1 0.6863038539886475
gene O 0 0.042840875685214996
was O 0 0.008009993471205235
performed O 0 0.008887352421879768
to O 0 0.004695070907473564
define O 0 0.0100534213706851
the O 0 0.005210729315876961
localization O 0 0.016616178676486015
of O 0 0.005128794815391302
deletions O 0 0.024564670398831367
and O 0 0.006825586780905724
duplications O 0 0.028871934860944748
in O 0 0.006625069770962
relation O 0 0.015208347700536251
to O 0 0.006311947479844093
the O 0 0.010071647353470325
different O 0 0.02076234295964241
DMD B-Disease 1 0.9997175335884094
promoters O 1 0.6035340428352356
. O 0 0.03977561742067337

Qualitative O 0 0.06592220067977905
analysis O 0 0.026225533336400986
of O 0 0.008710820227861404
the O 0 0.009593183174729347
Dp71 O 0 0.05897511541843414
transcript O 0 0.023827124387025833
and O 0 0.006385022308677435
testing O 0 0.011939567513763905
for O 0 0.0035109661985188723
the O 0 0.003475732635706663
specific O 0 0.00696371216326952
first O 0 0.007030085660517216
exon O 0 0.03102428838610649
of O 0 0.007011071778833866
Dp140 O 0 0.03602824732661247
were O 0 0.006139520555734634
also O 0 0.005915060173720121
carried O 0 0.011026870459318161
out O 0 0.012002125382423401
. O 0 0.017176667228341103

Neuropsychological O 1 0.6202414631843567
analysis O 0 0.05310733616352081
assessed O 0 0.04644028842449188
verbal O 0 0.04214226454496384
and O 0 0.01355225220322609
visuospatial O 1 0.6341055035591125
intelligence O 0 0.021083880215883255
, O 0 0.009249292314052582
verbal O 0 0.027373310178518295
memory O 0 0.018882956355810165
, O 0 0.007623435463756323
and O 0 0.007917472161352634
reading O 0 0.017142361029982567
skills O 0 0.02719755284488201
. O 0 0.025271613150835037

Comparison O 0 0.04687908664345741
of O 0 0.014073031954467297
molecular O 0 0.03329118341207504
and O 0 0.011998330242931843
psychometric O 0 0.11204793304204941
findings O 0 0.02100837044417858
demonstrated O 0 0.01736336760222912
that O 0 0.006336302496492863
deletions O 0 0.02917850762605667
and O 0 0.006956949830055237
duplications O 0 0.02865007519721985
that O 0 0.0053976657800376415
were O 0 0.004956499207764864
localized O 0 0.024611391127109528
in O 0 0.0047770906239748
the O 0 0.005448197480291128
distal O 0 0.1845964789390564
part O 0 0.006830644328147173
of O 0 0.004464445170015097
the O 0 0.005916927475482225
gene O 0 0.029289785772562027
seemed O 0 0.01292148232460022
to O 0 0.0057314313016831875
be O 0 0.005731420125812292
preferentially O 0 0.032956644892692566
associated O 0 0.015186295844614506
with O 0 0.011583458632230759
cognitive B-Disease 1 0.6687432527542114
impairment I-Disease 1 0.9946042895317078
. O 0 0.03237541764974594

Two O 0 0.03296441584825516
altered O 0 0.05278094857931137
Dp71 O 0 0.09248638898134232
transcripts O 0 0.030165985226631165
and O 0 0.0086661446839571
two O 0 0.009072497487068176
deleted O 0 0.027137432247400284
Dp140 O 0 0.05006076395511627
DNA O 0 0.027765890583395958
sequences O 0 0.018180247396230698
were O 0 0.0048692612908780575
found O 0 0.006378823891282082
in O 0 0.006045381538569927
four O 0 0.010229078121483326
patients O 1 0.999518871307373
with O 0 0.03266623243689537
severe O 1 0.999915599822998
cerebral B-Disease 1 0.9999815225601196
dysfunction I-Disease 1 0.9999336004257202
. O 0 0.04630574584007263

These O 0 0.019411496818065643
findings O 0 0.027168532833456993
suggest O 0 0.017718922346830368
that O 0 0.005244891624897718
some O 0 0.005113168619573116
sequences O 0 0.01204980444163084
located O 0 0.006626104936003685
in O 0 0.0033798166550695896
the O 0 0.004162976983934641
distal O 0 0.10238290578126907
part O 0 0.007311352528631687
of O 0 0.0034016924910247326
the O 0 0.004229568876326084
gene O 0 0.017618009820580482
and O 0 0.003920596092939377
, O 0 0.003592055756598711
in O 0 0.003985407296568155
particular O 0 0.007227660622447729
, O 0 0.005948113277554512
some O 0 0.008190655149519444
DMD B-Disease 1 0.9999128580093384
isoforms O 0 0.03516409918665886
expressed O 0 0.01190206129103899
in O 0 0.005163261666893959
the O 0 0.005711461417376995
brain O 1 0.8052850961685181
may O 0 0.008146657608449459
be O 0 0.003253726754337549
related O 0 0.007268713787198067
to O 0 0.004527802113443613
the O 0 0.006552558392286301
cognitive B-Disease 1 0.7475966215133667
impairment I-Disease 1 0.998685896396637
associated O 0 0.02243504859507084
with O 0 0.01899978145956993
DMD B-Disease 1 0.9999415874481201
. O 0 0.02043158933520317
. O 0 0.023026224225759506

I1307K O 1 0.7115568518638611
APC O 1 0.7485426664352417
and O 0 0.025720657780766487
hMLH1 O 0 0.2835560142993927
mutations O 0 0.07407498359680176
in O 0 0.00893943291157484
a O 0 0.010367026552557945
non O 0 0.016844579949975014
- O 0 0.026588354259729385
Jewish O 0 0.01585645042359829
family O 0 0.014159506186842918
with O 0 0.012162973172962666
hereditary B-Disease 1 0.9990127086639404
non I-Disease 1 0.9939513206481934
- I-Disease 1 0.9999521970748901
polyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999958276748657
. O 0 0.0745019018650055

We O 0 0.02574922889471054
describe O 0 0.03314032033085823
a O 0 0.016787001863121986
French O 0 0.03138824179768562
Canadian O 0 0.04317346215248108
hereditary B-Disease 1 0.9989618062973022
non I-Disease 1 0.9973660111427307
- I-Disease 1 0.99997878074646
polyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 1 0.9728935360908508
HNPCC B-Disease 1 0.999915361404419
) O 0 0.02732149511575699
kindred O 0 0.4070804715156555
which O 0 0.012512368150055408
carries O 0 0.018754879012703896
a O 0 0.013948298059403896
novel O 0 0.029891371726989746
truncating O 0 0.26109063625335693
mutation O 0 0.31578898429870605
in O 0 0.029602959752082825
hMLH1 O 0 0.15071046352386475
. O 0 0.0395498052239418

Interestingly O 0 0.07679224014282227
, O 0 0.01657749153673649
the O 0 0.01485921535640955
I1307K O 0 0.23163941502571106
APC O 1 0.6837438941001892
polymorphism O 0 0.05953162536025047
, O 0 0.00932751502841711
associated O 0 0.010543851181864738
with O 0 0.0060884831473231316
an O 0 0.0065892222337424755
increased O 0 0.026104532182216644
risk O 1 0.9968788623809814
of O 0 0.04641991853713989
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999997615814209
, O 0 0.008042617700994015
is O 0 0.004877773579210043
also O 0 0.0037442445755004883
present O 0 0.004678521305322647
in O 0 0.004643397405743599
this O 0 0.005693122744560242
family O 0 0.017502209171652794
. O 0 0.020521007478237152

The O 0 0.03445998206734657
I1307K O 0 0.09442871063947678
polymorphism O 0 0.060989364981651306
has O 0 0.011592132039368153
previously O 0 0.008416073396801949
only O 0 0.005221234634518623
been O 0 0.004740031436085701
identified O 0 0.007416252512484789
in O 0 0.00442210678011179
individuals O 0 0.007777433842420578
of O 0 0.006164687220007181
self O 0 0.020597605034708977
- O 0 0.051242005079984665
reported O 0 0.0293034166097641
Ashkenazi O 0 0.1308635026216507
Jewish O 0 0.037549182772636414
origins O 0 0.05023156851530075
. O 0 0.03250288590788841

In O 0 0.015348714776337147
addition O 0 0.012057374231517315
, O 0 0.006460669916123152
in O 0 0.004628395661711693
this O 0 0.003522509476169944
family O 0 0.005437629297375679
, O 0 0.003033692017197609
there O 0 0.002802233910188079
appears O 0 0.0053351572714746
to O 0 0.0026220071595162153
be O 0 0.0023652054369449615
no O 0 0.004340005572885275
relationship O 0 0.009637055918574333
between O 0 0.0062700239941477776
the O 0 0.006093534640967846
I1307K O 0 0.04983067885041237
polymorphism O 0 0.03909735754132271
and O 0 0.006388211622834206
the O 0 0.00561381783336401
presence O 0 0.011719313450157642
or O 0 0.00894073024392128
absence O 0 0.016835330054163933
of O 0 0.009922618046402931
cancer B-Disease 1 0.9997363686561584
. O 0 0.014925154857337475
. O 0 0.020050134509801865

Identification O 0 0.03853033110499382
of O 0 0.0100910859182477
a O 0 0.011472727172076702
novel O 0 0.01603340357542038
mutation O 0 0.04280823469161987
of O 0 0.006097659934312105
the O 0 0.00669337110593915
CPO O 0 0.04306604713201523
gene O 0 0.031556643545627594
in O 0 0.008928608149290085
a O 0 0.010259538888931274
Japanese O 0 0.02172813005745411
hereditary B-Disease 1 0.7103023529052734
coproporphyria I-Disease 1 0.7048832178115845
family O 0 0.04216966778039932
. O 0 0.030844423919916153

Hereditary B-Disease 1 0.9876328706741333
coproporphyria I-Disease 1 0.985453724861145
( O 0 0.06676166504621506
HCP B-Disease 1 0.9907956719398499
) O 0 0.01922355778515339
is O 0 0.011246835812926292
an O 0 0.011998733505606651
autosomal B-Disease 1 0.9998034834861755
dominant I-Disease 1 0.9974484443664551
disease I-Disease 1 0.9999934434890747
characterized O 1 0.8909963965415955
by O 0 0.012880881316959858
a O 0 0.0160964448004961
deficiency B-Disease 1 0.9999479055404663
of I-Disease 0 0.016810690984129906
coproporphyrinogen I-Disease 1 0.979558527469635
oxidase I-Disease 1 0.9730085134506226
( O 0 0.02498810552060604
CPO O 0 0.06878203898668289
) O 0 0.01357327215373516
caused O 0 0.01958589069545269
by O 0 0.007053588051348925
a O 0 0.009647555649280548
mutation O 0 0.04757104068994522
in O 0 0.00831043254584074
the O 0 0.010732756927609444
CPO O 0 0.06701238453388214
gene O 0 0.07063170522451401
. O 0 0.030612586066126823

Only O 0 0.023548640310764313
11 O 0 0.020374523475766182
mutations O 0 0.0454164482653141
of O 0 0.006667468696832657
the O 0 0.006866924464702606
gene O 0 0.025389166548848152
have O 0 0.006158169824630022
been O 0 0.006738776341080666
reported O 0 0.014203578233718872
in O 0 0.013537579216063023
HCP B-Disease 1 0.9986000657081604
patients O 1 0.9979682564735413
. O 0 0.03280646353960037

We O 0 0.02082156389951706
report O 0 0.017991406843066216
another O 0 0.01655317097902298
mutation O 0 0.05223732441663742
in O 0 0.00963519886136055
a O 0 0.009673085995018482
Japanese O 0 0.01679043285548687
family O 0 0.02431393973529339
. O 0 0.023049721494317055

Polymerase O 1 0.6206920146942139
chain O 0 0.10462265461683273
reaction O 0 0.07909444719552994
- O 0 0.05711621418595314
single O 0 0.03220305219292641
strand O 0 0.061276793479919434
conformational O 0 0.07310886681079865
polymorphism O 0 0.05907580256462097
and O 0 0.011553519405424595
direct O 0 0.01645098440349102
sequence O 0 0.020326679572463036
analyses O 0 0.022190487012267113
demonstrated O 0 0.017948340624570847
a O 0 0.01082348171621561
C O 0 0.026956778019666672
to O 0 0.009117328561842442
T O 0 0.08817125111818314
substitution O 0 0.02304047718644142
in O 0 0.007818729616701603
exon O 0 0.029948456212878227
1 O 0 0.008232013322412968
of O 0 0.004741312470287085
the O 0 0.0064208004623651505
CPO O 0 0.03879658505320549
gene O 0 0.033999573439359665
at O 0 0.01066034846007824
nucleotide O 0 0.02840234525501728
position O 0 0.01013957243412733
85 O 0 0.014719199389219284
, O 0 0.005369544494897127
which O 0 0.004385612439364195
lies O 0 0.010300825349986553
in O 0 0.004937233403325081
the O 0 0.006101186852902174
putative O 0 0.03692997246980667
presequence O 0 0.0500919409096241
for O 0 0.008536715060472488
targeting O 0 0.026762383058667183
to O 0 0.012945271097123623
mitochondria O 0 0.06764430552721024
. O 0 0.029075192287564278

This O 0 0.03233534097671509
mutation O 0 0.10481639951467514
changes O 0 0.02230559103190899
the O 0 0.011874552816152573
codon O 0 0.04909893125295639
for O 0 0.011528746224939823
glutamine O 0 0.04291409254074097
to O 0 0.009348971769213676
a O 0 0.014491549693048
termination O 0 0.0890791118144989
codon O 0 0.06232543662190437
at O 0 0.017832763493061066
amino O 0 0.0410696342587471
acid O 0 0.05959617719054222
position O 0 0.021555040031671524
29 O 0 0.031425558030605316
. O 0 0.02643893100321293

MaeI O 0 0.43674346804618835
restriction O 0 0.05247553810477257
analysis O 0 0.022105969488620758
showed O 0 0.013276561163365841
two O 0 0.00588174257427454
other O 0 0.005392277613282204
carriers O 0 0.019439224153757095
in O 0 0.0059412322007119656
the O 0 0.008810625411570072
family O 0 0.02233204059302807
. O 0 0.022242121398448944

The O 0 0.03422442078590393
C O 0 0.2332017421722412
- O 1 0.8069217205047607
T O 1 0.9658534526824951
mutation O 0 0.23982839286327362
is O 0 0.008808951824903488
located O 0 0.008755541406571865
within O 0 0.007426702417433262
a O 0 0.006934683304280043
recently O 0 0.011476108804345131
proposed O 0 0.013416471891105175
putative O 0 0.04149817302823067
alternative O 0 0.021323969587683678
translation O 0 0.020834965631365776
initiation O 0 0.051953140646219254
codon O 0 0.06767908483743668
( O 0 0.028068626299500465
TIC O 1 0.987444281578064
- O 0 0.03582281246781349
1 O 0 0.012448040768504143
) O 0 0.008399470709264278
, O 0 0.005650743376463652
supporting O 0 0.00842081755399704
that O 0 0.006825043819844723
TIC O 1 0.9507547616958618
- O 0 0.023164406418800354
1 O 0 0.009638148359954357
is O 0 0.005193514749407768
the O 0 0.006030815187841654
real O 0 0.015092036686837673
TIC O 1 0.9305397272109985
rather O 0 0.013445555232465267
than O 0 0.010873215273022652
TIC O 1 0.9906567335128784
- O 0 0.040334705263376236
2 O 0 0.019104233011603355
. O 0 0.012423423118889332
. O 0 0.01939687877893448

Human B-Disease 0 0.07662582397460938
complement I-Disease 0 0.3028627634048462
factor I-Disease 1 0.9910404086112976
H I-Disease 1 0.9999622106552124
deficiency I-Disease 1 0.999998927116394
associated O 1 0.9742153882980347
with O 1 0.9592897295951843
hemolytic B-Disease 1 0.9999998807907104
uremic I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.999998927116394
. O 0 0.09318815171718597

This O 0 0.016081728041172028
study O 0 0.014446691609919071
reports O 0 0.009378177113831043
on O 0 0.0047292690724134445
six O 0 0.0064750961028039455
cases O 0 0.012608043849468231
of O 0 0.007387109100818634
deficiency B-Disease 1 0.9999175071716309
in I-Disease 0 0.006341504864394665
the I-Disease 0 0.005623352248221636
human I-Disease 0 0.013291055336594582
complement I-Disease 0 0.027715986594557762
regulatory I-Disease 0 0.05677958205342293
protein I-Disease 0 0.06160998344421387
Factor I-Disease 0 0.1284472495317459
H I-Disease 1 0.9734975695610046
( O 0 0.02618485502898693
FH O 1 0.995550274848938
) O 0 0.00902849342674017
in O 0 0.00381199037656188
the O 0 0.003664592979475856
context O 0 0.009857243858277798
of O 0 0.00751783512532711
an O 0 0.023397520184516907
acute B-Disease 1 0.9999974966049194
renal I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999970197677612
. O 0 0.07005903869867325

Five O 0 0.015363682061433792
of O 0 0.006125422660261393
the O 0 0.005990719422698021
cases O 0 0.011640775017440319
were O 0 0.005011171568185091
observed O 0 0.010745548643171787
in O 0 0.006308162119239569
children O 0 0.017706608399748802
presenting O 0 0.10886291414499283
with O 1 0.7955068945884705
idiopathic O 1 0.9999997615814209
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9867095351219177
HUS B-Disease 1 0.9998195767402649
) O 0 0.04672807827591896
. O 0 0.03284786269068718

Two O 0 0.014679882675409317
of O 0 0.006816912908107042
the O 0 0.008372873067855835
children O 0 0.01591956429183483
exhibited O 0 0.02637391909956932
a O 0 0.015469529666006565
homozygous O 1 0.9875319600105286
deficiency O 1 0.9999866485595703
characterized O 0 0.11002866178750992
by O 0 0.006713659502565861
the O 0 0.005944035481661558
absence O 0 0.010939457453787327
of O 0 0.004885493777692318
the O 0 0.005895325914025307
150 O 0 0.014139358885586262
- O 0 0.04326227679848671
kD O 1 0.6314108967781067
form O 0 0.012760953046381474
of O 0 0.00732050184160471
Factor O 0 0.02688753418624401
H O 0 0.15658336877822876
and O 0 0.005586687009781599
the O 0 0.004866470582783222
presence O 0 0.010088257491588593
, O 0 0.00431407755240798
upon O 0 0.0059106373228132725
immunoblotting O 0 0.028034262359142303
, O 0 0.004664467182010412
of O 0 0.003967671189457178
the O 0 0.006306213792413473
42 O 0 0.020893702283501625
- O 0 0.161824569106102
kD O 1 0.9826883673667908
Factor O 0 0.12965068221092224
H O 1 0.8667547106742859
- O 0 0.048031676560640335
like O 0 0.016136489808559418
protein O 0 0.029576553031802177
1 O 0 0.01631208509206772
( O 0 0.01836121827363968
FHL O 1 0.9725655913352966
- O 0 0.03030102699995041
1 O 0 0.010351123288273811
) O 0 0.008385990746319294
and O 0 0.005551069509238005
other O 0 0.008417084813117981
FH O 1 0.9994887113571167
- O 0 0.239467054605484
related O 0 0.027873992919921875
protein O 0 0.04430527240037918
( O 0 0.02552870102226734
FHR O 0 0.2346513271331787
) O 0 0.023268865421414375
bands O 0 0.037856098264455795
. O 0 0.02678486332297325

Southern O 0 0.05648350343108177
blot O 0 0.10209508240222931
and O 0 0.0167834535241127
PCR O 0 0.0509505458176136
analysis O 0 0.015376281924545765
of O 0 0.006526346318423748
DNA O 0 0.01709858886897564
of O 0 0.005662893410772085
one O 0 0.008222262375056744
patient O 1 0.8705450892448425
with O 0 0.012521927244961262
homozygous O 1 0.9898965358734131
deficiency O 1 0.9999891519546509
ruled O 0 0.018820462748408318
out O 0 0.006133727263659239
the O 0 0.004385269246995449
presence O 0 0.009051579982042313
of O 0 0.003931732382625341
a O 0 0.00526477349922061
large O 0 0.007885536178946495
deletion O 0 0.03459789231419563
of O 0 0.007234735880047083
the O 0 0.009916955605149269
FH O 1 0.9982151985168457
gene O 0 0.041423164308071136
as O 0 0.006295955274254084
the O 0 0.007894703187048435
underlying O 0 0.02894509583711624
defect O 1 0.9064618945121765
for O 0 0.012026813812553883
the O 0 0.0183763075619936
deficiency O 1 0.9999223947525024
. O 0 0.03613786771893501

The O 0 0.014754543080925941
other O 0 0.008493897505104542
four O 0 0.008321993052959442
children O 0 0.015166198834776878
presented O 0 0.013035615906119347
with O 0 0.013057241216301918
heterozygous O 1 0.9286494851112366
deficiency O 1 0.9999581575393677
and O 0 0.01192901935428381
exhibited O 0 0.022662285715341568
a O 0 0.011433931067585945
normal O 0 0.02408488094806671
immunoblotting O 0 0.07969807088375092
pattern O 0 0.025404972955584526
of O 0 0.008517341688275337
proteins O 0 0.01953243650496006
of O 0 0.008866454474627972
the O 0 0.014600081369280815
FH O 1 0.9958227872848511
family O 0 0.03735256567597389
. O 0 0.031133584678173065

Factor B-Disease 1 0.9774659872055054
H I-Disease 1 0.9994027614593506
deficiency I-Disease 1 0.9999092817306519
is O 0 0.014107145369052887
the O 0 0.010453966446220875
only O 0 0.013568210415542126
complement B-Disease 1 0.8677213788032532
deficiency I-Disease 1 0.9999934434890747
associated O 0 0.038124650716781616
with O 0 0.026493990793824196
HUS B-Disease 1 0.9991127848625183
. O 0 0.038727112114429474

These O 0 0.023327089846134186
observations O 0 0.027081124484539032
suggest O 0 0.018521331250667572
a O 0 0.00881045963615179
role O 0 0.012758622877299786
for O 0 0.009732638485729694
FH O 1 0.9987230896949768
and O 0 0.014662972651422024
/ O 1 0.9324966073036194
or O 0 0.0227900892496109
FH O 1 0.9994699358940125
receptors O 0 0.2564416527748108
in O 0 0.01017072331160307
the O 0 0.011163881979882717
pathogenesis O 1 0.9959203004837036
of O 0 0.023106958717107773
idiopathic O 1 0.9999611377716064
HUS B-Disease 1 0.9997171759605408
. O 0 0.02857760153710842
. O 0 0.03192945197224617

Further O 0 0.02358144521713257
evidence O 0 0.013206361792981625
for O 0 0.0074393255636096
a O 0 0.0093978401273489
major O 0 0.015545129776000977
ancient O 0 0.024409504607319832
mutation O 1 0.9974644184112549
underlying O 1 0.9963645339012146
myotonic B-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999994039535522
from O 0 0.0348220132291317
linkage O 1 0.9718199372291565
disequilibrium O 1 0.9830254316329956
studies O 0 0.020914366468787193
in O 0 0.007955493405461311
the O 0 0.008391544222831726
Japanese O 0 0.018753526732325554
population O 0 0.022333549335598946
. O 0 0.02329237386584282

The O 0 0.23534241318702698
myotonic B-Disease 1 0.9999866485595703
dystrophy I-Disease 1 0.9999991655349731
( O 1 0.981497049331665
DM B-Disease 1 0.9999828338623047
) O 0 0.035851459950208664
mutation O 0 0.3337194621562958
is O 0 0.011445297859609127
an O 0 0.009489944204688072
unstable O 0 0.3854684829711914
( O 0 0.019577112048864365
CTG O 1 0.8604706525802612
) O 0 0.015480884350836277
n O 0 0.019926851615309715
repeat O 0 0.023473551496863365
, O 0 0.00515622878447175
present O 0 0.005356810986995697
at O 0 0.005108467768877745
a O 0 0.004281911067664623
copy O 0 0.00785882119089365
number O 0 0.004129026085138321
of O 0 0.004171098116785288
5 O 0 0.009503134526312351
- O 0 0.01985539123415947
37 O 0 0.016574282199144363
repeats O 0 0.02060132846236229
on O 0 0.005957667715847492
normal O 0 0.015324633568525314
chromosomes O 0 0.026473939418792725
but O 0 0.008462118916213512
amplified O 0 0.023630764335393906
to O 0 0.007277948781847954
50 O 0 0.01359710656106472
- O 0 0.02869562618434429
3000 O 0 0.04496482387185097
copies O 0 0.020585834980010986
on O 0 0.0203385092318058
DM B-Disease 1 0.9994200468063354
chromosomes O 0 0.10946688801050186
. O 0 0.03910209238529205

Previous O 0 0.039454467594623566
findings O 0 0.03283745050430298
in O 0 0.015078446827828884
Caucasian O 0 0.2928667664527893
populations O 0 0.03808736056089401
of O 0 0.012489835731685162
a O 0 0.021395958960056305
DM B-Disease 1 0.9999344348907471
founder O 0 0.04265590384602547
chromosome O 0 0.09292126446962357
raise O 0 0.01802031323313713
a O 0 0.007802056148648262
question O 0 0.008403928950428963
about O 0 0.004695667885243893
the O 0 0.004623903427273035
molecular O 0 0.015199879184365273
events O 0 0.009875359944999218
involved O 0 0.009297473356127739
in O 0 0.007117512170225382
the O 0 0.010257873684167862
expansion O 0 0.03344832360744476
mutation O 1 0.572238028049469
. O 0 0.03071417845785618

To O 0 0.020976707339286804
investigate O 0 0.02724296785891056
whether O 0 0.014877304434776306
a O 0 0.010824562981724739
founder O 0 0.022372325882315636
chromosome O 0 0.0474412739276886
for O 0 0.008601312525570393
the O 0 0.013297109864652157
DM B-Disease 1 0.9999746084213257
mutation O 1 0.776957631111145
exists O 0 0.01415844913572073
in O 0 0.0051643685437738895
the O 0 0.005124784540385008
Japanese O 0 0.01004562247544527
population O 0 0.00942731648683548
, O 0 0.006011836230754852
we O 0 0.006559133064001799
genotyped O 0 0.0420447401702404
families O 0 0.015263549983501434
using O 0 0.01404842734336853
polymorphic O 0 0.21737731993198395
markers O 0 0.03339705243706703
near O 0 0.01713796891272068
the O 0 0.00853169709444046
( O 0 0.01898881420493126
CTG O 1 0.771358847618103
) O 0 0.01678023487329483
n O 0 0.024433765560388565
repeat O 0 0.02943292073905468
region O 0 0.01551941130310297
and O 0 0.010515511967241764
constructed O 0 0.025666169822216034
haplotypes O 1 0.6381547451019287
. O 0 0.034837812185287476

Six O 0 0.03591163456439972
different O 0 0.021092498674988747
haplotypes O 0 0.11692275106906891
were O 0 0.013082624413073063
found O 0 0.015556435100734234
and O 0 0.016891460865736008
DM B-Disease 1 0.9998781681060791
alleles O 0 0.48926061391830444
were O 0 0.015652522444725037
always O 0 0.02545124851167202
haplotype O 1 0.6399970650672913
A O 0 0.02713858149945736
. O 0 0.028020406141877174

To O 0 0.016868026927113533
find O 0 0.014292255975306034
an O 0 0.006220325827598572
origin O 0 0.00918907392770052
of O 0 0.005427133291959763
the O 0 0.0076521094888448715
( O 0 0.017618298530578613
CTG O 1 0.7232537269592285
) O 0 0.017323538661003113
n O 0 0.026032457128167152
repeat O 0 0.033319056034088135
mutation O 0 0.04464412480592728
and O 0 0.005915929097682238
to O 0 0.004504174459725618
investigate O 0 0.010046230629086494
the O 0 0.004334636963903904
mechanism O 0 0.01193581148982048
of O 0 0.003615654306486249
the O 0 0.005103015340864658
expansion O 0 0.013637502677738667
mutation O 0 0.037656210362911224
in O 0 0.004432170186191797
the O 0 0.004114020615816116
Japanese O 0 0.008474394679069519
population O 0 0.008152090944349766
we O 0 0.004183396231383085
have O 0 0.004966711159795523
studied O 0 0.010051428340375423
90 O 0 0.015597714111208916
Japanese O 0 0.01978832297027111
DM B-Disease 1 0.9996651411056519
families O 0 0.02192523516714573
comprising O 0 0.019873829558491707
190 O 0 0.03181952238082886
affected O 0 0.027701519429683685
and O 0 0.010991141200065613
130 O 0 0.028853604570031166
unaffected O 0 0.061902835965156555
members O 0 0.018319685012102127
. O 0 0.023719897493720055

The O 0 0.01722978986799717
results O 0 0.01897694356739521
suggest O 0 0.015581320971250534
that O 0 0.005602619610726833
a O 0 0.006377814803272486
few O 0 0.007269416004419327
common O 0 0.01173645630478859
ancestral O 0 0.027158444747328758
mutations O 0 0.09352140128612518
in O 0 0.007047252729535103
both O 0 0.006990174297243357
Caucasian O 0 0.22620731592178345
and O 0 0.006603152025490999
Japanese O 0 0.011781889013946056
populations O 0 0.016851823776960373
have O 0 0.005382249131798744
originated O 0 0.01211466733366251
by O 0 0.005580652970820665
expansion O 0 0.010929732583463192
of O 0 0.005198780447244644
an O 0 0.007217953447252512
ancestral O 0 0.028464708477258682
n O 0 0.0389459952712059
= O 0 0.04218314588069916
5 O 0 0.01599223166704178
repeat O 0 0.027871178463101387
to O 0 0.010408598929643631
n O 0 0.028983179479837418
= O 0 0.037820953875780106
19 O 0 0.015709901228547096
- O 0 0.0276124756783247
37 O 0 0.02079792693257332
copies O 0 0.01855149120092392
. O 0 0.02081645093858242

These O 0 0.023685280233621597
data O 0 0.017204955220222473
support O 0 0.020010342821478844
multistep O 0 0.06366375088691711
models O 0 0.023243645206093788
of O 0 0.010687246918678284
triplet O 0 0.2365911304950714
repeat O 0 0.036044005304574966
expansion O 0 0.01600547321140766
that O 0 0.005309439264237881
have O 0 0.004480444360524416
been O 0 0.004352231044322252
proposed O 0 0.007273918949067593
for O 0 0.005567994900047779
both O 0 0.010437872260808945
DM B-Disease 1 0.9999457597732544
and O 0 0.01524940226227045
Friedreichs B-Disease 1 0.9890809059143066
ataxia I-Disease 1 0.9995449185371399
. O 0 0.020987916737794876
. O 0 0.0271765049546957

The O 0 0.023578954860568047
molecular O 0 0.04417147859930992
basis O 0 0.016949646174907684
of O 0 0.015333659946918488
C6 B-Disease 1 0.9999202489852905
deficiency I-Disease 1 0.9999828338623047
in O 0 0.010753956623375416
the O 0 0.008365195244550705
western O 0 0.014868378639221191
Cape O 0 0.02916143089532852
, O 0 0.009096682071685791
South O 0 0.016993530094623566
Africa O 0 0.03429824113845825
. O 0 0.023831438273191452

Deficiency B-Disease 1 0.9995444416999817
of I-Disease 0 0.01428020279854536
the I-Disease 0 0.009952803142368793
sixth I-Disease 0 0.020011551678180695
component I-Disease 0 0.01943385973572731
of I-Disease 0 0.006956890691071749
human I-Disease 0 0.01469199825078249
complement I-Disease 0 0.026494931429624557
( O 0 0.01928884908556938
C6 O 1 0.9209846258163452
) O 0 0.00919823907315731
has O 0 0.004603900481015444
been O 0 0.004122194368392229
reported O 0 0.00610725674778223
in O 0 0.003457631915807724
a O 0 0.003211328759789467
number O 0 0.002958616940304637
of O 0 0.0026831794530153275
families O 0 0.007019332144409418
from O 0 0.004595481790602207
the O 0 0.004914864897727966
western O 0 0.012371555902063847
Cape O 0 0.024672599509358406
, O 0 0.008738616481423378
South O 0 0.01490520779043436
Africa O 0 0.03080330416560173
. O 0 0.023356478661298752

Meningococcal B-Disease 1 0.9999759197235107
disease I-Disease 1 0.9999338388442993
is O 0 0.019853603094816208
endemic O 0 0.03676068037748337
in O 0 0.006469196639955044
the O 0 0.005913532804697752
Cape O 0 0.019039718434214592
and O 0 0.004842150025069714
almost O 0 0.0063604568131268024
all O 0 0.005013376008719206
pedigrees O 0 0.03334037959575653
of O 0 0.008322682231664658
total O 0 0.023190168663859367
C6 B-Disease 1 0.9999804496765137
deficiency I-Disease 1 0.9999986886978149
( O 0 0.043171778321266174
C6Q0 O 1 0.8866135478019714
) O 0 0.011112530715763569
have O 0 0.0055044167675077915
been O 0 0.005976380314677954
ascertained O 0 0.022657375782728195
because O 0 0.011364521458745003
of O 0 0.012956383638083935
recurrent O 1 0.9995647072792053
disease O 1 0.9999358654022217
. O 0 0.039703503251075745

We O 0 0.01781427301466465
have O 0 0.012137269601225853
sequenced O 0 0.02840968407690525
the O 0 0.007580619305372238
expressed O 0 0.012829051353037357
exons O 0 0.03193175047636032
of O 0 0.006972898729145527
the O 0 0.009350902400910854
C6 O 1 0.9285221695899963
gene O 0 0.030525222420692444
from O 0 0.0054744272492825985
selected O 0 0.0056771631352603436
cases O 0 0.008038049563765526
and O 0 0.003307575825601816
have O 0 0.0038915162440389395
found O 0 0.004830047022551298
three O 0 0.005438470281660557
molecular O 0 0.021008845418691635
defects O 1 0.8985816836357117
leading O 0 0.011380943469703197
to O 0 0.0067368485033512115
total O 0 0.012988210655748844
deficiency O 1 0.9999803304672241
879delG O 0 0.4456872045993805
, O 0 0.005409587640315294
which O 0 0.003863286692649126
is O 0 0.0034460709430277348
the O 0 0.0036410565953701735
common O 0 0.009284976869821548
defect O 0 0.15736646950244904
in O 0 0.005624962970614433
the O 0 0.005503085441887379
Cape O 0 0.01786733791232109
and O 0 0.006132707465440035
hitherto O 0 0.02175939455628395
unreported O 0 0.028379688039422035
, O 0 0.007191683631390333
and O 0 0.005910116247832775
1195delC O 0 0.03777002543210983
and O 0 0.006738865748047829
1936delG O 0 0.03251373767852783
, O 0 0.0050498610362410545
which O 0 0.00379668059758842
have O 0 0.0034118208568543196
been O 0 0.003272818634286523
previously O 0 0.0057627977803349495
reported O 0 0.008204818703234196
in O 0 0.004962129518389702
African O 0 0.017499027773737907
- O 0 0.05032874271273613
Americans O 0 0.031557515263557434
. O 0 0.025754259899258614

We O 0 0.015307517722249031
also O 0 0.008360256440937519
show O 0 0.010111631825566292
that O 0 0.004979315679520369
the O 0 0.006442971993237734
879delG O 0 0.046452704817056656
and O 0 0.009846643544733524
1195delC O 1 0.7040330171585083
defects O 1 0.9548490047454834
are O 0 0.007639371324330568
associated O 0 0.01391160674393177
with O 0 0.012750577181577682
characteristic O 0 0.41733941435813904
C6 O 1 0.9997767806053162
/ O 1 0.9960504174232483
C7 O 1 0.9911330342292786
region O 0 0.037633419036865234
DNA O 0 0.05223911628127098
marker O 0 0.06328850239515305
haplotypes O 1 0.7276595830917358
, O 0 0.00925383809953928
although O 0 0.009951064363121986
small O 0 0.01061241328716278
variations O 0 0.01861092634499073
were O 0 0.007804973516613245
observed O 0 0.023954348638653755
. O 0 0.021822500973939896

The O 0 0.0335511714220047
1936delG O 0 0.30560028553009033
defect O 0 0.4274759590625763
was O 0 0.010192040354013443
observed O 0 0.011538716964423656
only O 0 0.00462904991582036
once O 0 0.005620249081403017
in O 0 0.003559872740879655
the O 0 0.00461681978777051
Cape O 0 0.015557443723082542
, O 0 0.004861549474298954
but O 0 0.004496672190725803
its O 0 0.005914457608014345
associated O 0 0.013991976156830788
haplotype O 1 0.7551233768463135
could O 0 0.012096338905394077
be O 0 0.00809017475694418
deduced O 0 0.03870071843266487
. O 0 0.023805581033229828

The O 0 0.01884295605123043
data O 0 0.013195759616792202
from O 0 0.00870482251048088
the O 0 0.007757122628390789
haplotypes O 0 0.30567964911460876
indicate O 0 0.012920599430799484
that O 0 0.0037905066274106503
these O 0 0.003624573815613985
three O 0 0.005901784170418978
molecular O 0 0.022530801594257355
defects O 1 0.671881377696991
account O 0 0.008700808510184288
for O 0 0.0035676041152328253
the O 0 0.004498747177422047
defects O 0 0.2228715419769287
in O 0 0.004216501489281654
all O 0 0.0035384087823331356
the O 0 0.0051634181290864944
38 O 0 0.015949036926031113
unrelated O 0 0.027226470410823822
C6Q0 O 1 0.5057393908500671
individuals O 0 0.012706958688795567
we O 0 0.005385887809097767
have O 0 0.005007005296647549
studied O 0 0.008006423711776733
from O 0 0.005428536795079708
the O 0 0.007700695656239986
Cape O 0 0.03749353811144829
. O 0 0.022035345435142517

We O 0 0.016837909817695618
have O 0 0.009207585826516151
also O 0 0.007799812592566013
observed O 0 0.013780477456748486
the O 0 0.008700011298060417
879delG O 0 0.14302535355091095
defect O 0 0.36546334624290466
in O 0 0.008778966963291168
two O 0 0.010276325047016144
Dutch O 0 0.04437609389424324
C6 B-Disease 1 0.9997816681861877
- I-Disease 1 0.9493038654327393
deficient I-Disease 1 0.9978088736534119
kindreds O 1 0.887546718120575
, O 0 0.010488862171769142
but O 0 0.007562768179923296
the O 0 0.00780927250161767
879delG O 0 0.1541854590177536
defect O 0 0.2961897850036621
in O 0 0.006606652867048979
the O 0 0.006008027121424675
Cape O 0 0.020234260708093643
probably O 0 0.009965196251869202
did O 0 0.005078909918665886
not O 0 0.0034283276181668043
come O 0 0.004879377316683531
from O 0 0.003992433659732342
The O 0 0.005885965656489134
Netherlands O 0 0.016577530652284622
. O 0 0.009738467633724213
. O 0 0.018863795325160027

Complement B-Disease 1 0.9554276466369629
C7 I-Disease 1 0.9998714923858643
deficiency I-Disease 1 0.9999910593032837
: O 0 0.0319698303937912
seven O 0 0.015829620882868767
further O 0 0.013038234785199165
molecular O 0 0.03568829596042633
defects O 1 0.8646534085273743
and O 0 0.008717133663594723
their O 0 0.009181939996778965
associated O 0 0.023413727059960365
marker O 0 0.06894025951623917
haplotypes O 1 0.9262865781784058
. O 0 0.03999418765306473

Seven O 0 0.03283943235874176
further O 0 0.021235277876257896
molecular O 0 0.04215554520487785
bases O 0 0.028318528085947037
of O 0 0.019117945805191994
C7 B-Disease 1 0.9999414682388306
deficiency I-Disease 1 0.9999916553497314
are O 0 0.019770663231611252
described O 0 0.03155406564474106
. O 0 0.023599229753017426

All O 0 0.01794942282140255
these O 0 0.0110776387155056
new O 0 0.014776102267205715
molecular O 0 0.03856872022151947
defects O 1 0.8514121770858765
involve O 0 0.02541421912610531
single O 0 0.021172642707824707
- O 0 0.040138110518455505
nucleotide O 0 0.046439457684755325
events O 0 0.01720643788576126
, O 0 0.008312500081956387
deletions O 0 0.029434282332658768
and O 0 0.0062060048803687096
substitutions O 0 0.015459197573363781
, O 0 0.004233051091432571
some O 0 0.003728390671312809
of O 0 0.004036684054881334
which O 0 0.006106463726609945
alter O 0 0.027163434773683548
splice O 0 0.053304560482501984
sites O 0 0.012287288904190063
, O 0 0.007114156614989042
and O 0 0.007642057724297047
others O 0 0.014733366668224335
codons O 0 0.06153106316924095
. O 0 0.02396337129175663

They O 0 0.016031982377171516
are O 0 0.009496929123997688
distributed O 0 0.013889016583561897
along O 0 0.011465040035545826
the O 0 0.011247190646827221
C7 O 1 0.6862496137619019
gene O 0 0.04485836252570152
, O 0 0.00782778300344944
but O 0 0.0054594068787992
predominantly O 0 0.009642117656767368
towards O 0 0.00934583693742752
the O 0 0.007164022885262966
3 O 0 0.014986959286034107
end O 0 0.018208516761660576
. O 0 0.020825695246458054

All O 0 0.016345540061593056
were O 0 0.008426576852798462
found O 0 0.011012008413672447
in O 0 0.011262080632150173
compound O 0 0.03473006933927536
heterozygous O 0 0.07042902708053589
individuals O 0 0.029475444927811623
. O 0 0.029453018680214882

The O 0 0.06300484389066696
C6 O 1 0.9978664517402649
/ O 1 0.9936042428016663
C7 O 1 0.9931815266609192
marker O 0 0.47585105895996094
haplotypes O 1 0.9578663110733032
associated O 0 0.025342898443341255
with O 0 0.012439743615686893
most O 0 0.01575101539492607
C7 B-Disease 1 0.99437415599823
defects I-Disease 1 0.9554767608642578
are O 0 0.0117152975872159
tabulated O 0 0.030087700113654137
. O 0 0.015912797302007675
. O 0 0.02225503697991371

A O 0 0.03711505979299545
genome O 0 0.0738285705447197
- O 0 0.04703317955136299
wide O 0 0.023844243958592415
search O 0 0.02094274014234543
for O 0 0.015016946941614151
chromosomal O 1 0.5950802564620972
loci O 1 0.6464373469352722
linked O 0 0.09476917237043381
to O 0 0.01663362607359886
mental O 1 0.9942960143089294
health O 1 0.8553479909896851
wellness O 1 0.8918925523757935
in O 0 0.009916334412992
relatives O 0 0.019749006256461143
at O 0 0.011013762094080448
high O 0 0.01775306463241577
risk O 1 0.9559468030929565
for O 0 0.02223188802599907
bipolar B-Disease 1 0.9999980926513672
affective I-Disease 1 0.9999499320983887
disorder I-Disease 1 0.9999231100082397
among O 0 0.01645464077591896
the O 0 0.01029893010854721
Old O 0 0.019074028357863426
Order O 0 0.01627839170396328
Amish O 0 0.07093118876218796
. O 0 0.031506624072790146

Bipolar B-Disease 1 0.9999961853027344
affective I-Disease 1 0.9999775886535645
disorder I-Disease 1 0.9999971389770508
( O 1 0.9874188303947449
BPAD B-Disease 1 0.9999287128448486
; O 1 0.9935658574104309
manic B-Disease 1 0.9999974966049194
- I-Disease 1 0.9999269247055054
depressive I-Disease 1 0.9999977350234985
illness I-Disease 1 0.999923825263977
) O 0 0.020674671977758408
is O 0 0.009925615973770618
characterized O 0 0.026156697422266006
by O 0 0.006675830576568842
episodes O 0 0.016270285472273827
of O 0 0.010746663436293602
mania B-Disease 1 0.9993739724159241
and O 0 0.012715977616608143
/ O 1 0.9793212413787842
or O 0 0.019392630085349083
hypomania B-Disease 1 0.9995415210723877
interspersed O 0 0.045286573469638824
with O 0 0.01517731137573719
periods O 0 0.03675467520952225
of O 0 0.01531976368278265
depression B-Disease 1 0.9902878999710083
. O 0 0.03622996062040329

Compelling O 0 0.058705028146505356
evidence O 0 0.022260131314396858
supports O 0 0.020994415506720543
a O 0 0.010356058366596699
significant O 0 0.013445327058434486
genetic O 0 0.029099708423018456
component O 0 0.01844707503914833
in O 0 0.006723244208842516
the O 0 0.008877319283783436
susceptibility O 1 0.5857189893722534
to O 0 0.013872215524315834
develop O 0 0.048693396151065826
BPAD B-Disease 1 0.9729640483856201
. O 0 0.03518648445606232

To O 0 0.017458148300647736
date O 0 0.014864717610180378
, O 0 0.006511567160487175
however O 0 0.006461321841925383
, O 0 0.0056244079023599625
linkage O 0 0.029855795204639435
studies O 0 0.009257371537387371
have O 0 0.004034500569105148
attempted O 0 0.008427780121564865
only O 0 0.0038109549786895514
to O 0 0.005401253700256348
identify O 0 0.017917277291417122
chromosomal O 1 0.8093041777610779
loci O 1 0.5855698585510254
that O 0 0.0077274576760828495
cause O 0 0.02268887124955654
or O 0 0.00835210457444191
increase O 0 0.011706739664077759
the O 0 0.007861047983169556
risk O 0 0.07139577716588974
of O 0 0.010259130969643593
developing O 0 0.04342547059059143
BPAD B-Disease 1 0.993289053440094
. O 0 0.027787622064352036

To O 0 0.0173636507242918
determine O 0 0.018885135650634766
whether O 0 0.010405466891825199
there O 0 0.005294024478644133
could O 0 0.0065529365092515945
be O 0 0.005216619931161404
protective O 0 0.0716039389371872
alleles O 0 0.37752610445022583
that O 0 0.007480914238840342
prevent O 0 0.01777779310941696
or O 0 0.009075199253857136
reduce O 0 0.017179204151034355
the O 0 0.0066939787939190865
risk O 0 0.0653177946805954
of O 0 0.00588113022968173
developing O 0 0.024203283712267876
BPAD B-Disease 1 0.9679875373840332
, O 0 0.006667879410088062
similar O 0 0.006582452915608883
to O 0 0.0036532958038151264
what O 0 0.004359671846032143
is O 0 0.0040029254741966724
observed O 0 0.007752895355224609
in O 0 0.0044805980287492275
other O 0 0.006474488414824009
genetic B-Disease 1 0.998407781124115
disorders I-Disease 1 0.9999927282333374
, O 0 0.007755214348435402
we O 0 0.005243124905973673
used O 0 0.008418126031756401
mental O 1 0.9978058934211731
health O 1 0.9629984498023987
wellness O 1 0.9895755052566528
( O 0 0.012403616681694984
absence O 0 0.014497173950076103
of O 0 0.006210971157997847
any O 0 0.009314284659922123
psychiatric B-Disease 1 0.9998906850814819
disorder I-Disease 1 0.9999029636383057
) O 0 0.00909082219004631
as O 0 0.004600840155035257
the O 0 0.00518741924315691
phenotype O 0 0.29425597190856934
in O 0 0.007002916652709246
our O 0 0.010134619660675526
genome O 0 0.0380869023501873
- O 0 0.035240184515714645
wide O 0 0.02147587016224861
linkage O 0 0.056213442236185074
scan O 0 0.031648900359869
of O 0 0.00570110697299242
several O 0 0.006369890179485083
large O 0 0.010429061949253082
multigeneration O 0 0.046823650598526
Old O 0 0.01735725812613964
Order O 0 0.012719964608550072
Amish O 0 0.048033203929662704
pedigrees O 0 0.06826195865869522
exhibiting O 0 0.04222777858376503
an O 0 0.01318198163062334
extremely O 0 0.025632629171013832
high O 0 0.022172337397933006
incidence O 1 0.9202742576599121
of O 0 0.021946262568235397
BPAD B-Disease 1 0.9769976139068604
. O 0 0.0381530225276947

We O 0 0.015719328075647354
have O 0 0.008461895398795605
found O 0 0.00815559271723032
strong O 0 0.009401854127645493
evidence O 0 0.0070291138254106045
for O 0 0.0050185928121209145
a O 0 0.009232650510966778
locus O 0 0.046748582273721695
on O 0 0.013053609058260918
chromosome O 0 0.4313015639781952
4p O 1 0.842153787612915
at O 0 0.020833738148212433
D4S2949 O 0 0.06692077219486237
( O 0 0.02198263444006443
maximum O 0 0.02634689211845398
GENEHUNTER O 0 0.3917333781719208
- O 0 0.05755212903022766
PLUS O 0 0.04659183323383331
nonparametric O 0 0.08997278660535812
linkage O 0 0.06972202658653259
score O 0 0.024048659950494766
= O 0 0.039487890899181366
4 O 0 0.014205067418515682
. O 0 0.00884799100458622
05 O 0 0.032431282103061676
, O 0 0.009925278834998608
P O 0 0.045056894421577454
= O 0 0.033082522451877594
5 O 0 0.011251985095441341
. O 0 0.005855809431523085
22 O 0 0.009587920270860195
x O 0 0.01807134598493576
10 O 0 0.008088881149888039
( O 0 0.010995910502970219
- O 0 0.02049013413488865
4 O 0 0.012801487930119038
) O 0 0.012064214795827866
; O 0 0.012762648053467274
SIBPAL O 0 0.3028548061847687
Pempirical O 0 0.06404202431440353
value O 0 0.015323282219469547
< O 0 0.05849374830722809
3 O 0 0.01247407030314207
x O 0 0.017666080966591835
10 O 0 0.008787594735622406
( O 0 0.010589465498924255
- O 0 0.017581801861524582
5 O 0 0.009447997435927391
) O 0 0.007453175727277994
) O 0 0.0060264491476118565
and O 0 0.004511767067015171
suggestive O 0 0.022677138447761536
evidence O 0 0.007549688220024109
for O 0 0.0046809157356619835
a O 0 0.008471742272377014
locus O 0 0.043577611446380615
on O 0 0.01159745454788208
chromosome O 1 0.694321870803833
4q O 1 0.9795834422111511
at O 0 0.02112116850912571
D4S397 O 0 0.06903912127017975
( O 0 0.021214205771684647
maximum O 0 0.02423275262117386
GENEHUNTER O 0 0.3925272226333618
- O 0 0.05297466367483139
PLUS O 0 0.040485043078660965
nonparametric O 0 0.07673593610525131
linkage O 0 0.06873070448637009
score O 0 0.022292237728834152
= O 0 0.03221086785197258
3 O 0 0.010273405350744724
. O 0 0.005870521068572998
29 O 0 0.010129676200449467
, O 0 0.007674124091863632
P O 0 0.03565223887562752
= O 0 0.02832247130572796
2 O 0 0.009316678158938885
. O 0 0.006153595633804798
57 O 0 0.013436405919492245
x O 0 0.018052062019705772
10 O 0 0.009481376968324184
( O 0 0.011862746439874172
- O 0 0.020503802224993706
3 O 0 0.013335025869309902
) O 0 0.010619599372148514
; O 0 0.013265620917081833
SIBPAL O 0 0.26414111256599426
Pempirical O 0 0.06755529344081879
value O 0 0.014743935316801071
< O 0 0.0525779165327549
1 O 0 0.012233562767505646
x O 0 0.01924067735671997
10 O 0 0.008314340375363827
( O 0 0.009414653293788433
- O 0 0.017057321965694427
3 O 0 0.009117473848164082
) O 0 0.0076346262358129025
) O 0 0.0053983526304364204
that O 0 0.003600082825869322
are O 0 0.004463105462491512
linked O 0 0.021857624873518944
to O 0 0.011365994811058044
mental O 1 0.9902839064598083
health O 1 0.9255406260490417
wellness O 1 0.9866192936897278
. O 0 0.031978897750377655

These O 0 0.020292408764362335
findings O 0 0.023883938789367676
are O 0 0.00774244824424386
consistent O 0 0.01138434000313282
with O 0 0.005638923496007919
the O 0 0.005911070853471756
hypothesis O 0 0.020557386800646782
that O 0 0.005885563790798187
certain O 0 0.010461421683430672
alleles O 0 0.17738501727581024
could O 0 0.010594522580504417
prevent O 0 0.01779881864786148
or O 0 0.01000244915485382
modify O 0 0.02300526201725006
the O 0 0.007944388315081596
clinical O 1 0.6643314957618713
manifestations O 0 0.08749429136514664
of O 0 0.008755984716117382
BPAD B-Disease 1 0.9824892282485962
and O 0 0.009067184291779995
perhaps O 0 0.014180068857967854
other O 0 0.009476623497903347
related O 0 0.0682452842593193
affective B-Disease 1 0.9990680813789368
disorders I-Disease 1 0.9999340772628784
. O 0 0.046691495925188065

Segregation O 1 0.5288020968437195
distortion O 1 0.8179665803909302
in O 0 0.0688064843416214
myotonic B-Disease 1 0.9999661445617676
dystrophy I-Disease 1 0.9999912977218628
. O 0 0.0807761624455452

Myotonic B-Disease 1 0.9999948740005493
dystrophy I-Disease 1 0.9999992847442627
( O 1 0.9904104471206665
DM B-Disease 1 0.9999796152114868
) O 0 0.02529584802687168
is O 0 0.012115946039557457
an O 0 0.012713020667433739
autosomal B-Disease 1 0.9997703433036804
dominant I-Disease 1 0.9721377491950989
disease I-Disease 1 0.9999034404754639
which O 0 0.006530101411044598
, O 0 0.005166186951100826
in O 0 0.004395974334329367
the O 0 0.004865699447691441
typical O 0 0.015191672369837761
pedigree O 0 0.0285783763974905
, O 0 0.006011540535837412
shows O 0 0.00892674457281828
a O 0 0.007158876396715641
three O 0 0.008740730583667755
generation O 0 0.032055530697107315
anticipation O 0 0.04469330236315727
cascade O 0 0.10529646277427673
. O 0 0.03191395848989487

This O 0 0.025420265272259712
results O 0 0.032360758632421494
in O 0 0.023682788014411926
infertility B-Disease 1 0.9999886751174927
and O 1 0.9129422307014465
congenital B-Disease 1 0.9999997615814209
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999997615814209
( O 1 0.5547983646392822
CDM B-Disease 1 0.9951698184013367
) O 0 0.01504725031554699
with O 0 0.00789039395749569
the O 0 0.008476478047668934
disappearance O 0 0.028875332325696945
of O 0 0.011582087725400925
DM B-Disease 1 0.9998083710670471
in O 0 0.013599389232695103
that O 0 0.013529893942177296
pedigree O 0 0.07182978838682175
. O 0 0.029835477471351624

The O 0 0.019871389493346214
concept O 0 0.023236539214849472
of O 0 0.011503658257424831
segregation O 0 0.044039152562618256
distortion O 0 0.042173419147729874
, O 0 0.0071879662573337555
where O 0 0.005828866735100746
there O 0 0.00474464101716876
is O 0 0.00535779120400548
preferential O 0 0.0224941223859787
transmission O 0 0.023278698325157166
of O 0 0.004760549403727055
the O 0 0.00598895875737071
larger O 0 0.014739475212991238
allele O 0 0.058425214141607285
at O 0 0.013233396224677563
the O 0 0.013056534342467785
DM B-Disease 1 0.9997788071632385
locus O 0 0.04879676550626755
, O 0 0.007362946402281523
has O 0 0.00507020577788353
been O 0 0.004551552701741457
put O 0 0.006635691504925489
forward O 0 0.00654752878472209
to O 0 0.005491453688591719
explain O 0 0.011881845071911812
partially O 0 0.01632605493068695
the O 0 0.007020356599241495
maintenance O 0 0.020227758213877678
of O 0 0.011025243438780308
DM B-Disease 1 0.9996675252914429
in O 0 0.010039342567324638
the O 0 0.009927916340529919
population O 0 0.02249463088810444
. O 0 0.023722248151898384

In O 0 0.018319491297006607
a O 0 0.014538700692355633
survey O 0 0.020738808438181877
of O 0 0.012564468197524548
DM B-Disease 1 0.9995377063751221
in O 0 0.009639286436140537
Northern O 0 0.013662051409482956
Ireland O 0 0.014742141589522362
, O 0 0.009603179059922695
59 O 0 0.02453540824353695
pedigrees O 0 0.0509147047996521
were O 0 0.013477782718837261
ascertained O 0 0.0651034563779831
. O 0 0.028935782611370087

Sibships O 0 0.10134971141815186
where O 0 0.012904973700642586
the O 0 0.005907303653657436
status O 0 0.007645905949175358
of O 0 0.0031543930526822805
all O 0 0.00245422194711864
the O 0 0.0027464269660413265
members O 0 0.0040665422566235065
had O 0 0.003621262265369296
been O 0 0.003152592806145549
identified O 0 0.00561331445351243
were O 0 0.002867341274395585
examined O 0 0.009217954240739346
to O 0 0.003315996378660202
determine O 0 0.007220961153507233
the O 0 0.004307025112211704
transmission O 0 0.0170145221054554
of O 0 0.005226220935583115
the O 0 0.009099029004573822
DM B-Disease 1 0.9999408721923828
expansion O 0 0.021022051572799683
from O 0 0.00842868909239769
affected O 0 0.020552242174744606
parents O 0 0.014186727814376354
to O 0 0.006549948360770941
their O 0 0.009191982448101044
offspring O 0 0.05656980350613594
. O 0 0.026545433327555656

Where O 0 0.02512073703110218
the O 0 0.01614556275308132
transmitting O 0 0.05288023501634598
parent O 0 0.03963795304298401
was O 0 0.012304035946726799
male O 0 0.029463009908795357
, O 0 0.013908217661082745
58 O 0 0.03748846799135208
. O 0 0.027163952589035034

3 O 0 0.028073979541659355
% O 0 0.014928702265024185
of O 0 0.006134314928203821
the O 0 0.0052462052553892136
offspring O 0 0.019822193309664726
were O 0 0.004778251051902771
affected O 0 0.010127246379852295
, O 0 0.003317312803119421
and O 0 0.0023373477160930634
in O 0 0.002502864459529519
the O 0 0.002790033584460616
case O 0 0.005189215764403343
of O 0 0.0036236129235476255
a O 0 0.007418833207339048
female O 0 0.017397886142134666
transmitting O 0 0.04244120791554451
parent O 0 0.04566844180226326
, O 0 0.015296561643481255
68 O 0 0.041546374559402466
. O 0 0.023517360910773277

7 O 0 0.045634813606739044
% O 0 0.027127349749207497
were O 0 0.012998569756746292
affected O 0 0.03940088674426079
. O 0 0.02780698798596859

Studies O 0 0.050437211990356445
on O 0 0.01982443407177925
meiotic O 1 0.7958846092224121
drive O 0 0.04049651697278023
in O 0 0.016344452276825905
DM B-Disease 1 0.9998624324798584
have O 0 0.011744694784283638
shown O 0 0.011456548236310482
increased O 0 0.01125624030828476
transmission O 0 0.02021816186606884
of O 0 0.004870772361755371
the O 0 0.006145828869193792
larger O 0 0.01241466123610735
allele O 0 0.04966375604271889
at O 0 0.011786174960434437
the O 0 0.013095855712890625
DM B-Disease 1 0.9996509552001953
locus O 0 0.08817031234502792
in O 0 0.01913941279053688
non O 0 0.05722257122397423
- O 1 0.9949625730514526
DM O 1 0.9999759197235107
heterozygotes O 1 0.991413950920105
for O 0 0.02708427608013153
CTGn O 1 0.5217986106872559
. O 0 0.041009508073329926

This O 0 0.016605084761977196
study O 0 0.0167051050812006
provides O 0 0.012995205819606781
further O 0 0.007301129400730133
evidence O 0 0.00771817984059453
that O 0 0.006081060040742159
the O 0 0.010008636862039566
DM B-Disease 1 0.9998100399971008
expansion O 0 0.02605523355305195
tends O 0 0.027746234089136124
to O 0 0.008852318860590458
be O 0 0.008513878099620342
transmitted O 0 0.047188736498355865
preferentially O 0 0.08278993517160416
. O 0 0.028974927961826324

Diagnosis O 1 0.9987369179725647
of O 0 0.05861660838127136
hemochromatosis B-Disease 1 0.9997686743736267
. O 0 0.06197581812739372

If O 0 0.19043678045272827
untreated O 1 0.9997395873069763
, O 0 0.1589667648077011
hemochromatosis B-Disease 1 0.9999957084655762
can O 0 0.26245757937431335
cause O 1 0.993680477142334
serious O 1 0.9108919501304626
illness O 1 0.9996023774147034
and O 0 0.007779797073453665
early B-Disease 0 0.009137243032455444
death I-Disease 0 0.011023718863725662
, O 0 0.004694927949458361
but O 0 0.005004460923373699
the O 0 0.006628761067986488
disease O 1 0.9994105100631714
is O 0 0.007800484541803598
still O 0 0.009747153148055077
substantially O 0 0.024771790951490402
under O 0 0.015940120443701744
- O 1 0.9671444892883301
diagnosed O 1 0.9998644590377808
. O 0 0.037134140729904175

The O 0 0.02265254035592079
cornerstone O 0 0.039394836872816086
of O 0 0.01022027712315321
screening O 0 0.02909177355468273
and O 0 0.007580469362437725
case O 0 0.01053168810904026
detection O 0 0.02560383453965187
is O 0 0.005924909375607967
the O 0 0.007011991459876299
measurement O 0 0.020846080034971237
of O 0 0.010525112971663475
serum O 1 0.6765869855880737
transferrin O 0 0.45947664976119995
saturation O 0 0.06807465851306915
and O 0 0.009764870628714561
the O 0 0.011374586261808872
serum O 1 0.5766263008117676
ferritin O 0 0.3059237003326416
level O 0 0.03341720625758171
. O 0 0.029632946476340294

Once O 0 0.03382004797458649
the O 0 0.01823810674250126
diagnosis O 1 0.9934681057929993
is O 0 0.013688873499631882
suspected O 0 0.026321925222873688
, O 0 0.009882957674562931
physicians O 0 0.1049024760723114
must O 0 0.012691529467701912
use O 0 0.013885202817618847
serum O 1 0.9487805366516113
ferritin O 1 0.9311583042144775
levels O 0 0.039084017276763916
and O 0 0.014622759073972702
hepatic O 1 0.9997865557670593
iron O 0 0.11135964840650558
stores O 0 0.019548773765563965
on O 0 0.013723138719797134
liver O 1 0.9998223185539246
biopsy O 1 0.9984285235404968
specimens O 0 0.026699388399720192
to O 0 0.009001475758850574
assess O 0 0.04201742261648178
patients O 1 0.8877609968185425
for O 0 0.006417302880436182
the O 0 0.006022779271006584
presence O 0 0.01627933792769909
of O 0 0.009700952097773552
iron B-Disease 0 0.0718238577246666
overload I-Disease 1 0.9287207722663879
. O 0 0.03757259622216225

Liver O 1 0.9995501637458801
biopsy O 1 0.8846150636672974
is O 0 0.010602913796901703
also O 0 0.00574329262599349
used O 0 0.0041120159439742565
to O 0 0.003398218424990773
establish O 0 0.008145974017679691
the O 0 0.004812987986952066
presence O 0 0.010957824997603893
or O 0 0.006913325283676386
absence O 0 0.014946228824555874
of O 0 0.007842089980840683
cirrhosis B-Disease 1 0.9994828701019287
, O 0 0.006740231066942215
which O 0 0.006211588624864817
can O 0 0.009616619907319546
affect O 0 0.031863026320934296
prognosis O 1 0.9983443021774292
and O 0 0.012530313804745674
management O 0 0.03600441664457321
. O 0 0.02248075045645237

A O 0 0.03303249552845955
DNA O 0 0.04624738544225693
- O 0 0.0366273932158947
based O 0 0.013577058911323547
test O 0 0.014974132180213928
for O 0 0.006576755084097385
the O 0 0.008100336417555809
HFE O 1 0.9132553935050964
gene O 0 0.03678632155060768
is O 0 0.007082284428179264
commercially O 0 0.009504827670753002
available O 0 0.004670887254178524
, O 0 0.0035384728107601404
but O 0 0.0028187395073473454
its O 0 0.0029380887281149626
place O 0 0.0043585896492004395
in O 0 0.004141363315284252
the O 0 0.006631255149841309
diagnosis O 1 0.9980859756469727
of O 0 0.012101753614842892
hemochromatosis B-Disease 1 0.9999605417251587
is O 0 0.010677213780581951
still O 0 0.011046417988836765
being O 0 0.009974139742553234
evaluated O 0 0.03495079278945923
. O 0 0.02242693491280079

Currently O 0 0.01781897246837616
, O 0 0.0075174011290073395
the O 0 0.005099743138998747
most O 0 0.004453230649232864
useful O 0 0.006445103324949741
role O 0 0.00606750650331378
for O 0 0.003113566432148218
this O 0 0.003195232478901744
test O 0 0.006773923523724079
is O 0 0.003136545419692993
in O 0 0.003069863421842456
the O 0 0.004521873779594898
detection O 0 0.02053484506905079
of O 0 0.006953415926545858
hemochromatosis B-Disease 1 0.999760091304779
in O 0 0.00649949861690402
the O 0 0.005069708917289972
family O 0 0.0082828588783741
members O 0 0.005787838716059923
of O 0 0.005651975981891155
patients O 1 0.9227526783943176
with O 0 0.00592868821695447
a O 0 0.007439599372446537
proven O 0 0.01731482334434986
case O 0 0.009385259822010994
of O 0 0.006488103419542313
the O 0 0.011344577185809612
disease O 1 0.999649167060852
. O 0 0.02819606103003025

It O 0 0.020015975460410118
is O 0 0.015118368901312351
crucial O 0 0.022031791508197784
to O 0 0.020873628556728363
diagnose O 1 0.9999113082885742
hemochromatosis B-Disease 1 0.9999954700469971
before O 1 0.7572773694992065
hepatic B-Disease 1 0.9999970197677612
cirrhosis I-Disease 1 0.9999945163726807
develops O 1 0.9994078874588013
because O 1 0.6904738545417786
phlebotomy O 1 0.9999706745147705
therapy O 1 0.9999768733978271
can O 1 0.679743766784668
avert O 1 0.9995946288108826
serious O 1 0.9996483325958252
chronic O 1 0.9999994039535522
disease O 1 0.9999873638153076
and O 0 0.00920597743242979
can O 0 0.008845502510666847
even O 0 0.006027094088494778
lead O 0 0.009881013073027134
to O 0 0.005323994904756546
normal O 0 0.01563253439962864
life O 0 0.015758106485009193
expectancy O 0 0.03981758654117584
. O 0 0.015372095629572868
. O 0 0.020903456956148148

Prevalence O 1 0.7576128244400024
of O 0 0.02295001409947872
the O 0 0.021971533074975014
I1307K O 1 0.5375763773918152
APC B-Disease 1 0.8980016708374023
gene O 0 0.10372262448072433
variant O 0 0.05318521708250046
in O 0 0.008608285337686539
Israeli O 0 0.012161814607679844
Jews O 0 0.009362473152577877
of O 0 0.004677580203860998
differing O 0 0.013816425576806068
ethnic O 0 0.012033559381961823
origin O 0 0.0147746866568923
and O 0 0.0109371617436409
risk O 1 0.9929009675979614
for O 0 0.056799136102199554
colorectal B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999920129776001
. O 0 0.05214669927954674

BACKGROUND O 0 0.07103042304515839
& O 0 0.04752349853515625
AIMS O 0 0.03531069681048393
Israeli O 0 0.017237041145563126
Jews O 0 0.01142551563680172
of O 0 0.005006765481084585
European O 0 0.009717079810798168
birth O 0 0.015440826304256916
, O 0 0.006681850645691156
i O 0 0.007093224208801985
. O 0 0.00499791419133544
e O 0 0.012959304265677929
. O 0 0.004417777061462402
, O 0 0.005030420143157244
Ashkenazim O 0 0.20868723094463348
, O 0 0.005320940166711807
have O 0 0.00459526339545846
the O 0 0.007205474656075239
highest O 1 0.6458145976066589
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999988079071045
incidence O 1 0.9984779953956604
of O 0 0.009143704548478127
any O 0 0.008693859912455082
Israeli O 0 0.016564302146434784
ethnic O 0 0.018065402284264565
group O 0 0.02591363526880741
. O 0 0.026767531409859657

The O 0 0.050138115882873535
I1307K O 0 0.37531688809394836
APC B-Disease 1 0.8114162683486938
gene O 0 0.09884075820446014
variant O 0 0.06265513598918915
was O 0 0.011843479238450527
found O 0 0.011469169519841671
in O 0 0.010286174714565277
6 O 0 0.023035233840346336
. O 0 0.021608708426356316

1 O 0 0.027064193040132523
% O 0 0.016021043062210083
of O 0 0.006918794941157103
American O 0 0.010133185423910618
Jews O 0 0.010437124408781528
, O 0 0.006115435156971216
28 O 0 0.009004462510347366
% O 0 0.008682779967784882
of O 0 0.005857991520315409
their O 0 0.01629553735256195
familial O 1 0.9999974966049194
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
cases O 0 0.42001503705978394
, O 0 0.007062273565679789
but O 0 0.0051464298740029335
not O 0 0.004421273712068796
in O 0 0.005934904795140028
non O 0 0.01620231755077839
- O 0 0.03474406152963638
Jews O 0 0.022273428738117218
. O 0 0.02029314450919628

We O 0 0.025699472054839134
assessed O 0 0.03764450177550316
the O 0 0.018143586814403534
I1307K O 0 0.19427533447742462
prevalence O 1 0.758764386177063
in O 0 0.009459499269723892
Israeli O 0 0.013662785291671753
Jews O 0 0.011037004180252552
of O 0 0.006077216472476721
differing O 0 0.016145797446370125
ethnic O 0 0.014882855117321014
origin O 0 0.016732970252633095
and O 0 0.012397916987538338
risk O 1 0.9925509691238403
for O 0 0.05625884607434273
colorectal B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999926090240479
. O 0 0.05031002312898636

METHODS O 0 0.05886086821556091
DNA O 0 0.0481128953397274
samples O 0 0.03281143307685852
from O 0 0.012135354802012444
500 O 0 0.01833849586546421
unrelated O 0 0.020514599978923798
Jews O 0 0.010717472992837429
of O 0 0.005372978281229734
European O 0 0.01004203874617815
or O 0 0.0081914272159338
non O 0 0.011839997954666615
- O 0 0.01796097680926323
European O 0 0.008798690512776375
origin O 0 0.008443202823400497
, O 0 0.004140317440032959
with O 0 0.0040631662122905254
or O 0 0.005503967870026827
without O 0 0.004637959413230419
a O 0 0.004636847414076328
personal O 0 0.007563261780887842
and O 0 0.00559574831277132
/ O 0 0.244813933968544
or O 0 0.006756672170013189
family O 0 0.009016265161335468
history O 0 0.008411478251218796
of O 0 0.006682118866592646
neoplasia B-Disease 1 0.9937518239021301
, O 0 0.006558336783200502
were O 0 0.004697719123214483
examined O 0 0.013363619334995747
for O 0 0.004463110119104385
the O 0 0.0070671564899384975
I1307K O 0 0.04550180956721306
variant O 0 0.03721621260046959
by O 0 0.010234135203063488
the O 0 0.01066546980291605
allele O 0 0.11805950850248337
- O 0 0.05673068389296532
specific O 0 0.027163319289684296
oligonucleotide O 1 0.5080113410949707
( O 0 0.03363439813256264
ASO O 0 0.4268355071544647
) O 0 0.02467568963766098
method O 0 0.029203739017248154
. O 0 0.025263452902436256

RESULTS O 0 0.04128628969192505
In O 0 0.01453667227178812
persons O 0 0.01823282614350319
at O 0 0.012824316509068012
average O 0 0.021557018160820007
risk O 1 0.9856134057044983
for O 0 0.043891534209251404
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999966621398926
, O 0 0.013236678205430508
I1307K O 0 0.07773774117231369
was O 0 0.007298033684492111
found O 0 0.008165979757905006
in O 0 0.006936424411833286
5 O 0 0.016766849905252457
. O 0 0.017444070428609848

0 O 0 0.051765765994787216
% O 0 0.020039817318320274
of O 0 0.008838520385324955
120 O 0 0.015372976660728455
European O 0 0.011233190074563026
and O 0 0.008983638137578964
1 O 0 0.016890468075871468
. O 0 0.02083371952176094

6 O 0 0.03923609480261803
% O 0 0.021223710849881172
of O 0 0.011590640060603619
188 O 0 0.033688388764858246
non O 0 0.025249900296330452
- O 0 0.03970621898770332
European O 0 0.01853647641837597
Jews O 0 0.023099394515156746
( O 0 0.02302359603345394
P O 0 0.11990868300199509
= O 0 0.054288871586322784
0 O 0 0.025905614718794823
. O 0 0.00942139606922865
08 O 0 0.03208393603563309
) O 0 0.019322283565998077
. O 0 0.02051934227347374

It O 0 0.024837449193000793
occurred O 0 0.03697359934449196
in O 0 0.014908043667674065
15 O 0 0.02552507072687149
. O 0 0.024875393137335777

4 O 0 0.033039215952157974
% O 0 0.01892111264169216
of O 0 0.010331233963370323
52 O 0 0.028338085860013962
Ashkenazi O 0 0.17331282794475555
Israelis O 0 0.04628052935004234
with O 0 0.020751720294356346
familial O 1 0.9999122619628906
cancer B-Disease 1 0.9999743700027466
( O 0 0.04964419826865196
P O 1 0.6676480770111084
= O 0 0.062405407428741455
0 O 0 0.022993046790361404
. O 0 0.009050515480339527
02 O 0 0.04921175166964531
) O 0 0.0074141365475952625
and O 0 0.0038318370934575796
was O 0 0.003672575345262885
not O 0 0.0037083905190229416
detected O 0 0.015092447400093079
in O 0 0.004844136070460081
51 O 0 0.01296222023665905
non O 0 0.015084369108080864
- O 0 0.025189394131302834
European O 0 0.01183944009244442
Jews O 0 0.014477853663265705
at O 0 0.013943196274340153
increased O 0 0.11511017382144928
cancer B-Disease 1 0.9999384880065918
risk O 1 0.9700541496276855
. O 0 0.030963443219661713

Colorectal B-Disease 1 0.9999614953994751
neoplasia I-Disease 1 0.9995896220207214
occurred O 0 0.05536743253469467
personally O 0 0.027217216789722443
or O 0 0.01006247103214264
in O 0 0.004918814171105623
the O 0 0.003949383273720741
families O 0 0.0077413818798959255
of O 0 0.004235631786286831
13 O 0 0.007528983056545258
of O 0 0.005266384221613407
20 O 0 0.0117240184918046
Ashkenazi O 0 0.08420504629611969
I1307K O 0 0.10007619857788086
carriers O 0 0.0275984276086092
, O 0 0.006236191838979721
8 O 0 0.006877797655761242
of O 0 0.0032724610064178705
whom O 0 0.006190032698214054
also O 0 0.003811783855780959
had O 0 0.0042368266731500626
a O 0 0.004490877967327833
personal O 0 0.006529421079903841
or O 0 0.00696168839931488
family O 0 0.011527311988174915
history O 0 0.012719318270683289
of O 0 0.014358628541231155
noncolonic O 1 0.907123863697052
neoplasia B-Disease 1 0.9981587529182434
. O 0 0.040945835411548615

CONCLUSIONS O 0 0.07600154727697372
The O 0 0.03412993624806404
I1307K O 0 0.24448862671852112
APC O 1 0.824444591999054
variant O 0 0.14038072526454926
may O 0 0.02068493887782097
represent O 0 0.015263349749147892
a O 0 0.016716737300157547
susceptibility O 1 0.9940717816352844
gene O 1 0.5357597470283508
for O 0 0.012871820479631424
colorectal B-Disease 1 0.9999743700027466
, I-Disease 0 0.009810280054807663
or I-Disease 0 0.007739887572824955
other I-Disease 0 0.005875368136912584
, I-Disease 0 0.00868323165923357
cancers I-Disease 1 0.9987955093383789
in O 0 0.008740561082959175
Ashkenazi O 0 0.049282509833574295
Jews O 0 0.012591805309057236
, O 0 0.005904051475226879
and O 0 0.005675682332366705
partially O 0 0.017968278378248215
explains O 0 0.019663603976368904
the O 0 0.008638993836939335
higher O 0 0.020769784227013588
incidence O 1 0.999243974685669
of O 0 0.03212950751185417
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999921321868896
in O 0 0.015624458901584148
European O 0 0.024256233125925064
Israelis O 0 0.04723932594060898
. O 0 0.025295928120613098

Systematic O 0 0.08960331231355667
analysis O 0 0.04476698115468025
of O 0 0.025590084493160248
coproporphyrinogen O 1 0.9208157062530518
oxidase O 1 0.9872729182243347
gene O 1 0.8680055737495422
defects O 1 0.993187427520752
in O 0 0.02059885673224926
hereditary B-Disease 1 0.9578135013580322
coproporphyria I-Disease 1 0.9183576107025146
and O 0 0.023180263116955757
mutation O 1 0.8269993662834167
update O 0 0.07572437822818756
. O 0 0.03332046419382095

Hereditary B-Disease 1 0.9732994437217712
coproporphyria I-Disease 1 0.945152759552002
( O 0 0.0540192686021328
HC B-Disease 1 0.9859163165092468
) O 0 0.022897636517882347
is O 0 0.012176282703876495
an O 0 0.017856989055871964
acute O 1 0.9999836683273315
hepatic B-Disease 1 0.9999959468841553
porphyria I-Disease 1 0.9999858140945435
with O 0 0.06700310111045837
autosomal O 1 0.9998700618743896
dominant O 1 0.9002044200897217
inheritance O 1 0.9747656583786011
caused O 1 0.6547163128852844
by O 0 0.01538698561489582
deficient B-Disease 1 0.7634613513946533
activity I-Disease 0 0.02821274846792221
of I-Disease 0 0.013863947242498398
coproporphyrinogen I-Disease 1 0.9482191205024719
III I-Disease 1 0.639496386051178
oxidase I-Disease 1 0.7529851198196411
( O 0 0.033225614577531815
CPO O 0 0.06772414594888687
) O 0 0.025152813643217087
. O 0 0.02534313313663006

Clinical O 1 0.9805777072906494
manifestations O 0 0.360075443983078
of O 0 0.014209375716745853
the O 0 0.013837608508765697
disease O 1 0.9998866319656372
are O 0 0.011837241239845753
characterized O 1 0.7466238737106323
by O 0 0.013503128662705421
acute O 1 0.9999468326568604
attacks O 0 0.3638651371002197
of O 0 0.02013862133026123
neurological B-Disease 1 0.9999954700469971
dysfunction I-Disease 1 0.9999898672103882
often O 0 0.03229323402047157
precipitated O 1 0.9250898957252502
by O 0 0.01130891777575016
drugs O 0 0.33532363176345825
, O 0 0.010985016822814941
fasting O 0 0.2778611183166504
, O 0 0.013982230797410011
cyclical O 1 0.9898255467414856
hormonal O 1 0.9972407817840576
changes O 0 0.02232510969042778
, O 0 0.014563363045454025
or O 0 0.09917914122343063
infectious B-Disease 1 0.9999499320983887
diseases I-Disease 1 0.9999279975891113
. O 0 0.03479394316673279

Skin O 1 0.9999209642410278
photosensitivity O 1 0.9993804693222046
may O 0 0.029288247227668762
also O 0 0.010423550382256508
be O 0 0.00812591053545475
present O 0 0.01446649618446827
. O 0 0.02055448666214943

The O 0 0.025597043335437775
seven O 0 0.0253750067204237
exons O 0 0.06036587059497833
, O 0 0.012525323778390884
the O 0 0.01195298507809639
exon O 0 0.07583221048116684
/ O 0 0.33617061376571655
intron O 0 0.14303316175937653
boundaries O 0 0.013529029674828053
and O 0 0.005966773722320795
part O 0 0.00810582097619772
of O 0 0.005818739999085665
3 O 0 0.011921626515686512
noncoding O 0 0.045254308730363846
sequence O 0 0.014409025199711323
of O 0 0.005384810268878937
the O 0 0.006299834698438644
CPO O 0 0.03423619270324707
gene O 0 0.027370788156986237
were O 0 0.0062057399190962315
systematically O 0 0.02065514214336872
analyzed O 0 0.01565263792872429
by O 0 0.006076686549931765
an O 0 0.00827981997281313
exon O 0 0.04496233910322189
- O 0 0.041249290108680725
by O 0 0.016888940706849098
- O 0 0.07741262763738632
exon O 0 0.2161070555448532
denaturing O 1 0.967045247554779
gradient O 1 0.8184025287628174
gel O 1 0.9906445741653442
electrophoresis O 1 0.7649041414260864
( O 0 0.03371665999293327
DGGE O 0 0.3934991657733917
) O 0 0.015523072332143784
strategy O 0 0.018349258229136467
followed O 0 0.009921067394316196
by O 0 0.006450846791267395
direct O 0 0.012681829743087292
sequencing O 0 0.02519124001264572
in O 0 0.007607996463775635
seven O 0 0.012772961519658566
unrelated O 0 0.04039345309138298
heterozygous O 1 0.8361888527870178
HC B-Disease 1 0.9996036887168884
patients O 1 0.9984440207481384
from O 0 0.013799912296235561
France O 0 0.019395818933844566
, O 0 0.008614928461611271
Holland O 0 0.027556899935007095
, O 0 0.007676510140299797
and O 0 0.008335313759744167
Czech O 0 0.026857782155275345
Republic O 0 0.02305954322218895
. O 0 0.02252119593322277

Seven O 0 0.036268673837184906
novel O 0 0.04134361445903778
mutations O 0 0.07698027789592743
and O 0 0.009022065438330173
two O 0 0.00834381952881813
new O 0 0.013481734320521355
polymorphisms O 0 0.07060334086418152
were O 0 0.015160074457526207
detected O 0 0.056097377091646194
. O 0 0.02800293266773224

Among O 0 0.03320840001106262
these O 0 0.018352722749114037
mutations O 0 0.06585802882909775
two O 0 0.011448374949395657
are O 0 0.011424546130001545
missense O 0 0.24505853652954102
( O 0 0.023209374397993088
G197W O 0 0.06231265515089035
, O 0 0.010118397884070873
W427R O 0 0.04286940023303032
) O 0 0.008284222334623337
, O 0 0.0041316719725728035
two O 0 0.004063301254063845
are O 0 0.005255724769085646
nonsense O 0 0.023321334272623062
( O 0 0.013579914346337318
Q306X O 0 0.041406773030757904
, O 0 0.008561725728213787
Q385X O 0 0.03644321486353874
) O 0 0.00724815996363759
, O 0 0.003891601227223873
two O 0 0.003941061440855265
are O 0 0.004660121165215969
small O 0 0.010236960835754871
deletions O 0 0.04284803569316864
( O 0 0.01962275244295597
662de14bp O 0 0.07366731017827988
; O 0 0.01525579672306776
1168del3bp O 0 0.06196223571896553
removing O 0 0.021175431087613106
a O 0 0.010257283225655556
glycine O 0 0.03418799862265587
at O 0 0.008461694233119488
position O 0 0.008359642699360847
390 O 0 0.022183358669281006
) O 0 0.007327913772314787
, O 0 0.004116912838071585
and O 0 0.0032927931752055883
one O 0 0.004335015546530485
is O 0 0.005595562979578972
a O 0 0.009920360520482063
splicing O 0 0.06713923811912537
mutation O 1 0.6134332418441772
( O 0 0.03249829635024071
IVS1 O 1 0.9481984376907349
- O 1 0.6505765318870544
15c O 1 0.9747193455696106
- O 1 0.8359600305557251
- O 1 0.6551558971405029
> O 1 0.5637738108634949
g O 0 0.04559382423758507
) O 0 0.011528084985911846
which O 0 0.00687270937487483
creates O 0 0.018136359751224518
a O 0 0.009284797124564648
new O 0 0.012231476604938507
acceptor O 0 0.0645625963807106
splice O 0 0.10668528825044632
site O 0 0.034098070114851
. O 0 0.027588121592998505

The O 0 0.026469474658370018
pathological O 0 0.05667703598737717
significance O 0 0.01690915785729885
of O 0 0.006652490701526403
the O 0 0.008261953480541706
point O 0 0.01553319487720728
mutations O 0 0.3634427487850189
G197W O 0 0.0882483497262001
, O 0 0.010089533403515816
W427R O 0 0.0325637012720108
, O 0 0.005156041122972965
and O 0 0.003787516849115491
the O 0 0.00444831233471632
in O 0 0.006211324129253626
- O 0 0.029941916465759277
frame O 0 0.027206817641854286
deletion O 0 0.09180561453104019
390delGly O 0 0.05503806471824646
were O 0 0.006366890389472246
assessed O 0 0.013305400498211384
by O 0 0.004782018717378378
their O 0 0.005557575263082981
respective O 0 0.01163763739168644
expression O 0 0.015087388455867767
in O 0 0.005820765160024166
a O 0 0.007383180782198906
prokaryotic O 0 0.022286076098680496
system O 0 0.01413256861269474
using O 0 0.010869310237467289
site O 0 0.016165753826498985
- O 0 0.03603062406182289
directed O 0 0.033175740391016006
mutagenesis O 0 0.11911388486623764
. O 0 0.037894077599048615

These O 0 0.029300998896360397
mutations O 0 0.24396149814128876
resulted O 0 0.02210356295108795
in O 0 0.00672916928306222
the O 0 0.005655133631080389
absence O 0 0.015347229316830635
or O 0 0.009356874972581863
a O 0 0.010211097076535225
dramatic O 0 0.022834325209259987
decrease O 0 0.027308495715260506
of O 0 0.010041402652859688
CPO O 0 0.06256235390901566
activity O 0 0.040744613856077194
. O 0 0.030048459768295288

The O 0 0.020680595189332962
two O 0 0.015888456255197525
polymorphisms O 0 0.0660354495048523
were O 0 0.01109644491225481
localized O 0 0.04041582718491554
in O 0 0.010220581665635109
noncoding O 0 0.043768707662820816
part O 0 0.007904037833213806
of O 0 0.0044115702621638775
the O 0 0.0058798473328351974
gene O 0 0.024978529661893845
1 O 0 0.011885820887982845
) O 0 0.009572740644216537
a O 0 0.010954689234495163
C O 0 0.05422114580869675
/ O 1 0.5039005875587463
G O 0 0.045321229845285416
polymorphism O 0 0.032360468059778214
in O 0 0.006580002140253782
the O 0 0.007934742607176304
promotor O 1 0.5212056636810303
region O 0 0.02358759008347988
, O 0 0.010182236321270466
142 O 0 0.03134692832827568
bp O 0 0.03223764896392822
upstream O 0 0.023262333124876022
from O 0 0.008106131106615067
the O 0 0.00796886719763279
transcriptional O 0 0.05127058923244476
initiation O 0 0.03979997709393501
site O 0 0.01664542965590954
( O 0 0.0217196773737669
- O 0 0.11448464542627335
142C O 1 0.7668800354003906
/ O 1 0.7006867527961731
G O 0 0.044113919138908386
) O 0 0.008584734052419662
, O 0 0.004310830030590296
and O 0 0.0038908510468900204
2 O 0 0.007207613904029131
) O 0 0.006144899874925613
a O 0 0.005533913150429726
6 O 0 0.011563990265130997
bp O 0 0.03144867718219757
deletion O 0 0.04772389680147171
polymorphism O 0 0.035896219313144684
in O 0 0.007506188936531544
the O 0 0.0059217954985797405
3 O 0 0.010976781137287617
noncoding O 0 0.04091068357229233
part O 0 0.00751950079575181
of O 0 0.004747019615024328
the O 0 0.007103265263140202
CPO O 0 0.045626863837242126
gene O 0 0.043570782989263535
, O 0 0.012151949107646942
574 O 0 0.05529782176017761
bp O 0 0.03751501068472862
downstream O 0 0.02040102891623974
of O 0 0.004260669462382793
the O 0 0.004550861194729805
last O 0 0.0064363484270870686
base O 0 0.008437220938503742
of O 0 0.004235112573951483
the O 0 0.007875584065914154
normal O 0 0.028236616402864456
termination O 0 0.49368441104888916
codon O 0 0.08476045727729797
( O 0 0.0358123704791069
+ O 0 0.19802989065647125
574 O 0 0.35643458366394043
delATTCTT O 0 0.45318567752838135
) O 0 0.03465879335999489
. O 0 0.028792772442102432

Five O 0 0.04073501378297806
intragenic O 0 0.35356947779655457
dimorphisms O 0 0.09771216660737991
are O 0 0.009512457065284252
now O 0 0.008499537594616413
well O 0 0.0064930906519293785
characterized O 0 0.01711026392877102
and O 0 0.0038758874870836735
the O 0 0.005070073995739222
high O 0 0.0089238490909338
degree O 0 0.01133318617939949
of O 0 0.007275681477040052
allelic O 0 0.4038286805152893
heterogeneity O 0 0.15404675900936127
in O 0 0.011556873098015785
HC B-Disease 1 0.854518473148346
is O 0 0.008211212232708931
demonstrated O 0 0.012349970638751984
with O 0 0.005225809291005135
seven O 0 0.005904756486415863
new O 0 0.006394619587808847
different O 0 0.00728520005941391
mutations O 0 0.03062889724969864
making O 0 0.00641228910535574
a O 0 0.005703034810721874
total O 0 0.007339612580835819
of O 0 0.007073155138641596
nineteen O 0 0.02850799635052681
CPO O 0 0.35111039876937866
gene B-Disease 1 0.6111879944801331
defects I-Disease 1 0.9759416580200195
reported O 0 0.020081408321857452
so O 0 0.012405783869326115
far O 0 0.011818403378129005
. O 0 0.011602599173784256
. O 0 0.01884051412343979

Coincidence O 0 0.06602553278207779
of O 0 0.014770939946174622
two O 0 0.013561269268393517
novel O 0 0.02779734879732132
arylsulfatase O 0 0.07839901000261307
A O 0 0.0246469434350729
alleles O 0 0.1497826874256134
and O 0 0.023096228018403053
mutation O 1 0.7665886878967285
459 O 1 0.8015348315238953
+ O 1 0.5750391483306885
1G O 1 0.6251671314239502
> O 0 0.06570496410131454
A O 0 0.013727669604122639
within O 0 0.009263512678444386
a O 0 0.009523474611341953
family O 0 0.015136399306356907
with O 0 0.015908854082226753
metachromatic B-Disease 1 0.9917196035385132
leukodystrophy I-Disease 1 0.9996453523635864
: O 0 0.024035250768065453
molecular O 0 0.03060901165008545
basis O 0 0.01415831595659256
of O 0 0.012097375467419624
phenotypic O 0 0.08385951071977615
heterogeneity O 0 0.1324215531349182
. O 0 0.0409194678068161

In O 0 0.016754575073719025
a O 0 0.01024505216628313
family O 0 0.010569610632956028
with O 0 0.0059042139910161495
three O 0 0.006466549355536699
siblings O 0 0.019680768251419067
, O 0 0.0070908162742853165
one O 0 0.007263544015586376
developed O 0 0.018564539030194283
classical O 0 0.0211079902946949
late O 0 0.032726991921663284
infantile O 1 0.9998922348022461
metachromatic B-Disease 1 0.9997625946998596
leukodystrophy I-Disease 1 0.9999842643737793
( O 1 0.7906767725944519
MLD B-Disease 1 0.9998074173927307
) O 0 0.022273553535342216
, O 0 0.010994842275977135
fatal O 1 0.9120141863822937
at O 0 0.009787960909307003
age O 0 0.011051660403609276
5 O 0 0.008184773847460747
years O 0 0.005934232845902443
, O 0 0.0053435806185007095
with O 0 0.0074071078561246395
deficient O 1 0.5559965372085571
arylsulfatase O 0 0.3544219732284546
A O 0 0.017284343019127846
( O 0 0.02405988983809948
ARSA O 1 0.9819516539573669
) O 0 0.01663404516875744
activity O 0 0.017637604847550392
and O 0 0.008420220576226711
increased O 0 0.02098054066300392
galactosylsulfatide O 1 0.8737770915031433
( O 0 0.036815304309129715
GS O 1 0.9991130232810974
) O 0 0.03460150957107544
excretion O 0 0.2342238575220108
. O 0 0.03523433580994606

The O 0 0.015256241895258427
two O 0 0.00986024271696806
other O 0 0.009290729649364948
siblings O 0 0.027506988495588303
, O 0 0.008732748217880726
apparently O 0 0.017233634367585182
healthy O 0 0.02200429141521454
at O 0 0.007483729626983404
12 O 0 0.008483579382300377
( O 0 0.009036188013851643
1 O 0 0.009574861265718937
/ O 0 0.03649422153830528
2 O 0 0.006853685714304447
) O 0 0.004601160995662212
and O 0 0.0028417916037142277
15 O 0 0.004203526768833399
years O 0 0.003167291171848774
, O 0 0.0025391501840204
respectively O 0 0.0040635596960783005
, O 0 0.0025550604332238436
and O 0 0.002445824211463332
their O 0 0.002920733531937003
father O 0 0.006302679888904095
, O 0 0.004359620623290539
apparently O 0 0.010007919743657112
healthy O 0 0.01464493852108717
as O 0 0.003389789955690503
well O 0 0.005099900532513857
, O 0 0.005147898104041815
presented O 0 0.011492650955915451
ARSA O 1 0.965132474899292
and O 0 0.011314564384520054
GS O 1 0.9677929878234863
values O 0 0.015043094754219055
within O 0 0.010031207464635372
the O 0 0.008450484834611416
range O 0 0.018450133502483368
of O 0 0.016052817925810814
MLD B-Disease 1 0.999724805355072
patients O 1 0.9982379674911499
. O 0 0.03653137385845184

Mutation O 1 0.895507276058197
screening O 0 0.07109624147415161
and O 0 0.013418668881058693
sequence O 0 0.020321782678365707
analysis O 0 0.013641460798680782
disclosed O 0 0.016961585730314255
the O 0 0.006529857404530048
involvement O 0 0.016138512641191483
of O 0 0.005309625994414091
three O 0 0.0075540486723184586
different O 0 0.013251728378236294
ARSA O 1 0.9921452403068542
mutations O 0 0.15884414315223694
being O 0 0.008516745641827583
the O 0 0.007937971502542496
molecular O 0 0.020604316145181656
basis O 0 0.01142037846148014
of O 0 0.012630478478968143
intrafamilial O 0 0.10287117958068848
phenotypic O 0 0.09617086499929428
heterogeneity O 0 0.20451296865940094
. O 0 0.04767153412103653

The O 0 0.03852420672774315
late O 0 0.05593373253941536
infantile O 1 0.9996774196624756
patient O 1 0.9968082308769226
inherited O 1 0.6634114384651184
from O 0 0.011924996972084045
his O 0 0.00998750701546669
mother O 0 0.018316660076379776
the O 0 0.010852507315576077
frequent O 0 0.0358324758708477
0 O 0 0.03970668464899063
- O 0 0.1961936354637146
type O 0 0.08472689986228943
mutation O 1 0.909267783164978
459 O 1 0.916545569896698
+ O 1 0.6850278973579407
1G O 1 0.6718078255653381
> O 0 0.055922169238328934
A O 0 0.009054522961378098
, O 0 0.004709353670477867
and O 0 0.0034054869320243597
from O 0 0.004056992009282112
his O 0 0.004675296600908041
father O 0 0.009139317087829113
a O 0 0.0077474238350987434
novel O 0 0.012312140315771103
, O 0 0.00727297505363822
single O 0 0.015363812446594238
basepair O 0 0.08041224628686905
microdeletion O 0 0.06661645323038101
of O 0 0.01281615812331438
guanine O 0 0.0461060106754303
at O 0 0.014677661471068859
nucleotide O 0 0.03975074365735054
7 O 0 0.014553211629390717
in O 0 0.00849374383687973
exon O 0 0.04458705335855484
1 O 0 0.01977791078388691
( O 0 0.021761596202850342
7delG O 0 0.07667119055986404
) O 0 0.023791654035449028
. O 0 0.024384042248129845

The O 0 0.0250393133610487
two O 0 0.02323511615395546
clinically O 1 0.5652612447738647
unaffected O 0 0.20305217802524567
siblings O 0 0.05542169138789177
carried O 0 0.02163621410727501
the O 0 0.017770783975720406
maternal O 1 0.5509584546089172
mutation O 1 0.9633249640464783
459 O 1 0.9502406716346741
+ O 1 0.8134849667549133
1G O 1 0.8811976909637451
> O 0 0.07523436844348907
A O 0 0.010462173260748386
and O 0 0.0051316930912435055
, O 0 0.004573511891067028
on O 0 0.0034487738739699125
their O 0 0.005785293411463499
paternal O 0 0.028824731707572937
allele O 0 0.04953358322381973
, O 0 0.007162300869822502
a O 0 0.007822036743164062
novel O 0 0.01750585064291954
cytosine O 0 0.04813074320554733
to O 0 0.013081916607916355
thymidine O 0 0.0796419158577919
transition O 0 0.030350307002663612
at O 0 0.018621493130922318
nucleotide O 0 0.058493707329034805
2435 O 0 0.3987415134906769
in O 0 0.01558993011713028
exon O 0 0.055204737931489944
8 O 0 0.016811810433864594
, O 0 0.0074518462643027306
resulting O 0 0.014288870617747307
in O 0 0.006932364776730537
substitution O 0 0.022493500262498856
of O 0 0.009080860763788223
alanine O 0 0.06778895854949951
464 O 0 0.07871885597705841
by O 0 0.019467679783701897
valine O 0 0.16701342165470123
( O 0 0.03550059348344803
A464V O 0 0.10578687489032745
) O 0 0.028443660587072372
. O 0 0.027766607701778412

The O 0 0.039264846593141556
fathers O 0 0.07365308701992035
genotype O 0 0.4402662515640259
thus O 0 0.028033573180437088
was O 0 0.02014782279729843
7delG O 1 0.5649029612541199
/ O 1 0.8346989750862122
A464V O 0 0.23044270277023315
. O 0 0.0371999628841877

Mutation O 1 0.835527777671814
A464V O 0 0.10449046641588211
was O 0 0.013661691918969154
not O 0 0.0079327542334795
found O 0 0.00916555617004633
in O 0 0.007416687905788422
18 O 0 0.015778932720422745
unrelated O 0 0.4181745946407318
MLD B-Disease 1 0.9999282360076904
patients O 1 0.9958909749984741
and O 0 0.013211888261139393
50 O 0 0.019566966220736504
controls O 0 0.031968556344509125
. O 0 0.022009991109371185

A464V O 0 0.17419980466365814
, O 0 0.024622000753879547
although O 0 0.0200384259223938
clearly O 0 0.028058933094143867
modifying O 0 0.07119378447532654
ARSA O 1 0.996292769908905
and O 0 0.01848222315311432
GS O 1 0.9988670349121094
levels O 0 0.025064857676625252
, O 0 0.008294147439301014
apparently O 0 0.014862483367323875
bears O 0 0.01672579161822796
little O 0 0.012336106970906258
significance O 0 0.01306157372891903
for O 0 0.008116320706903934
clinical O 0 0.45939508080482483
manifestation O 0 0.09651613980531693
of O 0 0.013371676206588745
MLD B-Disease 1 0.9992170333862305
, O 0 0.019020862877368927
mimicking O 0 0.07482573390007019
the O 0 0.0227124635130167
frequent O 0 0.07744217664003372
ARSA O 1 0.9882453680038452
pseudodeficiency O 1 0.7924628853797913
allele O 0 0.30462509393692017
. O 0 0.04927407205104828

Our O 0 0.029164079576730728
results O 0 0.020826976746320724
demonstrate O 0 0.017742197960615158
that O 0 0.006116455886512995
in O 0 0.006724103353917599
certain O 0 0.012741505168378353
genetic O 0 0.3416646718978882
conditions O 0 0.3100731670856476
MLD B-Disease 1 0.9998899698257446
- O 1 0.7367637157440186
like O 0 0.026996666565537453
ARSA O 1 0.9933949112892151
and O 0 0.015835905447602272
GS O 1 0.9910494089126587
values O 0 0.014231111854314804
need O 0 0.009366684593260288
not O 0 0.0046881684102118015
be O 0 0.004584627691656351
paralleled O 0 0.022150810807943344
by O 0 0.010624204762279987
clinical O 1 0.9954438209533691
disease O 1 0.9998248219490051
, O 0 0.007867921143770218
a O 0 0.007750313263386488
finding O 0 0.01175389252603054
with O 0 0.008119314908981323
serious O 0 0.047511640936136246
diagnostic O 0 0.4018058180809021
and O 0 0.017788004130125046
prognostic O 1 0.9815248250961304
implications O 0 0.11164194345474243
. O 0 0.036544885486364365

Moreover O 0 0.06486847251653671
, O 0 0.02214222587645054
further O 0 0.028032056987285614
ARSA O 1 0.9720833897590637
alleles O 0 0.35295888781547546
functionally O 0 0.048147737979888916
similar O 0 0.015245986171066761
to O 0 0.008686170913279057
A464V O 0 0.038134507834911346
might O 0 0.01047147624194622
exist O 0 0.0067346603609621525
which O 0 0.0038861578796058893
, O 0 0.003941742703318596
together O 0 0.005036988295614719
with O 0 0.006561016198247671
0 O 0 0.01960323564708233
- O 0 0.20958450436592102
type O 0 0.18755190074443817
mutations O 1 0.8997915387153625
, O 0 0.011365887708961964
may O 0 0.019184535369277
cause O 0 0.4700832664966583
pathological O 1 0.9779190421104431
ARSA O 1 0.9990824460983276
and O 0 0.017639804631471634
GS O 1 0.999327540397644
levels O 0 0.024875789880752563
, O 0 0.006769971922039986
but O 0 0.005507132038474083
not O 0 0.0061133489944040775
clinical O 1 0.9174322485923767
outbreak O 1 0.9785043001174927
of O 0 0.007349763531237841
the O 0 0.010604164563119411
disease O 1 0.9998041987419128
. O 0 0.019250841811299324
. O 0 0.023804614320397377

Human O 1 0.9452695846557617
MLH1 O 1 0.9998705387115479
deficiency O 1 0.9999951124191284
predisposes O 1 0.9993578791618347
to O 0 0.05967770889401436
hematological B-Disease 1 0.9995935559272766
malignancy I-Disease 1 0.9996916055679321
and O 0 0.05476106330752373
neurofibromatosis B-Disease 1 0.9997275471687317
type I-Disease 0 0.1726638674736023
1 I-Disease 0 0.03789062798023224
. O 0 0.031714435666799545

Heterozygous O 1 0.7804853320121765
germ O 1 0.9938866496086121
- O 0 0.19460929930210114
line O 0 0.034868448972702026
mutations O 0 0.10646650195121765
in O 0 0.010215116664767265
the O 0 0.010554460808634758
DNA O 0 0.041853200644254684
mismatch O 1 0.8684805631637573
repair O 1 0.6408179998397827
genes O 0 0.13454614579677582
lead O 0 0.03479114547371864
to O 0 0.023831982165575027
hereditary B-Disease 1 0.9991883635520935
nonpolyposis I-Disease 1 0.9998218417167664
colorectal I-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999886751174927
. O 0 0.06160854175686836

The O 0 0.04986424371600151
disease O 1 0.9998900890350342
susceptibility O 1 0.9840243458747864
of O 0 0.009999617002904415
individuals O 0 0.012828409671783447
who O 0 0.00933923851698637
constitutionally O 0 0.018192961812019348
lack O 0 0.01340575236827135
both O 0 0.008298490196466446
wild O 0 0.02259429730474949
- O 0 0.06228726729750633
type O 0 0.043318405747413635
alleles O 0 0.17851464450359344
is O 0 0.01657215878367424
unknown O 0 0.02825697883963585
. O 0 0.023609867319464684

We O 0 0.016583992168307304
have O 0 0.009562487713992596
identified O 0 0.013492575846612453
three O 0 0.00785702932626009
offspring O 0 0.028675107285380363
in O 0 0.00970953144133091
a O 0 0.01841510273516178
hereditary B-Disease 1 0.9992572665214539
nonpolyposis I-Disease 1 0.9999569654464722
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999982118606567
family O 0 0.23650741577148438
who O 0 0.029154082760214806
developed O 0 0.3268773853778839
hematological B-Disease 1 0.9998107552528381
malignancy I-Disease 1 0.9995710253715515
at O 0 0.01304886769503355
a O 0 0.006974616087973118
very O 0 0.005754871293902397
early O 0 0.00704520707949996
age O 0 0.006956515368074179
, O 0 0.003462492022663355
and O 0 0.0027730073779821396
at O 0 0.0035898517817258835
least O 0 0.0035340669564902782
two O 0 0.0025503539945930243
of O 0 0.002669875742867589
them O 0 0.0038270496297627687
displayed O 0 0.009593007154762745
signs O 0 0.01807403936982155
of O 0 0.011463673785328865
neurofibromatosis B-Disease 1 0.9998695850372314
type I-Disease 0 0.07468181848526001
1 I-Disease 0 0.023658286780118942
( O 0 0.02925473265349865
NF1 B-Disease 1 0.9706470966339111
) O 0 0.026569567620754242
. O 0 0.023790905252099037

DNA O 0 0.07983380556106567
sequence O 0 0.03930407762527466
analysis O 0 0.023884302005171776
and O 0 0.01179590541869402
allele O 0 0.07549367845058441
- O 0 0.03807351365685463
specific O 0 0.019566847011446953
amplification O 0 0.04429195076227188
in O 0 0.007937224581837654
two O 0 0.0083645423874259
siblings O 0 0.03189660236239433
revealed O 0 0.02429637312889099
a O 0 0.019993914291262627
homozygous O 0 0.3103715479373932
MLH1 O 1 0.9968714118003845
mutation O 1 0.9838483929634094
( O 0 0.04537010192871094
C676T O 1 0.8085960745811462
- O 1 0.8476417064666748
- O 1 0.83953857421875
> O 1 0.7998684644699097
Arg226Stop O 0 0.4853770434856415
) O 0 0.03561170771718025
. O 0 0.03286663442850113

Thus O 0 0.03774316608905792
, O 0 0.02157759852707386
a O 0 0.0254852082580328
homozygous O 0 0.2874278724193573
germ O 1 0.9965336322784424
- O 1 0.7164828181266785
line O 0 0.04893024265766144
MLH1 O 1 0.9989515542984009
mutation O 1 0.9910813570022583
and O 0 0.025106120854616165
consequent O 1 0.9949541687965393
mismatch O 1 0.999603807926178
repair O 1 0.9996370077133179
deficiency O 1 0.9999868869781494
results O 0 0.024890374392271042
in O 0 0.01306545827537775
a O 0 0.019495854154229164
mutator O 1 0.9992935657501221
phenotype O 1 0.9993569254875183
characterized O 1 0.9833735227584839
by O 0 0.02845996618270874
leukemia B-Disease 1 0.9999980926513672
and O 0 0.07374995201826096
/ O 1 0.9998049139976501
or O 1 0.7131925225257874
lymphoma B-Disease 1 0.9999996423721313
associated O 0 0.11905263364315033
with O 0 0.023195605725049973
neurofibromatosis B-Disease 1 0.9998960494995117
type I-Disease 0 0.05759882554411888
1 I-Disease 0 0.018373830243945122
. O 0 0.013881795108318329
. O 0 0.021095899865031242

Missense O 1 0.8815232515335083
mutations O 0 0.15512654185295105
in O 0 0.013014658354222775
the O 0 0.007948549464344978
most O 0 0.007049197796732187
ancient O 0 0.009510179981589317
residues O 0 0.019026970490813255
of O 0 0.006902758963406086
the O 0 0.009639622643589973
PAX6 O 1 0.9756709337234497
paired O 0 0.04770832881331444
domain O 0 0.03005497343838215
underlie O 0 0.07730907201766968
a O 0 0.013781435787677765
spectrum O 0 0.03209848701953888
of O 0 0.01256651058793068
human O 0 0.2984195053577423
congenital B-Disease 1 0.9999959468841553
eye I-Disease 1 0.9997419714927673
malformations I-Disease 1 0.9997445940971375
. O 0 0.04229404404759407

Mutations O 0 0.20252279937267303
of O 0 0.015910586342215538
the O 0 0.015116921626031399
human O 0 0.039175745099782944
PAX6 O 1 0.9992907047271729
gene O 1 0.9908609390258789
underlie O 1 0.9992104768753052
aniridia B-Disease 1 0.9997807145118713
( O 0 0.47729289531707764
congenital B-Disease 1 0.9999679327011108
absence I-Disease 0 0.02654220163822174
of I-Disease 0 0.006718780845403671
the I-Disease 0 0.009149771183729172
iris I-Disease 0 0.47632741928100586
) O 0 0.011947856284677982
, O 0 0.006627750117331743
a O 0 0.008229984901845455
rare O 0 0.025163741782307625
dominant O 0 0.05808349698781967
malformation B-Disease 1 0.9962767958641052
of I-Disease 0 0.01155412383377552
the I-Disease 0 0.016547488048672676
eye I-Disease 1 0.7131674289703369
. O 0 0.02849106676876545

The O 0 0.03210560604929924
spectrum O 0 0.05359402671456337
of O 0 0.02178560569882393
PAX6 O 1 0.9981574416160583
mutations O 1 0.9825584888458252
in O 0 0.02039315365254879
aniridia B-Disease 1 0.998755931854248
patients O 1 0.995112955570221
is O 0 0.008908402174711227
highly O 0 0.012482555583119392
biased O 0 0.017794301733374596
, O 0 0.0061516365967690945
with O 0 0.004996262025088072
92 O 0 0.015783214941620827
% O 0 0.007274992763996124
of O 0 0.0038880319334566593
all O 0 0.0044244383461773396
reported O 0 0.016119791194796562
mutations O 0 0.141346275806427
leading O 0 0.01464830432087183
to O 0 0.009692325256764889
premature O 0 0.07182162255048752
truncation O 0 0.03925217688083649
of O 0 0.007369360886514187
the O 0 0.00886924285441637
protein O 0 0.02455117367208004
( O 0 0.014948911033570766
nonsense O 0 0.02587995119392872
, O 0 0.009723355062305927
splicing O 0 0.04223299399018288
, O 0 0.009436726570129395
insertions O 0 0.040919072926044464
and O 0 0.00822423491626978
deletions O 0 0.027910353615880013
) O 0 0.007948997430503368
and O 0 0.004183165729045868
just O 0 0.005055153742432594
2 O 0 0.006174569483846426
% O 0 0.006448139436542988
leading O 0 0.0058816843666136265
to O 0 0.003931418992578983
substitution O 0 0.011944924481213093
of O 0 0.00395438214763999
one O 0 0.006385319400578737
amino O 0 0.020662279799580574
acid O 0 0.028750957921147346
by O 0 0.00859104748815298
another O 0 0.014273987151682377
( O 0 0.02234010584652424
missense O 0 0.16181784868240356
) O 0 0.02443208359181881
. O 0 0.02268930710852146

The O 0 0.025762423872947693
extraordinary O 0 0.03624945506453514
conservation O 0 0.03020341321825981
of O 0 0.01007174700498581
the O 0 0.01380704715847969
PAX6 O 1 0.8109773993492126
protein O 0 0.03567223623394966
at O 0 0.010569321922957897
the O 0 0.007921616546809673
amino O 0 0.02552196756005287
acid O 0 0.040556322783231735
level O 0 0.01705072447657585
amongst O 0 0.01647082529962063
vertebrates O 0 0.036182306706905365
predicts O 0 0.05347982794046402
that O 0 0.013102217577397823
pathological O 1 0.6587141156196594
missense O 1 0.9733489155769348
mutations O 1 0.7341698408126831
should O 0 0.00848039798438549
in O 0 0.0049493876285851
fact O 0 0.006212118547409773
be O 0 0.003373879473656416
common O 0 0.007209494709968567
even O 0 0.005068150348961353
though O 0 0.005196260288357735
they O 0 0.0033646051306277514
are O 0 0.004449950996786356
hardly O 0 0.015914559364318848
ever O 0 0.010020437650382519
seen O 0 0.013289609923958778
in O 0 0.01331245806068182
aniridia B-Disease 1 0.9980733394622803
patients O 1 0.9985330104827881
. O 0 0.03233965113759041

This O 0 0.017247360199689865
indicates O 0 0.020510058850049973
that O 0 0.0059969862923026085
there O 0 0.0046156588941812515
is O 0 0.004772023297846317
a O 0 0.008171137422323227
heavy O 0 0.021583328023552895
ascertainment O 0 0.349631130695343
bias O 0 0.0313698947429657
in O 0 0.006455340422689915
the O 0 0.005343732424080372
selection O 0 0.009275425225496292
of O 0 0.006909345276653767
patients O 1 0.9814977645874023
for O 0 0.012257602997124195
PAX6 O 1 0.9979162812232971
mutation O 1 0.5115431547164917
analysis O 0 0.016166457906365395
and O 0 0.006576805375516415
that O 0 0.0067495787516236305
the O 0 0.0102699538692832
missing O 0 0.034758519381284714
PAX6 O 1 0.997426450252533
missense O 1 0.9864857196807861
mutations O 1 0.9575472474098206
frequently O 0 0.043746788054704666
may O 0 0.034295134246349335
underlie O 1 0.8321341872215271
phenotypes O 1 0.6568655371665955
distinct O 0 0.038075465708971024
from O 0 0.01916627027094364
textbook O 0 0.06935109198093414
aniridia B-Disease 1 0.9504837989807129
. O 0 0.04291180148720741

Here O 0 0.02223602682352066
we O 0 0.011080658063292503
present O 0 0.012902605347335339
four O 0 0.01396838016808033
novel O 0 0.03500881791114807
PAX6 O 1 0.9963189363479614
missense O 1 0.9379628896713257
mutations O 0 0.3722115457057953
, O 0 0.00951419211924076
two O 0 0.005804893095046282
in O 0 0.007636451628059149
association O 0 0.018446141853928566
with O 0 0.013199150562286377
atypical O 1 0.9956175088882446
phenotypes O 1 0.9933213591575623
ectopia B-Disease 1 0.9891049265861511
pupillae I-Disease 1 0.950897216796875
( O 0 0.024747774004936218
displaced B-Disease 0 0.04535248503088951
pupils I-Disease 0 0.03672412782907486
) O 0 0.017760656774044037
and O 0 0.015397990122437477
congenital B-Disease 1 0.999988317489624
nystagmus I-Disease 1 0.9997214674949646
( O 0 0.023852264508605003
searching B-Disease 0 0.025474319234490395
gaze I-Disease 0 0.036822836846113205
) O 0 0.008402863517403603
, O 0 0.003950966522097588
and O 0 0.003030443098396063
two O 0 0.0031852363608777523
in O 0 0.004191583953797817
association O 0 0.010928742587566376
with O 0 0.007978448644280434
more O 0 0.011805295944213867
recognizable O 0 0.05899885296821594
aniridia B-Disease 1 0.9822225570678711
phenotypes O 1 0.8981180191040039
. O 0 0.04714762791991234

Strikingly O 0 0.06315574049949646
, O 0 0.012268160469830036
all O 0 0.006777903065085411
four O 0 0.00840219296514988
mutations O 0 0.03394264355301857
are O 0 0.0048387921415269375
located O 0 0.007670075632631779
within O 0 0.006169816479086876
the O 0 0.0075488160364329815
PAX6 O 1 0.8176229000091553
paired O 0 0.034337036311626434
domain O 0 0.019746266305446625
and O 0 0.007855566218495369
affect O 0 0.01897585019469261
amino O 0 0.019817430526018143
acids O 0 0.016500435769557953
which O 0 0.0049854242242872715
are O 0 0.0035616084933280945
highly O 0 0.008210581727325916
conserved O 0 0.010974613018333912
in O 0 0.0048436070792376995
all O 0 0.005121687892824411
known O 0 0.011936203576624393
paired O 0 0.035271283239126205
domain O 0 0.03450151905417442
proteins O 0 0.04113347455859184
. O 0 0.02661934122443199

Our O 0 0.024069465696811676
results O 0 0.017445474863052368
support O 0 0.011454707011580467
the O 0 0.00599152036011219
hypothesis O 0 0.016510777175426483
that O 0 0.004014845937490463
the O 0 0.0040728370659053326
under O 0 0.0065737213008105755
- O 0 0.018951240926980972
representation O 0 0.012524074874818325
of O 0 0.009050806984305382
missense O 1 0.8333741426467896
mutations O 1 0.7663804292678833
is O 0 0.012658027932047844
caused O 0 0.03356514871120453
by O 0 0.010996490716934204
ascertainment O 1 0.790509819984436
bias O 0 0.044597260653972626
and O 0 0.008463419042527676
suggest O 0 0.011576215736567974
that O 0 0.004417543765157461
a O 0 0.00672195153310895
substantial O 0 0.013740705326199532
burden O 0 0.06572224944829941
of O 0 0.011499788612127304
PAX6 B-Disease 1 0.9999138116836548
- I-Disease 1 0.9927101135253906
related I-Disease 1 0.6270180940628052
disease I-Disease 1 0.9998770952224731
remains O 0 0.010998554527759552
to O 0 0.005570788402110338
be O 0 0.005207809153944254
uncovered O 0 0.021263327449560165
. O 0 0.012474329210817814
. O 0 0.020440608263015747

The O 0 0.02943437732756138
chromosomal O 0 0.10052593052387238
order O 0 0.016643550246953964
of O 0 0.01081188302487135
genes O 0 0.038614772260189056
controlling O 0 0.034862857311964035
the O 0 0.01030809711664915
major O 0 0.01934751868247986
histocompatibility O 1 0.9923825860023499
complex O 0 0.024188008159399033
, O 0 0.012304210104048252
properdin O 0 0.47145459055900574
factor O 0 0.03178765997290611
B O 0 0.0335775688290596
, O 0 0.006919931620359421
and O 0 0.007169418036937714
deficiency B-Disease 1 0.9996185302734375
of I-Disease 0 0.00582739757373929
the I-Disease 0 0.005701056215912104
second I-Disease 0 0.008197286166250706
component I-Disease 0 0.018375856801867485
of I-Disease 0 0.008252340368926525
complement I-Disease 0 0.03733251616358757
. O 0 0.023028990253806114

The O 0 0.019141215831041336
relationship O 0 0.02423374354839325
of O 0 0.0074774338863790035
the O 0 0.010674946941435337
genes O 0 0.04279809817671776
coding O 0 0.043830517679452896
for O 0 0.009925068356096745
HLA O 1 0.898501455783844
to O 0 0.00917674321681261
those O 0 0.009200750850141048
coding O 0 0.03767446428537369
for O 0 0.010552001185715199
properdin O 0 0.29757872223854065
Factor O 0 0.037535540759563446
B O 0 0.04653052240610123
allotypes O 0 0.07011865824460983
and O 0 0.006549988407641649
for O 0 0.00692536449059844
deficiency B-Disease 1 0.9994463324546814
of I-Disease 0 0.0045197512954473495
the I-Disease 0 0.004121836274862289
second I-Disease 0 0.007385788019746542
component I-Disease 0 0.01155176479369402
of I-Disease 0 0.005406999494880438
complement I-Disease 0 0.02187330089509487
( O 0 0.015186565928161144
C2 O 1 0.982316792011261
) O 0 0.008151751942932606
was O 0 0.004829570185393095
studied O 0 0.006781930103898048
in O 0 0.004105690401047468
families O 0 0.009480893611907959
of O 0 0.006764113437384367
patients O 1 0.9996320009231567
with O 0 0.03052251785993576
connective O 1 0.999950647354126
tissue O 1 0.9998565912246704
disorders O 1 0.9999687671661377
. O 0 0.05163168907165527

Patients O 1 0.9560309052467346
were O 0 0.010348858311772346
selected O 0 0.010917697101831436
because O 0 0.007553569506853819
they O 0 0.004715280141681433
were O 0 0.005844738334417343
heterozygous O 0 0.04041021689772606
or O 0 0.01781810261309147
homozygous O 0 0.27548253536224365
for O 0 0.02724154107272625
C2 B-Disease 1 0.9999895095825195
deficiency I-Disease 1 0.9999969005584717
. O 0 0.04968427121639252

12 O 0 0.038765959441661835
families O 0 0.029683539643883705
with O 0 0.016835803166031837
15 O 0 0.021878113970160484
matings O 0 0.4677444100379944
informative O 0 0.052309099584817886
for O 0 0.022658072412014008
C2 B-Disease 1 0.9999868869781494
deficiency I-Disease 1 0.9999933242797852
were O 0 0.016570644453167915
found O 0 0.02016534097492695
. O 0 0.024915220215916634

Of O 0 0.02236315980553627
57 O 0 0.04062843695282936
informative O 0 0.0411628820002079
meioses O 0 0.060721296817064285
, O 0 0.00967682246118784
two O 0 0.006389822345227003
crossovers O 0 0.023021137341856956
were O 0 0.005316480062901974
noted O 0 0.00722719868645072
between O 0 0.009041397832334042
the O 0 0.012696166522800922
C2 B-Disease 1 0.9999943971633911
deficiency I-Disease 1 0.9999986886978149
gene O 1 0.5007142424583435
and O 0 0.009653408080339432
the O 0 0.012471792288124561
HLA O 1 0.9994852542877197
- O 0 0.33687788248062134
B O 0 0.05517751723527908
gene O 0 0.03692294657230377
, O 0 0.0069718617014586926
with O 0 0.006328189745545387
a O 0 0.010642283596098423
recombinant O 0 0.04687895625829697
fraction O 0 0.025662992149591446
of O 0 0.012331058271229267
0 O 0 0.0391465425491333
. O 0 0.025611985474824905

035 O 1 0.8119058012962341
. O 0 0.09792483597993851

A O 0 0.04501889646053314
lod O 0 0.10521073639392853
score O 0 0.016816137358546257
of O 0 0.006640703417360783
13 O 0 0.01059309858828783
was O 0 0.006652182433754206
calculated O 0 0.015480396337807178
for O 0 0.00894354097545147
linkage O 1 0.6381579637527466
between O 0 0.08372550457715988
C2 B-Disease 1 0.9999983310699463
deficiency I-Disease 1 0.9999994039535522
and O 0 0.032182734459638596
HLA O 1 0.999874472618103
- O 0 0.24593809247016907
B O 0 0.037121646106243134
at O 0 0.0084784971550107
a O 0 0.00688873091712594
maximum O 0 0.011204340495169163
likelihood O 0 0.017425591126084328
value O 0 0.006747591309249401
of O 0 0.004243123810738325
the O 0 0.006488447077572346
recombinant O 0 0.04823613539338112
fraction O 0 0.02705453708767891
of O 0 0.013304605148732662
0 O 0 0.04023323580622673
. O 0 0.022417794913053513

04 O 1 0.5468120574951172
. O 0 0.07375454157590866

18 O 0 0.03352263942360878
families O 0 0.023682497441768646
with O 0 0.011534378863871098
21 O 0 0.018651967868208885
informative O 0 0.027865856885910034
matings O 0 0.062407802790403366
for O 0 0.009928334504365921
both O 0 0.012515561655163765
properdin O 0 0.22964021563529968
Factor O 0 0.050605408847332
B O 0 0.06296868622303009
allotype O 0 0.4699071943759918
and O 0 0.015741651877760887
HLA O 1 0.9988585710525513
- O 0 0.16042686998844147
B O 0 0.04520540311932564
were O 0 0.011403379030525684
found O 0 0.019039371982216835
. O 0 0.020732929930090904

Of O 0 0.02737320587038994
72 O 0 0.05173654854297638
informative O 0 0.043518126010894775
meioses O 0 0.06375286728143692
, O 0 0.009813318960368633
three O 0 0.008134691044688225
recombinants O 0 0.0365658774971962
were O 0 0.005343722645193338
found O 0 0.0066550434567034245
, O 0 0.005678966641426086
giving O 0 0.01081813219934702
a O 0 0.009444762021303177
recombinant O 0 0.044471949338912964
fraction O 0 0.025579720735549927
of O 0 0.012165333144366741
0 O 0 0.030520150437951088
. O 0 0.01998123899102211

042 O 0 0.3971988558769226
. O 0 0.08398561179637909

A O 0 0.04041615128517151
lod O 0 0.10032524913549423
score O 0 0.018126066774129868
of O 0 0.007525296416133642
16 O 0 0.013346944004297256
between O 0 0.014669897966086864
HLA O 1 0.9989173412322998
- O 0 0.1435343325138092
B O 0 0.040879104286432266
and O 0 0.010398848913609982
Factor O 0 0.02726866863667965
B O 0 0.03399963676929474
allotypes O 0 0.04314986616373062
was O 0 0.0067186602391302586
calculated O 0 0.009395895525813103
at O 0 0.006002002861350775
a O 0 0.005842532962560654
maximum O 0 0.010747596621513367
likelihood O 0 0.015157653018832207
value O 0 0.005825341679155827
of O 0 0.004216691013425589
the O 0 0.006516001187264919
recombinant O 0 0.04105447977781296
fraction O 0 0.02406909316778183
of O 0 0.010619333945214748
0 O 0 0.036661505699157715
. O 0 0.022951504215598106

04 O 0 0.4959375262260437
. O 0 0.06777966767549515

A O 0 0.02963966317474842
crossover O 0 0.038405656814575195
was O 0 0.009547037072479725
shown O 0 0.010012341663241386
to O 0 0.005234408192336559
have O 0 0.005389490630477667
occurred O 0 0.012164897285401821
between O 0 0.008100113831460476
genes O 0 0.019915279000997543
for O 0 0.0065391347743570805
Factor O 0 0.024665096774697304
B O 0 0.05060013011097908
and O 0 0.010175439529120922
HLA O 1 0.9998026490211487
- O 1 0.5827414989471436
D O 0 0.37268298864364624
, O 0 0.009637846611440182
in O 0 0.007434756960719824
which O 0 0.011808795854449272
HLA O 1 0.9994221925735474
- O 1 0.7925518155097961
D O 1 0.9390837550163269
segregared O 1 0.7180993556976318
with O 0 0.019204549491405487
HLA O 1 0.9983419179916382
- O 0 0.04623609408736229
A O 0 0.015145913697779179
and O 0 0.013088061474263668
B O 0 0.05036519840359688
. O 0 0.023146647959947586

These O 0 0.02100297622382641
studies O 0 0.022130390629172325
suggest O 0 0.017703887075185776
that O 0 0.005787806585431099
the O 0 0.006671170704066753
genes O 0 0.0239073745906353
for O 0 0.008440005593001842
Factor O 0 0.0467250756919384
B O 0 0.41711878776550293
and O 0 0.01673446036875248
C2 B-Disease 1 0.9999929666519165
deficiency I-Disease 1 0.9999942779541016
are O 0 0.00677869888022542
located O 0 0.007768494077026844
outside O 0 0.005450212862342596
those O 0 0.0044461581856012344
for O 0 0.004361315164715052
HLA O 1 0.9595179557800293
, O 0 0.004315847530961037
that O 0 0.0027897947002202272
the O 0 0.0032461362425237894
order O 0 0.004735157825052738
of O 0 0.0056152259930968285
genese O 0 0.13643348217010498
is O 0 0.01045067235827446
HLA O 1 0.9974683523178101
- O 0 0.03270244598388672
A O 0 0.010076302103698254
, O 0 0.008451634086668491
- O 0 0.038925882428884506
B O 0 0.03666004538536072
, O 0 0.01007886789739132
- O 0 0.11600615084171295
D O 1 0.5066922307014465
, O 0 0.014371625147759914
Factor O 0 0.04319604113698006
B O 0 0.23279023170471191
allotype O 1 0.9668307900428772
, O 0 0.05181855708360672
C2 B-Disease 1 0.9999924898147583
deficiency I-Disease 1 0.9999949932098389
, O 0 0.011005102656781673
that O 0 0.006505499593913555
the O 0 0.007784873712807894
genes O 0 0.04073351249098778
coding O 0 0.1964118480682373
for O 0 0.01973583735525608
C2 B-Disease 1 0.9999922513961792
deficiency I-Disease 1 0.9999970197677612
and O 0 0.01783810928463936
Factor O 0 0.04181136190891266
B O 0 0.0452713742852211
allotypes O 0 0.05253397300839424
are O 0 0.006887954194098711
approximately O 0 0.010806727223098278
3 O 0 0.014105508103966713
- O 0 0.0310655664652586
- O 0 0.03273911774158478
5 O 0 0.016730256378650665
centimorgans O 0 0.04458083584904671
from O 0 0.010122112929821014
the O 0 0.011369670741260052
HLA O 1 0.9984138011932373
- O 0 0.0536261610686779
A O 0 0.013905731961131096
and O 0 0.011499300599098206
HLA O 1 0.9993793964385986
- O 0 0.4253723621368408
B O 0 0.09143780171871185
loci O 0 0.06981725990772247
, O 0 0.006189169827848673
and O 0 0.003782021114602685
that O 0 0.0037230311427265406
the O 0 0.004562066867947578
apparent O 0 0.01632167585194111
lack O 0 0.012727716006338596
of O 0 0.006629998330026865
recombinants O 0 0.03710666671395302
between O 0 0.009260069578886032
the O 0 0.009491538628935814
Factor O 0 0.062053319066762924
B O 0 0.4521041512489319
gene O 1 0.8532986044883728
and O 0 0.056471940129995346
C2 B-Disease 1 0.9999970197677612
deficiency I-Disease 1 0.9999991655349731
gene O 1 0.7806464433670044
suggests O 0 0.023242931813001633
that O 0 0.005571644753217697
these O 0 0.0043790629133582115
two O 0 0.005332147236913443
genes O 0 0.020198578014969826
lie O 0 0.013027073815464973
in O 0 0.005560015793889761
close O 0 0.008926705457270145
proximity O 0 0.01631304994225502
to O 0 0.006151624955236912
one O 0 0.007616465445607901
another O 0 0.014421422965824604
. O 0 0.020183885470032692

Distribution O 0 0.03912874311208725
of O 0 0.01520564779639244
emerin O 0 0.07783180475234985
and O 0 0.013983073644340038
lamins O 1 0.5690674781799316
in O 0 0.00905523356050253
the O 0 0.008578287437558174
heart O 0 0.1508837789297104
and O 0 0.00842802319675684
implications O 0 0.03069658763706684
for O 0 0.01255930494517088
Emery B-Disease 1 0.9903682470321655
- I-Disease 1 0.9966492056846619
Dreifuss I-Disease 1 0.999854564666748
muscular I-Disease 1 0.9999454021453857
dystrophy I-Disease 1 0.99998939037323
. O 0 0.06560464948415756

Emerin O 0 0.13711586594581604
is O 0 0.01716008596122265
a O 0 0.014291999861598015
nuclear O 0 0.022060835734009743
membrane O 0 0.03135122358798981
protein O 0 0.020979592576622963
which O 0 0.006128698121756315
is O 0 0.006627973634749651
missing O 0 0.014204406179487705
or O 0 0.010235010646283627
defective O 1 0.6783180236816406
in O 0 0.01409109216183424
Emery B-Disease 1 0.9965367317199707
- I-Disease 1 0.9988369345664978
Dreifuss I-Disease 1 0.9999372959136963
muscular I-Disease 1 0.9999822378158569
dystrophy I-Disease 1 0.9999980926513672
( O 1 0.5781294107437134
EDMD B-Disease 1 0.9974855184555054
) O 0 0.0390789732336998
. O 0 0.02724207192659378

It O 0 0.012544294819235802
is O 0 0.007089430000633001
one O 0 0.004053128883242607
member O 0 0.005017711315304041
of O 0 0.003986530005931854
a O 0 0.005433182697743177
family O 0 0.009373332373797894
of O 0 0.007279074750840664
lamina O 1 0.9847835898399353
- O 0 0.04573940113186836
associated O 0 0.01718687079846859
proteins O 0 0.018542511388659477
which O 0 0.006706835236400366
includes O 0 0.011414981447160244
LAP1 O 0 0.17497287690639496
, O 0 0.011591835878789425
LAP2 O 0 0.3579174876213074
and O 0 0.01663229800760746
lamin O 1 0.9782739281654358
B O 1 0.6431360244750977
receptor O 1 0.8678602576255798
( O 0 0.04202796518802643
LBR O 1 0.9933298230171204
) O 0 0.03400839865207672
. O 0 0.026779239997267723

A O 0 0.03204238414764404
panel O 0 0.03201373666524887
of O 0 0.013738987036049366
16 O 0 0.029195021837949753
monoclonal O 1 0.8354262113571167
antibodies O 1 0.9026930332183838
( O 0 0.03057781048119068
mAbs O 1 0.5660583972930908
) O 0 0.013282683677971363
has O 0 0.006034829653799534
been O 0 0.004519886802881956
mapped O 0 0.011844717897474766
to O 0 0.004178126808255911
six O 0 0.004782052244991064
specific O 0 0.006798865273594856
sites O 0 0.0076928832568228245
throughout O 0 0.00811461266130209
the O 0 0.00767395319417119
emerin O 0 0.08418447524309158
molecule O 0 0.03773876652121544
using O 0 0.017465006560087204
phage O 1 0.9732378125190735
- O 0 0.043056268244981766
displayed O 0 0.020238317549228668
peptide O 0 0.03712588921189308
libraries O 0 0.010528182610869408
and O 0 0.003980129491537809
has O 0 0.004356560297310352
been O 0 0.004075384698808193
used O 0 0.004966340959072113
to O 0 0.005817041266709566
localize O 0 0.05169598013162613
emerin O 0 0.05262579768896103
in O 0 0.008218145929276943
human O 0 0.016023192554712296
and O 0 0.013226175680756569
rabbit O 1 0.951317548751831
heart O 1 0.9288160800933838
. O 0 0.028633445501327515

Several O 0 0.038740552961826324
mAbs O 0 0.28089088201522827
against O 0 0.025667648762464523
different O 0 0.01863056607544422
emerin O 0 0.48370057344436646
epitopes O 0 0.34573930501937866
did O 0 0.014195994473993778
not O 0 0.008858350105583668
recognize O 0 0.020735999569296837
intercalated O 0 0.08408121764659882
discs O 0 0.018770964816212654
in O 0 0.00600407924503088
the O 0 0.006929031107574701
heart O 0 0.10961105674505234
, O 0 0.006166887003928423
though O 0 0.005972777958959341
they O 0 0.004500302020460367
recognized O 0 0.01271313987672329
cardiomyocyte O 0 0.10011229664087296
nuclei O 0 0.030103718861937523
strongly O 0 0.010368137620389462
, O 0 0.004783435259014368
both O 0 0.0044274721294641495
at O 0 0.005068876314908266
the O 0 0.004595180973410606
rim O 0 0.024067360907793045
and O 0 0.006494936533272266
in O 0 0.008980954997241497
intranuclear O 0 0.09195861220359802
spots O 0 0.03555795177817345
or O 0 0.019998598843812943
channels O 0 0.03622747212648392
. O 0 0.023657795041799545

A O 0 0.08164741098880768
polyclonal O 1 0.9659292697906494
rabbit O 1 0.9505733251571655
antiserum O 1 0.8484095931053162
against O 0 0.032270777970552444
emerin O 0 0.11062132567167282
did O 0 0.015461817383766174
recognize O 0 0.019855182617902756
both O 0 0.009005934931337833
nuclear O 0 0.014851399697363377
membrane O 0 0.0222149770706892
and O 0 0.00799250416457653
intercalated O 0 0.1064249724149704
discs O 0 0.020777840167284012
but O 0 0.006829774472862482
, O 0 0.005991258658468723
after O 0 0.008204049430787563
affinity O 0 0.02826550230383873
purification O 0 0.02482008934020996
against O 0 0.008708144538104534
a O 0 0.008922449313104153
pure O 0 0.01708732731640339
- O 0 0.03125372529029846
emerin O 0 0.04923263564705849
band O 0 0.011395415291190147
on O 0 0.004513634834438562
a O 0 0.006248538848012686
western O 0 0.010836860164999962
blot O 0 0.03940041363239288
, O 0 0.006792393047362566
it O 0 0.005404905416071415
stained O 0 0.02978966012597084
only O 0 0.005970948841422796
the O 0 0.007260226644575596
nuclear O 0 0.02094969153404236
membrane O 0 0.04633158817887306
. O 0 0.02391132153570652

These O 0 0.015257315710186958
results O 0 0.014082305133342743
would O 0 0.006253758445382118
not O 0 0.004292339086532593
be O 0 0.003931551706045866
expected O 0 0.006118424702435732
if O 0 0.007503173779696226
immunostaining O 0 0.04147794842720032
at O 0 0.007969659753143787
intercalated O 0 0.0457565002143383
discs O 0 0.013376262038946152
were O 0 0.0037957713939249516
due O 0 0.005215927958488464
to O 0 0.003273329231888056
a O 0 0.0037549035623669624
product O 0 0.006005923729389906
of O 0 0.003877567360177636
the O 0 0.005972449202090502
emerin O 0 0.24017208814620972
gene O 0 0.02928209863603115
and O 0 0.00504168588668108
, O 0 0.004649991635233164
therefore O 0 0.005084546282887459
, O 0 0.003896695328876376
cast O 0 0.006463713012635708
some O 0 0.0044379811733961105
doubt O 0 0.009643328376114368
upon O 0 0.0060128564946353436
the O 0 0.006075131706893444
hypothesis O 0 0.029532475396990776
that O 0 0.0122482655569911
cardiac B-Disease 1 0.9999727010726929
defects I-Disease 1 0.999281108379364
in O 0 0.010517159476876259
EDMD B-Disease 1 0.9976734519004822
are O 0 0.00725320540368557
caused O 0 0.01766088418662548
by O 0 0.006480497308075428
absence O 0 0.014451151713728905
of O 0 0.008072354830801487
emerin O 0 0.09390338510274887
from O 0 0.013714835979044437
intercalated O 0 0.2835994362831116
discs O 0 0.051902104169130325
. O 0 0.02869478240609169

Although O 0 0.0339006632566452
emerin O 0 0.06938692182302475
was O 0 0.011454403400421143
abundant O 0 0.016189051792025566
in O 0 0.006381719373166561
the O 0 0.0067505124025046825
membranes O 0 0.030172007158398628
of O 0 0.007915472611784935
cardiomyocyte O 0 0.12813366949558258
nuclei O 0 0.029700864106416702
, O 0 0.006370079703629017
it O 0 0.00411212956532836
was O 0 0.005191559437662363
absent O 0 0.01566602848470211
from O 0 0.006182123441249132
many O 0 0.006329989526420832
non O 0 0.02062339521944523
- O 0 0.45956283807754517
myocyte O 1 0.996941864490509
cells O 0 0.07704583555459976
in O 0 0.010386570356786251
the O 0 0.012082704342901707
heart O 0 0.44189298152923584
. O 0 0.028415871784090996

This O 0 0.018097063526511192
distribution O 0 0.018418092280626297
of O 0 0.008555745705962181
emerin O 0 0.04008685424923897
was O 0 0.005821764934808016
similar O 0 0.006475856527686119
to O 0 0.003601622302085161
that O 0 0.003204819280654192
of O 0 0.004507896490395069
lamin O 0 0.05431731045246124
A O 0 0.0073898653499782085
, O 0 0.0045436955988407135
a O 0 0.00575234042480588
candidate O 0 0.011020948179066181
gene O 0 0.026136862114071846
for O 0 0.006404594983905554
an O 0 0.00925078708678484
autosomal O 1 0.9732391238212585
form O 0 0.022085795179009438
of O 0 0.01452051941305399
EDMD B-Disease 1 0.9878126978874207
. O 0 0.03560939431190491

In O 0 0.03556019440293312
contrast O 0 0.05427303537726402
, O 0 0.026277052238583565
lamin O 1 0.9893848299980164
B1 O 1 0.9975142478942871
was O 0 0.01821654476225376
absent O 0 0.03131059929728508
from O 0 0.014331829734146595
cardiomyocyte O 0 0.24513952434062958
nuclei O 0 0.0378178134560585
, O 0 0.009583882056176662
showing O 0 0.01624985970556736
that O 0 0.011156737804412842
lamin O 1 0.967477023601532
B1 O 1 0.99186110496521
is O 0 0.007232585921883583
not O 0 0.0038609933108091354
essential O 0 0.006942884065210819
for O 0 0.0043265242129564285
localization O 0 0.018598904833197594
of O 0 0.005801547318696976
emerin O 0 0.03762762248516083
to O 0 0.007167836185544729
the O 0 0.009315410628914833
nuclear O 0 0.029573921114206314
lamina O 1 0.7362013459205627
. O 0 0.030268466100096703

Lamin O 1 0.9880240559577942
B1 O 1 0.9895550012588501
is O 0 0.019354090094566345
also O 0 0.01050975825637579
almost O 0 0.012026938609778881
completely O 0 0.019052013754844666
absent O 0 0.033826932311058044
from O 0 0.01730533316731453
skeletal O 1 0.9955280423164368
muscle O 1 0.9970748424530029
nuclei O 0 0.23826561868190765
. O 0 0.035005539655685425

In O 0 0.02714603766798973
EDMD B-Disease 1 0.6408355236053467
, O 0 0.011434977874159813
the O 0 0.006978778168559074
additional O 0 0.011484826914966106
absence O 0 0.01902330480515957
of O 0 0.012282121926546097
lamin O 1 0.9977606534957886
B1 O 1 0.999674916267395
from O 0 0.018289893865585327
heart O 1 0.9059581160545349
and O 0 0.012095870450139046
skeletal O 1 0.9949554800987244
muscle O 1 0.9978965520858765
nuclei O 0 0.056883737444877625
which O 0 0.008934712037444115
already O 0 0.012572516687214375
lack O 0 0.017475511878728867
emerin O 0 0.2197805941104889
may O 0 0.011131657287478447
offer O 0 0.00970714632421732
an O 0 0.005603916477411985
alternative O 0 0.011819306761026382
explanation O 0 0.011043981648981571
of O 0 0.004996458534151316
why O 0 0.010495596565306187
these O 0 0.006042906548827887
tissues O 0 0.030771031975746155
are O 0 0.0065762815065681934
particularly O 0 0.01380129437893629
affected O 0 0.02245897427201271
. O 0 0.012332933954894543
. O 0 0.020867666229605675

Genetic O 0 0.11222025007009506
mapping O 0 0.05143659561872482
of O 0 0.01550876535475254
the O 0 0.01595008373260498
copper B-Disease 0 0.06219051405787468
toxicosis I-Disease 1 0.9873812198638916
locus O 0 0.09606436640024185
in O 0 0.022388821467757225
Bedlington O 1 0.9086313247680664
terriers O 0 0.2000499963760376
to O 0 0.01683984510600567
dog O 0 0.04576551541686058
chromosome O 0 0.06388810276985168
10 O 0 0.010265630669891834
, O 0 0.005850107409060001
in O 0 0.004950209520757198
a O 0 0.0073306686244904995
region O 0 0.017575714737176895
syntenic O 0 0.05837393179535866
to O 0 0.009481493383646011
human O 0 0.01994645968079567
chromosome O 0 0.4994228780269623
region O 0 0.04980112612247467
2p13 O 1 0.8224239349365234
- O 1 0.5815964937210083
p16 O 1 0.9026755094528198
. O 0 0.04854418709874153

Abnormal O 1 0.9995717406272888
hepatic B-Disease 1 0.9999620914459229
copper I-Disease 1 0.7265361547470093
accumulation I-Disease 0 0.3811272382736206
is O 0 0.010767320170998573
recognized O 0 0.009914049878716469
as O 0 0.005677044857293367
an O 0 0.009354532696306705
inherited B-Disease 1 0.9995624423027039
disorder I-Disease 1 0.9999774694442749
in O 0 0.011429744772613049
man O 0 0.017868677154183388
, O 0 0.010310474783182144
mouse O 0 0.059889569878578186
, O 0 0.014869984239339828
rat O 0 0.34807083010673523
and O 0 0.014188517816364765
dog O 0 0.06472548842430115
. O 0 0.0268331840634346

The O 0 0.02007819525897503
major O 0 0.0213124081492424
cause O 0 0.18674081563949585
of O 0 0.015510615892708302
hepatic B-Disease 1 0.9999443292617798
copper I-Disease 0 0.4998292028903961
accumulation I-Disease 0 0.18662486970424652
in O 0 0.009782901965081692
man O 0 0.015887174755334854
is O 0 0.009941673837602139
a O 0 0.012468903325498104
dysfunctional O 1 0.8640025854110718
ATP7B O 1 0.9931373596191406
gene O 1 0.7795382738113403
, O 0 0.020748330280184746
causing O 1 0.9813848733901978
Wilson B-Disease 1 0.9918307662010193
disease I-Disease 1 0.9999797344207764
( O 0 0.22289685904979706
WD B-Disease 1 0.9993740916252136
) O 0 0.03386430814862251
. O 0 0.024003177881240845

Mutations O 0 0.3154127597808838
in O 0 0.015493150800466537
the O 0 0.012867921032011509
ATP7B O 0 0.44244763255119324
genes O 0 0.03180563822388649
have O 0 0.007004315499216318
also O 0 0.005445553921163082
been O 0 0.005395551677793264
demonstrated O 0 0.012149093672633171
in O 0 0.007431358564645052
mouse O 0 0.04350074380636215
and O 0 0.01398733351379633
rat O 0 0.4642537534236908
. O 0 0.026390688493847847

The O 0 0.03132852539420128
ATP7B O 0 0.44868215918540955
gene O 0 0.056936442852020264
has O 0 0.010986652225255966
been O 0 0.007036326453089714
excluded O 0 0.012536642141640186
in O 0 0.005121723748743534
the O 0 0.005434314254671335
much O 0 0.009115088731050491
rarer O 1 0.6828157901763916
human O 0 0.07184751331806183
copper B-Disease 1 0.9881035685539246
overload I-Disease 1 0.999897837638855
disease O 1 0.9999772310256958
non B-Disease 0 0.21055801212787628
- I-Disease 1 0.7789590358734131
Indian I-Disease 0 0.03747024014592171
childhood I-Disease 1 0.9949344992637634
cirrhosis I-Disease 1 0.9998487234115601
, O 0 0.02539304457604885
indicating O 0 0.04890797287225723
genetic O 0 0.22848835587501526
heterogeneity O 0 0.3390667736530304
. O 0 0.042003434151411057

By O 0 0.0274635199457407
investigating O 0 0.03943650424480438
the O 0 0.018858376890420914
common O 0 0.05887968838214874
autosomal O 1 0.999829888343811
recessive O 1 0.9999107122421265
copper B-Disease 1 0.9965378046035767
toxicosis I-Disease 1 0.9997674822807312
( O 0 0.08364987373352051
CT B-Disease 1 0.9936484694480896
) O 0 0.022267885506153107
in O 0 0.01223142072558403
Bedlington O 1 0.9262206554412842
terriers O 0 0.21262261271476746
, O 0 0.008193960413336754
we O 0 0.004879701416939497
have O 0 0.005226116627454758
identified O 0 0.008610466495156288
a O 0 0.006535372231155634
new O 0 0.009083947166800499
locus O 0 0.046634241938591
involved O 0 0.02057427167892456
in O 0 0.01772763580083847
progressive O 1 0.9981548190116882
liver B-Disease 1 0.9999979734420776
disease I-Disease 1 0.9999939203262329
. O 0 0.04734358191490173

We O 0 0.028174174949526787
examined O 0 0.03718240559101105
whether O 0 0.01799839548766613
the O 0 0.016169939190149307
WD B-Disease 1 0.9992557168006897
gene O 0 0.1989770233631134
ATP7B O 1 0.5236706733703613
was O 0 0.009821513667702675
also O 0 0.008989132009446621
causative O 0 0.0919664204120636
for O 0 0.010578181594610214
CT B-Disease 1 0.8795207142829895
by O 0 0.008834251202642918
investigating O 0 0.01797427050769329
the O 0 0.01207653060555458
chromosomal O 1 0.7143211364746094
co O 0 0.16894887387752533
- O 0 0.04943237081170082
localization O 0 0.03642004728317261
of O 0 0.00939737819135189
ATP7B O 0 0.16086353361606598
and O 0 0.009731562808156013
C04107 O 0 0.04538777098059654
, O 0 0.009919432923197746
using O 0 0.013523991219699383
fluorescence O 0 0.05260840058326721
in O 0 0.014821361750364304
situ O 0 0.1300181746482849
hybridization O 0 0.0725870355963707
( O 0 0.02466639131307602
FISH O 0 0.029643090441823006
) O 0 0.025248253718018532
. O 0 0.02480451576411724

C04107 O 0 0.13594549894332886
is O 0 0.01984219439327717
an O 0 0.016980981454253197
anonymous O 0 0.046207692474126816
microsatellite O 0 0.26161909103393555
marker O 0 0.05852747708559036
closely O 0 0.030810130760073662
linked O 0 0.048963263630867004
to O 0 0.020217744633555412
CT B-Disease 1 0.9728015661239624
. O 0 0.036205992102622986

However O 0 0.037289299070835114
, O 0 0.02785419300198555
BAC O 1 0.6665369868278503
clones O 0 0.0787309780716896
containing O 0 0.02618739753961563
ATP7B O 0 0.19026008248329163
and O 0 0.013274374417960644
C04107 O 0 0.04989442601799965
mapped O 0 0.025388259440660477
to O 0 0.009569350630044937
the O 0 0.012100395746529102
canine O 1 0.6053138971328735
chromosome O 0 0.43790775537490845
regions O 0 0.03537208214402199
CFA22q11 O 0 0.19128920137882233
and O 0 0.011237076483666897
CFA10q26 O 0 0.09433344751596451
, O 0 0.008792665787041187
respectively O 0 0.010195123963057995
, O 0 0.006579531356692314
demonstrating O 0 0.016516197472810745
that O 0 0.00884129386395216
WD B-Disease 1 0.9976668357849121
cannot O 0 0.014515738002955914
be O 0 0.008997384458780289
homologous O 0 0.05464768409729004
to O 0 0.018975436687469482
CT B-Disease 1 0.947310209274292
. O 0 0.03307180479168892

The O 0 0.02463352307677269
copper O 0 0.0525546669960022
transport O 0 0.03359061852097511
genes O 0 0.052942849695682526
CTR1 O 0 0.3605954945087433
and O 0 0.01235885452479124
CTR2 O 0 0.0673898458480835
were O 0 0.0055900998413562775
also O 0 0.005470765754580498
excluded O 0 0.012087145820260048
as O 0 0.004982222802937031
candidate O 0 0.010363279841840267
genes O 0 0.022467784583568573
for O 0 0.007376633584499359
CT B-Disease 1 0.8569764494895935
since O 0 0.007163917645812035
they O 0 0.004338840022683144
both O 0 0.006200460251420736
mapped O 0 0.018414977937936783
to O 0 0.011228317394852638
canine O 1 0.6450826525688171
chromosome O 1 0.7400312423706055
region O 0 0.055929094552993774
CFA11q22 O 1 0.6589497327804565
. O 0 0.03610409423708916

2 O 0 0.06162800267338753
- O 0 0.08071482181549072
22 O 0 0.044961318373680115
. O 0 0.03599785640835762

5 O 0 0.08360005915164948
. O 0 0.049153491854667664

A O 0 0.03684740141034126
transcribed O 0 0.05491366237401962
sequence O 0 0.028511231765151024
identified O 0 0.0164444949477911
from O 0 0.00883292406797409
the O 0 0.009563969448208809
C04107 O 0 0.05962458997964859
- O 0 0.03260042518377304
containing O 0 0.018225042149424553
BAC O 0 0.2722586989402771
was O 0 0.007400555070489645
found O 0 0.00628105690702796
to O 0 0.004135889001190662
be O 0 0.0037450934760272503
homologous O 0 0.02548777312040329
to O 0 0.005676105618476868
a O 0 0.008496837690472603
gene O 0 0.029784822836518288
expressed O 0 0.012249378487467766
from O 0 0.008396988734602928
human O 0 0.018070098012685776
chromosome O 1 0.7763441205024719
2p13 O 1 0.8297041058540344
- O 0 0.3260232210159302
p16 O 1 0.768069863319397
, O 0 0.010031397454440594
a O 0 0.00998602993786335
region O 0 0.018105700612068176
devoid O 0 0.02164524234831333
of O 0 0.0067777554504573345
any O 0 0.010350165888667107
positional O 0 0.04360480234026909
candidate O 0 0.030898991972208023
genes O 0 0.06784757971763611
. O 0 0.03315415605902672

Molecular O 0 0.06477288901805878
analysis O 0 0.0260009765625
of O 0 0.01003328338265419
the O 0 0.012202027253806591
APC B-Disease 0 0.19863778352737427
gene O 0 0.04287893325090408
in O 0 0.010823654010891914
205 O 0 0.03878391906619072
families O 0 0.021861247718334198
: O 0 0.01803574711084366
extended O 0 0.02638883702456951
genotype O 1 0.9880704879760742
- O 1 0.8720966577529907
phenotype O 1 0.9864639043807983
correlations O 0 0.07062550634145737
in O 0 0.013759017921984196
FAP B-Disease 1 0.9964562058448792
and O 0 0.007495710160583258
evidence O 0 0.006986608263105154
for O 0 0.0036528666969388723
the O 0 0.004469194449484348
role O 0 0.008701356127858162
of O 0 0.007572846487164497
APC B-Disease 1 0.5815193057060242
amino O 0 0.049940094351768494
acid O 1 0.6236096024513245
changes O 0 0.035608284175395966
in O 0 0.05601106584072113
colorectal B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999978542327881
predisposition O 1 0.9993021488189697
. O 0 0.055447958409786224

BACKGROUND O 0 0.08702556043863297
/ O 0 0.273179292678833
AIMS O 0 0.039614975452423096
The O 0 0.010814443230628967
development O 0 0.01769152097404003
of O 0 0.0158074963837862
colorectal B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.999982476234436
and O 0 0.01086683850735426
a O 0 0.012000552378594875
variable O 0 0.030848361551761627
range O 0 0.018193319439888
of O 0 0.011124169453978539
extracolonic O 1 0.9531188607215881
manifestations O 1 0.9636331796646118
in O 0 0.03682411462068558
familial B-Disease 1 0.9999949932098389
adenomatous I-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999994039535522
( O 1 0.8330049514770508
FAP B-Disease 1 0.9996864795684814
) O 0 0.014089476317167282
is O 0 0.004728245548903942
the O 0 0.0043397811241447926
result O 0 0.006557840388268232
of O 0 0.004351850599050522
the O 0 0.0059819938614964485
dominant O 0 0.03561621531844139
inheritance O 1 0.7014797925949097
of O 0 0.04094716161489487
adenomatous B-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9999992847442627
coli I-Disease 1 0.9999830722808838
( O 0 0.44526612758636475
APC B-Disease 1 0.9919402003288269
) O 0 0.042408984154462814
gene O 0 0.4592142403125763
mutations O 1 0.8544456362724304
. O 0 0.042201172560453415

In O 0 0.017178576439619064
this O 0 0.009652998298406601
study O 0 0.013155695982277393
, O 0 0.007476613856852055
direct O 0 0.013825914822518826
mutation O 0 0.04448622465133667
analysis O 0 0.010397318750619888
of O 0 0.005289945751428604
the O 0 0.006448918022215366
APC B-Disease 0 0.1222108006477356
gene O 0 0.03274383395910263
was O 0 0.007538822945207357
performed O 0 0.011024759151041508
to O 0 0.00639481283724308
determine O 0 0.016050174832344055
genotype O 1 0.9097526669502258
- O 0 0.41166600584983826
phenotype O 1 0.9423236846923828
correlations O 0 0.03976840898394585
for O 0 0.008549356833100319
nine O 0 0.012396439909934998
extracolonic O 0 0.2509671747684479
manifestations O 0 0.036696139723062515
and O 0 0.005762677639722824
to O 0 0.005230958107858896
investigate O 0 0.013722892850637436
the O 0 0.007749179843813181
incidence O 1 0.8282938599586487
of O 0 0.011591077782213688
APC B-Disease 1 0.9768900871276855
mutations O 1 0.9484044313430786
in O 0 0.02046220749616623
non O 1 0.8924513459205627
- O 1 0.9997310042381287
FAP O 1 0.9999963045120239
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999924898147583
. O 0 0.06718701869249344

METHODS O 0 0.05267587676644325
The O 0 0.02412371337413788
APC B-Disease 0 0.1769811064004898
gene O 0 0.053403399884700775
was O 0 0.013257178477942944
analysed O 0 0.028359027579426765
in O 0 0.01046206895262003
190 O 0 0.031986746937036514
unrelated O 0 0.05320332571864128
FAP B-Disease 1 0.9989728927612305
and O 0 0.013020513579249382
15 O 0 0.02375616505742073
non O 1 0.8380435109138489
- O 1 0.9998807907104492
FAP O 1 0.9999983310699463
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
patients O 1 0.9998680353164673
using O 0 0.046469248831272125
denaturing O 1 0.993039608001709
gradient O 1 0.8867746591567993
gel O 1 0.9868262410163879
electrophoresis O 0 0.39195820689201355
, O 0 0.0144543731585145
the O 0 0.010940602980554104
protein O 0 0.031736861914396286
truncation O 0 0.04756943881511688
test O 0 0.017790595069527626
, O 0 0.008117699064314365
and O 0 0.007591306697577238
direct O 0 0.02177407033741474
sequencing O 0 0.04736202955245972
. O 0 0.025324765592813492

RESULTS O 0 0.06681393086910248
Chain O 0 0.06336439400911331
terminating O 0 0.0642569363117218
signals O 0 0.02847285382449627
were O 0 0.005836304277181625
only O 0 0.00494447723031044
identified O 0 0.010691317729651928
in O 0 0.00597161753103137
patients O 1 0.7124354243278503
belonging O 0 0.012622654438018799
to O 0 0.007373988162726164
the O 0 0.010353870689868927
FAP B-Disease 1 0.9985861778259277
group O 0 0.02404317632317543
( O 0 0.02054811455309391
105 O 0 0.04409351572394371
patients O 1 0.9936368465423584
) O 0 0.020584916695952415
. O 0 0.021542957052588463

Amino O 0 0.08513297140598297
acid O 0 0.06926926970481873
changes O 0 0.016043925657868385
were O 0 0.0056284526363015175
identified O 0 0.00978392269462347
in O 0 0.005011791363358498
four O 0 0.006826934404671192
patients O 1 0.6487993001937866
, O 0 0.0045273141004145145
three O 0 0.003979976288974285
of O 0 0.0035584045108407736
whom O 0 0.00875529833137989
belonged O 0 0.00946015678346157
to O 0 0.004085913300514221
the O 0 0.006287803873419762
non O 0 0.02360134944319725
- O 1 0.97223961353302
FAP O 1 0.9999251365661621
group O 0 0.46967265009880066
of O 0 0.14339964091777802
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
patients O 1 0.9998476505279541
. O 0 0.05970599502325058

Genotype O 1 0.9939727187156677
- O 1 0.9556277990341187
phenotype O 1 0.984406590461731
correlations O 0 0.08560183644294739
identified O 0 0.02241341769695282
significant O 0 0.01323949359357357
differences O 0 0.010828341357409954
in O 0 0.0048300838097929955
the O 0 0.004805795848369598
nature O 0 0.008652787655591965
of O 0 0.005372427869588137
certain O 0 0.01355593092739582
extracolonic O 1 0.8527246713638306
manifestations O 1 0.8422165513038635
in O 0 0.018372979015111923
FAP B-Disease 1 0.9998915195465088
patients O 1 0.9952860474586487
belonging O 0 0.029121680185198784
to O 0 0.012288019061088562
three O 0 0.016298379749059677
mutation O 0 0.30805766582489014
subgroups O 0 0.070189468562603
. O 0 0.029120611026883125

CONCLUSIONS O 0 0.0860021635890007
Extended O 0 0.06440906971693039
genotype O 1 0.9784084558486938
- O 1 0.7228566408157349
phenotype O 1 0.9198980331420898
correlations O 0 0.041979722678661346
made O 0 0.007970195263624191
in O 0 0.00503826467320323
this O 0 0.004011680372059345
study O 0 0.006362127140164375
may O 0 0.004787622485309839
have O 0 0.0030771102756261826
the O 0 0.0027088415808975697
potential O 0 0.007276273798197508
to O 0 0.002900685416534543
determine O 0 0.005841690581291914
the O 0 0.0043981182388961315
most O 0 0.004950590431690216
appropriate O 0 0.011106546968221664
surveillance O 0 0.018923772498965263
and O 0 0.009101144969463348
prophylactic O 1 0.9994940757751465
treatment O 1 0.9993242025375366
regimens O 1 0.9987780451774597
for O 0 0.008649483323097229
those O 0 0.01046734768897295
patients O 1 0.9986147880554199
with O 0 0.012566770426928997
mutations O 1 0.9092831611633301
associated O 0 0.017597446218132973
with O 0 0.011518936604261398
life O 0 0.019296320155262947
threatening O 0 0.372435986995697
conditions O 0 0.04631002992391586
. O 0 0.02725367248058319

This O 0 0.014925658702850342
study O 0 0.014712574891746044
also O 0 0.00555038545280695
provided O 0 0.007434235420078039
evidence O 0 0.006149811204522848
for O 0 0.004275457002222538
the O 0 0.005897573195397854
pathological O 0 0.031102800741791725
nature O 0 0.012423047795891762
of O 0 0.006230972241610289
amino O 0 0.022415027022361755
acid O 0 0.03492652252316475
changes O 0 0.01164023857563734
in O 0 0.007387305144220591
APC O 0 0.14697785675525665
associated O 0 0.0133274607360363
with O 0 0.007776804734021425
both O 0 0.011114793829619884
FAP B-Disease 1 0.9995908141136169
and O 0 0.017943909391760826
non O 1 0.9416860342025757
- O 1 0.9999344348907471
FAP O 1 0.9999994039535522
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
patients O 1 0.9999228715896606
. O 0 0.03264434263110161
. O 0 0.030445871874690056

Inherited B-Disease 1 0.9998894929885864
colorectal I-Disease 1 0.9999990463256836
polyposis I-Disease 1 0.9999973773956299
and O 1 0.6508678197860718
cancer B-Disease 1 0.999968409538269
risk O 1 0.8667293787002563
of O 0 0.013382436707615852
the O 0 0.016726521775126457
APC O 1 0.7773526310920715
I1307K O 0 0.4848986566066742
polymorphism O 0 0.13062632083892822
. O 0 0.04061480611562729

Germ O 1 0.9911993145942688
- O 0 0.09101080894470215
line O 0 0.02978324703872204
and O 0 0.016512025147676468
somatic O 0 0.35133329033851624
truncating O 1 0.5983358025550842
mutations O 0 0.15021218359470367
of O 0 0.010354241356253624
the O 0 0.011346695013344288
APC B-Disease 1 0.6377732753753662
gene O 0 0.05182917043566704
are O 0 0.009081586264073849
thought O 0 0.015685895457863808
to O 0 0.01187072042375803
initiate O 1 0.9631803035736084
colorectal B-Disease 1 0.999998927116394
tumor I-Disease 1 0.9999796152114868
formation O 1 0.9785837531089783
in O 0 0.4839459955692291
familial B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.48010367155075073
sporadic O 1 0.9971420168876648
colorectal O 1 0.9999955892562866
carcinogenesis O 1 0.9993733763694763
, O 0 0.024852726608514786
respectively O 0 0.034153472632169724
. O 0 0.02752007357776165

Recently O 0 0.043973516672849655
, O 0 0.0197567380964756
an O 0 0.015281192027032375
isoleucine O 1 0.5048037171363831
- O 1 0.6837711334228516
- O 1 0.6473821997642517
> O 1 0.6509854793548584
lysine O 0 0.16400443017482758
polymorphism O 0 0.09469716250896454
at O 0 0.02965926006436348
codon O 0 0.0946454107761383
1307 O 1 0.5366331338882446
( O 0 0.027203533798456192
I1307K O 0 0.05247562378644943
) O 0 0.010290481150150299
of O 0 0.005544167011976242
the O 0 0.007318858988583088
APC B-Disease 0 0.2940335273742676
gene O 0 0.030198223888874054
has O 0 0.006818805355578661
been O 0 0.0050420379266142845
identified O 0 0.007288704626262188
in O 0 0.004017762374132872
6 O 0 0.007332528941333294
% O 0 0.007146908901631832
- O 0 0.01412396039813757
7 O 0 0.008184998296201229
% O 0 0.00749079417437315
of O 0 0.004973261617124081
the O 0 0.008959081955254078
Ashkenazi O 0 0.055160749703645706
Jewish O 0 0.026763850823044777
population O 0 0.029901400208473206
. O 0 0.02547990344464779

To O 0 0.023531179875135422
assess O 0 0.0379350371658802
the O 0 0.011628733947873116
risk O 0 0.03153016418218613
of O 0 0.008022760041058064
this O 0 0.008519957773387432
common O 0 0.02342996932566166
APC B-Disease 1 0.9842010140419006
allelic O 1 0.9917696714401245
variant O 1 0.9637425541877747
in O 0 0.025499451905488968
colorectal O 1 0.9999939203262329
carcinogenesis O 1 0.9984410405158997
, O 0 0.01097236666828394
we O 0 0.005995991639792919
have O 0 0.0051395283080637455
analyzed O 0 0.01272276695817709
a O 0 0.006451732944697142
large O 0 0.009531069546937943
cohort O 0 0.040451981127262115
of O 0 0.00904899276793003
unselected O 0 0.09721248596906662
Ashkenazi O 0 0.13948094844818115
Jewish O 0 0.02930368296802044
subjects O 0 0.027661669999361038
with O 0 0.02614808827638626
adenomatous B-Disease 1 0.9999924898147583
polyps I-Disease 1 0.9999244213104248
and O 0 0.016325119882822037
. O 0 0.018961908295750618
or O 1 0.8373448848724365
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999912977218628
, I-Disease 0 0.011334221810102463
for O 0 0.007774192374199629
the O 0 0.012283377349376678
APC O 1 0.7942091226577759
I1307K O 0 0.49236825108528137
polymorphism O 0 0.13317181169986725
. O 0 0.03472718596458435

The O 0 0.047771647572517395
APC O 0 0.30346643924713135
I1307K O 0 0.13154849410057068
allele O 0 0.0859839990735054
was O 0 0.012442638166248798
identified O 0 0.014241524040699005
in O 0 0.0075768898241221905
48 O 0 0.01228394452482462
( O 0 0.008449333719909191
10 O 0 0.0058635203167796135
. O 0 0.004319726023823023
1 O 0 0.007213635835796595
% O 0 0.009816879406571388
) O 0 0.00916072353720665
of O 0 0.00880005955696106
476 O 1 0.8141652345657349
patients O 1 0.9962305426597595
. O 0 0.027766717597842216

Compared O 0 0.02506125159561634
with O 0 0.00913464929908514
the O 0 0.006447335705161095
frequency O 0 0.013777955435216427
in O 0 0.0040618423372507095
two O 0 0.003924318589270115
separate O 0 0.006548930425196886
population O 0 0.009505284950137138
control O 0 0.011693940497934818
groups O 0 0.00915811862796545
, O 0 0.0058767604641616344
the O 0 0.00708878505975008
APC O 1 0.6142752766609192
I1307K O 0 0.2918536067008972
allele O 0 0.06685565412044525
is O 0 0.008231854066252708
associated O 0 0.009429534897208214
with O 0 0.00527018029242754
an O 0 0.006116615142673254
estimated O 0 0.014443670399487019
relative O 0 0.020743535831570625
risk O 0 0.04518701881170273
of O 0 0.01006622426211834
1 O 0 0.021854311227798462
. O 0 0.021634366363286972

5 O 0 0.05636762082576752
- O 0 0.08094185590744019
1 O 0 0.045126501470804214
. O 0 0.03768999129533768

7 O 0 0.06859419494867325
for O 0 0.03660873696208
colorectal B-Disease 1 0.9999794960021973
neoplasia I-Disease 1 0.9995635151863098
( O 0 0.03457457944750786
both O 0 0.021059226244688034
P O 0 0.23098430037498474
= O 0 0.07880308479070663
. O 0 0.01796262338757515
01 O 0 0.3126460015773773
) O 0 0.03076634183526039
. O 0 0.02700880728662014

Furthermore O 0 0.054470907896757126
, O 0 0.017877181991934776
compared O 0 0.02166648767888546
with O 0 0.01502184383571148
noncarriers O 0 0.21597254276275635
, O 0 0.017824912443757057
APC O 1 0.7756480574607849
I1307K O 0 0.3417696952819824
carriers O 0 0.043928034603595734
had O 0 0.010914567857980728
increased O 0 0.015722021460533142
numbers O 0 0.012840806506574154
of O 0 0.011253567412495613
adenomas B-Disease 1 0.9999123811721802
and O 0 0.10017097741365433
colorectal B-Disease 1 0.999998927116394
cancers I-Disease 1 0.9999794960021973
per O 0 0.03098325990140438
patient O 1 0.9954362511634827
( O 0 0.027547676116228104
P O 1 0.5108081102371216
= O 0 0.04782359302043915
. O 0 0.008048176765441895
03 O 0 0.04981173574924469
) O 0 0.006957430392503738
, O 0 0.0037243333645164967
as O 0 0.002732811728492379
well O 0 0.003428257768973708
as O 0 0.003457717364653945
a O 0 0.006361659616231918
younger O 0 0.016239358112215996
age O 0 0.015302516520023346
at O 0 0.016665978357195854
diagnosis O 1 0.9958314299583435
. O 0 0.023443074896931648

We O 0 0.02467970922589302
conclude O 0 0.03429095819592476
that O 0 0.009802632965147495
the O 0 0.012484683655202389
APC O 1 0.5052242279052734
I1307K O 0 0.3666306138038635
variant O 0 0.1591591089963913
leads O 0 0.035256724804639816
to O 0 0.01293142233043909
increased O 0 0.030612705275416374
adenoma B-Disease 1 0.9998902082443237
formation O 0 0.033163636922836304
and O 0 0.008786547929048538
directly O 0 0.012328270822763443
contributes O 0 0.021591337397694588
to O 0 0.005990535020828247
3 O 0 0.009376457892358303
% O 0 0.00896998681128025
- O 0 0.016236692667007446
4 O 0 0.009227653965353966
% O 0 0.008581370115280151
of O 0 0.005182367283850908
all O 0 0.00969000905752182
Ashkenazi O 1 0.9717773199081421
Jewish O 1 0.8454412817955017
colorectal B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999861717224121
. O 0 0.05702297016978264

The O 0 0.02235874906182289
estimated O 0 0.031916528940200806
relative O 0 0.03214989975094795
risk O 0 0.17791098356246948
for O 0 0.010419557802379131
carriers O 0 0.0937996506690979
may O 0 0.015011051669716835
justify O 0 0.021494517102837563
specific O 0 0.012468726374208927
clinical O 0 0.3395092785358429
screening O 0 0.02012835256755352
for O 0 0.003913102205842733
the O 0 0.003888735780492425
360 O 0 0.011217576451599598
, O 0 0.004379213321954012
000 O 0 0.013009820133447647
Americans O 0 0.010187312960624695
expected O 0 0.0054934327490627766
to O 0 0.004844839684665203
harbor O 0 0.013099479489028454
this O 0 0.004727590829133987
allele O 0 0.03552992641925812
, O 0 0.006107320077717304
and O 0 0.005418851971626282
genetic O 0 0.018754584714770317
testing O 0 0.010796476155519485
in O 0 0.003584220539778471
the O 0 0.0035231790971010923
setting O 0 0.006788729690015316
of O 0 0.004034650046378374
long O 0 0.01274316105991602
- O 0 0.05635115131735802
term O 0 0.017877867445349693
- O 0 0.06754333525896072
outcome O 0 0.02127731591463089
studies O 0 0.018838951364159584
may O 0 0.014220427721738815
impact O 0 0.024608198553323746
significantly O 0 0.09026183933019638
on O 0 0.02378089912235737
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
prevention O 1 0.9991029500961304
in O 0 0.010640296153724194
this O 0 0.009103872813284397
population O 0 0.022418739274144173
. O 0 0.020717032253742218

Localization O 0 0.07207570970058441
of O 0 0.014321412891149521
human O 0 0.02320966124534607
BRCA1 O 1 0.9058903455734253
and O 0 0.007660881616175175
its O 0 0.006706763058900833
loss O 0 0.014910158701241016
in O 0 0.005816098302602768
high O 0 0.012049839831888676
- O 0 0.03132527321577072
grade O 0 0.023318346589803696
, O 0 0.010501282289624214
non B-Disease 0 0.037662044167518616
- I-Disease 1 0.986055850982666
inherited I-Disease 1 0.9994164705276489
breast I-Disease 1 0.9999865293502808
carcinomas I-Disease 1 0.9998676776885986
. O 0 0.05191577598452568

Although O 0 0.021675435826182365
the O 0 0.012965465895831585
link O 0 0.030890678986907005
between O 0 0.016480667516589165
the O 0 0.02039623260498047
BRCA1 O 1 0.999872088432312
tumour B-Disease 1 0.9999905824661255
- O 1 0.9986758828163147
suppressor O 1 0.9992901086807251
gene O 1 0.9551095962524414
and O 0 0.03096865303814411
hereditary B-Disease 1 0.9998805522918701
breast I-Disease 1 0.9999982118606567
and I-Disease 1 0.9523109197616577
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999897480010986
is O 0 0.009476828388869762
established O 0 0.007456602528691292
, O 0 0.004067668225616217
the O 0 0.0035042092204093933
role O 0 0.005937887821346521
, O 0 0.0035677803680300713
if O 0 0.0036996202543377876
any O 0 0.00357809173874557
, O 0 0.003795573255047202
of O 0 0.0049996646121144295
BRCA1 O 1 0.9866518974304199
in O 0 0.009284217841923237
non B-Disease 0 0.07008446753025055
- I-Disease 1 0.9925950169563293
familial I-Disease 1 0.9998979568481445
cancers I-Disease 1 0.9999241828918457
is O 0 0.020122600719332695
unclear O 0 0.030879750847816467
. O 0 0.0258648619055748

BRCA1 O 1 0.9988441467285156
mutations O 1 0.9794012308120728
are O 0 0.01713360659778118
rare O 0 0.030929891392588615
in O 0 0.01363410335034132
sporadic B-Disease 0 0.40824878215789795
cancers I-Disease 1 0.9996908903121948
, O 0 0.009779618121683598
but O 0 0.008383014239370823
loss O 0 0.019848568364977837
of O 0 0.008505163714289665
BRCA1 O 1 0.9967977404594421
resulting O 0 0.032122209668159485
from O 0 0.01156242098659277
reduced O 0 0.018267057836055756
expression O 0 0.020175259560346603
or O 0 0.010905789211392403
incorrect O 0 0.023076636716723442
subcellular O 0 0.034353289753198624
localization O 0 0.0298647228628397
is O 0 0.007608478888869286
postulated O 0 0.01898631639778614
to O 0 0.005681018810719252
be O 0 0.0036280627828091383
important O 0 0.00497235544025898
in O 0 0.006295191589742899
non B-Disease 0 0.05196663364768028
- I-Disease 1 0.9983824491500854
familial I-Disease 1 0.9999921321868896
breast I-Disease 1 0.9999988079071045
and I-Disease 1 0.935441792011261
ovarian I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999935626983643
. O 0 0.05875169485807419

Epigenetic O 1 0.8826147317886353
loss O 0 0.06254443526268005
, O 0 0.011053691618144512
however O 0 0.006938795559108257
, O 0 0.004849465098232031
has O 0 0.004060076083987951
not O 0 0.003051762469112873
received O 0 0.004917043261229992
general O 0 0.00540584372356534
acceptance O 0 0.011515572667121887
due O 0 0.007018866948783398
to O 0 0.004611329175531864
controversy O 0 0.013033101335167885
regarding O 0 0.009365338832139969
the O 0 0.007031892891973257
subcellular O 0 0.03493089973926544
localization O 0 0.029070373624563217
of O 0 0.009571967646479607
BRCA1 O 1 0.9797866344451904
proteins O 0 0.022242199629545212
, O 0 0.005547696258872747
reports O 0 0.005507074296474457
of O 0 0.003158574691042304
which O 0 0.003634969238191843
have O 0 0.004430272616446018
ranged O 0 0.011436304077506065
from O 0 0.004958963952958584
exclusively O 0 0.007153953425586224
nuclear O 0 0.008791549131274223
, O 0 0.004023305606096983
to O 0 0.003731698961928487
conditionally O 0 0.01924753561615944
nuclear O 0 0.010197622701525688
, O 0 0.004085121676325798
to O 0 0.004965177271515131
the O 0 0.007954394444823265
ER O 1 0.9879575371742249
/ O 1 0.7119541168212891
golgi O 0 0.23171116411685944
, O 0 0.008457518182694912
to O 0 0.007326922379434109
cytoplasmic O 0 0.041833482682704926
invaginations O 0 0.04810818284749985
into O 0 0.01161917857825756
the O 0 0.012051035650074482
nucleus O 0 0.050167012959718704
. O 0 0.026595711708068848

In O 0 0.01471069548279047
an O 0 0.008440094068646431
attempt O 0 0.013434945605695248
to O 0 0.00613458501175046
resolve O 0 0.014775283634662628
this O 0 0.005172540433704853
issue O 0 0.00717118987813592
, O 0 0.004964906722307205
we O 0 0.005547164008021355
have O 0 0.007111933082342148
comprehensively O 0 0.030239278450608253
characterized O 0 0.052939523011446
19 O 0 0.02656140923500061
anti O 0 0.07323712110519409
- O 1 0.9357795715332031
BRCA1 O 1 0.9989938139915466
antibodies O 1 0.976392388343811
. O 0 0.04863060638308525

These O 0 0.034531570971012115
reagents O 0 0.08748549968004227
detect O 0 0.05894166976213455
a O 0 0.021608658134937286
220 O 0 0.042047858238220215
- O 0 0.08590009063482285
kD O 1 0.8183152675628662
protein O 0 0.05075406655669212
localized O 0 0.051034633070230484
in O 0 0.01200362853705883
discrete O 0 0.02772865630686283
nuclear O 0 0.022857828065752983
foci O 0 0.04784483462572098
in O 0 0.0077611529268324375
all O 0 0.00724733667448163
epithelial O 1 0.7529590129852295
cell O 0 0.033932819962501526
lines O 0 0.012942628003656864
, O 0 0.005745166912674904
including O 0 0.0055818199180066586
those O 0 0.007197739090770483
derived O 0 0.019674241542816162
from O 0 0.0193469300866127
breast B-Disease 1 0.9997833371162415
malignancies I-Disease 1 0.9979618787765503
. O 0 0.042649418115615845

Immunohistochemical O 1 0.9788151979446411
staining O 1 0.8574185967445374
of O 0 0.023180905729532242
human O 0 0.07155357301235199
breast O 1 0.9997873902320862
specimens O 0 0.032737720757722855
also O 0 0.013774360530078411
revealed O 0 0.03137466683983803
BRCA1 O 1 0.9985166192054749
nuclear O 0 0.04934198409318924
foci O 1 0.9755717515945435
in O 0 0.022828852757811546
benign O 1 0.999923586845398
breast O 1 0.9999891519546509
, O 0 0.23057575523853302
invasive B-Disease 1 0.9999281167984009
lobular I-Disease 1 0.9999971389770508
cancers I-Disease 1 0.9999794960021973
and O 0 0.02096533589065075
low B-Disease 0 0.22101658582687378
- I-Disease 1 0.9409752488136292
grade I-Disease 1 0.685754656791687
ductal I-Disease 1 0.9998774528503418
carcinomas I-Disease 1 0.9997392296791077
. O 0 0.06083325669169426

Conversely O 0 0.14455093443393707
, O 0 0.02788938209414482
BRCA1 O 1 0.9628216624259949
expression O 0 0.03210150822997093
was O 0 0.010600713081657887
reduced O 0 0.01686745136976242
or O 0 0.010322997346520424
undetectable O 0 0.0638708546757698
in O 0 0.0054107727482914925
the O 0 0.0049578957259655
majority O 0 0.008613267913460732
of O 0 0.00514894537627697
high O 0 0.011730109341442585
- O 0 0.10693137347698212
grade O 0 0.03407256305217743
, O 0 0.016055839136242867
ductal B-Disease 1 0.9999747276306152
carcinomas I-Disease 1 0.9999488592147827
, O 0 0.011572704650461674
suggesting O 0 0.017154553905129433
that O 0 0.006379222963005304
absence O 0 0.013327506370842457
of O 0 0.007357970345765352
BRCA1 O 1 0.9968771934509277
may O 0 0.013879811391234398
contribute O 0 0.014316425658762455
to O 0 0.005125284660607576
the O 0 0.006125417072325945
pathogenesis O 0 0.37763750553131104
of O 0 0.0060046943835914135
a O 0 0.008083944208920002
significant O 0 0.01164179015904665
percentage O 0 0.018272260203957558
of O 0 0.012171088717877865
sporadic B-Disease 1 0.8725775480270386
breast I-Disease 1 0.9999803304672241
cancers I-Disease 1 0.999934196472168
. O 0 0.0264385137706995
. O 0 0.032143086194992065

